data_2rst_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2rst _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.413 ' CD1' ' N ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.461 0.11 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.785 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -155.24 171.28 20.08 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.613 179.815 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.447 ' O ' ' HA ' ' A' ' 129' ' ' ILE . 2.0 m-85 -109.2 123.41 49.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.23 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.434 ' CD1' ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -108.23 103.72 15.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.842 0.353 . . . . 0.0 110.275 179.674 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.579 ' HB2' ' O ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -127.98 126.84 42.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.763 -179.036 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.437 ' O ' ' HD2' ' A' ' 9' ' ' LYS . 0.9 OUTLIER -46.15 138.44 5.29 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.019 0.437 . . . . 0.0 111.575 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -81.13 -11.28 59.5 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.082 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 61.4 tp -92.9 -56.54 2.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.165 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -83.24 -21.09 33.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.83 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.18 4.08 77.7 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.284 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.579 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 1.1 mmmm -85.26 164.25 18.15 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.555 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 12.6 m -106.95 137.0 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-O 120.769 0.318 . . . . 0.0 110.722 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 21.0 mt -68.31 136.57 53.65 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -138.26 152.01 48.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.841 0.353 . . . . 0.0 111.111 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.46 HD13 ' CZ2' ' A' ' 46' ' ' TRP . 1.5 mt . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.872 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 N-CA-C 112.588 -0.205 . . . . 0.0 112.588 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.37 132.91 37.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.945 0.403 . . . . 0.0 111.114 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.87 155.65 30.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.311 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.445 HD13 HG21 ' A' ' 63' ' ' ILE . 47.8 pt -115.31 144.59 22.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.921 0.391 . . . . 0.0 111.676 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -156.09 -176.68 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.581 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.2 p -101.75 148.56 25.14 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.343 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 10.4 t-105 -159.1 173.84 15.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.709 0.29 . . . . 0.0 111.009 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -71.85 138.32 48.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.815 0.341 . . . . 0.0 110.86 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.176 -179.852 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.442 ' O ' HD12 ' A' ' 45' ' ' LEU . . . . . . . . 0 N--CA 1.457 -0.116 0 CA-C-O 120.758 0.314 . . . . 0.0 110.885 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.583 ' HA ' HD12 ' A' ' 45' ' ' LEU . 99.6 t -49.73 -28.07 3.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.191 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -67.07 -9.0 34.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.804 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -119.6 6.14 11.05 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.153 0.501 . . . . 0.0 109.821 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.785 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 1.2 mp -116.07 138.86 50.86 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.583 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.46 ' CZ2' HD13 ' A' ' 19' ' ' ILE . 21.1 m95 -132.54 167.92 19.15 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.035 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.499 ' CE1' ' HB2' ' A' ' 55' ' ' ARG . 41.2 p90 -140.44 163.93 31.48 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.146 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -105.1 132.6 51.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.849 0.357 . . . . 0.0 111.345 -178.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -77.65 165.85 23.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.154 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -62.71 -24.16 67.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.14 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -90.3 -4.1 57.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.328 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.11 13.37 46.08 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.858 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.6 t -103.97 123.02 57.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.712 0.291 . . . . 0.0 110.533 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.48 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -75.71 149.23 6.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.369 0.604 . . . . 0.0 111.941 -179.828 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.499 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 7.5 mmm-85 -149.36 133.5 17.26 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.235 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 8.2 m . . . . . 0 C--N 1.326 -0.444 0 CA-C-O 121.468 0.651 . . . . 0.0 111.862 -178.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.846 0.355 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.0 153.2 29.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.265 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.465 ' O ' ' CD1' ' A' ' 84' ' ' TRP . 0.2 OUTLIER -78.54 153.65 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.475 179.742 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.546 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 6.9 p-10 -133.63 132.94 41.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.203 0.525 . . . . 0.0 111.554 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -97.28 43.63 1.06 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.27 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.7 m -74.54 -45.56 44.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.084 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -94.66 171.9 8.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.834 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -50.87 -41.94 58.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.086 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.77 144.3 31.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.967 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.636 ' CG1' ' HA ' ' A' ' 115' ' ' CYS . 2.8 mm -72.47 135.95 26.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-O 121.642 0.734 . . . . 0.0 111.516 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -135.99 163.25 30.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.724 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.428 ' CG2' HG23 ' A' ' 19' ' ' ILE . 31.7 p -105.73 140.03 39.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.965 0.412 . . . . 0.0 111.195 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.46 ' CB ' ' HD2' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -162.41 169.09 9.7 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.29 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.46 ' HD2' ' CB ' ' A' ' 73' ' ' GLN . 19.4 Cg_endo -60.54 139.31 85.47 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.307 2.005 . . . . 0.0 111.913 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -57.0 138.21 54.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.088 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -129.98 119.15 18.77 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.685 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -56.53 -34.64 95.57 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.538 2.159 . . . . 0.0 112.907 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -86.54 -1.39 57.59 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -108.92 102.42 48.38 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.656 0.265 . . . . 0.0 110.957 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.429 ' O ' ' CD2' ' A' ' 94' ' ' LEU . 88.0 Cg_endo -76.78 24.57 0.47 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.725 2.283 . . . . 0.0 113.276 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.546 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 37.7 mmtt -120.03 -18.43 8.14 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 120.519 0.2 . . . . 0.0 111.195 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 2.0 mtt180 -89.14 20.06 3.91 Favored 'General case' 0 C--N 1.341 0.219 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.699 ' O ' HD22 ' A' ' 94' ' ' LEU . . . -129.3 99.62 5.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.093 0.473 . . . . 0.0 110.691 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.465 ' CD1' ' O ' ' A' ' 63' ' ' ILE . 60.5 m95 -108.99 134.92 51.0 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.123 0.487 . . . . 0.0 112.057 -178.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.4 pt -112.82 153.76 14.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.296 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.2 t -101.76 127.0 55.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.898 0.38 . . . . 0.0 111.087 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 25.2 t -119.49 95.21 4.69 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.632 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.47 -100.03 0.7 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.677 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.501 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.32 29.67 7.36 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.575 0.226 . . . . 0.0 110.962 -179.449 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.6 149.98 30.58 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.315 0.579 . . . . 0.0 112.474 -178.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.426 ' O ' ' HA ' ' A' ' 100' ' ' VAL . 12.6 mm -94.28 122.09 45.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.458 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.419 ' CB ' ' CG1' ' A' ' 100' ' ' VAL . . . -122.29 142.32 50.6 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.419 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -64.74 148.09 51.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.469 179.648 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.699 HD22 ' O ' ' A' ' 83' ' ' ALA . 2.7 pt? -62.43 -56.79 14.84 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.918 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.549 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 7.0 p -75.99 -4.0 38.78 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -178.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -141.16 89.82 2.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.866 0.365 . . . . 0.0 111.241 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -67.6 -16.4 64.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.259 178.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -92.5 10.03 31.93 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.476 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.486 ' O ' HG13 ' A' ' 100' ' ' VAL . 11.6 mm -123.51 128.24 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.477 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.486 HG13 ' O ' ' A' ' 99' ' ' ILE . 30.5 m -146.48 135.84 16.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.771 0.32 . . . . 0.0 111.667 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.467 ' HA ' ' O ' ' A' ' 115' ' ' CYS . 8.6 mt -47.09 154.4 0.36 Allowed 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.639 0.733 . . . . 0.0 111.475 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -155.85 166.89 32.15 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.875 -177.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.423 ' HA ' HG23 ' A' ' 114' ' ' ILE . 35.0 mm -89.73 120.54 38.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.426 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -64.84 138.89 22.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.038 0.447 . . . . 0.0 111.512 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 10.1 mmtp 76.01 -4.02 2.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.031 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 17.1 m 45.68 30.04 0.75 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.823 0.344 . . . . 0.0 111.285 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -100.41 165.09 11.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.215 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.54 -15.55 51.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.058 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -47.28 128.81 12.34 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.203 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -80.95 161.46 24.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.115 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 72.05 17.93 77.48 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.178 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.85 138.23 33.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.888 0.375 . . . . 0.0 110.967 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 28.9 m170 -62.87 171.07 2.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.787 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.479 ' O ' HG12 ' A' ' 70' ' ' ILE . 0.7 OUTLIER -142.67 161.76 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.688 -179.657 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.636 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 28.4 p -155.71 171.4 20.06 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.448 ' HB1' ' CG2' ' A' ' 99' ' ' ILE . . . -95.83 126.84 41.36 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.459 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 76.1 t-105 -134.98 162.61 31.94 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.567 0.699 . . . . 0.0 112.123 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.459 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.0 OUTLIER -60.72 120.92 11.01 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.607 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -52.09 123.8 11.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.886 0.374 . . . . 0.0 111.277 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.413 ' CE1' ' HA3' ' A' ' 122' ' ' GLY . 6.6 p80 -128.84 3.3 5.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.361 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.62 8.48 81.31 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.836 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.413 ' HA3' ' CE1' ' A' ' 120' ' ' HIS . . . -63.67 142.0 46.21 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.55 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.81 -31.2 71.36 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.528 2.152 . . . . 0.0 112.295 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -69.42 -11.95 61.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.319 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -101.68 13.5 34.73 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.703 0.287 . . . . 0.0 111.138 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.6 mmmm -100.34 126.27 46.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.351 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.417 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 32.6 m-85 -129.13 154.98 46.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.333 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.0 mt -116.21 141.57 33.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.295 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.447 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 26.1 mm -113.33 141.16 30.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.288 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -141.59 95.3 2.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.753 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 47.5 m -54.77 108.12 0.36 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.289 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.383 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.417 ' HA ' ' O ' ' A' ' 46' ' ' TRP . 71.7 m-85 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.647 0.261 . . . . 0.0 110.691 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.615 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -153.75 171.6 18.62 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 120.978 0.418 . . . . 0.0 111.178 179.118 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.431 ' CE2' HD13 ' A' ' 45' ' ' LEU . 0.1 OUTLIER -111.66 123.6 50.58 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.213 179.044 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.434 ' CD1' ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -106.97 106.55 20.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.886 0.374 . . . . 0.0 110.095 179.802 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -106.78 137.73 44.27 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.648 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.38 109.42 10.08 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.444 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 6.0 tt0 -62.88 -10.91 15.08 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.521 -178.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 43.0 tp -84.24 -62.32 1.59 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.938 0.399 . . . . 0.0 111.037 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -86.25 -12.32 49.93 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.23 3.98 71.9 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.071 -1.061 . . . . 0.0 111.545 -178.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.443 ' O ' ' HG3' ' A' ' 9' ' ' LYS . 5.1 mmtm -91.85 175.91 6.71 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.9 m -118.47 143.83 28.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.725 0.298 . . . . 0.0 110.603 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.3 mt -69.25 136.29 51.75 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.004 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -144.96 144.24 30.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.795 0.331 . . . . 0.0 111.146 -179.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 4.3 mm . . . . . 0 C--N 1.327 -0.37 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 178.765 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.518 0 CA-C-O 120.185 -0.231 . . . . 0.0 113.192 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.3 t -73.34 128.85 36.66 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 117.243 0.521 . . . . 0.0 110.994 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.1 mmtp -80.38 158.12 26.11 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.282 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.499 HD12 HG23 ' A' ' 63' ' ' ILE . 43.3 pt -117.0 145.97 22.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.613 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.442 ' HA ' ' CD1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -153.65 178.61 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.182 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.943 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.3 p -101.87 149.4 24.24 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.567 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 26.0 t-105 -159.27 173.89 15.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.635 0.255 . . . . 0.0 110.869 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -69.46 133.02 47.22 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.798 0.332 . . . . 0.0 110.776 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.992 -179.854 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.501 ' O ' HD12 ' A' ' 45' ' ' LEU . . . . . . . . 0 C--O 1.23 0.07 0 N-CA-C 111.566 0.21 . . . . 0.0 111.566 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.465 ' HA ' ' CD1' ' A' ' 45' ' ' LEU . 1.6 t -59.26 -18.53 14.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.675 0.274 . . . . 0.0 110.821 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -63.8 -10.65 21.26 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.755 0.312 . . . . 0.0 110.894 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -111.12 7.95 21.55 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.615 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 1.1 mp -121.1 146.45 46.72 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 114.662 -1.153 . . . . 0.0 111.296 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.465 ' CH2' ' CG1' ' A' ' 63' ' ' ILE . 26.0 m95 -133.46 170.46 15.46 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.678 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.559 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 1.5 p90 -136.62 160.39 38.94 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.039 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 33.2 p -107.77 134.41 50.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.71 0.29 . . . . 0.0 111.285 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -77.67 170.47 16.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.281 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -63.22 -22.79 67.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.038 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -97.35 -2.93 41.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.148 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.6 5.52 53.88 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.976 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 23.6 t -88.08 116.59 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 CA-C-O 120.864 0.364 . . . . 0.0 110.778 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.559 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -78.5 150.27 5.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.242 0.544 . . . . 0.0 111.821 -179.86 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.531 ' HB2' ' CE2' ' A' ' 47' ' ' TYR . 10.0 mmm-85 -147.16 133.14 19.17 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.454 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.464 0 CA-C-O 121.162 0.505 . . . . 0.0 111.877 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.99 0.424 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -97.17 150.19 21.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.807 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.499 HG23 HD12 ' A' ' 30' ' ' ILE . 0.2 OUTLIER -78.07 150.23 5.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.283 179.903 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.57 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 15.7 p-10 -130.71 131.34 44.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.071 0.462 . . . . 0.0 111.583 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -96.83 42.77 1.08 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.175 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.8 -45.18 45.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.216 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -96.45 172.86 7.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.014 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -47.33 -49.41 24.28 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.923 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -98.96 146.96 25.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.929 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.579 ' CG1' ' HA ' ' A' ' 115' ' ' CYS . 2.6 mm -76.22 140.82 16.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-O 121.531 0.681 . . . . 0.0 111.441 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -133.05 166.54 22.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.618 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.468 ' C ' ' HG2' ' A' ' 73' ' ' GLN . 24.8 p -112.13 137.06 50.73 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.717 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.468 ' HG2' ' C ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -163.57 165.63 13.74 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.062 179.655 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -52.38 141.26 51.31 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.379 2.053 . . . . 0.0 111.935 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -60.5 132.55 54.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.388 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -123.49 132.13 24.29 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.411 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -68.79 -33.56 20.49 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.52 2.147 . . . . 0.0 113.283 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -87.14 1.04 54.28 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -105.57 103.69 44.53 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.56 0.219 . . . . 0.0 111.28 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.43 ' O ' ' CD2' ' A' ' 94' ' ' LEU . 6.1 Cg_exo -77.78 20.42 0.71 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.959 2.439 . . . . 0.0 112.828 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.57 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 11.3 mmtm -120.35 -17.89 8.09 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.993 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.486 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 39.2 mtt180 -89.08 19.59 4.13 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.305 -179.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.673 ' O ' HD22 ' A' ' 94' ' ' LEU . . . -130.03 99.1 4.96 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.053 0.454 . . . . 0.0 110.937 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.494 ' NE1' ' O ' ' A' ' 63' ' ' ILE . 54.3 m95 -108.58 134.9 50.7 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.14 0.495 . . . . 0.0 111.801 -178.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.4 pp -111.48 154.52 13.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.318 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.4 t -102.3 128.57 54.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.993 0.425 . . . . 0.0 111.139 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.6 t -121.33 94.23 4.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.398 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.16 -100.13 0.76 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.503 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.493 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.63 29.25 7.52 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.617 0.246 . . . . 0.0 110.974 -179.737 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.408 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.78 147.29 29.7 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.633 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.413 ' O ' ' HA ' ' A' ' 100' ' ' VAL . 20.0 mm -94.29 120.52 43.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.384 178.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.438 ' CB ' HG13 ' A' ' 100' ' ' VAL . . . -121.91 145.07 48.45 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -178.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.441 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -65.4 149.09 50.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.493 179.568 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.673 HD22 ' O ' ' A' ' 83' ' ' ALA . 2.6 pt? -62.91 -57.35 11.09 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.819 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.53 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -76.22 -3.89 38.86 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -178.559 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -139.84 88.6 2.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.783 0.325 . . . . 0.0 110.926 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.48 -16.34 62.9 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.181 179.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.86 11.76 19.31 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.216 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.49 ' O ' HG12 ' A' ' 100' ' ' VAL . 6.9 tt -131.53 137.78 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.49 HG12 ' O ' ' A' ' 99' ' ' ILE . 18.6 m -148.66 138.5 16.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.819 0.343 . . . . 0.0 111.789 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.508 ' HA ' ' O ' ' A' ' 115' ' ' CYS . 10.8 mt -45.96 153.24 0.31 Allowed 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 121.708 0.766 . . . . 0.0 111.791 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.409 ' OD2' ' HG2' ' A' ' 125' ' ' GLN . 10.9 t70 -156.64 166.94 31.95 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.383 -1.28 . . . . 0.0 110.745 -177.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.3 mp -89.73 120.58 38.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.33 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.7 tp -64.66 139.05 22.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.999 0.428 . . . . 0.0 111.494 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 71.46 -2.13 2.54 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.165 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.4 m 41.91 32.23 0.27 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.803 0.335 . . . . 0.0 111.52 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -96.39 156.83 16.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.18 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.27 -13.92 59.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.097 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -52.0 124.51 12.98 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.157 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.4 159.76 33.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.086 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.86 14.0 81.96 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.288 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.46 132.33 39.56 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.853 0.359 . . . . 0.0 110.993 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -65.02 171.15 3.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.964 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.494 ' O ' HG12 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -135.92 161.67 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.514 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.579 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 13.6 p -153.98 169.03 24.46 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -95.34 126.13 40.43 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.521 -0.471 . . . . 0.0 109.747 178.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.461 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 76.0 t-105 -133.92 162.47 31.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.566 0.698 . . . . 0.0 112.298 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.461 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 4.3 tmtm? -61.89 122.58 15.8 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.752 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -60.54 125.52 24.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.346 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -134.68 9.0 3.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.631 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 80.82 7.45 88.56 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.486 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.54 152.93 44.34 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.505 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.71 -26.12 53.45 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.654 2.236 . . . . 0.0 112.324 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -75.39 -3.5 34.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.485 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.409 ' HG2' ' OD2' ' A' ' 102' ' ' ASP . 0.5 OUTLIER -108.95 14.41 24.13 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.194 -179.815 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 1.3 mmtp -105.53 133.22 50.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.768 0.318 . . . . 0.0 111.321 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.406 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 5.9 m-85 -136.41 155.77 49.56 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.544 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.4 mt -113.72 138.86 42.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.187 0.518 . . . . 0.0 110.409 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.429 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 36.4 mm -113.41 140.41 33.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.589 -179.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -139.16 111.48 7.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.509 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.35 110.63 2.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.118 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.957 -179.993 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.434 ' HA ' ' O ' ' A' ' 46' ' ' TRP . 1.3 p90 . . . . . 0 C--O 1.23 0.068 0 N-CA-C 110.31 -0.256 . . . . 0.0 110.31 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.751 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -158.84 175.57 13.42 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.795 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.425 ' CE1' ' HB3' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -114.74 123.81 50.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.24 179.196 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.456 HD13 HG23 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -104.56 109.88 28.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.926 0.393 . . . . 0.0 110.374 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.64 135.87 45.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.32 -178.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -75.55 107.21 7.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.516 178.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.404 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 1.8 tt0 -63.82 -11.03 23.59 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.661 -178.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.402 ' HB2' ' HA ' ' A' ' 124' ' ' ASN . 37.7 tp -84.68 -62.77 1.47 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.898 0.38 . . . . 0.0 110.988 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -84.23 -11.48 56.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.333 -178.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.81 3.53 73.93 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.136 -1.03 . . . . 0.0 111.416 -178.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -91.28 -172.8 3.41 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.5 m -124.48 140.83 46.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.708 0.29 . . . . 0.0 110.469 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.4 mt -69.8 134.78 48.92 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.016 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -142.99 158.58 43.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.968 0.413 . . . . 0.0 111.239 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.406 ' CD1' HG23 ' A' ' 72' ' ' THR . 19.2 mt . . . . . 0 C--N 1.326 -0.416 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.419 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 CA-C-O 120.272 -0.182 . . . . 0.0 113.347 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.6 m -75.81 129.94 37.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.157 0.479 . . . . 0.0 111.258 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.2 mmtp -82.4 160.81 22.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.437 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.436 HD11 HG21 ' A' ' 63' ' ' ILE . 41.1 pt -119.4 147.09 23.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.78 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.44 ' HA ' ' CD1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -155.17 179.39 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.208 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.511 -179.777 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.6 p -101.77 149.07 24.55 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.622 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 24.3 t-105 -156.99 171.85 19.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.857 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -70.12 135.79 49.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.76 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.145 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.479 ' O ' HD11 ' A' ' 45' ' ' LEU . . . . . . . . 0 N--CA 1.457 -0.081 0 CA-C-O 120.678 0.275 . . . . 0.0 111.189 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.572 ' HA ' HD11 ' A' ' 45' ' ' LEU . 47.7 t -49.38 -27.73 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.085 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -64.97 -9.59 22.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.791 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.425 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 6.0 mt-30 -120.45 7.42 10.64 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.099 0.476 . . . . 0.0 109.766 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.751 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 1.3 mp -116.95 139.88 50.13 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.781 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.456 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 24.7 m95 -133.95 168.82 18.09 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.127 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.543 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 30.1 p90 -140.71 165.0 28.69 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.112 178.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.0 p -107.76 134.0 51.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.813 0.34 . . . . 0.0 111.429 -178.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -77.8 169.89 17.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.192 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -63.49 -24.15 67.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.143 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -93.95 -2.82 52.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.136 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.49 8.49 54.66 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.84 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 40.4 t -93.98 119.43 41.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.89 0.345 . . . . 0.0 110.552 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.543 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -77.26 147.92 7.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.299 0.571 . . . . 0.0 111.763 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.496 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 9.0 mmm-85 -149.85 133.74 16.95 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.474 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 37.9 m . . . . . 0 C--N 1.326 -0.448 0 CA-C-O 121.476 0.655 . . . . 0.0 111.863 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.893 0.378 . . . . 0.0 110.825 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -110.55 155.85 21.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.492 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.493 ' O ' ' NE1' ' A' ' 84' ' ' TRP . 0.2 OUTLIER -82.89 151.76 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.636 179.6 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.583 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 10.0 p-10 -132.44 130.31 40.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.106 0.479 . . . . 0.0 111.429 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -94.3 39.62 1.08 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.467 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.3 m -74.34 -45.89 44.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.141 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 15.3 m170 -91.13 167.91 12.01 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.943 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -46.74 -47.19 20.71 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.928 0.394 . . . . 0.0 110.833 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.34 146.18 27.92 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.701 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.591 ' CG1' ' HA ' ' A' ' 115' ' ' CYS . 2.7 mm -73.51 136.45 25.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 CA-C-O 121.738 0.78 . . . . 0.0 111.595 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -132.34 163.82 27.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.094 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.449 ' C ' ' HG2' ' A' ' 73' ' ' GLN . 41.6 p -109.33 136.71 48.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.591 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.449 ' HG2' ' C ' ' A' ' 72' ' ' THR . 0.5 OUTLIER -163.1 167.32 11.9 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.452 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.406 ' O ' ' HD3' ' A' ' 82' ' ' ARG . 50.4 Cg_exo -53.46 137.0 65.04 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.432 2.088 . . . . 0.0 111.759 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -65.47 141.6 58.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.964 0.411 . . . . 0.0 111.412 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.12 139.62 35.51 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.59 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.02 -30.53 20.91 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.511 2.141 . . . . 0.0 112.864 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -89.57 0.05 57.18 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -106.19 102.57 40.81 Favored Pre-proline 0 CA--C 1.529 0.17 0 CA-C-O 120.568 0.223 . . . . 0.0 111.187 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.434 ' O ' ' CD2' ' A' ' 94' ' ' LEU . 5.8 Cg_exo -77.27 20.1 0.68 Allowed 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.94 2.427 . . . . 0.0 113.034 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.583 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 0.1 OUTLIER -117.85 -20.42 8.83 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 120.634 0.254 . . . . 0.0 110.96 -179.859 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.48 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 6.8 mtm-85 -88.41 19.76 3.66 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.414 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.682 ' O ' HD22 ' A' ' 94' ' ' LEU . . . -128.58 99.2 5.28 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.089 0.471 . . . . 0.0 110.696 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.493 ' NE1' ' O ' ' A' ' 63' ' ' ILE . 62.7 m95 -108.85 134.63 51.28 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.216 0.531 . . . . 0.0 112.016 -178.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.6 pt -112.12 153.23 13.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.201 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.4 t -101.75 127.02 55.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.943 0.402 . . . . 0.0 110.98 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.9 t -119.82 95.06 4.61 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.566 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.87 -100.27 0.75 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.557 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.499 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.79 29.82 7.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.603 0.239 . . . . 0.0 110.864 -179.668 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.413 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -148.76 148.43 29.97 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 121.358 0.599 . . . . 0.0 112.595 -178.548 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 14.6 mm -93.93 120.93 44.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.393 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.448 ' CB ' HG11 ' A' ' 100' ' ' VAL . . . -123.71 144.06 49.89 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.83 152.34 36.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.476 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.682 HD22 ' O ' ' A' ' 83' ' ' ALA . 2.7 pt? -65.73 -56.9 9.59 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.402 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.545 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 1.2 m -79.34 -1.93 39.16 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -138.07 85.03 2.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.891 0.377 . . . . 0.0 110.998 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.45 -17.79 64.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.221 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -92.7 10.28 31.35 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.466 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.51 ' O ' HG11 ' A' ' 100' ' ' VAL . 11.9 mm -123.07 128.66 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.501 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.51 HG11 ' O ' ' A' ' 99' ' ' ILE . 28.5 m -146.39 135.17 16.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.463 ' HG ' ' CZ3' ' A' ' 84' ' ' TRP . 11.3 mt -45.62 154.21 0.22 Allowed 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.746 0.784 . . . . 0.0 111.861 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -159.55 169.39 23.93 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.65 -177.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 17.6 mm -88.07 121.11 38.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.168 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.403 ' O ' ' CB ' ' A' ' 105' ' ' LYS . 52.7 mt -70.42 136.83 25.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.841 0.353 . . . . 0.0 111.215 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.403 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 0.2 OUTLIER 80.88 -9.03 1.38 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.802 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 38.2 m 47.39 30.49 1.58 Allowed 'General case' 0 N--CA 1.461 0.108 0 CA-C-O 120.785 0.326 . . . . 0.0 111.289 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -98.55 154.05 18.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.015 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.25 -11.56 60.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.316 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -52.36 129.12 27.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.206 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.95 161.51 29.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.008 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 70.64 15.62 73.47 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.867 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.92 133.41 39.25 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.824 0.345 . . . . 0.0 110.793 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 14.8 m80 -64.0 170.43 3.56 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.019 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.504 ' O ' HG12 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -135.89 161.71 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.425 179.779 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.591 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 29.1 p -154.53 169.06 24.69 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.448 ' HB3' ' CG2' ' A' ' 99' ' ' ILE . . . -94.84 127.63 41.0 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.459 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 75.8 t-105 -135.9 162.75 31.95 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.608 0.718 . . . . 0.0 112.212 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.459 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 12.2 tptt -61.95 117.14 5.54 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.625 -1.171 . . . . 0.0 110.875 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.56 127.59 32.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.772 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -139.08 12.02 2.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.27 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 75.86 60.46 3.15 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.266 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -116.15 144.26 18.36 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.557 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.78 -33.89 72.57 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.5 2.134 . . . . 0.0 112.226 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.402 ' HA ' ' HB2' ' A' ' 12' ' ' LEU . 12.9 p-10 -76.68 -2.22 31.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.508 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.413 ' O ' ' CG2' ' A' ' 90' ' ' THR . 0.0 OUTLIER -107.97 9.82 28.51 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.745 -0.207 . . . . 0.0 111.184 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.42 ' O ' ' CD1' ' A' ' 127' ' ' PHE . 9.8 mmtp -106.5 139.43 40.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.762 0.315 . . . . 0.0 111.439 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.42 ' CD1' ' O ' ' A' ' 126' ' ' LYS . 7.5 m-85 -138.61 156.34 47.54 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.244 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.4 mt -113.17 138.64 41.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.158 0.504 . . . . 0.0 110.65 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 25.2 mm -114.17 140.36 35.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.62 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.95 96.04 3.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.588 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.2 t -51.91 111.48 0.62 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.313 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.427 ' HB3' ' CE2' ' A' ' 5' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.898 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.491 ' HA ' ' O ' ' A' ' 46' ' ' TRP . 3.1 p90 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.649 0.261 . . . . 0.0 110.851 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.74 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -159.48 173.75 15.71 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.204 179.693 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.425 ' O ' ' HA ' ' A' ' 129' ' ' ILE . 0.2 OUTLIER -109.41 123.47 49.4 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.359 179.091 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.438 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -107.92 104.11 16.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.847 -179.709 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.582 ' HA ' ' HA ' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -127.22 125.44 41.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.471 -179.504 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.442 ' O ' ' HD2' ' A' ' 9' ' ' LYS . 28.7 t -46.24 139.7 4.52 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.04 0.447 . . . . 0.0 111.474 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.408 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 3.9 tt0 -82.64 -10.73 58.82 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.02 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 38.1 tp -90.25 -58.31 2.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.804 0.335 . . . . 0.0 111.034 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -84.1 -19.09 34.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.846 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.13 5.28 75.71 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.306 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.577 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 2.9 mmmm -85.74 165.49 16.88 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.582 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 15.4 m -107.2 136.43 42.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.823 0.344 . . . . 0.0 110.754 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.7 mt -69.99 137.91 51.8 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -140.05 149.95 43.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.836 0.35 . . . . 0.0 111.157 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.469 HD13 ' CZ2' ' A' ' 46' ' ' TRP . 1.1 mt . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.839 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.411 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.8 m -77.22 137.48 38.87 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.039 0.447 . . . . 0.0 111.171 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.3 mmtm -83.86 157.62 21.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.219 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.442 HD13 HG23 ' A' ' 63' ' ' ILE . 44.1 pt -115.95 145.68 21.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.889 0.376 . . . . 0.0 111.633 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.431 ' HA ' ' CD1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -155.4 -179.5 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.126 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.779 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.8 p -103.18 150.73 23.39 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.579 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 28.0 t-105 -155.47 170.59 21.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.657 0.265 . . . . 0.0 110.979 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -71.83 137.27 47.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.831 0.348 . . . . 0.0 110.763 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.008 -179.919 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.452 ' O ' ' CD1' ' A' ' 45' ' ' LEU . . . . . . . . 0 CA--C 1.527 0.091 0 CA-C-O 120.646 0.26 . . . . 0.0 111.308 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.585 ' HA ' HD11 ' A' ' 45' ' ' LEU . 65.8 t -51.26 -31.25 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.937 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -66.99 -10.62 51.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.696 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -116.09 7.41 14.23 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.74 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 0.9 OUTLIER -117.66 141.29 48.56 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.713 -179.083 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.491 ' O ' ' HA ' ' A' ' 5' ' ' PHE . 24.4 m95 -133.27 167.69 19.91 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.041 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.506 ' CE1' ' HB2' ' A' ' 55' ' ' ARG . 37.6 p90 -140.56 165.03 28.55 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.106 178.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 46.0 p -105.6 132.63 51.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.828 0.346 . . . . 0.0 111.336 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -77.79 165.84 23.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.117 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.13 -25.49 67.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.234 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -90.86 -4.05 56.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.469 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.96 11.87 48.28 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.845 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.9 t -100.7 121.44 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-O 120.744 0.307 . . . . 0.0 110.488 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.503 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -76.07 148.43 7.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.31 0.576 . . . . 0.0 111.889 -179.751 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.506 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 12.3 mmm-85 -149.23 133.74 17.61 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.408 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.488 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.455 0 CA-C-O 121.54 0.686 . . . . 0.0 111.893 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 . . . . . 0 C--O 1.233 0.22 0 CA-C-O 120.892 0.377 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -108.83 152.59 24.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.081 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.46 ' O ' ' CD1' ' A' ' 84' ' ' TRP . 0.2 OUTLIER -78.66 152.99 4.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.68 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.524 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 6.7 p-10 -134.2 133.42 40.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.277 0.56 . . . . 0.0 111.69 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -97.42 43.49 1.07 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.217 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.0 t -74.71 -43.98 52.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.087 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 65.8 m170 -97.2 172.47 7.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.925 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -48.32 -48.81 35.92 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.14 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -99.0 145.62 26.88 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.126 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.594 ' CG1' ' HA ' ' A' ' 115' ' ' CYS . 3.1 mm -73.93 138.54 20.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.552 0.692 . . . . 0.0 111.455 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -139.2 167.75 21.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.799 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 63' ' ' ILE . 57.0 p -106.77 139.41 41.24 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.052 0.453 . . . . 0.0 111.528 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.403 ' CB ' ' CD ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -159.46 175.07 3.44 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.993 179.643 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.403 ' CD ' ' CB ' ' A' ' 73' ' ' GLN . 17.3 Cg_exo -66.65 138.86 50.91 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.513 2.142 . . . . 0.0 111.583 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -62.29 128.82 37.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.814 0.34 . . . . 0.0 111.031 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -122.18 125.85 26.46 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.674 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -56.92 -35.4 98.55 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.457 2.105 . . . . 0.0 112.794 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 21.3 m-20 -86.35 -2.73 58.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.777 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -101.19 100.6 13.77 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-O 120.611 0.243 . . . . 0.0 110.786 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.551 ' O ' HD22 ' A' ' 94' ' ' LEU . 82.9 Cg_endo -76.66 21.16 0.58 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.638 2.225 . . . . 0.0 113.48 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 40.3 mmtt -120.94 -18.37 7.58 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 120.689 0.28 . . . . 0.0 111.134 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.471 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 40.3 mtt180 -88.09 21.42 2.76 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -178.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.587 ' O ' HD21 ' A' ' 94' ' ' LEU . . . -130.25 99.84 5.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.203 0.525 . . . . 0.0 111.051 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.47 ' CZ3' ' HG ' ' A' ' 101' ' ' LEU . 60.4 m95 -110.21 135.06 51.57 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.227 0.537 . . . . 0.0 111.914 -178.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.4 pt -113.86 154.24 15.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.125 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.9 t -102.14 127.99 55.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.912 0.387 . . . . 0.0 111.115 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 46.6 t -121.07 95.1 4.56 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.553 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.28 -100.66 0.81 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.554 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.504 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.94 29.86 7.16 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.587 0.232 . . . . 0.0 110.735 -179.76 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -149.16 148.36 29.54 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 121.358 0.599 . . . . 0.0 112.348 -178.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 14.3 mm -94.32 121.08 44.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.629 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.439 ' CB ' ' CG1' ' A' ' 100' ' ' VAL . . . -120.84 143.0 49.12 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -178.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.438 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -67.31 146.05 54.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.699 179.763 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.594 ' HG ' ' N ' ' A' ' 95' ' ' SER . 2.6 pt? -61.05 -56.13 24.55 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.664 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.594 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 7.9 m -73.72 -6.68 48.36 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -178.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -139.75 89.65 2.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.881 0.372 . . . . 0.0 111.071 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.26 -16.23 63.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.182 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.73 12.86 21.95 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.096 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.516 ' O ' HG11 ' A' ' 100' ' ' VAL . 6.8 tt -131.08 137.16 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.516 HG11 ' O ' ' A' ' 99' ' ' ILE . 15.9 m -148.9 138.46 15.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.855 0.359 . . . . 0.0 111.637 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.51 ' HA ' ' O ' ' A' ' 115' ' ' CYS . 10.5 mt -46.39 155.19 0.23 Allowed 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.593 0.711 . . . . 0.0 111.71 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -157.49 166.71 32.23 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.588 -177.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.0 mp -92.8 118.33 38.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.461 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.425 ' O ' ' CB ' ' A' ' 105' ' ' LYS . 8.5 tt -62.45 141.98 17.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.791 0.329 . . . . 0.0 111.164 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.425 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 10.5 tptt 82.43 -20.81 0.33 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.71 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.6 m 53.9 39.41 30.41 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.917 0.389 . . . . 0.0 111.013 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -113.36 167.01 10.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.029 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.75 -13.83 58.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.984 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -48.29 142.41 5.54 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.098 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -90.1 158.16 17.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.2 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 76.35 12.84 83.91 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.543 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.5 132.9 39.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.878 0.37 . . . . 0.0 111.01 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 12.9 m80 -65.52 173.33 2.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.029 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.535 ' O ' HG12 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -137.36 161.5 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.513 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.594 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 7.2 t -152.52 166.14 32.93 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.91 121.54 34.37 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.471 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 76.2 t-105 -128.73 162.19 27.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.67 0.747 . . . . 0.0 112.241 -179.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.471 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.8 OUTLIER -64.8 123.38 19.22 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.7 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -58.48 123.29 15.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.045 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -134.2 4.44 3.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.493 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 79.39 56.56 3.37 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.286 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -109.28 147.47 16.91 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.519 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.74 -29.3 59.63 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.57 2.18 . . . . 0.0 112.083 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -76.91 -4.35 43.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.234 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.421 ' NE2' ' CG2' ' A' ' 100' ' ' VAL . 3.2 mt-30 -102.73 -7.14 21.92 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.463 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.408 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 8.6 mmtm -83.73 132.66 34.83 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.772 0.32 . . . . 0.0 111.295 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -131.11 153.64 49.14 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.344 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.4 mt -113.68 137.48 46.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.163 0.506 . . . . 0.0 110.644 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.425 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 20.8 mm -114.26 142.05 28.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.593 -179.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -137.02 110.41 7.91 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.285 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 44.1 m -60.02 114.41 2.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.322 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.23 -0.89 . . . . 0.0 111.494 179.714 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.481 ' HA ' ' O ' ' A' ' 46' ' ' TRP . 1.5 p90 . . . . . 0 C--O 1.231 0.117 0 N-CA-C 110.501 -0.185 . . . . 0.0 110.501 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.745 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -160.38 176.45 11.66 Favored 'General case' 0 CA--C 1.512 -0.512 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.774 179.919 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.438 ' CE2' HD13 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -114.86 123.78 50.04 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.297 179.228 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.435 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -104.14 109.89 28.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.23 179.904 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.29 136.85 45.28 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.273 -178.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 48.7 m -75.95 107.82 8.41 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.418 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 5.2 tt0 -63.19 -11.15 18.72 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.47 -178.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 56.3 tp -84.66 -62.49 1.53 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.848 0.356 . . . . 0.0 110.973 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -84.97 -12.94 52.19 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.69 2.57 76.45 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.214 -0.993 . . . . 0.0 111.513 -178.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.41 -178.64 5.65 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.9 m -120.37 140.34 44.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.673 0.273 . . . . 0.0 110.527 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.6 mt -70.19 134.8 48.45 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -142.61 158.21 43.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.901 0.381 . . . . 0.0 111.204 -179.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.441 HD13 HG23 ' A' ' 19' ' ' ILE . 31.3 mt . . . . . 0 C--N 1.327 -0.398 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.458 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 CA-C-O 120.154 -0.248 . . . . 0.0 113.604 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.85 136.25 43.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 117.316 0.558 . . . . 0.0 111.0 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.2 159.78 18.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.694 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.406 HD11 ' HB ' ' A' ' 70' ' ' ILE . 46.4 pt -120.33 148.03 23.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.821 0.343 . . . . 0.0 111.637 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.407 HG21 ' HA ' ' A' ' 113' ' ' HIS . 0.3 OUTLIER -156.26 -178.39 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.243 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.425 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.6 p -100.87 148.55 24.84 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.585 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 28.0 t-105 -158.42 172.63 17.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.689 0.28 . . . . 0.0 110.91 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -70.86 135.76 48.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.765 0.317 . . . . 0.0 110.708 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.007 -179.968 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.507 ' O ' HD12 ' A' ' 45' ' ' LEU . . . . . . . . 0 CA--C 1.527 0.084 0 CA-C-O 120.617 0.246 . . . . 0.0 111.412 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.576 ' HA ' HD12 ' A' ' 45' ' ' LEU . 49.4 t -50.08 -27.39 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.055 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -64.57 -10.27 25.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.718 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.427 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 1.6 mt-30 -118.92 7.76 11.55 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.745 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 1.3 mp -117.65 140.7 49.3 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.8 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.481 ' O ' ' HA ' ' A' ' 5' ' ' PHE . 26.9 m95 -134.12 168.77 18.23 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.938 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.57 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 15.7 p90 -141.69 165.93 26.13 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.1 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 72.8 p -106.79 132.4 52.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.768 0.318 . . . . 0.0 111.313 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -77.63 165.62 24.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.09 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -58.69 -25.49 62.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.027 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -93.55 -3.52 52.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.324 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.34 6.8 55.1 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.874 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.3 t -90.43 117.65 34.13 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-O 120.771 0.319 . . . . 0.0 110.687 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.57 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.6 OUTLIER -75.99 144.08 12.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.076 0.465 . . . . 0.0 111.049 179.596 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.562 ' HG3' ' O ' ' A' ' 54' ' ' ILE . 0.4 OUTLIER -149.75 133.54 16.89 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.88 179.222 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 72.7 m . . . . . 0 C--N 1.327 -0.392 0 CA-C-O 121.582 0.706 . . . . 0.0 112.127 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.435 ' CE2' ' HD3' ' A' ' 74' ' ' PRO . 1.5 m-85 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.863 0.363 . . . . 0.0 110.874 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -101.68 148.3 25.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.201 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.5 ' O ' ' CD1' ' A' ' 84' ' ' TRP . 0.3 OUTLIER -77.99 152.45 5.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.684 179.786 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.619 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 6.6 p-10 -133.18 130.72 39.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.191 0.52 . . . . 0.0 111.682 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -95.07 42.05 1.09 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.418 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 60.4 p -74.62 -43.18 56.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.369 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 23.4 m80 -97.89 171.81 8.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.102 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -48.82 -44.01 38.88 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.916 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.06 144.49 31.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.641 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.64 ' CG1' ' HA ' ' A' ' 115' ' ' CYS . 1.7 mm -76.37 141.95 15.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.666 0.746 . . . . 0.0 111.8 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -139.26 166.59 24.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.863 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 63' ' ' ILE . 41.6 p -104.27 138.18 41.1 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.861 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.409 ' HG2' ' C ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -163.53 167.54 11.14 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.26 179.755 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.435 ' HD3' ' CE2' ' A' ' 61' ' ' PHE . 32.2 Cg_exo -57.88 137.33 80.46 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.415 2.077 . . . . 0.0 111.861 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -67.18 127.2 31.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.855 0.359 . . . . 0.0 110.886 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -117.48 139.55 26.3 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.48 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.4 -32.26 41.01 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.527 2.151 . . . . 0.0 112.905 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 32.3 m-20 -88.79 -1.59 58.16 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -107.11 101.12 36.4 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.571 0.224 . . . . 0.0 111.007 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.435 ' O ' ' CD2' ' A' ' 94' ' ' LEU . 5.6 Cg_exo -77.16 21.28 0.61 Allowed 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.869 2.379 . . . . 0.0 112.98 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.619 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -116.47 -21.92 8.98 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.94 -179.827 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.454 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 41.7 mtt180 -87.62 20.28 3.02 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.47 -179.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.716 ' O ' HD23 ' A' ' 94' ' ' LEU . . . -130.01 99.33 5.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.074 0.464 . . . . 0.0 110.854 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.5 ' CD1' ' O ' ' A' ' 63' ' ' ILE . 58.9 m95 -109.45 137.26 47.56 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.223 0.535 . . . . 0.0 111.89 -178.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.3 pt -115.1 153.63 16.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.237 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.9 t -100.21 125.39 53.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.905 0.383 . . . . 0.0 110.948 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 21.5 t -117.85 93.89 4.32 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.526 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.89 -100.57 0.78 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.601 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.499 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.55 29.36 7.48 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.568 0.223 . . . . 0.0 110.921 -179.549 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -148.76 148.55 30.11 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.314 0.578 . . . . 0.0 112.522 -178.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 17.6 mm -93.38 121.28 43.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.44 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.46 ' CB ' HG11 ' A' ' 100' ' ' VAL . . . -124.67 145.3 49.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.32 0.581 . . . . 0.0 112.557 -178.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.421 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -65.26 149.53 49.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.508 179.729 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.716 HD23 ' O ' ' A' ' 83' ' ' ALA . 2.7 pt? -62.2 -56.88 14.27 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.717 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.542 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 35.7 m -79.65 -1.61 38.99 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -138.5 85.9 2.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.875 0.369 . . . . 0.0 111.009 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.63 -18.32 65.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.072 178.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -91.51 8.73 35.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.445 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.495 ' O ' HG11 ' A' ' 100' ' ' VAL . 12.7 mm -121.15 126.29 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.494 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.495 HG11 ' O ' ' A' ' 99' ' ' ILE . 22.3 m -145.98 134.49 16.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.836 0.351 . . . . 0.0 111.892 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.505 ' HA ' ' O ' ' A' ' 115' ' ' CYS . 16.2 mt -46.26 154.09 0.29 Allowed 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 121.755 0.788 . . . . 0.0 111.964 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -156.85 167.41 30.56 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.293 -1.321 . . . . 0.0 110.752 -177.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.439 ' HA ' HG21 ' A' ' 114' ' ' ILE . 34.0 mm -89.0 126.08 42.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.566 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.2 tt -68.05 137.99 23.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.01 0.434 . . . . 0.0 111.558 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 29.7 mtpt 67.44 3.41 3.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.114 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 40.0 t 40.9 32.33 0.16 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.744 0.307 . . . . 0.0 111.454 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.1 p30 -96.08 157.41 15.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.181 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.93 -14.97 58.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.199 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -51.1 123.07 8.62 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.847 0.356 . . . . 0.0 111.107 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.18 161.15 31.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.172 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 73.29 16.64 78.7 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.181 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.85 135.58 35.95 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 120.875 0.369 . . . . 0.0 111.056 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.407 ' HA ' HG21 ' A' ' 31' ' ' ILE . 1.4 m80 -61.86 170.29 2.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.783 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.439 HG21 ' HA ' ' A' ' 103' ' ' ILE . 0.5 OUTLIER -143.22 161.8 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.872 -179.698 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.64 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 12.8 p -157.15 174.16 15.9 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.461 ' HB3' ' CG2' ' A' ' 99' ' ' ILE . . . -95.81 129.67 42.98 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 178.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.458 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 75.8 t-105 -136.05 162.38 33.04 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.602 0.715 . . . . 0.0 112.051 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.458 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.2 OUTLIER -60.36 119.74 8.54 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.689 179.928 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.401 ' HA ' ' NE2' ' A' ' 125' ' ' GLN . 12.2 tt0 -60.1 127.3 31.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.081 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -137.52 11.0 2.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.207 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 78.4 10.28 86.34 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.882 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.78 139.78 46.82 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.521 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.5 -28.92 57.14 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.495 2.13 . . . . 0.0 112.24 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -74.55 -5.42 42.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.423 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.401 ' NE2' ' HA ' ' A' ' 119' ' ' GLN . 0.1 OUTLIER -106.57 16.36 24.69 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.096 -179.829 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.418 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 2.7 mmmt -105.91 132.95 51.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.743 0.306 . . . . 0.0 111.398 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.422 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 5.2 m-85 -136.12 155.1 50.67 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.417 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 mt -114.27 140.32 35.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.179 0.514 . . . . 0.0 110.67 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.1 mm -114.04 139.78 38.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.617 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.21 96.14 3.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.614 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.4 m -50.76 111.71 0.59 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.405 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.421 ' HB3' ' CE2' ' A' ' 5' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.918 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.137 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.763 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -156.41 172.76 17.95 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.735 179.878 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.429 ' CE1' ' HB3' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -112.22 123.86 51.2 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.103 179.04 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.433 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -105.1 109.29 27.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.004 0.431 . . . . 0.0 110.693 -179.73 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 16' ' ' VAL . 0.1 OUTLIER -102.15 132.49 48.02 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.008 -179.065 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.1 p -74.16 107.29 6.25 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -63.8 -9.86 16.96 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.537 -178.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 28.7 tp -83.44 -62.99 1.44 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.815 0.34 . . . . 0.0 110.752 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -85.59 -7.87 58.61 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.79 6.65 67.75 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.071 -1.062 . . . . 0.0 111.558 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -94.11 -171.97 2.69 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 4.8 m -121.84 140.65 45.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.755 0.312 . . . . 0.0 110.528 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.1 mt -69.79 133.47 47.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.329 -0.396 . . . . 0.0 109.95 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -144.04 147.79 34.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.827 0.346 . . . . 0.0 111.144 -179.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.437 HD11 ' CZ2' ' A' ' 46' ' ' TRP . 22.3 mt . . . . . 0 C--N 1.327 -0.38 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.42 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.26 0 CA-C-O 120.214 -0.214 . . . . 0.0 113.439 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.2 t -73.17 139.29 46.23 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 117.22 0.51 . . . . 0.0 111.121 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.3 mptm? -90.65 158.49 16.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.487 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 36.8 pt -116.88 145.53 22.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.854 0.359 . . . . 0.0 111.708 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.442 ' HA ' ' CD1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -154.97 177.92 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.458 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.5 p -100.94 149.57 23.76 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.498 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 9.0 t-105 -155.47 170.66 21.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.745 0.307 . . . . 0.0 110.993 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.09 135.43 47.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.827 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.906 -179.969 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.451 ' O ' ' CD1' ' A' ' 45' ' ' LEU . . . . . . . . 0 CA--C 1.527 0.064 0 CA-C-O 120.621 0.248 . . . . 0.0 111.311 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.593 ' HA ' HD13 ' A' ' 45' ' ' LEU . 53.2 t -50.6 -31.9 9.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.915 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -65.19 -11.25 38.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.889 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.429 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 3.7 mt-30 -117.6 8.78 12.95 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.763 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 0.9 OUTLIER -118.43 141.15 48.83 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.861 -179.143 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.472 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 26.1 m95 -134.23 169.49 17.1 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.052 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.537 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 28.3 p90 -141.45 164.47 30.15 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.143 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -109.11 136.41 48.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.829 0.347 . . . . 0.0 111.397 -178.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -77.75 170.7 16.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.2 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -62.31 -22.48 66.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.089 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -98.77 -2.46 37.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.167 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.8 3.77 54.82 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.884 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.8 t -85.99 116.24 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 CA-C-N 116.977 0.389 . . . . 0.0 110.693 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.537 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -78.21 147.8 6.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.383 0.611 . . . . 0.0 112.034 -179.59 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.507 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 8.8 mmm-85 -150.62 133.67 16.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.152 178.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.472 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.413 0 CA-C-O 121.456 0.646 . . . . 0.0 112.055 -178.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 . . . . . 0 C--O 1.234 0.265 0 CA-C-O 120.909 0.385 . . . . 0.0 110.979 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -107.46 153.19 23.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.524 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.502 ' O ' ' CD1' ' A' ' 84' ' ' TRP . 0.3 OUTLIER -78.85 152.05 5.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.778 179.667 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.553 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 4.1 p-10 -132.78 137.83 46.95 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.964 0.411 . . . . 0.0 111.368 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -104.06 42.37 1.19 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.429 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.37 -44.82 50.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.833 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 7.2 m80 -93.84 169.22 10.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.934 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -48.4 -46.0 36.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.956 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -99.73 142.74 30.82 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.138 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.595 ' CG1' ' HA ' ' A' ' 115' ' ' CYS . 3.5 mm -73.44 139.53 19.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-O 121.55 0.691 . . . . 0.0 111.382 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -140.56 169.35 17.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.944 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 63' ' ' ILE . 49.9 p -106.28 138.65 42.09 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.262 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.452 ' HG2' ' C ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -164.92 169.36 7.65 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.033 179.684 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -49.56 141.82 25.38 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.416 2.077 . . . . 0.0 112.08 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.434 ' O ' ' HB2' ' A' ' 82' ' ' ARG . 53.1 t80 -47.94 -56.62 7.19 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.3 t70 61.29 118.15 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.67 0.272 . . . . 0.0 110.346 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.08 -27.32 25.06 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.488 2.125 . . . . 0.0 113.546 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -88.43 0.85 55.81 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.435 ' CB ' ' HD2' ' A' ' 82' ' ' ARG . 1.7 m-80 -105.96 103.76 46.04 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.586 0.232 . . . . 0.0 111.331 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.432 ' O ' ' CD2' ' A' ' 94' ' ' LEU . 5.6 Cg_exo -77.33 18.79 0.76 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.996 2.464 . . . . 0.0 113.105 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.553 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 8.2 mmtt -119.95 -18.27 8.23 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 120.648 0.261 . . . . 0.0 110.91 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.463 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 32.2 mtt180 -90.97 23.13 3.31 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.15 -179.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.697 ' O ' HD22 ' A' ' 94' ' ' LEU . . . -131.23 99.8 4.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.983 0.421 . . . . 0.0 110.765 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.502 ' CD1' ' O ' ' A' ' 63' ' ' ILE . 51.3 m95 -110.35 136.94 48.75 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.246 0.546 . . . . 0.0 112.106 -178.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.7 pp -114.13 154.71 15.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.198 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.2 t -101.47 127.21 55.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.95 0.405 . . . . 0.0 111.105 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.3 t -119.51 94.38 4.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.347 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.19 -100.43 0.79 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.497 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.502 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.89 29.77 7.21 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.56 0.219 . . . . 0.0 110.871 -179.692 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.411 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -148.03 148.05 30.28 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.502 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 15.2 mm -93.69 120.09 42.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.131 -0.941 . . . . 0.0 109.336 178.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.461 ' CB ' HG13 ' A' ' 100' ' ' VAL . . . -121.94 143.73 49.29 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.432 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -67.28 147.34 53.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.732 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.697 HD22 ' O ' ' A' ' 83' ' ' ALA . 2.6 pt? -60.97 -56.86 16.13 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.798 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.535 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 2.2 m -75.17 -4.63 39.92 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -139.6 87.61 2.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.789 0.328 . . . . 0.0 110.967 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 16.3 mmt85 -67.6 -17.42 64.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.117 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -94.05 11.78 28.61 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.486 179.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.548 ' O ' HG13 ' A' ' 100' ' ' VAL . 10.2 mm -124.4 130.83 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.548 HG13 ' O ' ' A' ' 99' ' ' ILE . 34.7 m -147.64 136.75 15.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.836 0.351 . . . . 0.0 111.91 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.462 ' HG ' ' CZ3' ' A' ' 84' ' ' TRP . 11.2 mt -46.06 154.29 0.26 Allowed 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.693 0.758 . . . . 0.0 111.867 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -159.59 168.57 25.78 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 114.375 -1.284 . . . . 0.0 110.666 -177.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.4 mp -87.41 119.46 35.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.031 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 52.9 mt -70.24 137.51 23.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.913 0.387 . . . . 0.0 111.525 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.0 10.77 7.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.714 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.3 m 45.69 -139.18 0.47 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.938 -0.119 . . . . 0.0 110.94 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 68.84 162.88 0.22 Allowed 'General case' 0 N--CA 1.46 0.067 0 CA-C-O 120.803 0.335 . . . . 0.0 110.878 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 4.3 tttp -89.32 -11.57 43.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.533 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -41.94 135.74 2.28 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.812 0.339 . . . . 0.0 111.62 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -88.46 161.31 17.1 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.303 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 71.94 17.2 76.83 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.027 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.79 135.08 35.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.801 0.334 . . . . 0.0 110.896 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 15.5 m170 -65.14 173.96 2.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.012 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.54 ' O ' HG12 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -137.77 161.94 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.476 -179.917 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.595 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 4.9 t -152.77 167.3 29.48 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.444 ' HB2' ' CG2' ' A' ' 99' ' ' ILE . . . -94.93 126.08 40.03 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.458 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 75.8 t-105 -136.92 162.65 32.68 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.589 0.709 . . . . 0.0 112.304 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.458 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.1 OUTLIER -59.6 119.73 8.11 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.884 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -66.68 130.35 42.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.013 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -142.54 16.07 2.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.88 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 81.95 13.11 80.12 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.83 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.62 136.84 41.83 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.433 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.46 -31.79 70.29 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.465 2.11 . . . . 0.0 112.115 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -75.45 -4.21 38.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.323 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.411 ' O ' ' CG2' ' A' ' 90' ' ' THR . 0.0 OUTLIER -105.53 13.63 29.76 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.244 -179.812 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.96 142.69 37.69 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.871 0.367 . . . . 0.0 111.373 -179.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.429 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 6.6 m-85 -140.84 156.45 46.13 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.118 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.42 HD13 HG22 ' A' ' 128' ' ' ILE . 1.5 mt -112.4 139.62 36.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.109 0.481 . . . . 0.0 110.75 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 24.4 mm -114.63 141.74 29.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.67 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -139.17 94.37 2.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.7 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.8 m -54.29 107.09 0.24 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.227 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.888 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.411 ' HA ' ' O ' ' A' ' 46' ' ' TRP . 0.8 OUTLIER . . . . . 0 N--CA 1.461 0.081 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.731 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -157.5 174.49 15.3 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 120.49 -0.484 . . . . 0.0 111.648 179.634 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.421 ' CE1' ' HB3' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -113.13 123.76 51.01 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.132 179.17 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.431 ' CD1' ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -105.53 109.78 28.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.891 0.377 . . . . 0.0 110.387 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -105.81 134.63 48.61 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.325 -178.709 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.6 p -75.74 106.29 7.23 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.411 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 4.3 tt0 -62.66 -10.68 13.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.539 -178.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 51.2 tp -82.79 -62.82 1.5 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.894 0.378 . . . . 0.0 110.856 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.432 ' HB2' ' HG2' ' A' ' 15' ' ' LYS . 6.4 m-20 -85.98 -9.78 56.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.319 -178.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.12 5.0 69.7 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.139 -1.029 . . . . 0.0 111.48 -178.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.432 ' HG2' ' HB2' ' A' ' 13' ' ' ASN . 8.4 mmtm -91.76 -177.98 4.91 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 10.8 m -120.85 141.39 41.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.703 0.287 . . . . 0.0 110.538 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.9 mt -69.33 134.26 48.87 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.038 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.449 ' HB2' ' HG3' ' A' ' 44' ' ' GLN . 9.7 t70 -146.62 153.74 40.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.864 0.364 . . . . 0.0 111.108 -179.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.432 HD12 HG22 ' A' ' 19' ' ' ILE . 6.9 mm . . . . . 0 C--N 1.328 -0.35 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.446 0 N-CA-C 112.762 -0.135 . . . . 0.0 112.762 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.3 m -73.64 124.96 26.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.974 0.416 . . . . 0.0 111.105 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -75.08 161.45 29.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.045 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.417 HD12 HG21 ' A' ' 63' ' ' ILE . 41.6 pt -118.88 146.56 23.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.853 0.359 . . . . 0.0 111.928 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.441 ' HA ' ' CD1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -153.56 178.01 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.139 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.686 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.4 p -103.73 151.14 23.37 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.695 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 27.0 t-105 -154.86 169.64 23.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.735 0.303 . . . . 0.0 110.884 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.56 132.68 46.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.767 0.318 . . . . 0.0 110.666 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.217 -179.822 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.45 ' O ' ' CD1' ' A' ' 45' ' ' LEU . . . . . . . . 0 N--CA 1.458 -0.053 0 CA-C-O 120.756 0.312 . . . . 0.0 110.975 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.568 ' HA ' HD12 ' A' ' 45' ' ' LEU . 50.0 t -51.21 -33.93 14.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.301 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -68.91 -7.86 38.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.6 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.449 ' HG3' ' HB2' ' A' ' 18' ' ' ASP . 1.8 mt-30 -114.5 6.27 15.82 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.731 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 0.9 OUTLIER -118.67 142.34 47.76 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.157 -0.928 . . . . 0.0 111.567 -178.913 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.499 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 26.1 m95 -134.51 169.47 17.23 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.187 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.502 ' CE2' ' HB2' ' A' ' 55' ' ' ARG . 42.1 p90 -141.25 164.14 31.05 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.533 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.58 135.18 50.26 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.784 0.326 . . . . 0.0 111.443 -178.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -78.19 170.93 15.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.144 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -66.33 -24.3 66.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.097 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.8 -4.09 55.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.253 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.38 9.78 49.8 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.875 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 40.1 t -97.48 119.73 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 CA-C-N 116.883 0.341 . . . . 0.0 110.512 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.465 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.6 OUTLIER -78.77 150.86 5.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.495 0.664 . . . . 0.0 111.951 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.502 ' HB2' ' CE2' ' A' ' 47' ' ' TYR . 11.2 mmm-85 -147.36 132.94 18.76 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.628 178.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.499 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.591 0 CA-C-O 121.713 0.768 . . . . 0.0 111.981 -178.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.411 ' CE1' ' HD3' ' A' ' 74' ' ' PRO . 7.1 m-85 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.808 0.337 . . . . 0.0 110.838 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -98.29 150.71 21.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.938 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.499 ' O ' ' NE1' ' A' ' 84' ' ' TRP . 0.2 OUTLIER -80.82 150.89 4.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.273 179.476 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.565 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 8.6 p-10 -133.06 131.58 40.79 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.215 0.531 . . . . 0.0 111.603 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -96.18 40.96 1.11 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.256 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 68.2 m -73.91 -43.41 58.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.342 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 65.0 m80 -97.59 172.56 7.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.11 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -48.04 -47.15 33.79 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.136 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -102.33 146.5 27.94 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.912 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.578 ' CG1' ' HA ' ' A' ' 115' ' ' CYS . 1.9 mm -78.1 144.15 11.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-O 121.614 0.721 . . . . 0.0 111.755 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -144.51 168.75 19.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.001 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 63' ' ' ILE . 80.9 p -105.44 136.98 44.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.993 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.444 ' CB ' ' HD2' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -161.2 168.06 12.21 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.136 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.444 ' HD2' ' CB ' ' A' ' 73' ' ' GLN . 13.9 Cg_endo -57.37 134.49 64.08 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.404 2.07 . . . . 0.0 112.055 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -62.46 132.61 53.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.864 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -121.62 139.22 29.54 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.775 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.12 -34.05 17.63 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.515 2.143 . . . . 0.0 112.67 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -88.13 -0.72 57.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.653 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.414 ' HB3' ' HD2' ' A' ' 82' ' ' ARG . 1.7 m120 -109.31 100.02 39.23 Favored Pre-proline 0 C--O 1.232 0.175 0 CA-C-O 120.583 0.23 . . . . 0.0 111.029 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.428 ' O ' ' CD2' ' A' ' 94' ' ' LEU . 4.0 Cg_exo -76.44 25.48 0.43 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.923 2.415 . . . . 0.0 113.027 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.565 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 0.1 OUTLIER -118.71 -21.33 7.92 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 120.616 0.246 . . . . 0.0 111.19 -179.721 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.431 ' HG3' ' HB3' ' A' ' 64' ' ' ASP . 0.4 OUTLIER -88.56 18.94 4.18 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.064 -0.517 . . . . 0.0 112.365 -179.028 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.69 ' O ' HD22 ' A' ' 94' ' ' LEU . . . -128.41 99.26 5.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.097 0.475 . . . . 0.0 110.775 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.499 ' NE1' ' O ' ' A' ' 63' ' ' ILE . 58.3 m95 -108.84 136.45 48.37 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.15 0.5 . . . . 0.0 111.907 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.9 pt -113.81 154.47 15.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.085 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.7 t -102.53 127.84 55.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.988 0.423 . . . . 0.0 111.111 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 30.5 t -120.88 95.14 4.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.35 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.2 -101.07 0.84 Allowed Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.477 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.498 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -121.02 30.15 7.0 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.496 0.189 . . . . 0.0 110.867 -179.802 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.421 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.34 147.49 30.38 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.597 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.1 mm -94.06 119.98 42.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.336 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.46 ' CB ' HG11 ' A' ' 100' ' ' VAL . . . -123.98 144.57 49.74 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.86 149.53 46.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.661 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.69 HD22 ' O ' ' A' ' 83' ' ' ALA . 2.6 pt? -62.33 -57.11 12.54 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.672 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.533 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 92.6 p -79.8 -2.64 44.19 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -137.52 84.65 2.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.841 0.353 . . . . 0.0 111.004 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.6 mpp_? -66.34 -18.18 65.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.174 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.46 10.29 28.32 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.538 179.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.521 ' O ' HG11 ' A' ' 100' ' ' VAL . 11.2 mm -124.36 129.39 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.466 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.521 HG11 ' O ' ' A' ' 99' ' ' ILE . 30.8 m -146.68 136.01 16.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.48 ' HA ' ' O ' ' A' ' 115' ' ' CYS . 12.7 mt -46.47 153.79 0.34 Allowed 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 121.753 0.787 . . . . 0.0 111.837 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.404 ' OD2' ' HG2' ' A' ' 125' ' ' GLN . 9.9 t70 -158.36 168.02 28.11 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.587 -177.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.4 mp -87.26 122.38 39.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.194 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.1 tt -65.37 136.73 26.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.072 0.463 . . . . 0.0 111.482 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 70.63 1.22 3.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.997 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 51.4 p 43.68 31.39 0.45 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.761 0.315 . . . . 0.0 111.365 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -94.7 154.29 17.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.267 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.91 -14.14 58.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.156 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -49.03 118.51 2.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.265 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.1 157.93 17.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.054 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 73.25 15.67 78.79 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.214 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.94 132.86 39.28 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.834 0.349 . . . . 0.0 110.95 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -65.58 172.02 3.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.925 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.498 ' O ' HG12 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -136.42 161.63 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.517 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.578 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 95.7 m -153.77 168.96 24.56 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.447 ' HB3' ' CG2' ' A' ' 99' ' ' ILE . . . -95.7 126.62 41.1 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.467 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 76.1 t-105 -134.49 162.57 31.88 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.603 0.716 . . . . 0.0 112.129 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.467 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.1 OUTLIER -62.43 117.43 6.15 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.596 -1.183 . . . . 0.0 110.781 179.885 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -62.4 126.65 28.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.962 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -138.18 13.72 2.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.165 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 76.19 60.8 2.98 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.518 -0.848 . . . . 0.0 112.315 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -117.3 145.99 18.7 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.551 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.68 -32.39 75.36 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.403 2.069 . . . . 0.0 112.013 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -76.29 -2.69 32.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.586 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.421 ' O ' ' CG2' ' A' ' 90' ' ' THR . 0.9 OUTLIER -107.8 11.06 28.55 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.466 0.174 . . . . 0.0 111.172 180.0 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.411 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 1.7 mmmm -106.76 138.21 43.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.846 0.355 . . . . 0.0 111.529 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -138.59 155.77 48.05 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.246 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.3 mt -113.36 138.64 42.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.149 0.5 . . . . 0.0 110.776 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 26.4 mm -113.86 139.71 38.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.524 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -139.5 94.68 2.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.655 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 18.6 p -51.34 110.73 0.47 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.327 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.948 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.451 ' O ' ' CD1' ' A' ' 6' ' ' PHE . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.091 0 N-CA-C 110.476 -0.194 . . . . 0.0 110.476 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.757 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -158.84 173.95 15.74 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 120.469 -0.492 . . . . 0.0 111.496 179.883 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.41 ' CE2' HD12 ' A' ' 45' ' ' LEU . 0.4 OUTLIER -109.46 123.79 49.96 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.204 179.13 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.414 ' CD1' ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -109.02 104.56 17.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.939 -179.755 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.624 ' HB2' ' O ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -122.81 140.11 53.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.453 -179.751 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.9 m -60.69 135.45 57.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.925 0.393 . . . . 0.0 110.744 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -77.99 -11.84 59.94 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.961 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 41.1 tp -89.03 -58.64 2.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.793 0.33 . . . . 0.0 110.986 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -84.94 -17.74 36.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.262 -0.426 . . . . 0.0 112.017 -179.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.4 5.81 73.72 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.308 -0.949 . . . . 0.0 112.231 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.624 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 1.5 mmmt -86.29 165.64 16.28 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.599 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 9.5 m -106.5 137.15 38.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.822 0.344 . . . . 0.0 110.723 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.3 mt -69.13 137.58 53.52 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -143.7 151.19 39.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.018 0.437 . . . . 0.0 111.439 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.418 HD13 ' CH2' ' A' ' 46' ' ' TRP . 23.1 mt . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.459 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 CA-C-O 120.293 -0.171 . . . . 0.0 113.239 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.7 t -77.2 132.54 38.8 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 117.093 0.446 . . . . 0.0 111.345 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.6 mmtt -81.46 160.53 23.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.645 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.436 HD13 ' HB ' ' A' ' 70' ' ' ILE . 47.3 pt -120.98 149.03 23.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.445 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -155.73 -178.98 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.173 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.75 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 p -101.36 149.19 24.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.419 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 19.5 t-105 -156.81 171.49 20.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.732 0.301 . . . . 0.0 110.989 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -71.33 138.54 49.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.705 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.284 -179.846 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.528 ' O ' HD11 ' A' ' 45' ' ' LEU . . . . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.744 0.307 . . . . 0.0 110.951 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.569 ' HA ' HD11 ' A' ' 45' ' ' LEU . 17.5 t -50.33 -27.65 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.961 179.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -64.65 -10.56 27.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.619 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -118.56 7.79 11.87 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.135 0.493 . . . . 0.0 109.675 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.757 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 1.3 mp -117.05 140.37 49.57 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.664 -179.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.485 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 25.9 m95 -134.43 169.4 17.31 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.035 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.604 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 15.1 p90 -141.42 165.51 27.32 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.954 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.2 p -109.68 136.67 48.66 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.902 0.382 . . . . 0.0 111.475 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.0 173.39 12.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.327 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -63.29 -21.24 66.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.12 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -101.36 -2.8 30.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.168 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.21 2.6 51.28 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.868 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.8 t -83.06 114.26 23.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.873 0.368 . . . . 0.0 110.82 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.604 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -76.78 146.72 8.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.253 0.549 . . . . 0.0 111.766 -179.795 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.499 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 2.7 mmm-85 -151.56 133.68 15.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.539 178.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.485 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 12.5 m . . . . . 0 C--N 1.326 -0.419 0 CA-C-O 121.271 0.558 . . . . 0.0 111.903 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.426 ' CE2' ' HD3' ' A' ' 74' ' ' PRO . 1.1 m-85 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.894 0.378 . . . . 0.0 110.759 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -105.73 150.03 25.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.081 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.476 ' O ' ' CD1' ' A' ' 84' ' ' TRP . 0.2 OUTLIER -78.64 153.76 4.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.92 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.55 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 5.1 p-10 -133.6 132.91 41.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.227 0.537 . . . . 0.0 111.569 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -96.73 41.78 1.1 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.197 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.4 m -74.53 -46.36 39.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.225 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -93.95 170.66 9.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.952 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -47.29 -48.06 25.04 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.944 0.402 . . . . 0.0 110.959 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -99.73 144.24 29.04 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.917 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.607 ' CG1' ' HA ' ' A' ' 115' ' ' CYS . 2.7 mm -71.05 136.13 26.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-O 121.527 0.679 . . . . 0.0 111.366 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -130.33 162.76 28.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.237 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.0 p -105.5 138.71 41.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.549 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.82 159.16 19.3 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.668 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.426 ' HD3' ' CE2' ' A' ' 61' ' ' PHE . 53.7 Cg_exo -52.03 143.29 41.27 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.429 2.086 . . . . 0.0 111.737 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -59.07 126.03 26.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.915 0.388 . . . . 0.0 111.354 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.429 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 8.1 t70 -119.54 130.32 24.9 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.166 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.6 -33.82 21.07 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.602 2.202 . . . . 0.0 113.47 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -85.71 0.25 53.29 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.429 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 3.2 m120 -106.49 104.33 50.13 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.563 0.221 . . . . 0.0 111.343 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.431 ' O ' ' CD2' ' A' ' 94' ' ' LEU . 5.6 Cg_exo -77.34 20.07 0.69 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.868 2.379 . . . . 0.0 112.697 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 24.6 mmtp -120.15 -18.34 8.09 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.038 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.495 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 6.4 mtt180 -88.66 18.73 4.42 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.943 -0.572 . . . . 0.0 112.187 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.697 ' O ' HD22 ' A' ' 94' ' ' LEU . . . -127.79 99.27 5.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.131 0.491 . . . . 0.0 110.647 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.476 ' CD1' ' O ' ' A' ' 63' ' ' ILE . 61.8 m95 -108.55 136.42 48.18 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.114 0.483 . . . . 0.0 111.859 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 pt -115.21 154.24 16.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.272 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.5 t -101.2 124.41 54.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.012 0.434 . . . . 0.0 110.987 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 23.1 t -116.8 94.43 4.6 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.437 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.66 -100.95 0.79 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.505 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.51 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.79 30.17 7.03 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.587 0.232 . . . . 0.0 110.915 -179.63 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.92 148.0 30.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.394 0.616 . . . . 0.0 112.537 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 13.6 mm -93.94 120.15 42.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.411 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.452 ' CB ' HG11 ' A' ' 100' ' ' VAL . . . -124.89 146.67 49.2 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -178.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.437 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -67.17 148.83 51.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.811 179.808 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.697 HD22 ' O ' ' A' ' 83' ' ' ALA . 2.7 pt? -61.07 -56.54 19.75 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.719 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.546 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 57.9 m -80.17 -3.44 48.98 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -136.56 85.44 2.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.838 0.351 . . . . 0.0 111.075 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -66.83 -17.97 65.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.155 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -92.08 9.83 31.75 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.521 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.506 ' O ' HG11 ' A' ' 100' ' ' VAL . 12.2 mm -123.14 127.4 74.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.531 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.506 HG11 ' O ' ' A' ' 99' ' ' ILE . 23.5 m -146.17 135.04 16.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.86 0.362 . . . . 0.0 111.862 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.486 ' HA ' ' O ' ' A' ' 115' ' ' CYS . 11.0 mt -46.72 154.37 0.32 Allowed 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.7 0.762 . . . . 0.0 112.008 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -155.63 167.78 29.29 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.319 -1.31 . . . . 0.0 110.694 -177.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.519 ' HA ' HG22 ' A' ' 114' ' ' ILE . 3.7 mp -92.94 124.52 45.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.509 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.411 HG13 ' N ' ' A' ' 105' ' ' LYS . 0.9 OUTLIER -68.24 139.6 20.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.961 0.41 . . . . 0.0 111.324 -179.83 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.411 ' N ' HG13 ' A' ' 104' ' ' ILE . 0.0 OUTLIER 78.4 -9.8 1.45 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.851 179.745 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.4 m 47.13 34.94 3.19 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.806 0.336 . . . . 0.0 111.188 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -106.94 166.92 10.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.195 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.4 -14.39 58.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.037 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -50.47 135.84 21.73 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.202 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -88.97 162.3 16.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.095 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.01 16.45 79.51 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.233 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.43 137.87 33.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.897 0.379 . . . . 0.0 110.967 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 3.1 m170 -61.9 167.98 3.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.847 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.519 HG22 ' HA ' ' A' ' 103' ' ' ILE . 0.0 OUTLIER -138.74 161.01 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.582 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.607 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 25.7 p -156.75 170.68 21.88 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.452 ' HB1' ' CG2' ' A' ' 99' ' ' ILE . . . -95.49 127.01 41.18 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 178.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.456 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 70.7 t-105 -132.37 162.88 29.98 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.529 0.68 . . . . 0.0 112.282 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.456 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.5 OUTLIER -63.55 120.78 12.39 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.659 179.843 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -58.91 124.45 19.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.177 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -132.68 8.1 4.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.631 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 82.38 6.74 88.42 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.164 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -66.0 142.62 43.55 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.401 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -56.86 -25.15 60.16 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.457 2.105 . . . . 0.0 112.508 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 34.5 p-10 -70.46 -9.09 55.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.706 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -107.02 17.99 22.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.698 0.285 . . . . 0.0 111.014 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.5 mmtp -103.59 123.78 47.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.793 0.33 . . . . 0.0 111.157 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.419 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 4.3 m-85 -127.96 153.0 47.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.632 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.6 mt -115.61 139.47 41.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.452 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.414 ' CD1' ' CG2' ' A' ' 8' ' ' ILE . 32.3 mm -113.94 144.05 22.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.677 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -136.07 94.18 3.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.609 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.47 109.3 0.43 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.312 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.913 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.726 0.298 . . . . 0.0 110.757 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.621 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -151.92 170.71 19.19 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 120.97 0.414 . . . . 0.0 111.213 178.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.435 ' CE2' HD13 ' A' ' 45' ' ' LEU . 0.1 OUTLIER -111.45 123.82 50.99 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.143 179.173 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.45 HD13 HG23 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -107.12 106.36 20.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.245 179.879 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -106.77 137.06 45.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.384 -178.7 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.9 108.67 10.11 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -62.69 -10.53 12.92 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.483 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 30.3 tp -83.36 -62.47 1.58 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.865 0.364 . . . . 0.0 111.039 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.401 ' HA ' ' HG3' ' A' ' 108' ' ' LYS . 6.9 m-20 -86.83 -10.65 52.98 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.1 5.03 69.7 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.086 -1.054 . . . . 0.0 111.398 -178.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' A' ' 9' ' ' LYS . 1.7 mmmm -91.78 178.22 5.97 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.9 m -119.93 142.59 34.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.689 0.281 . . . . 0.0 110.507 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.3 mt -68.11 135.93 52.94 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.432 ' CB ' ' HG3' ' A' ' 44' ' ' GLN . 19.9 t0 -145.33 142.44 29.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.719 0.295 . . . . 0.0 111.114 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.428 HD11 HG22 ' A' ' 19' ' ' ILE . 14.0 mm . . . . . 0 C--N 1.327 -0.402 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.394 0 N-CA-C 112.806 -0.118 . . . . 0.0 112.806 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.91 134.56 41.57 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.96 0.409 . . . . 0.0 111.213 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.9 mmtt -81.72 157.03 24.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.213 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.444 HD11 HG22 ' A' ' 63' ' ' ILE . 47.5 pt -116.63 145.96 21.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.906 -0.317 . . . . 0.0 111.483 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.4 HG22 ' HA ' ' A' ' 113' ' ' HIS . 0.2 OUTLIER -155.49 -178.85 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.196 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.982 -179.667 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.5 p -101.98 148.88 24.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.551 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 32.4 t-105 -159.13 173.28 16.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.686 0.279 . . . . 0.0 110.845 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -70.14 134.58 48.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.813 0.339 . . . . 0.0 110.757 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.01 -179.966 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.503 ' O ' HD12 ' A' ' 45' ' ' LEU . . . . . . . . 0 C--O 1.23 0.056 0 N-CA-C 111.525 0.194 . . . . 0.0 111.525 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.477 ' HA ' ' CD1' ' A' ' 45' ' ' LEU . 2.2 t -58.95 -18.21 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-O 120.706 0.289 . . . . 0.0 110.596 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -61.84 -11.86 14.72 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.928 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.432 ' HG3' ' CB ' ' A' ' 18' ' ' ASP . 7.7 mp0 -111.56 7.76 20.72 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.621 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 1.4 mp -121.06 146.44 46.72 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.232 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.461 ' CH2' ' CG1' ' A' ' 63' ' ' ILE . 25.4 m95 -133.27 170.11 15.93 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.65 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.55 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 1.5 p90 -136.09 159.46 41.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.92 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.8 p -107.17 134.18 50.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.786 0.327 . . . . 0.0 111.303 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -77.87 166.53 22.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.147 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -59.37 -22.69 61.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.164 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -97.4 -2.83 41.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.281 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.91 5.45 55.0 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.873 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.2 t -87.84 116.67 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-O 120.8 0.333 . . . . 0.0 110.635 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.55 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.8 OUTLIER -78.55 150.49 5.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.326 0.584 . . . . 0.0 111.942 -179.758 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.538 ' HB2' ' CE2' ' A' ' 47' ' ' TYR . 2.9 mmm-85 -147.44 133.18 18.93 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.207 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.424 ' HB2' ' CE2' ' A' ' 46' ' ' TRP . 47.2 t . . . . . 0 C--N 1.325 -0.474 0 CA-C-O 121.307 0.575 . . . . 0.0 112.138 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.43 ' CE2' ' HD3' ' A' ' 74' ' ' PRO . 3.8 m-85 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 121.018 0.437 . . . . 0.0 110.597 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -98.46 150.06 22.04 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.894 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.489 ' O ' ' NE1' ' A' ' 84' ' ' TRP . 0.2 OUTLIER -77.92 150.8 5.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.214 179.713 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.569 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 7.8 p-10 -131.59 133.02 44.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.156 0.503 . . . . 0.0 111.558 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.65 41.44 1.16 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.178 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.4 m -73.49 -42.62 61.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.061 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -98.2 172.83 7.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.936 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -49.47 -47.82 48.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.181 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -99.74 144.33 28.94 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.141 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.64 ' CG1' ' HA ' ' A' ' 115' ' ' CYS . 2.3 mm -76.31 142.86 13.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 CA-C-O 121.541 0.686 . . . . 0.0 111.764 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -141.8 168.41 19.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.196 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 49.4 p -108.24 139.88 42.29 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.085 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.49 165.17 14.51 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.304 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.43 ' HD3' ' CE2' ' A' ' 61' ' ' PHE . 10.6 Cg_endo -53.6 139.37 66.81 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.533 2.155 . . . . 0.0 111.92 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -61.5 131.74 51.13 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.881 0.372 . . . . 0.0 111.232 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.92 133.84 24.21 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.555 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -69.05 -34.48 16.86 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.451 2.101 . . . . 0.0 112.664 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -88.04 0.31 56.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.77 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -105.71 102.21 37.04 Favored Pre-proline 0 C--O 1.233 0.2 0 CA-C-O 120.517 0.199 . . . . 0.0 111.051 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.429 ' O ' ' CD2' ' A' ' 94' ' ' LEU . 5.9 Cg_exo -77.62 22.05 0.61 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.921 2.414 . . . . 0.0 112.994 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.569 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 33.7 mmtt -119.93 -18.54 8.18 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 120.599 0.238 . . . . 0.0 111.139 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.504 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 3.1 mtm180 -89.63 18.84 5.06 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.357 -179.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.675 ' O ' HD21 ' A' ' 94' ' ' LEU . . . -127.8 99.06 5.39 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.054 0.454 . . . . 0.0 110.802 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.489 ' NE1' ' O ' ' A' ' 63' ' ' ILE . 58.0 m95 -108.77 135.53 49.84 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.192 0.52 . . . . 0.0 111.938 -178.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.3 pt -113.58 154.41 14.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.254 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.3 t -101.32 125.83 55.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.967 0.413 . . . . 0.0 111.045 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 47.0 t -118.44 93.68 4.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.456 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.9 -100.41 0.77 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.519 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.495 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.42 29.19 7.58 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.532 0.206 . . . . 0.0 111.017 -179.578 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.426 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.57 147.56 30.21 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.607 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.41 ' O ' ' HA ' ' A' ' 100' ' ' VAL . 18.9 mm -93.76 120.47 43.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.127 178.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.452 ' CB ' HG13 ' A' ' 100' ' ' VAL . . . -123.87 145.31 49.19 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.423 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -66.22 148.45 51.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.648 179.786 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.675 HD21 ' O ' ' A' ' 83' ' ' ALA . 2.6 pt? -60.77 -57.02 14.44 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.804 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.533 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 66.9 p -78.99 -3.7 46.33 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -137.09 86.59 2.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.877 0.37 . . . . 0.0 111.001 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.59 -18.68 65.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.082 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -91.96 9.87 31.28 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.459 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.509 ' O ' HG13 ' A' ' 100' ' ' VAL . 13.3 mm -121.84 126.46 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.47 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.509 HG13 ' O ' ' A' ' 99' ' ' ILE . 25.4 m -146.14 134.9 16.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.96 0.41 . . . . 0.0 111.973 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.509 ' HA ' ' O ' ' A' ' 115' ' ' CYS . 13.6 mt -47.94 154.22 0.56 Allowed 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 121.782 0.801 . . . . 0.0 112.095 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.401 ' OD2' ' CG ' ' A' ' 125' ' ' GLN . 9.9 t70 -156.2 167.02 31.74 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.271 -1.331 . . . . 0.0 110.78 -177.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.427 ' HA ' HG21 ' A' ' 114' ' ' ILE . 4.4 mp -88.62 122.92 40.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.256 179.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.8 tt -69.03 139.47 20.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.066 0.46 . . . . 0.0 111.675 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 75.61 -7.21 1.83 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.074 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.1 m 46.61 29.15 0.88 Allowed 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.766 0.317 . . . . 0.0 111.179 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -99.43 161.53 13.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.071 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.401 ' HG3' ' HA ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -78.64 -14.36 59.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.202 179.769 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -49.06 123.6 7.45 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.895 0.379 . . . . 0.0 111.252 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.59 162.17 29.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.103 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 70.63 18.96 76.13 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.0 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.37 136.41 35.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.903 0.382 . . . . 0.0 111.0 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.4 ' HA ' HG22 ' A' ' 31' ' ' ILE . 1.2 m170 -63.61 171.39 2.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.751 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.489 ' O ' HG12 ' A' ' 70' ' ' ILE . 0.7 OUTLIER -142.44 162.02 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.806 -179.681 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.64 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 5.0 p -155.51 172.02 18.95 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.45 ' HB2' ' CG2' ' A' ' 99' ' ' ILE . . . -96.02 126.99 41.64 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 178.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.458 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 69.8 t-105 -132.77 162.01 32.58 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.567 0.699 . . . . 0.0 112.158 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.458 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 2.4 tptt -61.21 121.14 11.79 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.637 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -62.0 125.28 23.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.896 0.379 . . . . 0.0 111.211 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -134.92 12.17 3.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.169 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 79.62 8.16 87.94 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.927 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -60.47 149.76 42.52 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.52 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.21 -25.2 57.8 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.639 2.226 . . . . 0.0 112.206 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -74.0 -5.16 39.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.426 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.426 ' O ' ' CG2' ' A' ' 90' ' ' THR . 83.8 mt-30 -108.14 18.69 20.85 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.615 0.245 . . . . 0.0 111.19 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt -104.74 127.69 52.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.798 0.332 . . . . 0.0 111.273 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.415 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 15.1 m-85 -134.04 154.38 51.19 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 120.939 0.4 . . . . 0.0 110.399 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.4 mt -113.56 138.98 41.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.456 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.422 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 36.2 mm -113.64 140.85 31.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.613 -179.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -138.45 112.15 8.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.512 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.82 109.07 3.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.047 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.905 179.958 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.45 ' O ' ' CD1' ' A' ' 6' ' ' PHE . 25.3 m-85 . . . . . 0 C--O 1.231 0.097 0 N-CA-C 110.516 -0.179 . . . . 0.0 110.516 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.71 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -159.46 176.34 12.21 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.793 179.764 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.421 ' CE2' HD22 ' A' ' 45' ' ' LEU . 21.5 m-85 -111.84 124.29 52.06 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.276 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.431 ' CD1' ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -107.61 107.07 21.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.818 0.342 . . . . 0.0 110.275 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 15' ' ' LYS . 6.0 tttt -106.5 137.07 45.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.099 -0.501 . . . . 0.0 112.322 -178.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.0 m -75.94 109.83 9.89 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 178.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -64.46 -11.38 32.95 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.492 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 24.0 tp -84.34 -62.3 1.59 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.939 0.399 . . . . 0.0 111.034 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -85.28 -12.6 52.05 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.79 3.07 72.43 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.095 -1.05 . . . . 0.0 111.485 -178.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.419 ' O ' ' HG3' ' A' ' 9' ' ' LYS . 1.7 mmtt -90.43 -179.2 5.54 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.3 m -121.93 142.44 38.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.728 0.299 . . . . 0.0 110.586 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.3 mt -67.23 135.08 52.87 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.434 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 12.7 t70 -145.41 146.64 31.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.683 0.278 . . . . 0.0 111.13 -178.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.0 mm . . . . . 0 C--N 1.33 -0.266 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.135 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 CA-C-O 120.367 -0.129 . . . . 0.0 112.99 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.3 m -76.67 126.59 31.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.901 0.381 . . . . 0.0 111.259 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -76.14 159.94 30.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.282 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.407 HG13 ' CG1' ' A' ' 114' ' ' ILE . 50.9 pt -119.96 147.4 23.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.892 0.377 . . . . 0.0 111.824 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.445 HG22 HD12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -155.9 -177.81 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.163 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.495 -179.901 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 p -103.36 150.38 23.86 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.648 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 27.2 t-105 -156.53 170.74 21.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.668 0.27 . . . . 0.0 110.849 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -69.6 132.9 46.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.758 0.313 . . . . 0.0 110.665 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.16 -179.855 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.449 ' O ' ' CD1' ' A' ' 45' ' ' LEU . . . . . . . . 0 N--CA 1.457 -0.088 0 CA-C-O 120.831 0.348 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.559 ' HA ' HD12 ' A' ' 45' ' ' LEU . 73.4 t -50.06 -35.12 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.965 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.434 ' HB3' ' OD1' ' A' ' 18' ' ' ASP . 17.8 t30 -69.13 -7.82 39.68 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.995 -179.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -118.01 7.75 12.34 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.71 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 0.9 OUTLIER -117.68 140.72 49.27 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.312 -179.096 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.529 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 25.4 m95 -134.67 169.29 17.55 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.813 -178.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.525 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 6.3 p90 -137.86 161.18 37.3 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.296 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 65.1 p -107.58 136.32 47.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.729 0.299 . . . . 0.0 111.003 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -77.77 166.59 22.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.938 0.399 . . . . 0.0 111.168 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -57.81 -20.93 39.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.189 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -102.79 -2.45 28.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.386 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.24 0.47 47.54 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.043 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 23.2 t -81.24 113.32 20.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.921 0.36 . . . . 0.0 110.58 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.525 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.6 OUTLIER -79.59 150.33 5.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.439 0.638 . . . . 0.0 112.089 -179.602 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.475 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 9.0 mmm-85 -151.02 132.59 14.79 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.834 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.529 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 66.2 p . . . . . 0 CA--C 1.509 -0.63 0 CA-C-O 121.648 0.737 . . . . 0.0 111.384 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.437 ' CE2' ' HD3' ' A' ' 74' ' ' PRO . 3.7 m-85 . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.808 0.337 . . . . 0.0 111.054 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.406 ' CB ' ' HD2' ' A' ' 55' ' ' ARG . . . -103.61 150.85 23.58 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.21 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.472 ' CG1' ' CH2' ' A' ' 46' ' ' TRP . 0.2 OUTLIER -80.49 152.04 4.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.178 179.499 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.545 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 6.9 p-10 -133.36 135.72 44.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.17 0.51 . . . . 0.0 111.653 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -98.13 44.08 1.05 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.205 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 94.2 p -74.12 -43.64 56.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.462 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -100.89 176.06 5.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.084 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -49.03 -44.71 41.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.823 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.74 148.87 26.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.602 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.607 ' CD1' ' HA ' ' A' ' 115' ' ' CYS . 1.3 mm -77.93 140.84 16.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 CA-C-O 121.651 0.738 . . . . 0.0 111.612 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -133.31 159.84 39.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.766 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 39.2 p -102.29 137.53 40.43 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.34 179.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.485 ' CB ' ' HD2' ' A' ' 74' ' ' PRO . 0.3 OUTLIER -164.47 170.95 6.12 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.253 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.485 ' HD2' ' CB ' ' A' ' 73' ' ' GLN . 20.0 Cg_endo -60.45 133.35 48.48 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.19 1.927 . . . . 0.0 111.815 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -57.63 135.71 56.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.953 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.08 122.96 26.82 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.787 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -56.39 -34.58 94.72 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.467 2.111 . . . . 0.0 112.698 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -87.94 -0.67 57.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.761 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -108.74 100.31 38.46 Favored Pre-proline 0 C--O 1.232 0.183 0 CA-C-O 120.603 0.24 . . . . 0.0 110.922 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.436 ' O ' ' CD2' ' A' ' 94' ' ' LEU . 3.8 Cg_exo -76.47 25.37 0.44 Allowed 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.91 2.407 . . . . 0.0 113.236 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.545 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 21.0 mmtp -120.01 -19.91 7.66 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 120.581 0.229 . . . . 0.0 111.066 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.414 ' HG3' ' HB3' ' A' ' 64' ' ' ASP . 0.2 OUTLIER -88.89 18.75 4.55 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.162 -179.304 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.701 ' O ' HD21 ' A' ' 94' ' ' LEU . . . -127.56 99.16 5.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.13 0.491 . . . . 0.0 110.738 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.471 ' CD1' ' O ' ' A' ' 63' ' ' ILE . 58.8 m95 -108.48 135.39 49.84 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.138 0.494 . . . . 0.0 111.734 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 pt -113.55 155.27 14.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.257 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.7 t -103.38 129.06 55.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.965 0.412 . . . . 0.0 111.139 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 40.3 t -121.74 95.72 4.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.308 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.13 -101.14 0.85 Allowed Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.274 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.5 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.85 30.41 6.9 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.573 0.225 . . . . 0.0 110.811 -179.797 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.405 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.66 147.44 29.99 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.621 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 18.4 mm -94.38 120.24 43.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.385 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.494 ' CB ' HG11 ' A' ' 100' ' ' VAL . . . -123.66 145.34 49.03 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -178.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.438 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -65.65 148.38 51.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.513 179.646 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.701 HD21 ' O ' ' A' ' 83' ' ' ALA . 2.6 pt? -62.19 -56.77 15.42 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.836 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.531 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 20.6 p -77.91 -4.13 45.22 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -178.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.4 ' O ' HG23 ' A' ' 99' ' ' ILE . 2.1 m-20 -138.05 87.0 2.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.777 0.322 . . . . 0.0 110.863 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.11 -16.16 63.07 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.204 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -90.35 11.83 20.2 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.182 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.506 ' O ' HG11 ' A' ' 100' ' ' VAL . 6.3 tt -130.94 137.92 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.506 HG11 ' O ' ' A' ' 99' ' ' ILE . 23.9 m -148.86 137.12 14.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.763 0.316 . . . . 0.0 111.729 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.555 ' HA ' ' O ' ' A' ' 115' ' ' CYS . 24.8 mt -45.53 153.4 0.25 Allowed 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.705 0.764 . . . . 0.0 111.788 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.42 ' O ' HG21 ' A' ' 114' ' ' ILE . 10.0 t70 -158.46 168.4 27.06 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.381 -1.282 . . . . 0.0 110.763 -177.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.444 ' HA ' HG21 ' A' ' 114' ' ' ILE . 4.5 mp -90.48 123.55 42.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.452 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.2 tp -67.9 140.73 18.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.938 0.399 . . . . 0.0 111.332 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 76.56 -5.83 2.11 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.945 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.7 t 46.36 29.69 0.91 Allowed 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.77 0.319 . . . . 0.0 111.194 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -100.79 161.75 13.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.105 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.9 -13.98 58.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.141 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -48.6 123.43 6.74 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.237 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.88 160.27 32.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.063 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 72.56 16.32 77.63 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.092 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -79.26 135.09 36.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.816 0.341 . . . . 0.0 110.886 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 18.8 m170 -61.83 166.6 4.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.911 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.444 HG21 ' HA ' ' A' ' 103' ' ' ILE . 0.0 OUTLIER -136.35 160.44 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.476 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.607 ' HA ' ' CD1' ' A' ' 70' ' ' ILE . 26.2 p -157.8 172.29 18.74 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 101' ' ' LEU . . . -95.51 127.67 41.74 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.625 -0.43 . . . . 0.0 109.922 178.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.461 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 75.7 t-105 -133.23 163.04 30.19 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.578 0.704 . . . . 0.0 111.97 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.461 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.0 OUTLIER -64.23 123.11 18.26 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.727 179.93 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.93 121.83 9.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.157 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.423 ' CE1' ' HA3' ' A' ' 122' ' ' GLY . 6.9 p80 -126.59 3.01 6.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.434 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 80.82 5.92 89.74 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.973 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.423 ' HA3' ' CE1' ' A' ' 120' ' ' HIS . . . -64.8 154.0 49.5 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.575 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.9 -23.58 54.58 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.616 2.211 . . . . 0.0 112.348 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -76.76 -2.17 31.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.56 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.405 ' O ' ' CG2' ' A' ' 90' ' ' THR . 0.0 OUTLIER -108.97 9.6 26.47 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.219 -179.961 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.402 ' O ' ' CD1' ' A' ' 127' ' ' PHE . 19.9 mmmt -103.38 136.92 42.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.773 0.32 . . . . 0.0 111.249 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.407 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 6.6 m-85 -137.57 155.61 49.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.45 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.3 mt -113.47 138.89 41.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.098 0.475 . . . . 0.0 110.559 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.401 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 27.1 mm -114.17 141.34 30.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.661 -179.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -138.95 94.64 2.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.611 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.75 113.41 0.9 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.422 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.964 179.989 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.418 ' CE2' ' HB3' ' A' ' 132' ' ' GLU . 1.4 p90 . . . . . 0 C--O 1.231 0.115 0 N-CA-C 110.422 -0.214 . . . . 0.0 110.422 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.694 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -156.89 175.26 14.31 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 120.481 -0.487 . . . . 0.0 111.731 179.806 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.464 ' O ' ' HA ' ' A' ' 129' ' ' ILE . 9.9 m-85 -109.33 124.58 51.18 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.157 179.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.434 ' CD1' ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -108.51 106.24 20.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.871 0.367 . . . . 0.0 110.296 179.735 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -105.76 134.6 48.63 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -178.566 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 57.9 p -75.78 106.55 7.42 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -63.4 -10.54 17.43 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.591 -178.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 33.1 tp -83.5 -62.91 1.46 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.924 0.392 . . . . 0.0 110.794 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -84.23 -10.27 57.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.313 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.45 3.75 67.33 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.129 -1.034 . . . . 0.0 111.382 -178.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.1 mmmt -92.66 -176.59 4.31 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 7.5 m -121.78 142.44 38.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.708 0.29 . . . . 0.0 110.58 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.7 mt -70.05 134.63 48.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.014 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.4 ' HB2' ' HG3' ' A' ' 44' ' ' GLN . 9.5 t0 -146.71 150.36 35.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.707 0.289 . . . . 0.0 111.033 -179.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.7 mm . . . . . 0 C--N 1.328 -0.351 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.006 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.412 0 CA-C-O 120.349 -0.14 . . . . 0.0 113.188 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.52 127.51 32.76 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 117.027 0.414 . . . . 0.0 111.037 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -78.75 159.83 27.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.189 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.465 HD12 HG23 ' A' ' 63' ' ' ILE . 42.6 pt -117.89 146.29 22.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.771 0.32 . . . . 0.0 111.783 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.433 ' HA ' ' CD1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -154.44 178.01 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.17 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.78 -179.806 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.2 p -101.13 148.69 24.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.623 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.41 ' CZ3' ' HB2' ' A' ' 110' ' ' ALA . 34.9 t-105 -158.23 172.9 17.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.708 0.289 . . . . 0.0 110.918 -179.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -69.01 132.93 47.44 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.758 0.313 . . . . 0.0 110.738 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.019 -179.869 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.452 ' O ' ' CD1' ' A' ' 45' ' ' LEU . . . . . . . . 0 CA--C 1.529 0.164 0 N-CA-C 111.619 0.229 . . . . 0.0 111.619 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.574 ' HA ' HD11 ' A' ' 45' ' ' LEU . 59.4 t -50.92 -33.57 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.116 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -69.73 -7.51 40.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.76 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.4 ' HG3' ' HB2' ' A' ' 18' ' ' ASP . 2.6 mt-30 -115.79 6.26 14.32 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.694 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 0.9 OUTLIER -117.8 142.22 47.54 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.216 -179.273 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.482 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 26.3 m95 -133.74 168.71 18.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.541 -179.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.512 ' CZ ' ' HB2' ' A' ' 55' ' ' ARG . 43.1 p90 -141.32 164.16 31.01 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.382 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 54' ' ' ILE . 67.5 p -109.19 135.37 50.42 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.783 0.325 . . . . 0.0 111.539 -178.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -78.36 170.88 15.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.12 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.34 -25.15 65.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.999 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -89.3 -5.02 57.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.201 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.24 11.74 44.45 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.837 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 37.2 t -100.68 120.43 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-O 120.779 0.323 . . . . 0.0 110.489 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.434 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.6 OUTLIER -78.78 149.75 5.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.541 0.686 . . . . 0.0 111.883 -179.806 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.512 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -147.0 132.53 18.71 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.647 178.612 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.482 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.492 0 CA-C-O 121.569 0.699 . . . . 0.0 111.857 -178.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.413 ' CE2' ' HG3' ' A' ' 74' ' ' PRO . 32.7 m-85 . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.96 0.41 . . . . 0.0 110.858 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -104.4 154.16 20.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.397 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.481 ' O ' ' CD1' ' A' ' 84' ' ' TRP . 0.2 OUTLIER -79.86 150.37 5.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.59 179.665 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.557 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 6.3 p-10 -132.6 134.75 45.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.138 0.494 . . . . 0.0 111.501 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.06 43.29 1.06 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.334 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.1 m -74.06 -43.07 59.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.142 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 57.2 m80 -98.78 173.1 7.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.931 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -49.32 -46.96 47.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.983 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -99.69 145.03 28.09 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.936 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.596 ' CG1' ' HA ' ' A' ' 115' ' ' CYS . 2.4 mm -76.8 142.38 14.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-O 121.591 0.71 . . . . 0.0 111.511 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -140.31 168.61 19.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.062 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 63' ' ' ILE . 58.8 p -106.87 138.51 42.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.97 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.48 161.11 17.9 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.329 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.413 ' HG3' ' CE2' ' A' ' 61' ' ' PHE . 57.3 Cg_exo -51.44 139.19 46.58 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.449 2.099 . . . . 0.0 112.074 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -62.94 127.8 32.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.129 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -117.56 136.32 23.54 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.597 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -68.96 -34.81 16.5 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.56 2.173 . . . . 0.0 112.93 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -87.34 0.15 55.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.8 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -108.53 101.03 41.26 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 120.588 0.232 . . . . 0.0 111.147 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.436 ' O ' ' CD2' ' A' ' 94' ' ' LEU . 4.8 Cg_exo -77.09 24.7 0.48 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.989 2.459 . . . . 0.0 113.043 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.557 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 21.0 mmtp -120.26 -19.72 7.57 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 120.568 0.223 . . . . 0.0 111.101 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.456 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 0.4 OUTLIER -88.72 17.07 5.85 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.09 -0.505 . . . . 0.0 112.285 -179.208 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.688 ' O ' HD21 ' A' ' 94' ' ' LEU . . . -126.61 98.85 5.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.081 0.467 . . . . 0.0 110.823 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.481 ' CD1' ' O ' ' A' ' 63' ' ' ILE . 56.2 m95 -107.94 136.05 48.29 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.157 0.503 . . . . 0.0 111.81 -178.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.5 pt -111.25 153.5 13.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.197 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.2 t -102.28 127.69 55.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.008 0.432 . . . . 0.0 111.042 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.4 t -120.59 94.75 4.46 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.448 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.99 -100.13 0.75 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.531 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.499 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.85 29.74 7.23 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.52 0.2 . . . . 0.0 110.868 -179.676 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.425 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -148.14 147.77 29.84 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.577 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.9 mm -94.13 120.34 43.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.047 -0.978 . . . . 0.0 109.351 178.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.506 ' CB ' HG11 ' A' ' 100' ' ' VAL . . . -122.26 144.01 49.25 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -178.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.415 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -64.61 148.91 49.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.527 179.834 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.688 HD21 ' O ' ' A' ' 83' ' ' ALA . 2.6 pt? -64.34 -57.23 9.96 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.688 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.53 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 13.5 t -74.22 -4.1 33.9 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -178.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.482 ' O ' HG23 ' A' ' 99' ' ' ILE . 56.7 m-20 -143.46 92.22 2.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.919 0.39 . . . . 0.0 111.025 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -72.89 -14.32 61.46 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.287 179.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -90.25 11.19 21.91 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.297 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.51 ' O ' HG11 ' A' ' 100' ' ' VAL . 9.0 tt -130.64 138.27 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.51 HG11 ' O ' ' A' ' 99' ' ' ILE . 26.7 m -148.99 138.15 15.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.837 0.351 . . . . 0.0 111.907 -179.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.479 ' HA ' ' O ' ' A' ' 115' ' ' CYS . 11.1 mt -45.53 153.3 0.26 Allowed 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 121.754 0.788 . . . . 0.0 111.772 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -158.63 168.24 27.42 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.833 -177.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.4 mp -88.0 122.96 40.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.204 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 7.8 tp -66.63 138.27 23.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.057 0.456 . . . . 0.0 111.476 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.4 1.06 3.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.983 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.4 t 44.17 30.88 0.48 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.781 0.324 . . . . 0.0 111.344 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.7 p30 -96.67 155.79 16.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.152 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -82.24 -17.17 46.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.106 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -45.28 116.12 1.06 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.279 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.41 ' HB2' ' CZ3' ' A' ' 33' ' ' TRP . . . -58.4 156.74 9.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.247 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.63 14.47 81.2 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.312 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.88 131.81 39.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.902 0.382 . . . . 0.0 110.985 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -64.87 171.25 3.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.014 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.518 ' O ' HG12 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -136.38 161.75 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.445 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.596 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 26.5 p -153.51 168.45 26.11 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -95.06 126.71 40.59 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 178.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.468 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 76.5 t-105 -134.71 162.49 32.2 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.63 0.729 . . . . 0.0 112.196 -179.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.468 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.9 OUTLIER -62.53 120.87 11.96 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.646 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -58.55 125.5 23.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.089 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.424 ' CE1' ' HA3' ' A' ' 122' ' ' GLY . 19.9 p80 -132.97 8.51 4.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.357 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 81.82 7.17 88.34 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.086 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.424 ' HA3' ' CE1' ' A' ' 120' ' ' HIS . . . -63.73 152.15 48.44 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.58 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.59 -26.35 54.14 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.604 2.203 . . . . 0.0 112.33 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -75.05 -4.11 36.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.506 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.425 ' O ' ' CG2' ' A' ' 90' ' ' THR . 0.0 OUTLIER -107.5 14.38 25.89 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.183 -179.811 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.3 mmmm -107.08 136.92 46.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.793 0.33 . . . . 0.0 111.472 -179.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.42 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 6.1 m-85 -138.2 155.23 48.88 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.21 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.414 HG22 HD11 ' A' ' 128' ' ' ILE . 1.3 mt -112.03 138.43 40.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.091 0.472 . . . . 0.0 110.392 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.464 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 27.9 mm -112.99 140.19 34.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.563 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.7 112.02 8.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.457 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 5.7 t -66.4 109.95 2.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.13 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.418 ' HB3' ' CE2' ' A' ' 5' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.188 -0.911 . . . . 0.0 110.898 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.425 ' HA ' ' O ' ' A' ' 46' ' ' TRP . 1.4 p90 . . . . . 0 N--CA 1.462 0.16 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.69 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -159.01 175.61 13.32 Favored 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.94 179.889 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.437 ' CE2' HD21 ' A' ' 45' ' ' LEU . 4.7 m-85 -110.6 124.01 51.06 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.055 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.481 ' HB ' ' CD2' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -106.5 106.87 21.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.844 0.354 . . . . 0.0 110.436 179.824 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 15' ' ' LYS . 8.7 tttt -107.85 138.54 43.91 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.305 -178.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.91 109.2 10.53 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -64.01 -10.95 24.7 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.579 -178.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 56.8 tp -84.26 -62.48 1.55 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.88 0.371 . . . . 0.0 111.026 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -85.43 -12.93 50.79 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 77.17 0.84 72.18 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.103 -1.046 . . . . 0.0 111.413 -177.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.42 ' O ' ' HG3' ' A' ' 9' ' ' LYS . 0.5 OUTLIER -89.01 179.74 6.1 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.503 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.2 m -121.36 141.46 41.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.481 ' CD2' ' HB ' ' A' ' 8' ' ' ILE . 0.4 OUTLIER -73.49 137.61 44.57 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.123 179.475 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -142.6 153.09 43.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.873 0.368 . . . . 0.0 111.127 -179.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.422 HD13 HG23 ' A' ' 19' ' ' ILE . 25.3 mt . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.662 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.387 0 CA-C-O 120.249 -0.195 . . . . 0.0 113.108 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.11 137.04 50.8 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 117.122 0.461 . . . . 0.0 110.918 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.3 mmtp -88.32 157.6 18.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.606 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.439 HD12 HG21 ' A' ' 63' ' ' ILE . 44.2 pt -117.96 146.77 22.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.348 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.403 HG23 ' HA ' ' A' ' 113' ' ' HIS . 0.2 OUTLIER -155.19 179.73 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.182 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.885 -179.737 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.1 p -101.6 149.0 24.56 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.48 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 35.4 t-105 -157.81 172.21 18.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.711 0.291 . . . . 0.0 110.965 -179.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -72.48 139.08 47.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.81 0.338 . . . . 0.0 110.805 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.939 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.441 ' O ' HD13 ' A' ' 45' ' ' LEU . . . . . . . . 0 CA--C 1.528 0.121 0 CA-C-O 120.657 0.265 . . . . 0.0 111.037 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.585 ' HA ' HD13 ' A' ' 45' ' ' LEU . 48.5 t -50.29 -27.48 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.065 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -66.83 -9.45 37.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.582 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -118.46 5.89 11.76 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.69 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 1.3 mp -116.98 141.44 48.23 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.531 -179.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.426 ' CH2' ' CG1' ' A' ' 63' ' ' ILE . 26.1 m95 -134.18 169.01 17.81 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.249 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.553 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 11.3 p90 -141.98 166.22 25.31 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.981 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 39.7 p -108.38 133.87 51.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.882 0.372 . . . . 0.0 111.559 -178.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -77.96 167.78 20.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.026 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -60.9 -24.85 66.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.138 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.2 tp60 -92.74 -3.34 54.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.269 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.96 8.79 55.16 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.765 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.1 t -93.83 119.68 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-O 120.744 0.307 . . . . 0.0 110.587 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.553 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -75.96 145.64 10.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.168 0.509 . . . . 0.0 111.779 -179.835 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.531 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 13.5 mmm-85 -149.47 133.73 17.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.719 179.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 74.5 m . . . . . 0 C--N 1.327 -0.396 0 CA-C-O 121.598 0.714 . . . . 0.0 111.984 -179.087 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.428 ' CE2' ' HD3' ' A' ' 74' ' ' PRO . 2.7 m-85 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.814 0.34 . . . . 0.0 110.899 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.42 145.55 27.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.205 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.504 ' O ' ' CD1' ' A' ' 84' ' ' TRP . 0.2 OUTLIER -76.95 152.64 5.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.6 179.733 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.61 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 5.0 p-10 -132.37 129.87 39.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.249 0.547 . . . . 0.0 111.777 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -94.29 40.8 1.09 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.272 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.4 t -75.11 -45.5 40.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.543 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -94.7 170.33 9.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.962 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -49.16 -42.18 38.89 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.014 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.59 140.05 38.57 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.813 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.633 ' CG1' ' HA ' ' A' ' 115' ' ' CYS . 3.1 mm -69.94 137.12 24.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-O 121.464 0.649 . . . . 0.0 111.367 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.54 165.68 24.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.118 -0.947 . . . . 0.0 111.17 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.9 p -106.62 140.25 39.79 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.238 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.11 163.79 13.33 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.481 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.428 ' HD3' ' CE2' ' A' ' 61' ' ' PHE . 40.4 Cg_exo -56.73 142.81 91.54 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.451 2.1 . . . . 0.0 111.673 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -57.13 128.77 38.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.859 0.362 . . . . 0.0 111.358 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -118.17 131.02 24.38 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.532 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -68.14 -36.77 16.02 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.453 2.102 . . . . 0.0 112.758 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -87.55 0.31 55.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.812 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -105.19 102.65 37.78 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-O 120.53 0.205 . . . . 0.0 111.086 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.543 ' O ' HD21 ' A' ' 94' ' ' LEU . 5.7 Cg_exo -77.32 21.63 0.61 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.887 2.391 . . . . 0.0 112.978 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.61 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 7.6 mptt -119.92 -21.03 7.3 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 120.753 0.311 . . . . 0.0 111.001 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.52 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 2.7 mtt180 -86.85 20.84 2.44 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.554 ' O ' HD23 ' A' ' 94' ' ' LEU . . . -130.68 99.58 5.01 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.276 0.56 . . . . 0.0 110.937 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.504 ' CD1' ' O ' ' A' ' 63' ' ' ILE . 61.0 m95 -109.39 136.07 49.41 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.923 -178.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 27.8 pt -113.17 153.45 14.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.196 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.0 t -100.2 123.0 52.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.901 0.382 . . . . 0.0 110.948 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 37.6 t -115.8 93.49 4.28 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.438 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.97 -100.56 0.78 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.533 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.502 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.73 29.67 7.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.496 0.189 . . . . 0.0 110.923 -179.594 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.406 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -148.05 148.23 30.45 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.36 0.6 . . . . 0.0 112.583 -178.63 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 23.9 mm -93.65 119.47 41.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.542 178.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.49 ' CB ' HG13 ' A' ' 100' ' ' VAL . . . -123.99 147.56 47.68 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.421 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.3 OUTLIER -65.17 149.88 49.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.849 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.58 ' HG ' ' N ' ' A' ' 95' ' ' SER . 2.7 pt? -64.29 -56.88 11.48 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.444 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.58 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 0.3 OUTLIER -77.25 -1.77 31.3 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.363 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.525 ' O ' HG21 ' A' ' 99' ' ' ILE . 49.7 t0 -145.09 91.14 2.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.165 0.507 . . . . 0.0 110.942 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 3.8 mmm180 -74.09 -13.69 60.87 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.526 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -87.35 9.81 19.32 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.518 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.553 ' O ' HG13 ' A' ' 100' ' ' VAL . 6.8 tt -132.89 140.24 47.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 179.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.553 HG13 ' O ' ' A' ' 99' ' ' ILE . 20.0 m -149.77 138.84 15.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.77 0.319 . . . . 0.0 111.826 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.469 ' HG ' ' CZ3' ' A' ' 84' ' ' TRP . 21.8 mt -46.15 154.89 0.23 Allowed 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 121.733 0.778 . . . . 0.0 111.948 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -156.97 167.67 29.77 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.792 -177.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.434 ' HA ' HG21 ' A' ' 114' ' ' ILE . 4.6 mp -89.38 123.96 41.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.427 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.9 tt -68.04 144.48 14.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.947 0.403 . . . . 0.0 111.421 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 5.2 mttt 70.34 -0.8 2.71 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.015 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.1 m 42.09 31.61 0.25 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.734 0.302 . . . . 0.0 111.474 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -102.78 162.39 12.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.068 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.23 -14.5 57.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.255 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -48.21 133.11 15.8 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.21 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -81.91 159.37 23.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.147 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.49 16.37 80.05 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.287 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -82.0 135.79 35.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.841 0.353 . . . . 0.0 111.124 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.403 ' HA ' HG23 ' A' ' 31' ' ' ILE . 6.7 m80 -61.86 172.85 1.19 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.962 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.493 ' O ' HG12 ' A' ' 70' ' ' ILE . 0.7 OUTLIER -143.28 161.6 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.758 -179.777 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.633 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 4.6 t -155.43 169.95 23.07 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.48 ' HB3' HG12 ' A' ' 99' ' ' ILE . . . -93.6 126.53 38.81 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.458 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 75.9 t-105 -131.47 160.98 33.58 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.635 0.731 . . . . 0.0 112.361 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.458 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.3 OUTLIER -62.87 124.77 21.91 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.764 -179.885 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.88 121.28 8.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.127 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.432 ' CE1' ' HA3' ' A' ' 122' ' ' GLY . 6.6 p80 -127.34 2.4 6.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.493 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 79.4 5.23 89.26 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.881 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.432 ' HA3' ' CE1' ' A' ' 120' ' ' HIS . . . -63.34 156.28 42.32 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.536 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.75 -25.04 46.54 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.589 2.193 . . . . 0.0 112.365 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 36.3 p-10 -74.53 -3.8 33.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.644 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.406 ' O ' ' CG2' ' A' ' 90' ' ' THR . 0.0 OUTLIER -108.88 15.81 23.2 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.533 0.206 . . . . 0.0 111.116 -179.978 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -106.3 131.29 53.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.835 0.35 . . . . 0.0 111.465 -179.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.422 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 3.0 m-85 -134.9 154.6 51.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.285 179.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 mt -114.07 140.04 36.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.131 0.491 . . . . 0.0 110.677 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.42 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 20.8 mm -113.38 141.4 29.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.602 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.46 94.66 2.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.711 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 5.0 t -49.96 109.64 0.31 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.426 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.433 179.751 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.458 ' HA ' ' O ' ' A' ' 46' ' ' TRP . 1.1 p90 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.402 0.144 . . . . 0.0 110.629 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.74 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -159.87 176.57 11.75 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.861 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.424 ' CZ ' HD11 ' A' ' 45' ' ' LEU . 0.7 OUTLIER -112.64 124.16 51.94 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.299 179.371 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.432 ' CD1' ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -105.54 108.48 25.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.914 0.387 . . . . 0.0 110.339 179.873 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.5 tptp -105.27 135.3 46.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.422 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.7 t -75.65 108.04 8.21 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.426 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 2.7 tt0 -63.84 -10.76 22.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.633 -178.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 52.5 tp -83.25 -62.71 1.52 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.92 0.391 . . . . 0.0 110.924 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -86.32 -9.85 55.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.429 -178.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.86 5.01 68.41 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.145 -1.026 . . . . 0.0 111.369 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.8 mmmt -91.57 -177.18 4.73 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.9 m -120.3 140.28 44.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.784 0.326 . . . . 0.0 110.513 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.3 mt -70.89 136.06 48.39 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -143.83 158.57 43.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.936 0.398 . . . . 0.0 111.345 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.435 HD12 ' CH2' ' A' ' 46' ' ' TRP . 27.5 mt . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.406 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.409 0 CA-C-O 120.409 -0.106 . . . . 0.0 112.951 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.71 130.05 38.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.987 0.422 . . . . 0.0 111.198 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -80.73 161.83 24.39 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.422 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.433 HD12 ' HB ' ' A' ' 70' ' ' ILE . 48.4 pt -122.82 150.29 26.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.783 0.325 . . . . 0.0 111.705 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -156.39 -178.62 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.785 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.2 p -100.29 148.59 24.5 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.468 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 30.6 t-105 -157.16 171.9 19.62 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.77 0.319 . . . . 0.0 111.109 -179.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.7 140.6 47.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.799 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.946 179.903 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.48 ' O ' HD13 ' A' ' 45' ' ' LEU . . . . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.691 0.281 . . . . 0.0 111.163 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.58 ' HA ' HD13 ' A' ' 45' ' ' LEU . 15.7 t -49.34 -26.2 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.19 179.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -65.74 -10.02 33.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.738 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -119.6 6.04 11.05 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.103 0.478 . . . . 0.0 109.772 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.74 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 1.4 mp -116.59 139.8 50.1 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.617 -179.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.464 ' CH2' ' CG1' ' A' ' 63' ' ' ILE . 25.5 m95 -133.73 168.09 19.34 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.228 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.587 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 6.4 p90 -139.61 163.51 32.37 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.009 178.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 81.1 p -109.13 136.41 48.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.786 0.327 . . . . 0.0 111.4 -178.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.83 173.2 12.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.288 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.85 -20.93 65.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.063 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -101.74 -2.14 30.87 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.221 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.75 1.91 52.61 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.929 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.7 t -81.8 114.41 22.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.915 0.358 . . . . 0.0 110.767 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.587 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -77.5 148.02 6.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.263 0.554 . . . . 0.0 111.783 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.518 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 0.3 OUTLIER -154.4 133.85 12.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.608 179.139 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.455 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 1.9 m . . . . . 0 C--N 1.328 -0.341 0 CA-C-O 121.356 0.598 . . . . 0.0 111.913 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.89 0.376 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -105.04 150.79 24.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.348 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.516 ' O ' ' NE1' ' A' ' 84' ' ' TRP . 0.3 OUTLIER -77.08 155.07 5.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.527 179.76 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.539 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 4.4 p-10 -134.48 133.48 40.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.173 0.511 . . . . 0.0 111.873 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -100.25 40.09 1.29 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.367 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.0 p -74.27 -43.87 55.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.458 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -98.43 173.48 6.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.117 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -46.08 -48.77 17.01 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.816 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -104.59 149.84 25.17 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.601 ' CG1' ' HA ' ' A' ' 115' ' ' CYS . 0.0 OUTLIER -78.39 144.65 10.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 CA-C-O 121.729 0.776 . . . . 0.0 111.805 -179.203 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -135.91 158.61 43.98 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.052 179.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.434 ' C ' ' HG2' ' A' ' 73' ' ' GLN . 36.4 p -101.15 140.81 34.92 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.541 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.434 ' HG2' ' C ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -163.67 164.24 15.28 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.896 179.8 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.49 139.99 74.81 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.341 2.027 . . . . 0.0 111.754 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -56.16 122.84 12.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.911 0.386 . . . . 0.0 111.007 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -112.69 129.44 24.43 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.58 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.96 -34.81 22.32 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.449 2.099 . . . . 0.0 112.971 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -88.0 -0.64 57.27 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -102.88 103.95 36.52 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 120.509 0.195 . . . . 0.0 110.957 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.548 ' O ' HD22 ' A' ' 94' ' ' LEU . 4.9 Cg_exo -77.1 19.95 0.67 Allowed 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.87 2.38 . . . . 0.0 113.246 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 11.5 mptt -120.45 -18.08 7.97 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 120.584 0.23 . . . . 0.0 111.27 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.466 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 4.4 mtt180 -90.3 21.59 3.76 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.615 ' O ' HD21 ' A' ' 94' ' ' LEU . . . -129.32 99.5 5.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.231 0.539 . . . . 0.0 110.928 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.517 ' HH2' ' HB1' ' A' ' 116' ' ' ALA . 59.1 m95 -109.91 133.96 52.6 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.271 0.558 . . . . 0.0 112.151 -178.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.9 pt -113.23 154.57 14.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.066 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.8 t -103.24 131.07 52.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.965 0.412 . . . . 0.0 111.228 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 43.7 t -124.43 94.87 4.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.406 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.02 -100.71 0.87 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.449 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.496 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -121.13 28.98 7.55 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.603 0.24 . . . . 0.0 110.703 -179.933 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.433 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.2 146.97 30.02 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.321 0.582 . . . . 0.0 112.446 -178.642 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.443 ' CG2' HD13 ' A' ' 101' ' ' LEU . 10.6 mm -94.56 121.24 44.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.338 178.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.419 ' CB ' ' CG1' ' A' ' 100' ' ' VAL . . . -120.96 141.49 50.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.247 0.546 . . . . 0.0 112.462 -178.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.68 146.56 54.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.545 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.615 HD21 ' O ' ' A' ' 83' ' ' ALA . 2.7 pt? -61.04 -56.6 19.16 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.826 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.569 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 97.2 p -73.81 -6.73 48.85 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -178.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.4 ' CB ' ' HB ' ' A' ' 99' ' ' ILE . 61.9 m-20 -139.63 91.06 2.45 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.869 -0.333 . . . . 0.0 111.203 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -66.6 -17.8 65.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.093 178.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.31 12.51 26.64 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.467 179.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.498 ' O ' HG11 ' A' ' 100' ' ' VAL . 10.2 mm -124.5 128.49 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.412 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.498 HG11 ' O ' ' A' ' 99' ' ' ILE . 19.3 m -146.31 135.54 16.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.832 0.348 . . . . 0.0 111.93 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.485 ' HA ' ' O ' ' A' ' 115' ' ' CYS . 6.7 mt -45.55 152.2 0.34 Allowed 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.728 0.775 . . . . 0.0 111.781 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -157.46 167.65 29.61 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.88 -177.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.476 ' HA ' HG21 ' A' ' 114' ' ' ILE . 4.6 mp -88.57 121.12 38.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.278 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.408 ' O ' ' CB ' ' A' ' 105' ' ' LYS . 56.1 mt -70.48 138.33 22.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.748 0.309 . . . . 0.0 111.161 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.408 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 0.1 OUTLIER 81.34 -9.68 1.26 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.7 179.893 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 46.76 29.99 1.09 Allowed 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 120.757 0.313 . . . . 0.0 111.425 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.5 p30 -102.34 160.41 14.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.931 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.69 -14.28 58.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.484 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -51.95 118.95 3.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.83 0.348 . . . . 0.0 111.158 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.44 161.07 23.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.114 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.33 14.74 80.56 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.202 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.38 133.84 38.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.82 0.343 . . . . 0.0 111.063 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -61.38 163.25 6.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.06 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.476 HG21 ' HA ' ' A' ' 103' ' ' ILE . 0.6 OUTLIER -135.6 161.7 38.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.708 -179.836 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.601 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 26.2 p -162.3 176.94 10.05 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.517 ' HB1' ' HH2' ' A' ' 84' ' ' TRP . . . -96.91 132.24 42.89 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.826 -0.349 . . . . 0.0 110.261 178.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.467 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 75.9 t-105 -136.32 163.23 30.91 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.422 0.629 . . . . 0.0 111.756 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.467 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.1 OUTLIER -64.98 117.18 7.25 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.774 179.956 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -62.8 125.62 24.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.877 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -136.1 13.17 3.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.215 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 77.49 59.74 2.99 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.354 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -116.16 152.55 17.91 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.486 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.55 -30.67 79.76 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.51 2.14 . . . . 0.0 111.976 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -77.21 -2.05 32.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.403 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.433 ' O ' ' CG2' ' A' ' 90' ' ' THR . 5.2 mm-40 -107.82 9.69 28.84 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.746 -0.206 . . . . 0.0 111.276 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.426 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 10.0 mmtt -106.5 140.99 38.52 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.872 0.368 . . . . 0.0 111.39 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -141.12 156.27 45.99 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.234 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.3 mt -112.14 138.45 41.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.072 0.463 . . . . 0.0 110.639 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 23.7 mm -113.73 140.29 34.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.599 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -139.58 94.84 2.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.668 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 53.0 m -53.0 111.14 0.62 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.35 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.412 ' HB3' ' CD2' ' A' ' 5' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.884 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 . . . . . 0 C--O 1.231 0.12 0 N-CA-C 110.488 -0.19 . . . . 0.0 110.488 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.599 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -152.66 170.53 20.02 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.405 179.302 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.423 ' CE2' HD12 ' A' ' 45' ' ' LEU . 0.1 OUTLIER -112.06 123.6 50.62 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.815 178.863 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.437 ' HB ' ' CD2' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -106.56 108.67 25.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.892 0.377 . . . . 0.0 110.488 -179.866 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -107.81 137.14 46.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.252 -178.907 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.3 t -75.13 107.76 7.42 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -62.4 -12.05 19.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.451 -178.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.8 tp -82.92 -62.15 1.68 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.871 0.367 . . . . 0.0 111.163 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -86.79 -11.85 49.76 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -178.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.64 0.68 68.78 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.041 -1.076 . . . . 0.0 111.46 -178.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.412 ' O ' ' HG3' ' A' ' 9' ' ' LYS . 7.6 mmtm -89.06 177.69 6.58 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.5 m -119.72 141.26 40.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.437 ' CD2' ' HB ' ' A' ' 8' ' ' ILE . 0.1 OUTLIER -72.24 136.51 46.36 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.242 179.613 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -140.97 148.7 40.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.899 -179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.1 mt . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.128 179.246 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 CA-C-O 120.165 -0.242 . . . . 0.0 113.665 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.2 m -71.52 122.41 20.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.316 0.558 . . . . 0.0 111.141 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -76.6 160.56 29.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.586 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.438 HD12 HG23 ' A' ' 63' ' ' ILE . 44.5 pt -121.37 147.63 25.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.902 0.382 . . . . 0.0 111.992 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -155.77 -178.29 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.219 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.386 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.5 p -102.31 149.48 24.29 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.603 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 20.8 t-105 -160.38 174.56 13.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.676 0.274 . . . . 0.0 110.843 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -71.12 136.29 48.11 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.814 0.34 . . . . 0.0 110.729 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.947 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.53 ' O ' HD11 ' A' ' 45' ' ' LEU . . . . . . . . 0 CA--C 1.527 0.074 0 N-CA-C 111.525 0.195 . . . . 0.0 111.525 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.509 ' HA ' ' CD1' ' A' ' 45' ' ' LEU . 1.6 t -58.62 -18.48 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 120.686 0.279 . . . . 0.0 110.79 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -62.57 -9.93 10.42 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.12 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -114.55 7.46 16.13 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.599 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 1.7 mp -119.12 145.72 45.72 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.159 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.462 ' CH2' ' CG1' ' A' ' 63' ' ' ILE . 22.8 m95 -133.22 170.65 15.11 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.882 -178.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.548 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 1.1 p90 -135.85 159.8 40.55 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.856 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.8 p -106.15 132.98 51.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.732 0.301 . . . . 0.0 111.196 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -77.57 164.64 25.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.949 0.404 . . . . 0.0 111.268 -179.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 22.2 mm100 -57.77 -23.3 51.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.13 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.61 -1.84 42.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.292 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.31 4.67 56.24 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.987 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 23.9 t -87.72 117.68 32.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.921 0.361 . . . . 0.0 110.544 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.548 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.9 OUTLIER -78.62 150.03 5.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.278 0.561 . . . . 0.0 111.939 -179.77 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.527 ' HB2' ' CE2' ' A' ' 47' ' ' TYR . 8.8 mmm-85 -146.9 133.2 19.5 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.308 178.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.422 ' OG ' ' CE2' ' A' ' 46' ' ' TRP . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.413 0 CA-C-O 121.333 0.587 . . . . 0.0 112.098 -178.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.437 ' CE2' ' HD3' ' A' ' 74' ' ' PRO . 3.7 m-85 . . . . . 0 C--O 1.233 0.235 0 CA-C-O 120.96 0.41 . . . . 0.0 110.627 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -102.15 151.27 22.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.042 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.489 ' O ' ' NE1' ' A' ' 84' ' ' TRP . 0.2 OUTLIER -78.61 151.19 5.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.484 179.692 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.579 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 7.7 p-10 -131.95 129.87 40.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.084 0.469 . . . . 0.0 111.646 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -95.32 41.42 1.1 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.363 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.9 m -74.51 -44.65 50.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.218 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 33.6 m170 -94.94 170.73 9.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.976 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -48.59 -44.62 37.07 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.939 0.399 . . . . 0.0 110.951 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.13 144.67 31.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.659 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.65 ' CG1' ' HA ' ' A' ' 115' ' ' CYS . 2.1 mm -76.35 143.9 12.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.521 0.677 . . . . 0.0 111.649 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -143.31 167.86 21.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.947 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 63' ' ' ILE . 71.6 p -107.49 140.31 40.66 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.296 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.33 164.76 15.25 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.309 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.437 ' HD3' ' CE2' ' A' ' 61' ' ' PHE . 51.4 Cg_exo -52.82 138.34 60.34 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.399 2.066 . . . . 0.0 111.844 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -60.74 133.48 56.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.85 0.357 . . . . 0.0 111.113 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.86 134.79 25.61 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.639 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.03 -34.78 16.22 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.46 2.106 . . . . 0.0 112.847 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 36.6 m-20 -86.87 -0.52 56.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.735 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -105.8 101.38 32.68 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-O 120.639 0.257 . . . . 0.0 111.078 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.431 ' O ' ' CD2' ' A' ' 94' ' ' LEU . 74.1 Cg_endo -77.2 21.45 0.61 Allowed 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.63 2.22 . . . . 0.0 113.091 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.579 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 6.6 mptt -117.97 -19.86 8.98 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.127 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.508 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 3.2 mtm180 -88.88 19.99 3.79 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -178.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.698 ' O ' HD23 ' A' ' 94' ' ' LEU . . . -128.86 99.23 5.23 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.091 0.472 . . . . 0.0 110.81 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.489 ' NE1' ' O ' ' A' ' 63' ' ' ILE . 59.5 m95 -109.54 135.5 50.44 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.148 0.499 . . . . 0.0 111.91 -178.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.2 pp -114.05 154.37 15.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.297 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.5 t -100.53 125.05 54.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.919 0.39 . . . . 0.0 111.085 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 12.9 t -117.62 93.55 4.2 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.433 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.12 -100.52 0.79 Allowed Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.538 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.492 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.64 29.42 7.43 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.534 0.207 . . . . 0.0 110.927 -179.658 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.87 147.83 30.19 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.334 0.588 . . . . 0.0 112.473 -178.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.44 ' O ' ' HA ' ' A' ' 100' ' ' VAL . 14.7 mm -93.49 119.88 42.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.144 178.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.416 ' HB1' HG12 ' A' ' 100' ' ' VAL . . . -122.25 145.17 48.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.236 0.541 . . . . 0.0 112.434 -178.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.434 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -66.84 148.3 52.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.627 179.719 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.698 HD23 ' O ' ' A' ' 83' ' ' ALA . 2.7 pt? -60.6 -56.74 17.7 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.554 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.539 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 0.3 OUTLIER -77.74 -3.51 41.6 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 -178.428 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -138.1 86.33 2.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.799 0.333 . . . . 0.0 110.961 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 14.7 mmt180 -67.74 -18.04 64.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.21 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -92.93 11.33 27.67 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.43 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.492 ' O ' HG11 ' A' ' 100' ' ' VAL . 9.8 mm -124.93 130.25 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.569 179.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.492 HG11 ' O ' ' A' ' 99' ' ' ILE . 27.7 m -147.34 136.91 16.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.84 0.352 . . . . 0.0 111.783 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.492 ' HA ' ' O ' ' A' ' 115' ' ' CYS . 9.4 mt -46.71 154.7 0.3 Allowed 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.674 0.749 . . . . 0.0 111.909 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -160.49 169.74 22.39 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.493 -1.231 . . . . 0.0 110.746 -177.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.439 ' HA ' HG23 ' A' ' 114' ' ' ILE . 4.0 mp -86.48 124.13 40.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.238 179.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.1 tt -63.57 138.38 23.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.066 0.46 . . . . 0.0 111.582 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 25.5 mttp 48.62 24.99 0.86 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.6 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 33.2 t 44.48 -121.32 0.82 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.98 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 61.11 150.26 0.02 OUTLIER 'General case' 0 C--N 1.334 -0.079 0 CA-C-O 120.923 0.392 . . . . 0.0 111.203 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.22 -13.5 55.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.182 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -45.74 136.5 6.07 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.369 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -89.84 162.2 15.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.21 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 73.36 18.03 79.15 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.192 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -85.03 136.67 33.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.805 0.336 . . . . 0.0 110.885 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -61.07 170.84 1.45 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.888 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.45 ' O ' HG12 ' A' ' 70' ' ' ILE . 0.7 OUTLIER -142.11 161.63 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.685 -179.859 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.65 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 20.8 p -156.84 173.75 16.53 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.463 ' HB2' ' CG2' ' A' ' 99' ' ' ILE . . . -95.47 128.79 42.61 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.464 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 73.9 t-105 -136.61 162.44 33.13 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.585 0.707 . . . . 0.0 112.128 -179.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.464 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.1 OUTLIER -60.26 119.43 7.9 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.663 179.887 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -62.45 129.04 38.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.095 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -139.35 12.88 2.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.107 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 80.64 11.79 83.62 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.833 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.25 139.08 41.67 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.497 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.51 -28.37 54.54 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.472 2.115 . . . . 0.0 112.326 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -74.66 -2.15 24.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.622 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -104.45 -15.53 15.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.745 -0.207 . . . . 0.0 111.441 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.415 ' O ' ' CD1' ' A' ' 127' ' ' PHE . 0.2 OUTLIER -78.07 137.87 38.47 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.899 0.38 . . . . 0.0 111.361 -179.29 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.415 ' CD1' ' O ' ' A' ' 126' ' ' LYS . 8.4 m-85 -137.5 156.26 48.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.155 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.416 HD12 HG21 ' A' ' 128' ' ' ILE . 1.2 mt -114.32 137.03 48.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.151 0.501 . . . . 0.0 110.57 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.417 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 33.5 mm -113.59 139.49 38.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.574 -179.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -138.82 109.39 6.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.501 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.76 110.24 1.11 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.047 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.894 180.0 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.138 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.761 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -155.89 172.39 18.44 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.804 179.638 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.435 ' CE1' ' HB3' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -112.95 123.85 51.27 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.13 179.135 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.435 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -105.18 108.96 26.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.906 0.384 . . . . 0.0 110.389 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' A' ' 15' ' ' LYS . 7.7 tttt -105.82 136.14 45.99 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.235 -178.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 70.3 m -73.85 109.17 7.15 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.426 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 3.8 tt0 -63.14 -12.39 27.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.521 -178.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 43.5 tp -84.8 -62.12 1.62 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.894 0.378 . . . . 0.0 111.115 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.406 ' CB ' ' HG2' ' A' ' 15' ' ' LYS . 8.9 m-20 -84.33 -12.71 54.1 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -178.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.5 3.02 70.4 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.007 -1.092 . . . . 0.0 111.632 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' A' ' 9' ' ' LYS . 13.2 mmtp -91.58 -177.26 4.75 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 4.3 m -121.7 142.21 38.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.787 0.327 . . . . 0.0 110.614 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.2 mt -70.56 134.94 48.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.276 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 19' ' ' ILE . 61.5 t0 -142.51 141.72 32.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.767 0.318 . . . . 0.0 111.043 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.426 HG21 HD12 ' A' ' 19' ' ' ILE . 25.1 mt . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.564 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.462 0 CA-C-O 120.28 -0.178 . . . . 0.0 112.912 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.88 139.73 50.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 117.028 0.414 . . . . 0.0 110.784 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.88 158.38 16.33 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.485 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.473 HD12 HG23 ' A' ' 63' ' ' ILE . 37.3 pt -117.53 147.56 20.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.548 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.441 ' HA ' ' CD1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -155.44 -179.72 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.728 -179.84 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 p -103.77 150.55 23.98 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.667 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 31.4 t-105 -158.8 173.49 16.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.643 0.259 . . . . 0.0 110.922 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -68.89 131.68 45.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.82 0.343 . . . . 0.0 110.693 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.427 ' HG3' ' CE1' ' A' ' 7' ' ' TYR . 5.3 tt0 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.348 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.583 ' O ' HD11 ' A' ' 45' ' ' LEU . . . . . . . . 0 N--CA 1.456 -0.156 0 CA-C-O 120.767 0.317 . . . . 0.0 110.443 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.551 ' HA ' HD11 ' A' ' 45' ' ' LEU . 60.4 t -50.48 -28.84 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.817 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -57.65 -13.75 4.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.144 -179.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.435 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -121.31 12.24 10.91 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 120.926 0.393 . . . . 0.0 110.364 -179.909 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.761 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 1.2 mp -118.32 140.13 50.29 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.062 -179.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.503 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 23.8 m95 -133.3 169.19 17.27 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.098 -179.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.516 ' CZ ' ' HB2' ' A' ' 55' ' ' ARG . 31.1 p90 -142.39 165.71 26.67 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.317 179.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 74.6 p -106.84 131.79 53.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.81 0.338 . . . . 0.0 111.272 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -77.44 165.6 24.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.077 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -63.12 -26.9 69.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.951 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -85.97 -4.64 59.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.277 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.48 15.08 41.97 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.82 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 40.2 t -106.09 123.74 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-O 120.662 0.267 . . . . 0.0 110.495 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.48 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.6 OUTLIER -77.5 148.74 6.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.289 0.566 . . . . 0.0 111.828 -179.963 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.516 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -150.06 133.28 16.34 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.323 178.903 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.503 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 16.5 m . . . . . 0 C--N 1.326 -0.437 0 CA-C-O 121.512 0.673 . . . . 0.0 112.029 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.444 ' CE2' ' HD3' ' A' ' 74' ' ' PRO . 2.9 m-85 . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.818 0.342 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -109.51 153.24 24.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.405 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.482 ' O ' ' CD1' ' A' ' 84' ' ' TRP . 0.2 OUTLIER -79.15 151.82 4.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.595 179.647 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.617 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 10.5 p-10 -133.42 130.54 38.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.261 0.553 . . . . 0.0 111.787 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -93.58 41.26 1.08 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.398 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 77.7 p -74.73 -42.87 57.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.379 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -98.11 171.04 8.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.096 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -47.6 -46.34 28.26 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.095 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.05 143.98 31.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.029 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.572 ' CG1' ' HA ' ' A' ' 115' ' ' CYS . 3.0 mm -71.38 136.38 25.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 CA-C-O 121.605 0.717 . . . . 0.0 111.454 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -133.07 165.59 24.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.351 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.441 ' C ' ' HG2' ' A' ' 73' ' ' GLN . 27.5 p -105.21 134.45 48.29 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.212 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.441 ' HG2' ' C ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -161.75 167.82 12.22 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.181 -179.681 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.444 ' HD3' ' CE2' ' A' ' 61' ' ' PHE . 21.4 Cg_endo -61.11 139.44 84.12 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.308 2.005 . . . . 0.0 112.015 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -59.58 139.65 56.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.935 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -129.38 135.0 26.89 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.791 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -68.24 -35.63 18.52 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.505 2.137 . . . . 0.0 112.762 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -88.79 -1.25 57.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.699 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.401 ' HB3' ' HD2' ' A' ' 82' ' ' ARG . 2.9 t-20 -110.91 99.05 41.02 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-O 120.611 0.243 . . . . 0.0 110.846 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.53 ' O ' HD23 ' A' ' 94' ' ' LEU . 4.4 Cg_exo -74.94 27.98 0.36 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.878 2.385 . . . . 0.0 113.387 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.617 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -119.03 -23.63 6.8 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-O 120.673 0.273 . . . . 0.0 111.036 -179.833 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.433 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 0.6 OUTLIER -86.35 22.97 1.68 Allowed 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -179.076 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.571 ' O ' HD22 ' A' ' 94' ' ' LEU . . . -133.7 99.96 4.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.206 0.527 . . . . 0.0 111.17 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.482 ' CD1' ' O ' ' A' ' 63' ' ' ILE . 59.7 m95 -109.67 136.61 48.75 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.891 -178.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 20.4 pt -113.37 154.52 14.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.112 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.5 t -101.75 125.93 55.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.993 0.425 . . . . 0.0 111.057 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.9 t -118.74 93.87 4.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.338 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.41 -100.73 0.83 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.425 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.499 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -121.15 29.78 7.15 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.544 0.211 . . . . 0.0 110.842 -179.868 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.408 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.12 147.46 30.58 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -178.6 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.409 ' O ' ' HB ' ' A' ' 100' ' ' VAL . 14.1 mm -93.86 119.17 41.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.492 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.495 ' CB ' HG11 ' A' ' 100' ' ' VAL . . . -123.27 146.68 47.67 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -178.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.422 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.1 OUTLIER -64.78 149.18 49.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.599 179.867 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.575 ' HG ' ' N ' ' A' ' 95' ' ' SER . 2.7 pt? -64.61 -56.88 11.08 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.551 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.575 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 47.3 t -76.2 -2.3 30.57 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -178.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.473 ' CB ' HG22 ' A' ' 99' ' ' ILE . 11.1 m-20 -145.85 90.85 2.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.029 0.442 . . . . 0.0 110.939 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.43 -13.7 61.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.546 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -86.15 10.44 14.49 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.486 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.581 ' O ' HG11 ' A' ' 100' ' ' VAL . 3.2 tt -135.12 142.38 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.581 HG11 ' O ' ' A' ' 99' ' ' ILE . 32.1 m -150.51 139.51 15.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.851 0.357 . . . . 0.0 111.871 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.464 ' HG ' ' CZ3' ' A' ' 84' ' ' TRP . 11.9 mt -45.58 154.13 0.22 Allowed 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.8 0.809 . . . . 0.0 111.997 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.408 ' OD2' ' CG ' ' A' ' 125' ' ' GLN . 9.4 t70 -157.51 167.71 29.41 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 114.18 -1.373 . . . . 0.0 110.563 -177.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.5 mp -90.42 122.44 41.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.406 179.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 8.9 tt -67.45 140.86 18.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.971 0.415 . . . . 0.0 111.379 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt 76.95 -7.32 1.87 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.935 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.6 m 46.56 28.85 0.82 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 120.76 0.314 . . . . 0.0 111.232 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -99.63 159.96 14.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.052 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.36 -14.43 58.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.182 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -47.48 126.18 9.39 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.163 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.87 158.31 36.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.225 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.57 14.77 80.89 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.327 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.1 131.91 38.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.816 0.341 . . . . 0.0 110.872 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 8.1 m170 -65.1 173.52 2.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.024 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.523 ' O ' HG12 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -136.35 161.5 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.367 179.928 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.572 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 7.4 t -152.47 166.57 31.55 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.449 ' HB3' HG12 ' A' ' 99' ' ' ILE . . . -93.92 125.02 38.3 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.46 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 68.2 t-105 -131.49 161.72 31.89 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.672 0.748 . . . . 0.0 112.455 -179.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.46 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.0 OUTLIER -63.85 121.13 13.3 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.792 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -60.43 124.11 19.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.977 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -136.18 8.4 3.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.503 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 79.53 57.16 3.18 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.479 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -116.51 143.31 18.01 Favored Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.488 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.82 -32.53 77.44 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.57 2.18 . . . . 0.0 112.326 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -73.71 -5.33 39.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.632 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.408 ' O ' ' CG2' ' A' ' 90' ' ' THR . 93.0 mt-30 -107.29 10.11 29.85 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.509 0.195 . . . . 0.0 111.362 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.426 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -106.21 140.86 38.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.864 0.364 . . . . 0.0 111.104 -179.627 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.414 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 7.9 m-85 -139.35 156.84 46.74 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.45 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.4 mt -113.79 139.17 40.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.095 0.474 . . . . 0.0 110.679 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 25.5 mm -114.6 139.96 37.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.62 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -137.47 94.56 2.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.59 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 27.2 m -51.04 108.67 0.26 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.356 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.198 -0.906 . . . . 0.0 111.172 179.824 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.454 ' HA ' ' O ' ' A' ' 46' ' ' TRP . 17.0 m-85 . . . . . 0 C--O 1.231 0.087 0 N-CA-C 110.493 -0.188 . . . . 0.0 110.493 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.763 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -159.42 176.02 12.61 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.76 179.694 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.419 ' CE1' ' HB3' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -114.96 124.12 50.87 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.365 179.099 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.468 HG23 HD11 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -105.89 109.4 27.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.465 179.921 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.405 ' HG3' ' O ' ' A' ' 15' ' ' LYS . 1.3 tttm -105.82 136.61 45.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.064 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 79.3 p -76.51 107.76 9.02 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 178.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -63.15 -10.33 14.57 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.467 -178.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 27.0 tp -83.16 -62.67 1.53 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.862 0.363 . . . . 0.0 110.911 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -86.25 -10.83 53.86 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -178.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.39 3.74 72.07 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.172 -1.014 . . . . 0.0 111.421 -178.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.405 ' O ' ' HG3' ' A' ' 9' ' ' LYS . 4.0 mmmm -91.67 -177.73 4.86 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 122.583 0.353 . . . . 0.0 110.054 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.5 m -121.27 140.83 44.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.69 0.281 . . . . 0.0 110.484 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.1 mt -70.67 136.26 48.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.233 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -140.51 153.98 46.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.85 0.357 . . . . 0.0 111.147 -179.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.469 HD11 ' CZ2' ' A' ' 46' ' ' TRP . 1.6 mt . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.59 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.404 0 N-CA-C 112.7 -0.16 . . . . 0.0 112.7 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.7 m -71.75 137.47 47.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.903 0.382 . . . . 0.0 111.134 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.99 156.64 19.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.299 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.481 HD13 HG22 ' A' ' 63' ' ' ILE . 44.2 pt -116.42 145.59 21.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.913 0.387 . . . . 0.0 111.598 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -155.93 -178.91 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.164 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.529 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.4 p -101.2 148.92 24.53 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.561 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 18.1 t-105 -156.81 171.67 19.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.721 0.296 . . . . 0.0 110.98 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.45 134.51 47.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.719 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.112 -179.913 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.45 ' O ' ' CD1' ' A' ' 45' ' ' LEU . . . . . . . . 0 N--CA 1.457 -0.115 0 CA-C-O 120.722 0.296 . . . . 0.0 111.109 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.563 ' HA ' HD12 ' A' ' 45' ' ' LEU . 81.6 t -49.44 -33.24 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.103 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -66.26 -9.26 30.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.046 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.419 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 6.4 mt-30 -118.95 8.22 11.61 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.763 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 0.9 OUTLIER -117.65 140.11 50.09 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.71 -178.943 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.491 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 23.1 m95 -134.0 168.62 18.46 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.545 -178.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.549 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 5.3 p90 -136.53 160.29 39.21 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.081 179.031 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 29.1 p -105.72 134.55 48.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.708 0.29 . . . . 0.0 110.9 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -77.42 165.68 24.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.88 0.371 . . . . 0.0 111.092 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.1 mm-40 -55.45 -21.76 17.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.28 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -103.94 -1.26 27.9 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.414 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.62 -0.15 49.4 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.69 -0.766 . . . . 0.0 113.068 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.0 t -78.95 113.62 18.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.817 0.342 . . . . 0.0 110.695 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.549 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.8 OUTLIER -79.55 147.14 6.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.407 0.622 . . . . 0.0 112.212 -179.537 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.461 ' HB2' ' CE2' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -150.82 132.58 14.98 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.904 178.5 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 99.9 p . . . . . 0 CA--C 1.508 -0.639 0 CA-C-O 121.758 0.789 . . . . 0.0 111.818 -179.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.745 0.307 . . . . 0.0 110.816 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -104.94 151.22 24.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.514 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.481 ' O ' ' CD1' ' A' ' 84' ' ' TRP . 0.2 OUTLIER -79.79 151.82 4.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.465 179.607 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.603 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 7.4 p-10 -133.38 130.69 39.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.244 0.545 . . . . 0.0 111.776 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -93.33 43.48 1.12 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.245 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.0 m -75.48 -45.63 37.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.448 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -95.85 171.89 8.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.018 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -49.17 -41.77 37.68 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.91 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.24 144.23 32.32 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.801 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.638 ' CG1' ' HA ' ' A' ' 115' ' ' CYS . 2.5 mm -74.3 139.71 18.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.537 0.684 . . . . 0.0 111.441 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -138.61 166.83 23.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.718 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 63' ' ' ILE . 47.3 p -105.09 138.91 40.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.139 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.07 169.54 8.03 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.2 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -61.16 137.35 70.67 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.491 2.128 . . . . 0.0 112.028 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -54.84 128.0 31.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.074 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.417 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 8.9 t70 -116.9 129.33 25.39 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.64 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -68.52 -35.35 17.69 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.546 2.164 . . . . 0.0 113.01 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 56.4 m-20 -86.78 -1.59 57.88 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.417 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 1.6 t-20 -116.36 99.52 52.79 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-O 120.659 0.266 . . . . 0.0 110.795 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.548 ' O ' HD23 ' A' ' 94' ' ' LEU . 8.1 Cg_exo -72.51 32.63 0.28 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.068 2.512 . . . . 0.0 113.498 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.603 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 0.7 OUTLIER -118.89 -23.96 6.76 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 120.656 0.265 . . . . 0.0 111.171 -179.718 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.46 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 8.3 mtt-85 -85.13 18.71 2.44 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.549 ' O ' HD22 ' A' ' 94' ' ' LEU . . . -127.76 99.26 5.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.201 0.524 . . . . 0.0 111.317 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.481 ' CD1' ' O ' ' A' ' 63' ' ' ILE . 59.7 m95 -109.93 135.56 50.61 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.803 -179.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.9 pt -114.79 155.6 15.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.19 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.3 t -103.22 130.25 53.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.962 0.41 . . . . 0.0 111.143 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 30.5 t -123.04 94.99 4.44 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.286 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.25 -100.51 0.8 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.423 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.501 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.93 29.68 7.25 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.532 0.206 . . . . 0.0 110.919 -179.756 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.403 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.39 147.24 30.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.394 0.616 . . . . 0.0 112.648 -178.536 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 100' ' ' VAL . 17.3 mm -94.12 119.87 42.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.2 178.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.438 ' CB ' HG12 ' A' ' 100' ' ' VAL . . . -122.54 144.88 48.8 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.432 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -64.99 147.74 52.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.52 179.452 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.584 ' HG ' ' N ' ' A' ' 95' ' ' SER . 2.6 pt? -62.73 -56.52 16.86 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.436 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.584 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 45.6 p -75.15 -4.59 39.62 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -178.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.424 ' O ' HG21 ' A' ' 99' ' ' ILE . 8.6 m-20 -140.1 89.03 2.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.815 0.34 . . . . 0.0 110.864 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.8 mmm-85 -70.78 -15.87 62.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.235 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.22 11.88 21.99 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.154 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.487 ' O ' HG11 ' A' ' 100' ' ' VAL . 1.0 OUTLIER -130.38 136.84 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.086 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.487 HG11 ' O ' ' A' ' 99' ' ' ILE . 26.8 m -148.47 138.41 16.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.777 0.322 . . . . 0.0 111.643 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.486 ' HA ' ' O ' ' A' ' 115' ' ' CYS . 10.7 mt -45.98 153.84 0.28 Allowed 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.723 0.773 . . . . 0.0 111.768 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -157.51 167.7 29.43 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.789 -177.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.455 ' HA ' HG23 ' A' ' 114' ' ' ILE . 4.3 mp -89.18 120.57 38.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.553 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.436 HG12 ' HA ' ' A' ' 114' ' ' ILE . 45.7 mm -69.2 143.25 15.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.823 0.344 . . . . 0.0 111.13 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 80.13 -9.82 1.36 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.689 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 46.76 29.51 0.99 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.749 0.309 . . . . 0.0 111.238 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 54.0 p30 -105.46 163.54 12.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.033 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -80.56 -14.38 58.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.181 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -49.24 120.96 4.4 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.174 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.03 161.99 30.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.25 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 72.24 18.53 78.14 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.231 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -82.85 136.48 34.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.803 0.335 . . . . 0.0 111.112 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 5.5 m170 -62.61 168.08 3.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.939 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.491 ' O ' HG12 ' A' ' 70' ' ' ILE . 0.7 OUTLIER -138.33 161.35 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.74 -179.772 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.638 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 5.2 t -155.15 169.67 23.62 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 101' ' ' LEU . . . -94.08 125.91 38.99 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.046 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.459 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 76.3 t-105 -132.88 162.28 31.99 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.622 0.725 . . . . 0.0 112.311 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.459 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.1 OUTLIER -61.2 120.2 9.9 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.581 -1.191 . . . . 0.0 110.608 179.855 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -59.25 126.63 28.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.122 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -134.63 10.01 3.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.289 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 78.92 8.85 87.59 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.923 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.36 152.32 44.61 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.537 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.88 -27.09 59.06 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.606 2.204 . . . . 0.0 112.206 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -76.31 -1.93 29.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.479 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.403 ' O ' ' CG2' ' A' ' 90' ' ' THR . 0.0 OUTLIER -109.17 13.31 24.51 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 116.736 -0.211 . . . . 0.0 111.072 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 7.5 mmmt -104.61 132.53 50.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.789 0.328 . . . . 0.0 111.273 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.43 ' CD1' ' N ' ' A' ' 127' ' ' PHE . 1.7 m-85 -135.83 154.99 51.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.376 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 mt -114.33 139.82 38.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.163 0.506 . . . . 0.0 110.706 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.404 ' CD1' ' CG2' ' A' ' 8' ' ' ILE . 24.6 mm -114.54 140.73 33.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.707 -179.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -139.15 95.33 2.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.616 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.8 m -50.25 113.15 0.8 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.466 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.908 -179.986 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.464 ' HA ' ' O ' ' A' ' 46' ' ' TRP . 1.6 p90 . . . . . 0 C--O 1.231 0.087 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.765 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -159.9 176.16 12.21 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.746 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.437 ' CE1' ' HB3' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -113.71 123.91 51.01 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.26 179.195 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.431 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -105.09 109.42 27.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.912 0.386 . . . . 0.0 110.58 -179.983 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 15' ' ' LYS . 2.8 tttt -107.09 138.61 42.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.022 -0.535 . . . . 0.0 112.271 -178.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.1 p -77.54 109.29 11.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.658 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 4.1 tt0 -64.58 -10.14 24.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.598 -178.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 65.0 tp -84.0 -62.79 1.48 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.974 0.416 . . . . 0.0 110.906 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -85.53 -12.36 51.89 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -178.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.83 1.9 74.5 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.038 -1.077 . . . . 0.0 111.245 -178.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.418 ' O ' ' HG3' ' A' ' 9' ' ' LYS . 6.6 mmmt -90.41 179.81 5.78 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.0 m -121.13 141.66 40.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 179.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.419 ' CD2' ' HB ' ' A' ' 8' ' ' ILE . 0.1 OUTLIER -71.89 136.62 46.99 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.374 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -142.1 150.37 41.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.948 0.404 . . . . 0.0 111.335 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.439 HD12 ' CZ2' ' A' ' 46' ' ' TRP . 23.7 mt . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.507 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 CA-C-O 120.361 -0.133 . . . . 0.0 113.09 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.23 129.71 37.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.942 0.401 . . . . 0.0 111.118 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.4 ' HA ' ' HG3' ' A' ' 71' ' ' GLU . 9.8 mmtt -81.16 159.51 24.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.554 179.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.477 HD11 HG23 ' A' ' 63' ' ' ILE . 48.2 pt -119.89 147.91 23.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.976 0.417 . . . . 0.0 111.729 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -155.74 -179.34 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.176 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.581 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.8 p -100.97 148.45 25.0 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.639 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 51.6 t-105 -156.77 170.92 21.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.681 0.277 . . . . 0.0 110.819 -179.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.62 135.53 48.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.744 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.019 -179.893 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.435 ' O ' ' CD1' ' A' ' 45' ' ' LEU . . . . . . . . 0 CA--C 1.528 0.105 0 CA-C-O 120.684 0.278 . . . . 0.0 111.307 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.598 ' HA ' HD11 ' A' ' 45' ' ' LEU . 57.3 t -48.88 -27.12 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.272 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -64.38 -11.74 35.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.912 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.437 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 5.6 mt-30 -120.28 7.16 10.7 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.096 0.474 . . . . 0.0 109.784 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.765 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 1.3 mp -118.18 140.21 50.12 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.949 -179.064 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.464 ' O ' ' HA ' ' A' ' 5' ' ' PHE . 25.5 m95 -135.12 169.88 16.77 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.019 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.574 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 5.2 p90 -141.13 165.5 27.36 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.158 178.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.53 131.7 52.6 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.827 0.346 . . . . 0.0 111.195 -179.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -77.61 165.48 24.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.093 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -59.94 -25.26 65.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.12 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -91.84 -3.57 55.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.391 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.75 10.4 52.9 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.891 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.5 t -98.23 121.22 48.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.778 0.323 . . . . 0.0 110.495 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.574 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -75.63 147.5 8.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.198 0.523 . . . . 0.0 111.884 -179.733 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.559 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -151.79 135.59 16.36 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.62 179.063 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 73.1 m . . . . . 0 C--N 1.328 -0.368 0 CA-C-O 121.255 0.55 . . . . 0.0 112.047 -179.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.425 ' CZ ' ' HG3' ' A' ' 74' ' ' PRO . 2.3 m-85 . . . . . 0 C--O 1.233 0.185 0 CA-C-O 120.81 0.338 . . . . 0.0 110.725 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -109.4 150.96 27.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.458 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.477 ' O ' ' CD1' ' A' ' 84' ' ' TRP . 0.3 OUTLIER -78.45 153.77 5.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.583 179.614 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.593 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 4.7 p-10 -133.28 130.19 38.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.226 0.536 . . . . 0.0 111.832 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -93.95 39.92 1.08 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.433 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.31 -44.73 51.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.172 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 50.6 m170 -94.11 169.44 10.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.928 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -46.9 -47.66 21.44 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.999 0.428 . . . . 0.0 110.956 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.409 ' OE1' ' CE1' ' A' ' 113' ' ' HIS . 0.0 OUTLIER -100.98 145.17 29.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.623 179.212 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.641 ' CG1' ' HA ' ' A' ' 115' ' ' CYS . 2.3 mm -73.09 137.8 22.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-O 121.553 0.692 . . . . 0.0 111.489 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.4 ' HG3' ' HA ' ' A' ' 29' ' ' LYS . 3.7 tt0 -132.34 161.93 32.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.015 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 63' ' ' ILE . 28.3 p -104.04 138.89 39.92 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.635 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.91 160.46 15.02 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.654 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.425 ' HG3' ' CZ ' ' A' ' 61' ' ' PHE . 51.1 Cg_exo -53.51 141.88 61.12 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.441 2.094 . . . . 0.0 111.785 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -55.13 134.6 49.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.875 0.369 . . . . 0.0 111.352 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -126.31 118.96 23.33 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.609 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -58.33 -36.66 97.41 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.633 2.222 . . . . 0.0 113.231 -179.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 29.1 m-20 -86.1 -0.68 56.2 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -106.5 103.54 46.65 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.6 0.238 . . . . 0.0 111.137 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.542 ' O ' HD22 ' A' ' 94' ' ' LEU . 79.1 Cg_endo -77.37 23.09 0.55 Allowed 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.649 2.233 . . . . 0.0 113.132 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.593 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 0.7 OUTLIER -119.87 -21.18 7.27 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.966 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.515 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 2.5 mtm180 -86.66 20.93 2.34 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.006 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.543 ' O ' HD21 ' A' ' 94' ' ' LEU . . . -129.79 99.91 5.3 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.275 0.56 . . . . 0.0 111.066 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.477 ' CD1' ' O ' ' A' ' 63' ' ' ILE . 63.4 m95 -110.47 136.8 49.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.846 -178.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 pp -117.01 155.45 18.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.215 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.1 t -100.79 125.77 54.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.917 0.389 . . . . 0.0 111.054 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 12.7 t -118.5 93.62 4.18 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.487 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.22 -100.84 0.82 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.517 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.501 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.74 29.32 7.47 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.557 0.218 . . . . 0.0 110.939 -179.655 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.419 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.82 148.18 30.61 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.379 0.609 . . . . 0.0 112.552 -178.576 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 100' ' ' VAL . 16.7 mm -93.41 119.98 42.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.303 178.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.429 ' HB2' HG11 ' A' ' 100' ' ' VAL . . . -123.55 145.29 48.99 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -178.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.434 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -66.67 147.05 53.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.723 179.713 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.591 ' HG ' ' N ' ' A' ' 95' ' ' SER . 2.6 pt? -60.81 -56.23 23.65 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.499 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.591 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 2.8 m -76.75 -3.95 40.83 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -178.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -139.04 87.88 2.24 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.88 0.371 . . . . 0.0 111.071 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -66.92 -18.25 65.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.173 179.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.27 10.42 32.03 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.509 179.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.476 ' O ' HG11 ' A' ' 100' ' ' VAL . 12.1 mm -122.37 127.29 75.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.596 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.476 HG11 ' O ' ' A' ' 99' ' ' ILE . 29.6 m -146.14 135.52 17.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.821 0.343 . . . . 0.0 111.796 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.488 ' HA ' ' O ' ' A' ' 115' ' ' CYS . 10.8 mt -45.97 154.0 0.27 Allowed 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.66 0.743 . . . . 0.0 111.913 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -157.92 168.59 26.74 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.88 -177.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.496 ' HA ' HG23 ' A' ' 114' ' ' ILE . 34.6 mm -88.77 126.95 41.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.603 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -64.16 134.11 29.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.184 0.516 . . . . 0.0 111.449 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 12.7 tttm 62.46 10.2 3.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.929 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.0 p 40.22 33.21 0.15 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.697 0.284 . . . . 0.0 111.587 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.93 154.73 18.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.931 0.396 . . . . 0.0 111.191 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.28 -16.17 56.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.322 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -49.36 126.52 13.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.791 0.329 . . . . 0.0 111.308 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -73.1 157.95 36.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.031 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.48 14.08 81.27 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.17 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.52 134.03 38.4 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.924 0.392 . . . . 0.0 111.035 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.409 ' CE1' ' OE1' ' A' ' 69' ' ' GLN . 0.3 OUTLIER -60.91 167.08 3.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.878 -179.798 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.496 HG23 ' HA ' ' A' ' 103' ' ' ILE . 0.1 OUTLIER -139.48 161.41 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.728 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.641 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 5.7 p -157.6 173.3 17.07 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.457 ' HB1' ' CG2' ' A' ' 99' ' ' ILE . . . -95.27 129.47 42.38 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.456 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 75.7 t-105 -136.04 162.47 32.79 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.565 0.698 . . . . 0.0 112.096 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.456 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.0 OUTLIER -61.63 118.77 7.51 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.773 179.976 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -59.01 127.13 30.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.997 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -134.08 11.25 3.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.155 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 77.44 7.64 87.06 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.864 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.5 154.88 41.4 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.507 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.46 -28.4 53.99 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.625 2.216 . . . . 0.0 112.28 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -74.52 -4.07 34.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.589 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.419 ' O ' ' CG2' ' A' ' 90' ' ' THR . 0.0 OUTLIER -108.34 15.81 23.69 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.571 0.224 . . . . 0.0 111.176 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.406 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 16.7 mmtt -107.06 134.01 50.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.765 0.317 . . . . 0.0 111.384 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.419 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 4.5 m-85 -137.05 155.29 49.85 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.303 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.4 mt -113.55 139.14 40.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.174 0.511 . . . . 0.0 110.587 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 24.0 mm -113.97 139.79 37.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.616 -179.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -136.77 94.68 3.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.628 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.3 p -52.48 110.81 0.54 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.253 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.432 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 5.2 tp10 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.996 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.46 ' HA ' ' O ' ' A' ' 46' ' ' TRP . 2.3 p90 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.451 0.167 . . . . 0.0 110.7 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.726 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -161.08 177.8 9.94 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.628 179.73 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.425 ' CZ ' HD12 ' A' ' 45' ' ' LEU . 1.0 OUTLIER -112.61 123.83 51.18 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.42 179.379 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.436 ' CD1' ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -103.97 109.42 27.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.123 0.487 . . . . 0.0 109.802 179.552 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 127' ' ' PHE . 0.0 OUTLIER -102.89 130.84 50.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.579 -178.025 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.68 103.18 7.46 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 178.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.402 ' HB3' ' O ' ' A' ' 126' ' ' LYS . 3.3 tt0 -65.58 -8.22 18.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.768 -178.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 36.1 tp -83.16 -63.6 1.33 Allowed 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.44 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -83.72 -7.78 59.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.862 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.78 4.85 72.54 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.11 -1.043 . . . . 0.0 111.234 -177.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm -94.43 -166.31 1.46 Allowed 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 122.809 0.444 . . . . 0.0 109.958 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.3 m -130.78 143.93 39.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 179.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.3 mt -70.19 135.11 48.76 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -145.15 155.97 43.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.915 0.388 . . . . 0.0 111.196 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.45 HG21 HD11 ' A' ' 19' ' ' ILE . 17.4 mt . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.517 179.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 CA-C-O 120.285 -0.175 . . . . 0.0 113.3 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.55 125.24 26.97 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 117.102 0.451 . . . . 0.0 111.258 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -77.64 159.99 28.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.562 179.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.413 HD12 ' HB ' ' A' ' 70' ' ' ILE . 47.9 pt -121.1 148.27 24.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.885 0.374 . . . . 0.0 111.771 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.406 HG23 ' HA ' ' A' ' 113' ' ' HIS . 0.3 OUTLIER -156.01 -178.3 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.219 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.551 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.6 p -100.54 147.94 25.35 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.617 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 25.6 t-105 -159.15 173.79 15.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.66 0.267 . . . . 0.0 110.798 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -69.8 134.7 48.83 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.815 0.34 . . . . 0.0 110.762 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.125 -179.87 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.575 ' O ' HD11 ' A' ' 45' ' ' LEU . . . . . . . . 0 N--CA 1.456 -0.151 0 CA-C-O 120.754 0.311 . . . . 0.0 110.447 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.528 ' HA ' HD11 ' A' ' 45' ' ' LEU . 28.3 t -50.32 -25.77 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.091 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -61.62 -11.33 11.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.712 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -120.13 8.43 10.95 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.015 0.436 . . . . 0.0 109.978 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.726 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 1.5 mp -116.98 139.77 50.27 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.828 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.46 ' O ' ' HA ' ' A' ' 5' ' ' PHE . 23.9 m95 -134.38 168.04 19.65 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.027 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.545 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 26.5 p90 -140.11 164.2 30.69 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.101 178.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -106.45 133.74 50.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.859 0.361 . . . . 0.0 111.327 -179.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -77.69 166.03 23.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.063 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.28 -24.08 62.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.112 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -94.74 -3.23 49.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.42 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.99 7.82 54.76 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.826 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.2 t -92.76 118.48 38.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.76 0.28 . . . . 0.0 110.549 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.545 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -76.11 146.98 8.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.294 0.568 . . . . 0.0 111.863 -179.786 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.519 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 7.7 mmm-85 -150.21 135.27 17.81 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.629 179.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 15.0 m . . . . . 0 C--N 1.327 -0.411 0 CA-C-O 121.369 0.604 . . . . 0.0 112.012 -179.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.874 0.368 . . . . 0.0 110.787 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -113.07 154.12 27.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.352 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.498 ' O ' ' CD1' ' A' ' 84' ' ' TRP . 0.2 OUTLIER -79.77 153.09 4.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.725 179.776 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.583 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 6.3 p-10 -132.33 132.8 43.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.126 0.489 . . . . 0.0 111.609 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -97.75 39.86 1.19 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.317 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.42 -43.52 60.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.252 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -96.29 172.08 8.18 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.018 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -47.73 -48.72 29.57 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.042 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.83 147.64 26.26 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.666 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.658 ' CG1' ' HA ' ' A' ' 115' ' ' CYS . 1.6 mm -78.62 144.01 11.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-O 121.649 0.738 . . . . 0.0 111.992 -179.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.73 166.07 25.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.799 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 63' ' ' ILE . 73.9 p -102.33 138.95 38.57 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.051 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.48 159.94 20.38 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.392 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -52.54 136.59 57.32 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.441 2.094 . . . . 0.0 111.887 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -57.09 132.19 52.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.223 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -121.75 134.46 24.64 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.608 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.3 -34.93 15.02 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.424 2.083 . . . . 0.0 112.608 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -87.4 -0.77 57.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.55 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -108.96 100.18 38.74 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-O 120.622 0.248 . . . . 0.0 111.021 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.42 ' O ' ' CD2' ' A' ' 94' ' ' LEU . 4.0 Cg_exo -76.73 25.14 0.45 Allowed 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.988 2.459 . . . . 0.0 113.02 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.583 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 42.7 mmtt -119.72 -21.06 7.41 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 120.635 0.255 . . . . 0.0 110.893 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.498 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 3.6 mtm180 -87.01 17.91 3.88 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.24 -179.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.681 ' O ' HD22 ' A' ' 94' ' ' LEU . . . -127.25 99.29 5.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.166 0.508 . . . . 0.0 110.764 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.498 ' CD1' ' O ' ' A' ' 63' ' ' ILE . 62.1 m95 -109.27 136.27 49.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.105 0.479 . . . . 0.0 111.77 -178.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.6 pp -115.73 154.6 17.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.139 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.8 t -102.03 130.0 52.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.932 0.396 . . . . 0.0 111.184 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 36.7 t -122.61 95.18 4.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.447 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.45 -100.71 0.83 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.545 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.499 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.97 29.67 7.25 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.509 0.195 . . . . 0.0 110.789 -179.731 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.424 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.72 147.63 30.13 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -178.49 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 27.5 mm -94.03 120.47 43.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.421 178.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.46 ' CB ' HG11 ' A' ' 100' ' ' VAL . . . -124.27 146.11 48.97 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -178.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.437 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.1 OUTLIER -65.42 150.06 48.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.673 179.894 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.681 HD22 ' O ' ' A' ' 83' ' ' ALA . 2.7 pt? -62.81 -57.22 11.63 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.721 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.551 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 1.5 m -79.8 -2.06 41.64 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -178.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -137.48 85.54 2.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.842 0.353 . . . . 0.0 110.809 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 16.4 mmt85 -69.48 -16.68 63.51 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.158 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -90.35 11.29 21.87 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.138 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.545 ' O ' HG11 ' A' ' 100' ' ' VAL . 5.6 tt -130.21 136.42 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.545 HG11 ' O ' ' A' ' 99' ' ' ILE . 19.8 m -148.57 137.36 15.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.455 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.507 ' HA ' ' O ' ' A' ' 115' ' ' CYS . 25.8 mt -45.31 153.99 0.19 Allowed 'General case' 0 CA--C 1.51 -0.596 0 CA-C-O 121.713 0.768 . . . . 0.0 111.622 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.4 ' HB2' ' HG2' ' A' ' 125' ' ' GLN . 27.4 t70 -157.49 167.72 29.38 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.964 -177.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.416 ' HA ' HG22 ' A' ' 114' ' ' ILE . 33.1 mm -86.46 123.34 39.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.232 179.063 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -68.26 139.3 20.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.1 0.476 . . . . 0.0 111.65 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.12 18.36 3.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.815 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 13.4 m 45.1 -132.87 0.84 Allowed 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.918 -0.128 . . . . 0.0 111.041 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 65.45 162.9 0.15 Allowed 'General case' 0 CA--C 1.526 0.037 0 CA-C-O 120.772 0.32 . . . . 0.0 111.025 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -90.04 -12.4 38.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.448 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -44.81 132.54 6.56 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.391 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -89.22 164.74 14.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.245 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 71.61 19.01 77.61 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.048 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -86.18 138.34 31.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.841 0.353 . . . . 0.0 110.915 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.406 ' HA ' HG23 ' A' ' 31' ' ' ILE . 34.7 m80 -62.12 170.52 2.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.749 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.446 ' O ' HG12 ' A' ' 70' ' ' ILE . 0.6 OUTLIER -143.94 161.84 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.928 -179.497 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.658 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 6.0 p -156.65 173.49 16.86 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 101' ' ' LEU . . . -95.99 128.71 43.13 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 178.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.451 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 75.0 t-105 -134.81 162.68 31.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.494 0.664 . . . . 0.0 112.059 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.451 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.3 OUTLIER -62.33 122.99 17.05 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.787 179.929 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -56.99 124.1 17.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.054 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -128.78 5.57 5.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.394 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 81.69 6.86 88.75 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.88 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -65.98 148.93 51.32 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.528 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.03 -27.01 57.91 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.564 2.176 . . . . 0.0 112.382 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 42.5 p-10 -66.95 -12.26 59.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.561 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.424 ' O ' ' CG2' ' A' ' 90' ' ' THR . 6.0 mt-30 -103.5 17.57 23.79 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.338 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 11' ' ' GLU . 12.3 mmtp -106.43 136.28 46.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.856 0.36 . . . . 0.0 111.568 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.419 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 3.0 m-85 -141.13 155.28 46.13 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.909 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 mt -110.65 139.68 33.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.146 0.498 . . . . 0.0 110.651 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 21.9 mm -112.98 139.69 36.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.648 -179.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -138.08 94.46 2.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.618 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.5 t -52.13 113.16 0.94 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.341 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.459 ' HB3' ' CE2' ' A' ' 5' ' ' PHE . 2.2 tm-20 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.272 -0.871 . . . . 0.0 110.932 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.593 0.235 . . . . 0.0 110.665 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.602 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -152.46 170.22 20.66 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 120.952 0.406 . . . . 0.0 111.14 179.303 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.447 ' O ' ' HA ' ' A' ' 129' ' ' ILE . 0.1 OUTLIER -108.62 123.74 49.42 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.932 178.942 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.447 ' CD1' ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -107.72 106.12 20.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.341 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.3 tptp -104.92 134.63 47.71 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 54.2 m -75.82 107.13 7.79 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.428 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 4.3 tt0 -63.14 -10.49 15.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.61 -178.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 51.1 tp -81.84 -62.96 1.49 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.97 0.414 . . . . 0.0 110.869 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -86.31 -7.46 58.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.244 -178.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.48 6.54 62.38 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.05 -1.071 . . . . 0.0 111.459 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.6 mmmm -94.94 -176.22 3.78 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.6 m -122.52 142.2 39.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.424 ' CD2' ' HB ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -72.56 138.23 46.74 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.174 179.52 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 19' ' ' ILE . 31.5 t0 -146.01 142.38 28.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.78 0.324 . . . . 0.0 111.033 -178.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.405 ' N ' ' OD1' ' A' ' 18' ' ' ASP . 7.9 mm . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.319 -0.4 . . . . 0.0 109.925 179.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 CA-C-O 120.236 -0.202 . . . . 0.0 113.066 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.5 m -72.55 138.61 47.01 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 117.085 0.443 . . . . 0.0 110.69 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.48 157.44 19.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.784 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.469 HD11 HG22 ' A' ' 63' ' ' ILE . 42.1 pt -115.74 145.9 20.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.377 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.409 ' HA ' ' CD1' ' A' ' 114' ' ' ILE . 0.3 OUTLIER -153.46 177.71 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.156 -179.741 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.8 p -102.03 148.89 24.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.759 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 41.0 t-105 -157.45 172.08 19.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.713 0.292 . . . . 0.0 110.826 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.65 134.21 48.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.732 0.301 . . . . 0.0 110.734 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.055 -179.942 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.51 ' O ' HD12 ' A' ' 45' ' ' LEU . . . . . . . . 0 CA--C 1.524 -0.03 0 CA-C-O 120.545 0.212 . . . . 0.0 111.168 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.485 ' HA ' ' CD1' ' A' ' 45' ' ' LEU . 2.5 t -60.27 -17.29 14.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.761 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 29.7 p30 -60.36 -13.51 13.55 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.047 178.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -111.38 7.36 20.87 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.602 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 1.8 mp -120.09 147.63 44.61 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.469 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.46 ' CH2' ' CG1' ' A' ' 63' ' ' ILE . 25.4 m95 -133.34 169.57 16.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.818 -179.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.501 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 1.5 p90 -136.14 159.19 42.47 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.007 178.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.0 p -106.22 132.88 51.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.763 0.316 . . . . 0.0 111.256 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -77.67 165.36 24.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.108 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -60.94 -24.07 65.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.017 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -93.17 -3.35 54.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.44 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.95 8.75 53.69 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.883 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.8 t -95.5 119.74 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 116.946 0.373 . . . . 0.0 110.638 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.501 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.8 OUTLIER -79.35 151.9 4.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.246 0.546 . . . . 0.0 111.863 -179.826 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.488 ' HB2' ' CE2' ' A' ' 47' ' ' TYR . 8.6 mmm-85 -148.11 133.3 18.36 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.289 179.063 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.48 0 CA-C-O 121.323 0.582 . . . . 0.0 111.968 -178.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.424 ' CE2' ' HD3' ' A' ' 74' ' ' PRO . 2.2 m-85 . . . . . 0 C--O 1.233 0.214 0 CA-C-O 121.121 0.486 . . . . 0.0 110.7 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -98.87 152.22 19.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.118 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.508 ' O ' ' NE1' ' A' ' 84' ' ' TRP . 0.2 OUTLIER -77.9 149.91 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.349 179.523 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.634 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 3.7 p-10 -131.51 133.16 44.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.133 0.492 . . . . 0.0 111.79 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.36 42.41 1.1 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.369 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 66.4 p -74.34 -44.53 52.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.15 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -96.72 172.53 7.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.963 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -48.86 -44.19 39.49 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.056 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.68 145.43 29.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.986 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.588 ' CG1' ' HA ' ' A' ' 115' ' ' CYS . 2.8 mm -75.77 141.8 15.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-O 121.555 0.693 . . . . 0.0 111.358 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -136.96 168.76 18.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.001 -0.999 . . . . 0.0 111.432 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.2 p -108.54 135.79 49.23 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.213 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.419 ' HA ' ' CE2' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -165.54 171.9 4.77 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.429 -179.725 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.424 ' HD3' ' CE2' ' A' ' 61' ' ' PHE . 75.6 Cg_exo -49.09 139.83 25.87 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.506 2.137 . . . . 0.0 111.957 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -47.74 -59.58 3.19 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 63.56 118.83 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 -179.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.47 -28.65 21.6 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.527 2.151 . . . . 0.0 113.445 -179.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -87.25 0.58 55.15 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.425 ' CB ' ' HD2' ' A' ' 82' ' ' ARG . 1.9 m120 -104.42 101.97 30.68 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 120.63 0.253 . . . . 0.0 111.328 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.433 ' O ' ' CD2' ' A' ' 94' ' ' LEU . 94.8 Cg_endo -77.58 18.6 0.81 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.733 2.288 . . . . 0.0 113.319 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.634 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -118.97 -19.84 8.35 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 120.716 0.293 . . . . 0.0 110.905 179.818 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.484 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 36.5 mtt180 -91.01 25.62 2.38 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.227 -178.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.663 ' O ' HD21 ' A' ' 94' ' ' LEU . . . -136.96 99.48 4.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.94 0.4 . . . . 0.0 110.898 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.508 ' NE1' ' O ' ' A' ' 63' ' ' ILE . 38.6 m95 -109.58 139.13 44.97 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.246 0.546 . . . . 0.0 111.78 -178.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 pp -112.7 155.92 13.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.287 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.6 t -102.64 128.15 55.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.962 0.41 . . . . 0.0 111.246 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.9 t -120.92 94.6 4.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.209 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.41 -100.98 0.85 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.34 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.5 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.76 29.84 7.2 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.579 0.228 . . . . 0.0 110.843 -179.81 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.425 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.44 147.51 30.29 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.383 0.611 . . . . 0.0 112.64 -178.595 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' ' 100' ' ' VAL . 20.1 mm -94.02 120.29 43.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.292 178.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.421 ' CB ' ' CG1' ' A' ' 100' ' ' VAL . . . -122.2 144.11 49.16 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.441 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -64.82 148.14 51.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.435 179.566 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.663 HD21 ' O ' ' A' ' 83' ' ' ALA . 2.5 pt? -62.79 -57.49 10.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.8 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.513 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 3.5 t -75.81 -3.91 37.69 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -141.14 89.63 2.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.841 0.353 . . . . 0.0 110.891 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 8.8 mmt85 -70.79 -16.02 62.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.232 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -88.93 10.87 19.79 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.253 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.498 ' O ' HG13 ' A' ' 100' ' ' VAL . 5.3 tt -131.05 137.54 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.498 HG13 ' O ' ' A' ' 99' ' ' ILE . 17.5 m -148.39 138.59 16.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.774 0.321 . . . . 0.0 111.536 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.486 ' HA ' ' O ' ' A' ' 115' ' ' CYS . 10.9 mt -46.32 153.87 0.31 Allowed 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.634 0.731 . . . . 0.0 111.581 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -158.85 168.08 27.75 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.46 -1.245 . . . . 0.0 110.669 -177.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.6 mp -87.34 120.69 37.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.139 179.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 40.2 mm -70.03 136.39 26.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.883 0.373 . . . . 0.0 111.253 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 8.4 tttt 78.92 -6.1 1.94 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.764 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.1 m 46.45 29.7 0.94 Allowed 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 120.809 0.338 . . . . 0.0 111.27 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.39 155.01 17.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.039 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.1 -13.74 59.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.097 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -48.78 123.14 6.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.229 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.4 157.86 30.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.037 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.24 12.55 81.76 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.146 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.51 131.52 41.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.873 0.368 . . . . 0.0 111.052 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -64.87 172.44 2.84 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.111 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.518 ' O ' HG12 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -136.71 161.67 36.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.349 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.588 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 6.3 t -153.38 167.47 29.29 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -94.75 125.24 39.28 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 177.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.459 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 76.1 t-105 -133.56 162.38 32.07 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.629 0.728 . . . . 0.0 112.291 -179.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.459 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.0 OUTLIER -61.79 119.82 9.49 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.621 179.836 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -59.74 126.05 26.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.1 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -134.11 10.7 3.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.21 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 81.15 7.88 87.96 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.981 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.48 150.09 47.74 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.603 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.37 -27.02 55.29 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.561 2.174 . . . . 0.0 112.182 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 32.1 p-10 -75.45 -4.42 39.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.425 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.425 ' O ' ' CG2' ' A' ' 90' ' ' THR . 0.0 OUTLIER -105.82 12.95 30.22 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.29 -179.741 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.428 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 5.9 mmtt -106.02 140.3 39.23 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.863 0.364 . . . . 0.0 111.367 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.414 ' CD1' ' O ' ' A' ' 126' ' ' LYS . 8.9 m-85 -138.67 155.27 48.42 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.162 179.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 mt -111.45 137.24 44.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.049 0.452 . . . . 0.0 110.41 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.447 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 36.6 mm -113.47 140.9 31.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.64 -179.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -140.83 106.2 5.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.596 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.61 109.11 0.94 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.044 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 34.5 tp10 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.232 -0.89 . . . . 0.0 111.127 179.888 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.464 ' HA ' ' O ' ' A' ' 46' ' ' TRP . 2.1 p90 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.484 0.183 . . . . 0.0 110.618 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.742 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -159.92 175.97 12.43 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.596 179.744 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.42 ' CE2' HD11 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -114.22 123.88 50.66 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.288 179.206 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.436 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -104.12 109.77 28.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.37 -179.924 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.63 135.42 47.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.464 -178.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.8 t -75.27 105.66 6.4 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -62.66 -11.88 19.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.594 -178.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.459 ' HB2' ' HA ' ' A' ' 124' ' ' ASN . 12.3 tp -84.51 -62.49 1.54 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.964 0.412 . . . . 0.0 110.967 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -83.08 -12.81 56.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.48 -178.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.53 2.9 76.7 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.143 -1.027 . . . . 0.0 111.491 -178.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -91.86 -175.14 4.04 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.4 m -121.62 140.22 46.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.656 0.265 . . . . 0.0 110.437 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.5 mt -69.4 134.76 49.41 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -143.61 153.99 43.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.888 0.375 . . . . 0.0 111.196 -178.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.463 HG23 HD12 ' A' ' 19' ' ' ILE . 34.0 mt . . . . . 0 C--N 1.327 -0.409 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.572 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.395 0 CA-C-O 120.332 -0.149 . . . . 0.0 113.08 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.75 138.61 48.58 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.946 0.403 . . . . 0.0 111.056 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.3 mptt -89.4 157.71 18.04 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.216 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.454 HD11 HG23 ' A' ' 63' ' ' ILE . 38.0 pt -116.34 145.91 21.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.799 0.333 . . . . 0.0 111.743 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.44 ' HA ' ' CD1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -155.32 178.17 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.192 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.537 -179.827 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.6 p -100.68 148.77 24.49 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 121.001 -0.279 . . . . 0.0 110.65 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 24.3 t-105 -157.69 172.57 18.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.706 0.289 . . . . 0.0 110.883 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -69.77 133.93 48.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.852 0.358 . . . . 0.0 110.706 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.411 ' HG3' ' CE1' ' A' ' 7' ' ' TYR . 6.9 tt0 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.112 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.444 ' O ' ' CD1' ' A' ' 45' ' ' LEU . . . . . . . . 0 CA--C 1.527 0.088 0 CA-C-O 120.765 0.317 . . . . 0.0 111.124 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.574 ' HA ' HD13 ' A' ' 45' ' ' LEU . 45.3 t -49.69 -29.77 4.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.113 179.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -65.69 -10.91 40.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.927 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.419 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 3.5 mt-30 -118.2 7.59 12.14 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.19 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.742 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 1.1 mp -118.82 140.38 50.05 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.981 -179.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.464 ' O ' ' HA ' ' A' ' 5' ' ' PHE . 24.8 m95 -134.12 168.82 18.13 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.92 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.533 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 32.0 p90 -140.73 164.93 28.87 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.219 178.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 81.1 p -107.6 134.32 50.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.833 0.349 . . . . 0.0 111.378 -178.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -77.81 170.25 16.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.15 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.17 -23.62 67.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.077 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.3 mm100 -94.04 -3.45 51.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.242 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.95 8.78 53.65 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.917 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.413 HG11 ' CE2' ' A' ' 75' ' ' PHE . 42.2 t -95.14 119.63 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-O 120.83 0.348 . . . . 0.0 110.693 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.533 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -76.68 147.85 7.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.341 0.591 . . . . 0.0 111.9 -179.792 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.502 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 8.2 mmm-85 -149.48 133.69 17.31 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.39 179.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.45 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 70.0 m . . . . . 0 C--N 1.326 -0.422 0 CA-C-O 121.463 0.649 . . . . 0.0 111.848 -178.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.434 ' CE2' ' HD3' ' A' ' 74' ' ' PRO . 2.8 m-85 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.828 0.347 . . . . 0.0 110.77 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -109.26 154.9 21.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.547 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.491 ' O ' ' NE1' ' A' ' 84' ' ' TRP . 0.2 OUTLIER -80.37 150.79 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.466 179.587 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.561 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 6.4 p-10 -131.61 132.09 43.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.064 0.459 . . . . 0.0 111.419 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -97.51 41.66 1.11 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.192 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.4 t -74.83 -45.54 42.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.158 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 59.6 m80 -94.44 170.76 9.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.982 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -47.83 -48.02 31.0 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.106 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -99.6 143.86 29.35 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.099 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.58 ' CG1' ' HA ' ' A' ' 115' ' ' CYS . 3.0 mm -74.2 139.95 18.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 CA-C-O 121.554 0.692 . . . . 0.0 111.478 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -139.88 168.94 18.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.262 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 63' ' ' ILE . 63.4 p -108.59 139.2 43.7 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.281 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.6 163.02 16.72 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.485 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.434 ' HD3' ' CE2' ' A' ' 61' ' ' PHE . 50.7 Cg_exo -55.08 136.06 71.49 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.474 2.116 . . . . 0.0 111.729 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.413 ' CE2' HG11 ' A' ' 53' ' ' VAL . 32.7 t80 -52.77 134.72 36.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.97 0.414 . . . . 0.0 111.489 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -124.21 116.8 27.03 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.477 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -56.98 -33.76 96.18 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.532 2.155 . . . . 0.0 113.045 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 33.5 m-20 -86.89 -0.07 55.86 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -179.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 -112.55 104.07 55.78 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 120.629 0.252 . . . . 0.0 111.114 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.426 ' O ' ' CD2' ' A' ' 94' ' ' LEU . 84.4 Cg_endo -76.84 27.11 0.43 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.733 2.289 . . . . 0.0 113.105 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.561 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 40.7 mmtt -120.29 -19.5 7.64 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 116.687 -0.233 . . . . 0.0 111.162 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.493 ' HG2' ' HB3' ' A' ' 64' ' ' ASP . 3.5 mtm180 -88.43 19.71 3.71 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.329 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.689 ' O ' HD22 ' A' ' 94' ' ' LEU . . . -130.03 99.38 5.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.075 0.464 . . . . 0.0 110.784 179.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.491 ' NE1' ' O ' ' A' ' 63' ' ' ILE . 58.8 m95 -109.05 135.77 49.66 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.146 0.498 . . . . 0.0 111.979 -178.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 pp -111.82 152.87 13.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.084 179.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.3 t -100.57 126.37 54.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.941 0.4 . . . . 0.0 111.133 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.3 t -119.39 94.85 4.56 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.577 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.81 -100.41 0.76 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.643 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.491 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.51 29.64 7.34 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.518 0.199 . . . . 0.0 110.977 -179.492 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -149.71 149.11 30.09 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.337 0.589 . . . . 0.0 112.493 -178.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 12.3 mm -94.01 120.71 43.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.449 178.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.545 ' CB ' HG13 ' A' ' 100' ' ' VAL . . . -121.38 144.54 48.61 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -178.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.419 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -66.33 149.02 51.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.929 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.689 HD22 ' O ' ' A' ' 83' ' ' ALA . 2.6 pt? -64.26 -57.36 9.67 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.018 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.551 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 3.5 m -74.06 -4.12 33.54 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.484 ' CB ' HG22 ' A' ' 99' ' ' ILE . 73.2 m-20 -146.73 93.01 2.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.099 0.476 . . . . 0.0 111.035 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.04 -13.12 61.15 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.587 179.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -87.89 12.02 14.23 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.481 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.554 ' O ' HG13 ' A' ' 100' ' ' VAL . 2.6 tt -135.09 143.25 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.554 HG13 ' O ' ' A' ' 99' ' ' ILE . 34.9 m -151.66 139.71 14.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.789 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.476 ' HG ' ' CZ3' ' A' ' 84' ' ' TRP . 10.6 mt -46.2 154.31 0.27 Allowed 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 121.722 0.772 . . . . 0.0 111.706 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -158.3 168.29 27.42 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.629 -177.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 26.8 mm -89.35 120.97 38.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.389 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 7.9 tp -64.72 138.66 22.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.023 0.44 . . . . 0.0 111.457 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 73.54 -3.71 2.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.043 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 45.3 t 44.19 31.26 0.53 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.76 0.314 . . . . 0.0 111.428 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -97.36 158.12 15.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.194 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.99 -13.4 59.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.183 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -49.11 131.93 19.29 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.26 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -77.17 158.86 30.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.017 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 72.3 15.34 76.98 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.145 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.05 132.61 40.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.895 0.378 . . . . 0.0 110.929 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -64.99 171.53 3.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.934 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.54 ' O ' HG12 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -135.45 161.25 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.397 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.58 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 5.8 t -152.39 167.22 29.41 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.459 ' HB3' HG12 ' A' ' 99' ' ' ILE . . . -94.99 124.73 39.21 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.447 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 77.0 t-105 -133.49 161.4 34.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.619 0.723 . . . . 0.0 112.236 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.447 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.0 OUTLIER -61.03 123.0 16.38 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.57 -1.195 . . . . 0.0 110.806 -179.906 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -58.84 125.05 21.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.951 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 13.3 p80 -136.98 6.32 2.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.595 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 78.26 57.1 3.49 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.273 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -112.0 138.73 15.18 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.509 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.67 -31.42 60.32 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.447 2.098 . . . . 0.0 112.18 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.459 ' HA ' ' HB2' ' A' ' 12' ' ' LEU . 10.9 p-10 -72.0 -8.0 52.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.575 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -101.9 -14.31 17.28 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.57 0.211 . . . . 0.0 111.57 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.428 ' O ' ' CD1' ' A' ' 127' ' ' PHE . 2.3 mmtt -78.27 136.73 37.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.811 0.339 . . . . 0.0 111.373 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.428 ' CD1' ' O ' ' A' ' 126' ' ' LYS . 6.8 m-85 -139.15 156.22 47.28 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.136 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.419 HD12 HG22 ' A' ' 128' ' ' ILE . 1.2 mt -112.33 137.77 43.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.176 0.513 . . . . 0.0 110.592 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 19.5 mm -114.36 138.7 43.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.527 -179.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -134.52 94.29 3.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.54 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.15 108.06 0.48 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.134 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.295 -0.86 . . . . 0.0 111.358 179.726 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mmm . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.878 0.371 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.9 mmmt -116.02 91.22 30.77 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.948 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.0 -170.35 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.489 2.126 . . . . 0.0 112.253 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.402 ' O ' ' CB ' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -114.67 141.3 47.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.92 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.471 ' CD1' ' HG3' ' A' ' 57' ' ' LYS . 0.1 OUTLIER -104.05 175.82 5.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.351 179.821 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.785 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -155.24 171.28 20.08 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.613 179.815 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.447 ' O ' ' HA ' ' A' ' 129' ' ' ILE . 2.0 m-85 -109.2 123.41 49.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.23 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.434 ' CD1' ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -108.23 103.72 15.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.842 0.353 . . . . 0.0 110.275 179.674 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.579 ' HB2' ' O ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -127.98 126.84 42.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.763 -179.036 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.437 ' O ' ' HD2' ' A' ' 9' ' ' LYS . 0.9 OUTLIER -46.15 138.44 5.29 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.019 0.437 . . . . 0.0 111.575 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -81.13 -11.28 59.5 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.082 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 61.4 tp -92.9 -56.54 2.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.165 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -83.24 -21.09 33.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.83 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.18 4.08 77.7 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.284 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.579 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 1.1 mmmm -85.26 164.25 18.15 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.555 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 12.6 m -106.95 137.0 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-O 120.769 0.318 . . . . 0.0 110.722 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 21.0 mt -68.31 136.57 53.65 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -138.26 152.01 48.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.841 0.353 . . . . 0.0 111.111 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.46 HD13 ' CZ2' ' A' ' 46' ' ' TRP . 1.5 mt -101.12 118.92 48.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.872 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -63.42 95.87 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.891 0.377 . . . . 0.0 110.444 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 157.24 -44.16 0.51 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.373 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 48.7 51.24 16.03 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.812 0.339 . . . . 0.0 111.323 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -177.17 171.98 0.86 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.053 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.56 -17.15 40.05 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.748 2.299 . . . . 0.0 112.418 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -45.51 99.49 0.21 Allowed Pre-proline 0 CA--C 1.531 0.215 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.329 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -69.17 150.65 72.06 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.69 2.26 . . . . 0.0 112.134 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.55 8.66 55.88 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.588 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.37 132.91 37.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.945 0.403 . . . . 0.0 111.114 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.87 155.65 30.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.311 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.445 HD13 HG21 ' A' ' 63' ' ' ILE . 47.8 pt -115.31 144.59 22.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.921 0.391 . . . . 0.0 111.676 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -156.09 -176.68 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.581 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.2 p -101.75 148.56 25.14 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.343 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 10.4 t-105 -159.1 173.84 15.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.709 0.29 . . . . 0.0 111.009 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -71.85 138.32 48.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.815 0.341 . . . . 0.0 110.86 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -64.79 137.28 57.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.176 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.9 mmmt -109.17 165.04 11.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.683 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.3 mtmt -128.14 112.19 14.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.983 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 146.05 -163.35 28.36 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.638 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -72.2 -1.18 9.7 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.983 2.455 . . . . 0.0 112.884 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.5 t -111.91 36.45 3.3 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.098 0.475 . . . . 0.0 110.666 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.442 ' O ' HD12 ' A' ' 45' ' ' LEU . . . -107.89 -18.95 13.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.885 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.583 ' HA ' HD12 ' A' ' 45' ' ' LEU . 99.6 t -49.73 -28.07 3.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.191 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -67.07 -9.0 34.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.804 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -119.6 6.14 11.05 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.153 0.501 . . . . 0.0 109.821 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.785 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 1.2 mp -116.07 138.86 50.86 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.583 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.46 ' CZ2' HD13 ' A' ' 19' ' ' ILE . 21.1 m95 -132.54 167.92 19.15 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.035 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.499 ' CE1' ' HB2' ' A' ' 55' ' ' ARG . 41.2 p90 -140.44 163.93 31.48 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.146 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -105.1 132.6 51.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.849 0.357 . . . . 0.0 111.345 -178.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -77.65 165.85 23.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.154 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -62.71 -24.16 67.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.14 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -90.3 -4.1 57.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.328 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.11 13.37 46.08 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.858 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.6 t -103.97 123.02 57.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.712 0.291 . . . . 0.0 110.533 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.48 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -75.71 149.23 6.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.369 0.604 . . . . 0.0 111.941 -179.828 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.499 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 7.5 mmm-85 -149.36 133.5 17.26 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.235 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 8.2 m -57.57 140.49 50.77 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.468 0.651 . . . . 0.0 111.862 -178.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.495 ' HB3' ' CG1' ' A' ' 42' ' ' VAL . 4.0 tttt -51.51 -24.32 5.04 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.838 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.435 ' N ' ' CG1' ' A' ' 42' ' ' VAL . 3.9 pp -56.46 -41.24 76.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.287 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 177.91 178.67 0.34 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.921 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.74 84.0 0.19 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.759 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -145.85 128.13 15.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.872 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.0 153.2 29.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.265 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.465 ' O ' ' CD1' ' A' ' 84' ' ' TRP . 0.2 OUTLIER -78.54 153.65 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.475 179.742 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.546 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 6.9 p-10 -133.63 132.94 41.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.203 0.525 . . . . 0.0 111.554 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -97.28 43.63 1.06 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.27 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.7 m -74.54 -45.56 44.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.084 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -94.66 171.9 8.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.834 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -50.87 -41.94 58.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.086 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.77 144.3 31.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.967 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.636 ' CG1' ' HA ' ' A' ' 115' ' ' CYS . 2.8 mm -72.47 135.95 26.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-O 121.642 0.734 . . . . 0.0 111.516 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -135.99 163.25 30.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.724 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.428 ' CG2' HG23 ' A' ' 19' ' ' ILE . 31.7 p -105.73 140.03 39.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.965 0.412 . . . . 0.0 111.195 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.46 ' CB ' ' HD2' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -162.41 169.09 9.7 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.29 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.46 ' HD2' ' CB ' ' A' ' 73' ' ' GLN . 19.4 Cg_endo -60.54 139.31 85.47 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.307 2.005 . . . . 0.0 111.913 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -57.0 138.21 54.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.088 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -129.98 119.15 18.77 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.685 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -56.53 -34.64 95.57 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.538 2.159 . . . . 0.0 112.907 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -86.54 -1.39 57.59 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -108.92 102.42 48.38 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.656 0.265 . . . . 0.0 110.957 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.429 ' O ' ' CD2' ' A' ' 94' ' ' LEU . 88.0 Cg_endo -76.78 24.57 0.47 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.725 2.283 . . . . 0.0 113.276 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.546 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 37.7 mmtt -120.03 -18.43 8.14 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 120.519 0.2 . . . . 0.0 111.195 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 2.0 mtt180 -89.14 20.06 3.91 Favored 'General case' 0 C--N 1.341 0.219 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.699 ' O ' HD22 ' A' ' 94' ' ' LEU . . . -129.3 99.62 5.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.093 0.473 . . . . 0.0 110.691 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.465 ' CD1' ' O ' ' A' ' 63' ' ' ILE . 60.5 m95 -108.99 134.92 51.0 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.123 0.487 . . . . 0.0 112.057 -178.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.4 pt -112.82 153.76 14.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.296 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.2 t -101.76 127.0 55.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.898 0.38 . . . . 0.0 111.087 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 25.2 t -119.49 95.21 4.69 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.632 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.47 -100.03 0.7 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.677 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.501 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.32 29.67 7.36 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.575 0.226 . . . . 0.0 110.962 -179.449 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.6 149.98 30.58 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.315 0.579 . . . . 0.0 112.474 -178.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.426 ' O ' ' HA ' ' A' ' 100' ' ' VAL . 12.6 mm -94.28 122.09 45.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.458 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.419 ' CB ' ' CG1' ' A' ' 100' ' ' VAL . . . -122.29 142.32 50.6 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.419 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -64.74 148.09 51.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.469 179.648 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.699 HD22 ' O ' ' A' ' 83' ' ' ALA . 2.7 pt? -62.43 -56.79 14.84 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.918 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.549 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 7.0 p -75.99 -4.0 38.78 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -178.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -141.16 89.82 2.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.866 0.365 . . . . 0.0 111.241 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -67.6 -16.4 64.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.259 178.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -92.5 10.03 31.93 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.476 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.486 ' O ' HG13 ' A' ' 100' ' ' VAL . 11.6 mm -123.51 128.24 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.477 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.486 HG13 ' O ' ' A' ' 99' ' ' ILE . 30.5 m -146.48 135.84 16.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.771 0.32 . . . . 0.0 111.667 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.467 ' HA ' ' O ' ' A' ' 115' ' ' CYS . 8.6 mt -47.09 154.4 0.36 Allowed 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.639 0.733 . . . . 0.0 111.475 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -155.85 166.89 32.15 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.875 -177.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.423 ' HA ' HG23 ' A' ' 114' ' ' ILE . 35.0 mm -89.73 120.54 38.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.426 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -64.84 138.89 22.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.038 0.447 . . . . 0.0 111.512 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 10.1 mmtp 76.01 -4.02 2.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.031 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 17.1 m 45.68 30.04 0.75 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.823 0.344 . . . . 0.0 111.285 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -100.41 165.09 11.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.215 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.54 -15.55 51.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.058 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -47.28 128.81 12.34 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.203 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -80.95 161.46 24.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.115 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 72.05 17.93 77.48 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.178 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.85 138.23 33.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.888 0.375 . . . . 0.0 110.967 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 28.9 m170 -62.87 171.07 2.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.787 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.479 ' O ' HG12 ' A' ' 70' ' ' ILE . 0.7 OUTLIER -142.67 161.76 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.688 -179.657 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.636 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 28.4 p -155.71 171.4 20.06 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.448 ' HB1' ' CG2' ' A' ' 99' ' ' ILE . . . -95.83 126.84 41.36 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.459 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 76.1 t-105 -134.98 162.61 31.94 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.567 0.699 . . . . 0.0 112.123 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.459 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.0 OUTLIER -60.72 120.92 11.01 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.607 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -52.09 123.8 11.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.886 0.374 . . . . 0.0 111.277 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.413 ' CE1' ' HA3' ' A' ' 122' ' ' GLY . 6.6 p80 -128.84 3.3 5.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.361 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.62 8.48 81.31 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.836 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.413 ' HA3' ' CE1' ' A' ' 120' ' ' HIS . . . -63.67 142.0 46.21 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.55 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.81 -31.2 71.36 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.528 2.152 . . . . 0.0 112.295 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -69.42 -11.95 61.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.319 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -101.68 13.5 34.73 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.703 0.287 . . . . 0.0 111.138 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.6 mmmm -100.34 126.27 46.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.351 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.417 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 32.6 m-85 -129.13 154.98 46.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.333 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.0 mt -116.21 141.57 33.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.295 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.447 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 26.1 mm -113.33 141.16 30.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.288 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -141.59 95.3 2.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.753 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 47.5 m -54.77 108.12 0.36 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.289 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.383 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.3 mtt . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.837 0.351 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ttpp -94.78 123.14 58.78 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.839 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.73 179.06 5.59 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.468 2.112 . . . . 0.0 112.402 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -95.87 122.46 38.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.78 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.417 ' HA ' ' O ' ' A' ' 46' ' ' TRP . 71.7 m-85 -96.22 174.24 6.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.691 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.615 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -153.75 171.6 18.62 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 120.978 0.418 . . . . 0.0 111.178 179.118 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.431 ' CE2' HD13 ' A' ' 45' ' ' LEU . 0.1 OUTLIER -111.66 123.6 50.58 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.213 179.044 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.434 ' CD1' ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -106.97 106.55 20.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.886 0.374 . . . . 0.0 110.095 179.802 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -106.78 137.73 44.27 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.648 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.38 109.42 10.08 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.444 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 6.0 tt0 -62.88 -10.91 15.08 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.521 -178.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 43.0 tp -84.24 -62.32 1.59 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.938 0.399 . . . . 0.0 111.037 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -86.25 -12.32 49.93 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.23 3.98 71.9 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.071 -1.061 . . . . 0.0 111.545 -178.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.443 ' O ' ' HG3' ' A' ' 9' ' ' LYS . 5.1 mmtm -91.85 175.91 6.71 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.9 m -118.47 143.83 28.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.725 0.298 . . . . 0.0 110.603 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.3 mt -69.25 136.29 51.75 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.004 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -144.96 144.24 30.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.795 0.331 . . . . 0.0 111.146 -179.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 4.3 mm -75.65 131.26 35.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.93 115.72 3.04 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.771 0.32 . . . . 0.0 111.129 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 47.95 48.71 24.59 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.302 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 61.48 -168.69 0.18 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.633 0.254 . . . . 0.0 110.341 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.437 ' N ' ' HD3' ' A' ' 24' ' ' PRO . 51.9 t30 -140.11 62.71 21.77 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.141 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.437 ' HD3' ' N ' ' A' ' 23' ' ' ASN . 21.0 Cg_exo -64.99 -28.94 57.54 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.502 2.134 . . . . 0.0 111.808 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.21 157.49 70.92 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.071 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.432 ' HB3' ' CD ' ' A' ' 74' ' ' PRO . 18.7 Cg_endo -60.38 146.71 96.12 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.763 2.309 . . . . 0.0 112.544 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.67 3.17 40.25 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.503 -0.856 . . . . 0.0 113.192 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.3 t -73.34 128.85 36.66 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 117.243 0.521 . . . . 0.0 110.994 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.1 mmtp -80.38 158.12 26.11 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.282 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.499 HD12 HG23 ' A' ' 63' ' ' ILE . 43.3 pt -117.0 145.97 22.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.613 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.442 ' HA ' ' CD1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -153.65 178.61 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.182 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.943 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.3 p -101.87 149.4 24.24 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.567 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 26.0 t-105 -159.27 173.89 15.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.635 0.255 . . . . 0.0 110.869 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -69.46 133.02 47.22 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.798 0.332 . . . . 0.0 110.776 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -61.25 148.53 40.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.992 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -115.79 160.66 19.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.823 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.6 mmtm -119.66 107.32 13.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.949 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 150.34 176.41 23.33 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.525 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -71.06 -3.9 13.79 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.882 2.388 . . . . 0.0 112.735 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.6 p -106.07 29.53 6.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.769 0.319 . . . . 0.0 111.018 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.501 ' O ' HD12 ' A' ' 45' ' ' LEU . . . -121.92 4.97 9.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.566 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.49 ' CG1' ' HB3' ' A' ' 57' ' ' LYS . 1.6 t -59.26 -18.53 14.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.675 0.274 . . . . 0.0 110.821 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -63.8 -10.65 21.26 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.755 0.312 . . . . 0.0 110.894 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -111.12 7.95 21.55 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.615 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 1.1 mp -121.1 146.45 46.72 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 114.662 -1.153 . . . . 0.0 111.296 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.465 ' CH2' ' CG1' ' A' ' 63' ' ' ILE . 26.0 m95 -133.46 170.46 15.46 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.678 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.559 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 1.5 p90 -136.62 160.39 38.94 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.039 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 33.2 p -107.77 134.41 50.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.71 0.29 . . . . 0.0 111.285 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -77.67 170.47 16.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.281 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -63.22 -22.79 67.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.038 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -97.35 -2.93 41.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.148 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.6 5.52 53.88 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.976 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 23.6 t -88.08 116.59 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 CA-C-O 120.864 0.364 . . . . 0.0 110.778 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.559 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -78.5 150.27 5.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.242 0.544 . . . . 0.0 111.821 -179.86 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.531 ' HB2' ' CE2' ' A' ' 47' ' ' TYR . 10.0 mmm-85 -147.16 133.14 19.17 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.454 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -178.36 0.74 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.162 0.505 . . . . 0.0 111.877 -178.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.49 ' HB3' ' CG1' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -47.2 -23.09 0.47 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.448 179.806 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.474 ' HB2' ' HB2' ' A' ' 61' ' ' PHE . 1.8 mm? -47.48 -23.66 0.67 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.508 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.444 ' CB ' ' O ' ' A' ' 58' ' ' LEU . 22.0 m-20 85.43 -9.15 0.81 Allowed 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -176.68 53.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.918 0.389 . . . . 0.0 111.466 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.474 ' HB2' ' HB2' ' A' ' 58' ' ' LEU . 23.2 m-85 -140.85 108.99 5.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.99 0.424 . . . . 0.0 110.642 179.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -97.17 150.19 21.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.807 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.499 HG23 HD12 ' A' ' 30' ' ' ILE . 0.2 OUTLIER -78.07 150.23 5.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.283 179.903 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.57 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 15.7 p-10 -130.71 131.34 44.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.071 0.462 . . . . 0.0 111.583 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -96.83 42.77 1.08 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.175 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.8 -45.18 45.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.216 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -96.45 172.86 7.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.014 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -47.33 -49.41 24.28 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.923 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -98.96 146.96 25.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.929 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.579 ' CG1' ' HA ' ' A' ' 115' ' ' CYS . 2.6 mm -76.22 140.82 16.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-O 121.531 0.681 . . . . 0.0 111.441 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -133.05 166.54 22.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.618 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.468 ' C ' ' HG2' ' A' ' 73' ' ' GLN . 24.8 p -112.13 137.06 50.73 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.717 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.468 ' HG2' ' C ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -163.57 165.63 13.74 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.062 179.655 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.432 ' CD ' ' HB3' ' A' ' 26' ' ' PRO . 54.1 Cg_exo -52.38 141.26 51.31 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.379 2.053 . . . . 0.0 111.935 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -60.5 132.55 54.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.388 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -123.49 132.13 24.29 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.411 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -68.79 -33.56 20.49 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.52 2.147 . . . . 0.0 113.283 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -87.14 1.04 54.28 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -105.57 103.69 44.53 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.56 0.219 . . . . 0.0 111.28 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.43 ' O ' ' CD2' ' A' ' 94' ' ' LEU . 6.1 Cg_exo -77.78 20.42 0.71 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.959 2.439 . . . . 0.0 112.828 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.57 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 11.3 mmtm -120.35 -17.89 8.09 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.993 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.486 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 39.2 mtt180 -89.08 19.59 4.13 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.305 -179.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.673 ' O ' HD22 ' A' ' 94' ' ' LEU . . . -130.03 99.1 4.96 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.053 0.454 . . . . 0.0 110.937 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.494 ' NE1' ' O ' ' A' ' 63' ' ' ILE . 54.3 m95 -108.58 134.9 50.7 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.14 0.495 . . . . 0.0 111.801 -178.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.4 pp -111.48 154.52 13.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.318 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.4 t -102.3 128.57 54.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.993 0.425 . . . . 0.0 111.139 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.6 t -121.33 94.23 4.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.398 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.16 -100.13 0.76 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.503 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.493 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.63 29.25 7.52 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.617 0.246 . . . . 0.0 110.974 -179.737 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.408 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.78 147.29 29.7 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.633 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.413 ' O ' ' HA ' ' A' ' 100' ' ' VAL . 20.0 mm -94.29 120.52 43.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.384 178.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.438 ' CB ' HG13 ' A' ' 100' ' ' VAL . . . -121.91 145.07 48.45 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -178.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.441 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -65.4 149.09 50.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.493 179.568 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.673 HD22 ' O ' ' A' ' 83' ' ' ALA . 2.6 pt? -62.91 -57.35 11.09 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.819 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.53 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -76.22 -3.89 38.86 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -178.559 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -139.84 88.6 2.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.783 0.325 . . . . 0.0 110.926 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.48 -16.34 62.9 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.181 179.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.86 11.76 19.31 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.216 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.49 ' O ' HG12 ' A' ' 100' ' ' VAL . 6.9 tt -131.53 137.78 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.49 HG12 ' O ' ' A' ' 99' ' ' ILE . 18.6 m -148.66 138.5 16.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.819 0.343 . . . . 0.0 111.789 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.508 ' HA ' ' O ' ' A' ' 115' ' ' CYS . 10.8 mt -45.96 153.24 0.31 Allowed 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 121.708 0.766 . . . . 0.0 111.791 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.409 ' OD2' ' HG2' ' A' ' 125' ' ' GLN . 10.9 t70 -156.64 166.94 31.95 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.383 -1.28 . . . . 0.0 110.745 -177.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.3 mp -89.73 120.58 38.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.33 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.7 tp -64.66 139.05 22.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.999 0.428 . . . . 0.0 111.494 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 71.46 -2.13 2.54 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.165 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.4 m 41.91 32.23 0.27 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.803 0.335 . . . . 0.0 111.52 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -96.39 156.83 16.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.18 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.27 -13.92 59.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.097 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -52.0 124.51 12.98 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.157 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.4 159.76 33.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.086 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.86 14.0 81.96 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.288 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.46 132.33 39.56 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.853 0.359 . . . . 0.0 110.993 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -65.02 171.15 3.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.964 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.494 ' O ' HG12 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -135.92 161.67 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.514 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.579 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 13.6 p -153.98 169.03 24.46 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -95.34 126.13 40.43 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.521 -0.471 . . . . 0.0 109.747 178.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.461 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 76.0 t-105 -133.92 162.47 31.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.566 0.698 . . . . 0.0 112.298 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.461 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 4.3 tmtm? -61.89 122.58 15.8 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.752 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -60.54 125.52 24.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.346 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -134.68 9.0 3.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.631 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 80.82 7.45 88.56 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.486 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.54 152.93 44.34 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.505 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.71 -26.12 53.45 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.654 2.236 . . . . 0.0 112.324 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -75.39 -3.5 34.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.485 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.409 ' HG2' ' OD2' ' A' ' 102' ' ' ASP . 0.5 OUTLIER -108.95 14.41 24.13 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.194 -179.815 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 1.3 mmtp -105.53 133.22 50.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.768 0.318 . . . . 0.0 111.321 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.406 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 5.9 m-85 -136.41 155.77 49.56 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.544 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.4 mt -113.72 138.86 42.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.187 0.518 . . . . 0.0 110.409 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.429 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 36.4 mm -113.41 140.41 33.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.589 -179.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -139.16 111.48 7.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.509 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.35 110.63 2.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.118 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.957 -179.993 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.2 ttm . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.805 0.336 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.76 118.55 66.77 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.85 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.59 100.22 0.48 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.436 2.091 . . . . 0.0 112.302 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.72 74.29 1.4 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.005 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.453 ' CD1' ' HG3' ' A' ' 57' ' ' LYS . 1.3 p90 -97.64 175.79 6.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.31 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.751 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -158.84 175.57 13.42 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.795 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.425 ' CE1' ' HB3' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -114.74 123.81 50.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.24 179.196 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.456 HD13 HG23 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -104.56 109.88 28.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.926 0.393 . . . . 0.0 110.374 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.64 135.87 45.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.32 -178.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -75.55 107.21 7.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.516 178.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.404 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 1.8 tt0 -63.82 -11.03 23.59 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.661 -178.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.402 ' HB2' ' HA ' ' A' ' 124' ' ' ASN . 37.7 tp -84.68 -62.77 1.47 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.898 0.38 . . . . 0.0 110.988 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -84.23 -11.48 56.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.333 -178.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.81 3.53 73.93 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.136 -1.03 . . . . 0.0 111.416 -178.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -91.28 -172.8 3.41 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.5 m -124.48 140.83 46.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.708 0.29 . . . . 0.0 110.469 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.4 mt -69.8 134.78 48.92 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.016 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -142.99 158.58 43.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.968 0.413 . . . . 0.0 111.239 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.406 ' CD1' HG23 ' A' ' 72' ' ' THR . 19.2 mt -100.91 133.72 43.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.419 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -40.51 96.77 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.769 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 49.03 64.27 3.4 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.61 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 59.47 -163.27 0.23 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.582 0.23 . . . . 0.0 110.421 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.457 ' N ' ' HD3' ' A' ' 24' ' ' PRO . 9.2 t-20 -138.96 62.2 25.44 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.71 0.29 . . . . 0.0 111.079 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.457 ' HD3' ' N ' ' A' ' 23' ' ' ASN . 16.7 Cg_exo -67.08 -37.59 18.43 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.524 2.15 . . . . 0.0 111.798 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.94 152.89 80.72 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.995 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.416 ' HB3' ' CD ' ' A' ' 74' ' ' PRO . 23.9 Cg_exo -63.66 139.96 72.25 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.645 2.23 . . . . 0.0 112.204 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.52 4.57 24.97 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.445 -0.883 . . . . 0.0 113.347 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.6 m -75.81 129.94 37.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.157 0.479 . . . . 0.0 111.258 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.2 mmtp -82.4 160.81 22.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.437 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.436 HD11 HG21 ' A' ' 63' ' ' ILE . 41.1 pt -119.4 147.09 23.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.78 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.44 ' HA ' ' CD1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -155.17 179.39 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.208 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.511 -179.777 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.6 p -101.77 149.07 24.55 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.622 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 24.3 t-105 -156.99 171.85 19.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.857 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -70.12 135.79 49.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.76 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.1 114.85 1.6 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.145 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.63 161.99 22.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.813 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.9 mtpp -131.83 108.94 9.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.914 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 154.65 -163.6 31.3 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.517 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -76.86 4.27 5.84 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 123.09 2.526 . . . . 0.0 112.862 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.1 t -113.64 18.82 17.27 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.692 0.282 . . . . 0.0 111.207 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.479 ' O ' HD11 ' A' ' 45' ' ' LEU . . . -79.85 -19.44 48.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.189 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.572 ' HA ' HD11 ' A' ' 45' ' ' LEU . 47.7 t -49.38 -27.73 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.085 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -64.97 -9.59 22.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.791 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.425 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 6.0 mt-30 -120.45 7.42 10.64 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.099 0.476 . . . . 0.0 109.766 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.751 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 1.3 mp -116.95 139.88 50.13 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.781 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.456 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 24.7 m95 -133.95 168.82 18.09 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.127 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.543 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 30.1 p90 -140.71 165.0 28.69 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.112 178.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.0 p -107.76 134.0 51.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.813 0.34 . . . . 0.0 111.429 -178.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -77.8 169.89 17.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.192 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -63.49 -24.15 67.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.143 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -93.95 -2.82 52.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.136 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.49 8.49 54.66 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.84 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 40.4 t -93.98 119.43 41.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.89 0.345 . . . . 0.0 110.552 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.543 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -77.26 147.92 7.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.299 0.571 . . . . 0.0 111.763 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.496 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 9.0 mmm-85 -149.85 133.74 16.95 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.474 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 37.9 m -54.83 143.48 25.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.476 0.655 . . . . 0.0 111.863 -178.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.466 ' HB3' ' CG1' ' A' ' 42' ' ' VAL . 11.7 tttm -53.45 -23.82 11.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.719 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.426 ' N ' ' CG1' ' A' ' 42' ' ' VAL . 3.6 pp -56.15 -43.62 78.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.202 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.4 t30 178.34 -171.15 0.11 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.862 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.81 83.16 1.65 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.835 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.413 ' CD1' ' OD1' ' A' ' 23' ' ' ASN . 31.9 m-85 -144.94 122.0 11.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.825 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -110.55 155.85 21.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.492 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.493 ' O ' ' NE1' ' A' ' 84' ' ' TRP . 0.2 OUTLIER -82.89 151.76 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.636 179.6 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.583 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 10.0 p-10 -132.44 130.31 40.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.106 0.479 . . . . 0.0 111.429 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -94.3 39.62 1.08 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.467 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.3 m -74.34 -45.89 44.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.141 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 15.3 m170 -91.13 167.91 12.01 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.943 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -46.74 -47.19 20.71 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.928 0.394 . . . . 0.0 110.833 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.34 146.18 27.92 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.701 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.591 ' CG1' ' HA ' ' A' ' 115' ' ' CYS . 2.7 mm -73.51 136.45 25.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 CA-C-O 121.738 0.78 . . . . 0.0 111.595 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -132.34 163.82 27.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.094 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.449 ' C ' ' HG2' ' A' ' 73' ' ' GLN . 41.6 p -109.33 136.71 48.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.591 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.449 ' HG2' ' C ' ' A' ' 72' ' ' THR . 0.5 OUTLIER -163.1 167.32 11.9 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.452 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.416 ' CD ' ' HB3' ' A' ' 26' ' ' PRO . 50.4 Cg_exo -53.46 137.0 65.04 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.432 2.088 . . . . 0.0 111.759 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -65.47 141.6 58.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.964 0.411 . . . . 0.0 111.412 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.12 139.62 35.51 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.59 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.02 -30.53 20.91 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.511 2.141 . . . . 0.0 112.864 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -89.57 0.05 57.18 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -106.19 102.57 40.81 Favored Pre-proline 0 CA--C 1.529 0.17 0 CA-C-O 120.568 0.223 . . . . 0.0 111.187 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.434 ' O ' ' CD2' ' A' ' 94' ' ' LEU . 5.8 Cg_exo -77.27 20.1 0.68 Allowed 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.94 2.427 . . . . 0.0 113.034 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.583 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 0.1 OUTLIER -117.85 -20.42 8.83 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 120.634 0.254 . . . . 0.0 110.96 -179.859 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.48 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 6.8 mtm-85 -88.41 19.76 3.66 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.414 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.682 ' O ' HD22 ' A' ' 94' ' ' LEU . . . -128.58 99.2 5.28 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.089 0.471 . . . . 0.0 110.696 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.493 ' NE1' ' O ' ' A' ' 63' ' ' ILE . 62.7 m95 -108.85 134.63 51.28 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.216 0.531 . . . . 0.0 112.016 -178.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.6 pt -112.12 153.23 13.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.201 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.4 t -101.75 127.02 55.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.943 0.402 . . . . 0.0 110.98 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.9 t -119.82 95.06 4.61 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.566 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.87 -100.27 0.75 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.557 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.499 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.79 29.82 7.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.603 0.239 . . . . 0.0 110.864 -179.668 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.413 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -148.76 148.43 29.97 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 121.358 0.599 . . . . 0.0 112.595 -178.548 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 14.6 mm -93.93 120.93 44.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.393 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.448 ' CB ' HG11 ' A' ' 100' ' ' VAL . . . -123.71 144.06 49.89 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.83 152.34 36.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.476 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.682 HD22 ' O ' ' A' ' 83' ' ' ALA . 2.7 pt? -65.73 -56.9 9.59 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.402 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.545 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 1.2 m -79.34 -1.93 39.16 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -138.07 85.03 2.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.891 0.377 . . . . 0.0 110.998 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.45 -17.79 64.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.221 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -92.7 10.28 31.35 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.466 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.51 ' O ' HG11 ' A' ' 100' ' ' VAL . 11.9 mm -123.07 128.66 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.501 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.51 HG11 ' O ' ' A' ' 99' ' ' ILE . 28.5 m -146.39 135.17 16.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.463 ' HG ' ' CZ3' ' A' ' 84' ' ' TRP . 11.3 mt -45.62 154.21 0.22 Allowed 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.746 0.784 . . . . 0.0 111.861 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -159.55 169.39 23.93 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.65 -177.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 17.6 mm -88.07 121.11 38.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.168 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.403 ' O ' ' CB ' ' A' ' 105' ' ' LYS . 52.7 mt -70.42 136.83 25.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.841 0.353 . . . . 0.0 111.215 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.403 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 0.2 OUTLIER 80.88 -9.03 1.38 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.802 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 38.2 m 47.39 30.49 1.58 Allowed 'General case' 0 N--CA 1.461 0.108 0 CA-C-O 120.785 0.326 . . . . 0.0 111.289 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -98.55 154.05 18.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.015 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.25 -11.56 60.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.316 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -52.36 129.12 27.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.206 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.95 161.51 29.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.008 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 70.64 15.62 73.47 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.867 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.92 133.41 39.25 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.824 0.345 . . . . 0.0 110.793 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 14.8 m80 -64.0 170.43 3.56 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.019 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.504 ' O ' HG12 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -135.89 161.71 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.425 179.779 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.591 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 29.1 p -154.53 169.06 24.69 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.448 ' HB3' ' CG2' ' A' ' 99' ' ' ILE . . . -94.84 127.63 41.0 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.459 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 75.8 t-105 -135.9 162.75 31.95 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.608 0.718 . . . . 0.0 112.212 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.459 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 12.2 tptt -61.95 117.14 5.54 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.625 -1.171 . . . . 0.0 110.875 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.56 127.59 32.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.772 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -139.08 12.02 2.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.27 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 75.86 60.46 3.15 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.266 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -116.15 144.26 18.36 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.557 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.78 -33.89 72.57 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.5 2.134 . . . . 0.0 112.226 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.402 ' HA ' ' HB2' ' A' ' 12' ' ' LEU . 12.9 p-10 -76.68 -2.22 31.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.508 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.413 ' O ' ' CG2' ' A' ' 90' ' ' THR . 0.0 OUTLIER -107.97 9.82 28.51 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.745 -0.207 . . . . 0.0 111.184 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.42 ' O ' ' CD1' ' A' ' 127' ' ' PHE . 9.8 mmtp -106.5 139.43 40.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.762 0.315 . . . . 0.0 111.439 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.42 ' CD1' ' O ' ' A' ' 126' ' ' LYS . 7.5 m-85 -138.61 156.34 47.54 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.244 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.4 mt -113.17 138.64 41.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.158 0.504 . . . . 0.0 110.65 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 25.2 mm -114.17 140.36 35.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.62 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.95 96.04 3.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.588 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.2 t -51.91 111.48 0.62 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.313 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.427 ' HB3' ' CE2' ' A' ' 5' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.898 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.825 0.345 . . . . 0.0 111.189 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.76 132.46 24.19 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.803 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.6 173.24 14.67 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.47 2.113 . . . . 0.0 112.397 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.44 148.01 49.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.684 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.491 ' HA ' ' O ' ' A' ' 46' ' ' TRP . 3.1 p90 -89.72 173.04 8.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.851 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.74 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -159.48 173.75 15.71 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.204 179.693 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.425 ' O ' ' HA ' ' A' ' 129' ' ' ILE . 0.2 OUTLIER -109.41 123.47 49.4 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.359 179.091 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.438 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -107.92 104.11 16.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.847 -179.709 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.582 ' HA ' ' HA ' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -127.22 125.44 41.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.471 -179.504 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.442 ' O ' ' HD2' ' A' ' 9' ' ' LYS . 28.7 t -46.24 139.7 4.52 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.04 0.447 . . . . 0.0 111.474 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.408 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 3.9 tt0 -82.64 -10.73 58.82 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.02 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 38.1 tp -90.25 -58.31 2.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.804 0.335 . . . . 0.0 111.034 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -84.1 -19.09 34.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.846 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.13 5.28 75.71 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.306 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.577 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 2.9 mmmm -85.74 165.49 16.88 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.582 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 15.4 m -107.2 136.43 42.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.823 0.344 . . . . 0.0 110.754 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.7 mt -69.99 137.91 51.8 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -140.05 149.95 43.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.836 0.35 . . . . 0.0 111.157 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.469 HD13 ' CZ2' ' A' ' 46' ' ' TRP . 1.1 mt -99.33 116.25 42.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.839 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -61.72 96.13 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.864 0.364 . . . . 0.0 110.611 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 158.21 -45.01 0.47 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.372 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 52.12 48.64 22.3 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.832 0.349 . . . . 0.0 111.176 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.403 ' CB ' ' CD ' ' A' ' 24' ' ' PRO . 1.0 OUTLIER -177.65 175.66 0.54 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.996 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.403 ' CD ' ' CB ' ' A' ' 23' ' ' ASN . 25.3 Cg_exo -62.89 -12.64 30.29 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.824 2.349 . . . . 0.0 112.605 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -43.35 102.43 0.28 Allowed Pre-proline 0 CA--C 1.53 0.176 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.497 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.426 ' HB3' ' HD3' ' A' ' 74' ' ' PRO . 70.1 Cg_endo -72.96 143.96 37.43 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.585 2.19 . . . . 0.0 112.272 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.68 6.68 52.34 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.515 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.8 m -77.22 137.48 38.87 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.039 0.447 . . . . 0.0 111.171 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.3 mmtm -83.86 157.62 21.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.219 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.442 HD13 HG23 ' A' ' 63' ' ' ILE . 44.1 pt -115.95 145.68 21.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.889 0.376 . . . . 0.0 111.633 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.431 ' HA ' ' CD1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -155.4 -179.5 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.126 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.779 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.8 p -103.18 150.73 23.39 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.579 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 28.0 t-105 -155.47 170.59 21.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.657 0.265 . . . . 0.0 110.979 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -71.83 137.27 47.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.831 0.348 . . . . 0.0 110.763 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -56.63 135.19 54.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.008 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.9 168.12 9.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.83 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.26 103.29 6.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.926 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 163.94 -164.8 36.69 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.593 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -80.92 7.39 4.94 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.801 2.334 . . . . 0.0 113.102 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.1 17.55 21.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.652 0.263 . . . . 0.0 111.184 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.452 ' O ' ' CD1' ' A' ' 45' ' ' LEU . . . -82.17 -18.52 42.45 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.308 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.585 ' HA ' HD11 ' A' ' 45' ' ' LEU . 65.8 t -51.26 -31.25 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.937 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -66.99 -10.62 51.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.696 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -116.09 7.41 14.23 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.74 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 0.9 OUTLIER -117.66 141.29 48.56 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.713 -179.083 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.491 ' O ' ' HA ' ' A' ' 5' ' ' PHE . 24.4 m95 -133.27 167.69 19.91 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.041 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.506 ' CE1' ' HB2' ' A' ' 55' ' ' ARG . 37.6 p90 -140.56 165.03 28.55 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.106 178.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 46.0 p -105.6 132.63 51.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.828 0.346 . . . . 0.0 111.336 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -77.79 165.84 23.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.117 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.13 -25.49 67.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.234 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -90.86 -4.05 56.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.469 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.96 11.87 48.28 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.845 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.9 t -100.7 121.44 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-O 120.744 0.307 . . . . 0.0 110.488 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.503 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -76.07 148.43 7.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.31 0.576 . . . . 0.0 111.889 -179.751 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.506 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 12.3 mmm-85 -149.23 133.74 17.61 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.408 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.488 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -56.51 142.12 40.22 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.54 0.686 . . . . 0.0 111.893 -178.873 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.453 ' HG3' ' CD1' ' A' ' 5' ' ' PHE . 21.0 tttt -54.09 -22.31 10.65 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.715 -1.13 . . . . 0.0 111.673 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.431 ' N ' ' CG1' ' A' ' 42' ' ' VAL . 3.4 pp -58.93 -41.87 88.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.777 0.322 . . . . 0.0 111.12 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -179.36 -179.69 0.56 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.791 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -70.99 84.4 0.69 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.806 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.402 ' CZ ' ' O ' ' A' ' 24' ' ' PRO . 1.9 m-85 -145.92 123.5 11.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.899 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -108.83 152.59 24.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.081 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.46 ' O ' ' CD1' ' A' ' 84' ' ' TRP . 0.2 OUTLIER -78.66 152.99 4.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.68 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.524 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 6.7 p-10 -134.2 133.42 40.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.277 0.56 . . . . 0.0 111.69 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -97.42 43.49 1.07 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.217 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.0 t -74.71 -43.98 52.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.087 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 65.8 m170 -97.2 172.47 7.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.925 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -48.32 -48.81 35.92 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.14 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -99.0 145.62 26.88 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.126 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.594 ' CG1' ' HA ' ' A' ' 115' ' ' CYS . 3.1 mm -73.93 138.54 20.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.552 0.692 . . . . 0.0 111.455 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -139.2 167.75 21.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.799 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 63' ' ' ILE . 57.0 p -106.77 139.41 41.24 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.052 0.453 . . . . 0.0 111.528 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.403 ' CB ' ' CD ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -159.46 175.07 3.44 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.993 179.643 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.426 ' HD3' ' HB3' ' A' ' 26' ' ' PRO . 17.3 Cg_exo -66.65 138.86 50.91 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.513 2.142 . . . . 0.0 111.583 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -62.29 128.82 37.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.814 0.34 . . . . 0.0 111.031 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -122.18 125.85 26.46 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.674 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -56.92 -35.4 98.55 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.457 2.105 . . . . 0.0 112.794 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 21.3 m-20 -86.35 -2.73 58.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.777 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -101.19 100.6 13.77 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-O 120.611 0.243 . . . . 0.0 110.786 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.551 ' O ' HD22 ' A' ' 94' ' ' LEU . 82.9 Cg_endo -76.66 21.16 0.58 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.638 2.225 . . . . 0.0 113.48 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 40.3 mmtt -120.94 -18.37 7.58 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 120.689 0.28 . . . . 0.0 111.134 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.471 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 40.3 mtt180 -88.09 21.42 2.76 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -178.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.587 ' O ' HD21 ' A' ' 94' ' ' LEU . . . -130.25 99.84 5.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.203 0.525 . . . . 0.0 111.051 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.47 ' CZ3' ' HG ' ' A' ' 101' ' ' LEU . 60.4 m95 -110.21 135.06 51.57 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.227 0.537 . . . . 0.0 111.914 -178.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.4 pt -113.86 154.24 15.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.125 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.9 t -102.14 127.99 55.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.912 0.387 . . . . 0.0 111.115 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 46.6 t -121.07 95.1 4.56 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.553 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.28 -100.66 0.81 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.554 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.504 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.94 29.86 7.16 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.587 0.232 . . . . 0.0 110.735 -179.76 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -149.16 148.36 29.54 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 121.358 0.599 . . . . 0.0 112.348 -178.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 14.3 mm -94.32 121.08 44.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.629 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.439 ' CB ' ' CG1' ' A' ' 100' ' ' VAL . . . -120.84 143.0 49.12 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -178.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.438 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -67.31 146.05 54.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.699 179.763 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.594 ' HG ' ' N ' ' A' ' 95' ' ' SER . 2.6 pt? -61.05 -56.13 24.55 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.664 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.594 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 7.9 m -73.72 -6.68 48.36 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -178.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -139.75 89.65 2.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.881 0.372 . . . . 0.0 111.071 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.26 -16.23 63.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.182 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.73 12.86 21.95 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.096 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.516 ' O ' HG11 ' A' ' 100' ' ' VAL . 6.8 tt -131.08 137.16 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.516 HG11 ' O ' ' A' ' 99' ' ' ILE . 15.9 m -148.9 138.46 15.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.855 0.359 . . . . 0.0 111.637 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.51 ' HA ' ' O ' ' A' ' 115' ' ' CYS . 10.5 mt -46.39 155.19 0.23 Allowed 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.593 0.711 . . . . 0.0 111.71 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -157.49 166.71 32.23 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.588 -177.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.0 mp -92.8 118.33 38.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.461 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.425 ' O ' ' CB ' ' A' ' 105' ' ' LYS . 8.5 tt -62.45 141.98 17.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.791 0.329 . . . . 0.0 111.164 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.425 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 10.5 tptt 82.43 -20.81 0.33 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.71 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.6 m 53.9 39.41 30.41 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.917 0.389 . . . . 0.0 111.013 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -113.36 167.01 10.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.029 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.75 -13.83 58.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.984 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -48.29 142.41 5.54 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.098 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -90.1 158.16 17.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.2 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 76.35 12.84 83.91 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.543 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.5 132.9 39.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.878 0.37 . . . . 0.0 111.01 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 12.9 m80 -65.52 173.33 2.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.029 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.535 ' O ' HG12 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -137.36 161.5 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.513 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.594 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 7.2 t -152.52 166.14 32.93 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.91 121.54 34.37 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.471 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 76.2 t-105 -128.73 162.19 27.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.67 0.747 . . . . 0.0 112.241 -179.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.471 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.8 OUTLIER -64.8 123.38 19.22 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.7 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -58.48 123.29 15.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.045 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -134.2 4.44 3.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.493 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 79.39 56.56 3.37 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.286 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -109.28 147.47 16.91 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.519 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.74 -29.3 59.63 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.57 2.18 . . . . 0.0 112.083 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -76.91 -4.35 43.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.234 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.421 ' NE2' ' CG2' ' A' ' 100' ' ' VAL . 3.2 mt-30 -102.73 -7.14 21.92 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.463 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.408 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 8.6 mmtm -83.73 132.66 34.83 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.772 0.32 . . . . 0.0 111.295 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -131.11 153.64 49.14 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.344 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.4 mt -113.68 137.48 46.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.163 0.506 . . . . 0.0 110.644 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.425 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 20.8 mm -114.26 142.05 28.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.593 -179.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -137.02 110.41 7.91 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.285 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 44.1 m -60.02 114.41 2.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.322 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.23 -0.89 . . . . 0.0 111.494 179.714 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.6 ttt . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.786 0.327 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 63.59 126.21 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.863 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.6 148.21 36.24 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.466 2.11 . . . . 0.0 112.343 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -118.92 139.94 50.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.826 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.485 ' CD1' ' HG3' ' A' ' 57' ' ' LYS . 1.5 p90 -95.1 175.04 6.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.501 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.745 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -160.38 176.45 11.66 Favored 'General case' 0 CA--C 1.512 -0.512 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.774 179.919 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.438 ' CE2' HD13 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -114.86 123.78 50.04 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.297 179.228 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.435 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -104.14 109.89 28.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.23 179.904 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.29 136.85 45.28 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.273 -178.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 48.7 m -75.95 107.82 8.41 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.418 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 5.2 tt0 -63.19 -11.15 18.72 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.47 -178.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 56.3 tp -84.66 -62.49 1.53 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.848 0.356 . . . . 0.0 110.973 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -84.97 -12.94 52.19 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.69 2.57 76.45 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.214 -0.993 . . . . 0.0 111.513 -178.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.41 -178.64 5.65 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.9 m -120.37 140.34 44.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.673 0.273 . . . . 0.0 110.527 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.6 mt -70.19 134.8 48.45 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -142.61 158.21 43.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.901 0.381 . . . . 0.0 111.204 -179.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.441 HD13 HG23 ' A' ' 19' ' ' ILE . 31.3 mt -100.19 137.86 26.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.458 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -41.16 96.0 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.73 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' A' ' 23' ' ' ASN . . . 45.12 39.13 6.58 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.182 -0.532 . . . . 0.0 112.987 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.74 -74.31 0.06 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.85 0.357 . . . . 0.0 110.766 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 21' ' ' GLY . 1.7 t30 59.8 92.52 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.025 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -64.96 -9.39 21.3 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.705 2.27 . . . . 0.0 112.571 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -93.5 151.84 40.47 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-O 120.724 0.297 . . . . 0.0 111.078 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.437 ' HB3' ' HB3' ' A' ' 73' ' ' GLN . 16.2 Cg_exo -68.41 135.73 34.7 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.832 2.355 . . . . 0.0 112.468 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.21 1.29 16.36 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.604 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.85 136.25 43.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 117.316 0.558 . . . . 0.0 111.0 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.2 159.78 18.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.694 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.406 HD11 ' HB ' ' A' ' 70' ' ' ILE . 46.4 pt -120.33 148.03 23.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.821 0.343 . . . . 0.0 111.637 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.407 HG21 ' HA ' ' A' ' 113' ' ' HIS . 0.3 OUTLIER -156.26 -178.39 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.243 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.425 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.6 p -100.87 148.55 24.84 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.585 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 28.0 t-105 -158.42 172.63 17.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.689 0.28 . . . . 0.0 110.91 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -70.86 135.76 48.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.765 0.317 . . . . 0.0 110.708 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -56.73 125.96 24.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.007 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.25 164.55 12.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.951 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.7 mmmt -131.68 111.22 11.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.961 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 154.23 -165.76 31.9 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.635 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.64 2.52 6.84 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.131 2.554 . . . . 0.0 112.859 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.12 16.95 19.08 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.653 0.263 . . . . 0.0 111.153 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.507 ' O ' HD12 ' A' ' 45' ' ' LEU . . . -80.35 -18.1 50.04 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.412 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.576 ' HA ' HD12 ' A' ' 45' ' ' LEU . 49.4 t -50.08 -27.39 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.055 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -64.57 -10.27 25.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.718 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.427 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 1.6 mt-30 -118.92 7.76 11.55 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.745 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 1.3 mp -117.65 140.7 49.3 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.8 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.481 ' O ' ' HA ' ' A' ' 5' ' ' PHE . 26.9 m95 -134.12 168.77 18.23 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.938 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.57 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 15.7 p90 -141.69 165.93 26.13 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.1 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 72.8 p -106.79 132.4 52.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.768 0.318 . . . . 0.0 111.313 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -77.63 165.62 24.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.09 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -58.69 -25.49 62.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.027 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -93.55 -3.52 52.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.324 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.34 6.8 55.1 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.874 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.3 t -90.43 117.65 34.13 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-O 120.771 0.319 . . . . 0.0 110.687 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.57 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.6 OUTLIER -75.99 144.08 12.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.076 0.465 . . . . 0.0 111.049 179.596 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.562 ' HG3' ' O ' ' A' ' 54' ' ' ILE . 0.4 OUTLIER -149.75 133.54 16.89 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.88 179.222 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 72.7 m -51.5 144.74 9.81 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.582 0.706 . . . . 0.0 112.127 -178.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.485 ' HG3' ' CD1' ' A' ' 5' ' ' PHE . 10.0 tttt -57.96 -20.26 36.67 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.877 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.481 ' N ' ' CG1' ' A' ' 42' ' ' VAL . 0.5 OUTLIER -47.58 -45.81 27.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.794 -179.253 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -171.24 -72.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.66 0.266 . . . . 0.0 111.282 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -176.42 81.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.913 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.435 ' CE2' ' HD3' ' A' ' 74' ' ' PRO . 1.5 m-85 -140.84 122.99 15.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.874 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -101.68 148.3 25.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.201 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.5 ' O ' ' CD1' ' A' ' 84' ' ' TRP . 0.3 OUTLIER -77.99 152.45 5.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.684 179.786 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.619 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 6.6 p-10 -133.18 130.72 39.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.191 0.52 . . . . 0.0 111.682 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -95.07 42.05 1.09 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.418 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 60.4 p -74.62 -43.18 56.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.369 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 23.4 m80 -97.89 171.81 8.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.102 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -48.82 -44.01 38.88 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.916 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.06 144.49 31.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.641 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.64 ' CG1' ' HA ' ' A' ' 115' ' ' CYS . 1.7 mm -76.37 141.95 15.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.666 0.746 . . . . 0.0 111.8 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -139.26 166.59 24.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.863 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 63' ' ' ILE . 41.6 p -104.27 138.18 41.1 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.861 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.437 ' HB3' ' HB3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -163.53 167.54 11.14 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.26 179.755 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.435 ' HD3' ' CE2' ' A' ' 61' ' ' PHE . 32.2 Cg_exo -57.88 137.33 80.46 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.415 2.077 . . . . 0.0 111.861 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -67.18 127.2 31.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.855 0.359 . . . . 0.0 110.886 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -117.48 139.55 26.3 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.48 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.4 -32.26 41.01 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.527 2.151 . . . . 0.0 112.905 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 32.3 m-20 -88.79 -1.59 58.16 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -107.11 101.12 36.4 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.571 0.224 . . . . 0.0 111.007 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.435 ' O ' ' CD2' ' A' ' 94' ' ' LEU . 5.6 Cg_exo -77.16 21.28 0.61 Allowed 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.869 2.379 . . . . 0.0 112.98 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.619 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -116.47 -21.92 8.98 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.94 -179.827 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.454 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 41.7 mtt180 -87.62 20.28 3.02 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.47 -179.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.716 ' O ' HD23 ' A' ' 94' ' ' LEU . . . -130.01 99.33 5.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.074 0.464 . . . . 0.0 110.854 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.5 ' CD1' ' O ' ' A' ' 63' ' ' ILE . 58.9 m95 -109.45 137.26 47.56 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.223 0.535 . . . . 0.0 111.89 -178.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.3 pt -115.1 153.63 16.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.237 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.9 t -100.21 125.39 53.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.905 0.383 . . . . 0.0 110.948 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 21.5 t -117.85 93.89 4.32 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.526 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.89 -100.57 0.78 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.601 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.499 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.55 29.36 7.48 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.568 0.223 . . . . 0.0 110.921 -179.549 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -148.76 148.55 30.11 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.314 0.578 . . . . 0.0 112.522 -178.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 17.6 mm -93.38 121.28 43.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.44 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.46 ' CB ' HG11 ' A' ' 100' ' ' VAL . . . -124.67 145.3 49.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.32 0.581 . . . . 0.0 112.557 -178.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.421 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -65.26 149.53 49.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.508 179.729 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.716 HD23 ' O ' ' A' ' 83' ' ' ALA . 2.7 pt? -62.2 -56.88 14.27 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.717 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.542 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 35.7 m -79.65 -1.61 38.99 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -138.5 85.9 2.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.875 0.369 . . . . 0.0 111.009 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.63 -18.32 65.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.072 178.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -91.51 8.73 35.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.445 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.495 ' O ' HG11 ' A' ' 100' ' ' VAL . 12.7 mm -121.15 126.29 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.494 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.495 HG11 ' O ' ' A' ' 99' ' ' ILE . 22.3 m -145.98 134.49 16.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.836 0.351 . . . . 0.0 111.892 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.505 ' HA ' ' O ' ' A' ' 115' ' ' CYS . 16.2 mt -46.26 154.09 0.29 Allowed 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 121.755 0.788 . . . . 0.0 111.964 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -156.85 167.41 30.56 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.293 -1.321 . . . . 0.0 110.752 -177.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.439 ' HA ' HG21 ' A' ' 114' ' ' ILE . 34.0 mm -89.0 126.08 42.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.566 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.2 tt -68.05 137.99 23.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.01 0.434 . . . . 0.0 111.558 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 29.7 mtpt 67.44 3.41 3.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.114 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 40.0 t 40.9 32.33 0.16 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.744 0.307 . . . . 0.0 111.454 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.1 p30 -96.08 157.41 15.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.181 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.93 -14.97 58.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.199 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -51.1 123.07 8.62 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.847 0.356 . . . . 0.0 111.107 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.18 161.15 31.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.172 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 73.29 16.64 78.7 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.181 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.85 135.58 35.95 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 120.875 0.369 . . . . 0.0 111.056 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.407 ' HA ' HG21 ' A' ' 31' ' ' ILE . 1.4 m80 -61.86 170.29 2.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.783 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.439 HG21 ' HA ' ' A' ' 103' ' ' ILE . 0.5 OUTLIER -143.22 161.8 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.872 -179.698 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.64 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 12.8 p -157.15 174.16 15.9 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.461 ' HB3' ' CG2' ' A' ' 99' ' ' ILE . . . -95.81 129.67 42.98 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 178.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.458 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 75.8 t-105 -136.05 162.38 33.04 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.602 0.715 . . . . 0.0 112.051 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.458 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.2 OUTLIER -60.36 119.74 8.54 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.689 179.928 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.401 ' HA ' ' NE2' ' A' ' 125' ' ' GLN . 12.2 tt0 -60.1 127.3 31.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.081 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -137.52 11.0 2.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.207 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 78.4 10.28 86.34 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.882 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.78 139.78 46.82 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.521 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.5 -28.92 57.14 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.495 2.13 . . . . 0.0 112.24 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -74.55 -5.42 42.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.423 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.401 ' NE2' ' HA ' ' A' ' 119' ' ' GLN . 0.1 OUTLIER -106.57 16.36 24.69 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.096 -179.829 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.418 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 2.7 mmmt -105.91 132.95 51.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.743 0.306 . . . . 0.0 111.398 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.422 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 5.2 m-85 -136.12 155.1 50.67 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.417 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 mt -114.27 140.32 35.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.179 0.514 . . . . 0.0 110.67 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.1 mm -114.04 139.78 38.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.617 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.21 96.14 3.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.614 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.4 m -50.76 111.71 0.59 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.405 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.421 ' HB3' ' CE2' ' A' ' 5' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.918 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.5 mtp . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 120.807 0.337 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -115.92 105.37 51.41 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.92 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.43 ' HG2' ' CD1' ' A' ' 47' ' ' TYR . 39.3 Cg_endo -67.04 161.07 44.32 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.37 2.047 . . . . 0.0 112.322 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -47.94 151.35 0.95 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.673 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.473 ' CD1' ' HG3' ' A' ' 57' ' ' LYS . 0.2 OUTLIER -105.85 176.46 5.16 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.139 179.666 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.763 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -156.41 172.76 17.95 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.735 179.878 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.429 ' CE1' ' HB3' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -112.22 123.86 51.2 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.103 179.04 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.433 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -105.1 109.29 27.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.004 0.431 . . . . 0.0 110.693 -179.73 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 16' ' ' VAL . 0.1 OUTLIER -102.15 132.49 48.02 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.008 -179.065 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.1 p -74.16 107.29 6.25 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -63.8 -9.86 16.96 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.537 -178.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 28.7 tp -83.44 -62.99 1.44 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.815 0.34 . . . . 0.0 110.752 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -85.59 -7.87 58.61 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.79 6.65 67.75 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.071 -1.062 . . . . 0.0 111.558 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -94.11 -171.97 2.69 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 4.8 m -121.84 140.65 45.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.755 0.312 . . . . 0.0 110.528 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.1 mt -69.79 133.47 47.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.329 -0.396 . . . . 0.0 109.95 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -144.04 147.79 34.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.827 0.346 . . . . 0.0 111.144 -179.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.437 HD11 ' CZ2' ' A' ' 46' ' ' TRP . 22.3 mt -89.52 133.77 30.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.42 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -41.85 101.57 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.196 -0.456 . . . . 0.0 112.025 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 23' ' ' ASN . . . 42.6 31.41 1.07 Allowed Glycine 0 C--N 1.332 0.32 0 CA-C-N 115.927 -0.579 . . . . 0.0 113.351 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.2 mp0 63.48 -76.06 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.746 0.308 . . . . 0.0 111.332 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.404 ' N ' ' O ' ' A' ' 21' ' ' GLY . 3.0 m120 63.32 100.44 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.819 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -62.43 -11.01 20.87 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.625 2.217 . . . . 0.0 112.631 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -95.58 147.94 33.8 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-O 120.68 0.276 . . . . 0.0 111.048 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.428 ' HB3' ' HB3' ' A' ' 73' ' ' GLN . 19.6 Cg_exo -66.31 144.19 73.3 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.738 2.292 . . . . 0.0 112.476 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.07 2.19 22.06 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.454 -0.879 . . . . 0.0 113.439 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.2 t -73.17 139.29 46.23 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 117.22 0.51 . . . . 0.0 111.121 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.3 mptm? -90.65 158.49 16.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.487 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 36.8 pt -116.88 145.53 22.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.854 0.359 . . . . 0.0 111.708 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.442 ' HA ' ' CD1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -154.97 177.92 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.458 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.5 p -100.94 149.57 23.76 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.498 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 9.0 t-105 -155.47 170.66 21.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.745 0.307 . . . . 0.0 110.993 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.09 135.43 47.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.827 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -58.98 130.03 45.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.906 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.23 176.43 5.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.838 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.0 mttp -127.9 156.67 42.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.823 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 110.3 -164.04 12.32 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.501 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -80.89 7.84 4.66 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.746 2.297 . . . . 0.0 113.13 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 43.1 p -106.25 16.27 25.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.635 0.255 . . . . 0.0 111.244 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.451 ' O ' ' CD1' ' A' ' 45' ' ' LEU . . . -84.11 -19.85 33.54 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.311 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.593 ' HA ' HD13 ' A' ' 45' ' ' LEU . 53.2 t -50.6 -31.9 9.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.915 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -65.19 -11.25 38.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.889 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.429 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 3.7 mt-30 -117.6 8.78 12.95 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.763 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 0.9 OUTLIER -118.43 141.15 48.83 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.861 -179.143 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.472 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 26.1 m95 -134.23 169.49 17.1 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.052 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.537 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 28.3 p90 -141.45 164.47 30.15 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.143 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -109.11 136.41 48.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.829 0.347 . . . . 0.0 111.397 -178.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -77.75 170.7 16.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.2 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -62.31 -22.48 66.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.089 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -98.77 -2.46 37.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.167 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.8 3.77 54.82 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.884 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.8 t -85.99 116.24 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 CA-C-N 116.977 0.389 . . . . 0.0 110.693 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.537 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -78.21 147.8 6.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.383 0.611 . . . . 0.0 112.034 -179.59 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.507 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 8.8 mmm-85 -150.62 133.67 16.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.152 178.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.472 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -55.27 146.05 20.15 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.456 0.646 . . . . 0.0 112.055 -178.721 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.473 ' HG3' ' CD1' ' A' ' 5' ' ' PHE . 8.2 tttm -57.89 -20.7 38.82 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.81 -1.087 . . . . 0.0 111.886 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.432 ' N ' ' CG1' ' A' ' 42' ' ' VAL . 0.8 OUTLIER -59.49 -33.1 70.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.832 0.349 . . . . 0.0 111.087 -179.533 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.1 t30 174.74 -169.82 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.712 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -82.34 82.78 7.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.721 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -144.23 124.97 14.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.979 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -107.46 153.19 23.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.524 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.502 ' O ' ' CD1' ' A' ' 84' ' ' TRP . 0.3 OUTLIER -78.85 152.05 5.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.778 179.667 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.553 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 4.1 p-10 -132.78 137.83 46.95 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.964 0.411 . . . . 0.0 111.368 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -104.06 42.37 1.19 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.429 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.37 -44.82 50.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.833 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 7.2 m80 -93.84 169.22 10.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.934 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -48.4 -46.0 36.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.956 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -99.73 142.74 30.82 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.138 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.595 ' CG1' ' HA ' ' A' ' 115' ' ' CYS . 3.5 mm -73.44 139.53 19.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-O 121.55 0.691 . . . . 0.0 111.382 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -140.56 169.35 17.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.944 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 63' ' ' ILE . 49.9 p -106.28 138.65 42.09 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.262 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.452 ' HG2' ' C ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -164.92 169.36 7.65 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.033 179.684 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -49.56 141.82 25.38 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.416 2.077 . . . . 0.0 112.08 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.434 ' O ' ' HB2' ' A' ' 82' ' ' ARG . 53.1 t80 -47.94 -56.62 7.19 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.3 t70 61.29 118.15 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.67 0.272 . . . . 0.0 110.346 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.08 -27.32 25.06 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.488 2.125 . . . . 0.0 113.546 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -88.43 0.85 55.81 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.435 ' CB ' ' HD2' ' A' ' 82' ' ' ARG . 1.7 m-80 -105.96 103.76 46.04 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.586 0.232 . . . . 0.0 111.331 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.432 ' O ' ' CD2' ' A' ' 94' ' ' LEU . 5.6 Cg_exo -77.33 18.79 0.76 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.996 2.464 . . . . 0.0 113.105 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.553 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 8.2 mmtt -119.95 -18.27 8.23 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 120.648 0.261 . . . . 0.0 110.91 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.463 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 32.2 mtt180 -90.97 23.13 3.31 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.15 -179.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.697 ' O ' HD22 ' A' ' 94' ' ' LEU . . . -131.23 99.8 4.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.983 0.421 . . . . 0.0 110.765 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.502 ' CD1' ' O ' ' A' ' 63' ' ' ILE . 51.3 m95 -110.35 136.94 48.75 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.246 0.546 . . . . 0.0 112.106 -178.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.7 pp -114.13 154.71 15.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.198 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.2 t -101.47 127.21 55.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.95 0.405 . . . . 0.0 111.105 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.3 t -119.51 94.38 4.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.347 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.19 -100.43 0.79 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.497 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.502 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.89 29.77 7.21 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.56 0.219 . . . . 0.0 110.871 -179.692 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.411 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -148.03 148.05 30.28 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.502 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 15.2 mm -93.69 120.09 42.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.131 -0.941 . . . . 0.0 109.336 178.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.461 ' CB ' HG13 ' A' ' 100' ' ' VAL . . . -121.94 143.73 49.29 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.432 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -67.28 147.34 53.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.732 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.697 HD22 ' O ' ' A' ' 83' ' ' ALA . 2.6 pt? -60.97 -56.86 16.13 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.798 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.535 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 2.2 m -75.17 -4.63 39.92 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -139.6 87.61 2.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.789 0.328 . . . . 0.0 110.967 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 16.3 mmt85 -67.6 -17.42 64.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.117 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -94.05 11.78 28.61 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.486 179.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.548 ' O ' HG13 ' A' ' 100' ' ' VAL . 10.2 mm -124.4 130.83 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.548 HG13 ' O ' ' A' ' 99' ' ' ILE . 34.7 m -147.64 136.75 15.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.836 0.351 . . . . 0.0 111.91 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.462 ' HG ' ' CZ3' ' A' ' 84' ' ' TRP . 11.2 mt -46.06 154.29 0.26 Allowed 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.693 0.758 . . . . 0.0 111.867 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -159.59 168.57 25.78 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 114.375 -1.284 . . . . 0.0 110.666 -177.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.4 mp -87.41 119.46 35.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.031 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 52.9 mt -70.24 137.51 23.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.913 0.387 . . . . 0.0 111.525 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.0 10.77 7.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.714 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.3 m 45.69 -139.18 0.47 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.938 -0.119 . . . . 0.0 110.94 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 68.84 162.88 0.22 Allowed 'General case' 0 N--CA 1.46 0.067 0 CA-C-O 120.803 0.335 . . . . 0.0 110.878 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 4.3 tttp -89.32 -11.57 43.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.533 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -41.94 135.74 2.28 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.812 0.339 . . . . 0.0 111.62 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -88.46 161.31 17.1 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.303 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 71.94 17.2 76.83 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.027 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.79 135.08 35.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.801 0.334 . . . . 0.0 110.896 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 15.5 m170 -65.14 173.96 2.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.012 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.54 ' O ' HG12 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -137.77 161.94 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.476 -179.917 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.595 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 4.9 t -152.77 167.3 29.48 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.444 ' HB2' ' CG2' ' A' ' 99' ' ' ILE . . . -94.93 126.08 40.03 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.458 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 75.8 t-105 -136.92 162.65 32.68 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.589 0.709 . . . . 0.0 112.304 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.458 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.1 OUTLIER -59.6 119.73 8.11 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.884 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -66.68 130.35 42.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.013 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -142.54 16.07 2.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.88 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 81.95 13.11 80.12 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.83 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.62 136.84 41.83 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.433 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.46 -31.79 70.29 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.465 2.11 . . . . 0.0 112.115 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -75.45 -4.21 38.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.323 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.411 ' O ' ' CG2' ' A' ' 90' ' ' THR . 0.0 OUTLIER -105.53 13.63 29.76 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.244 -179.812 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.96 142.69 37.69 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.871 0.367 . . . . 0.0 111.373 -179.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.429 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 6.6 m-85 -140.84 156.45 46.13 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.118 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.42 HD13 HG22 ' A' ' 128' ' ' ILE . 1.5 mt -112.4 139.62 36.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.109 0.481 . . . . 0.0 110.75 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 24.4 mm -114.63 141.74 29.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.67 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -139.17 94.37 2.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.7 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.8 m -54.29 107.09 0.24 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.227 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.888 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mtp . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.867 0.365 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.411 ' CB ' ' CD ' ' A' ' 3' ' ' PRO . 17.7 mttt -76.47 -61.24 0.8 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.041 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.411 ' CD ' ' CB ' ' A' ' 2' ' ' LYS . 65.7 Cg_endo -73.86 143.3 33.0 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.503 2.135 . . . . 0.0 112.405 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -87.31 118.42 26.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.93 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.482 ' CG ' ' HD2' ' A' ' 57' ' ' LYS . 0.8 OUTLIER -99.61 176.19 5.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.495 179.875 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.731 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -157.5 174.49 15.3 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 120.49 -0.484 . . . . 0.0 111.648 179.634 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.421 ' CE1' ' HB3' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -113.13 123.76 51.01 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.132 179.17 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.431 ' CD1' ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -105.53 109.78 28.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.891 0.377 . . . . 0.0 110.387 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -105.81 134.63 48.61 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.325 -178.709 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.6 p -75.74 106.29 7.23 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.411 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 4.3 tt0 -62.66 -10.68 13.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.539 -178.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 51.2 tp -82.79 -62.82 1.5 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.894 0.378 . . . . 0.0 110.856 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.432 ' HB2' ' HG2' ' A' ' 15' ' ' LYS . 6.4 m-20 -85.98 -9.78 56.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.319 -178.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.12 5.0 69.7 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.139 -1.029 . . . . 0.0 111.48 -178.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.432 ' HG2' ' HB2' ' A' ' 13' ' ' ASN . 8.4 mmtm -91.76 -177.98 4.91 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 10.8 m -120.85 141.39 41.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.703 0.287 . . . . 0.0 110.538 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.9 mt -69.33 134.26 48.87 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.038 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.449 ' HB2' ' HG3' ' A' ' 44' ' ' GLN . 9.7 t70 -146.62 153.74 40.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.864 0.364 . . . . 0.0 111.108 -179.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.432 HD12 HG22 ' A' ' 19' ' ' ILE . 6.9 mm -74.9 143.39 13.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.409 ' HG2' ' N ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -69.85 128.81 37.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.967 0.413 . . . . 0.0 111.659 -179.116 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 60.89 15.4 42.17 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.823 -0.626 . . . . 0.0 113.193 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 45.84 29.81 0.77 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.907 0.354 . . . . 0.0 111.215 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -76.62 111.14 14.12 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.093 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -73.66 0.41 8.21 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.696 2.264 . . . . 0.0 112.686 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -84.12 144.78 44.76 Favored Pre-proline 0 C--N 1.332 -0.165 0 CA-C-O 120.675 0.274 . . . . 0.0 111.216 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.435 ' HB3' ' CD ' ' A' ' 74' ' ' PRO . 50.1 Cg_exo -54.35 141.43 71.79 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.65 2.233 . . . . 0.0 112.445 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.25 3.45 55.55 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.762 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.3 m -73.64 124.96 26.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.974 0.416 . . . . 0.0 111.105 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.409 ' N ' ' HG2' ' A' ' 20' ' ' GLU . 0.3 OUTLIER -75.08 161.45 29.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.045 179.479 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.417 HD12 HG21 ' A' ' 63' ' ' ILE . 41.6 pt -118.88 146.56 23.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.853 0.359 . . . . 0.0 111.928 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.441 ' HA ' ' CD1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -153.56 178.01 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.139 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.686 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.4 p -103.73 151.14 23.37 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.695 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 27.0 t-105 -154.86 169.64 23.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.735 0.303 . . . . 0.0 110.884 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.56 132.68 46.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.767 0.318 . . . . 0.0 110.666 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -55.08 114.84 1.92 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.217 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.19 170.29 10.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.678 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.6 mtmm -130.94 112.89 13.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.915 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 151.1 -162.82 29.59 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.594 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -74.95 1.01 8.18 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 123.013 2.475 . . . . 0.0 112.866 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.0 t -104.41 26.11 9.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.709 0.29 . . . . 0.0 111.123 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.45 ' O ' ' CD1' ' A' ' 45' ' ' LEU . . . -93.93 -20.58 19.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.975 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.568 ' HA ' HD12 ' A' ' 45' ' ' LEU . 50.0 t -51.21 -33.93 14.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.301 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -68.91 -7.86 38.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.6 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.449 ' HG3' ' HB2' ' A' ' 18' ' ' ASP . 1.8 mt-30 -114.5 6.27 15.82 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.731 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 0.9 OUTLIER -118.67 142.34 47.76 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.157 -0.928 . . . . 0.0 111.567 -178.913 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.499 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 26.1 m95 -134.51 169.47 17.23 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.187 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.502 ' CE2' ' HB2' ' A' ' 55' ' ' ARG . 42.1 p90 -141.25 164.14 31.05 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.533 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.58 135.18 50.26 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.784 0.326 . . . . 0.0 111.443 -178.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -78.19 170.93 15.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.144 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -66.33 -24.3 66.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.097 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.8 -4.09 55.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.253 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.38 9.78 49.8 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.875 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 40.1 t -97.48 119.73 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 CA-C-N 116.883 0.341 . . . . 0.0 110.512 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.465 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.6 OUTLIER -78.77 150.86 5.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.495 0.664 . . . . 0.0 111.951 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.502 ' HB2' ' CE2' ' A' ' 47' ' ' TYR . 11.2 mmm-85 -147.36 132.94 18.76 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.628 178.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.499 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -60.83 141.97 56.57 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.713 0.768 . . . . 0.0 111.981 -178.481 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.482 ' HD2' ' CG ' ' A' ' 5' ' ' PHE . 21.9 tttm -56.64 -20.58 22.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.445 -1.252 . . . . 0.0 111.69 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.417 ' HA ' HG12 ' A' ' 42' ' ' VAL . 1.0 OUTLIER -48.19 -31.7 6.11 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.736 -179.188 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -179.86 -81.46 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.735 0.303 . . . . 0.0 111.036 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 32.0 p-10 -176.44 77.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.897 0.38 . . . . 0.0 110.926 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.411 ' CE1' ' HD3' ' A' ' 74' ' ' PRO . 7.1 m-85 -145.22 132.26 20.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.838 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -98.29 150.71 21.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.938 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.499 ' O ' ' NE1' ' A' ' 84' ' ' TRP . 0.2 OUTLIER -80.82 150.89 4.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.273 179.476 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.565 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 8.6 p-10 -133.06 131.58 40.79 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.215 0.531 . . . . 0.0 111.603 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -96.18 40.96 1.11 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.256 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 68.2 m -73.91 -43.41 58.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.342 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 65.0 m80 -97.59 172.56 7.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.11 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -48.04 -47.15 33.79 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.136 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -102.33 146.5 27.94 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.912 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.578 ' CG1' ' HA ' ' A' ' 115' ' ' CYS . 1.9 mm -78.1 144.15 11.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-O 121.614 0.721 . . . . 0.0 111.755 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -144.51 168.75 19.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.001 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 63' ' ' ILE . 80.9 p -105.44 136.98 44.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.993 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.444 ' CB ' ' HD2' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -161.2 168.06 12.21 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.136 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.444 ' HD2' ' CB ' ' A' ' 73' ' ' GLN . 13.9 Cg_endo -57.37 134.49 64.08 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.404 2.07 . . . . 0.0 112.055 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -62.46 132.61 53.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.864 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -121.62 139.22 29.54 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.775 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.12 -34.05 17.63 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.515 2.143 . . . . 0.0 112.67 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -88.13 -0.72 57.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.653 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.414 ' HB3' ' HD2' ' A' ' 82' ' ' ARG . 1.7 m120 -109.31 100.02 39.23 Favored Pre-proline 0 C--O 1.232 0.175 0 CA-C-O 120.583 0.23 . . . . 0.0 111.029 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.428 ' O ' ' CD2' ' A' ' 94' ' ' LEU . 4.0 Cg_exo -76.44 25.48 0.43 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.923 2.415 . . . . 0.0 113.027 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.565 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 0.1 OUTLIER -118.71 -21.33 7.92 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 120.616 0.246 . . . . 0.0 111.19 -179.721 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.431 ' HG3' ' HB3' ' A' ' 64' ' ' ASP . 0.4 OUTLIER -88.56 18.94 4.18 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.064 -0.517 . . . . 0.0 112.365 -179.028 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.69 ' O ' HD22 ' A' ' 94' ' ' LEU . . . -128.41 99.26 5.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.097 0.475 . . . . 0.0 110.775 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.499 ' NE1' ' O ' ' A' ' 63' ' ' ILE . 58.3 m95 -108.84 136.45 48.37 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.15 0.5 . . . . 0.0 111.907 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.9 pt -113.81 154.47 15.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.085 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.7 t -102.53 127.84 55.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.988 0.423 . . . . 0.0 111.111 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 30.5 t -120.88 95.14 4.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.35 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.2 -101.07 0.84 Allowed Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.477 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.498 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -121.02 30.15 7.0 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.496 0.189 . . . . 0.0 110.867 -179.802 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.421 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.34 147.49 30.38 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.597 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.1 mm -94.06 119.98 42.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.336 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.46 ' CB ' HG11 ' A' ' 100' ' ' VAL . . . -123.98 144.57 49.74 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.86 149.53 46.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.661 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.69 HD22 ' O ' ' A' ' 83' ' ' ALA . 2.6 pt? -62.33 -57.11 12.54 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.672 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.533 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 92.6 p -79.8 -2.64 44.19 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -137.52 84.65 2.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.841 0.353 . . . . 0.0 111.004 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.6 mpp_? -66.34 -18.18 65.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.174 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.46 10.29 28.32 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.538 179.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.521 ' O ' HG11 ' A' ' 100' ' ' VAL . 11.2 mm -124.36 129.39 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.466 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.521 HG11 ' O ' ' A' ' 99' ' ' ILE . 30.8 m -146.68 136.01 16.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.48 ' HA ' ' O ' ' A' ' 115' ' ' CYS . 12.7 mt -46.47 153.79 0.34 Allowed 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 121.753 0.787 . . . . 0.0 111.837 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.404 ' OD2' ' HG2' ' A' ' 125' ' ' GLN . 9.9 t70 -158.36 168.02 28.11 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.587 -177.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.4 mp -87.26 122.38 39.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.194 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.1 tt -65.37 136.73 26.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.072 0.463 . . . . 0.0 111.482 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 70.63 1.22 3.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.997 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 51.4 p 43.68 31.39 0.45 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.761 0.315 . . . . 0.0 111.365 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -94.7 154.29 17.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.267 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.91 -14.14 58.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.156 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -49.03 118.51 2.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.265 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.1 157.93 17.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.054 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 73.25 15.67 78.79 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.214 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.94 132.86 39.28 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.834 0.349 . . . . 0.0 110.95 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -65.58 172.02 3.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.925 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.498 ' O ' HG12 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -136.42 161.63 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.517 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.578 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 95.7 m -153.77 168.96 24.56 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.447 ' HB3' ' CG2' ' A' ' 99' ' ' ILE . . . -95.7 126.62 41.1 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.467 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 76.1 t-105 -134.49 162.57 31.88 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.603 0.716 . . . . 0.0 112.129 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.467 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.1 OUTLIER -62.43 117.43 6.15 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.596 -1.183 . . . . 0.0 110.781 179.885 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -62.4 126.65 28.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.962 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -138.18 13.72 2.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.165 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 76.19 60.8 2.98 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.518 -0.848 . . . . 0.0 112.315 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -117.3 145.99 18.7 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.551 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.68 -32.39 75.36 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.403 2.069 . . . . 0.0 112.013 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -76.29 -2.69 32.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.586 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.421 ' O ' ' CG2' ' A' ' 90' ' ' THR . 0.9 OUTLIER -107.8 11.06 28.55 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.466 0.174 . . . . 0.0 111.172 180.0 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.411 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 1.7 mmmm -106.76 138.21 43.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.846 0.355 . . . . 0.0 111.529 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -138.59 155.77 48.05 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.246 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.3 mt -113.36 138.64 42.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.149 0.5 . . . . 0.0 110.776 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 26.4 mm -113.86 139.71 38.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.524 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -139.5 94.68 2.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.655 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 18.6 p -51.34 110.73 0.47 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.327 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.948 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 mtt . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.796 0.331 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.4 mttt 60.33 82.12 0.23 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.837 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.62 106.78 1.88 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.547 2.164 . . . . 0.0 112.327 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 11.4 mttm -96.46 121.16 37.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.817 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.495 ' CD1' ' HG3' ' A' ' 57' ' ' LYS . 0.9 OUTLIER -100.64 175.93 5.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.476 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.757 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -158.84 173.95 15.74 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 120.469 -0.492 . . . . 0.0 111.496 179.883 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.41 ' CE2' HD12 ' A' ' 45' ' ' LEU . 0.4 OUTLIER -109.46 123.79 49.96 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.204 179.13 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.414 ' CD1' ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -109.02 104.56 17.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.939 -179.755 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.624 ' HB2' ' O ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -122.81 140.11 53.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.453 -179.751 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.9 m -60.69 135.45 57.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.925 0.393 . . . . 0.0 110.744 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -77.99 -11.84 59.94 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.961 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 41.1 tp -89.03 -58.64 2.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.793 0.33 . . . . 0.0 110.986 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -84.94 -17.74 36.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.262 -0.426 . . . . 0.0 112.017 -179.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.4 5.81 73.72 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.308 -0.949 . . . . 0.0 112.231 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.624 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 1.5 mmmt -86.29 165.64 16.28 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.599 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 9.5 m -106.5 137.15 38.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.822 0.344 . . . . 0.0 110.723 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.3 mt -69.13 137.58 53.52 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -143.7 151.19 39.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.018 0.437 . . . . 0.0 111.439 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.418 HD13 ' CH2' ' A' ' 46' ' ' TRP . 23.1 mt -92.73 133.64 33.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.459 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -40.64 96.3 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.962 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 44.43 32.94 2.92 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.925 -0.58 . . . . 0.0 113.302 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 67.67 -66.06 0.22 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.784 0.326 . . . . 0.0 111.021 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 63.55 90.75 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.847 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.63 -21.09 13.7 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.579 2.186 . . . . 0.0 112.505 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -96.23 153.94 38.9 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.066 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.45 ' HB3' ' HB3' ' A' ' 73' ' ' GLN . 10.7 Cg_exo -70.81 146.48 53.79 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.772 2.315 . . . . 0.0 112.092 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.98 3.38 23.25 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.52 -0.847 . . . . 0.0 113.239 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.7 t -77.2 132.54 38.8 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 117.093 0.446 . . . . 0.0 111.345 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.6 mmtt -81.46 160.53 23.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.645 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.436 HD13 ' HB ' ' A' ' 70' ' ' ILE . 47.3 pt -120.98 149.03 23.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.445 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -155.73 -178.98 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.173 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.75 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 p -101.36 149.19 24.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.419 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 19.5 t-105 -156.81 171.49 20.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.732 0.301 . . . . 0.0 110.989 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -71.33 138.54 49.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.705 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -52.1 112.14 0.74 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.284 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.0 168.01 13.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.902 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.98 151.6 51.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.877 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.96 -162.81 12.3 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.496 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -79.13 7.9 4.13 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.169 2.579 . . . . 0.0 112.849 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -114.07 18.0 17.44 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.655 0.264 . . . . 0.0 111.208 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.528 ' O ' HD11 ' A' ' 45' ' ' LEU . . . -82.42 -22.37 35.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.951 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.569 ' HA ' HD11 ' A' ' 45' ' ' LEU . 17.5 t -50.33 -27.65 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.961 179.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -64.65 -10.56 27.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.619 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -118.56 7.79 11.87 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.135 0.493 . . . . 0.0 109.675 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.757 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 1.3 mp -117.05 140.37 49.57 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.664 -179.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.485 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 25.9 m95 -134.43 169.4 17.31 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.035 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.604 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 15.1 p90 -141.42 165.51 27.32 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.954 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.2 p -109.68 136.67 48.66 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.902 0.382 . . . . 0.0 111.475 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.0 173.39 12.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.327 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -63.29 -21.24 66.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.12 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -101.36 -2.8 30.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.168 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.21 2.6 51.28 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.868 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.8 t -83.06 114.26 23.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.873 0.368 . . . . 0.0 110.82 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.604 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -76.78 146.72 8.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.253 0.549 . . . . 0.0 111.766 -179.795 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.499 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 2.7 mmm-85 -151.56 133.68 15.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.539 178.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.485 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 12.5 m -52.78 150.2 5.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.271 0.558 . . . . 0.0 111.903 -179.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.495 ' HG3' ' CD1' ' A' ' 5' ' ' PHE . 1.1 ttpt -60.33 -26.56 66.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.763 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.441 ' N ' ' CG1' ' A' ' 42' ' ' VAL . 0.8 OUTLIER -56.29 -32.91 65.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.282 -179.316 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 170.77 -171.87 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.775 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -76.4 84.78 3.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.705 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.426 ' CE2' ' HD3' ' A' ' 74' ' ' PRO . 1.1 m-85 -141.06 115.17 9.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.759 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -105.73 150.03 25.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.081 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.476 ' O ' ' CD1' ' A' ' 84' ' ' TRP . 0.2 OUTLIER -78.64 153.76 4.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.92 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.55 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 5.1 p-10 -133.6 132.91 41.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.227 0.537 . . . . 0.0 111.569 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -96.73 41.78 1.1 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.197 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.4 m -74.53 -46.36 39.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.225 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -93.95 170.66 9.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.952 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -47.29 -48.06 25.04 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.944 0.402 . . . . 0.0 110.959 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -99.73 144.24 29.04 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.917 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.607 ' CG1' ' HA ' ' A' ' 115' ' ' CYS . 2.7 mm -71.05 136.13 26.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-O 121.527 0.679 . . . . 0.0 111.366 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -130.33 162.76 28.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.237 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.0 p -105.5 138.71 41.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.549 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.45 ' HB3' ' HB3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -162.82 159.16 19.3 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.668 -179.769 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.426 ' HD3' ' CE2' ' A' ' 61' ' ' PHE . 53.7 Cg_exo -52.03 143.29 41.27 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.429 2.086 . . . . 0.0 111.737 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -59.07 126.03 26.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.915 0.388 . . . . 0.0 111.354 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.429 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 8.1 t70 -119.54 130.32 24.9 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.166 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.6 -33.82 21.07 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.602 2.202 . . . . 0.0 113.47 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -85.71 0.25 53.29 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.429 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 3.2 m120 -106.49 104.33 50.13 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.563 0.221 . . . . 0.0 111.343 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.431 ' O ' ' CD2' ' A' ' 94' ' ' LEU . 5.6 Cg_exo -77.34 20.07 0.69 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.868 2.379 . . . . 0.0 112.697 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 24.6 mmtp -120.15 -18.34 8.09 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.038 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.495 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 6.4 mtt180 -88.66 18.73 4.42 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.943 -0.572 . . . . 0.0 112.187 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.697 ' O ' HD22 ' A' ' 94' ' ' LEU . . . -127.79 99.27 5.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.131 0.491 . . . . 0.0 110.647 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.476 ' CD1' ' O ' ' A' ' 63' ' ' ILE . 61.8 m95 -108.55 136.42 48.18 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.114 0.483 . . . . 0.0 111.859 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 pt -115.21 154.24 16.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.272 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.5 t -101.2 124.41 54.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.012 0.434 . . . . 0.0 110.987 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 23.1 t -116.8 94.43 4.6 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.437 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.66 -100.95 0.79 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.505 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.51 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.79 30.17 7.03 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.587 0.232 . . . . 0.0 110.915 -179.63 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.92 148.0 30.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.394 0.616 . . . . 0.0 112.537 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 13.6 mm -93.94 120.15 42.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.411 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.452 ' CB ' HG11 ' A' ' 100' ' ' VAL . . . -124.89 146.67 49.2 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -178.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.437 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -67.17 148.83 51.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.811 179.808 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.697 HD22 ' O ' ' A' ' 83' ' ' ALA . 2.7 pt? -61.07 -56.54 19.75 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.719 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.546 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 57.9 m -80.17 -3.44 48.98 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -136.56 85.44 2.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.838 0.351 . . . . 0.0 111.075 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -66.83 -17.97 65.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.155 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -92.08 9.83 31.75 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.521 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.506 ' O ' HG11 ' A' ' 100' ' ' VAL . 12.2 mm -123.14 127.4 74.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.531 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.506 HG11 ' O ' ' A' ' 99' ' ' ILE . 23.5 m -146.17 135.04 16.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.86 0.362 . . . . 0.0 111.862 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.486 ' HA ' ' O ' ' A' ' 115' ' ' CYS . 11.0 mt -46.72 154.37 0.32 Allowed 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.7 0.762 . . . . 0.0 112.008 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -155.63 167.78 29.29 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.319 -1.31 . . . . 0.0 110.694 -177.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.519 ' HA ' HG22 ' A' ' 114' ' ' ILE . 3.7 mp -92.94 124.52 45.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.509 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.411 HG13 ' N ' ' A' ' 105' ' ' LYS . 0.9 OUTLIER -68.24 139.6 20.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.961 0.41 . . . . 0.0 111.324 -179.83 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.411 ' N ' HG13 ' A' ' 104' ' ' ILE . 0.0 OUTLIER 78.4 -9.8 1.45 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.851 179.745 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.4 m 47.13 34.94 3.19 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.806 0.336 . . . . 0.0 111.188 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -106.94 166.92 10.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.195 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.4 -14.39 58.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.037 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -50.47 135.84 21.73 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.202 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -88.97 162.3 16.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.095 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.01 16.45 79.51 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.233 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.43 137.87 33.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.897 0.379 . . . . 0.0 110.967 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 3.1 m170 -61.9 167.98 3.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.847 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.519 HG22 ' HA ' ' A' ' 103' ' ' ILE . 0.0 OUTLIER -138.74 161.01 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.582 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.607 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 25.7 p -156.75 170.68 21.88 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.452 ' HB1' ' CG2' ' A' ' 99' ' ' ILE . . . -95.49 127.01 41.18 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 178.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.456 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 70.7 t-105 -132.37 162.88 29.98 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.529 0.68 . . . . 0.0 112.282 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.456 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.5 OUTLIER -63.55 120.78 12.39 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.659 179.843 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -58.91 124.45 19.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.177 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -132.68 8.1 4.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.631 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 82.38 6.74 88.42 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.164 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -66.0 142.62 43.55 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.401 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -56.86 -25.15 60.16 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.457 2.105 . . . . 0.0 112.508 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 34.5 p-10 -70.46 -9.09 55.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.706 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -107.02 17.99 22.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.698 0.285 . . . . 0.0 111.014 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.5 mmtp -103.59 123.78 47.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.793 0.33 . . . . 0.0 111.157 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.419 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 4.3 m-85 -127.96 153.0 47.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.632 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.6 mt -115.61 139.47 41.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.452 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.414 ' CD1' ' CG2' ' A' ' 8' ' ' ILE . 32.3 mm -113.94 144.05 22.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.677 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -136.07 94.18 3.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.609 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.47 109.3 0.43 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.312 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.913 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.83 0.348 . . . . 0.0 111.166 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.457 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 0.1 OUTLIER -80.17 -47.78 1.33 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.2 -179.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.457 ' CD ' ' N ' ' A' ' 2' ' ' LYS . 85.0 Cg_endo -82.56 111.4 2.04 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.405 2.07 . . . . 0.0 112.539 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 47' ' ' TYR . 0.5 OUTLIER -102.76 76.84 1.54 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.773 179.876 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -99.21 175.04 6.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.757 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.621 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -151.92 170.71 19.19 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 120.97 0.414 . . . . 0.0 111.213 178.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.435 ' CE2' HD13 ' A' ' 45' ' ' LEU . 0.1 OUTLIER -111.45 123.82 50.99 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.143 179.173 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.45 HD13 HG23 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -107.12 106.36 20.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.245 179.879 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -106.77 137.06 45.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.384 -178.7 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.9 108.67 10.11 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -62.69 -10.53 12.92 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.483 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 30.3 tp -83.36 -62.47 1.58 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.865 0.364 . . . . 0.0 111.039 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.401 ' HA ' ' HG3' ' A' ' 108' ' ' LYS . 6.9 m-20 -86.83 -10.65 52.98 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.1 5.03 69.7 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.086 -1.054 . . . . 0.0 111.398 -178.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' A' ' 9' ' ' LYS . 1.7 mmmm -91.78 178.22 5.97 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.9 m -119.93 142.59 34.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.689 0.281 . . . . 0.0 110.507 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.3 mt -68.11 135.93 52.94 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.432 ' CB ' ' HG3' ' A' ' 44' ' ' GLN . 19.9 t0 -145.33 142.44 29.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.719 0.295 . . . . 0.0 111.114 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.428 HD11 HG22 ' A' ' 19' ' ' ILE . 14.0 mm -66.28 145.78 13.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -51.04 109.2 0.3 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.911 0.386 . . . . 0.0 111.511 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 49.76 26.38 7.97 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.97 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 50.75 68.94 0.7 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.848 0.356 . . . . 0.0 110.985 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -102.37 106.25 47.76 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.927 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.27 -7.92 20.42 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.739 2.293 . . . . 0.0 112.68 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -82.08 160.46 63.02 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.787 0.327 . . . . 0.0 111.088 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.449 ' HB3' ' CD ' ' A' ' 74' ' ' PRO . 72.1 Cg_endo -75.49 141.07 24.83 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.742 2.294 . . . . 0.0 112.387 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.14 5.5 52.85 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.806 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.91 134.56 41.57 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.96 0.409 . . . . 0.0 111.213 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.9 mmtt -81.72 157.03 24.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.213 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.444 HD11 HG22 ' A' ' 63' ' ' ILE . 47.5 pt -116.63 145.96 21.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.906 -0.317 . . . . 0.0 111.483 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.4 HG22 ' HA ' ' A' ' 113' ' ' HIS . 0.2 OUTLIER -155.49 -178.85 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.196 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.982 -179.667 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.5 p -101.98 148.88 24.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.551 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 32.4 t-105 -159.13 173.28 16.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.686 0.279 . . . . 0.0 110.845 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -70.14 134.58 48.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.813 0.339 . . . . 0.0 110.757 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -61.36 130.51 46.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.01 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.71 159.97 14.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.784 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -122.45 105.76 10.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.967 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 159.31 -178.12 35.58 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.51 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -77.19 4.57 5.73 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.04 2.493 . . . . 0.0 112.782 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.2 t -119.98 30.02 7.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.797 0.332 . . . . 0.0 110.917 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.503 ' O ' HD12 ' A' ' 45' ' ' LEU . . . -109.29 2.52 20.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.525 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.484 ' CG1' ' HB3' ' A' ' 57' ' ' LYS . 2.2 t -58.95 -18.21 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-O 120.706 0.289 . . . . 0.0 110.596 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.41 ' HA ' ' HG2' ' A' ' 57' ' ' LYS . 64.0 t30 -61.84 -11.86 14.72 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.928 178.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.432 ' HG3' ' CB ' ' A' ' 18' ' ' ASP . 7.7 mp0 -111.56 7.76 20.72 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.621 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 1.4 mp -121.06 146.44 46.72 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.232 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.461 ' CH2' ' CG1' ' A' ' 63' ' ' ILE . 25.4 m95 -133.27 170.11 15.93 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.65 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.55 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 1.5 p90 -136.09 159.46 41.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.92 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.8 p -107.17 134.18 50.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.786 0.327 . . . . 0.0 111.303 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -77.87 166.53 22.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.147 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -59.37 -22.69 61.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.164 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -97.4 -2.83 41.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.281 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.91 5.45 55.0 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.873 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.2 t -87.84 116.67 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-O 120.8 0.333 . . . . 0.0 110.635 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.55 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.8 OUTLIER -78.55 150.49 5.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.326 0.584 . . . . 0.0 111.942 -179.758 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.538 ' HB2' ' CE2' ' A' ' 47' ' ' TYR . 2.9 mmm-85 -147.44 133.18 18.93 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.207 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.424 ' HB2' ' CE2' ' A' ' 46' ' ' TRP . 47.2 t -68.8 -177.2 0.94 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.307 0.575 . . . . 0.0 112.138 -178.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.484 ' HB3' ' CG1' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -46.05 -23.56 0.33 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.838 -179.761 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.513 ' HB2' ' HB2' ' A' ' 61' ' ' PHE . 0.9 OUTLIER -50.45 -21.3 1.41 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.652 -179.315 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 58' ' ' LEU . 8.0 t30 84.44 -10.24 0.88 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 179.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -175.36 53.49 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.861 0.362 . . . . 0.0 111.546 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.513 ' HB2' ' HB2' ' A' ' 58' ' ' LEU . 3.8 m-85 -141.07 110.5 6.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.018 0.437 . . . . 0.0 110.597 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -98.46 150.06 22.04 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.894 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.489 ' O ' ' NE1' ' A' ' 84' ' ' TRP . 0.2 OUTLIER -77.92 150.8 5.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.214 179.713 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.569 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 7.8 p-10 -131.59 133.02 44.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.156 0.503 . . . . 0.0 111.558 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.65 41.44 1.16 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.178 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.4 m -73.49 -42.62 61.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.061 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -98.2 172.83 7.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.936 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -49.47 -47.82 48.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.181 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -99.74 144.33 28.94 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.141 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.64 ' CG1' ' HA ' ' A' ' 115' ' ' CYS . 2.3 mm -76.31 142.86 13.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 CA-C-O 121.541 0.686 . . . . 0.0 111.764 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -141.8 168.41 19.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.196 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 49.4 p -108.24 139.88 42.29 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.085 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.49 165.17 14.51 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.304 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.449 ' CD ' ' HB3' ' A' ' 26' ' ' PRO . 10.6 Cg_endo -53.6 139.37 66.81 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.533 2.155 . . . . 0.0 111.92 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -61.5 131.74 51.13 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.881 0.372 . . . . 0.0 111.232 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.92 133.84 24.21 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.555 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -69.05 -34.48 16.86 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.451 2.101 . . . . 0.0 112.664 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -88.04 0.31 56.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.77 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -105.71 102.21 37.04 Favored Pre-proline 0 C--O 1.233 0.2 0 CA-C-O 120.517 0.199 . . . . 0.0 111.051 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.429 ' O ' ' CD2' ' A' ' 94' ' ' LEU . 5.9 Cg_exo -77.62 22.05 0.61 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.921 2.414 . . . . 0.0 112.994 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.569 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 33.7 mmtt -119.93 -18.54 8.18 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 120.599 0.238 . . . . 0.0 111.139 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.504 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 3.1 mtm180 -89.63 18.84 5.06 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.357 -179.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.675 ' O ' HD21 ' A' ' 94' ' ' LEU . . . -127.8 99.06 5.39 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.054 0.454 . . . . 0.0 110.802 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.489 ' NE1' ' O ' ' A' ' 63' ' ' ILE . 58.0 m95 -108.77 135.53 49.84 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.192 0.52 . . . . 0.0 111.938 -178.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.3 pt -113.58 154.41 14.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.254 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.3 t -101.32 125.83 55.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.967 0.413 . . . . 0.0 111.045 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 47.0 t -118.44 93.68 4.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.456 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.9 -100.41 0.77 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.519 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.495 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.42 29.19 7.58 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.532 0.206 . . . . 0.0 111.017 -179.578 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.426 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.57 147.56 30.21 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.607 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.41 ' O ' ' HA ' ' A' ' 100' ' ' VAL . 18.9 mm -93.76 120.47 43.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.127 178.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.452 ' CB ' HG13 ' A' ' 100' ' ' VAL . . . -123.87 145.31 49.19 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.423 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -66.22 148.45 51.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.648 179.786 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.675 HD21 ' O ' ' A' ' 83' ' ' ALA . 2.6 pt? -60.77 -57.02 14.44 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.804 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.533 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 66.9 p -78.99 -3.7 46.33 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -137.09 86.59 2.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.877 0.37 . . . . 0.0 111.001 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.59 -18.68 65.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.082 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -91.96 9.87 31.28 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.459 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.509 ' O ' HG13 ' A' ' 100' ' ' VAL . 13.3 mm -121.84 126.46 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.47 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.509 HG13 ' O ' ' A' ' 99' ' ' ILE . 25.4 m -146.14 134.9 16.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.96 0.41 . . . . 0.0 111.973 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.509 ' HA ' ' O ' ' A' ' 115' ' ' CYS . 13.6 mt -47.94 154.22 0.56 Allowed 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 121.782 0.801 . . . . 0.0 112.095 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.401 ' OD2' ' CG ' ' A' ' 125' ' ' GLN . 9.9 t70 -156.2 167.02 31.74 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.271 -1.331 . . . . 0.0 110.78 -177.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.427 ' HA ' HG21 ' A' ' 114' ' ' ILE . 4.4 mp -88.62 122.92 40.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.256 179.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.8 tt -69.03 139.47 20.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.066 0.46 . . . . 0.0 111.675 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 75.61 -7.21 1.83 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.074 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.1 m 46.61 29.15 0.88 Allowed 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.766 0.317 . . . . 0.0 111.179 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -99.43 161.53 13.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.071 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.401 ' HG3' ' HA ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -78.64 -14.36 59.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.202 179.769 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -49.06 123.6 7.45 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.895 0.379 . . . . 0.0 111.252 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.59 162.17 29.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.103 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 70.63 18.96 76.13 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.0 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.37 136.41 35.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.903 0.382 . . . . 0.0 111.0 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.4 ' HA ' HG22 ' A' ' 31' ' ' ILE . 1.2 m170 -63.61 171.39 2.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.751 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.489 ' O ' HG12 ' A' ' 70' ' ' ILE . 0.7 OUTLIER -142.44 162.02 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.806 -179.681 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.64 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 5.0 p -155.51 172.02 18.95 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.45 ' HB2' ' CG2' ' A' ' 99' ' ' ILE . . . -96.02 126.99 41.64 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 178.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.458 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 69.8 t-105 -132.77 162.01 32.58 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.567 0.699 . . . . 0.0 112.158 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.458 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 2.4 tptt -61.21 121.14 11.79 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.637 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -62.0 125.28 23.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.896 0.379 . . . . 0.0 111.211 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -134.92 12.17 3.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.169 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 79.62 8.16 87.94 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.927 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -60.47 149.76 42.52 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.52 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.21 -25.2 57.8 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.639 2.226 . . . . 0.0 112.206 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -74.0 -5.16 39.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.426 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.426 ' O ' ' CG2' ' A' ' 90' ' ' THR . 83.8 mt-30 -108.14 18.69 20.85 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.615 0.245 . . . . 0.0 111.19 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt -104.74 127.69 52.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.798 0.332 . . . . 0.0 111.273 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.415 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 15.1 m-85 -134.04 154.38 51.19 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 120.939 0.4 . . . . 0.0 110.399 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.4 mt -113.56 138.98 41.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.456 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.422 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 36.2 mm -113.64 140.85 31.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.613 -179.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -138.45 112.15 8.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.512 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.82 109.07 3.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.047 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.905 179.958 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.6 mmt . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.799 0.333 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.405 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -87.66 -52.98 0.39 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.943 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.405 ' CD ' ' N ' ' A' ' 2' ' ' LYS . 50.2 Cg_exo -53.63 132.12 47.42 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.487 2.125 . . . . 0.0 112.246 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -78.69 109.61 13.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.911 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.516 ' CD1' ' HG3' ' A' ' 57' ' ' LYS . 25.3 m-85 -92.39 175.2 6.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.516 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.71 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -159.46 176.34 12.21 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.793 179.764 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.421 ' CE2' HD22 ' A' ' 45' ' ' LEU . 21.5 m-85 -111.84 124.29 52.06 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.276 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.431 ' CD1' ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -107.61 107.07 21.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.818 0.342 . . . . 0.0 110.275 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 15' ' ' LYS . 6.0 tttt -106.5 137.07 45.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.099 -0.501 . . . . 0.0 112.322 -178.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.0 m -75.94 109.83 9.89 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 178.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -64.46 -11.38 32.95 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.492 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 24.0 tp -84.34 -62.3 1.59 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.939 0.399 . . . . 0.0 111.034 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -85.28 -12.6 52.05 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.79 3.07 72.43 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.095 -1.05 . . . . 0.0 111.485 -178.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.419 ' O ' ' HG3' ' A' ' 9' ' ' LYS . 1.7 mmtt -90.43 -179.2 5.54 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.3 m -121.93 142.44 38.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.728 0.299 . . . . 0.0 110.586 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.3 mt -67.23 135.08 52.87 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.434 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 12.7 t70 -145.41 146.64 31.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.683 0.278 . . . . 0.0 111.13 -178.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.0 mm -74.32 144.9 11.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -62.28 128.68 37.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.013 0.435 . . . . 0.0 111.909 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 47.35 24.94 2.67 Favored Glycine 0 C--N 1.331 0.298 0 CA-C-N 115.825 -0.625 . . . . 0.0 113.671 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 47.63 27.49 1.04 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.851 0.326 . . . . 0.0 111.333 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -66.03 108.02 1.96 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.064 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -76.0 -2.82 13.07 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.727 2.285 . . . . 0.0 112.489 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -85.32 147.97 48.61 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 120.725 0.298 . . . . 0.0 111.232 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -56.94 134.35 63.97 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.532 2.155 . . . . 0.0 112.372 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.32 5.44 32.33 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.99 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.3 m -76.67 126.59 31.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.901 0.381 . . . . 0.0 111.259 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -76.14 159.94 30.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.282 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.407 HG13 ' CG1' ' A' ' 114' ' ' ILE . 50.9 pt -119.96 147.4 23.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.892 0.377 . . . . 0.0 111.824 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.445 HG22 HD12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -155.9 -177.81 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.163 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.495 -179.901 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 p -103.36 150.38 23.86 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.648 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 27.2 t-105 -156.53 170.74 21.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.668 0.27 . . . . 0.0 110.849 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -69.6 132.9 46.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.758 0.313 . . . . 0.0 110.665 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -57.27 147.4 25.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.16 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.53 165.45 15.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.775 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.9 mttm -125.6 109.61 12.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 144.29 -160.8 27.9 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.623 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -72.73 -1.91 11.09 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 123.005 2.47 . . . . 0.0 112.861 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.7 p -102.14 30.49 4.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.94 0.4 . . . . 0.0 111.033 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.449 ' O ' ' CD1' ' A' ' 45' ' ' LEU . . . -106.62 -17.11 14.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.908 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.559 ' HA ' HD12 ' A' ' 45' ' ' LEU . 73.4 t -50.06 -35.12 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.965 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.434 ' HB3' ' OD1' ' A' ' 18' ' ' ASP . 17.8 t30 -69.13 -7.82 39.68 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.995 -179.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -118.01 7.75 12.34 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.71 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 0.9 OUTLIER -117.68 140.72 49.27 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.312 -179.096 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.529 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 25.4 m95 -134.67 169.29 17.55 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.813 -178.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.525 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 6.3 p90 -137.86 161.18 37.3 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.296 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 65.1 p -107.58 136.32 47.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.729 0.299 . . . . 0.0 111.003 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -77.77 166.59 22.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.938 0.399 . . . . 0.0 111.168 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -57.81 -20.93 39.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.189 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -102.79 -2.45 28.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.386 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.24 0.47 47.54 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.043 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 23.2 t -81.24 113.32 20.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.921 0.36 . . . . 0.0 110.58 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.525 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.6 OUTLIER -79.59 150.33 5.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.439 0.638 . . . . 0.0 112.089 -179.602 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.475 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 9.0 mmm-85 -151.02 132.59 14.79 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.834 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.529 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 66.2 p -57.42 156.59 7.67 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.648 0.737 . . . . 0.0 111.384 -179.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.516 ' HG3' ' CD1' ' A' ' 5' ' ' PHE . 58.7 tttm -61.25 -9.32 4.81 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.686 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.487 HD13 ' HB2' ' A' ' 56' ' ' SER . 4.6 mp -42.13 -49.86 4.81 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.059 0.457 . . . . 0.0 111.035 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.7 p30 172.52 -53.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.534 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.5 t0 179.71 76.82 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.668 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.437 ' CE2' ' HD3' ' A' ' 74' ' ' PRO . 3.7 m-85 -143.49 126.88 16.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.054 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.406 ' CB ' ' HD2' ' A' ' 55' ' ' ARG . . . -103.61 150.85 23.58 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.21 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.472 ' CG1' ' CH2' ' A' ' 46' ' ' TRP . 0.2 OUTLIER -80.49 152.04 4.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.178 179.499 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.545 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 6.9 p-10 -133.36 135.72 44.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.17 0.51 . . . . 0.0 111.653 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -98.13 44.08 1.05 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.205 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 94.2 p -74.12 -43.64 56.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.462 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -100.89 176.06 5.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.084 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -49.03 -44.71 41.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.823 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.74 148.87 26.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.602 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.607 ' CD1' ' HA ' ' A' ' 115' ' ' CYS . 1.3 mm -77.93 140.84 16.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 CA-C-O 121.651 0.738 . . . . 0.0 111.612 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -133.31 159.84 39.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.766 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 39.2 p -102.29 137.53 40.43 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.34 179.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.485 ' CB ' ' HD2' ' A' ' 74' ' ' PRO . 0.3 OUTLIER -164.47 170.95 6.12 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.253 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.485 ' HD2' ' CB ' ' A' ' 73' ' ' GLN . 20.0 Cg_endo -60.45 133.35 48.48 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.19 1.927 . . . . 0.0 111.815 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -57.63 135.71 56.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.953 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.08 122.96 26.82 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.787 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -56.39 -34.58 94.72 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.467 2.111 . . . . 0.0 112.698 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -87.94 -0.67 57.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.761 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -108.74 100.31 38.46 Favored Pre-proline 0 C--O 1.232 0.183 0 CA-C-O 120.603 0.24 . . . . 0.0 110.922 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.436 ' O ' ' CD2' ' A' ' 94' ' ' LEU . 3.8 Cg_exo -76.47 25.37 0.44 Allowed 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.91 2.407 . . . . 0.0 113.236 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.545 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 21.0 mmtp -120.01 -19.91 7.66 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 120.581 0.229 . . . . 0.0 111.066 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.414 ' HG3' ' HB3' ' A' ' 64' ' ' ASP . 0.2 OUTLIER -88.89 18.75 4.55 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.162 -179.304 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.701 ' O ' HD21 ' A' ' 94' ' ' LEU . . . -127.56 99.16 5.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.13 0.491 . . . . 0.0 110.738 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.471 ' CD1' ' O ' ' A' ' 63' ' ' ILE . 58.8 m95 -108.48 135.39 49.84 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.138 0.494 . . . . 0.0 111.734 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 pt -113.55 155.27 14.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.257 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.7 t -103.38 129.06 55.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.965 0.412 . . . . 0.0 111.139 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 40.3 t -121.74 95.72 4.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.308 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.13 -101.14 0.85 Allowed Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.274 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.5 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.85 30.41 6.9 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.573 0.225 . . . . 0.0 110.811 -179.797 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.405 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.66 147.44 29.99 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.621 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 18.4 mm -94.38 120.24 43.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.385 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.494 ' CB ' HG11 ' A' ' 100' ' ' VAL . . . -123.66 145.34 49.03 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -178.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.438 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -65.65 148.38 51.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.513 179.646 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.701 HD21 ' O ' ' A' ' 83' ' ' ALA . 2.6 pt? -62.19 -56.77 15.42 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.836 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.531 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 20.6 p -77.91 -4.13 45.22 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -178.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.4 ' O ' HG23 ' A' ' 99' ' ' ILE . 2.1 m-20 -138.05 87.0 2.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.777 0.322 . . . . 0.0 110.863 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.11 -16.16 63.07 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.204 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -90.35 11.83 20.2 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.182 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.506 ' O ' HG11 ' A' ' 100' ' ' VAL . 6.3 tt -130.94 137.92 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.506 HG11 ' O ' ' A' ' 99' ' ' ILE . 23.9 m -148.86 137.12 14.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.763 0.316 . . . . 0.0 111.729 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.555 ' HA ' ' O ' ' A' ' 115' ' ' CYS . 24.8 mt -45.53 153.4 0.25 Allowed 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.705 0.764 . . . . 0.0 111.788 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.42 ' O ' HG21 ' A' ' 114' ' ' ILE . 10.0 t70 -158.46 168.4 27.06 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.381 -1.282 . . . . 0.0 110.763 -177.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.444 ' HA ' HG21 ' A' ' 114' ' ' ILE . 4.5 mp -90.48 123.55 42.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.452 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.2 tp -67.9 140.73 18.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.938 0.399 . . . . 0.0 111.332 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 76.56 -5.83 2.11 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.945 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.7 t 46.36 29.69 0.91 Allowed 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.77 0.319 . . . . 0.0 111.194 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -100.79 161.75 13.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.105 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.9 -13.98 58.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.141 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -48.6 123.43 6.74 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.237 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.88 160.27 32.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.063 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 72.56 16.32 77.63 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.092 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -79.26 135.09 36.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.816 0.341 . . . . 0.0 110.886 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 18.8 m170 -61.83 166.6 4.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.911 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.444 HG21 ' HA ' ' A' ' 103' ' ' ILE . 0.0 OUTLIER -136.35 160.44 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.476 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.607 ' HA ' ' CD1' ' A' ' 70' ' ' ILE . 26.2 p -157.8 172.29 18.74 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 101' ' ' LEU . . . -95.51 127.67 41.74 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.625 -0.43 . . . . 0.0 109.922 178.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.461 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 75.7 t-105 -133.23 163.04 30.19 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.578 0.704 . . . . 0.0 111.97 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.461 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.0 OUTLIER -64.23 123.11 18.26 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.727 179.93 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.93 121.83 9.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.157 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.423 ' CE1' ' HA3' ' A' ' 122' ' ' GLY . 6.9 p80 -126.59 3.01 6.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.434 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 80.82 5.92 89.74 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.973 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.423 ' HA3' ' CE1' ' A' ' 120' ' ' HIS . . . -64.8 154.0 49.5 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.575 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.9 -23.58 54.58 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.616 2.211 . . . . 0.0 112.348 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -76.76 -2.17 31.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.56 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.405 ' O ' ' CG2' ' A' ' 90' ' ' THR . 0.0 OUTLIER -108.97 9.6 26.47 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.219 -179.961 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.402 ' O ' ' CD1' ' A' ' 127' ' ' PHE . 19.9 mmmt -103.38 136.92 42.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.773 0.32 . . . . 0.0 111.249 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.407 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 6.6 m-85 -137.57 155.61 49.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.45 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.3 mt -113.47 138.89 41.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.098 0.475 . . . . 0.0 110.559 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.401 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 27.1 mm -114.17 141.34 30.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.661 -179.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -138.95 94.64 2.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.611 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.75 113.41 0.9 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.422 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.964 179.989 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.863 0.363 . . . . 0.0 111.165 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 58.1 mttt 61.92 153.77 0.11 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.93 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.7 -178.01 0.12 Allowed 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.703 2.269 . . . . 0.0 112.274 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.4 mmmm -147.59 80.91 1.51 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.103 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.455 ' CG ' ' HD2' ' A' ' 57' ' ' LYS . 1.4 p90 -100.27 176.73 5.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.422 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.694 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -156.89 175.26 14.31 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 120.481 -0.487 . . . . 0.0 111.731 179.806 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.464 ' O ' ' HA ' ' A' ' 129' ' ' ILE . 9.9 m-85 -109.33 124.58 51.18 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.157 179.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.434 ' CD1' ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -108.51 106.24 20.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.871 0.367 . . . . 0.0 110.296 179.735 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -105.76 134.6 48.63 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -178.566 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 57.9 p -75.78 106.55 7.42 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -63.4 -10.54 17.43 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.591 -178.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 33.1 tp -83.5 -62.91 1.46 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.924 0.392 . . . . 0.0 110.794 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -84.23 -10.27 57.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.313 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.45 3.75 67.33 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.129 -1.034 . . . . 0.0 111.382 -178.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.1 mmmt -92.66 -176.59 4.31 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 7.5 m -121.78 142.44 38.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.708 0.29 . . . . 0.0 110.58 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.7 mt -70.05 134.63 48.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.014 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.4 ' HB2' ' HG3' ' A' ' 44' ' ' GLN . 9.5 t0 -146.71 150.36 35.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.707 0.289 . . . . 0.0 111.033 -179.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.415 HG13 ' CD2' ' A' ' 58' ' ' LEU . 2.7 mm -73.32 147.37 9.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.58 122.96 14.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.925 0.393 . . . . 0.0 111.485 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 45.9 28.26 2.72 Favored Glycine 0 C--N 1.332 0.36 0 CA-C-N 115.986 -0.552 . . . . 0.0 113.104 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 43.2 60.53 2.51 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.934 0.397 . . . . 0.0 111.428 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.95 106.0 48.31 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.922 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -71.24 1.01 5.85 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.75 2.3 . . . . 0.0 112.853 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -82.96 155.8 67.49 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-O 120.796 0.331 . . . . 0.0 111.174 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.415 ' HB3' ' CD ' ' A' ' 74' ' ' PRO . 35.9 Cg_endo -65.21 131.31 28.04 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.735 2.29 . . . . 0.0 112.46 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.04 2.59 36.23 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.477 -0.868 . . . . 0.0 113.188 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.52 127.51 32.76 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 117.027 0.414 . . . . 0.0 111.037 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -78.75 159.83 27.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.189 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.465 HD12 HG23 ' A' ' 63' ' ' ILE . 42.6 pt -117.89 146.29 22.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.771 0.32 . . . . 0.0 111.783 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.433 ' HA ' ' CD1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -154.44 178.01 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.17 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.78 -179.806 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.2 p -101.13 148.69 24.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.623 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.41 ' CZ3' ' HB2' ' A' ' 110' ' ' ALA . 34.9 t-105 -158.23 172.9 17.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.708 0.289 . . . . 0.0 110.918 -179.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -69.01 132.93 47.44 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.758 0.313 . . . . 0.0 110.738 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -58.55 138.95 56.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.019 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.1 mmmm -102.79 157.67 16.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.771 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.16 101.72 8.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.845 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 146.3 -164.61 28.33 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.631 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -72.08 -2.44 11.58 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.968 2.445 . . . . 0.0 112.853 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.4 p -94.6 0.96 55.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.535 0.207 . . . . 0.0 111.346 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.452 ' O ' ' CD1' ' A' ' 45' ' ' LEU . . . -82.09 -9.44 59.54 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.619 0.229 . . . . 0.0 111.619 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.574 ' HA ' HD11 ' A' ' 45' ' ' LEU . 59.4 t -50.92 -33.57 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.116 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -69.73 -7.51 40.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.76 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.4 ' HG3' ' HB2' ' A' ' 18' ' ' ASP . 2.6 mt-30 -115.79 6.26 14.32 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.694 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 0.9 OUTLIER -117.8 142.22 47.54 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.216 -179.273 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.482 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 26.3 m95 -133.74 168.71 18.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.541 -179.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.512 ' CZ ' ' HB2' ' A' ' 55' ' ' ARG . 43.1 p90 -141.32 164.16 31.01 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.382 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 54' ' ' ILE . 67.5 p -109.19 135.37 50.42 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.783 0.325 . . . . 0.0 111.539 -178.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -78.36 170.88 15.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.12 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.34 -25.15 65.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.999 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -89.3 -5.02 57.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.201 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.24 11.74 44.45 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.837 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 37.2 t -100.68 120.43 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-O 120.779 0.323 . . . . 0.0 110.489 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.434 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.6 OUTLIER -78.78 149.75 5.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.541 0.686 . . . . 0.0 111.883 -179.806 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.512 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -147.0 132.53 18.71 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.647 178.612 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.482 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -57.64 143.06 42.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.569 0.699 . . . . 0.0 111.857 -178.679 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.477 ' HB3' ' CG1' ' A' ' 42' ' ' VAL . 5.4 tttp -53.96 -22.18 9.74 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 114.634 -1.166 . . . . 0.0 111.471 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.442 ' HA ' HG13 ' A' ' 42' ' ' VAL . 3.6 pp -56.74 -39.04 73.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.857 0.36 . . . . 0.0 111.089 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.3 t30 176.31 172.82 0.39 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.669 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.41 79.24 0.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.817 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.413 ' CE2' ' HG3' ' A' ' 74' ' ' PRO . 32.7 m-85 -145.08 123.97 12.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.858 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -104.4 154.16 20.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.397 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.481 ' O ' ' CD1' ' A' ' 84' ' ' TRP . 0.2 OUTLIER -79.86 150.37 5.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.59 179.665 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.557 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 6.3 p-10 -132.6 134.75 45.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.138 0.494 . . . . 0.0 111.501 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.06 43.29 1.06 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.334 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.1 m -74.06 -43.07 59.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.142 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 57.2 m80 -98.78 173.1 7.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.931 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -49.32 -46.96 47.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.983 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -99.69 145.03 28.09 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.936 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.596 ' CG1' ' HA ' ' A' ' 115' ' ' CYS . 2.4 mm -76.8 142.38 14.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-O 121.591 0.71 . . . . 0.0 111.511 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -140.31 168.61 19.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.062 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 63' ' ' ILE . 58.8 p -106.87 138.51 42.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.97 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.48 161.11 17.9 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.329 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.415 ' CD ' ' HB3' ' A' ' 26' ' ' PRO . 57.3 Cg_exo -51.44 139.19 46.58 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.449 2.099 . . . . 0.0 112.074 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -62.94 127.8 32.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.129 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -117.56 136.32 23.54 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.597 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -68.96 -34.81 16.5 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.56 2.173 . . . . 0.0 112.93 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -87.34 0.15 55.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.8 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -108.53 101.03 41.26 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 120.588 0.232 . . . . 0.0 111.147 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.436 ' O ' ' CD2' ' A' ' 94' ' ' LEU . 4.8 Cg_exo -77.09 24.7 0.48 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.989 2.459 . . . . 0.0 113.043 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.557 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 21.0 mmtp -120.26 -19.72 7.57 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 120.568 0.223 . . . . 0.0 111.101 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.456 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 0.4 OUTLIER -88.72 17.07 5.85 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.09 -0.505 . . . . 0.0 112.285 -179.208 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.688 ' O ' HD21 ' A' ' 94' ' ' LEU . . . -126.61 98.85 5.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.081 0.467 . . . . 0.0 110.823 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.481 ' CD1' ' O ' ' A' ' 63' ' ' ILE . 56.2 m95 -107.94 136.05 48.29 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.157 0.503 . . . . 0.0 111.81 -178.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.5 pt -111.25 153.5 13.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.197 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.2 t -102.28 127.69 55.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.008 0.432 . . . . 0.0 111.042 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.4 t -120.59 94.75 4.46 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.448 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.99 -100.13 0.75 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.531 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.499 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.85 29.74 7.23 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.52 0.2 . . . . 0.0 110.868 -179.676 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.425 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -148.14 147.77 29.84 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.577 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.9 mm -94.13 120.34 43.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.047 -0.978 . . . . 0.0 109.351 178.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.506 ' CB ' HG11 ' A' ' 100' ' ' VAL . . . -122.26 144.01 49.25 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -178.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.415 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -64.61 148.91 49.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.527 179.834 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.688 HD21 ' O ' ' A' ' 83' ' ' ALA . 2.6 pt? -64.34 -57.23 9.96 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.688 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.53 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 13.5 t -74.22 -4.1 33.9 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -178.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.482 ' O ' HG23 ' A' ' 99' ' ' ILE . 56.7 m-20 -143.46 92.22 2.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.919 0.39 . . . . 0.0 111.025 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -72.89 -14.32 61.46 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.287 179.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -90.25 11.19 21.91 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.297 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.51 ' O ' HG11 ' A' ' 100' ' ' VAL . 9.0 tt -130.64 138.27 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.51 HG11 ' O ' ' A' ' 99' ' ' ILE . 26.7 m -148.99 138.15 15.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.837 0.351 . . . . 0.0 111.907 -179.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.479 ' HA ' ' O ' ' A' ' 115' ' ' CYS . 11.1 mt -45.53 153.3 0.26 Allowed 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 121.754 0.788 . . . . 0.0 111.772 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -158.63 168.24 27.42 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.833 -177.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.4 mp -88.0 122.96 40.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.204 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 7.8 tp -66.63 138.27 23.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.057 0.456 . . . . 0.0 111.476 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.4 1.06 3.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.983 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.4 t 44.17 30.88 0.48 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.781 0.324 . . . . 0.0 111.344 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.7 p30 -96.67 155.79 16.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.152 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -82.24 -17.17 46.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.106 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -45.28 116.12 1.06 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.279 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.41 ' HB2' ' CZ3' ' A' ' 33' ' ' TRP . . . -58.4 156.74 9.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.247 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.63 14.47 81.2 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.312 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.88 131.81 39.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.902 0.382 . . . . 0.0 110.985 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -64.87 171.25 3.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.014 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.518 ' O ' HG12 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -136.38 161.75 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.445 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.596 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 26.5 p -153.51 168.45 26.11 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -95.06 126.71 40.59 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 178.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.468 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 76.5 t-105 -134.71 162.49 32.2 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.63 0.729 . . . . 0.0 112.196 -179.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.468 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.9 OUTLIER -62.53 120.87 11.96 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.646 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -58.55 125.5 23.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.089 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.424 ' CE1' ' HA3' ' A' ' 122' ' ' GLY . 19.9 p80 -132.97 8.51 4.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.357 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 81.82 7.17 88.34 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.086 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.424 ' HA3' ' CE1' ' A' ' 120' ' ' HIS . . . -63.73 152.15 48.44 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.58 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.59 -26.35 54.14 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.604 2.203 . . . . 0.0 112.33 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -75.05 -4.11 36.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.506 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.425 ' O ' ' CG2' ' A' ' 90' ' ' THR . 0.0 OUTLIER -107.5 14.38 25.89 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.183 -179.811 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.3 mmmm -107.08 136.92 46.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.793 0.33 . . . . 0.0 111.472 -179.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.42 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 6.1 m-85 -138.2 155.23 48.88 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.21 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.414 HG22 HD11 ' A' ' 128' ' ' ILE . 1.3 mt -112.03 138.43 40.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.091 0.472 . . . . 0.0 110.392 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.464 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 27.9 mm -112.99 140.19 34.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.563 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.7 112.02 8.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.457 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 5.7 t -66.4 109.95 2.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.13 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.418 ' HB3' ' CE2' ' A' ' 5' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.188 -0.911 . . . . 0.0 110.898 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.792 0.329 . . . . 0.0 111.147 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.75 68.9 82.21 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.889 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.12 105.55 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.623 2.215 . . . . 0.0 112.304 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.51 121.86 42.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.993 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.489 ' CD1' ' HG3' ' A' ' 57' ' ' LYS . 1.4 p90 -95.79 175.21 6.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.254 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.69 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -159.01 175.61 13.32 Favored 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.94 179.889 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.437 ' CE2' HD21 ' A' ' 45' ' ' LEU . 4.7 m-85 -110.6 124.01 51.06 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.055 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.481 ' HB ' ' CD2' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -106.5 106.87 21.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.844 0.354 . . . . 0.0 110.436 179.824 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 15' ' ' LYS . 8.7 tttt -107.85 138.54 43.91 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.305 -178.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.91 109.2 10.53 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -64.01 -10.95 24.7 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.579 -178.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 56.8 tp -84.26 -62.48 1.55 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.88 0.371 . . . . 0.0 111.026 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -85.43 -12.93 50.79 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 77.17 0.84 72.18 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.103 -1.046 . . . . 0.0 111.413 -177.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.42 ' O ' ' HG3' ' A' ' 9' ' ' LYS . 0.5 OUTLIER -89.01 179.74 6.1 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.503 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.2 m -121.36 141.46 41.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.481 ' CD2' ' HB ' ' A' ' 8' ' ' ILE . 0.4 OUTLIER -73.49 137.61 44.57 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.123 179.475 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -142.6 153.09 43.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.873 0.368 . . . . 0.0 111.127 -179.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.422 HD13 HG23 ' A' ' 19' ' ' ILE . 25.3 mt -93.03 134.66 30.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.662 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -43.6 96.25 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.917 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 43.23 32.93 1.8 Allowed Glycine 0 C--N 1.331 0.28 0 CA-C-N 115.981 -0.554 . . . . 0.0 113.363 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.405 ' CG ' ' ND2' ' A' ' 43' ' ' ASN . 3.2 mp0 68.41 -66.54 0.23 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.835 0.35 . . . . 0.0 110.931 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 64.82 90.73 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.79 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -51.94 -22.08 13.47 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.649 2.233 . . . . 0.0 112.482 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.3 149.36 35.62 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.115 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.438 ' HB3' ' CD ' ' A' ' 74' ' ' PRO . 33.7 Cg_endo -64.63 151.85 84.08 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.654 2.236 . . . . 0.0 112.371 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 109.12 0.59 31.54 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.475 -0.869 . . . . 0.0 113.108 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.11 137.04 50.8 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 117.122 0.461 . . . . 0.0 110.918 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.3 mmtp -88.32 157.6 18.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.606 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.439 HD12 HG21 ' A' ' 63' ' ' ILE . 44.2 pt -117.96 146.77 22.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.348 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.403 HG23 ' HA ' ' A' ' 113' ' ' HIS . 0.2 OUTLIER -155.19 179.73 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.182 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.885 -179.737 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.1 p -101.6 149.0 24.56 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.48 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 35.4 t-105 -157.81 172.21 18.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.711 0.291 . . . . 0.0 110.965 -179.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -72.48 139.08 47.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.81 0.338 . . . . 0.0 110.805 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.89 137.43 57.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.939 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.94 168.02 9.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.86 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.04 95.98 4.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.969 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 166.52 170.17 31.06 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.488 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -51.32 -24.93 16.81 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.595 2.197 . . . . 0.0 112.335 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 43.1 p -78.09 9.84 3.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.035 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.441 ' O ' HD13 ' A' ' 45' ' ' LEU . . . -77.41 -17.23 58.32 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.657 0.265 . . . . 0.0 111.037 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.585 ' HA ' HD13 ' A' ' 45' ' ' LEU . 48.5 t -50.29 -27.48 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.065 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.405 ' ND2' ' CG ' ' A' ' 22' ' ' GLN . 1.5 m120 -66.83 -9.45 37.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.582 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -118.46 5.89 11.76 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.69 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 1.3 mp -116.98 141.44 48.23 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.531 -179.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.426 ' CH2' ' CG1' ' A' ' 63' ' ' ILE . 26.1 m95 -134.18 169.01 17.81 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.249 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.553 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 11.3 p90 -141.98 166.22 25.31 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.981 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 39.7 p -108.38 133.87 51.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.882 0.372 . . . . 0.0 111.559 -178.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -77.96 167.78 20.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.026 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -60.9 -24.85 66.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.138 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.2 tp60 -92.74 -3.34 54.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.269 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.96 8.79 55.16 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.765 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.1 t -93.83 119.68 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-O 120.744 0.307 . . . . 0.0 110.587 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.553 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -75.96 145.64 10.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.168 0.509 . . . . 0.0 111.779 -179.835 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.531 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 13.5 mmm-85 -149.47 133.73 17.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.719 179.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 74.5 m -50.5 147.1 4.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.598 0.714 . . . . 0.0 111.984 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.489 ' HG3' ' CD1' ' A' ' 5' ' ' PHE . 17.6 tttm -60.26 -18.24 47.67 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 114.658 -1.156 . . . . 0.0 112.022 -179.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.47 ' N ' ' CG1' ' A' ' 42' ' ' VAL . 0.6 OUTLIER -51.08 -49.62 60.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.747 -179.325 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 22.6 m-20 -166.06 -69.24 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.745 0.307 . . . . 0.0 111.062 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.2 p30 179.65 82.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.733 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.428 ' CE2' ' HD3' ' A' ' 74' ' ' PRO . 2.7 m-85 -138.05 119.95 15.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.899 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.42 145.55 27.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.205 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.504 ' O ' ' CD1' ' A' ' 84' ' ' TRP . 0.2 OUTLIER -76.95 152.64 5.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.6 179.733 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.61 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 5.0 p-10 -132.37 129.87 39.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.249 0.547 . . . . 0.0 111.777 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -94.29 40.8 1.09 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.272 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.4 t -75.11 -45.5 40.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.543 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -94.7 170.33 9.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.962 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -49.16 -42.18 38.89 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.014 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.59 140.05 38.57 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.813 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.633 ' CG1' ' HA ' ' A' ' 115' ' ' CYS . 3.1 mm -69.94 137.12 24.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-O 121.464 0.649 . . . . 0.0 111.367 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.54 165.68 24.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.118 -0.947 . . . . 0.0 111.17 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.9 p -106.62 140.25 39.79 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.238 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.11 163.79 13.33 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.481 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.438 ' CD ' ' HB3' ' A' ' 26' ' ' PRO . 40.4 Cg_exo -56.73 142.81 91.54 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.451 2.1 . . . . 0.0 111.673 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -57.13 128.77 38.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.859 0.362 . . . . 0.0 111.358 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -118.17 131.02 24.38 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.532 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -68.14 -36.77 16.02 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.453 2.102 . . . . 0.0 112.758 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -87.55 0.31 55.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.812 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -105.19 102.65 37.78 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-O 120.53 0.205 . . . . 0.0 111.086 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.543 ' O ' HD21 ' A' ' 94' ' ' LEU . 5.7 Cg_exo -77.32 21.63 0.61 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.887 2.391 . . . . 0.0 112.978 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.61 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 7.6 mptt -119.92 -21.03 7.3 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 120.753 0.311 . . . . 0.0 111.001 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.52 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 2.7 mtt180 -86.85 20.84 2.44 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.554 ' O ' HD23 ' A' ' 94' ' ' LEU . . . -130.68 99.58 5.01 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.276 0.56 . . . . 0.0 110.937 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.504 ' CD1' ' O ' ' A' ' 63' ' ' ILE . 61.0 m95 -109.39 136.07 49.41 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.923 -178.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 27.8 pt -113.17 153.45 14.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.196 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.0 t -100.2 123.0 52.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.901 0.382 . . . . 0.0 110.948 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 37.6 t -115.8 93.49 4.28 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.438 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.97 -100.56 0.78 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.533 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.502 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.73 29.67 7.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.496 0.189 . . . . 0.0 110.923 -179.594 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.406 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -148.05 148.23 30.45 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.36 0.6 . . . . 0.0 112.583 -178.63 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 23.9 mm -93.65 119.47 41.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.542 178.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.49 ' CB ' HG13 ' A' ' 100' ' ' VAL . . . -123.99 147.56 47.68 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.421 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.3 OUTLIER -65.17 149.88 49.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.849 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.58 ' HG ' ' N ' ' A' ' 95' ' ' SER . 2.7 pt? -64.29 -56.88 11.48 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.444 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.58 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 0.3 OUTLIER -77.25 -1.77 31.3 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.363 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.525 ' O ' HG21 ' A' ' 99' ' ' ILE . 49.7 t0 -145.09 91.14 2.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.165 0.507 . . . . 0.0 110.942 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 3.8 mmm180 -74.09 -13.69 60.87 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.526 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -87.35 9.81 19.32 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.518 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.553 ' O ' HG13 ' A' ' 100' ' ' VAL . 6.8 tt -132.89 140.24 47.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 179.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.553 HG13 ' O ' ' A' ' 99' ' ' ILE . 20.0 m -149.77 138.84 15.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.77 0.319 . . . . 0.0 111.826 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.469 ' HG ' ' CZ3' ' A' ' 84' ' ' TRP . 21.8 mt -46.15 154.89 0.23 Allowed 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 121.733 0.778 . . . . 0.0 111.948 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -156.97 167.67 29.77 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.792 -177.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.434 ' HA ' HG21 ' A' ' 114' ' ' ILE . 4.6 mp -89.38 123.96 41.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.427 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.9 tt -68.04 144.48 14.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.947 0.403 . . . . 0.0 111.421 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 5.2 mttt 70.34 -0.8 2.71 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.015 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.1 m 42.09 31.61 0.25 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.734 0.302 . . . . 0.0 111.474 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -102.78 162.39 12.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.068 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.23 -14.5 57.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.255 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -48.21 133.11 15.8 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.21 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -81.91 159.37 23.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.147 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.49 16.37 80.05 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.287 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -82.0 135.79 35.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.841 0.353 . . . . 0.0 111.124 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.403 ' HA ' HG23 ' A' ' 31' ' ' ILE . 6.7 m80 -61.86 172.85 1.19 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.962 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.493 ' O ' HG12 ' A' ' 70' ' ' ILE . 0.7 OUTLIER -143.28 161.6 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.758 -179.777 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.633 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 4.6 t -155.43 169.95 23.07 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.48 ' HB3' HG12 ' A' ' 99' ' ' ILE . . . -93.6 126.53 38.81 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.458 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 75.9 t-105 -131.47 160.98 33.58 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.635 0.731 . . . . 0.0 112.361 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.458 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.3 OUTLIER -62.87 124.77 21.91 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.764 -179.885 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.88 121.28 8.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.127 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.432 ' CE1' ' HA3' ' A' ' 122' ' ' GLY . 6.6 p80 -127.34 2.4 6.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.493 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 79.4 5.23 89.26 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.881 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.432 ' HA3' ' CE1' ' A' ' 120' ' ' HIS . . . -63.34 156.28 42.32 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.536 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.75 -25.04 46.54 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.589 2.193 . . . . 0.0 112.365 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 36.3 p-10 -74.53 -3.8 33.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.644 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.406 ' O ' ' CG2' ' A' ' 90' ' ' THR . 0.0 OUTLIER -108.88 15.81 23.2 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.533 0.206 . . . . 0.0 111.116 -179.978 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -106.3 131.29 53.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.835 0.35 . . . . 0.0 111.465 -179.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.422 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 3.0 m-85 -134.9 154.6 51.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.285 179.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 mt -114.07 140.04 36.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.131 0.491 . . . . 0.0 110.677 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.42 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 20.8 mm -113.38 141.4 29.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.602 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.46 94.66 2.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.711 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 5.0 t -49.96 109.64 0.31 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.426 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.433 179.751 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.715 0.293 . . . . 0.0 111.183 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.466 ' HB2' ' HD3' ' A' ' 3' ' ' PRO . 75.1 mmtt -91.97 -46.91 0.34 Allowed Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.765 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.466 ' HD3' ' HB2' ' A' ' 2' ' ' LYS . 87.7 Cg_endo -83.64 112.82 1.89 Allowed 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.374 2.05 . . . . 0.0 112.667 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.8 tppt? -63.75 117.03 6.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.743 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.49 ' CD1' ' HG3' ' A' ' 57' ' ' LYS . 1.1 p90 -96.67 176.06 6.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.629 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.74 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -159.87 176.57 11.75 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.861 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.424 ' CZ ' HD11 ' A' ' 45' ' ' LEU . 0.7 OUTLIER -112.64 124.16 51.94 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.299 179.371 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.432 ' CD1' ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -105.54 108.48 25.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.914 0.387 . . . . 0.0 110.339 179.873 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.5 tptp -105.27 135.3 46.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.422 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.7 t -75.65 108.04 8.21 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.426 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 2.7 tt0 -63.84 -10.76 22.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.633 -178.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 52.5 tp -83.25 -62.71 1.52 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.92 0.391 . . . . 0.0 110.924 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -86.32 -9.85 55.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.429 -178.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.86 5.01 68.41 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.145 -1.026 . . . . 0.0 111.369 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.8 mmmt -91.57 -177.18 4.73 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.9 m -120.3 140.28 44.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.784 0.326 . . . . 0.0 110.513 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.3 mt -70.89 136.06 48.39 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -143.83 158.57 43.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.936 0.398 . . . . 0.0 111.345 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.435 HD12 ' CH2' ' A' ' 46' ' ' TRP . 27.5 mt -98.92 136.13 31.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.406 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -39.67 95.97 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.983 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 42.28 33.58 1.38 Allowed Glycine 0 C--N 1.333 0.389 0 CA-C-N 115.925 -0.58 . . . . 0.0 113.225 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 68.31 -66.33 0.23 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.787 0.327 . . . . 0.0 110.771 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 50.0 t30 61.83 92.53 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.992 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.18 -22.02 18.52 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.502 2.135 . . . . 0.0 112.406 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -93.47 145.01 29.18 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.094 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.456 ' HB3' ' HD2' ' A' ' 74' ' ' PRO . 24.4 Cg_exo -63.24 155.86 59.07 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.535 2.157 . . . . 0.0 112.13 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.22 3.87 47.68 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.951 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.71 130.05 38.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.987 0.422 . . . . 0.0 111.198 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -80.73 161.83 24.39 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.422 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.433 HD12 ' HB ' ' A' ' 70' ' ' ILE . 48.4 pt -122.82 150.29 26.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.783 0.325 . . . . 0.0 111.705 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -156.39 -178.62 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.785 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.2 p -100.29 148.59 24.5 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.468 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 30.6 t-105 -157.16 171.9 19.62 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.77 0.319 . . . . 0.0 111.109 -179.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.7 140.6 47.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.799 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -57.76 154.6 11.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.946 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -137.11 173.29 11.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.856 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.7 mmtp -135.84 116.42 13.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.98 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 157.24 -169.05 34.22 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.606 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -77.19 4.68 5.63 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.145 2.563 . . . . 0.0 112.83 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.6 t -114.49 16.44 17.69 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.654 0.264 . . . . 0.0 111.164 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.48 ' O ' HD13 ' A' ' 45' ' ' LEU . . . -79.23 -20.14 48.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.163 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.58 ' HA ' HD13 ' A' ' 45' ' ' LEU . 15.7 t -49.34 -26.2 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.19 179.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -65.74 -10.02 33.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.738 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -119.6 6.04 11.05 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.103 0.478 . . . . 0.0 109.772 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.74 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 1.4 mp -116.59 139.8 50.1 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.617 -179.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.464 ' CH2' ' CG1' ' A' ' 63' ' ' ILE . 25.5 m95 -133.73 168.09 19.34 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.228 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.587 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 6.4 p90 -139.61 163.51 32.37 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.009 178.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 81.1 p -109.13 136.41 48.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.786 0.327 . . . . 0.0 111.4 -178.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.83 173.2 12.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.288 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.85 -20.93 65.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.063 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -101.74 -2.14 30.87 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.221 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.75 1.91 52.61 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.929 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.7 t -81.8 114.41 22.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.915 0.358 . . . . 0.0 110.767 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.587 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -77.5 148.02 6.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.263 0.554 . . . . 0.0 111.783 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.518 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 0.3 OUTLIER -154.4 133.85 12.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.608 179.139 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.455 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 1.9 m -51.1 153.35 1.94 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.356 0.598 . . . . 0.0 111.913 -179.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.491 ' HB3' ' CG1' ' A' ' 42' ' ' VAL . 0.4 OUTLIER -61.84 -24.08 66.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.841 -179.513 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.433 ' N ' HG11 ' A' ' 42' ' ' VAL . 1.3 pt? -57.64 -37.0 72.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.325 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 170.89 -173.96 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.751 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -69.38 84.58 0.4 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.733 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -142.31 114.0 7.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.908 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -105.04 150.79 24.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.348 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.516 ' O ' ' NE1' ' A' ' 84' ' ' TRP . 0.3 OUTLIER -77.08 155.07 5.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.527 179.76 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.539 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 4.4 p-10 -134.48 133.48 40.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.173 0.511 . . . . 0.0 111.873 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -100.25 40.09 1.29 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.367 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.0 p -74.27 -43.87 55.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.458 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -98.43 173.48 6.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.117 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -46.08 -48.77 17.01 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.816 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -104.59 149.84 25.17 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.601 ' CG1' ' HA ' ' A' ' 115' ' ' CYS . 0.0 OUTLIER -78.39 144.65 10.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 CA-C-O 121.729 0.776 . . . . 0.0 111.805 -179.203 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -135.91 158.61 43.98 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.052 179.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.434 ' C ' ' HG2' ' A' ' 73' ' ' GLN . 36.4 p -101.15 140.81 34.92 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.541 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.434 ' HG2' ' C ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -163.67 164.24 15.28 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.896 179.8 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 26' ' ' PRO . 10.8 Cg_endo -54.49 139.99 74.81 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.341 2.027 . . . . 0.0 111.754 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -56.16 122.84 12.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.911 0.386 . . . . 0.0 111.007 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -112.69 129.44 24.43 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.58 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.96 -34.81 22.32 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.449 2.099 . . . . 0.0 112.971 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -88.0 -0.64 57.27 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -102.88 103.95 36.52 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 120.509 0.195 . . . . 0.0 110.957 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.548 ' O ' HD22 ' A' ' 94' ' ' LEU . 4.9 Cg_exo -77.1 19.95 0.67 Allowed 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.87 2.38 . . . . 0.0 113.246 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 11.5 mptt -120.45 -18.08 7.97 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 120.584 0.23 . . . . 0.0 111.27 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.466 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 4.4 mtt180 -90.3 21.59 3.76 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.615 ' O ' HD21 ' A' ' 94' ' ' LEU . . . -129.32 99.5 5.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.231 0.539 . . . . 0.0 110.928 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.517 ' HH2' ' HB1' ' A' ' 116' ' ' ALA . 59.1 m95 -109.91 133.96 52.6 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.271 0.558 . . . . 0.0 112.151 -178.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.9 pt -113.23 154.57 14.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.066 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.8 t -103.24 131.07 52.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.965 0.412 . . . . 0.0 111.228 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 43.7 t -124.43 94.87 4.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.406 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.02 -100.71 0.87 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.449 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.496 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -121.13 28.98 7.55 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.603 0.24 . . . . 0.0 110.703 -179.933 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.433 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.2 146.97 30.02 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.321 0.582 . . . . 0.0 112.446 -178.642 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.443 ' CG2' HD13 ' A' ' 101' ' ' LEU . 10.6 mm -94.56 121.24 44.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.338 178.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.419 ' CB ' ' CG1' ' A' ' 100' ' ' VAL . . . -120.96 141.49 50.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.247 0.546 . . . . 0.0 112.462 -178.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.68 146.56 54.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.545 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.615 HD21 ' O ' ' A' ' 83' ' ' ALA . 2.7 pt? -61.04 -56.6 19.16 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.826 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.569 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 97.2 p -73.81 -6.73 48.85 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -178.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.4 ' CB ' ' HB ' ' A' ' 99' ' ' ILE . 61.9 m-20 -139.63 91.06 2.45 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.869 -0.333 . . . . 0.0 111.203 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -66.6 -17.8 65.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.093 178.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.31 12.51 26.64 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.467 179.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.498 ' O ' HG11 ' A' ' 100' ' ' VAL . 10.2 mm -124.5 128.49 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.412 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.498 HG11 ' O ' ' A' ' 99' ' ' ILE . 19.3 m -146.31 135.54 16.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.832 0.348 . . . . 0.0 111.93 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.485 ' HA ' ' O ' ' A' ' 115' ' ' CYS . 6.7 mt -45.55 152.2 0.34 Allowed 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.728 0.775 . . . . 0.0 111.781 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -157.46 167.65 29.61 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.88 -177.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.476 ' HA ' HG21 ' A' ' 114' ' ' ILE . 4.6 mp -88.57 121.12 38.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.278 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.408 ' O ' ' CB ' ' A' ' 105' ' ' LYS . 56.1 mt -70.48 138.33 22.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.748 0.309 . . . . 0.0 111.161 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.408 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 0.1 OUTLIER 81.34 -9.68 1.26 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.7 179.893 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 46.76 29.99 1.09 Allowed 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 120.757 0.313 . . . . 0.0 111.425 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.5 p30 -102.34 160.41 14.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.931 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.69 -14.28 58.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.484 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -51.95 118.95 3.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.83 0.348 . . . . 0.0 111.158 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.44 161.07 23.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.114 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.33 14.74 80.56 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.202 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.38 133.84 38.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.82 0.343 . . . . 0.0 111.063 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -61.38 163.25 6.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.06 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.476 HG21 ' HA ' ' A' ' 103' ' ' ILE . 0.6 OUTLIER -135.6 161.7 38.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.708 -179.836 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.601 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 26.2 p -162.3 176.94 10.05 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.517 ' HB1' ' HH2' ' A' ' 84' ' ' TRP . . . -96.91 132.24 42.89 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.826 -0.349 . . . . 0.0 110.261 178.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.467 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 75.9 t-105 -136.32 163.23 30.91 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.422 0.629 . . . . 0.0 111.756 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.467 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.1 OUTLIER -64.98 117.18 7.25 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.774 179.956 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -62.8 125.62 24.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.877 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -136.1 13.17 3.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.215 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 77.49 59.74 2.99 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.354 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -116.16 152.55 17.91 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.486 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.55 -30.67 79.76 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.51 2.14 . . . . 0.0 111.976 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -77.21 -2.05 32.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.403 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.433 ' O ' ' CG2' ' A' ' 90' ' ' THR . 5.2 mm-40 -107.82 9.69 28.84 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.746 -0.206 . . . . 0.0 111.276 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.426 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 10.0 mmtt -106.5 140.99 38.52 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.872 0.368 . . . . 0.0 111.39 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -141.12 156.27 45.99 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.234 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.3 mt -112.14 138.45 41.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.072 0.463 . . . . 0.0 110.639 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 23.7 mm -113.73 140.29 34.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.599 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -139.58 94.84 2.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.668 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 53.0 m -53.0 111.14 0.62 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.35 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.412 ' HB3' ' CD2' ' A' ' 5' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.884 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 ttt . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.769 0.319 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.72 94.13 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.923 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.09 178.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.538 2.158 . . . . 0.0 112.315 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.89 117.85 21.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.951 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.492 ' CE1' ' HA ' ' A' ' 57' ' ' LYS . 27.8 m-85 -97.63 173.13 7.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.488 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.599 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -152.66 170.53 20.02 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.405 179.302 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.423 ' CE2' HD12 ' A' ' 45' ' ' LEU . 0.1 OUTLIER -112.06 123.6 50.62 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.815 178.863 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.437 ' HB ' ' CD2' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -106.56 108.67 25.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.892 0.377 . . . . 0.0 110.488 -179.866 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -107.81 137.14 46.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.252 -178.907 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.3 t -75.13 107.76 7.42 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -62.4 -12.05 19.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.451 -178.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.8 tp -82.92 -62.15 1.68 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.871 0.367 . . . . 0.0 111.163 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -86.79 -11.85 49.76 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -178.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.64 0.68 68.78 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.041 -1.076 . . . . 0.0 111.46 -178.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.412 ' O ' ' HG3' ' A' ' 9' ' ' LYS . 7.6 mmtm -89.06 177.69 6.58 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.5 m -119.72 141.26 40.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.437 ' CD2' ' HB ' ' A' ' 8' ' ' ILE . 0.1 OUTLIER -72.24 136.51 46.36 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.242 179.613 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -140.97 148.7 40.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.899 -179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.1 mt -89.03 122.02 39.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.128 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.65 117.86 9.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.923 0.392 . . . . 0.0 110.904 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 128.12 -32.39 3.44 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.537 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 53.01 24.74 3.6 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.828 0.346 . . . . 0.0 111.024 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -125.16 153.7 71.66 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.567 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.414 ' O ' ' CZ ' ' A' ' 61' ' ' PHE . 3.9 Cg_endo -86.18 36.98 0.52 Allowed 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.019 2.48 . . . . 0.0 112.865 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -99.28 143.14 25.87 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-O 120.594 0.235 . . . . 0.0 110.986 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.411 ' HB3' ' CD ' ' A' ' 74' ' ' PRO . 16.7 Cg_exo -67.9 131.96 25.33 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.676 2.251 . . . . 0.0 112.698 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.4 0.71 27.95 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.623 -0.798 . . . . 0.0 113.665 179.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.2 m -71.52 122.41 20.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.316 0.558 . . . . 0.0 111.141 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -76.6 160.56 29.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.586 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.438 HD12 HG23 ' A' ' 63' ' ' ILE . 44.5 pt -121.37 147.63 25.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.902 0.382 . . . . 0.0 111.992 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -155.77 -178.29 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.219 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.386 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.5 p -102.31 149.48 24.29 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.603 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 20.8 t-105 -160.38 174.56 13.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.676 0.274 . . . . 0.0 110.843 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -71.12 136.29 48.11 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.814 0.34 . . . . 0.0 110.729 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -63.24 159.78 17.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.947 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -128.9 163.62 24.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.848 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 47.7 mmtt -122.78 107.67 12.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.921 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 156.73 178.77 31.15 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.493 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -77.35 0.93 9.27 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.703 2.269 . . . . 0.0 112.904 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 41.5 p -111.67 29.66 7.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.744 0.306 . . . . 0.0 111.036 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.53 ' O ' HD11 ' A' ' 45' ' ' LEU . . . -116.44 4.19 13.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.525 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.509 ' HA ' ' CD1' ' A' ' 45' ' ' LEU . 1.6 t -58.62 -18.48 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 120.686 0.279 . . . . 0.0 110.79 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -62.57 -9.93 10.42 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.12 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -114.55 7.46 16.13 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.599 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 1.7 mp -119.12 145.72 45.72 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.159 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.462 ' CH2' ' CG1' ' A' ' 63' ' ' ILE . 22.8 m95 -133.22 170.65 15.11 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.882 -178.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.548 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 1.1 p90 -135.85 159.8 40.55 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.856 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.8 p -106.15 132.98 51.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.732 0.301 . . . . 0.0 111.196 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -77.57 164.64 25.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.949 0.404 . . . . 0.0 111.268 -179.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 22.2 mm100 -57.77 -23.3 51.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.13 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.61 -1.84 42.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.292 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.31 4.67 56.24 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.987 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 23.9 t -87.72 117.68 32.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.921 0.361 . . . . 0.0 110.544 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.548 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.9 OUTLIER -78.62 150.03 5.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.278 0.561 . . . . 0.0 111.939 -179.77 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.527 ' HB2' ' CE2' ' A' ' 47' ' ' TYR . 8.8 mmm-85 -146.9 133.2 19.5 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.308 178.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.443 ' HB3' ' CD2' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -69.51 -177.53 1.21 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.333 0.587 . . . . 0.0 112.098 -178.621 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.492 ' HA ' ' CE1' ' A' ' 5' ' ' PHE . 17.9 pttt -46.78 -22.56 0.32 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.742 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.508 ' HB2' ' HB2' ' A' ' 61' ' ' PHE . 1.4 mm? -50.39 -21.62 1.51 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.555 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.503 ' CB ' ' O ' ' A' ' 58' ' ' LEU . 7.8 t30 91.91 -34.54 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 122.729 0.412 . . . . 0.0 111.686 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -156.51 60.33 0.55 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.854 0.359 . . . . 0.0 111.423 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.508 ' HB2' ' HB2' ' A' ' 58' ' ' LEU . 3.7 m-85 -142.53 114.07 7.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.627 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -102.15 151.27 22.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.042 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.489 ' O ' ' NE1' ' A' ' 84' ' ' TRP . 0.2 OUTLIER -78.61 151.19 5.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.484 179.692 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.579 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 7.7 p-10 -131.95 129.87 40.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.084 0.469 . . . . 0.0 111.646 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -95.32 41.42 1.1 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.363 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.9 m -74.51 -44.65 50.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.218 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 33.6 m170 -94.94 170.73 9.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.976 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -48.59 -44.62 37.07 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.939 0.399 . . . . 0.0 110.951 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.13 144.67 31.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.659 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.65 ' CG1' ' HA ' ' A' ' 115' ' ' CYS . 2.1 mm -76.35 143.9 12.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.521 0.677 . . . . 0.0 111.649 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -143.31 167.86 21.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.947 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 63' ' ' ILE . 71.6 p -107.49 140.31 40.66 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.296 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.33 164.76 15.25 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.309 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.437 ' HD3' ' CE2' ' A' ' 61' ' ' PHE . 51.4 Cg_exo -52.82 138.34 60.34 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.399 2.066 . . . . 0.0 111.844 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -60.74 133.48 56.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.85 0.357 . . . . 0.0 111.113 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.86 134.79 25.61 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.639 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.03 -34.78 16.22 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.46 2.106 . . . . 0.0 112.847 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 36.6 m-20 -86.87 -0.52 56.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.735 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -105.8 101.38 32.68 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-O 120.639 0.257 . . . . 0.0 111.078 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.431 ' O ' ' CD2' ' A' ' 94' ' ' LEU . 74.1 Cg_endo -77.2 21.45 0.61 Allowed 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.63 2.22 . . . . 0.0 113.091 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.579 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 6.6 mptt -117.97 -19.86 8.98 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.127 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.508 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 3.2 mtm180 -88.88 19.99 3.79 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -178.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.698 ' O ' HD23 ' A' ' 94' ' ' LEU . . . -128.86 99.23 5.23 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.091 0.472 . . . . 0.0 110.81 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.489 ' NE1' ' O ' ' A' ' 63' ' ' ILE . 59.5 m95 -109.54 135.5 50.44 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.148 0.499 . . . . 0.0 111.91 -178.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.2 pp -114.05 154.37 15.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.297 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.5 t -100.53 125.05 54.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.919 0.39 . . . . 0.0 111.085 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 12.9 t -117.62 93.55 4.2 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.433 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.12 -100.52 0.79 Allowed Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.538 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.492 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.64 29.42 7.43 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.534 0.207 . . . . 0.0 110.927 -179.658 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.87 147.83 30.19 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.334 0.588 . . . . 0.0 112.473 -178.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.44 ' O ' ' HA ' ' A' ' 100' ' ' VAL . 14.7 mm -93.49 119.88 42.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.144 178.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.416 ' HB1' HG12 ' A' ' 100' ' ' VAL . . . -122.25 145.17 48.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.236 0.541 . . . . 0.0 112.434 -178.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.434 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -66.84 148.3 52.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.627 179.719 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.698 HD23 ' O ' ' A' ' 83' ' ' ALA . 2.7 pt? -60.6 -56.74 17.7 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.554 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.539 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 0.3 OUTLIER -77.74 -3.51 41.6 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 -178.428 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -138.1 86.33 2.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.799 0.333 . . . . 0.0 110.961 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 14.7 mmt180 -67.74 -18.04 64.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.21 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -92.93 11.33 27.67 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.43 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.492 ' O ' HG11 ' A' ' 100' ' ' VAL . 9.8 mm -124.93 130.25 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.569 179.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.492 HG11 ' O ' ' A' ' 99' ' ' ILE . 27.7 m -147.34 136.91 16.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.84 0.352 . . . . 0.0 111.783 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.492 ' HA ' ' O ' ' A' ' 115' ' ' CYS . 9.4 mt -46.71 154.7 0.3 Allowed 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.674 0.749 . . . . 0.0 111.909 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -160.49 169.74 22.39 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.493 -1.231 . . . . 0.0 110.746 -177.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.439 ' HA ' HG23 ' A' ' 114' ' ' ILE . 4.0 mp -86.48 124.13 40.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.238 179.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.1 tt -63.57 138.38 23.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.066 0.46 . . . . 0.0 111.582 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 25.5 mttp 48.62 24.99 0.86 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.6 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 33.2 t 44.48 -121.32 0.82 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.98 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 61.11 150.26 0.02 OUTLIER 'General case' 0 C--N 1.334 -0.079 0 CA-C-O 120.923 0.392 . . . . 0.0 111.203 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.22 -13.5 55.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.182 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -45.74 136.5 6.07 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.369 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -89.84 162.2 15.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.21 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 73.36 18.03 79.15 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.192 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -85.03 136.67 33.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.805 0.336 . . . . 0.0 110.885 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -61.07 170.84 1.45 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.888 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.45 ' O ' HG12 ' A' ' 70' ' ' ILE . 0.7 OUTLIER -142.11 161.63 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.685 -179.859 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.65 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 20.8 p -156.84 173.75 16.53 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.463 ' HB2' ' CG2' ' A' ' 99' ' ' ILE . . . -95.47 128.79 42.61 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.464 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 73.9 t-105 -136.61 162.44 33.13 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.585 0.707 . . . . 0.0 112.128 -179.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.464 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.1 OUTLIER -60.26 119.43 7.9 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.663 179.887 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -62.45 129.04 38.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.095 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -139.35 12.88 2.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.107 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 80.64 11.79 83.62 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.833 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.25 139.08 41.67 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.497 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.51 -28.37 54.54 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.472 2.115 . . . . 0.0 112.326 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -74.66 -2.15 24.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.622 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -104.45 -15.53 15.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.745 -0.207 . . . . 0.0 111.441 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.415 ' O ' ' CD1' ' A' ' 127' ' ' PHE . 0.2 OUTLIER -78.07 137.87 38.47 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.899 0.38 . . . . 0.0 111.361 -179.29 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.415 ' CD1' ' O ' ' A' ' 126' ' ' LYS . 8.4 m-85 -137.5 156.26 48.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.155 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.416 HD12 HG21 ' A' ' 128' ' ' ILE . 1.2 mt -114.32 137.03 48.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.151 0.501 . . . . 0.0 110.57 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.417 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 33.5 mm -113.59 139.49 38.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.574 -179.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -138.82 109.39 6.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.501 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.76 110.24 1.11 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.047 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.894 180.0 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.824 0.345 . . . . 0.0 111.172 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.3 mttp 59.77 64.81 2.7 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.921 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -61.14 79.71 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.616 2.211 . . . . 0.0 112.175 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.76 126.65 41.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.041 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.455 ' CD1' ' HG3' ' A' ' 57' ' ' LYS . 0.1 OUTLIER -105.17 175.22 5.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.07 179.683 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.761 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -155.89 172.39 18.44 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.804 179.638 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.435 ' CE1' ' HB3' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -112.95 123.85 51.27 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.13 179.135 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.435 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -105.18 108.96 26.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.906 0.384 . . . . 0.0 110.389 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' A' ' 15' ' ' LYS . 7.7 tttt -105.82 136.14 45.99 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.235 -178.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 70.3 m -73.85 109.17 7.15 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.426 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 3.8 tt0 -63.14 -12.39 27.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.521 -178.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 43.5 tp -84.8 -62.12 1.62 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.894 0.378 . . . . 0.0 111.115 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.406 ' CB ' ' HG2' ' A' ' 15' ' ' LYS . 8.9 m-20 -84.33 -12.71 54.1 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -178.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.5 3.02 70.4 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.007 -1.092 . . . . 0.0 111.632 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' A' ' 9' ' ' LYS . 13.2 mmtp -91.58 -177.26 4.75 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 4.3 m -121.7 142.21 38.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.787 0.327 . . . . 0.0 110.614 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.2 mt -70.56 134.94 48.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.276 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 19' ' ' ILE . 61.5 t0 -142.51 141.72 32.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.767 0.318 . . . . 0.0 111.043 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.426 HG21 HD12 ' A' ' 19' ' ' ILE . 25.1 mt -84.03 134.8 26.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.564 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -39.39 104.79 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 41.04 34.19 0.8 Allowed Glycine 0 C--N 1.332 0.315 0 CA-C-N 115.74 -0.664 . . . . 0.0 113.841 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 48.71 35.1 5.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.911 0.355 . . . . 0.0 111.217 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -46.28 102.63 0.31 Allowed Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.262 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -62.65 -14.63 41.18 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.658 2.239 . . . . 0.0 112.526 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -91.98 147.71 35.42 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.203 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.42 ' HB3' ' HB3' ' A' ' 73' ' ' GLN . 25.5 Cg_exo -62.52 145.56 95.45 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.675 2.25 . . . . 0.0 112.169 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.51 1.6 40.54 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.411 -0.9 . . . . 0.0 112.912 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.88 139.73 50.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 117.028 0.414 . . . . 0.0 110.784 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.88 158.38 16.33 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.485 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.473 HD12 HG23 ' A' ' 63' ' ' ILE . 37.3 pt -117.53 147.56 20.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.548 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.441 ' HA ' ' CD1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -155.44 -179.72 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.728 -179.84 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 p -103.77 150.55 23.98 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.667 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 31.4 t-105 -158.8 173.49 16.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.643 0.259 . . . . 0.0 110.922 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -68.89 131.68 45.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.82 0.343 . . . . 0.0 110.693 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.427 ' HG3' ' CE1' ' A' ' 7' ' ' TYR . 5.3 tt0 -59.71 141.13 55.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.348 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.78 158.35 17.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.414 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.59 108.71 13.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.837 0.351 . . . . 0.0 111.234 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 109.28 -139.2 15.19 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.526 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -48.12 166.72 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.451 2.101 . . . . 0.0 112.414 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.4 t 44.34 23.14 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.536 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.583 ' O ' HD11 ' A' ' 45' ' ' LEU . . . -86.33 -26.59 24.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.767 0.317 . . . . 0.0 110.443 178.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.551 ' HA ' HD11 ' A' ' 45' ' ' LEU . 60.4 t -50.48 -28.84 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.817 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -57.65 -13.75 4.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.144 -179.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.435 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -121.31 12.24 10.91 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 120.926 0.393 . . . . 0.0 110.364 -179.909 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.761 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 1.2 mp -118.32 140.13 50.29 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.062 -179.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.503 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 23.8 m95 -133.3 169.19 17.27 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.098 -179.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.516 ' CZ ' ' HB2' ' A' ' 55' ' ' ARG . 31.1 p90 -142.39 165.71 26.67 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.317 179.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 74.6 p -106.84 131.79 53.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.81 0.338 . . . . 0.0 111.272 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -77.44 165.6 24.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.077 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -63.12 -26.9 69.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.951 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -85.97 -4.64 59.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.277 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.48 15.08 41.97 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.82 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 40.2 t -106.09 123.74 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-O 120.662 0.267 . . . . 0.0 110.495 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.48 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.6 OUTLIER -77.5 148.74 6.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.289 0.566 . . . . 0.0 111.828 -179.963 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.516 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -150.06 133.28 16.34 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.323 178.903 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.503 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 16.5 m -54.76 141.75 31.41 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.512 0.673 . . . . 0.0 112.029 -178.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.484 ' HB3' ' CG1' ' A' ' 42' ' ' VAL . 25.5 tttt -54.02 -23.24 12.75 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.427 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.431 ' N ' ' CG1' ' A' ' 42' ' ' VAL . 3.6 pp -57.74 -38.97 76.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.007 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 178.93 -178.0 0.3 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.746 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -74.83 82.45 2.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.813 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.444 ' CE2' ' HD3' ' A' ' 74' ' ' PRO . 2.9 m-85 -144.64 125.58 14.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.903 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -109.51 153.24 24.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.405 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.482 ' O ' ' CD1' ' A' ' 84' ' ' TRP . 0.2 OUTLIER -79.15 151.82 4.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.595 179.647 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.617 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 10.5 p-10 -133.42 130.54 38.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.261 0.553 . . . . 0.0 111.787 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -93.58 41.26 1.08 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.398 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 77.7 p -74.73 -42.87 57.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.379 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -98.11 171.04 8.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.096 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -47.6 -46.34 28.26 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.095 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.05 143.98 31.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.029 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.572 ' CG1' ' HA ' ' A' ' 115' ' ' CYS . 3.0 mm -71.38 136.38 25.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 CA-C-O 121.605 0.717 . . . . 0.0 111.454 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -133.07 165.59 24.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.351 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.441 ' C ' ' HG2' ' A' ' 73' ' ' GLN . 27.5 p -105.21 134.45 48.29 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.212 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.441 ' HG2' ' C ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -161.75 167.82 12.22 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.181 -179.681 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.444 ' HD3' ' CE2' ' A' ' 61' ' ' PHE . 21.4 Cg_endo -61.11 139.44 84.12 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.308 2.005 . . . . 0.0 112.015 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -59.58 139.65 56.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.935 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -129.38 135.0 26.89 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.791 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -68.24 -35.63 18.52 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.505 2.137 . . . . 0.0 112.762 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -88.79 -1.25 57.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.699 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.401 ' HB3' ' HD2' ' A' ' 82' ' ' ARG . 2.9 t-20 -110.91 99.05 41.02 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-O 120.611 0.243 . . . . 0.0 110.846 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.53 ' O ' HD23 ' A' ' 94' ' ' LEU . 4.4 Cg_exo -74.94 27.98 0.36 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.878 2.385 . . . . 0.0 113.387 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.617 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -119.03 -23.63 6.8 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-O 120.673 0.273 . . . . 0.0 111.036 -179.833 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.433 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 0.6 OUTLIER -86.35 22.97 1.68 Allowed 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -179.076 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.571 ' O ' HD22 ' A' ' 94' ' ' LEU . . . -133.7 99.96 4.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.206 0.527 . . . . 0.0 111.17 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.482 ' CD1' ' O ' ' A' ' 63' ' ' ILE . 59.7 m95 -109.67 136.61 48.75 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.891 -178.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 20.4 pt -113.37 154.52 14.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.112 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.5 t -101.75 125.93 55.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.993 0.425 . . . . 0.0 111.057 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.9 t -118.74 93.87 4.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.338 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.41 -100.73 0.83 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.425 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.499 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -121.15 29.78 7.15 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.544 0.211 . . . . 0.0 110.842 -179.868 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.408 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.12 147.46 30.58 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -178.6 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.409 ' O ' ' HB ' ' A' ' 100' ' ' VAL . 14.1 mm -93.86 119.17 41.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.492 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.495 ' CB ' HG11 ' A' ' 100' ' ' VAL . . . -123.27 146.68 47.67 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -178.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.422 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.1 OUTLIER -64.78 149.18 49.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.599 179.867 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.575 ' HG ' ' N ' ' A' ' 95' ' ' SER . 2.7 pt? -64.61 -56.88 11.08 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.551 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.575 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 47.3 t -76.2 -2.3 30.57 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -178.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.473 ' CB ' HG22 ' A' ' 99' ' ' ILE . 11.1 m-20 -145.85 90.85 2.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.029 0.442 . . . . 0.0 110.939 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.43 -13.7 61.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.546 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -86.15 10.44 14.49 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.486 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.581 ' O ' HG11 ' A' ' 100' ' ' VAL . 3.2 tt -135.12 142.38 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.581 HG11 ' O ' ' A' ' 99' ' ' ILE . 32.1 m -150.51 139.51 15.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.851 0.357 . . . . 0.0 111.871 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.464 ' HG ' ' CZ3' ' A' ' 84' ' ' TRP . 11.9 mt -45.58 154.13 0.22 Allowed 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.8 0.809 . . . . 0.0 111.997 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.408 ' OD2' ' CG ' ' A' ' 125' ' ' GLN . 9.4 t70 -157.51 167.71 29.41 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 114.18 -1.373 . . . . 0.0 110.563 -177.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.5 mp -90.42 122.44 41.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.406 179.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 8.9 tt -67.45 140.86 18.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.971 0.415 . . . . 0.0 111.379 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt 76.95 -7.32 1.87 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.935 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.6 m 46.56 28.85 0.82 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 120.76 0.314 . . . . 0.0 111.232 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -99.63 159.96 14.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.052 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.36 -14.43 58.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.182 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -47.48 126.18 9.39 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.163 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.87 158.31 36.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.225 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.57 14.77 80.89 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.327 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.1 131.91 38.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.816 0.341 . . . . 0.0 110.872 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 8.1 m170 -65.1 173.52 2.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.024 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.523 ' O ' HG12 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -136.35 161.5 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.367 179.928 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.572 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 7.4 t -152.47 166.57 31.55 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.449 ' HB3' HG12 ' A' ' 99' ' ' ILE . . . -93.92 125.02 38.3 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.46 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 68.2 t-105 -131.49 161.72 31.89 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.672 0.748 . . . . 0.0 112.455 -179.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.46 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.0 OUTLIER -63.85 121.13 13.3 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.792 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -60.43 124.11 19.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.977 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -136.18 8.4 3.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.503 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 79.53 57.16 3.18 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.479 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -116.51 143.31 18.01 Favored Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.488 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.82 -32.53 77.44 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.57 2.18 . . . . 0.0 112.326 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -73.71 -5.33 39.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.632 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.408 ' O ' ' CG2' ' A' ' 90' ' ' THR . 93.0 mt-30 -107.29 10.11 29.85 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.509 0.195 . . . . 0.0 111.362 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.426 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -106.21 140.86 38.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.864 0.364 . . . . 0.0 111.104 -179.627 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.414 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 7.9 m-85 -139.35 156.84 46.74 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.45 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.4 mt -113.79 139.17 40.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.095 0.474 . . . . 0.0 110.679 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 25.5 mm -114.6 139.96 37.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.62 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -137.47 94.56 2.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.59 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 27.2 m -51.04 108.67 0.26 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.356 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.198 -0.906 . . . . 0.0 111.172 179.824 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mtt . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.819 0.343 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.4 ' CB ' ' CD ' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -60.13 -61.12 8.56 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.972 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.4 ' CD ' ' CB ' ' A' ' 2' ' ' LYS . 48.2 Cg_endo -68.84 141.03 47.89 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.472 2.115 . . . . 0.0 112.356 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.8 pttp -118.44 138.55 52.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.933 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.469 ' CE1' ' HG3' ' A' ' 57' ' ' LYS . 17.0 m-85 -94.08 175.29 6.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.493 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.763 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -159.42 176.02 12.61 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.76 179.694 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.419 ' CE1' ' HB3' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -114.96 124.12 50.87 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.365 179.099 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.468 HG23 HD11 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -105.89 109.4 27.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.465 179.921 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.405 ' HG3' ' O ' ' A' ' 15' ' ' LYS . 1.3 tttm -105.82 136.61 45.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.064 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 79.3 p -76.51 107.76 9.02 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 178.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -63.15 -10.33 14.57 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.467 -178.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 27.0 tp -83.16 -62.67 1.53 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.862 0.363 . . . . 0.0 110.911 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -86.25 -10.83 53.86 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -178.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.39 3.74 72.07 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.172 -1.014 . . . . 0.0 111.421 -178.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.405 ' O ' ' HG3' ' A' ' 9' ' ' LYS . 4.0 mmmm -91.67 -177.73 4.86 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 122.583 0.353 . . . . 0.0 110.054 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.5 m -121.27 140.83 44.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.69 0.281 . . . . 0.0 110.484 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.1 mt -70.67 136.26 48.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.233 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -140.51 153.98 46.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.85 0.357 . . . . 0.0 111.147 -179.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.469 HD11 ' CZ2' ' A' ' 46' ' ' TRP . 1.6 mt -100.43 118.35 46.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.59 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -65.26 96.13 0.21 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.876 0.369 . . . . 0.0 110.602 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 156.16 -41.29 0.57 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.379 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 53.37 49.23 20.17 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.796 0.331 . . . . 0.0 111.124 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -176.97 170.69 1.01 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.064 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.428 ' O ' ' CZ ' ' A' ' 61' ' ' PHE . 24.2 Cg_exo -63.78 -12.34 31.13 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.834 2.356 . . . . 0.0 112.627 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -40.39 97.8 0.15 Allowed Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.657 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -61.11 142.33 96.6 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.652 2.235 . . . . 0.0 112.327 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.98 3.26 55.91 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.7 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.7 m -71.75 137.47 47.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.903 0.382 . . . . 0.0 111.134 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.99 156.64 19.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.299 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.481 HD13 HG22 ' A' ' 63' ' ' ILE . 44.2 pt -116.42 145.59 21.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.913 0.387 . . . . 0.0 111.598 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -155.93 -178.91 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.164 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.529 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.4 p -101.2 148.92 24.53 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.561 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 18.1 t-105 -156.81 171.67 19.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.721 0.296 . . . . 0.0 110.98 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.45 134.51 47.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.719 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -56.18 126.41 25.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.112 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.8 mmmt -92.43 160.99 14.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.926 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -126.03 102.52 7.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.869 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 151.02 -159.52 28.2 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.651 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -74.15 0.14 8.83 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.082 2.521 . . . . 0.0 112.904 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.2 t -103.99 22.22 15.0 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.806 0.336 . . . . 0.0 111.082 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.45 ' O ' ' CD1' ' A' ' 45' ' ' LEU . . . -89.96 -20.9 22.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.109 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.563 ' HA ' HD12 ' A' ' 45' ' ' LEU . 81.6 t -49.44 -33.24 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.103 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -66.26 -9.26 30.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.046 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.419 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 6.4 mt-30 -118.95 8.22 11.61 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.763 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 0.9 OUTLIER -117.65 140.11 50.09 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.71 -178.943 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.491 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 23.1 m95 -134.0 168.62 18.46 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.545 -178.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.549 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 5.3 p90 -136.53 160.29 39.21 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.081 179.031 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 29.1 p -105.72 134.55 48.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.708 0.29 . . . . 0.0 110.9 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -77.42 165.68 24.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.88 0.371 . . . . 0.0 111.092 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.1 mm-40 -55.45 -21.76 17.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.28 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -103.94 -1.26 27.9 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.414 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.62 -0.15 49.4 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.69 -0.766 . . . . 0.0 113.068 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.0 t -78.95 113.62 18.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.817 0.342 . . . . 0.0 110.695 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.549 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.8 OUTLIER -79.55 147.14 6.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.407 0.622 . . . . 0.0 112.212 -179.537 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.461 ' HB2' ' CE2' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -150.82 132.58 14.98 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.904 178.5 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.501 ' HB2' HD11 ' A' ' 58' ' ' LEU . 99.9 p -53.88 153.59 4.62 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 121.758 0.789 . . . . 0.0 111.818 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.469 ' HG3' ' CE1' ' A' ' 5' ' ' PHE . 79.5 tttt -59.69 -10.74 3.96 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 114.358 -1.292 . . . . 0.0 111.271 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.501 HD11 ' HB2' ' A' ' 56' ' ' SER . 0.7 OUTLIER -43.85 -50.53 7.89 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.956 0.408 . . . . 0.0 111.19 179.612 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 175.43 -55.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.548 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 179.55 77.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.947 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.428 ' CZ ' ' O ' ' A' ' 24' ' ' PRO . 1.8 m-85 -142.15 125.61 16.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.816 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -104.94 151.22 24.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.514 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.481 ' O ' ' CD1' ' A' ' 84' ' ' TRP . 0.2 OUTLIER -79.79 151.82 4.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.465 179.607 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.603 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 7.4 p-10 -133.38 130.69 39.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.244 0.545 . . . . 0.0 111.776 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -93.33 43.48 1.12 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.245 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.0 m -75.48 -45.63 37.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.448 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -95.85 171.89 8.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.018 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -49.17 -41.77 37.68 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.91 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.24 144.23 32.32 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.801 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.638 ' CG1' ' HA ' ' A' ' 115' ' ' CYS . 2.5 mm -74.3 139.71 18.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.537 0.684 . . . . 0.0 111.441 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -138.61 166.83 23.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.718 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 63' ' ' ILE . 47.3 p -105.09 138.91 40.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.139 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.07 169.54 8.03 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.2 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -61.16 137.35 70.67 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.491 2.128 . . . . 0.0 112.028 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -54.84 128.0 31.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.074 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.417 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 8.9 t70 -116.9 129.33 25.39 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.64 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -68.52 -35.35 17.69 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.546 2.164 . . . . 0.0 113.01 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 56.4 m-20 -86.78 -1.59 57.88 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.417 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 1.6 t-20 -116.36 99.52 52.79 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-O 120.659 0.266 . . . . 0.0 110.795 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.548 ' O ' HD23 ' A' ' 94' ' ' LEU . 8.1 Cg_exo -72.51 32.63 0.28 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.068 2.512 . . . . 0.0 113.498 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.603 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 0.7 OUTLIER -118.89 -23.96 6.76 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 120.656 0.265 . . . . 0.0 111.171 -179.718 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.46 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 8.3 mtt-85 -85.13 18.71 2.44 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.549 ' O ' HD22 ' A' ' 94' ' ' LEU . . . -127.76 99.26 5.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.201 0.524 . . . . 0.0 111.317 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.481 ' CD1' ' O ' ' A' ' 63' ' ' ILE . 59.7 m95 -109.93 135.56 50.61 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.803 -179.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.9 pt -114.79 155.6 15.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.19 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.3 t -103.22 130.25 53.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.962 0.41 . . . . 0.0 111.143 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 30.5 t -123.04 94.99 4.44 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.286 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.25 -100.51 0.8 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.423 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.501 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.93 29.68 7.25 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.532 0.206 . . . . 0.0 110.919 -179.756 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.403 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.39 147.24 30.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.394 0.616 . . . . 0.0 112.648 -178.536 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 100' ' ' VAL . 17.3 mm -94.12 119.87 42.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.2 178.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.438 ' CB ' HG12 ' A' ' 100' ' ' VAL . . . -122.54 144.88 48.8 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.432 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -64.99 147.74 52.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.52 179.452 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.584 ' HG ' ' N ' ' A' ' 95' ' ' SER . 2.6 pt? -62.73 -56.52 16.86 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.436 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.584 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 45.6 p -75.15 -4.59 39.62 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -178.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.424 ' O ' HG21 ' A' ' 99' ' ' ILE . 8.6 m-20 -140.1 89.03 2.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.815 0.34 . . . . 0.0 110.864 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.8 mmm-85 -70.78 -15.87 62.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.235 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.22 11.88 21.99 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.154 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.487 ' O ' HG11 ' A' ' 100' ' ' VAL . 1.0 OUTLIER -130.38 136.84 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.086 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.487 HG11 ' O ' ' A' ' 99' ' ' ILE . 26.8 m -148.47 138.41 16.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.777 0.322 . . . . 0.0 111.643 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.486 ' HA ' ' O ' ' A' ' 115' ' ' CYS . 10.7 mt -45.98 153.84 0.28 Allowed 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.723 0.773 . . . . 0.0 111.768 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -157.51 167.7 29.43 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.789 -177.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.455 ' HA ' HG23 ' A' ' 114' ' ' ILE . 4.3 mp -89.18 120.57 38.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.553 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.436 HG12 ' HA ' ' A' ' 114' ' ' ILE . 45.7 mm -69.2 143.25 15.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.823 0.344 . . . . 0.0 111.13 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 80.13 -9.82 1.36 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.689 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 46.76 29.51 0.99 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.749 0.309 . . . . 0.0 111.238 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 54.0 p30 -105.46 163.54 12.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.033 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -80.56 -14.38 58.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.181 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -49.24 120.96 4.4 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.174 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.03 161.99 30.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.25 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 72.24 18.53 78.14 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.231 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -82.85 136.48 34.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.803 0.335 . . . . 0.0 111.112 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 5.5 m170 -62.61 168.08 3.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.939 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.491 ' O ' HG12 ' A' ' 70' ' ' ILE . 0.7 OUTLIER -138.33 161.35 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.74 -179.772 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.638 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 5.2 t -155.15 169.67 23.62 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 101' ' ' LEU . . . -94.08 125.91 38.99 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.046 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.459 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 76.3 t-105 -132.88 162.28 31.99 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.622 0.725 . . . . 0.0 112.311 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.459 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.1 OUTLIER -61.2 120.2 9.9 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.581 -1.191 . . . . 0.0 110.608 179.855 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -59.25 126.63 28.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.122 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -134.63 10.01 3.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.289 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 78.92 8.85 87.59 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.923 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.36 152.32 44.61 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.537 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.88 -27.09 59.06 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.606 2.204 . . . . 0.0 112.206 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -76.31 -1.93 29.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.479 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.403 ' O ' ' CG2' ' A' ' 90' ' ' THR . 0.0 OUTLIER -109.17 13.31 24.51 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 116.736 -0.211 . . . . 0.0 111.072 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 7.5 mmmt -104.61 132.53 50.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.789 0.328 . . . . 0.0 111.273 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.43 ' CD1' ' N ' ' A' ' 127' ' ' PHE . 1.7 m-85 -135.83 154.99 51.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.376 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 mt -114.33 139.82 38.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.163 0.506 . . . . 0.0 110.706 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.404 ' CD1' ' CG2' ' A' ' 8' ' ' ILE . 24.6 mm -114.54 140.73 33.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.707 -179.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -139.15 95.33 2.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.616 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.8 m -50.25 113.15 0.8 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.466 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.908 -179.986 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 ttm . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.764 0.316 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.18 127.55 71.1 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.898 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.16 175.2 5.04 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.438 2.092 . . . . 0.0 112.248 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -140.38 76.4 1.55 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.015 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.464 ' HA ' ' O ' ' A' ' 46' ' ' TRP . 1.6 p90 -98.13 176.36 5.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.438 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.765 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -159.9 176.16 12.21 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.746 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.437 ' CE1' ' HB3' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -113.71 123.91 51.01 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.26 179.195 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.431 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -105.09 109.42 27.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.912 0.386 . . . . 0.0 110.58 -179.983 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 15' ' ' LYS . 2.8 tttt -107.09 138.61 42.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.022 -0.535 . . . . 0.0 112.271 -178.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.1 p -77.54 109.29 11.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.658 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 4.1 tt0 -64.58 -10.14 24.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.598 -178.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 65.0 tp -84.0 -62.79 1.48 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.974 0.416 . . . . 0.0 110.906 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -85.53 -12.36 51.89 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -178.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.83 1.9 74.5 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.038 -1.077 . . . . 0.0 111.245 -178.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.418 ' O ' ' HG3' ' A' ' 9' ' ' LYS . 6.6 mmmt -90.41 179.81 5.78 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.0 m -121.13 141.66 40.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 179.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.419 ' CD2' ' HB ' ' A' ' 8' ' ' ILE . 0.1 OUTLIER -71.89 136.62 46.99 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.374 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -142.1 150.37 41.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.948 0.404 . . . . 0.0 111.335 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.439 HD12 ' CZ2' ' A' ' 46' ' ' TRP . 23.7 mt -89.98 135.58 25.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.507 179.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -41.26 96.08 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.857 -179.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 44.24 35.07 3.56 Favored Glycine 0 C--N 1.331 0.304 0 CA-C-N 115.924 -0.58 . . . . 0.0 113.303 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 37.52 48.09 0.85 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.808 0.337 . . . . 0.0 111.726 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -48.34 105.85 0.54 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.069 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -49.95 -24.28 10.32 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.538 2.159 . . . . 0.0 112.486 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -91.99 147.98 35.96 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.983 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -63.11 144.92 93.42 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.55 2.167 . . . . 0.0 112.058 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.59 4.42 24.92 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.496 -0.859 . . . . 0.0 113.09 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.23 129.71 37.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.942 0.401 . . . . 0.0 111.118 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.4 ' HA ' ' HG3' ' A' ' 71' ' ' GLU . 9.8 mmtt -81.16 159.51 24.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.554 179.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.477 HD11 HG23 ' A' ' 63' ' ' ILE . 48.2 pt -119.89 147.91 23.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.976 0.417 . . . . 0.0 111.729 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -155.74 -179.34 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.176 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.581 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.8 p -100.97 148.45 25.0 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.639 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 51.6 t-105 -156.77 170.92 21.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.681 0.277 . . . . 0.0 110.819 -179.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.62 135.53 48.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.744 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -56.79 133.96 54.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.019 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.34 168.15 9.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.851 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.5 mttp -128.19 104.77 7.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.878 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 167.75 165.02 24.45 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.56 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.24 -27.5 30.54 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.609 2.206 . . . . 0.0 112.347 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.9 t -81.44 13.13 3.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.928 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.435 ' O ' ' CD1' ' A' ' 45' ' ' LEU . . . -72.8 -10.4 59.75 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.684 0.278 . . . . 0.0 111.307 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.598 ' HA ' HD11 ' A' ' 45' ' ' LEU . 57.3 t -48.88 -27.12 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.272 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -64.38 -11.74 35.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.912 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.437 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 5.6 mt-30 -120.28 7.16 10.7 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.096 0.474 . . . . 0.0 109.784 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.765 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 1.3 mp -118.18 140.21 50.12 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.949 -179.064 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.464 ' O ' ' HA ' ' A' ' 5' ' ' PHE . 25.5 m95 -135.12 169.88 16.77 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.019 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.574 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 5.2 p90 -141.13 165.5 27.36 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.158 178.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.53 131.7 52.6 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.827 0.346 . . . . 0.0 111.195 -179.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -77.61 165.48 24.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.093 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -59.94 -25.26 65.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.12 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -91.84 -3.57 55.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.391 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.75 10.4 52.9 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.891 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.5 t -98.23 121.22 48.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.778 0.323 . . . . 0.0 110.495 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.574 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -75.63 147.5 8.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.198 0.523 . . . . 0.0 111.884 -179.733 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.559 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -151.79 135.59 16.36 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.62 179.063 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 73.1 m -49.9 149.32 2.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.255 0.55 . . . . 0.0 112.047 -179.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.46 ' CG ' ' CG1' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -59.49 -20.07 52.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.996 179.914 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.428 ' N ' ' CG1' ' A' ' 42' ' ' VAL . 0.5 OUTLIER -61.35 -49.59 76.33 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.241 -179.665 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 32.2 p30 -176.56 -173.82 0.54 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.959 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -68.02 82.55 0.22 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.174 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.425 ' CZ ' ' HG3' ' A' ' 74' ' ' PRO . 2.3 m-85 -141.39 116.15 9.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.725 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -109.4 150.96 27.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.458 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.477 ' O ' ' CD1' ' A' ' 84' ' ' TRP . 0.3 OUTLIER -78.45 153.77 5.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.583 179.614 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.593 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 4.7 p-10 -133.28 130.19 38.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.226 0.536 . . . . 0.0 111.832 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -93.95 39.92 1.08 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.433 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.31 -44.73 51.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.172 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 50.6 m170 -94.11 169.44 10.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.928 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -46.9 -47.66 21.44 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.999 0.428 . . . . 0.0 110.956 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.409 ' OE1' ' CE1' ' A' ' 113' ' ' HIS . 0.0 OUTLIER -100.98 145.17 29.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.623 179.212 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.641 ' CG1' ' HA ' ' A' ' 115' ' ' CYS . 2.3 mm -73.09 137.8 22.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-O 121.553 0.692 . . . . 0.0 111.489 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.4 ' HG3' ' HA ' ' A' ' 29' ' ' LYS . 3.7 tt0 -132.34 161.93 32.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.015 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 63' ' ' ILE . 28.3 p -104.04 138.89 39.92 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.635 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.91 160.46 15.02 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.654 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.425 ' HG3' ' CZ ' ' A' ' 61' ' ' PHE . 51.1 Cg_exo -53.51 141.88 61.12 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.441 2.094 . . . . 0.0 111.785 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -55.13 134.6 49.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.875 0.369 . . . . 0.0 111.352 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -126.31 118.96 23.33 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.609 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -58.33 -36.66 97.41 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.633 2.222 . . . . 0.0 113.231 -179.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 29.1 m-20 -86.1 -0.68 56.2 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -106.5 103.54 46.65 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.6 0.238 . . . . 0.0 111.137 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.542 ' O ' HD22 ' A' ' 94' ' ' LEU . 79.1 Cg_endo -77.37 23.09 0.55 Allowed 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.649 2.233 . . . . 0.0 113.132 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.593 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 0.7 OUTLIER -119.87 -21.18 7.27 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.966 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.515 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 2.5 mtm180 -86.66 20.93 2.34 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.006 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.543 ' O ' HD21 ' A' ' 94' ' ' LEU . . . -129.79 99.91 5.3 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.275 0.56 . . . . 0.0 111.066 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.477 ' CD1' ' O ' ' A' ' 63' ' ' ILE . 63.4 m95 -110.47 136.8 49.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.846 -178.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 pp -117.01 155.45 18.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.215 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.1 t -100.79 125.77 54.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.917 0.389 . . . . 0.0 111.054 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 12.7 t -118.5 93.62 4.18 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.487 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.22 -100.84 0.82 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.517 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.501 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.74 29.32 7.47 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.557 0.218 . . . . 0.0 110.939 -179.655 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.419 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.82 148.18 30.61 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.379 0.609 . . . . 0.0 112.552 -178.576 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 100' ' ' VAL . 16.7 mm -93.41 119.98 42.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.303 178.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.429 ' HB2' HG11 ' A' ' 100' ' ' VAL . . . -123.55 145.29 48.99 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -178.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.434 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -66.67 147.05 53.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.723 179.713 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.591 ' HG ' ' N ' ' A' ' 95' ' ' SER . 2.6 pt? -60.81 -56.23 23.65 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.499 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.591 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 2.8 m -76.75 -3.95 40.83 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -178.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -139.04 87.88 2.24 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.88 0.371 . . . . 0.0 111.071 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -66.92 -18.25 65.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.173 179.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.27 10.42 32.03 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.509 179.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.476 ' O ' HG11 ' A' ' 100' ' ' VAL . 12.1 mm -122.37 127.29 75.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.596 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.476 HG11 ' O ' ' A' ' 99' ' ' ILE . 29.6 m -146.14 135.52 17.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.821 0.343 . . . . 0.0 111.796 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.488 ' HA ' ' O ' ' A' ' 115' ' ' CYS . 10.8 mt -45.97 154.0 0.27 Allowed 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.66 0.743 . . . . 0.0 111.913 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -157.92 168.59 26.74 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.88 -177.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.496 ' HA ' HG23 ' A' ' 114' ' ' ILE . 34.6 mm -88.77 126.95 41.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.603 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -64.16 134.11 29.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.184 0.516 . . . . 0.0 111.449 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 12.7 tttm 62.46 10.2 3.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.929 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.0 p 40.22 33.21 0.15 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.697 0.284 . . . . 0.0 111.587 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.93 154.73 18.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.931 0.396 . . . . 0.0 111.191 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.28 -16.17 56.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.322 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -49.36 126.52 13.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.791 0.329 . . . . 0.0 111.308 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -73.1 157.95 36.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.031 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.48 14.08 81.27 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.17 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.52 134.03 38.4 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.924 0.392 . . . . 0.0 111.035 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.409 ' CE1' ' OE1' ' A' ' 69' ' ' GLN . 0.3 OUTLIER -60.91 167.08 3.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.878 -179.798 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.496 HG23 ' HA ' ' A' ' 103' ' ' ILE . 0.1 OUTLIER -139.48 161.41 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.728 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.641 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 5.7 p -157.6 173.3 17.07 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.457 ' HB1' ' CG2' ' A' ' 99' ' ' ILE . . . -95.27 129.47 42.38 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.456 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 75.7 t-105 -136.04 162.47 32.79 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.565 0.698 . . . . 0.0 112.096 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.456 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.0 OUTLIER -61.63 118.77 7.51 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.773 179.976 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -59.01 127.13 30.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.997 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -134.08 11.25 3.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.155 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 77.44 7.64 87.06 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.864 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.5 154.88 41.4 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.507 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.46 -28.4 53.99 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.625 2.216 . . . . 0.0 112.28 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -74.52 -4.07 34.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.589 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.419 ' O ' ' CG2' ' A' ' 90' ' ' THR . 0.0 OUTLIER -108.34 15.81 23.69 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.571 0.224 . . . . 0.0 111.176 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.406 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 16.7 mmtt -107.06 134.01 50.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.765 0.317 . . . . 0.0 111.384 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.419 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 4.5 m-85 -137.05 155.29 49.85 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.303 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.4 mt -113.55 139.14 40.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.174 0.511 . . . . 0.0 110.587 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 24.0 mm -113.97 139.79 37.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.616 -179.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -136.77 94.68 3.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.628 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.3 p -52.48 110.81 0.54 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.253 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.432 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 5.2 tp10 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.996 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 ptp . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 120.894 0.378 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.48 143.9 27.5 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.85 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.05 133.9 17.07 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.516 2.144 . . . . 0.0 112.473 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.0 tttt -96.96 116.88 29.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.654 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.481 ' CD1' ' HG3' ' A' ' 57' ' ' LYS . 2.3 p90 -91.44 174.94 7.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.7 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.726 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -161.08 177.8 9.94 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.628 179.73 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.425 ' CZ ' HD12 ' A' ' 45' ' ' LEU . 1.0 OUTLIER -112.61 123.83 51.18 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.42 179.379 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.436 ' CD1' ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -103.97 109.42 27.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.123 0.487 . . . . 0.0 109.802 179.552 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 127' ' ' PHE . 0.0 OUTLIER -102.89 130.84 50.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.579 -178.025 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.68 103.18 7.46 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 178.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.402 ' HB3' ' O ' ' A' ' 126' ' ' LYS . 3.3 tt0 -65.58 -8.22 18.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.768 -178.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 36.1 tp -83.16 -63.6 1.33 Allowed 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.44 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -83.72 -7.78 59.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.862 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.78 4.85 72.54 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.11 -1.043 . . . . 0.0 111.234 -177.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm -94.43 -166.31 1.46 Allowed 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 122.809 0.444 . . . . 0.0 109.958 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.3 m -130.78 143.93 39.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 179.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.3 mt -70.19 135.11 48.76 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -145.15 155.97 43.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.915 0.388 . . . . 0.0 111.196 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.45 HG21 HD11 ' A' ' 19' ' ' ILE . 17.4 mt -97.53 130.77 45.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.517 179.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.45 104.27 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.042 -178.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 44.83 29.41 2.01 Favored Glycine 0 C--N 1.332 0.334 0 CA-C-N 115.824 -0.625 . . . . 0.0 113.406 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 65.82 -71.17 0.09 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.789 0.328 . . . . 0.0 111.063 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 49.4 t30 68.25 91.71 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.866 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.38 -20.42 20.18 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.6 2.2 . . . . 0.0 112.487 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -94.63 153.86 40.14 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.083 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.416 ' HB3' ' CD ' ' A' ' 74' ' ' PRO . 17.1 Cg_exo -66.96 151.42 82.16 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.672 2.248 . . . . 0.0 112.11 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.53 2.33 35.09 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.463 -0.875 . . . . 0.0 113.3 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.55 125.24 26.97 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 117.102 0.451 . . . . 0.0 111.258 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -77.64 159.99 28.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.562 179.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.413 HD12 ' HB ' ' A' ' 70' ' ' ILE . 47.9 pt -121.1 148.27 24.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.885 0.374 . . . . 0.0 111.771 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.406 HG23 ' HA ' ' A' ' 113' ' ' HIS . 0.3 OUTLIER -156.01 -178.3 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.219 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.551 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.6 p -100.54 147.94 25.35 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.617 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 25.6 t-105 -159.15 173.79 15.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.66 0.267 . . . . 0.0 110.798 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -69.8 134.7 48.83 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.815 0.34 . . . . 0.0 110.762 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -62.86 137.45 58.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.125 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.7 mmmt -99.66 157.12 16.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.824 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.63 106.27 11.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.302 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.413 ' O ' ' HB3' ' A' ' 41' ' ' ALA . . . 113.82 -123.87 6.28 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.507 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -66.52 169.4 14.3 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.354 2.036 . . . . 0.0 112.153 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.1 p 43.85 23.99 0.06 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.575 ' O ' HD11 ' A' ' 45' ' ' LEU . . . -87.26 -26.36 23.5 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.916 -0.314 . . . . 0.0 110.447 178.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.528 ' HA ' HD11 ' A' ' 45' ' ' LEU . 28.3 t -50.32 -25.77 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.091 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -61.62 -11.33 11.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.712 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -120.13 8.43 10.95 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.015 0.436 . . . . 0.0 109.978 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.726 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 1.5 mp -116.98 139.77 50.27 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.828 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.46 ' O ' ' HA ' ' A' ' 5' ' ' PHE . 23.9 m95 -134.38 168.04 19.65 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.027 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.545 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 26.5 p90 -140.11 164.2 30.69 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.101 178.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -106.45 133.74 50.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.859 0.361 . . . . 0.0 111.327 -179.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -77.69 166.03 23.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.063 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.28 -24.08 62.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.112 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -94.74 -3.23 49.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.42 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.99 7.82 54.76 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.826 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.2 t -92.76 118.48 38.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.76 0.28 . . . . 0.0 110.549 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.545 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -76.11 146.98 8.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.294 0.568 . . . . 0.0 111.863 -179.786 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.519 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 7.7 mmm-85 -150.21 135.27 17.81 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.629 179.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 15.0 m -55.6 143.75 28.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.369 0.604 . . . . 0.0 112.012 -179.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.481 ' HG3' ' CD1' ' A' ' 5' ' ' PHE . 4.6 tttt -54.15 -25.45 22.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.052 -179.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.401 ' N ' HG12 ' A' ' 42' ' ' VAL . 1.9 pp -56.58 -48.52 77.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.763 0.316 . . . . 0.0 111.351 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -172.12 -179.74 2.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.9 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.83 84.77 0.48 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.944 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -145.91 125.17 12.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.787 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -113.07 154.12 27.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.352 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.498 ' O ' ' CD1' ' A' ' 84' ' ' TRP . 0.2 OUTLIER -79.77 153.09 4.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.725 179.776 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.583 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 6.3 p-10 -132.33 132.8 43.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.126 0.489 . . . . 0.0 111.609 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -97.75 39.86 1.19 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.317 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.42 -43.52 60.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.252 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -96.29 172.08 8.18 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.018 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -47.73 -48.72 29.57 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.042 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.83 147.64 26.26 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.666 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.658 ' CG1' ' HA ' ' A' ' 115' ' ' CYS . 1.6 mm -78.62 144.01 11.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-O 121.649 0.738 . . . . 0.0 111.992 -179.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.73 166.07 25.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.799 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 63' ' ' ILE . 73.9 p -102.33 138.95 38.57 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.051 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.48 159.94 20.38 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.392 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.416 ' CD ' ' HB3' ' A' ' 26' ' ' PRO . 52.2 Cg_exo -52.54 136.59 57.32 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.441 2.094 . . . . 0.0 111.887 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -57.09 132.19 52.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.223 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -121.75 134.46 24.64 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.608 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.3 -34.93 15.02 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.424 2.083 . . . . 0.0 112.608 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -87.4 -0.77 57.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.55 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -108.96 100.18 38.74 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-O 120.622 0.248 . . . . 0.0 111.021 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.42 ' O ' ' CD2' ' A' ' 94' ' ' LEU . 4.0 Cg_exo -76.73 25.14 0.45 Allowed 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.988 2.459 . . . . 0.0 113.02 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.583 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 42.7 mmtt -119.72 -21.06 7.41 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 120.635 0.255 . . . . 0.0 110.893 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.498 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 3.6 mtm180 -87.01 17.91 3.88 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.24 -179.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.681 ' O ' HD22 ' A' ' 94' ' ' LEU . . . -127.25 99.29 5.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.166 0.508 . . . . 0.0 110.764 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.498 ' CD1' ' O ' ' A' ' 63' ' ' ILE . 62.1 m95 -109.27 136.27 49.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.105 0.479 . . . . 0.0 111.77 -178.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.6 pp -115.73 154.6 17.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.139 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.8 t -102.03 130.0 52.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.932 0.396 . . . . 0.0 111.184 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 36.7 t -122.61 95.18 4.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.447 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.45 -100.71 0.83 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.545 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.499 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.97 29.67 7.25 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.509 0.195 . . . . 0.0 110.789 -179.731 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.424 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.72 147.63 30.13 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -178.49 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 27.5 mm -94.03 120.47 43.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.421 178.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.46 ' CB ' HG11 ' A' ' 100' ' ' VAL . . . -124.27 146.11 48.97 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -178.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.437 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.1 OUTLIER -65.42 150.06 48.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.673 179.894 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.681 HD22 ' O ' ' A' ' 83' ' ' ALA . 2.7 pt? -62.81 -57.22 11.63 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.721 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.551 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 1.5 m -79.8 -2.06 41.64 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -178.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -137.48 85.54 2.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.842 0.353 . . . . 0.0 110.809 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 16.4 mmt85 -69.48 -16.68 63.51 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.158 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -90.35 11.29 21.87 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.138 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.545 ' O ' HG11 ' A' ' 100' ' ' VAL . 5.6 tt -130.21 136.42 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.545 HG11 ' O ' ' A' ' 99' ' ' ILE . 19.8 m -148.57 137.36 15.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.455 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.507 ' HA ' ' O ' ' A' ' 115' ' ' CYS . 25.8 mt -45.31 153.99 0.19 Allowed 'General case' 0 CA--C 1.51 -0.596 0 CA-C-O 121.713 0.768 . . . . 0.0 111.622 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.4 ' HB2' ' HG2' ' A' ' 125' ' ' GLN . 27.4 t70 -157.49 167.72 29.38 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.964 -177.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.416 ' HA ' HG22 ' A' ' 114' ' ' ILE . 33.1 mm -86.46 123.34 39.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.232 179.063 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -68.26 139.3 20.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.1 0.476 . . . . 0.0 111.65 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.12 18.36 3.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.815 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 13.4 m 45.1 -132.87 0.84 Allowed 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.918 -0.128 . . . . 0.0 111.041 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 65.45 162.9 0.15 Allowed 'General case' 0 CA--C 1.526 0.037 0 CA-C-O 120.772 0.32 . . . . 0.0 111.025 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -90.04 -12.4 38.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.448 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -44.81 132.54 6.56 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.391 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -89.22 164.74 14.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.245 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 71.61 19.01 77.61 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.048 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -86.18 138.34 31.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.841 0.353 . . . . 0.0 110.915 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.406 ' HA ' HG23 ' A' ' 31' ' ' ILE . 34.7 m80 -62.12 170.52 2.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.749 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.446 ' O ' HG12 ' A' ' 70' ' ' ILE . 0.6 OUTLIER -143.94 161.84 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.928 -179.497 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.658 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 6.0 p -156.65 173.49 16.86 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 101' ' ' LEU . . . -95.99 128.71 43.13 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 178.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.451 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 75.0 t-105 -134.81 162.68 31.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.494 0.664 . . . . 0.0 112.059 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.451 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.3 OUTLIER -62.33 122.99 17.05 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.787 179.929 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -56.99 124.1 17.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.054 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -128.78 5.57 5.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.394 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 81.69 6.86 88.75 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.88 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -65.98 148.93 51.32 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.528 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.03 -27.01 57.91 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.564 2.176 . . . . 0.0 112.382 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 42.5 p-10 -66.95 -12.26 59.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.561 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.424 ' O ' ' CG2' ' A' ' 90' ' ' THR . 6.0 mt-30 -103.5 17.57 23.79 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.338 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 11' ' ' GLU . 12.3 mmtp -106.43 136.28 46.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.856 0.36 . . . . 0.0 111.568 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.419 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 3.0 m-85 -141.13 155.28 46.13 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.909 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 mt -110.65 139.68 33.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.146 0.498 . . . . 0.0 110.651 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 21.9 mm -112.98 139.69 36.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.648 -179.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -138.08 94.46 2.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.618 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.5 t -52.13 113.16 0.94 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.341 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.459 ' HB3' ' CE2' ' A' ' 5' ' ' PHE . 2.2 tm-20 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.272 -0.871 . . . . 0.0 110.932 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.827 0.346 . . . . 0.0 111.203 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.7 mttp -128.67 89.44 49.24 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.849 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.02 60.35 3.75 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.595 2.197 . . . . 0.0 112.381 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.9 122.94 35.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.886 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -98.76 175.05 6.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.665 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.602 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -152.46 170.22 20.66 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 120.952 0.406 . . . . 0.0 111.14 179.303 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.447 ' O ' ' HA ' ' A' ' 129' ' ' ILE . 0.1 OUTLIER -108.62 123.74 49.42 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.932 178.942 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.447 ' CD1' ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -107.72 106.12 20.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.341 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.3 tptp -104.92 134.63 47.71 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 54.2 m -75.82 107.13 7.79 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.428 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 4.3 tt0 -63.14 -10.49 15.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.61 -178.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 51.1 tp -81.84 -62.96 1.49 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.97 0.414 . . . . 0.0 110.869 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -86.31 -7.46 58.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.244 -178.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.48 6.54 62.38 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.05 -1.071 . . . . 0.0 111.459 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.6 mmmm -94.94 -176.22 3.78 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.6 m -122.52 142.2 39.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.424 ' CD2' ' HB ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -72.56 138.23 46.74 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.174 179.52 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 19' ' ' ILE . 31.5 t0 -146.01 142.38 28.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.78 0.324 . . . . 0.0 111.033 -178.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.405 ' N ' ' OD1' ' A' ' 18' ' ' ASP . 7.9 mm -69.06 141.94 16.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.319 -0.4 . . . . 0.0 109.925 179.011 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -52.67 105.9 0.14 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.951 0.405 . . . . 0.0 111.468 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 53.46 31.77 44.27 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.993 -0.623 . . . . 0.0 113.01 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 43.91 30.5 0.41 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.728 0.299 . . . . 0.0 111.591 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -58.77 108.46 1.33 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.676 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -78.52 36.61 0.6 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.858 2.372 . . . . 0.0 112.928 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -124.72 150.04 64.24 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.655 0.264 . . . . 0.0 110.877 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.409 ' HG3' ' HD3' ' A' ' 74' ' ' PRO . 23.1 Cg_exo -63.22 130.91 30.22 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.513 2.142 . . . . 0.0 112.026 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.72 1.49 32.39 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.442 -0.885 . . . . 0.0 113.066 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.5 m -72.55 138.61 47.01 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 117.085 0.443 . . . . 0.0 110.69 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.48 157.44 19.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.784 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.469 HD11 HG22 ' A' ' 63' ' ' ILE . 42.1 pt -115.74 145.9 20.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.377 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.409 ' HA ' ' CD1' ' A' ' 114' ' ' ILE . 0.3 OUTLIER -153.46 177.71 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.156 -179.741 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.8 p -102.03 148.89 24.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.759 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 41.0 t-105 -157.45 172.08 19.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.713 0.292 . . . . 0.0 110.826 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.65 134.21 48.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.732 0.301 . . . . 0.0 110.734 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -56.88 127.7 33.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.055 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.87 162.47 13.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.868 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.18 101.87 7.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.878 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 166.84 158.78 11.6 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.461 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.49 -28.54 36.43 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.644 2.229 . . . . 0.0 112.348 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.8 t -90.12 28.86 1.31 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.476 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.51 ' O ' HD12 ' A' ' 45' ' ' LEU . . . -101.94 2.73 38.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.168 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.502 ' CG1' ' HB3' ' A' ' 57' ' ' LYS . 2.5 t -60.27 -17.29 14.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.761 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 29.7 p30 -60.36 -13.51 13.55 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.047 178.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -111.38 7.36 20.87 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.602 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 1.8 mp -120.09 147.63 44.61 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.469 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.46 ' CH2' ' CG1' ' A' ' 63' ' ' ILE . 25.4 m95 -133.34 169.57 16.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.818 -179.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.501 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 1.5 p90 -136.14 159.19 42.47 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.007 178.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.0 p -106.22 132.88 51.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.763 0.316 . . . . 0.0 111.256 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -77.67 165.36 24.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.108 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -60.94 -24.07 65.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.017 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -93.17 -3.35 54.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.44 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.95 8.75 53.69 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.883 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.8 t -95.5 119.74 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 116.946 0.373 . . . . 0.0 110.638 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.501 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.8 OUTLIER -79.35 151.9 4.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.246 0.546 . . . . 0.0 111.863 -179.826 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.488 ' HB2' ' CE2' ' A' ' 47' ' ' TYR . 8.6 mmm-85 -148.11 133.3 18.36 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.289 179.063 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.471 ' HB3' ' CD2' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -69.58 -176.77 1.07 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.323 0.582 . . . . 0.0 111.968 -178.708 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.502 ' HB3' ' CG1' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -46.09 -23.54 0.33 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.714 -179.876 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.493 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 1.5 mm? -49.08 -21.65 0.76 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.728 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.493 ' CB ' ' O ' ' A' ' 58' ' ' LEU . 10.9 t30 89.53 -25.64 0.07 Allowed 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 179.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -164.93 58.2 0.13 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.934 0.397 . . . . 0.0 111.419 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.436 ' HB2' ' HB2' ' A' ' 58' ' ' LEU . 2.2 m-85 -143.39 113.36 7.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.121 0.486 . . . . 0.0 110.7 179.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -98.87 152.22 19.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.118 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.508 ' O ' ' NE1' ' A' ' 84' ' ' TRP . 0.2 OUTLIER -77.9 149.91 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.349 179.523 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.634 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 3.7 p-10 -131.51 133.16 44.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.133 0.492 . . . . 0.0 111.79 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.36 42.41 1.1 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.369 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 66.4 p -74.34 -44.53 52.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.15 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -96.72 172.53 7.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.963 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -48.86 -44.19 39.49 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.056 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.68 145.43 29.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.986 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.588 ' CG1' ' HA ' ' A' ' 115' ' ' CYS . 2.8 mm -75.77 141.8 15.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-O 121.555 0.693 . . . . 0.0 111.358 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -136.96 168.76 18.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.001 -0.999 . . . . 0.0 111.432 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.2 p -108.54 135.79 49.23 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.213 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.419 ' HA ' ' CE2' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -165.54 171.9 4.77 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.429 -179.725 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.424 ' HD3' ' CE2' ' A' ' 61' ' ' PHE . 75.6 Cg_exo -49.09 139.83 25.87 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.506 2.137 . . . . 0.0 111.957 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -47.74 -59.58 3.19 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 63.56 118.83 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 -179.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.47 -28.65 21.6 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.527 2.151 . . . . 0.0 113.445 -179.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -87.25 0.58 55.15 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.425 ' CB ' ' HD2' ' A' ' 82' ' ' ARG . 1.9 m120 -104.42 101.97 30.68 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 120.63 0.253 . . . . 0.0 111.328 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.433 ' O ' ' CD2' ' A' ' 94' ' ' LEU . 94.8 Cg_endo -77.58 18.6 0.81 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.733 2.288 . . . . 0.0 113.319 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.634 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -118.97 -19.84 8.35 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 120.716 0.293 . . . . 0.0 110.905 179.818 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.484 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 36.5 mtt180 -91.01 25.62 2.38 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.227 -178.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.663 ' O ' HD21 ' A' ' 94' ' ' LEU . . . -136.96 99.48 4.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.94 0.4 . . . . 0.0 110.898 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.508 ' NE1' ' O ' ' A' ' 63' ' ' ILE . 38.6 m95 -109.58 139.13 44.97 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.246 0.546 . . . . 0.0 111.78 -178.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 pp -112.7 155.92 13.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.287 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.6 t -102.64 128.15 55.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.962 0.41 . . . . 0.0 111.246 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.9 t -120.92 94.6 4.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.209 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.41 -100.98 0.85 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.34 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.5 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.76 29.84 7.2 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.579 0.228 . . . . 0.0 110.843 -179.81 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.425 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.44 147.51 30.29 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.383 0.611 . . . . 0.0 112.64 -178.595 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' ' 100' ' ' VAL . 20.1 mm -94.02 120.29 43.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.292 178.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.421 ' CB ' ' CG1' ' A' ' 100' ' ' VAL . . . -122.2 144.11 49.16 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.441 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -64.82 148.14 51.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.435 179.566 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.663 HD21 ' O ' ' A' ' 83' ' ' ALA . 2.5 pt? -62.79 -57.49 10.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.8 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.513 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 3.5 t -75.81 -3.91 37.69 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -141.14 89.63 2.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.841 0.353 . . . . 0.0 110.891 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 8.8 mmt85 -70.79 -16.02 62.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.232 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -88.93 10.87 19.79 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.253 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.498 ' O ' HG13 ' A' ' 100' ' ' VAL . 5.3 tt -131.05 137.54 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.498 HG13 ' O ' ' A' ' 99' ' ' ILE . 17.5 m -148.39 138.59 16.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.774 0.321 . . . . 0.0 111.536 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.486 ' HA ' ' O ' ' A' ' 115' ' ' CYS . 10.9 mt -46.32 153.87 0.31 Allowed 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.634 0.731 . . . . 0.0 111.581 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -158.85 168.08 27.75 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.46 -1.245 . . . . 0.0 110.669 -177.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.6 mp -87.34 120.69 37.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.139 179.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 40.2 mm -70.03 136.39 26.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.883 0.373 . . . . 0.0 111.253 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 8.4 tttt 78.92 -6.1 1.94 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.764 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.1 m 46.45 29.7 0.94 Allowed 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 120.809 0.338 . . . . 0.0 111.27 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.39 155.01 17.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.039 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.1 -13.74 59.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.097 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -48.78 123.14 6.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.229 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.4 157.86 30.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.037 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.24 12.55 81.76 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.146 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.51 131.52 41.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.873 0.368 . . . . 0.0 111.052 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -64.87 172.44 2.84 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.111 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.518 ' O ' HG12 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -136.71 161.67 36.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.349 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.588 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 6.3 t -153.38 167.47 29.29 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -94.75 125.24 39.28 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 177.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.459 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 76.1 t-105 -133.56 162.38 32.07 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.629 0.728 . . . . 0.0 112.291 -179.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.459 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.0 OUTLIER -61.79 119.82 9.49 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.621 179.836 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -59.74 126.05 26.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.1 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -134.11 10.7 3.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.21 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 81.15 7.88 87.96 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.981 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.48 150.09 47.74 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.603 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.37 -27.02 55.29 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.561 2.174 . . . . 0.0 112.182 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 32.1 p-10 -75.45 -4.42 39.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.425 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.425 ' O ' ' CG2' ' A' ' 90' ' ' THR . 0.0 OUTLIER -105.82 12.95 30.22 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.29 -179.741 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.428 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 5.9 mmtt -106.02 140.3 39.23 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.863 0.364 . . . . 0.0 111.367 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.414 ' CD1' ' O ' ' A' ' 126' ' ' LYS . 8.9 m-85 -138.67 155.27 48.42 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.162 179.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 mt -111.45 137.24 44.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.049 0.452 . . . . 0.0 110.41 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.447 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 36.6 mm -113.47 140.9 31.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.64 -179.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -140.83 106.2 5.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.596 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.61 109.11 0.94 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.044 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 34.5 tp10 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.232 -0.89 . . . . 0.0 111.127 179.888 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 mmt . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 120.795 0.331 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -145.04 117.39 5.33 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.802 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.39 -173.92 0.91 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.389 2.059 . . . . 0.0 112.391 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.58 112.36 23.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.831 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.464 ' HA ' ' O ' ' A' ' 46' ' ' TRP . 2.1 p90 -92.8 174.97 6.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.618 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.742 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -159.92 175.97 12.43 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.596 179.744 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.42 ' CE2' HD11 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -114.22 123.88 50.66 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.288 179.206 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.436 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -104.12 109.77 28.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.37 -179.924 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.63 135.42 47.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.464 -178.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.8 t -75.27 105.66 6.4 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -62.66 -11.88 19.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.594 -178.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.459 ' HB2' ' HA ' ' A' ' 124' ' ' ASN . 12.3 tp -84.51 -62.49 1.54 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.964 0.412 . . . . 0.0 110.967 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -83.08 -12.81 56.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.48 -178.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.53 2.9 76.7 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.143 -1.027 . . . . 0.0 111.491 -178.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -91.86 -175.14 4.04 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.4 m -121.62 140.22 46.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.656 0.265 . . . . 0.0 110.437 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.5 mt -69.4 134.76 49.41 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -143.61 153.99 43.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.888 0.375 . . . . 0.0 111.196 -178.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.463 HG23 HD12 ' A' ' 19' ' ' ILE . 34.0 mt -95.98 137.24 24.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.572 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -34.14 97.85 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -179.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 44.1 39.52 5.29 Favored Glycine 0 C--N 1.332 0.309 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.498 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 46.77 30.72 1.24 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.707 0.289 . . . . 0.0 111.348 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -47.11 102.87 0.33 Allowed Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.147 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.11 -12.21 31.31 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.644 2.229 . . . . 0.0 112.635 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -88.46 145.0 34.61 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.642 0.258 . . . . 0.0 111.121 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.413 ' HB3' ' CD ' ' A' ' 74' ' ' PRO . 29.3 Cg_exo -61.55 142.67 95.6 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.599 2.2 . . . . 0.0 112.143 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.82 3.44 39.72 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.477 -0.868 . . . . 0.0 113.08 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.75 138.61 48.58 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.946 0.403 . . . . 0.0 111.056 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.3 mptt -89.4 157.71 18.04 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.216 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.454 HD11 HG23 ' A' ' 63' ' ' ILE . 38.0 pt -116.34 145.91 21.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.799 0.333 . . . . 0.0 111.743 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.44 ' HA ' ' CD1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -155.32 178.17 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.192 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.537 -179.827 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.6 p -100.68 148.77 24.49 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 121.001 -0.279 . . . . 0.0 110.65 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 24.3 t-105 -157.69 172.57 18.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.706 0.289 . . . . 0.0 110.883 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -69.77 133.93 48.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.852 0.358 . . . . 0.0 110.706 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.411 ' HG3' ' CE1' ' A' ' 7' ' ' TYR . 6.9 tt0 -56.68 119.51 6.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.112 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.34 164.83 13.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.795 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.0 mtpm? -131.68 116.85 17.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.94 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 149.2 -162.56 29.01 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.585 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -74.84 1.16 7.95 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.026 2.484 . . . . 0.0 112.827 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.09 19.13 18.72 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.661 0.267 . . . . 0.0 111.202 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.444 ' O ' ' CD1' ' A' ' 45' ' ' LEU . . . -81.89 -20.51 38.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.124 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.574 ' HA ' HD13 ' A' ' 45' ' ' LEU . 45.3 t -49.69 -29.77 4.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.113 179.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -65.69 -10.91 40.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.927 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.419 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 3.5 mt-30 -118.2 7.59 12.14 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.19 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.742 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 1.1 mp -118.82 140.38 50.05 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.981 -179.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.464 ' O ' ' HA ' ' A' ' 5' ' ' PHE . 24.8 m95 -134.12 168.82 18.13 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.92 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.533 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 32.0 p90 -140.73 164.93 28.87 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.219 178.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 81.1 p -107.6 134.32 50.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.833 0.349 . . . . 0.0 111.378 -178.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -77.81 170.25 16.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.15 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.17 -23.62 67.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.077 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.3 mm100 -94.04 -3.45 51.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.242 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.95 8.78 53.65 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.917 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.413 HG11 ' CE2' ' A' ' 75' ' ' PHE . 42.2 t -95.14 119.63 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-O 120.83 0.348 . . . . 0.0 110.693 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.533 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -76.68 147.85 7.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.341 0.591 . . . . 0.0 111.9 -179.792 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.502 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 8.2 mmm-85 -149.48 133.69 17.31 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.39 179.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.45 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 70.0 m -55.07 143.8 25.76 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.463 0.649 . . . . 0.0 111.848 -178.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.461 ' HB3' ' CG1' ' A' ' 42' ' ' VAL . 12.9 tttt -52.69 -24.07 7.87 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.7 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.431 ' N ' ' CG1' ' A' ' 42' ' ' VAL . 3.5 pp -56.59 -49.21 75.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.183 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -178.12 -176.47 0.54 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.871 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.75 83.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.855 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.434 ' CE2' ' HD3' ' A' ' 74' ' ' PRO . 2.8 m-85 -144.18 119.38 10.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.77 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -109.26 154.9 21.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.547 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.491 ' O ' ' NE1' ' A' ' 84' ' ' TRP . 0.2 OUTLIER -80.37 150.79 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.466 179.587 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.561 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 6.4 p-10 -131.61 132.09 43.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.064 0.459 . . . . 0.0 111.419 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -97.51 41.66 1.11 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.192 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.4 t -74.83 -45.54 42.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.158 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 59.6 m80 -94.44 170.76 9.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.982 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -47.83 -48.02 31.0 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.106 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -99.6 143.86 29.35 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.099 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.58 ' CG1' ' HA ' ' A' ' 115' ' ' CYS . 3.0 mm -74.2 139.95 18.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 CA-C-O 121.554 0.692 . . . . 0.0 111.478 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -139.88 168.94 18.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.262 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 63' ' ' ILE . 63.4 p -108.59 139.2 43.7 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.281 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.6 163.02 16.72 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.485 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.434 ' HD3' ' CE2' ' A' ' 61' ' ' PHE . 50.7 Cg_exo -55.08 136.06 71.49 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.474 2.116 . . . . 0.0 111.729 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.413 ' CE2' HG11 ' A' ' 53' ' ' VAL . 32.7 t80 -52.77 134.72 36.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.97 0.414 . . . . 0.0 111.489 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -124.21 116.8 27.03 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.477 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -56.98 -33.76 96.18 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.532 2.155 . . . . 0.0 113.045 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 33.5 m-20 -86.89 -0.07 55.86 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -179.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 -112.55 104.07 55.78 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 120.629 0.252 . . . . 0.0 111.114 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.426 ' O ' ' CD2' ' A' ' 94' ' ' LEU . 84.4 Cg_endo -76.84 27.11 0.43 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.733 2.289 . . . . 0.0 113.105 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.561 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 40.7 mmtt -120.29 -19.5 7.64 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 116.687 -0.233 . . . . 0.0 111.162 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.493 ' HG2' ' HB3' ' A' ' 64' ' ' ASP . 3.5 mtm180 -88.43 19.71 3.71 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.329 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.689 ' O ' HD22 ' A' ' 94' ' ' LEU . . . -130.03 99.38 5.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.075 0.464 . . . . 0.0 110.784 179.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.491 ' NE1' ' O ' ' A' ' 63' ' ' ILE . 58.8 m95 -109.05 135.77 49.66 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.146 0.498 . . . . 0.0 111.979 -178.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 pp -111.82 152.87 13.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.084 179.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.3 t -100.57 126.37 54.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.941 0.4 . . . . 0.0 111.133 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.3 t -119.39 94.85 4.56 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.577 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.81 -100.41 0.76 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.643 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.491 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.51 29.64 7.34 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.518 0.199 . . . . 0.0 110.977 -179.492 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -149.71 149.11 30.09 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.337 0.589 . . . . 0.0 112.493 -178.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 12.3 mm -94.01 120.71 43.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.449 178.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.545 ' CB ' HG13 ' A' ' 100' ' ' VAL . . . -121.38 144.54 48.61 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -178.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.419 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -66.33 149.02 51.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.929 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.689 HD22 ' O ' ' A' ' 83' ' ' ALA . 2.6 pt? -64.26 -57.36 9.67 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.018 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.551 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 3.5 m -74.06 -4.12 33.54 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.484 ' CB ' HG22 ' A' ' 99' ' ' ILE . 73.2 m-20 -146.73 93.01 2.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.099 0.476 . . . . 0.0 111.035 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.04 -13.12 61.15 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.587 179.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -87.89 12.02 14.23 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.481 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.554 ' O ' HG13 ' A' ' 100' ' ' VAL . 2.6 tt -135.09 143.25 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.554 HG13 ' O ' ' A' ' 99' ' ' ILE . 34.9 m -151.66 139.71 14.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.789 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.476 ' HG ' ' CZ3' ' A' ' 84' ' ' TRP . 10.6 mt -46.2 154.31 0.27 Allowed 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 121.722 0.772 . . . . 0.0 111.706 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -158.3 168.29 27.42 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.629 -177.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 26.8 mm -89.35 120.97 38.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.389 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 7.9 tp -64.72 138.66 22.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.023 0.44 . . . . 0.0 111.457 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 73.54 -3.71 2.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.043 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 45.3 t 44.19 31.26 0.53 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.76 0.314 . . . . 0.0 111.428 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -97.36 158.12 15.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.194 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.99 -13.4 59.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.183 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -49.11 131.93 19.29 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.26 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -77.17 158.86 30.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.017 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 72.3 15.34 76.98 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.145 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.05 132.61 40.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.895 0.378 . . . . 0.0 110.929 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -64.99 171.53 3.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.934 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.54 ' O ' HG12 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -135.45 161.25 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.397 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.58 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 5.8 t -152.39 167.22 29.41 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.459 ' HB3' HG12 ' A' ' 99' ' ' ILE . . . -94.99 124.73 39.21 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.447 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 77.0 t-105 -133.49 161.4 34.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.619 0.723 . . . . 0.0 112.236 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.447 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.0 OUTLIER -61.03 123.0 16.38 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.57 -1.195 . . . . 0.0 110.806 -179.906 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -58.84 125.05 21.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.951 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 13.3 p80 -136.98 6.32 2.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.595 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 78.26 57.1 3.49 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.273 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -112.0 138.73 15.18 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.509 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.67 -31.42 60.32 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.447 2.098 . . . . 0.0 112.18 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.459 ' HA ' ' HB2' ' A' ' 12' ' ' LEU . 10.9 p-10 -72.0 -8.0 52.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.575 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -101.9 -14.31 17.28 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.57 0.211 . . . . 0.0 111.57 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.428 ' O ' ' CD1' ' A' ' 127' ' ' PHE . 2.3 mmtt -78.27 136.73 37.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.811 0.339 . . . . 0.0 111.373 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.428 ' CD1' ' O ' ' A' ' 126' ' ' LYS . 6.8 m-85 -139.15 156.22 47.28 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.136 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.419 HD12 HG22 ' A' ' 128' ' ' ILE . 1.2 mt -112.33 137.77 43.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.176 0.513 . . . . 0.0 110.592 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 19.5 mm -114.36 138.7 43.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.527 -179.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -134.52 94.29 3.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.54 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.15 108.06 0.48 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.134 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.295 -0.86 . . . . 0.0 111.358 179.726 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.488 ' HD2' HD22 ' A' ' 45' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.461 0.11 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.793 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -155.24 171.28 20.08 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.613 179.815 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.81 ' OH ' ' HB1' ' A' ' 41' ' ' ALA . 2.0 m-85 -109.2 123.41 49.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.23 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.616 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -108.23 103.72 15.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.842 0.353 . . . . 0.0 110.275 179.674 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.855 ' HB3' HG12 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -127.98 126.84 42.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.763 -179.036 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.467 ' O ' ' HD2' ' A' ' 9' ' ' LYS . 0.9 OUTLIER -46.15 138.44 5.29 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.019 0.437 . . . . 0.0 111.575 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.543 ' HA ' HD11 ' A' ' 128' ' ' ILE . 3.2 tt0 -81.13 -11.28 59.5 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.082 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 61.4 tp -92.9 -56.54 2.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.165 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -83.24 -21.09 33.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.83 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.18 4.08 77.7 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.284 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.59 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 1.1 mmmm -85.26 164.25 18.15 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.855 HG12 ' HB3' ' A' ' 9' ' ' LYS . 12.6 m -106.95 137.0 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-O 120.769 0.318 . . . . 0.0 110.722 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 21.0 mt -68.31 136.57 53.65 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -138.26 152.01 48.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.841 0.353 . . . . 0.0 111.111 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.929 HD13 HG21 ' A' ' 72' ' ' THR . 1.5 mt . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.872 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 N-CA-C 112.588 -0.205 . . . . 0.0 112.588 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.37 132.91 37.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.945 0.403 . . . . 0.0 111.114 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.87 155.65 30.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.311 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.698 HG22 HG23 ' A' ' 19' ' ' ILE . 47.8 pt -115.31 144.59 22.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.921 0.391 . . . . 0.0 111.676 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.442 HG22 ' HA ' ' A' ' 113' ' ' HIS . 0.2 OUTLIER -156.09 -176.68 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.581 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.513 HG21 HD12 ' A' ' 103' ' ' ILE . 1.2 p -101.75 148.56 25.14 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.343 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 10.4 t-105 -159.1 173.84 15.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.709 0.29 . . . . 0.0 111.009 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -71.85 138.32 48.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.815 0.341 . . . . 0.0 110.86 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.619 ' HA ' HG21 ' A' ' 16' ' ' VAL . 28.4 tt0 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.176 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.898 ' O ' HD12 ' A' ' 45' ' ' LEU . . . . . . . . 0 N--CA 1.457 -0.116 0 CA-C-O 120.758 0.314 . . . . 0.0 110.885 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 99.6 t -49.73 -28.07 3.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.191 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -67.07 -9.0 34.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.804 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -119.6 6.14 11.05 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.153 0.501 . . . . 0.0 109.821 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.898 HD12 ' O ' ' A' ' 41' ' ' ALA . 1.2 mp -116.07 138.86 50.86 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.583 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.576 ' CZ2' HD11 ' A' ' 19' ' ' ILE . 21.1 m95 -132.54 167.92 19.15 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.035 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.509 ' CE1' ' HB2' ' A' ' 55' ' ' ARG . 41.2 p90 -140.44 163.93 31.48 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.146 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -105.1 132.6 51.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.849 0.357 . . . . 0.0 111.345 -178.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -77.65 165.85 23.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.154 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -62.71 -24.16 67.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.14 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -90.3 -4.1 57.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.328 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.738 ' O ' HG22 ' A' ' 85' ' ' ILE . . . 97.11 13.37 46.08 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.858 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.553 HG13 ' HA ' ' A' ' 83' ' ' ALA . 21.6 t -103.97 123.02 57.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.712 0.291 . . . . 0.0 110.533 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -75.71 149.23 6.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.369 0.604 . . . . 0.0 111.941 -179.828 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.684 ' CD ' ' HB2' ' A' ' 62' ' ' ALA . 7.5 mmm-85 -149.36 133.5 17.26 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.235 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 8.2 m . . . . . 0 C--N 1.326 -0.444 0 CA-C-O 121.468 0.651 . . . . 0.0 111.862 -178.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.846 0.355 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.684 ' HB2' ' CD ' ' A' ' 55' ' ' ARG . . . -114.0 153.2 29.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.265 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.762 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -78.54 153.65 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.475 179.742 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.56 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 6.9 p-10 -133.63 132.94 41.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.203 0.525 . . . . 0.0 111.554 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.647 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -97.28 43.63 1.06 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.27 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.7 m -74.54 -45.56 44.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.084 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -94.66 171.9 8.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.834 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -50.87 -41.94 58.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.086 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.77 144.3 31.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.967 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.762 HG22 HG22 ' A' ' 63' ' ' ILE . 2.8 mm -72.47 135.95 26.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-O 121.642 0.734 . . . . 0.0 111.516 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.417 ' O ' HG22 ' A' ' 63' ' ' ILE . 6.8 tt0 -135.99 163.25 30.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.724 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.929 HG21 HD13 ' A' ' 19' ' ' ILE . 31.7 p -105.73 140.03 39.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.965 0.412 . . . . 0.0 111.195 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.467 ' CB ' ' HD2' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -162.41 169.09 9.7 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.29 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.467 ' HD2' ' CB ' ' A' ' 73' ' ' GLN . 19.4 Cg_endo -60.54 139.31 85.47 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.307 2.005 . . . . 0.0 111.913 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.43 ' HE1' ' HB2' ' A' ' 83' ' ' ALA . 8.7 t80 -57.0 138.21 54.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.088 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.4 ' HB3' ' CB ' ' A' ' 79' ' ' ASN . 24.4 t0 -129.98 119.15 18.77 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.685 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -56.53 -34.64 95.57 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.538 2.159 . . . . 0.0 112.907 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -86.54 -1.39 57.59 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.4 ' CB ' ' HB3' ' A' ' 76' ' ' ASP . 2.8 t-20 -108.92 102.42 48.38 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.656 0.265 . . . . 0.0 110.957 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.833 ' O ' HD21 ' A' ' 94' ' ' LEU . 88.0 Cg_endo -76.78 24.57 0.47 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.725 2.283 . . . . 0.0 113.276 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.584 ' HD2' ' HB3' ' A' ' 65' ' ' ALA . 37.7 mmtt -120.03 -18.43 8.14 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 120.519 0.2 . . . . 0.0 111.195 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 2.0 mtt180 -89.14 20.06 3.91 Favored 'General case' 0 C--N 1.341 0.219 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 1.103 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -129.3 99.62 5.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.093 0.473 . . . . 0.0 110.691 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.647 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 60.5 m95 -108.99 134.92 51.0 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.123 0.487 . . . . 0.0 112.057 -178.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.738 HG22 ' O ' ' A' ' 52' ' ' GLY . 3.4 pt -112.82 153.76 14.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.296 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.2 t -101.76 127.0 55.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.898 0.38 . . . . 0.0 111.087 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 25.2 t -119.49 95.21 4.69 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.632 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.47 -100.03 0.7 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.677 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.501 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.32 29.67 7.36 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.575 0.226 . . . . 0.0 110.962 -179.449 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.6 149.98 30.58 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.315 0.579 . . . . 0.0 112.474 -178.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.835 ' HB ' HD12 ' A' ' 101' ' ' LEU . 12.6 mm -94.28 122.09 45.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.458 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.929 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -122.29 142.32 50.6 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.419 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -64.74 148.09 51.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.469 179.648 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.103 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.7 pt? -62.43 -56.79 14.84 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.918 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.58 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 7.0 p -75.99 -4.0 38.78 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -178.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.409 ' HB3' ' HB ' ' A' ' 99' ' ' ILE . 5.3 m-20 -141.16 89.82 2.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.866 0.365 . . . . 0.0 111.241 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -67.6 -16.4 64.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.259 178.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -92.5 10.03 31.93 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.476 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.812 ' CG2' ' HB1' ' A' ' 116' ' ' ALA . 11.6 mm -123.51 128.24 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.477 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.929 HG12 ' HB2' ' A' ' 92' ' ' ALA . 30.5 m -146.48 135.84 16.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.771 0.32 . . . . 0.0 111.667 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.835 HD12 ' HB ' ' A' ' 91' ' ' ILE . 8.6 mt -47.09 154.4 0.36 Allowed 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.639 0.733 . . . . 0.0 111.475 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.81 ' O ' HG22 ' A' ' 114' ' ' ILE . 30.0 t70 -155.85 166.89 32.15 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.875 -177.555 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.531 ' HA ' HG22 ' A' ' 114' ' ' ILE . 35.0 mm -89.73 120.54 38.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.426 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.805 HG22 ' O ' ' A' ' 113' ' ' HIS . 0.6 OUTLIER -64.84 138.89 22.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.038 0.447 . . . . 0.0 111.512 -179.622 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.402 ' N ' HG13 ' A' ' 104' ' ' ILE . 10.1 mmtp 76.01 -4.02 2.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.031 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 17.1 m 45.68 30.04 0.75 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.823 0.344 . . . . 0.0 111.285 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -100.41 165.09 11.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.215 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.54 -15.55 51.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.058 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -47.28 128.81 12.34 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.203 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -80.95 161.46 24.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.115 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 72.05 17.93 77.48 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.178 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.85 138.23 33.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.888 0.375 . . . . 0.0 110.967 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.805 ' O ' HG22 ' A' ' 104' ' ' ILE . 48.7 m-70 -62.87 171.07 2.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.787 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.81 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.7 OUTLIER -142.67 161.76 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.688 -179.657 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.648 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 28.4 p -155.71 171.4 20.06 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.812 ' HB1' ' CG2' ' A' ' 99' ' ' ILE . . . -95.83 126.84 41.36 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.213 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.459 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 76.1 t-105 -134.98 162.61 31.94 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.567 0.699 . . . . 0.0 112.123 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.459 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.0 OUTLIER -60.72 120.92 11.01 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.607 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -52.09 123.8 11.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.886 0.374 . . . . 0.0 111.277 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 22.3 p-80 -128.84 3.3 5.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.361 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.62 8.48 81.31 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.836 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.67 142.0 46.21 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.55 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.81 -31.2 71.36 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.528 2.152 . . . . 0.0 112.295 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -69.42 -11.95 61.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.319 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -101.68 13.5 34.73 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.703 0.287 . . . . 0.0 111.138 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.6 mmmm -100.34 126.27 46.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.351 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.449 ' HE2' HD11 ' A' ' 103' ' ' ILE . 32.6 m-85 -129.13 154.98 46.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.333 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.543 HD11 ' HA ' ' A' ' 11' ' ' GLU . 2.0 mt -116.21 141.57 33.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.295 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.587 HD12 HG23 ' A' ' 8' ' ' ILE . 26.1 mm -113.33 141.16 30.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.288 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -141.59 95.3 2.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.753 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 47.5 m -54.77 108.12 0.36 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.289 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.383 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.425 ' HA ' ' O ' ' A' ' 46' ' ' TRP . 71.7 m-85 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.647 0.261 . . . . 0.0 110.691 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.681 ' C ' HD23 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -153.75 171.6 18.62 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 120.978 0.418 . . . . 0.0 111.178 179.118 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.439 ' O ' ' HA ' ' A' ' 129' ' ' ILE . 0.1 OUTLIER -111.66 123.6 50.58 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.213 179.044 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.61 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -106.97 106.55 20.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.886 0.374 . . . . 0.0 110.095 179.802 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -106.78 137.73 44.27 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.648 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.38 109.42 10.08 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.469 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 6.0 tt0 -62.88 -10.91 15.08 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.521 -178.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.609 HD22 ' HA ' ' A' ' 124' ' ' ASN . 43.0 tp -84.24 -62.32 1.59 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.938 0.399 . . . . 0.0 111.037 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.513 ' ND2' ' HA ' ' A' ' 108' ' ' LYS . 3.6 m120 -86.25 -12.32 49.93 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.23 3.98 71.9 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.071 -1.061 . . . . 0.0 111.545 -178.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.438 ' O ' ' HG3' ' A' ' 9' ' ' LYS . 5.1 mmtm -91.85 175.91 6.71 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.607 HG21 ' HA ' ' A' ' 35' ' ' GLN . 5.9 m -118.47 143.83 28.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.725 0.298 . . . . 0.0 110.603 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.3 mt -69.25 136.29 51.75 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.004 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.402 ' CB ' ' HG3' ' A' ' 44' ' ' GLN . 14.0 t0 -144.96 144.24 30.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.795 0.331 . . . . 0.0 111.146 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.831 HD12 HG21 ' A' ' 72' ' ' THR . 4.3 mm . . . . . 0 C--N 1.327 -0.37 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.518 0 CA-C-O 120.185 -0.231 . . . . 0.0 113.192 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.3 t -73.34 128.85 36.66 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 117.243 0.521 . . . . 0.0 110.994 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.1 mmtp -80.38 158.12 26.11 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.282 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.675 HD11 ' HB ' ' A' ' 70' ' ' ILE . 43.3 pt -117.0 145.97 22.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.613 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.466 ' HA ' ' CD1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -153.65 178.61 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.182 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.943 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.3 p -101.87 149.4 24.24 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.567 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 26.0 t-105 -159.27 173.89 15.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.635 0.255 . . . . 0.0 110.869 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -69.46 133.02 47.22 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.798 0.332 . . . . 0.0 110.776 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.607 ' HA ' HG21 ' A' ' 16' ' ' VAL . 27.9 pt20 . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.992 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.514 ' O ' HD12 ' A' ' 45' ' ' LEU . . . . . . . . 0 C--O 1.23 0.07 0 N-CA-C 111.566 0.21 . . . . 0.0 111.566 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.476 ' HA ' ' CD1' ' A' ' 45' ' ' LEU . 1.6 t -59.26 -18.53 14.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.675 0.274 . . . . 0.0 110.821 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -63.8 -10.65 21.26 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.755 0.312 . . . . 0.0 110.894 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.402 ' HG3' ' CB ' ' A' ' 18' ' ' ASP . 1.2 mt-30 -111.12 7.95 21.55 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.426 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.681 HD23 ' C ' ' A' ' 6' ' ' PHE . 1.1 mp -121.1 146.45 46.72 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 114.662 -1.153 . . . . 0.0 111.296 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.601 ' CZ2' HD11 ' A' ' 19' ' ' ILE . 26.0 m95 -133.46 170.46 15.46 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.678 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.54 ' CE2' ' HB2' ' A' ' 55' ' ' ARG . 1.5 p90 -136.62 160.39 38.94 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.039 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.556 HG22 HG23 ' A' ' 54' ' ' ILE . 33.2 p -107.77 134.41 50.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.71 0.29 . . . . 0.0 111.285 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -77.67 170.47 16.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.281 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -63.22 -22.79 67.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.038 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -97.35 -2.93 41.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.148 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.6 5.52 53.88 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.976 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.436 HG11 ' CE1' ' A' ' 75' ' ' PHE . 23.6 t -88.08 116.59 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 CA-C-O 120.864 0.364 . . . . 0.0 110.778 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.556 HG23 HG22 ' A' ' 48' ' ' THR . 0.7 OUTLIER -78.5 150.27 5.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.242 0.544 . . . . 0.0 111.821 -179.86 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.54 ' HB2' ' CE2' ' A' ' 47' ' ' TYR . 10.0 mmm-85 -147.16 133.14 19.17 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.454 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.464 0 CA-C-O 121.162 0.505 . . . . 0.0 111.877 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.99 0.424 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -97.17 150.19 21.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.807 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.895 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -78.07 150.23 5.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.283 179.903 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.583 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 15.7 p-10 -130.71 131.34 44.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.071 0.462 . . . . 0.0 111.583 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.674 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -96.83 42.77 1.08 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.175 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.8 -45.18 45.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.216 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -96.45 172.86 7.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.014 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -47.33 -49.41 24.28 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.923 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -98.96 146.96 25.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.929 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.895 HG22 HG22 ' A' ' 63' ' ' ILE . 2.6 mm -76.22 140.82 16.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-O 121.531 0.681 . . . . 0.0 111.441 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -133.05 166.54 22.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.618 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.831 HG21 HD12 ' A' ' 19' ' ' ILE . 24.8 p -112.13 137.06 50.73 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.717 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.487 ' HG2' ' C ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -163.57 165.63 13.74 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.062 179.655 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.416 ' O ' ' HD3' ' A' ' 82' ' ' ARG . 54.1 Cg_exo -52.38 141.26 51.31 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.379 2.053 . . . . 0.0 111.935 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.436 ' CE1' HG11 ' A' ' 53' ' ' VAL . 36.0 t80 -60.5 132.55 54.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.388 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.405 ' HB2' ' NH1' ' A' ' 82' ' ' ARG . 20.2 t0 -123.49 132.13 24.29 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.411 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -68.79 -33.56 20.49 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.52 2.147 . . . . 0.0 113.283 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -87.14 1.04 54.28 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -105.57 103.69 44.53 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.56 0.219 . . . . 0.0 111.28 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.839 ' O ' HD21 ' A' ' 94' ' ' LEU . 6.1 Cg_exo -77.78 20.42 0.71 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.959 2.439 . . . . 0.0 112.828 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.583 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 11.3 mmtm -120.35 -17.89 8.09 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.993 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.509 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 39.2 mtt180 -89.08 19.59 4.13 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.305 -179.033 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 1.114 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -130.03 99.1 4.96 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.053 0.454 . . . . 0.0 110.937 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.674 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 54.3 m95 -108.58 134.9 50.7 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.14 0.495 . . . . 0.0 111.801 -178.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.4 pp -111.48 154.52 13.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.318 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.4 t -102.3 128.57 54.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.993 0.425 . . . . 0.0 111.139 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.6 t -121.33 94.23 4.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.398 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.16 -100.13 0.76 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.503 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.493 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.63 29.25 7.52 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.617 0.246 . . . . 0.0 110.974 -179.737 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.408 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.78 147.29 29.7 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.633 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.731 ' HB ' HD12 ' A' ' 101' ' ' LEU . 20.0 mm -94.29 120.52 43.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.384 178.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.903 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -121.91 145.07 48.45 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -178.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.441 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -65.4 149.09 50.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.493 179.568 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.114 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.6 pt? -62.91 -57.35 11.09 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.819 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.564 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -76.22 -3.89 38.86 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -178.559 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.561 ' O ' HG22 ' A' ' 99' ' ' ILE . 8.4 m-20 -139.84 88.6 2.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.783 0.325 . . . . 0.0 110.926 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.48 -16.34 62.9 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.181 179.034 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.86 11.76 19.31 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.216 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.561 HG22 ' O ' ' A' ' 96' ' ' ASP . 6.9 tt -131.53 137.78 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.08 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.903 HG12 ' HB2' ' A' ' 92' ' ' ALA . 18.6 m -148.66 138.5 16.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.819 0.343 . . . . 0.0 111.789 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.731 HD12 ' HB ' ' A' ' 91' ' ' ILE . 10.8 mt -45.96 153.24 0.31 Allowed 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 121.708 0.766 . . . . 0.0 111.791 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.731 ' O ' HG22 ' A' ' 114' ' ' ILE . 10.9 t70 -156.64 166.94 31.95 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.383 -1.28 . . . . 0.0 110.745 -177.549 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.621 HD12 ' O ' ' A' ' 124' ' ' ASN . 4.3 mp -89.73 120.58 38.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.33 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.816 HG22 ' O ' ' A' ' 113' ' ' HIS . 3.7 tp -64.66 139.05 22.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.999 0.428 . . . . 0.0 111.494 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 71.46 -2.13 2.54 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.165 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.4 m 41.91 32.23 0.27 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.803 0.335 . . . . 0.0 111.52 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.489 ' O ' ' ND2' ' A' ' 13' ' ' ASN . 3.1 m-20 -96.39 156.83 16.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.18 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.513 ' HA ' ' ND2' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -77.27 -13.92 59.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.097 179.675 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -52.0 124.51 12.98 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.157 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.4 159.76 33.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.086 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.86 14.0 81.96 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.288 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.46 132.33 39.56 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.853 0.359 . . . . 0.0 110.993 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.816 ' O ' HG22 ' A' ' 104' ' ' ILE . 75.8 m-70 -65.02 171.15 3.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.964 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.731 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -135.92 161.67 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.514 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.623 ' HA ' HD11 ' A' ' 70' ' ' ILE . 13.6 p -153.98 169.03 24.46 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.672 ' HB2' ' HH2' ' A' ' 84' ' ' TRP . . . -95.34 126.13 40.43 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.521 -0.471 . . . . 0.0 109.747 178.106 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.461 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 76.0 t-105 -133.92 162.47 31.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.566 0.698 . . . . 0.0 112.298 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.461 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 4.3 tmtm? -61.89 122.58 15.8 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.752 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.407 ' HA ' ' NE2' ' A' ' 125' ' ' GLN . 29.1 tt0 -60.54 125.52 24.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.346 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -134.68 9.0 3.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.631 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 80.82 7.45 88.56 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.486 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.54 152.93 44.34 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.505 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.71 -26.12 53.45 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.654 2.236 . . . . 0.0 112.324 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.621 ' O ' HD12 ' A' ' 103' ' ' ILE . 26.9 p-10 -75.39 -3.5 34.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.485 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.408 ' O ' ' CG2' ' A' ' 90' ' ' THR . 0.5 OUTLIER -108.95 14.41 24.13 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.194 -179.815 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.469 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 1.3 mmtp -105.53 133.22 50.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.768 0.318 . . . . 0.0 111.321 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.421 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 5.9 m-85 -136.41 155.77 49.56 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.544 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.4 mt -113.72 138.86 42.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.187 0.518 . . . . 0.0 110.409 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.524 ' CD1' HG23 ' A' ' 8' ' ' ILE . 36.4 mm -113.41 140.41 33.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.589 -179.12 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -139.16 111.48 7.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.509 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.35 110.63 2.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.118 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.957 -179.993 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.445 ' HA ' ' O ' ' A' ' 46' ' ' TRP . 1.3 p90 . . . . . 0 C--O 1.23 0.068 0 N-CA-C 110.31 -0.256 . . . . 0.0 110.31 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.754 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -158.84 175.57 13.42 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.795 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.447 ' CE1' ' HB3' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -114.74 123.81 50.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.24 179.196 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.616 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -104.56 109.88 28.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.926 0.393 . . . . 0.0 110.374 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -104.64 135.87 45.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.32 -178.824 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.702 ' OG ' HD11 ' A' ' 103' ' ' ILE . 0.6 OUTLIER -75.55 107.21 7.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.516 178.299 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.424 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 1.8 tt0 -63.82 -11.03 23.59 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.661 -178.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.689 HD22 ' CB ' ' A' ' 124' ' ' ASN . 37.7 tp -84.68 -62.77 1.47 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.898 0.38 . . . . 0.0 110.988 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -84.23 -11.48 56.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.333 -178.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.81 3.53 73.93 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.136 -1.03 . . . . 0.0 111.416 -178.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -91.28 -172.8 3.41 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.613 HG21 ' HA ' ' A' ' 35' ' ' GLN . 3.5 m -124.48 140.83 46.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.708 0.29 . . . . 0.0 110.469 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.4 mt -69.8 134.78 48.92 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.016 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -142.99 158.58 43.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.968 0.413 . . . . 0.0 111.239 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.949 HD13 HG21 ' A' ' 72' ' ' THR . 19.2 mt . . . . . 0 C--N 1.326 -0.416 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.419 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 CA-C-O 120.272 -0.182 . . . . 0.0 113.347 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.6 m -75.81 129.94 37.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.157 0.479 . . . . 0.0 111.258 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.2 mmtp -82.4 160.81 22.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.437 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.714 HD11 ' HB ' ' A' ' 70' ' ' ILE . 41.1 pt -119.4 147.09 23.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.78 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.46 ' HA ' ' CD1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -155.17 179.39 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.208 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.511 -179.777 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.49 HG21 HD12 ' A' ' 103' ' ' ILE . 1.6 p -101.77 149.07 24.55 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.622 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 24.3 t-105 -156.99 171.85 19.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.857 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -70.12 135.79 49.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.76 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.613 ' HA ' HG21 ' A' ' 16' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.145 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.862 ' O ' HD12 ' A' ' 45' ' ' LEU . . . . . . . . 0 N--CA 1.457 -0.081 0 CA-C-O 120.678 0.275 . . . . 0.0 111.189 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.7 t -49.38 -27.73 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.085 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -64.97 -9.59 22.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.791 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.447 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 6.0 mt-30 -120.45 7.42 10.64 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.099 0.476 . . . . 0.0 109.766 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.862 HD12 ' O ' ' A' ' 41' ' ' ALA . 1.3 mp -116.95 139.88 50.13 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.781 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.697 ' CZ2' HD11 ' A' ' 19' ' ' ILE . 24.7 m95 -133.95 168.82 18.09 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.127 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.524 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 30.1 p90 -140.71 165.0 28.69 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.112 178.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.559 HG22 HG23 ' A' ' 54' ' ' ILE . 15.0 p -107.76 134.0 51.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.813 0.34 . . . . 0.0 111.429 -178.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -77.8 169.89 17.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.192 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -63.49 -24.15 67.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.143 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -93.95 -2.82 52.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.136 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.49 8.49 54.66 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.84 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.469 HG12 ' HD3' ' A' ' 55' ' ' ARG . 40.4 t -93.98 119.43 41.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.89 0.345 . . . . 0.0 110.552 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.559 HG23 HG22 ' A' ' 48' ' ' THR . 0.7 OUTLIER -77.26 147.92 7.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.299 0.571 . . . . 0.0 111.763 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.7 ' CD ' ' HB2' ' A' ' 62' ' ' ALA . 9.0 mmm-85 -149.85 133.74 16.95 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.474 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.466 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 37.9 m . . . . . 0 C--N 1.326 -0.448 0 CA-C-O 121.476 0.655 . . . . 0.0 111.863 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.893 0.378 . . . . 0.0 110.825 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.7 ' HB2' ' CD ' ' A' ' 55' ' ' ARG . . . -110.55 155.85 21.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.492 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.848 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -82.89 151.76 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.636 179.6 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.598 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 10.0 p-10 -132.44 130.31 40.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.106 0.479 . . . . 0.0 111.429 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.67 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -94.3 39.62 1.08 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.467 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.3 m -74.34 -45.89 44.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.141 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 15.3 m170 -91.13 167.91 12.01 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.943 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -46.74 -47.19 20.71 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.928 0.394 . . . . 0.0 110.833 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.34 146.18 27.92 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.701 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.848 HG22 HG22 ' A' ' 63' ' ' ILE . 2.7 mm -73.51 136.45 25.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 CA-C-O 121.738 0.78 . . . . 0.0 111.595 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -132.34 163.82 27.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.094 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.949 HG21 HD13 ' A' ' 19' ' ' ILE . 41.6 p -109.33 136.71 48.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.591 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.466 ' HG2' ' C ' ' A' ' 72' ' ' THR . 0.5 OUTLIER -163.1 167.32 11.9 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.452 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.432 ' O ' ' HD3' ' A' ' 82' ' ' ARG . 50.4 Cg_exo -53.46 137.0 65.04 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.432 2.088 . . . . 0.0 111.759 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -65.47 141.6 58.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.964 0.411 . . . . 0.0 111.412 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.12 139.62 35.51 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.59 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.02 -30.53 20.91 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.511 2.141 . . . . 0.0 112.864 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -89.57 0.05 57.18 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -106.19 102.57 40.81 Favored Pre-proline 0 CA--C 1.529 0.17 0 CA-C-O 120.568 0.223 . . . . 0.0 111.187 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.853 ' O ' HD21 ' A' ' 94' ' ' LEU . 5.8 Cg_exo -77.27 20.1 0.68 Allowed 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.94 2.427 . . . . 0.0 113.034 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.598 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 0.1 OUTLIER -117.85 -20.42 8.83 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 120.634 0.254 . . . . 0.0 110.96 -179.859 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.503 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 6.8 mtm-85 -88.41 19.76 3.66 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.414 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 1.131 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -128.58 99.2 5.28 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.089 0.471 . . . . 0.0 110.696 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.67 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 62.7 m95 -108.85 134.63 51.28 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.216 0.531 . . . . 0.0 112.016 -178.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.6 pt -112.12 153.23 13.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.201 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.4 t -101.75 127.02 55.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.943 0.402 . . . . 0.0 110.98 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.9 t -119.82 95.06 4.61 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.566 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.87 -100.27 0.75 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.557 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.499 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.79 29.82 7.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.603 0.239 . . . . 0.0 110.864 -179.668 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.413 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -148.76 148.43 29.97 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 121.358 0.599 . . . . 0.0 112.595 -178.548 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.809 ' HB ' HD12 ' A' ' 101' ' ' LEU . 14.6 mm -93.93 120.93 44.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.393 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.966 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -123.71 144.06 49.89 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.411 ' HB3' ' HB2' ' A' ' 96' ' ' ASP . 1.6 tt0 -62.83 152.34 36.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.476 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.131 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.7 pt? -65.73 -56.9 9.59 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.402 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.577 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 1.2 m -79.34 -1.93 39.16 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.411 ' HB2' ' HB3' ' A' ' 93' ' ' GLN . 9.6 m-20 -138.07 85.03 2.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.891 0.377 . . . . 0.0 110.998 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.45 -17.79 64.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.221 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' A' ' 118' ' ' LYS . 4.6 m-20 -92.7 10.28 31.35 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.466 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.848 ' CG2' ' HB1' ' A' ' 116' ' ' ALA . 11.9 mm -123.07 128.66 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.501 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.966 HG12 ' HB2' ' A' ' 92' ' ' ALA . 28.5 m -146.39 135.17 16.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.809 HD12 ' HB ' ' A' ' 91' ' ' ILE . 11.3 mt -45.62 154.21 0.22 Allowed 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.746 0.784 . . . . 0.0 111.861 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.607 ' O ' HG22 ' A' ' 114' ' ' ILE . 13.6 t70 -159.55 169.39 23.93 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.65 -177.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.702 HD11 ' OG ' ' A' ' 10' ' ' SER . 17.6 mm -88.07 121.11 38.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.168 179.176 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.437 HD12 ' CB ' ' A' ' 113' ' ' HIS . 52.7 mt -70.42 136.83 25.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.841 0.353 . . . . 0.0 111.215 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.403 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 0.2 OUTLIER 80.88 -9.03 1.38 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.802 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 38.2 m 47.39 30.49 1.58 Allowed 'General case' 0 N--CA 1.461 0.108 0 CA-C-O 120.785 0.326 . . . . 0.0 111.289 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -98.55 154.05 18.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.015 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.25 -11.56 60.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.316 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -52.36 129.12 27.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.206 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.95 161.51 29.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.008 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 70.64 15.62 73.47 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.867 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.92 133.41 39.25 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.824 0.345 . . . . 0.0 110.793 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.437 ' CB ' HD12 ' A' ' 104' ' ' ILE . 40.4 m-70 -64.0 170.43 3.56 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.019 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.607 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -135.89 161.71 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.425 179.779 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.631 ' HA ' HD11 ' A' ' 70' ' ' ILE . 29.1 p -154.53 169.06 24.69 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.848 ' HB1' ' CG2' ' A' ' 99' ' ' ILE . . . -94.84 127.63 41.0 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.459 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 75.8 t-105 -135.9 162.75 31.95 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.608 0.718 . . . . 0.0 112.212 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.459 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 12.2 tptt -61.95 117.14 5.54 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.625 -1.171 . . . . 0.0 110.875 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.56 127.59 32.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.772 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -139.08 12.02 2.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.27 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 75.86 60.46 3.15 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.266 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -116.15 144.26 18.36 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.557 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.78 -33.89 72.57 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.5 2.134 . . . . 0.0 112.226 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.689 ' CB ' HD22 ' A' ' 12' ' ' LEU . 12.9 p-10 -76.68 -2.22 31.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.508 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.413 ' O ' ' CG2' ' A' ' 90' ' ' THR . 0.0 OUTLIER -107.97 9.82 28.51 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.745 -0.207 . . . . 0.0 111.184 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.424 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 9.8 mmtp -106.5 139.43 40.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.762 0.315 . . . . 0.0 111.439 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.43 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 7.5 m-85 -138.61 156.34 47.54 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.244 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.4 mt -113.17 138.64 41.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.158 0.504 . . . . 0.0 110.65 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.557 ' CD1' HG23 ' A' ' 8' ' ' ILE . 25.2 mm -114.17 140.36 35.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.62 -179.161 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.95 96.04 3.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.588 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.2 t -51.91 111.48 0.62 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.313 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.444 ' HB3' ' CD2' ' A' ' 5' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.898 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.5 ' HA ' ' O ' ' A' ' 46' ' ' TRP . 3.1 p90 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.649 0.261 . . . . 0.0 110.851 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.743 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -159.48 173.75 15.71 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.204 179.693 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.549 ' OH ' ' HB1' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -109.41 123.47 49.4 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.359 179.091 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.62 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -107.92 104.11 16.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.847 -179.709 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.837 ' HB3' HG12 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -127.22 125.44 41.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.471 -179.504 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.473 ' O ' ' HD2' ' A' ' 9' ' ' LYS . 28.7 t -46.24 139.7 4.52 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.04 0.447 . . . . 0.0 111.474 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.551 ' HA ' HD11 ' A' ' 128' ' ' ILE . 3.9 tt0 -82.64 -10.73 58.82 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.02 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 38.1 tp -90.25 -58.31 2.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.804 0.335 . . . . 0.0 111.034 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -84.1 -19.09 34.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.846 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.13 5.28 75.71 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.306 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.585 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 2.9 mmmm -85.74 165.49 16.88 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.837 HG12 ' HB3' ' A' ' 9' ' ' LYS . 15.4 m -107.2 136.43 42.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.823 0.344 . . . . 0.0 110.754 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.7 mt -69.99 137.91 51.8 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -140.05 149.95 43.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.836 0.35 . . . . 0.0 111.157 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.856 HD13 HG21 ' A' ' 72' ' ' THR . 1.1 mt . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.839 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.411 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.8 m -77.22 137.48 38.87 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.039 0.447 . . . . 0.0 111.171 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.3 mmtm -83.86 157.62 21.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.219 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.824 HG22 HG23 ' A' ' 19' ' ' ILE . 44.1 pt -115.95 145.68 21.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.889 0.376 . . . . 0.0 111.633 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.453 ' HA ' ' CD1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -155.4 -179.5 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.126 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.779 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.8 p -103.18 150.73 23.39 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.579 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 28.0 t-105 -155.47 170.59 21.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.657 0.265 . . . . 0.0 110.979 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -71.83 137.27 47.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.831 0.348 . . . . 0.0 110.763 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.008 -179.919 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.972 ' O ' HD12 ' A' ' 45' ' ' LEU . . . . . . . . 0 CA--C 1.527 0.091 0 CA-C-O 120.646 0.26 . . . . 0.0 111.308 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 65.8 t -51.26 -31.25 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.937 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -66.99 -10.62 51.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.696 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -116.09 7.41 14.23 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.972 HD12 ' O ' ' A' ' 41' ' ' ALA . 0.9 OUTLIER -117.66 141.29 48.56 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.713 -179.083 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.634 ' CZ2' HD11 ' A' ' 19' ' ' ILE . 24.4 m95 -133.27 167.69 19.91 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.041 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.518 ' CE1' ' HB2' ' A' ' 55' ' ' ARG . 37.6 p90 -140.56 165.03 28.55 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.106 178.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 46.0 p -105.6 132.63 51.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.828 0.346 . . . . 0.0 111.336 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -77.79 165.84 23.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.117 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.13 -25.49 67.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.234 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -90.86 -4.05 56.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.469 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.563 ' O ' HG22 ' A' ' 85' ' ' ILE . . . 97.96 11.87 48.28 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.845 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.451 HG13 ' HA ' ' A' ' 83' ' ' ALA . 30.9 t -100.7 121.44 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-O 120.744 0.307 . . . . 0.0 110.488 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.482 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -76.07 148.43 7.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.31 0.576 . . . . 0.0 111.889 -179.751 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.734 ' CD ' ' HB2' ' A' ' 62' ' ' ALA . 12.3 mmm-85 -149.23 133.74 17.61 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.408 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.506 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.455 0 CA-C-O 121.54 0.686 . . . . 0.0 111.893 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 . . . . . 0 C--O 1.233 0.22 0 CA-C-O 120.892 0.377 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.734 ' HB2' ' CD ' ' A' ' 55' ' ' ARG . . . -108.83 152.59 24.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.081 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.786 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -78.66 152.99 4.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.68 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.537 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 6.7 p-10 -134.2 133.42 40.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.277 0.56 . . . . 0.0 111.69 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.674 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -97.42 43.49 1.07 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.217 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.0 t -74.71 -43.98 52.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.087 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 65.8 m170 -97.2 172.47 7.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.925 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -48.32 -48.81 35.92 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.14 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -99.0 145.62 26.88 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.126 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.786 HG22 HG22 ' A' ' 63' ' ' ILE . 3.1 mm -73.93 138.54 20.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.552 0.692 . . . . 0.0 111.455 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.43 ' O ' HG22 ' A' ' 63' ' ' ILE . 1.3 pt-20 -139.2 167.75 21.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.799 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.856 HG21 HD13 ' A' ' 19' ' ' ILE . 57.0 p -106.77 139.41 41.24 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.052 0.453 . . . . 0.0 111.528 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.403 ' CB ' ' CD ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -159.46 175.07 3.44 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.993 179.643 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.403 ' CD ' ' CB ' ' A' ' 73' ' ' GLN . 17.3 Cg_exo -66.65 138.86 50.91 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.513 2.142 . . . . 0.0 111.583 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -62.29 128.82 37.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.814 0.34 . . . . 0.0 111.031 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.409 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 0.4 OUTLIER -122.18 125.85 26.46 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.674 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -56.92 -35.4 98.55 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.457 2.105 . . . . 0.0 112.794 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 21.3 m-20 -86.35 -2.73 58.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.777 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.41 ' CB ' ' HD2' ' A' ' 82' ' ' ARG . 8.7 t-20 -101.19 100.6 13.77 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-O 120.611 0.243 . . . . 0.0 110.786 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.555 ' O ' HD21 ' A' ' 94' ' ' LEU . 82.9 Cg_endo -76.66 21.16 0.58 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.638 2.225 . . . . 0.0 113.48 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.659 ' HD2' ' HB3' ' A' ' 65' ' ' ALA . 40.3 mmtt -120.94 -18.37 7.58 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 120.689 0.28 . . . . 0.0 111.134 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.495 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 40.3 mtt180 -88.09 21.42 2.76 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -178.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 1.003 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -130.25 99.84 5.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.203 0.525 . . . . 0.0 111.051 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.674 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 60.4 m95 -110.21 135.06 51.57 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.227 0.537 . . . . 0.0 111.914 -178.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.563 HG22 ' O ' ' A' ' 52' ' ' GLY . 2.4 pt -113.86 154.24 15.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.125 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.9 t -102.14 127.99 55.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.912 0.387 . . . . 0.0 111.115 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 46.6 t -121.07 95.1 4.56 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.553 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.28 -100.66 0.81 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.554 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.504 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.94 29.86 7.16 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.587 0.232 . . . . 0.0 110.735 -179.76 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -149.16 148.36 29.54 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 121.358 0.599 . . . . 0.0 112.348 -178.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.768 ' HB ' HD12 ' A' ' 101' ' ' LEU . 14.3 mm -94.32 121.08 44.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.629 178.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.833 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -120.84 143.0 49.12 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -178.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.438 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -67.31 146.05 54.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.699 179.763 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.003 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.6 pt? -61.05 -56.13 24.55 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.664 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.628 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 7.9 m -73.72 -6.68 48.36 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -178.364 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.533 ' O ' HG22 ' A' ' 99' ' ' ILE . 0.6 OUTLIER -139.75 89.65 2.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.881 0.372 . . . . 0.0 111.071 -179.777 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.26 -16.23 63.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.182 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.73 12.86 21.95 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.096 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.533 HG22 ' O ' ' A' ' 96' ' ' ASP . 6.8 tt -131.08 137.16 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.833 HG12 ' HB2' ' A' ' 92' ' ' ALA . 15.9 m -148.9 138.46 15.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.855 0.359 . . . . 0.0 111.637 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.768 HD12 ' HB ' ' A' ' 91' ' ' ILE . 10.5 mt -46.39 155.19 0.23 Allowed 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.593 0.711 . . . . 0.0 111.71 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.71 ' O ' HG22 ' A' ' 114' ' ' ILE . 35.6 t70 -157.49 166.71 32.23 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.588 -177.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.528 ' HA ' HG22 ' A' ' 114' ' ' ILE . 3.0 mp -92.8 118.33 38.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.461 179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.773 HG22 ' O ' ' A' ' 113' ' ' HIS . 8.5 tt -62.45 141.98 17.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.791 0.329 . . . . 0.0 111.164 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.425 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 10.5 tptt 82.43 -20.81 0.33 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.71 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.6 m 53.9 39.41 30.41 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.917 0.389 . . . . 0.0 111.013 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -113.36 167.01 10.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.029 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.75 -13.83 58.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.984 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -48.29 142.41 5.54 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.098 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.476 ' HB2' ' NZ ' ' A' ' 15' ' ' LYS . . . -90.1 158.16 17.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.2 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 76.35 12.84 83.91 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.543 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.5 132.9 39.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.878 0.37 . . . . 0.0 111.01 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.773 ' O ' HG22 ' A' ' 104' ' ' ILE . 12.9 m80 -65.52 173.33 2.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.029 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.71 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -137.36 161.5 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.513 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.598 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 7.2 t -152.52 166.14 32.93 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.638 ' HB2' ' HH2' ' A' ' 84' ' ' TRP . . . -92.91 121.54 34.37 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.005 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.471 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 76.2 t-105 -128.73 162.19 27.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.67 0.747 . . . . 0.0 112.241 -179.14 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.471 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.8 OUTLIER -64.8 123.38 19.22 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.7 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -58.48 123.29 15.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.045 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -134.2 4.44 3.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.493 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 79.39 56.56 3.37 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.286 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -109.28 147.47 16.91 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.519 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.74 -29.3 59.63 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.57 2.18 . . . . 0.0 112.083 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -76.91 -4.35 43.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.234 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.421 ' NE2' ' CG2' ' A' ' 100' ' ' VAL . 3.2 mt-30 -102.73 -7.14 21.92 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.463 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.44 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 8.6 mmtm -83.73 132.66 34.83 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.772 0.32 . . . . 0.0 111.295 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -131.11 153.64 49.14 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.344 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.813 HD12 ' CE ' ' A' ' 9' ' ' LYS . 1.4 mt -113.68 137.48 46.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.163 0.506 . . . . 0.0 110.644 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.575 HD12 HG23 ' A' ' 8' ' ' ILE . 20.8 mm -114.26 142.05 28.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.593 -179.031 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -137.02 110.41 7.91 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.285 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 44.1 m -60.02 114.41 2.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.322 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.23 -0.89 . . . . 0.0 111.494 179.714 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.49 ' HA ' ' O ' ' A' ' 46' ' ' TRP . 1.5 p90 . . . . . 0 C--O 1.231 0.117 0 N-CA-C 110.501 -0.185 . . . . 0.0 110.501 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.746 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -160.38 176.45 11.66 Favored 'General case' 0 CA--C 1.512 -0.512 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.774 179.919 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.449 ' CE1' ' HB3' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -114.86 123.78 50.04 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.297 179.228 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.623 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -104.14 109.89 28.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.23 179.904 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.29 136.85 45.28 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.273 -178.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.54 ' OG ' HD21 ' A' ' 17' ' ' LEU . 48.7 m -75.95 107.82 8.41 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 5.2 tt0 -63.19 -11.15 18.72 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.47 -178.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.568 HD22 ' HA ' ' A' ' 124' ' ' ASN . 56.3 tp -84.66 -62.49 1.53 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.848 0.356 . . . . 0.0 110.973 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.503 ' ND2' ' HA ' ' A' ' 108' ' ' LYS . 3.0 m120 -84.97 -12.94 52.19 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.69 2.57 76.45 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.214 -0.993 . . . . 0.0 111.513 -178.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.41 -178.64 5.65 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.601 HG21 ' HA ' ' A' ' 35' ' ' GLN . 7.9 m -120.37 140.34 44.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.673 0.273 . . . . 0.0 110.527 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.54 HD21 ' OG ' ' A' ' 10' ' ' SER . 10.6 mt -70.19 134.8 48.45 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -142.61 158.21 43.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.901 0.381 . . . . 0.0 111.204 -179.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.119 HD13 HG21 ' A' ' 72' ' ' THR . 31.3 mt . . . . . 0 C--N 1.327 -0.398 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.458 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 CA-C-O 120.154 -0.248 . . . . 0.0 113.604 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.85 136.25 43.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 117.316 0.558 . . . . 0.0 111.0 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.2 159.78 18.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.694 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.664 HG22 HG12 ' A' ' 19' ' ' ILE . 46.4 pt -120.33 148.03 23.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.821 0.343 . . . . 0.0 111.637 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.465 HG22 ' HA ' ' A' ' 113' ' ' HIS . 0.3 OUTLIER -156.26 -178.39 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.243 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.425 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.531 HG21 HD12 ' A' ' 103' ' ' ILE . 1.6 p -100.87 148.55 24.84 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.585 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 28.0 t-105 -158.42 172.63 17.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.689 0.28 . . . . 0.0 110.91 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -70.86 135.76 48.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.765 0.317 . . . . 0.0 110.708 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.601 ' HA ' HG21 ' A' ' 16' ' ' VAL . 5.7 tm0? . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.007 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.846 ' O ' HD12 ' A' ' 45' ' ' LEU . . . . . . . . 0 CA--C 1.527 0.084 0 CA-C-O 120.617 0.246 . . . . 0.0 111.412 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 49.4 t -50.08 -27.39 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.055 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -64.57 -10.27 25.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.718 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.449 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 1.6 mt-30 -118.92 7.76 11.55 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.846 HD12 ' O ' ' A' ' 41' ' ' ALA . 1.3 mp -117.65 140.7 49.3 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.8 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.719 ' CZ2' HD11 ' A' ' 19' ' ' ILE . 26.9 m95 -134.12 168.77 18.23 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.938 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.555 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 15.7 p90 -141.69 165.93 26.13 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.1 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 72.8 p -106.79 132.4 52.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.768 0.318 . . . . 0.0 111.313 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -77.63 165.62 24.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.09 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -58.69 -25.49 62.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.027 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -93.55 -3.52 52.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.324 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.34 6.8 55.1 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.874 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.3 t -90.43 117.65 34.13 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-O 120.771 0.319 . . . . 0.0 110.687 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.563 ' O ' ' HG3' ' A' ' 55' ' ' ARG . 0.6 OUTLIER -75.99 144.08 12.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.076 0.465 . . . . 0.0 111.049 179.596 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.563 ' HG3' ' O ' ' A' ' 54' ' ' ILE . 0.4 OUTLIER -149.75 133.54 16.89 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.88 179.222 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 72.7 m . . . . . 0 C--N 1.327 -0.392 0 CA-C-O 121.582 0.706 . . . . 0.0 112.127 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.414 ' CE2' ' HD3' ' A' ' 74' ' ' PRO . 1.5 m-85 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.863 0.363 . . . . 0.0 110.874 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -101.68 148.3 25.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.201 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.874 HG22 HG22 ' A' ' 70' ' ' ILE . 0.3 OUTLIER -77.99 152.45 5.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.684 179.786 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.634 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 6.6 p-10 -133.18 130.72 39.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.191 0.52 . . . . 0.0 111.682 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.675 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -95.07 42.05 1.09 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.418 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 60.4 p -74.62 -43.18 56.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.369 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 23.4 m80 -97.89 171.81 8.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.102 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -48.82 -44.01 38.88 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.916 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.06 144.49 31.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.641 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.874 HG22 HG22 ' A' ' 63' ' ' ILE . 1.7 mm -76.37 141.95 15.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.666 0.746 . . . . 0.0 111.8 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -139.26 166.59 24.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.863 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . 1.119 HG21 HD13 ' A' ' 19' ' ' ILE . 41.6 p -104.27 138.18 41.1 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.861 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.426 ' HG2' ' C ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -163.53 167.54 11.14 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.26 179.755 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.414 ' HD3' ' CE2' ' A' ' 61' ' ' PHE . 32.2 Cg_exo -57.88 137.33 80.46 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.415 2.077 . . . . 0.0 111.861 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.536 ' CE1' ' HB2' ' A' ' 83' ' ' ALA . 16.8 t80 -67.18 127.2 31.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.855 0.359 . . . . 0.0 110.886 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -117.48 139.55 26.3 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.48 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.4 -32.26 41.01 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.527 2.151 . . . . 0.0 112.905 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 32.3 m-20 -88.79 -1.59 58.16 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -107.11 101.12 36.4 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.571 0.224 . . . . 0.0 111.007 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.85 ' O ' HD21 ' A' ' 94' ' ' LEU . 5.6 Cg_exo -77.16 21.28 0.61 Allowed 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.869 2.379 . . . . 0.0 112.98 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.634 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -116.47 -21.92 8.98 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.94 -179.827 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.477 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 41.7 mtt180 -87.62 20.28 3.02 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.47 -179.016 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 1.071 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -130.01 99.33 5.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.074 0.464 . . . . 0.0 110.854 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.675 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 58.9 m95 -109.45 137.26 47.56 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.223 0.535 . . . . 0.0 111.89 -178.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.3 pt -115.1 153.63 16.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.237 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.9 t -100.21 125.39 53.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.905 0.383 . . . . 0.0 110.948 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 21.5 t -117.85 93.89 4.32 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.526 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.89 -100.57 0.78 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.601 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.499 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.55 29.36 7.48 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.568 0.223 . . . . 0.0 110.921 -179.549 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -148.76 148.55 30.11 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.314 0.578 . . . . 0.0 112.522 -178.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.639 ' HB ' HD12 ' A' ' 101' ' ' LEU . 17.6 mm -93.38 121.28 43.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.44 178.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.99 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -124.67 145.3 49.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.32 0.581 . . . . 0.0 112.557 -178.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.421 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -65.26 149.53 49.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.508 179.729 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.071 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.7 pt? -62.2 -56.88 14.27 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.717 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.575 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 35.7 m -79.65 -1.61 38.99 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.405 ' HB2' ' HB3' ' A' ' 93' ' ' GLN . 72.9 m-20 -138.5 85.9 2.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.875 0.369 . . . . 0.0 111.009 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.63 -18.32 65.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.072 178.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -91.51 8.73 35.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.445 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.822 ' CG2' ' HB1' ' A' ' 116' ' ' ALA . 12.7 mm -121.15 126.29 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.494 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.99 HG12 ' HB2' ' A' ' 92' ' ' ALA . 22.3 m -145.98 134.49 16.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.836 0.351 . . . . 0.0 111.892 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.639 HD12 ' HB ' ' A' ' 91' ' ' ILE . 16.2 mt -46.26 154.09 0.29 Allowed 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 121.755 0.788 . . . . 0.0 111.964 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.826 ' O ' HG22 ' A' ' 114' ' ' ILE . 25.6 t70 -156.85 167.41 30.56 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.293 -1.321 . . . . 0.0 110.752 -177.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.531 HD12 HG21 ' A' ' 32' ' ' THR . 34.0 mm -89.0 126.08 42.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.566 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.787 HG22 ' O ' ' A' ' 113' ' ' HIS . 1.2 tt -68.05 137.99 23.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.01 0.434 . . . . 0.0 111.558 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 29.7 mtpt 67.44 3.41 3.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.114 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 40.0 t 40.9 32.33 0.16 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.744 0.307 . . . . 0.0 111.454 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.49 ' O ' ' ND2' ' A' ' 13' ' ' ASN . 26.1 p30 -96.08 157.41 15.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.181 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.503 ' HA ' ' ND2' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -78.93 -14.97 58.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.199 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -51.1 123.07 8.62 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.847 0.356 . . . . 0.0 111.107 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.18 161.15 31.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.172 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 73.29 16.64 78.7 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.181 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.85 135.58 35.95 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 120.875 0.369 . . . . 0.0 111.056 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.787 ' O ' HG22 ' A' ' 104' ' ' ILE . 1.4 m80 -61.86 170.29 2.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.783 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.826 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.5 OUTLIER -143.22 161.8 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.872 -179.698 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.655 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 12.8 p -157.15 174.16 15.9 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.822 ' HB1' ' CG2' ' A' ' 99' ' ' ILE . . . -95.81 129.67 42.98 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 178.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.458 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 75.8 t-105 -136.05 162.38 33.04 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.602 0.715 . . . . 0.0 112.051 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.458 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.2 OUTLIER -60.36 119.74 8.54 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.689 179.928 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.414 ' HA ' ' NE2' ' A' ' 125' ' ' GLN . 12.2 tt0 -60.1 127.3 31.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.081 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -137.52 11.0 2.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.207 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 78.4 10.28 86.34 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.882 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.78 139.78 46.82 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.521 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.5 -28.92 57.14 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.495 2.13 . . . . 0.0 112.24 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.568 ' HA ' HD22 ' A' ' 12' ' ' LEU . 30.6 p-10 -74.55 -5.42 42.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.423 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.414 ' NE2' ' HA ' ' A' ' 119' ' ' GLN . 0.1 OUTLIER -106.57 16.36 24.69 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.096 -179.829 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.443 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 2.7 mmmt -105.91 132.95 51.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.743 0.306 . . . . 0.0 111.398 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.436 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 5.2 m-85 -136.12 155.1 50.67 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.417 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 mt -114.27 140.32 35.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.179 0.514 . . . . 0.0 110.67 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.543 HD12 HG23 ' A' ' 8' ' ' ILE . 20.1 mm -114.04 139.78 38.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.617 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.21 96.14 3.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.614 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.4 m -50.76 111.71 0.59 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.405 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.435 ' HB3' ' CD2' ' A' ' 5' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.918 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.461 ' HD2' HD22 ' A' ' 45' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.137 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.761 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -156.41 172.76 17.95 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.735 179.878 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.487 ' OH ' ' HB1' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -112.22 123.86 51.2 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.103 179.04 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.619 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -105.1 109.29 27.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.004 0.431 . . . . 0.0 110.693 -179.73 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 16' ' ' VAL . 0.1 OUTLIER -102.15 132.49 48.02 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.008 -179.065 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.1 p -74.16 107.29 6.25 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.415 ' HB3' ' O ' ' A' ' 126' ' ' LYS . 3.6 tt0 -63.8 -9.86 16.96 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.537 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.502 HD13 ' HA ' ' A' ' 124' ' ' ASN . 28.7 tp -83.44 -62.99 1.44 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.815 0.34 . . . . 0.0 110.752 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.555 HD21 HG21 ' A' ' 103' ' ' ILE . 5.0 m-80 -85.59 -7.87 58.61 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.79 6.65 67.75 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.071 -1.062 . . . . 0.0 111.558 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -94.11 -171.97 2.69 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 4.8 m -121.84 140.65 45.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.755 0.312 . . . . 0.0 110.528 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.1 mt -69.79 133.47 47.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.329 -0.396 . . . . 0.0 109.95 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -144.04 147.79 34.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.827 0.346 . . . . 0.0 111.144 -179.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.1 HD13 HG21 ' A' ' 72' ' ' THR . 22.3 mt . . . . . 0 C--N 1.327 -0.38 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.42 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.26 0 CA-C-O 120.214 -0.214 . . . . 0.0 113.439 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.2 t -73.17 139.29 46.23 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 117.22 0.51 . . . . 0.0 111.121 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.3 mptm? -90.65 158.49 16.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.487 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.704 HD11 ' HB ' ' A' ' 70' ' ' ILE . 36.8 pt -116.88 145.53 22.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.854 0.359 . . . . 0.0 111.708 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.46 ' HA ' ' CD1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -154.97 177.92 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.458 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.5 p -100.94 149.57 23.76 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.498 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 9.0 t-105 -155.47 170.66 21.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.745 0.307 . . . . 0.0 110.993 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.09 135.43 47.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.827 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.906 -179.969 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.981 ' O ' HD12 ' A' ' 45' ' ' LEU . . . . . . . . 0 CA--C 1.527 0.064 0 CA-C-O 120.621 0.248 . . . . 0.0 111.311 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 53.2 t -50.6 -31.9 9.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.915 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -65.19 -11.25 38.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.889 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.454 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 3.7 mt-30 -117.6 8.78 12.95 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.981 HD12 ' O ' ' A' ' 41' ' ' ALA . 0.9 OUTLIER -118.43 141.15 48.83 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.861 -179.143 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.746 ' CZ2' HD11 ' A' ' 19' ' ' ILE . 26.1 m95 -134.23 169.49 17.1 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.052 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.523 ' CZ ' ' HB2' ' A' ' 55' ' ' ARG . 28.3 p90 -141.45 164.47 30.15 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.143 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.493 HG22 HG23 ' A' ' 54' ' ' ILE . 0.7 OUTLIER -109.11 136.41 48.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.829 0.347 . . . . 0.0 111.397 -178.953 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -77.75 170.7 16.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.2 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -62.31 -22.48 66.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.089 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -98.77 -2.46 37.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.167 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.8 3.77 54.82 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.884 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.669 HG11 ' CD2' ' A' ' 75' ' ' PHE . 21.8 t -85.99 116.24 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 CA-C-N 116.977 0.389 . . . . 0.0 110.693 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.515 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -78.21 147.8 6.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.383 0.611 . . . . 0.0 112.034 -179.59 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.802 ' CD ' ' HB2' ' A' ' 62' ' ' ALA . 8.8 mmm-85 -150.62 133.67 16.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.152 178.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.487 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.413 0 CA-C-O 121.456 0.646 . . . . 0.0 112.055 -178.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 . . . . . 0 C--O 1.234 0.265 0 CA-C-O 120.909 0.385 . . . . 0.0 110.979 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.802 ' HB2' ' CD ' ' A' ' 55' ' ' ARG . . . -107.46 153.19 23.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.524 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.797 HG22 HG22 ' A' ' 70' ' ' ILE . 0.3 OUTLIER -78.85 152.05 5.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.778 179.667 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.568 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 4.1 p-10 -132.78 137.83 46.95 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.964 0.411 . . . . 0.0 111.368 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.635 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -104.06 42.37 1.19 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.429 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.37 -44.82 50.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.833 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 7.2 m80 -93.84 169.22 10.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.934 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -48.4 -46.0 36.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.956 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -99.73 142.74 30.82 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.138 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.797 HG22 HG22 ' A' ' 63' ' ' ILE . 3.5 mm -73.44 139.53 19.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-O 121.55 0.691 . . . . 0.0 111.382 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -140.56 169.35 17.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.944 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . 1.1 HG21 HD13 ' A' ' 19' ' ' ILE . 49.9 p -106.28 138.65 42.09 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.262 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.475 ' HG2' ' C ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -164.92 169.36 7.65 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.033 179.684 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -49.56 141.82 25.38 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.416 2.077 . . . . 0.0 112.08 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.669 ' CD2' HG11 ' A' ' 53' ' ' VAL . 53.1 t80 -47.94 -56.62 7.19 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.3 t70 61.29 118.15 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.67 0.272 . . . . 0.0 110.346 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.08 -27.32 25.06 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.488 2.125 . . . . 0.0 113.546 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -88.43 0.85 55.81 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.46 ' CB ' ' HD2' ' A' ' 82' ' ' ARG . 1.7 m-80 -105.96 103.76 46.04 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.586 0.232 . . . . 0.0 111.331 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.88 ' O ' HD21 ' A' ' 94' ' ' LEU . 5.6 Cg_exo -77.33 18.79 0.76 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.996 2.464 . . . . 0.0 113.105 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.568 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 8.2 mmtt -119.95 -18.27 8.23 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 120.648 0.261 . . . . 0.0 110.91 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.487 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 32.2 mtt180 -90.97 23.13 3.31 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.15 -179.081 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 1.149 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -131.23 99.8 4.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.983 0.421 . . . . 0.0 110.765 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.635 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 51.3 m95 -110.35 136.94 48.75 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.246 0.546 . . . . 0.0 112.106 -178.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.409 ' C ' HD12 ' A' ' 85' ' ' ILE . 2.7 pp -114.13 154.71 15.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.198 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.2 t -101.47 127.21 55.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.95 0.405 . . . . 0.0 111.105 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.3 t -119.51 94.38 4.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.347 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.19 -100.43 0.79 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.497 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.502 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.89 29.77 7.21 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.56 0.219 . . . . 0.0 110.871 -179.692 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.411 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -148.03 148.05 30.28 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.502 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.775 ' HB ' HD12 ' A' ' 101' ' ' LEU . 15.2 mm -93.69 120.09 42.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.131 -0.941 . . . . 0.0 109.336 178.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.919 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -121.94 143.73 49.29 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.432 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -67.28 147.34 53.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.732 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.149 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.6 pt? -60.97 -56.86 16.13 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.798 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.569 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 2.2 m -75.17 -4.63 39.92 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -139.6 87.61 2.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.789 0.328 . . . . 0.0 110.967 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 16.3 mmt85 -67.6 -17.42 64.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.117 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.41 ' O ' ' HA ' ' A' ' 118' ' ' LYS . 0.8 OUTLIER -94.05 11.78 28.61 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.486 179.165 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.848 ' CG2' ' HB1' ' A' ' 116' ' ' ALA . 10.2 mm -124.4 130.83 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.919 HG12 ' HB2' ' A' ' 92' ' ' ALA . 34.7 m -147.64 136.75 15.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.836 0.351 . . . . 0.0 111.91 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.775 HD12 ' HB ' ' A' ' 91' ' ' ILE . 11.2 mt -46.06 154.29 0.26 Allowed 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.693 0.758 . . . . 0.0 111.867 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.731 ' O ' HG22 ' A' ' 114' ' ' ILE . 10.3 t70 -159.59 168.57 25.78 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 114.375 -1.284 . . . . 0.0 110.666 -177.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.695 HD12 ' O ' ' A' ' 124' ' ' ASN . 4.4 mp -87.41 119.46 35.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.031 179.031 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.595 HG22 ' HG2' ' A' ' 105' ' ' LYS . 52.9 mt -70.24 137.51 23.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.913 0.387 . . . . 0.0 111.525 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.595 ' HG2' HG22 ' A' ' 104' ' ' ILE . 0.0 OUTLIER 67.0 10.77 7.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.714 179.763 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.3 m 45.69 -139.18 0.47 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.938 -0.119 . . . . 0.0 110.94 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 68.84 162.88 0.22 Allowed 'General case' 0 N--CA 1.46 0.067 0 CA-C-O 120.803 0.335 . . . . 0.0 110.878 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 4.3 tttp -89.32 -11.57 43.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.533 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -41.94 135.74 2.28 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.812 0.339 . . . . 0.0 111.62 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -88.46 161.31 17.1 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.303 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 71.94 17.2 76.83 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.027 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.79 135.08 35.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.801 0.334 . . . . 0.0 110.896 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 15.5 m170 -65.14 173.96 2.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.012 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.731 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -137.77 161.94 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.476 -179.917 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.599 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 4.9 t -152.77 167.3 29.48 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.848 ' HB1' ' CG2' ' A' ' 99' ' ' ILE . . . -94.93 126.08 40.03 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.145 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.458 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 75.8 t-105 -136.92 162.65 32.68 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.589 0.709 . . . . 0.0 112.304 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.458 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.1 OUTLIER -59.6 119.73 8.11 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.884 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -66.68 130.35 42.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.013 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -142.54 16.07 2.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.88 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 81.95 13.11 80.12 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.83 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.62 136.84 41.83 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.433 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.46 -31.79 70.29 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.465 2.11 . . . . 0.0 112.115 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.695 ' O ' HD12 ' A' ' 103' ' ' ILE . 22.7 p-10 -75.45 -4.21 38.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.323 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.411 ' O ' ' CG2' ' A' ' 90' ' ' THR . 0.0 OUTLIER -105.53 13.63 29.76 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.244 -179.812 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.415 ' O ' ' HB3' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -107.96 142.69 37.69 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.871 0.367 . . . . 0.0 111.373 -179.432 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.443 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 6.6 m-85 -140.84 156.45 46.13 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.118 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 mt -112.4 139.62 36.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.109 0.481 . . . . 0.0 110.75 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.495 ' CD1' HG23 ' A' ' 8' ' ' ILE . 24.4 mm -114.63 141.74 29.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.67 -179.14 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -139.17 94.37 2.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.7 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.8 m -54.29 107.09 0.24 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.227 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.888 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.421 ' HA ' ' O ' ' A' ' 46' ' ' TRP . 0.8 OUTLIER . . . . . 0 N--CA 1.461 0.081 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.739 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -157.5 174.49 15.3 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 120.49 -0.484 . . . . 0.0 111.648 179.634 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.495 ' OH ' ' HB1' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -113.13 123.76 51.01 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.132 179.17 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.621 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -105.53 109.78 28.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.891 0.377 . . . . 0.0 110.387 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.423 ' HA ' ' HA ' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -105.81 134.63 48.61 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.325 -178.709 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.6 p -75.74 106.29 7.23 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.433 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 4.3 tt0 -62.66 -10.68 13.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.539 -178.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.583 HD22 ' CB ' ' A' ' 124' ' ' ASN . 51.2 tp -82.79 -62.82 1.5 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.894 0.378 . . . . 0.0 110.856 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.549 HD21 HG21 ' A' ' 103' ' ' ILE . 6.4 m-20 -85.98 -9.78 56.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.319 -178.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.12 5.0 69.7 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.139 -1.029 . . . . 0.0 111.48 -178.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.592 ' HE2' ' HB2' ' A' ' 110' ' ' ALA . 8.4 mmtm -91.76 -177.98 4.91 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.585 HG11 ' HG3' ' A' ' 35' ' ' GLN . 10.8 m -120.85 141.39 41.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.703 0.287 . . . . 0.0 110.538 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.9 mt -69.33 134.26 48.87 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.038 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.461 ' HB2' ' HG3' ' A' ' 44' ' ' GLN . 9.7 t70 -146.62 153.74 40.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.864 0.364 . . . . 0.0 111.108 -179.051 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.569 HD12 HG21 ' A' ' 72' ' ' THR . 6.9 mm . . . . . 0 C--N 1.328 -0.35 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.446 0 N-CA-C 112.762 -0.135 . . . . 0.0 112.762 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.3 m -73.64 124.96 26.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.974 0.416 . . . . 0.0 111.105 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -75.08 161.45 29.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.045 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.546 HD11 ' HB ' ' A' ' 70' ' ' ILE . 41.6 pt -118.88 146.56 23.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.853 0.359 . . . . 0.0 111.928 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.459 ' HA ' ' CD1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -153.56 178.01 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.139 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.686 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.4 p -103.73 151.14 23.37 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.695 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 27.0 t-105 -154.86 169.64 23.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.735 0.303 . . . . 0.0 110.884 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.56 132.68 46.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.767 0.318 . . . . 0.0 110.666 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.585 ' HG3' HG11 ' A' ' 16' ' ' VAL . 9.4 tt0 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.217 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.988 ' O ' HD12 ' A' ' 45' ' ' LEU . . . . . . . . 0 N--CA 1.458 -0.053 0 CA-C-O 120.756 0.312 . . . . 0.0 110.975 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 50.0 t -51.21 -33.93 14.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.301 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -68.91 -7.86 38.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.6 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.461 ' HG3' ' HB2' ' A' ' 18' ' ' ASP . 1.8 mt-30 -114.5 6.27 15.82 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.988 HD12 ' O ' ' A' ' 41' ' ' ALA . 0.9 OUTLIER -118.67 142.34 47.76 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.157 -0.928 . . . . 0.0 111.567 -178.913 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.498 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 26.1 m95 -134.51 169.47 17.23 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.187 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.516 ' CE2' ' HB2' ' A' ' 55' ' ' ARG . 42.1 p90 -141.25 164.14 31.05 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.533 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.593 HG22 HG23 ' A' ' 54' ' ' ILE . 0.7 OUTLIER -108.58 135.18 50.26 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.784 0.326 . . . . 0.0 111.443 -178.876 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -78.19 170.93 15.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.144 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -66.33 -24.3 66.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.097 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.505 ' HG3' HG23 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -91.8 -4.09 55.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.253 179.846 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.38 9.78 49.8 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.875 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.505 HG23 ' HG3' ' A' ' 51' ' ' GLN . 40.1 t -97.48 119.73 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 CA-C-N 116.883 0.341 . . . . 0.0 110.512 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.593 HG23 HG22 ' A' ' 48' ' ' THR . 0.6 OUTLIER -78.77 150.86 5.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.495 0.664 . . . . 0.0 111.951 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.733 ' HD3' ' HB2' ' A' ' 62' ' ' ALA . 11.2 mmm-85 -147.36 132.94 18.76 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.628 178.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.498 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.591 0 CA-C-O 121.713 0.768 . . . . 0.0 111.981 -178.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.808 0.337 . . . . 0.0 110.838 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.733 ' HB2' ' HD3' ' A' ' 55' ' ' ARG . . . -98.29 150.71 21.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.938 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.863 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -80.82 150.89 4.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.273 179.476 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.58 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 8.6 p-10 -133.06 131.58 40.79 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.215 0.531 . . . . 0.0 111.603 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.631 ' HB2' ' CZ2' ' A' ' 84' ' ' TRP . . . -96.18 40.96 1.11 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.256 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 68.2 m -73.91 -43.41 58.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.342 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 65.0 m80 -97.59 172.56 7.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.11 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -48.04 -47.15 33.79 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.136 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -102.33 146.5 27.94 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.912 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.863 HG22 HG22 ' A' ' 63' ' ' ILE . 1.9 mm -78.1 144.15 11.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-O 121.614 0.721 . . . . 0.0 111.755 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -144.51 168.75 19.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.001 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.569 HG21 HD12 ' A' ' 19' ' ' ILE . 80.9 p -105.44 136.98 44.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.993 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.451 ' CB ' ' HD2' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -161.2 168.06 12.21 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.136 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.451 ' HD2' ' CB ' ' A' ' 73' ' ' GLN . 13.9 Cg_endo -57.37 134.49 64.08 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.404 2.07 . . . . 0.0 112.055 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.477 ' CE1' ' HB2' ' A' ' 83' ' ' ALA . 19.6 t80 -62.46 132.61 53.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.864 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -121.62 139.22 29.54 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.775 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.12 -34.05 17.63 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.515 2.143 . . . . 0.0 112.67 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -88.13 -0.72 57.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.653 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.442 ' HB3' ' HD2' ' A' ' 82' ' ' ARG . 1.7 m120 -109.31 100.02 39.23 Favored Pre-proline 0 C--O 1.232 0.175 0 CA-C-O 120.583 0.23 . . . . 0.0 111.029 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.849 ' O ' HD21 ' A' ' 94' ' ' LEU . 4.0 Cg_exo -76.44 25.48 0.43 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.923 2.415 . . . . 0.0 113.027 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.58 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 0.1 OUTLIER -118.71 -21.33 7.92 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 120.616 0.246 . . . . 0.0 111.19 -179.721 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.487 ' HG3' ' HB3' ' A' ' 64' ' ' ASP . 0.4 OUTLIER -88.56 18.94 4.18 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.064 -0.517 . . . . 0.0 112.365 -179.028 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 1.155 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -128.41 99.26 5.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.097 0.475 . . . . 0.0 110.775 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.631 ' CZ2' ' HB2' ' A' ' 65' ' ' ALA . 58.3 m95 -108.84 136.45 48.37 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.15 0.5 . . . . 0.0 111.907 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.9 pt -113.81 154.47 15.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.085 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.7 t -102.53 127.84 55.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.988 0.423 . . . . 0.0 111.111 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 30.5 t -120.88 95.14 4.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.35 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.2 -101.07 0.84 Allowed Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.477 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.498 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -121.02 30.15 7.0 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.496 0.189 . . . . 0.0 110.867 -179.802 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.421 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.34 147.49 30.38 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.597 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.709 ' HB ' HD12 ' A' ' 101' ' ' LEU . 19.1 mm -94.06 119.98 42.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.336 178.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.935 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -123.98 144.57 49.74 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.404 ' HB3' ' HB2' ' A' ' 96' ' ' ASP . 1.7 tt0 -63.86 149.53 46.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.661 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.155 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.6 pt? -62.33 -57.11 12.54 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.672 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.566 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 92.6 p -79.8 -2.64 44.19 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.404 ' HB2' ' HB3' ' A' ' 93' ' ' GLN . 49.0 m-20 -137.52 84.65 2.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.841 0.353 . . . . 0.0 111.004 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.6 mpp_? -66.34 -18.18 65.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.174 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.407 ' O ' ' HA ' ' A' ' 118' ' ' LYS . 0.4 OUTLIER -91.46 10.29 28.32 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.538 179.316 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.857 ' CG2' ' HB1' ' A' ' 116' ' ' ALA . 11.2 mm -124.36 129.39 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.466 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.935 HG12 ' HB2' ' A' ' 92' ' ' ALA . 30.8 m -146.68 136.01 16.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.709 HD12 ' HB ' ' A' ' 91' ' ' ILE . 12.7 mt -46.47 153.79 0.34 Allowed 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 121.753 0.787 . . . . 0.0 111.837 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.748 ' O ' HG22 ' A' ' 114' ' ' ILE . 9.9 t70 -158.36 168.02 28.11 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.587 -177.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.664 HD12 ' O ' ' A' ' 124' ' ' ASN . 4.4 mp -87.26 122.38 39.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.194 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.8 HG22 ' O ' ' A' ' 113' ' ' HIS . 3.1 tt -65.37 136.73 26.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.072 0.463 . . . . 0.0 111.482 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 70.63 1.22 3.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.997 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 51.4 p 43.68 31.39 0.45 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.761 0.315 . . . . 0.0 111.365 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -94.7 154.29 17.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.267 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.91 -14.14 58.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.156 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -49.03 118.51 2.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.265 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.592 ' HB2' ' HE2' ' A' ' 15' ' ' LYS . . . -62.1 157.93 17.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.054 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 73.25 15.67 78.79 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.214 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.94 132.86 39.28 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.834 0.349 . . . . 0.0 110.95 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.8 ' O ' HG22 ' A' ' 104' ' ' ILE . 17.1 m170 -65.58 172.02 3.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.925 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.748 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -136.42 161.63 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.517 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.597 ' HA ' HD11 ' A' ' 70' ' ' ILE . 95.7 m -153.77 168.96 24.56 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.857 ' HB1' ' CG2' ' A' ' 99' ' ' ILE . . . -95.7 126.62 41.1 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.467 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 76.1 t-105 -134.49 162.57 31.88 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.603 0.716 . . . . 0.0 112.129 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.467 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.1 OUTLIER -62.43 117.43 6.15 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.596 -1.183 . . . . 0.0 110.781 179.885 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -62.4 126.65 28.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.962 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -138.18 13.72 2.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.165 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 76.19 60.8 2.98 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.518 -0.848 . . . . 0.0 112.315 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -117.3 145.99 18.7 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.551 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.68 -32.39 75.36 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.403 2.069 . . . . 0.0 112.013 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.664 ' O ' HD12 ' A' ' 103' ' ' ILE . 30.3 p-10 -76.29 -2.69 32.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.586 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.421 ' O ' ' CG2' ' A' ' 90' ' ' THR . 0.9 OUTLIER -107.8 11.06 28.55 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.466 0.174 . . . . 0.0 111.172 180.0 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.433 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 1.7 mmmm -106.76 138.21 43.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.846 0.355 . . . . 0.0 111.529 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.413 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 7.0 m-85 -138.59 155.77 48.05 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.246 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.3 mt -113.36 138.64 42.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.149 0.5 . . . . 0.0 110.776 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.471 ' CD1' HG23 ' A' ' 8' ' ' ILE . 26.4 mm -113.86 139.71 38.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.524 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -139.5 94.68 2.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.655 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 18.6 p -51.34 110.73 0.47 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.327 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.614 ' HG3' HD21 ' A' ' 45' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.948 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.453 ' HA ' ' O ' ' A' ' 46' ' ' TRP . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.091 0 N-CA-C 110.476 -0.194 . . . . 0.0 110.476 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.758 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -158.84 173.95 15.74 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 120.469 -0.492 . . . . 0.0 111.496 179.883 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.836 ' OH ' ' HB1' ' A' ' 41' ' ' ALA . 0.4 OUTLIER -109.46 123.79 49.96 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.204 179.13 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.611 HG23 ' CD1' ' A' ' 129' ' ' ILE . 0.0 OUTLIER -109.02 104.56 17.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.939 -179.755 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.86 ' HE2' HD12 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -122.81 140.11 53.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.453 -179.751 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.41 ' O ' ' HD2' ' A' ' 9' ' ' LYS . 1.9 m -60.69 135.45 57.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.925 0.393 . . . . 0.0 110.744 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 4.2 tt0 -77.99 -11.84 59.94 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.961 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 41.1 tp -89.03 -58.64 2.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.793 0.33 . . . . 0.0 110.986 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.572 HD21 HG21 ' A' ' 103' ' ' ILE . 6.2 m-20 -84.94 -17.74 36.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.262 -0.426 . . . . 0.0 112.017 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.4 5.81 73.72 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.308 -0.949 . . . . 0.0 112.231 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.649 ' HE2' ' HB2' ' A' ' 110' ' ' ALA . 1.5 mmmt -86.29 165.64 16.28 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.765 HG12 ' HB3' ' A' ' 9' ' ' LYS . 9.5 m -106.5 137.15 38.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.822 0.344 . . . . 0.0 110.723 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.3 mt -69.13 137.58 53.52 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -143.7 151.19 39.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.018 0.437 . . . . 0.0 111.439 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.062 HD13 HG21 ' A' ' 72' ' ' THR . 23.1 mt . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.459 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 CA-C-O 120.293 -0.171 . . . . 0.0 113.239 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.7 t -77.2 132.54 38.8 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 117.093 0.446 . . . . 0.0 111.345 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.6 mmtt -81.46 160.53 23.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.645 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.572 HD13 HG21 ' A' ' 63' ' ' ILE . 47.3 pt -120.98 149.03 23.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.445 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.423 HG22 ' HA ' ' A' ' 113' ' ' HIS . 0.2 OUTLIER -155.73 -178.98 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.173 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.75 -179.812 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 p -101.36 149.19 24.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.419 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 19.5 t-105 -156.81 171.49 20.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.732 0.301 . . . . 0.0 110.989 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -71.33 138.54 49.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.705 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.529 ' HA ' HG21 ' A' ' 16' ' ' VAL . 4.6 tt0 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.284 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.844 ' O ' HD12 ' A' ' 45' ' ' LEU . . . . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.744 0.307 . . . . 0.0 110.951 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.5 t -50.33 -27.65 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.961 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -64.65 -10.56 27.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.619 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -118.56 7.79 11.87 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.135 0.493 . . . . 0.0 109.675 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.844 HD12 ' O ' ' A' ' 41' ' ' ALA . 1.3 mp -117.05 140.37 49.57 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.664 -179.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.661 ' CZ2' HD11 ' A' ' 19' ' ' ILE . 25.9 m95 -134.43 169.4 17.31 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.035 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.587 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 15.1 p90 -141.42 165.51 27.32 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.954 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.599 HG22 HG23 ' A' ' 54' ' ' ILE . 4.2 p -109.68 136.67 48.66 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.902 0.382 . . . . 0.0 111.475 -178.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.0 173.39 12.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.327 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -63.29 -21.24 66.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.12 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -101.36 -2.8 30.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.168 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.21 2.6 51.28 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.868 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.554 HG12 ' HD3' ' A' ' 55' ' ' ARG . 21.8 t -83.06 114.26 23.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.873 0.368 . . . . 0.0 110.82 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.599 HG23 HG22 ' A' ' 48' ' ' THR . 0.7 OUTLIER -76.78 146.72 8.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.253 0.549 . . . . 0.0 111.766 -179.795 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.659 ' HD2' ' HB2' ' A' ' 62' ' ' ALA . 2.7 mmm-85 -151.56 133.68 15.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.539 178.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 12.5 m . . . . . 0 C--N 1.326 -0.419 0 CA-C-O 121.271 0.558 . . . . 0.0 111.903 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.41 ' CE2' ' HD3' ' A' ' 74' ' ' PRO . 1.1 m-85 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.894 0.378 . . . . 0.0 110.759 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.659 ' HB2' ' HD2' ' A' ' 55' ' ' ARG . . . -105.73 150.03 25.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.081 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.824 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -78.64 153.76 4.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.92 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.564 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 5.1 p-10 -133.6 132.91 41.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.227 0.537 . . . . 0.0 111.569 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.668 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -96.73 41.78 1.1 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.197 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.4 m -74.53 -46.36 39.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.225 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -93.95 170.66 9.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.952 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -47.29 -48.06 25.04 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.944 0.402 . . . . 0.0 110.959 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -99.73 144.24 29.04 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.917 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.824 HG22 HG22 ' A' ' 63' ' ' ILE . 2.7 mm -71.05 136.13 26.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-O 121.527 0.679 . . . . 0.0 111.366 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -130.33 162.76 28.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.237 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . 1.062 HG21 HD13 ' A' ' 19' ' ' ILE . 18.0 p -105.5 138.71 41.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.549 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.82 159.16 19.3 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.668 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.423 ' O ' ' HD3' ' A' ' 82' ' ' ARG . 53.7 Cg_exo -52.03 143.29 41.27 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.429 2.086 . . . . 0.0 111.737 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.532 ' CE1' HG11 ' A' ' 53' ' ' VAL . 66.7 t80 -59.07 126.03 26.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.915 0.388 . . . . 0.0 111.354 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.422 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 8.1 t70 -119.54 130.32 24.9 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.166 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.6 -33.82 21.07 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.602 2.202 . . . . 0.0 113.47 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -85.71 0.25 53.29 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.422 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 3.2 m120 -106.49 104.33 50.13 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.563 0.221 . . . . 0.0 111.343 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.842 ' O ' HD21 ' A' ' 94' ' ' LEU . 5.6 Cg_exo -77.34 20.07 0.69 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.868 2.379 . . . . 0.0 112.697 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.579 ' HD2' ' HB3' ' A' ' 65' ' ' ALA . 24.6 mmtp -120.15 -18.34 8.09 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.038 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.525 ' HG2' ' HB3' ' A' ' 64' ' ' ASP . 6.4 mtt180 -88.66 18.73 4.42 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.943 -0.572 . . . . 0.0 112.187 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 1.132 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -127.79 99.27 5.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.131 0.491 . . . . 0.0 110.647 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.668 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 61.8 m95 -108.55 136.42 48.18 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.114 0.483 . . . . 0.0 111.859 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 pt -115.21 154.24 16.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.272 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.5 t -101.2 124.41 54.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.012 0.434 . . . . 0.0 110.987 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 23.1 t -116.8 94.43 4.6 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.437 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.66 -100.95 0.79 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.505 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.51 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.79 30.17 7.03 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.587 0.232 . . . . 0.0 110.915 -179.63 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.92 148.0 30.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.394 0.616 . . . . 0.0 112.537 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.751 ' HB ' HD12 ' A' ' 101' ' ' LEU . 13.6 mm -93.94 120.15 42.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.411 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.989 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -124.89 146.67 49.2 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -178.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.437 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -67.17 148.83 51.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.811 179.808 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.132 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.7 pt? -61.07 -56.54 19.75 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.719 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.578 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 57.9 m -80.17 -3.44 48.98 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.353 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -136.56 85.44 2.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.838 0.351 . . . . 0.0 111.075 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -66.83 -17.97 65.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.155 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -92.08 9.83 31.75 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.521 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.823 ' CG2' ' HB1' ' A' ' 116' ' ' ALA . 12.2 mm -123.14 127.4 74.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.531 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.989 HG12 ' HB2' ' A' ' 92' ' ' ALA . 23.5 m -146.17 135.04 16.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.86 0.362 . . . . 0.0 111.862 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.751 HD12 ' HB ' ' A' ' 91' ' ' ILE . 11.0 mt -46.72 154.37 0.32 Allowed 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.7 0.762 . . . . 0.0 112.008 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.804 ' O ' HG22 ' A' ' 114' ' ' ILE . 9.8 t70 -155.63 167.78 29.29 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.319 -1.31 . . . . 0.0 110.694 -177.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.572 HG21 HD21 ' A' ' 13' ' ' ASN . 3.7 mp -92.94 124.52 45.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.509 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.8 HG22 ' O ' ' A' ' 113' ' ' HIS . 0.9 OUTLIER -68.24 139.6 20.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.961 0.41 . . . . 0.0 111.324 -179.83 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.422 ' N ' HG13 ' A' ' 104' ' ' ILE . 0.0 OUTLIER 78.4 -9.8 1.45 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.851 179.745 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.4 m 47.13 34.94 3.19 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.806 0.336 . . . . 0.0 111.188 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -106.94 166.92 10.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.195 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.4 -14.39 58.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.037 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -50.47 135.84 21.73 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.202 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.649 ' HB2' ' HE2' ' A' ' 15' ' ' LYS . . . -88.97 162.3 16.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.095 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.01 16.45 79.51 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.233 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.43 137.87 33.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.897 0.379 . . . . 0.0 110.967 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.8 ' O ' HG22 ' A' ' 104' ' ' ILE . 3.1 m170 -61.9 167.98 3.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.847 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.804 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -138.74 161.01 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.582 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.672 ' HA ' HD11 ' A' ' 70' ' ' ILE . 25.7 p -156.75 170.68 21.88 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.823 ' HB1' ' CG2' ' A' ' 99' ' ' ILE . . . -95.49 127.01 41.18 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 178.252 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.456 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 70.7 t-105 -132.37 162.88 29.98 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.529 0.68 . . . . 0.0 112.282 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.456 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.5 OUTLIER -63.55 120.78 12.39 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.659 179.843 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -58.91 124.45 19.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.177 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -132.68 8.1 4.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.631 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 82.38 6.74 88.42 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.164 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -66.0 142.62 43.55 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.401 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -56.86 -25.15 60.16 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.457 2.105 . . . . 0.0 112.508 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 34.5 p-10 -70.46 -9.09 55.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.706 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -107.02 17.99 22.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.698 0.285 . . . . 0.0 111.014 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.427 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 4.5 mmtp -103.59 123.78 47.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.793 0.33 . . . . 0.0 111.157 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.431 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 4.3 m-85 -127.96 153.0 47.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.632 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.86 HD12 ' HE2' ' A' ' 9' ' ' LYS . 1.6 mt -115.61 139.47 41.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.452 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.611 ' CD1' HG23 ' A' ' 8' ' ' ILE . 32.3 mm -113.94 144.05 22.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.677 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -136.07 94.18 3.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.609 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.47 109.3 0.43 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.312 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.913 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.4 ' HA ' ' O ' ' A' ' 46' ' ' TRP . 97.9 m-85 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.726 0.298 . . . . 0.0 110.757 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.636 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -151.92 170.71 19.19 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 120.97 0.414 . . . . 0.0 111.213 178.982 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.432 ' O ' ' HA ' ' A' ' 129' ' ' ILE . 0.1 OUTLIER -111.45 123.82 50.99 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.143 179.173 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.616 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -107.12 106.36 20.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.245 179.879 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.424 ' HG3' ' O ' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -106.77 137.06 45.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.384 -178.7 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.9 108.67 10.11 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.421 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 3.1 tt0 -62.69 -10.53 12.92 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.483 -178.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.638 HD22 ' HA ' ' A' ' 124' ' ' ASN . 30.3 tp -83.36 -62.47 1.58 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.865 0.364 . . . . 0.0 111.039 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.506 ' ND2' ' O ' ' A' ' 107' ' ' ASP . 3.0 m120 -86.83 -10.65 52.98 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.1 5.03 69.7 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.086 -1.054 . . . . 0.0 111.398 -178.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.424 ' O ' ' HG3' ' A' ' 9' ' ' LYS . 1.7 mmmm -91.78 178.22 5.97 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.625 HG21 ' HA ' ' A' ' 35' ' ' GLN . 5.9 m -119.93 142.59 34.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.689 0.281 . . . . 0.0 110.507 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.3 mt -68.11 135.93 52.94 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.453 ' CB ' ' HG3' ' A' ' 44' ' ' GLN . 19.9 t0 -145.33 142.44 29.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.719 0.295 . . . . 0.0 111.114 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.737 HD12 HG21 ' A' ' 72' ' ' THR . 14.0 mm . . . . . 0 C--N 1.327 -0.402 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.394 0 N-CA-C 112.806 -0.118 . . . . 0.0 112.806 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.91 134.56 41.57 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.96 0.409 . . . . 0.0 111.213 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.417 ' HD3' ' HB3' ' A' ' 71' ' ' GLU . 45.9 mmtt -81.72 157.03 24.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.213 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.595 HD13 HG21 ' A' ' 63' ' ' ILE . 47.5 pt -116.63 145.96 21.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.906 -0.317 . . . . 0.0 111.483 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.447 HG22 ' HA ' ' A' ' 113' ' ' HIS . 0.2 OUTLIER -155.49 -178.85 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.196 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.982 -179.667 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.5 p -101.98 148.88 24.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.551 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 32.4 t-105 -159.13 173.28 16.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.686 0.279 . . . . 0.0 110.845 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -70.14 134.58 48.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.813 0.339 . . . . 0.0 110.757 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.625 ' HA ' HG21 ' A' ' 16' ' ' VAL . 20.4 tt0 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.01 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.52 ' O ' HD12 ' A' ' 45' ' ' LEU . . . . . . . . 0 C--O 1.23 0.056 0 N-CA-C 111.525 0.194 . . . . 0.0 111.525 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.488 ' HA ' ' CD1' ' A' ' 45' ' ' LEU . 2.2 t -58.95 -18.21 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-O 120.706 0.289 . . . . 0.0 110.596 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -61.84 -11.86 14.72 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.928 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.453 ' HG3' ' CB ' ' A' ' 18' ' ' ASP . 7.7 mp0 -111.56 7.76 20.72 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.636 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 1.4 mp -121.06 146.44 46.72 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.232 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.461 ' CH2' ' CG1' ' A' ' 63' ' ' ILE . 25.4 m95 -133.27 170.11 15.93 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.65 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.549 ' CE2' ' HB2' ' A' ' 55' ' ' ARG . 1.5 p90 -136.09 159.46 41.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.92 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.529 HG22 HG23 ' A' ' 54' ' ' ILE . 17.8 p -107.17 134.18 50.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.786 0.327 . . . . 0.0 111.303 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 53' ' ' VAL . 14.7 t70 -77.87 166.53 22.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.147 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -59.37 -22.69 61.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.164 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -97.4 -2.83 41.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.281 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.91 5.45 55.0 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.873 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.412 HG12 ' HD3' ' A' ' 55' ' ' ARG . 21.2 t -87.84 116.67 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-O 120.8 0.333 . . . . 0.0 110.635 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.529 HG23 HG22 ' A' ' 48' ' ' THR . 0.8 OUTLIER -78.55 150.49 5.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.326 0.584 . . . . 0.0 111.942 -179.758 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.549 ' HB2' ' CE2' ' A' ' 47' ' ' TYR . 2.9 mmm-85 -147.44 133.18 18.93 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.207 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.424 ' HB2' ' CE2' ' A' ' 46' ' ' TRP . 47.2 t . . . . . 0 C--N 1.325 -0.474 0 CA-C-O 121.307 0.575 . . . . 0.0 112.138 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.436 ' CE2' ' HD3' ' A' ' 74' ' ' PRO . 3.8 m-85 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 121.018 0.437 . . . . 0.0 110.597 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.417 ' HB2' ' CD ' ' A' ' 55' ' ' ARG . . . -98.46 150.06 22.04 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.894 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.836 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -77.92 150.8 5.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.214 179.713 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.583 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 7.8 p-10 -131.59 133.02 44.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.156 0.503 . . . . 0.0 111.558 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.638 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -99.65 41.44 1.16 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.178 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.4 m -73.49 -42.62 61.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.061 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -98.2 172.83 7.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.936 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -49.47 -47.82 48.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.181 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -99.74 144.33 28.94 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.141 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.836 HG22 HG22 ' A' ' 63' ' ' ILE . 2.3 mm -76.31 142.86 13.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 CA-C-O 121.541 0.686 . . . . 0.0 111.764 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.417 ' HB3' ' HD3' ' A' ' 29' ' ' LYS . 0.5 OUTLIER -141.8 168.41 19.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.196 -179.835 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.737 HG21 HD12 ' A' ' 19' ' ' ILE . 49.4 p -108.24 139.88 42.29 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.085 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.49 165.17 14.51 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.304 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.436 ' HD3' ' CE2' ' A' ' 61' ' ' PHE . 10.6 Cg_endo -53.6 139.37 66.81 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.533 2.155 . . . . 0.0 111.92 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -61.5 131.74 51.13 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.881 0.372 . . . . 0.0 111.232 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.405 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 0.3 OUTLIER -120.92 133.84 24.21 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.555 179.729 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -69.05 -34.48 16.86 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.451 2.101 . . . . 0.0 112.664 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -88.04 0.31 56.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.77 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.405 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 1.3 t-20 -105.71 102.21 37.04 Favored Pre-proline 0 C--O 1.233 0.2 0 CA-C-O 120.517 0.199 . . . . 0.0 111.051 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.852 ' O ' HD21 ' A' ' 94' ' ' LEU . 5.9 Cg_exo -77.62 22.05 0.61 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.921 2.414 . . . . 0.0 112.994 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.583 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 33.7 mmtt -119.93 -18.54 8.18 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 120.599 0.238 . . . . 0.0 111.139 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.527 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 3.1 mtm180 -89.63 18.84 5.06 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.357 -179.085 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 1.087 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -127.8 99.06 5.39 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.054 0.454 . . . . 0.0 110.802 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.638 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 58.0 m95 -108.77 135.53 49.84 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.192 0.52 . . . . 0.0 111.938 -178.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.3 pt -113.58 154.41 14.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.254 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.3 t -101.32 125.83 55.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.967 0.413 . . . . 0.0 111.045 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 47.0 t -118.44 93.68 4.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.456 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.9 -100.41 0.77 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.519 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.495 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.42 29.19 7.58 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.532 0.206 . . . . 0.0 111.017 -179.578 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.426 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.57 147.56 30.21 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.607 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.627 ' HB ' HD12 ' A' ' 101' ' ' LEU . 18.9 mm -93.76 120.47 43.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.127 178.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.967 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -123.87 145.31 49.19 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.423 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -66.22 148.45 51.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.648 179.786 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.087 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.6 pt? -60.77 -57.02 14.44 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.804 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.566 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 66.9 p -78.99 -3.7 46.33 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -137.09 86.59 2.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.877 0.37 . . . . 0.0 111.001 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.59 -18.68 65.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.082 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.402 ' O ' ' HA ' ' A' ' 118' ' ' LYS . 9.5 m-20 -91.96 9.87 31.28 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.459 179.231 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.817 ' CG2' ' HB1' ' A' ' 116' ' ' ALA . 13.3 mm -121.84 126.46 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.47 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.967 HG12 ' HB2' ' A' ' 92' ' ' ALA . 25.4 m -146.14 134.9 16.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.96 0.41 . . . . 0.0 111.973 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.627 HD12 ' HB ' ' A' ' 91' ' ' ILE . 13.6 mt -47.94 154.22 0.56 Allowed 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 121.782 0.801 . . . . 0.0 112.095 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.783 ' O ' HG22 ' A' ' 114' ' ' ILE . 9.9 t70 -156.2 167.02 31.74 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.271 -1.331 . . . . 0.0 110.78 -177.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.704 HD12 ' O ' ' A' ' 124' ' ' ASN . 4.4 mp -88.62 122.92 40.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.256 179.256 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.834 HG22 ' O ' ' A' ' 113' ' ' HIS . 2.8 tt -69.03 139.47 20.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.066 0.46 . . . . 0.0 111.675 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 75.61 -7.21 1.83 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.074 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.1 m 46.61 29.15 0.88 Allowed 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.766 0.317 . . . . 0.0 111.179 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.506 ' O ' ' ND2' ' A' ' 13' ' ' ASN . 0.6 OUTLIER -99.43 161.53 13.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.071 -179.816 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.489 ' HA ' ' ND2' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -78.64 -14.36 59.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.202 179.769 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -49.06 123.6 7.45 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.895 0.379 . . . . 0.0 111.252 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.59 162.17 29.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.103 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 70.63 18.96 76.13 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.0 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.37 136.41 35.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.903 0.382 . . . . 0.0 111.0 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.834 ' O ' HG22 ' A' ' 104' ' ' ILE . 1.2 m170 -63.61 171.39 2.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.751 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.783 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.7 OUTLIER -142.44 162.02 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.806 -179.681 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.652 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 5.0 p -155.51 172.02 18.95 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.817 ' HB1' ' CG2' ' A' ' 99' ' ' ILE . . . -96.02 126.99 41.64 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 178.279 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.458 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 69.8 t-105 -132.77 162.01 32.58 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.567 0.699 . . . . 0.0 112.158 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.458 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 2.4 tptt -61.21 121.14 11.79 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.637 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -62.0 125.28 23.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.896 0.379 . . . . 0.0 111.211 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -134.92 12.17 3.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.169 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 79.62 8.16 87.94 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.927 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -60.47 149.76 42.52 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.52 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.21 -25.2 57.8 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.639 2.226 . . . . 0.0 112.206 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.704 ' O ' HD12 ' A' ' 103' ' ' ILE . 13.3 p-10 -74.0 -5.16 39.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.426 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.426 ' O ' ' CG2' ' A' ' 90' ' ' THR . 83.8 mt-30 -108.14 18.69 20.85 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.615 0.245 . . . . 0.0 111.19 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.421 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 1.5 mmmt -104.74 127.69 52.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.798 0.332 . . . . 0.0 111.273 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.432 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 15.1 m-85 -134.04 154.38 51.19 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 120.939 0.4 . . . . 0.0 110.399 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.4 mt -113.56 138.98 41.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.456 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.513 ' CD1' HG23 ' A' ' 8' ' ' ILE . 36.2 mm -113.64 140.85 31.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.613 -179.135 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -138.45 112.15 8.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.512 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.82 109.07 3.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.047 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.905 179.958 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.458 ' HA ' ' O ' ' A' ' 46' ' ' TRP . 25.3 m-85 . . . . . 0 C--O 1.231 0.097 0 N-CA-C 110.516 -0.179 . . . . 0.0 110.516 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.722 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -159.46 176.34 12.21 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.793 179.764 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.839 ' CE2' HD21 ' A' ' 45' ' ' LEU . 21.5 m-85 -111.84 124.29 52.06 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.276 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.611 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -107.61 107.07 21.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.818 0.342 . . . . 0.0 110.275 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 15' ' ' LYS . 6.0 tttt -106.5 137.07 45.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.099 -0.501 . . . . 0.0 112.322 -178.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.0 m -75.94 109.83 9.89 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 178.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.411 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 3.8 tt0 -64.46 -11.38 32.95 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.492 -178.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.455 HD22 ' CB ' ' A' ' 124' ' ' ASN . 24.0 tp -84.34 -62.3 1.59 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.939 0.399 . . . . 0.0 111.034 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.513 ' ND2' ' HA ' ' A' ' 108' ' ' LYS . 3.4 m120 -85.28 -12.6 52.05 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.79 3.07 72.43 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.095 -1.05 . . . . 0.0 111.485 -178.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.432 ' HG2' ' HB2' ' A' ' 13' ' ' ASN . 1.7 mmtt -90.43 -179.2 5.54 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.541 HG21 ' HA ' ' A' ' 35' ' ' GLN . 4.3 m -121.93 142.44 38.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.728 0.299 . . . . 0.0 110.586 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.3 mt -67.23 135.08 52.87 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.44 ' O ' HD13 ' A' ' 31' ' ' ILE . 12.7 t70 -145.41 146.64 31.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.683 0.278 . . . . 0.0 111.13 -178.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.405 HD11 ' CZ2' ' A' ' 46' ' ' TRP . 3.0 mm . . . . . 0 C--N 1.33 -0.266 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 CA-C-O 120.367 -0.129 . . . . 0.0 112.99 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.3 m -76.67 126.59 31.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.901 0.381 . . . . 0.0 111.259 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -76.14 159.94 30.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.282 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.605 HD13 HG21 ' A' ' 63' ' ' ILE . 50.9 pt -119.96 147.4 23.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.892 0.377 . . . . 0.0 111.824 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.44 HD13 ' O ' ' A' ' 18' ' ' ASP . 0.2 OUTLIER -155.9 -177.81 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.163 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.495 -179.901 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 p -103.36 150.38 23.86 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.648 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 27.2 t-105 -156.53 170.74 21.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.668 0.27 . . . . 0.0 110.849 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -69.6 132.9 46.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.758 0.313 . . . . 0.0 110.665 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.541 ' HA ' HG21 ' A' ' 16' ' ' VAL . 4.5 pt20 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.16 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.985 ' O ' HD12 ' A' ' 45' ' ' LEU . . . . . . . . 0 N--CA 1.457 -0.088 0 CA-C-O 120.831 0.348 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 73.4 t -50.06 -35.12 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.965 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.438 ' HB3' ' OD1' ' A' ' 18' ' ' ASP . 17.8 t30 -69.13 -7.82 39.68 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.995 -179.301 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -118.01 7.75 12.34 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.985 HD12 ' O ' ' A' ' 41' ' ' ALA . 0.9 OUTLIER -117.68 140.72 49.27 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.312 -179.096 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.524 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 25.4 m95 -134.67 169.29 17.55 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.813 -178.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.498 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 6.3 p90 -137.86 161.18 37.3 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.296 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.61 HG22 ' CG2' ' A' ' 54' ' ' ILE . 65.1 p -107.58 136.32 47.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.729 0.299 . . . . 0.0 111.003 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.424 ' HB2' ' O ' ' A' ' 53' ' ' VAL . 25.4 t70 -77.77 166.59 22.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.938 0.399 . . . . 0.0 111.168 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -57.81 -20.93 39.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.189 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -102.79 -2.45 28.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.386 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.24 0.47 47.54 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.043 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.48 HG13 ' HA ' ' A' ' 83' ' ' ALA . 23.2 t -81.24 113.32 20.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.921 0.36 . . . . 0.0 110.58 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.61 ' CG2' HG22 ' A' ' 48' ' ' THR . 0.6 OUTLIER -79.59 150.33 5.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.439 0.638 . . . . 0.0 112.089 -179.602 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.851 ' CD ' ' HB2' ' A' ' 62' ' ' ALA . 9.0 mmm-85 -151.02 132.59 14.79 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.834 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.524 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 66.2 p . . . . . 0 CA--C 1.509 -0.63 0 CA-C-O 121.648 0.737 . . . . 0.0 111.384 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.441 ' CE2' ' HD3' ' A' ' 74' ' ' PRO . 3.7 m-85 . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.808 0.337 . . . . 0.0 111.054 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.851 ' HB2' ' CD ' ' A' ' 55' ' ' ARG . . . -103.61 150.85 23.58 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.21 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.954 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -80.49 152.04 4.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.178 179.499 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.558 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 6.9 p-10 -133.36 135.72 44.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.17 0.51 . . . . 0.0 111.653 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.653 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -98.13 44.08 1.05 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.205 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 94.2 p -74.12 -43.64 56.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.462 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -100.89 176.06 5.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.084 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -49.03 -44.71 41.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.823 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.74 148.87 26.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.602 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.954 HG22 HG22 ' A' ' 63' ' ' ILE . 1.3 mm -77.93 140.84 16.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 CA-C-O 121.651 0.738 . . . . 0.0 111.612 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -133.31 159.84 39.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.766 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 39.2 p -102.29 137.53 40.43 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.34 179.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.496 ' CB ' ' HD2' ' A' ' 74' ' ' PRO . 0.3 OUTLIER -164.47 170.95 6.12 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.253 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.496 ' HD2' ' CB ' ' A' ' 73' ' ' GLN . 20.0 Cg_endo -60.45 133.35 48.48 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.19 1.927 . . . . 0.0 111.815 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.416 ' CE1' ' HB2' ' A' ' 83' ' ' ALA . 28.8 t80 -57.63 135.71 56.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.953 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.08 122.96 26.82 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.787 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -56.39 -34.58 94.72 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.467 2.111 . . . . 0.0 112.698 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -87.94 -0.67 57.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.761 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.402 ' HB3' ' HD2' ' A' ' 82' ' ' ARG . 3.0 m120 -108.74 100.31 38.46 Favored Pre-proline 0 C--O 1.232 0.183 0 CA-C-O 120.603 0.24 . . . . 0.0 110.922 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.85 ' O ' HD21 ' A' ' 94' ' ' LEU . 3.8 Cg_exo -76.47 25.37 0.44 Allowed 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.91 2.407 . . . . 0.0 113.236 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.561 ' HD2' ' HB3' ' A' ' 65' ' ' ALA . 21.0 mmtp -120.01 -19.91 7.66 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 120.581 0.229 . . . . 0.0 111.066 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.469 ' HG3' ' HB3' ' A' ' 64' ' ' ASP . 0.2 OUTLIER -88.89 18.75 4.55 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.162 -179.304 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 1.127 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -127.56 99.16 5.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.13 0.491 . . . . 0.0 110.738 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.695 ' HH2' ' HB2' ' A' ' 116' ' ' ALA . 58.8 m95 -108.48 135.39 49.84 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.138 0.494 . . . . 0.0 111.734 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 pt -113.55 155.27 14.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.257 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.7 t -103.38 129.06 55.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.965 0.412 . . . . 0.0 111.139 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 40.3 t -121.74 95.72 4.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.308 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.13 -101.14 0.85 Allowed Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.274 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.5 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.85 30.41 6.9 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.573 0.225 . . . . 0.0 110.811 -179.797 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.405 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.66 147.44 29.99 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.621 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.461 ' HB ' HD12 ' A' ' 101' ' ' LEU . 18.4 mm -94.38 120.24 43.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.385 178.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.901 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -123.66 145.34 49.03 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -178.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.588 ' NE2' ' CZ2' ' A' ' 84' ' ' TRP . 0.8 OUTLIER -65.65 148.38 51.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.513 179.646 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.127 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.6 pt? -62.19 -56.77 15.42 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.836 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.563 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 20.6 p -77.91 -4.13 45.22 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -178.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.568 ' O ' HG22 ' A' ' 99' ' ' ILE . 2.1 m-20 -138.05 87.0 2.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.777 0.322 . . . . 0.0 110.863 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.11 -16.16 63.07 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.204 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -90.35 11.83 20.2 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.182 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.568 HG22 ' O ' ' A' ' 96' ' ' ASP . 6.3 tt -130.94 137.92 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.061 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.901 HG12 ' HB2' ' A' ' 92' ' ' ALA . 23.9 m -148.86 137.12 14.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.763 0.316 . . . . 0.0 111.729 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.557 ' HA ' ' O ' ' A' ' 115' ' ' CYS . 24.8 mt -45.53 153.4 0.25 Allowed 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.705 0.764 . . . . 0.0 111.788 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.437 ' O ' HG22 ' A' ' 114' ' ' ILE . 10.0 t70 -158.46 168.4 27.06 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.381 -1.282 . . . . 0.0 110.763 -177.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.544 HD12 ' O ' ' A' ' 124' ' ' ASN . 4.5 mp -90.48 123.55 42.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.452 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.85 HG22 ' O ' ' A' ' 113' ' ' HIS . 6.2 tp -67.9 140.73 18.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.938 0.399 . . . . 0.0 111.332 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 76.56 -5.83 2.11 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.945 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.7 t 46.36 29.69 0.91 Allowed 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.77 0.319 . . . . 0.0 111.194 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.5 ' O ' ' ND2' ' A' ' 13' ' ' ASN . 5.6 m-20 -100.79 161.75 13.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.105 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.513 ' HA ' ' ND2' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -80.9 -13.98 58.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.141 179.838 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -48.6 123.43 6.74 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.237 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.88 160.27 32.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.063 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 72.56 16.32 77.63 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.092 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -79.26 135.09 36.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.816 0.341 . . . . 0.0 110.886 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.85 ' O ' HG22 ' A' ' 104' ' ' ILE . 18.8 m170 -61.83 166.6 4.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.911 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.454 HG22 ' HA ' ' A' ' 103' ' ' ILE . 0.0 OUTLIER -136.35 160.44 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.476 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.735 ' HA ' HD11 ' A' ' 70' ' ' ILE . 26.2 p -157.8 172.29 18.74 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.695 ' HB2' ' HH2' ' A' ' 84' ' ' TRP . . . -95.51 127.67 41.74 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.625 -0.43 . . . . 0.0 109.922 178.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.461 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 75.7 t-105 -133.23 163.04 30.19 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.578 0.704 . . . . 0.0 111.97 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.461 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.0 OUTLIER -64.23 123.11 18.26 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.727 179.93 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.93 121.83 9.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.157 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.429 ' CE1' ' HA3' ' A' ' 122' ' ' GLY . 6.9 p80 -126.59 3.01 6.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.434 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 80.82 5.92 89.74 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.973 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.429 ' HA3' ' CE1' ' A' ' 120' ' ' HIS . . . -64.8 154.0 49.5 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.575 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.9 -23.58 54.58 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.616 2.211 . . . . 0.0 112.348 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.544 ' O ' HD12 ' A' ' 103' ' ' ILE . 27.1 p-10 -76.76 -2.17 31.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.56 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.405 ' O ' ' CG2' ' A' ' 90' ' ' THR . 0.0 OUTLIER -108.97 9.6 26.47 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.219 -179.961 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.411 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 19.9 mmmt -103.38 136.92 42.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.773 0.32 . . . . 0.0 111.249 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.42 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 6.6 m-85 -137.57 155.61 49.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.45 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.3 mt -113.47 138.89 41.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.098 0.475 . . . . 0.0 110.559 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.477 HD12 HG23 ' A' ' 8' ' ' ILE . 27.1 mm -114.17 141.34 30.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.661 -179.156 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -138.95 94.64 2.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.611 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.75 113.41 0.9 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.422 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.964 179.989 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.433 ' CD2' ' HB3' ' A' ' 132' ' ' GLU . 1.4 p90 . . . . . 0 C--O 1.231 0.115 0 N-CA-C 110.422 -0.214 . . . . 0.0 110.422 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.703 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -156.89 175.26 14.31 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 120.481 -0.487 . . . . 0.0 111.731 179.806 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.59 ' CZ ' HD11 ' A' ' 45' ' ' LEU . 9.9 m-85 -109.33 124.58 51.18 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.157 179.351 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.607 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -108.51 106.24 20.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.871 0.367 . . . . 0.0 110.296 179.735 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -105.76 134.6 48.63 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -178.566 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 57.9 p -75.78 106.55 7.42 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.201 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.404 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 3.6 tt0 -63.4 -10.54 17.43 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.591 -178.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.427 HD22 ' CB ' ' A' ' 124' ' ' ASN . 33.1 tp -83.5 -62.91 1.46 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.924 0.392 . . . . 0.0 110.794 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.525 HD21 HG21 ' A' ' 103' ' ' ILE . 4.9 m-20 -84.23 -10.27 57.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.313 -178.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.45 3.75 67.33 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.129 -1.034 . . . . 0.0 111.382 -178.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.1 mmmt -92.66 -176.59 4.31 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.659 HG21 ' HA ' ' A' ' 35' ' ' GLN . 7.5 m -121.78 142.44 38.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.708 0.29 . . . . 0.0 110.58 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.7 mt -70.05 134.63 48.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.014 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.405 ' HB2' ' HG3' ' A' ' 44' ' ' GLN . 9.5 t0 -146.71 150.36 35.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.707 0.289 . . . . 0.0 111.033 -179.031 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.518 HD12 HG21 ' A' ' 72' ' ' THR . 2.7 mm . . . . . 0 C--N 1.328 -0.351 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.412 0 CA-C-O 120.349 -0.14 . . . . 0.0 113.188 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.52 127.51 32.76 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 117.027 0.414 . . . . 0.0 111.037 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -78.75 159.83 27.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.189 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.654 HD11 ' HB ' ' A' ' 70' ' ' ILE . 42.6 pt -117.89 146.29 22.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.771 0.32 . . . . 0.0 111.783 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.453 ' HA ' ' CD1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -154.44 178.01 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.17 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.78 -179.806 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.2 p -101.13 148.69 24.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.623 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 34.9 t-105 -158.23 172.9 17.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.708 0.289 . . . . 0.0 110.918 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -69.01 132.93 47.44 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.758 0.313 . . . . 0.0 110.738 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.659 ' HA ' HG21 ' A' ' 16' ' ' VAL . 2.4 pt20 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.019 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.994 ' O ' HD12 ' A' ' 45' ' ' LEU . . . . . . . . 0 CA--C 1.529 0.164 0 N-CA-C 111.619 0.229 . . . . 0.0 111.619 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 59.4 t -50.92 -33.57 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.116 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.406 ' OD1' ' HB ' ' A' ' 19' ' ' ILE . 0.6 OUTLIER -69.73 -7.51 40.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.76 -179.649 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.405 ' HG3' ' HB2' ' A' ' 18' ' ' ASP . 2.6 mt-30 -115.79 6.26 14.32 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.994 HD12 ' O ' ' A' ' 41' ' ' ALA . 0.9 OUTLIER -117.8 142.22 47.54 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.216 -179.273 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.478 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 26.3 m95 -133.74 168.71 18.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.541 -179.109 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.526 ' CZ ' ' HB2' ' A' ' 55' ' ' ARG . 43.1 p90 -141.32 164.16 31.01 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.382 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.671 HG22 ' CG2' ' A' ' 54' ' ' ILE . 67.5 p -109.19 135.37 50.42 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.783 0.325 . . . . 0.0 111.539 -178.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -78.36 170.88 15.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.12 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.34 -25.15 65.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.999 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -89.3 -5.02 57.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.201 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.24 11.74 44.45 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.837 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.658 HG13 ' HA ' ' A' ' 83' ' ' ALA . 37.2 t -100.68 120.43 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-O 120.779 0.323 . . . . 0.0 110.489 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.671 ' CG2' HG22 ' A' ' 48' ' ' THR . 0.6 OUTLIER -78.78 149.75 5.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.541 0.686 . . . . 0.0 111.883 -179.806 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.657 ' HD3' ' HB2' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -147.0 132.53 18.71 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.647 178.612 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.478 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.492 0 CA-C-O 121.569 0.699 . . . . 0.0 111.857 -178.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.409 ' CE2' ' HG3' ' A' ' 74' ' ' PRO . 32.7 m-85 . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.96 0.41 . . . . 0.0 110.858 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.657 ' HB2' ' HD3' ' A' ' 55' ' ' ARG . . . -104.4 154.16 20.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.397 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.858 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -79.86 150.37 5.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.59 179.665 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.573 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 6.3 p-10 -132.6 134.75 45.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.138 0.494 . . . . 0.0 111.501 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.673 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -99.06 43.29 1.06 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.334 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.1 m -74.06 -43.07 59.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.142 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 57.2 m80 -98.78 173.1 7.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.931 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -49.32 -46.96 47.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.983 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -99.69 145.03 28.09 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.936 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.858 HG22 HG22 ' A' ' 63' ' ' ILE . 2.4 mm -76.8 142.38 14.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-O 121.591 0.71 . . . . 0.0 111.511 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -140.31 168.61 19.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.062 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.518 HG21 HD12 ' A' ' 19' ' ' ILE . 58.8 p -106.87 138.51 42.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.97 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.48 161.11 17.9 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.329 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.409 ' HG3' ' CE2' ' A' ' 61' ' ' PHE . 57.3 Cg_exo -51.44 139.19 46.58 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.449 2.099 . . . . 0.0 112.074 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.576 ' HE1' ' HB2' ' A' ' 83' ' ' ALA . 90.6 t80 -62.94 127.8 32.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.129 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.412 ' HB2' ' HD3' ' A' ' 82' ' ' ARG . 0.1 OUTLIER -117.56 136.32 23.54 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.597 179.68 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -68.96 -34.81 16.5 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.56 2.173 . . . . 0.0 112.93 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -87.34 0.15 55.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.8 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.409 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 0.7 OUTLIER -108.53 101.03 41.26 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 120.588 0.232 . . . . 0.0 111.147 -179.818 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.854 ' O ' HD21 ' A' ' 94' ' ' LEU . 4.8 Cg_exo -77.09 24.7 0.48 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.989 2.459 . . . . 0.0 113.043 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.573 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 21.0 mmtp -120.26 -19.72 7.57 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 120.568 0.223 . . . . 0.0 111.101 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.481 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 0.4 OUTLIER -88.72 17.07 5.85 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.09 -0.505 . . . . 0.0 112.285 -179.208 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 1.091 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -126.61 98.85 5.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.081 0.467 . . . . 0.0 110.823 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.673 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 56.2 m95 -107.94 136.05 48.29 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.157 0.503 . . . . 0.0 111.81 -178.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.5 pt -111.25 153.5 13.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.197 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.2 t -102.28 127.69 55.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.008 0.432 . . . . 0.0 111.042 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.4 t -120.59 94.75 4.46 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.448 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.99 -100.13 0.75 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.531 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.499 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.85 29.74 7.23 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.52 0.2 . . . . 0.0 110.868 -179.676 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.425 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -148.14 147.77 29.84 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.577 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.813 ' HB ' HD12 ' A' ' 101' ' ' LEU . 11.9 mm -94.13 120.34 43.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.047 -0.978 . . . . 0.0 109.351 178.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.875 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -122.26 144.01 49.25 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -178.48 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.415 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -64.61 148.91 49.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.527 179.834 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.091 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.6 pt? -64.34 -57.23 9.96 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.688 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.561 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 13.5 t -74.22 -4.1 33.9 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -178.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.555 ' O ' HG22 ' A' ' 99' ' ' ILE . 56.7 m-20 -143.46 92.22 2.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.919 0.39 . . . . 0.0 111.025 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -72.89 -14.32 61.46 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.287 179.127 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -90.25 11.19 21.91 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.297 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.555 HG22 ' O ' ' A' ' 96' ' ' ASP . 9.0 tt -130.64 138.27 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.875 HG12 ' HB2' ' A' ' 92' ' ' ALA . 26.7 m -148.99 138.15 15.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.837 0.351 . . . . 0.0 111.907 -179.321 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.813 HD12 ' HB ' ' A' ' 91' ' ' ILE . 11.1 mt -45.53 153.3 0.26 Allowed 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 121.754 0.788 . . . . 0.0 111.772 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.713 ' O ' HG22 ' A' ' 114' ' ' ILE . 9.8 t70 -158.63 168.24 27.42 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.833 -177.442 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.664 HD12 ' O ' ' A' ' 124' ' ' ASN . 4.4 mp -88.0 122.96 40.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.204 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.826 HG22 ' O ' ' A' ' 113' ' ' HIS . 7.8 tp -66.63 138.27 23.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.057 0.456 . . . . 0.0 111.476 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.4 1.06 3.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.983 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.4 t 44.17 30.88 0.48 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.781 0.324 . . . . 0.0 111.344 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.7 p30 -96.67 155.79 16.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.152 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -82.24 -17.17 46.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.106 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -45.28 116.12 1.06 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.279 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.4 156.74 9.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.247 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.63 14.47 81.2 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.312 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.88 131.81 39.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.902 0.382 . . . . 0.0 110.985 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.826 ' O ' HG22 ' A' ' 104' ' ' ILE . 0.8 OUTLIER -64.87 171.25 3.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.014 -179.814 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.713 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -136.38 161.75 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.445 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.605 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 26.5 p -153.51 168.45 26.11 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.663 ' HB2' ' HH2' ' A' ' 84' ' ' TRP . . . -95.06 126.71 40.59 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 178.041 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.468 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 76.5 t-105 -134.71 162.49 32.2 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.63 0.729 . . . . 0.0 112.196 -179.226 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.468 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.9 OUTLIER -62.53 120.87 11.96 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.646 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -58.55 125.5 23.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.089 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 20.9 p-80 -132.97 8.51 4.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.357 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 81.82 7.17 88.34 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.086 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.73 152.15 48.44 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.58 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.59 -26.35 54.14 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.604 2.203 . . . . 0.0 112.33 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.664 ' O ' HD12 ' A' ' 103' ' ' ILE . 30.6 p-10 -75.05 -4.11 36.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.506 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.425 ' O ' ' CG2' ' A' ' 90' ' ' THR . 0.0 OUTLIER -107.5 14.38 25.89 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.183 -179.811 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.404 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 2.3 mmmm -107.08 136.92 46.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.793 0.33 . . . . 0.0 111.472 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.435 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 6.1 m-85 -138.2 155.23 48.88 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.21 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.3 mt -112.03 138.43 40.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.091 0.472 . . . . 0.0 110.392 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 27.9 mm -112.99 140.19 34.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.563 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.7 112.02 8.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.457 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 5.7 t -66.4 109.95 2.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.13 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.477 ' HG3' HD21 ' A' ' 45' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.188 -0.911 . . . . 0.0 110.898 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.436 ' HA ' ' O ' ' A' ' 46' ' ' TRP . 1.4 p90 . . . . . 0 N--CA 1.462 0.16 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.691 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -159.01 175.61 13.32 Favored 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.94 179.889 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.582 ' CZ ' HD11 ' A' ' 45' ' ' LEU . 4.7 m-85 -110.6 124.01 51.06 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.055 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.768 HG13 HD11 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -106.5 106.87 21.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.844 0.354 . . . . 0.0 110.436 179.824 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 15' ' ' LYS . 8.7 tttt -107.85 138.54 43.91 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.305 -178.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.91 109.2 10.53 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -64.01 -10.95 24.7 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.579 -178.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.618 HD22 ' HA ' ' A' ' 124' ' ' ASN . 56.8 tp -84.26 -62.48 1.55 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.88 0.371 . . . . 0.0 111.026 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.533 ' ND2' ' HA ' ' A' ' 108' ' ' LYS . 2.8 m120 -85.43 -12.93 50.79 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.583 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 77.17 0.84 72.18 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.103 -1.046 . . . . 0.0 111.413 -177.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.421 ' HG2' ' HB2' ' A' ' 13' ' ' ASN . 0.5 OUTLIER -89.01 179.74 6.1 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.503 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.418 HG11 ' HG2' ' A' ' 35' ' ' GLN . 4.2 m -121.36 141.46 41.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.768 HD11 HG13 ' A' ' 8' ' ' ILE . 0.4 OUTLIER -73.49 137.61 44.57 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.123 179.475 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -142.6 153.09 43.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.873 0.368 . . . . 0.0 111.127 -179.078 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.051 HD13 HG21 ' A' ' 72' ' ' THR . 25.3 mt . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.662 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.387 0 CA-C-O 120.249 -0.195 . . . . 0.0 113.108 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.11 137.04 50.8 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 117.122 0.461 . . . . 0.0 110.918 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.3 mmtp -88.32 157.6 18.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.606 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.668 HD11 ' HB ' ' A' ' 70' ' ' ILE . 44.2 pt -117.96 146.77 22.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.348 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.444 HG22 ' HA ' ' A' ' 113' ' ' HIS . 0.2 OUTLIER -155.19 179.73 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.182 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.885 -179.737 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.1 p -101.6 149.0 24.56 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.48 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 35.4 t-105 -157.81 172.21 18.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.711 0.291 . . . . 0.0 110.965 -179.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -72.48 139.08 47.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.81 0.338 . . . . 0.0 110.805 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.418 ' HG2' HG11 ' A' ' 16' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.939 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.882 ' O ' HD12 ' A' ' 45' ' ' LEU . . . . . . . . 0 CA--C 1.528 0.121 0 CA-C-O 120.657 0.265 . . . . 0.0 111.037 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 48.5 t -50.29 -27.48 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.065 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -66.83 -9.45 37.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.582 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -118.46 5.89 11.76 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.882 HD12 ' O ' ' A' ' 41' ' ' ALA . 1.3 mp -116.98 141.44 48.23 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.531 -179.347 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.57 ' CZ2' HD11 ' A' ' 19' ' ' ILE . 26.1 m95 -134.18 169.01 17.81 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.249 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.55 ' CZ ' ' HB2' ' A' ' 55' ' ' ARG . 11.3 p90 -141.98 166.22 25.31 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.981 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.405 HG22 ' CG2' ' A' ' 54' ' ' ILE . 39.7 p -108.38 133.87 51.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.882 0.372 . . . . 0.0 111.559 -178.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 53' ' ' VAL . 42.9 t0 -77.96 167.78 20.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.026 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -60.9 -24.85 66.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.138 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.2 tp60 -92.74 -3.34 54.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.269 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.96 8.79 55.16 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.765 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.421 ' O ' ' HB2' ' A' ' 49' ' ' ASP . 31.1 t -93.83 119.68 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-O 120.744 0.307 . . . . 0.0 110.587 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.535 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -75.96 145.64 10.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.168 0.509 . . . . 0.0 111.779 -179.835 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.742 ' CD ' ' HB2' ' A' ' 62' ' ' ALA . 13.5 mmm-85 -149.47 133.73 17.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.719 179.046 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 74.5 m . . . . . 0 C--N 1.327 -0.396 0 CA-C-O 121.598 0.714 . . . . 0.0 111.984 -179.087 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.411 ' CZ ' ' HG3' ' A' ' 74' ' ' PRO . 2.7 m-85 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.814 0.34 . . . . 0.0 110.899 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.742 ' HB2' ' CD ' ' A' ' 55' ' ' ARG . . . -99.42 145.55 27.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.205 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.826 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -76.95 152.64 5.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.6 179.733 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.626 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 5.0 p-10 -132.37 129.87 39.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.249 0.547 . . . . 0.0 111.777 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.745 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -94.29 40.8 1.09 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.272 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.4 t -75.11 -45.5 40.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.543 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -94.7 170.33 9.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.962 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -49.16 -42.18 38.89 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.014 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.59 140.05 38.57 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.813 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.826 HG22 HG22 ' A' ' 63' ' ' ILE . 3.1 mm -69.94 137.12 24.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-O 121.464 0.649 . . . . 0.0 111.367 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.401 ' O ' HG22 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -134.54 165.68 24.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.118 -0.947 . . . . 0.0 111.17 -179.708 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . 1.051 HG21 HD13 ' A' ' 19' ' ' ILE . 23.9 p -106.62 140.25 39.79 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.238 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.11 163.79 13.33 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.481 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.461 ' O ' ' HD3' ' A' ' 82' ' ' ARG . 40.4 Cg_exo -56.73 142.81 91.54 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.451 2.1 . . . . 0.0 111.673 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.421 ' CD2' HG11 ' A' ' 53' ' ' VAL . 58.2 t80 -57.13 128.77 38.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.859 0.362 . . . . 0.0 111.358 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -118.17 131.02 24.38 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.532 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -68.14 -36.77 16.02 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.453 2.102 . . . . 0.0 112.758 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -87.55 0.31 55.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.812 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -105.19 102.65 37.78 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-O 120.53 0.205 . . . . 0.0 111.086 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.566 ' O ' HD21 ' A' ' 94' ' ' LEU . 5.7 Cg_exo -77.32 21.63 0.61 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.887 2.391 . . . . 0.0 112.978 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.626 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 7.6 mptt -119.92 -21.03 7.3 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 120.753 0.311 . . . . 0.0 111.001 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.546 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 2.7 mtt180 -86.85 20.84 2.44 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 1.033 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -130.68 99.58 5.01 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.276 0.56 . . . . 0.0 110.937 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.745 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 61.0 m95 -109.39 136.07 49.41 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.923 -178.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 27.8 pt -113.17 153.45 14.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.196 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.0 t -100.2 123.0 52.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.901 0.382 . . . . 0.0 110.948 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 37.6 t -115.8 93.49 4.28 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.438 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.97 -100.56 0.78 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.533 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.502 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.73 29.67 7.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.496 0.189 . . . . 0.0 110.923 -179.594 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.406 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -148.05 148.23 30.45 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.36 0.6 . . . . 0.0 112.583 -178.63 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.508 ' HB ' HD12 ' A' ' 101' ' ' LEU . 23.9 mm -93.65 119.47 41.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.542 178.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.981 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -123.99 147.56 47.68 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.566 ' NE2' ' CZ2' ' A' ' 84' ' ' TRP . 1.8 tp60 -65.17 149.88 49.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.849 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.033 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.7 pt? -64.29 -56.88 11.48 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.444 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.612 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 0.3 OUTLIER -77.25 -1.77 31.3 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.363 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.554 ' O ' HG22 ' A' ' 99' ' ' ILE . 49.7 t0 -145.09 91.14 2.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.165 0.507 . . . . 0.0 110.942 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 3.8 mmm180 -74.09 -13.69 60.87 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.526 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -87.35 9.81 19.32 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.518 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.831 HG12 ' HB1' ' A' ' 116' ' ' ALA . 6.8 tt -132.89 140.24 47.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 179.064 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.981 HG12 ' HB2' ' A' ' 92' ' ' ALA . 20.0 m -149.77 138.84 15.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.77 0.319 . . . . 0.0 111.826 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.508 HD12 ' HB ' ' A' ' 91' ' ' ILE . 21.8 mt -46.15 154.89 0.23 Allowed 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 121.733 0.778 . . . . 0.0 111.948 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.805 ' O ' HG22 ' A' ' 114' ' ' ILE . 11.0 t70 -156.97 167.67 29.77 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.792 -177.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.612 HD12 ' O ' ' A' ' 124' ' ' ASN . 4.6 mp -89.38 123.96 41.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.427 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.788 HG22 ' O ' ' A' ' 113' ' ' HIS . 3.9 tt -68.04 144.48 14.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.947 0.403 . . . . 0.0 111.421 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 5.2 mttt 70.34 -0.8 2.71 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.015 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.1 m 42.09 31.61 0.25 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.734 0.302 . . . . 0.0 111.474 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.477 ' O ' ' ND2' ' A' ' 13' ' ' ASN . 14.6 t0 -102.78 162.39 12.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.068 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.533 ' HA ' ' ND2' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -81.23 -14.5 57.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.255 179.918 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -48.21 133.11 15.8 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.21 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -81.91 159.37 23.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.147 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.49 16.37 80.05 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.287 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -82.0 135.79 35.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.841 0.353 . . . . 0.0 111.124 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.788 ' O ' HG22 ' A' ' 104' ' ' ILE . 6.7 m80 -61.86 172.85 1.19 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.962 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.805 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.7 OUTLIER -143.28 161.6 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.758 -179.777 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.645 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 4.6 t -155.43 169.95 23.07 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.831 ' HB1' HG12 ' A' ' 99' ' ' ILE . . . -93.6 126.53 38.81 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.228 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.458 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 75.9 t-105 -131.47 160.98 33.58 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.635 0.731 . . . . 0.0 112.361 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.458 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.3 OUTLIER -62.87 124.77 21.91 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.764 -179.885 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.88 121.28 8.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.127 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.438 ' CE1' ' HA3' ' A' ' 122' ' ' GLY . 6.6 p80 -127.34 2.4 6.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.493 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 79.4 5.23 89.26 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.881 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.438 ' HA3' ' CE1' ' A' ' 120' ' ' HIS . . . -63.34 156.28 42.32 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.536 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.75 -25.04 46.54 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.589 2.193 . . . . 0.0 112.365 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.618 ' HA ' HD22 ' A' ' 12' ' ' LEU . 36.3 p-10 -74.53 -3.8 33.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.644 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.406 ' O ' ' CG2' ' A' ' 90' ' ' THR . 0.0 OUTLIER -108.88 15.81 23.2 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.533 0.206 . . . . 0.0 111.116 -179.978 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -106.3 131.29 53.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.835 0.35 . . . . 0.0 111.465 -179.397 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.435 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 3.0 m-85 -134.9 154.6 51.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.285 179.459 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 mt -114.07 140.04 36.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.131 0.491 . . . . 0.0 110.677 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.472 HD12 HG23 ' A' ' 8' ' ' ILE . 20.8 mm -113.38 141.4 29.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.602 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.46 94.66 2.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.711 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 5.0 t -49.96 109.64 0.31 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.426 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.433 179.751 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.467 ' HA ' ' O ' ' A' ' 46' ' ' TRP . 1.1 p90 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.402 0.144 . . . . 0.0 110.629 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.743 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -159.87 176.57 11.75 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.861 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.822 ' OH ' ' HB1' ' A' ' 41' ' ' ALA . 0.7 OUTLIER -112.64 124.16 51.94 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.299 179.371 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.616 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -105.54 108.48 25.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.914 0.387 . . . . 0.0 110.339 179.873 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.456 ' HG2' ' HZ2' ' A' ' 9' ' ' LYS . 1.5 tptp -105.27 135.3 46.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.422 -178.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.7 t -75.65 108.04 8.21 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.448 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 2.7 tt0 -63.84 -10.76 22.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.633 -178.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.567 HD22 ' CB ' ' A' ' 124' ' ' ASN . 52.5 tp -83.25 -62.71 1.52 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.92 0.391 . . . . 0.0 110.924 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.534 HD21 ' HA ' ' A' ' 108' ' ' LYS . 2.8 m120 -86.32 -9.85 55.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.429 -178.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.86 5.01 68.41 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.145 -1.026 . . . . 0.0 111.369 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.41 ' HG2' ' HB2' ' A' ' 13' ' ' ASN . 1.8 mmmt -91.57 -177.18 4.73 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.537 HG11 ' HG2' ' A' ' 35' ' ' GLN . 2.9 m -120.3 140.28 44.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.784 0.326 . . . . 0.0 110.513 179.401 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.3 mt -70.89 136.06 48.39 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -143.83 158.57 43.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.936 0.398 . . . . 0.0 111.345 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.014 HD13 HG21 ' A' ' 72' ' ' THR . 27.5 mt . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.406 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.409 0 CA-C-O 120.409 -0.106 . . . . 0.0 112.951 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.71 130.05 38.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.987 0.422 . . . . 0.0 111.198 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -80.73 161.83 24.39 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.422 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.626 HG22 HG12 ' A' ' 19' ' ' ILE . 48.4 pt -122.82 150.29 26.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.783 0.325 . . . . 0.0 111.705 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.455 HG22 ' HA ' ' A' ' 113' ' ' HIS . 0.3 OUTLIER -156.39 -178.62 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.785 -179.738 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.2 p -100.29 148.59 24.5 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.468 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 30.6 t-105 -157.16 171.9 19.62 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.77 0.319 . . . . 0.0 111.109 -179.171 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.7 140.6 47.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.799 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.537 ' HG2' HG11 ' A' ' 16' ' ' VAL . 6.0 mt-30 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.946 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.858 ' O ' HD12 ' A' ' 45' ' ' LEU . . . . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.691 0.281 . . . . 0.0 111.163 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.7 t -49.34 -26.2 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.19 179.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -65.74 -10.02 33.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.738 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -119.6 6.04 11.05 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.103 0.478 . . . . 0.0 109.772 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.858 HD12 ' O ' ' A' ' 41' ' ' ALA . 1.4 mp -116.59 139.8 50.1 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.617 -179.1 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.555 ' CZ2' HD11 ' A' ' 19' ' ' ILE . 25.5 m95 -133.73 168.09 19.34 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.228 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.567 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 6.4 p90 -139.61 163.51 32.37 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.009 178.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.547 HG22 ' CG2' ' A' ' 54' ' ' ILE . 81.1 p -109.13 136.41 48.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.786 0.327 . . . . 0.0 111.4 -178.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.83 173.2 12.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.288 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.85 -20.93 65.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.063 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -101.74 -2.14 30.87 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.221 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.75 1.91 52.61 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.929 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.695 HG12 ' HD3' ' A' ' 55' ' ' ARG . 21.7 t -81.8 114.41 22.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.915 0.358 . . . . 0.0 110.767 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.567 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -77.5 148.02 6.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.263 0.554 . . . . 0.0 111.783 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.695 ' HD3' HG12 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -154.4 133.85 12.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.608 179.139 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.47 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 1.9 m . . . . . 0 C--N 1.328 -0.341 0 CA-C-O 121.356 0.598 . . . . 0.0 111.913 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.89 0.376 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.582 ' HB2' ' HD2' ' A' ' 55' ' ' ARG . . . -105.04 150.79 24.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.348 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.843 HG22 HG22 ' A' ' 70' ' ' ILE . 0.3 OUTLIER -77.08 155.07 5.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.527 179.76 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.55 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 4.4 p-10 -134.48 133.48 40.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.173 0.511 . . . . 0.0 111.873 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.597 ' HB2' ' CZ2' ' A' ' 84' ' ' TRP . . . -100.25 40.09 1.29 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.367 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.0 p -74.27 -43.87 55.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.458 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -98.43 173.48 6.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.117 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -46.08 -48.77 17.01 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.816 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -104.59 149.84 25.17 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.843 HG22 HG22 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -78.39 144.65 10.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 CA-C-O 121.729 0.776 . . . . 0.0 111.805 -179.203 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -135.91 158.61 43.98 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.052 179.056 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . 1.014 HG21 HD13 ' A' ' 19' ' ' ILE . 36.4 p -101.15 140.81 34.92 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.541 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.456 ' HG2' ' C ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -163.67 164.24 15.28 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.896 179.8 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.49 139.99 74.81 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.341 2.027 . . . . 0.0 111.754 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -56.16 122.84 12.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.911 0.386 . . . . 0.0 111.007 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.401 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 9.9 t70 -112.69 129.44 24.43 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.58 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.96 -34.81 22.32 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.449 2.099 . . . . 0.0 112.971 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -88.0 -0.64 57.27 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.401 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 4.3 t-20 -102.88 103.95 36.52 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 120.509 0.195 . . . . 0.0 110.957 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.581 ' O ' HD21 ' A' ' 94' ' ' LEU . 4.9 Cg_exo -77.1 19.95 0.67 Allowed 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.87 2.38 . . . . 0.0 113.246 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 11.5 mptt -120.45 -18.08 7.97 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 120.584 0.23 . . . . 0.0 111.27 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.487 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 4.4 mtt180 -90.3 21.59 3.76 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.642 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 1.111 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -129.32 99.5 5.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.231 0.539 . . . . 0.0 110.928 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.632 ' HH2' ' HB2' ' A' ' 116' ' ' ALA . 59.1 m95 -109.91 133.96 52.6 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.271 0.558 . . . . 0.0 112.151 -178.635 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.9 pt -113.23 154.57 14.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.066 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.8 t -103.24 131.07 52.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.965 0.412 . . . . 0.0 111.228 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 43.7 t -124.43 94.87 4.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.406 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.02 -100.71 0.87 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.449 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.496 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -121.13 28.98 7.55 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.603 0.24 . . . . 0.0 110.703 -179.933 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.433 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.2 146.97 30.02 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.321 0.582 . . . . 0.0 112.446 -178.642 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.849 ' HB ' HD12 ' A' ' 101' ' ' LEU . 10.6 mm -94.56 121.24 44.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.338 178.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.815 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -120.96 141.49 50.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.247 0.546 . . . . 0.0 112.462 -178.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.68 146.56 54.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.545 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.111 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.7 pt? -61.04 -56.6 19.16 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.826 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.601 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 97.2 p -73.81 -6.73 48.85 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -178.061 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.411 ' CB ' ' HB ' ' A' ' 99' ' ' ILE . 61.9 m-20 -139.63 91.06 2.45 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.869 -0.333 . . . . 0.0 111.203 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -66.6 -17.8 65.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.093 178.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.31 12.51 26.64 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.467 179.15 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.84 ' CG2' ' HB1' ' A' ' 116' ' ' ALA . 10.2 mm -124.5 128.49 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.412 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.815 HG12 ' HB2' ' A' ' 92' ' ' ALA . 19.3 m -146.31 135.54 16.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.832 0.348 . . . . 0.0 111.93 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.849 HD12 ' HB ' ' A' ' 91' ' ' ILE . 6.7 mt -45.55 152.2 0.34 Allowed 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.728 0.775 . . . . 0.0 111.781 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.821 ' O ' HG22 ' A' ' 114' ' ' ILE . 10.6 t70 -157.46 167.65 29.61 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.88 -177.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.553 HD12 ' O ' ' A' ' 124' ' ' ASN . 4.6 mp -88.57 121.12 38.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.278 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.826 HG22 ' HG2' ' A' ' 105' ' ' LYS . 56.1 mt -70.48 138.33 22.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.748 0.309 . . . . 0.0 111.161 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.826 ' HG2' HG22 ' A' ' 104' ' ' ILE . 0.1 OUTLIER 81.34 -9.68 1.26 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.7 179.893 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 46.76 29.99 1.09 Allowed 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 120.757 0.313 . . . . 0.0 111.425 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.528 ' O ' ' ND2' ' A' ' 13' ' ' ASN . 5.5 p30 -102.34 160.41 14.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.931 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.534 ' HA ' HD21 ' A' ' 13' ' ' ASN . 0.0 OUTLIER -79.69 -14.28 58.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.484 -179.86 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -51.95 118.95 3.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.83 0.348 . . . . 0.0 111.158 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.44 161.07 23.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.114 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.33 14.74 80.56 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.202 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.38 133.84 38.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.82 0.343 . . . . 0.0 111.063 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.572 ' HB2' HD12 ' A' ' 104' ' ' ILE . 35.9 m80 -61.38 163.25 6.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.06 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.821 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.6 OUTLIER -135.6 161.7 38.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.708 -179.836 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.608 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 26.2 p -162.3 176.94 10.05 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.248 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.84 ' HB1' ' CG2' ' A' ' 99' ' ' ILE . . . -96.91 132.24 42.89 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.826 -0.349 . . . . 0.0 110.261 178.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.467 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 75.9 t-105 -136.32 163.23 30.91 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.422 0.629 . . . . 0.0 111.756 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.467 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.1 OUTLIER -64.98 117.18 7.25 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.774 179.956 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -62.8 125.62 24.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.877 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -136.1 13.17 3.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.215 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 77.49 59.74 2.99 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.354 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -116.16 152.55 17.91 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.486 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.55 -30.67 79.76 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.51 2.14 . . . . 0.0 111.976 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.567 ' CB ' HD22 ' A' ' 12' ' ' LEU . 28.6 p-10 -77.21 -2.05 32.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.403 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.433 ' O ' ' CG2' ' A' ' 90' ' ' THR . 5.2 mm-40 -107.82 9.69 28.84 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.746 -0.206 . . . . 0.0 111.276 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.448 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 10.0 mmtt -106.5 140.99 38.52 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.872 0.368 . . . . 0.0 111.39 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -141.12 156.27 45.99 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.234 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.3 mt -112.14 138.45 41.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.072 0.463 . . . . 0.0 110.639 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.492 HD12 HG23 ' A' ' 8' ' ' ILE . 23.7 mm -113.73 140.29 34.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.599 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -139.58 94.84 2.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.668 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 53.0 m -53.0 111.14 0.62 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.35 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.739 ' OE2' HD21 ' A' ' 45' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.884 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 . . . . . 0 C--O 1.231 0.12 0 N-CA-C 110.488 -0.19 . . . . 0.0 110.488 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.613 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -152.66 170.53 20.02 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.405 179.302 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.426 ' O ' ' HA ' ' A' ' 129' ' ' ILE . 0.1 OUTLIER -112.06 123.6 50.62 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.815 178.863 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.672 ' HB ' HD21 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -106.56 108.67 25.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.892 0.377 . . . . 0.0 110.488 -179.866 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -107.81 137.14 46.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.252 -178.907 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.3 t -75.13 107.76 7.42 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.403 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 5.4 tt0 -62.4 -12.05 19.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.451 -178.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.8 tp -82.92 -62.15 1.68 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.871 0.367 . . . . 0.0 111.163 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.404 ' HB2' ' HG2' ' A' ' 15' ' ' LYS . 8.9 m-20 -86.79 -11.85 49.76 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -178.486 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.64 0.68 68.78 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.041 -1.076 . . . . 0.0 111.46 -178.092 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.407 ' O ' ' HG3' ' A' ' 9' ' ' LYS . 7.6 mmtm -89.06 177.69 6.58 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.556 HG21 ' HA ' ' A' ' 35' ' ' GLN . 4.5 m -119.72 141.26 40.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 179.252 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.672 HD21 ' HB ' ' A' ' 8' ' ' ILE . 0.1 OUTLIER -72.24 136.51 46.36 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.242 179.613 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.478 ' OD1' ' ND2' ' A' ' 43' ' ' ASN . 25.8 t0 -140.97 148.7 40.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.899 -179.273 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.078 HD13 HG21 ' A' ' 72' ' ' THR . 1.1 mt . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.128 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 CA-C-O 120.165 -0.242 . . . . 0.0 113.665 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.437 ' HB3' HG22 ' A' ' 19' ' ' ILE . 5.2 m -71.52 122.41 20.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.316 0.558 . . . . 0.0 111.141 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -76.6 160.56 29.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.586 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.585 HG22 HG23 ' A' ' 19' ' ' ILE . 44.5 pt -121.37 147.63 25.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.902 0.382 . . . . 0.0 111.992 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.427 HG22 ' HA ' ' A' ' 113' ' ' HIS . 0.3 OUTLIER -155.77 -178.29 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.219 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.386 179.805 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.5 p -102.31 149.48 24.29 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.603 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 20.8 t-105 -160.38 174.56 13.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.676 0.274 . . . . 0.0 110.843 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -71.12 136.29 48.11 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.814 0.34 . . . . 0.0 110.729 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.556 ' HA ' HG21 ' A' ' 16' ' ' VAL . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.947 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.55 ' O ' HD12 ' A' ' 45' ' ' LEU . . . . . . . . 0 CA--C 1.527 0.074 0 N-CA-C 111.525 0.195 . . . . 0.0 111.525 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.541 ' HA ' HD13 ' A' ' 45' ' ' LEU . 1.6 t -58.62 -18.48 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 120.686 0.279 . . . . 0.0 110.79 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.478 ' ND2' ' OD1' ' A' ' 18' ' ' ASP . 44.9 t30 -62.57 -9.93 10.42 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.12 178.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.406 ' HG3' ' CB ' ' A' ' 18' ' ' ASP . 1.1 mt-30 -114.55 7.46 16.13 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.622 HD22 ' OE1' ' A' ' 132' ' ' GLU . 1.7 mp -119.12 145.72 45.72 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.159 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.462 ' CH2' ' CG1' ' A' ' 63' ' ' ILE . 22.8 m95 -133.22 170.65 15.11 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.882 -178.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.54 ' CE2' ' HB2' ' A' ' 55' ' ' ARG . 1.1 p90 -135.85 159.8 40.55 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.856 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.43 HG22 HG23 ' A' ' 54' ' ' ILE . 11.8 p -106.15 132.98 51.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.732 0.301 . . . . 0.0 111.196 -179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -77.57 164.64 25.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.949 0.404 . . . . 0.0 111.268 -179.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 22.2 mm100 -57.77 -23.3 51.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.13 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.61 -1.84 42.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.292 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.31 4.67 56.24 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.987 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.604 HG11 ' CE1' ' A' ' 75' ' ' PHE . 23.9 t -87.72 117.68 32.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.921 0.361 . . . . 0.0 110.544 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.526 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.9 OUTLIER -78.62 150.03 5.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.278 0.561 . . . . 0.0 111.939 -179.77 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.54 ' HB2' ' CE2' ' A' ' 47' ' ' TYR . 8.8 mmm-85 -146.9 133.2 19.5 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.308 178.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.422 ' OG ' ' CE2' ' A' ' 46' ' ' TRP . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.413 0 CA-C-O 121.333 0.587 . . . . 0.0 112.098 -178.621 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.422 ' CE2' ' HD3' ' A' ' 74' ' ' PRO . 3.7 m-85 . . . . . 0 C--O 1.233 0.235 0 CA-C-O 120.96 0.41 . . . . 0.0 110.627 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.406 ' HB2' ' CD ' ' A' ' 55' ' ' ARG . . . -102.15 151.27 22.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.042 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.838 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -78.61 151.19 5.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.484 179.692 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.591 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 7.7 p-10 -131.95 129.87 40.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.084 0.469 . . . . 0.0 111.646 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.623 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -95.32 41.42 1.1 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.363 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.9 m -74.51 -44.65 50.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.218 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 33.6 m170 -94.94 170.73 9.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.976 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -48.59 -44.62 37.07 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.939 0.399 . . . . 0.0 110.951 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.13 144.67 31.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.659 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.838 HG22 HG22 ' A' ' 63' ' ' ILE . 2.1 mm -76.35 143.9 12.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.521 0.677 . . . . 0.0 111.649 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -143.31 167.86 21.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.947 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . 1.078 HG21 HD13 ' A' ' 19' ' ' ILE . 71.6 p -107.49 140.31 40.66 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.296 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.33 164.76 15.25 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.309 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.422 ' HD3' ' CE2' ' A' ' 61' ' ' PHE . 51.4 Cg_exo -52.82 138.34 60.34 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.399 2.066 . . . . 0.0 111.844 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.604 ' CE1' HG11 ' A' ' 53' ' ' VAL . 41.4 t80 -60.74 133.48 56.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.85 0.357 . . . . 0.0 111.113 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.408 ' CB ' ' HB2' ' A' ' 79' ' ' ASN . 0.5 OUTLIER -123.86 134.79 25.61 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.639 179.724 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.03 -34.78 16.22 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.46 2.106 . . . . 0.0 112.847 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 36.6 m-20 -86.87 -0.52 56.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.735 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.408 ' HB2' ' CB ' ' A' ' 76' ' ' ASP . 0.3 OUTLIER -105.8 101.38 32.68 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-O 120.639 0.257 . . . . 0.0 111.078 -179.859 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.856 ' O ' HD21 ' A' ' 94' ' ' LEU . 74.1 Cg_endo -77.2 21.45 0.61 Allowed 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.63 2.22 . . . . 0.0 113.091 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.591 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 6.6 mptt -117.97 -19.86 8.98 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.127 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.531 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 3.2 mtm180 -88.88 19.99 3.79 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -178.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 1.1 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -128.86 99.23 5.23 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.091 0.472 . . . . 0.0 110.81 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.623 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 59.5 m95 -109.54 135.5 50.44 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.148 0.499 . . . . 0.0 111.91 -178.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.2 pp -114.05 154.37 15.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.297 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.5 t -100.53 125.05 54.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.919 0.39 . . . . 0.0 111.085 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 12.9 t -117.62 93.55 4.2 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.433 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.12 -100.52 0.79 Allowed Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.538 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.492 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.64 29.42 7.43 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.534 0.207 . . . . 0.0 110.927 -179.658 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.488 HG22 ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.87 147.83 30.19 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.334 0.588 . . . . 0.0 112.473 -178.729 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.77 ' HB ' HD12 ' A' ' 101' ' ' LEU . 14.7 mm -93.49 119.88 42.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.144 178.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.982 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -122.25 145.17 48.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.236 0.541 . . . . 0.0 112.434 -178.417 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.434 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -66.84 148.3 52.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.627 179.719 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.1 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.7 pt? -60.6 -56.74 17.7 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.554 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.572 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 0.3 OUTLIER -77.74 -3.51 41.6 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 -178.428 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.407 ' HB2' ' HB3' ' A' ' 93' ' ' GLN . 4.9 m-20 -138.1 86.33 2.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.799 0.333 . . . . 0.0 110.961 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 14.7 mmt180 -67.74 -18.04 64.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.21 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -92.93 11.33 27.67 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.43 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.846 ' CG2' ' HB1' ' A' ' 116' ' ' ALA . 9.8 mm -124.93 130.25 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.569 179.433 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.982 HG12 ' HB2' ' A' ' 92' ' ' ALA . 27.7 m -147.34 136.91 16.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.84 0.352 . . . . 0.0 111.783 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.77 HD12 ' HB ' ' A' ' 91' ' ' ILE . 9.4 mt -46.71 154.7 0.3 Allowed 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.674 0.749 . . . . 0.0 111.909 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.771 ' O ' HG22 ' A' ' 114' ' ' ILE . 10.1 t70 -160.49 169.74 22.39 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.493 -1.231 . . . . 0.0 110.746 -177.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.803 HD12 ' O ' ' A' ' 124' ' ' ASN . 4.0 mp -86.48 124.13 40.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.238 179.2 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.799 HG22 ' O ' ' A' ' 113' ' ' HIS . 1.1 tt -63.57 138.38 23.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.066 0.46 . . . . 0.0 111.582 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 25.5 mttp 48.62 24.99 0.86 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.6 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 33.2 t 44.48 -121.32 0.82 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.98 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 61.11 150.26 0.02 OUTLIER 'General case' 0 C--N 1.334 -0.079 0 CA-C-O 120.923 0.392 . . . . 0.0 111.203 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.22 -13.5 55.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.182 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -45.74 136.5 6.07 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.369 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -89.84 162.2 15.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.21 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 73.36 18.03 79.15 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.192 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -85.03 136.67 33.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.805 0.336 . . . . 0.0 110.885 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.799 ' O ' HG22 ' A' ' 104' ' ' ILE . 2.6 m80 -61.07 170.84 1.45 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.888 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.771 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.7 OUTLIER -142.11 161.63 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.685 -179.859 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.666 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 20.8 p -156.84 173.75 16.53 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.545 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.846 ' HB1' ' CG2' ' A' ' 99' ' ' ILE . . . -95.47 128.79 42.61 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.436 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.464 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 73.9 t-105 -136.61 162.44 33.13 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.585 0.707 . . . . 0.0 112.128 -179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.464 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.1 OUTLIER -60.26 119.43 7.9 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.663 179.887 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -62.45 129.04 38.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.095 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -139.35 12.88 2.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.107 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 80.64 11.79 83.62 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.833 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.25 139.08 41.67 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.497 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.51 -28.37 54.54 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.472 2.115 . . . . 0.0 112.326 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.803 ' O ' HD12 ' A' ' 103' ' ' ILE . 14.5 p-10 -74.66 -2.15 24.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.622 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.488 ' O ' HG22 ' A' ' 90' ' ' THR . 91.5 mt-30 -104.45 -15.53 15.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.745 -0.207 . . . . 0.0 111.441 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.415 ' O ' ' CD1' ' A' ' 127' ' ' PHE . 0.2 OUTLIER -78.07 137.87 38.47 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.899 0.38 . . . . 0.0 111.361 -179.29 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.415 ' CD1' ' O ' ' A' ' 126' ' ' LYS . 8.4 m-85 -137.5 156.26 48.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.155 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 mt -114.32 137.03 48.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.151 0.501 . . . . 0.0 110.57 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.507 ' CD1' HG23 ' A' ' 8' ' ' ILE . 33.5 mm -113.59 139.49 38.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.574 -179.215 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -138.82 109.39 6.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.501 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.76 110.24 1.11 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.047 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.622 ' OE1' HD22 ' A' ' 45' ' ' LEU . 3.4 tt0 . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.894 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.138 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.762 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -155.89 172.39 18.44 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.804 179.638 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.458 ' CE1' ' HB3' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -112.95 123.85 51.27 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.13 179.135 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.621 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -105.18 108.96 26.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.906 0.384 . . . . 0.0 110.389 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.423 ' HG3' ' O ' ' A' ' 15' ' ' LYS . 7.7 tttt -105.82 136.14 45.99 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.235 -178.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.514 ' OG ' HD21 ' A' ' 17' ' ' LEU . 70.3 m -73.85 109.17 7.15 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.445 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 3.8 tt0 -63.14 -12.39 27.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.521 -178.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.494 HD22 ' CB ' ' A' ' 124' ' ' ASN . 43.5 tp -84.8 -62.12 1.62 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.894 0.378 . . . . 0.0 111.115 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.503 ' ND2' ' HA ' ' A' ' 108' ' ' LYS . 3.8 m120 -84.33 -12.71 54.1 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -178.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.5 3.02 70.4 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.007 -1.092 . . . . 0.0 111.632 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.44 ' HG2' ' HB2' ' A' ' 13' ' ' ASN . 13.2 mmtp -91.58 -177.26 4.75 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.643 HG21 ' HA ' ' A' ' 35' ' ' GLN . 4.3 m -121.7 142.21 38.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.787 0.327 . . . . 0.0 110.614 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.514 HD21 ' OG ' ' A' ' 10' ' ' SER . 9.2 mt -70.56 134.94 48.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.276 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 19' ' ' ILE . 61.5 t0 -142.51 141.72 32.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.767 0.318 . . . . 0.0 111.043 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.028 HD13 HG21 ' A' ' 72' ' ' THR . 25.1 mt . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.564 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.462 0 CA-C-O 120.28 -0.178 . . . . 0.0 112.912 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.88 139.73 50.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 117.028 0.414 . . . . 0.0 110.784 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.88 158.38 16.33 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.485 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.718 HD11 ' HB ' ' A' ' 70' ' ' ILE . 37.3 pt -117.53 147.56 20.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.548 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.463 ' HA ' ' CD1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -155.44 -179.72 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.728 -179.84 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 p -103.77 150.55 23.98 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.667 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 31.4 t-105 -158.8 173.49 16.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.643 0.259 . . . . 0.0 110.922 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -68.89 131.68 45.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.82 0.343 . . . . 0.0 110.693 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.643 ' HA ' HG21 ' A' ' 16' ' ' VAL . 5.3 tt0 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.348 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.827 ' O ' HD12 ' A' ' 45' ' ' LEU . . . . . . . . 0 N--CA 1.456 -0.156 0 CA-C-O 120.767 0.317 . . . . 0.0 110.443 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.4 t -50.48 -28.84 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.817 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -57.65 -13.75 4.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.144 -179.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.458 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -121.31 12.24 10.91 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 120.926 0.393 . . . . 0.0 110.364 -179.909 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.827 HD12 ' O ' ' A' ' 41' ' ' ALA . 1.2 mp -118.32 140.13 50.29 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.062 -179.074 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.707 ' CZ2' HD11 ' A' ' 19' ' ' ILE . 23.8 m95 -133.3 169.19 17.27 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.098 -179.559 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.53 ' CZ ' ' HB2' ' A' ' 55' ' ' ARG . 31.1 p90 -142.39 165.71 26.67 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.317 179.135 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.442 HG22 ' CG2' ' A' ' 54' ' ' ILE . 74.6 p -106.84 131.79 53.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.81 0.338 . . . . 0.0 111.272 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -77.44 165.6 24.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.077 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -63.12 -26.9 69.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.951 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -85.97 -4.64 59.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.277 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.431 ' O ' HG22 ' A' ' 85' ' ' ILE . . . 96.48 15.08 41.97 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.82 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.507 HG12 ' HD3' ' A' ' 55' ' ' ARG . 40.2 t -106.09 123.74 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-O 120.662 0.267 . . . . 0.0 110.495 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.464 HD11 ' HB2' ' A' ' 84' ' ' TRP . 0.6 OUTLIER -77.5 148.74 6.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.289 0.566 . . . . 0.0 111.828 -179.963 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.552 ' CD ' ' HB2' ' A' ' 62' ' ' ALA . 0.2 OUTLIER -150.06 133.28 16.34 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.323 178.903 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.518 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 16.5 m . . . . . 0 C--N 1.326 -0.437 0 CA-C-O 121.512 0.673 . . . . 0.0 112.029 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.443 ' CE2' ' HD3' ' A' ' 74' ' ' PRO . 2.9 m-85 . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.818 0.342 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.552 ' HB2' ' CD ' ' A' ' 55' ' ' ARG . . . -109.51 153.24 24.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.405 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.817 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -79.15 151.82 4.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.595 179.647 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.633 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 10.5 p-10 -133.42 130.54 38.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.261 0.553 . . . . 0.0 111.787 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.691 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -93.58 41.26 1.08 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.398 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 77.7 p -74.73 -42.87 57.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.379 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -98.11 171.04 8.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.096 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -47.6 -46.34 28.26 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.095 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.05 143.98 31.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.029 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.817 HG22 HG22 ' A' ' 63' ' ' ILE . 3.0 mm -71.38 136.38 25.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 CA-C-O 121.605 0.717 . . . . 0.0 111.454 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.438 ' O ' HG22 ' A' ' 63' ' ' ILE . 18.3 mt-10 -133.07 165.59 24.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.351 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . 1.028 HG21 HD13 ' A' ' 19' ' ' ILE . 27.5 p -105.21 134.45 48.29 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.212 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.462 ' HG2' ' C ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -161.75 167.82 12.22 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.181 -179.681 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.443 ' HD3' ' CE2' ' A' ' 61' ' ' PHE . 21.4 Cg_endo -61.11 139.44 84.12 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.308 2.005 . . . . 0.0 112.015 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.466 ' CE1' ' HB2' ' A' ' 83' ' ' ALA . 16.9 t80 -59.58 139.65 56.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.935 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.406 ' HB3' ' CB ' ' A' ' 79' ' ' ASN . 1.1 t0 -129.38 135.0 26.89 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.791 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -68.24 -35.63 18.52 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.505 2.137 . . . . 0.0 112.762 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -88.79 -1.25 57.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.699 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.427 ' HB3' ' HD2' ' A' ' 82' ' ' ARG . 2.9 t-20 -110.91 99.05 41.02 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-O 120.611 0.243 . . . . 0.0 110.846 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.532 ' O ' HD21 ' A' ' 94' ' ' LEU . 4.4 Cg_exo -74.94 27.98 0.36 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.878 2.385 . . . . 0.0 113.387 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.633 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -119.03 -23.63 6.8 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-O 120.673 0.273 . . . . 0.0 111.036 -179.833 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.47 ' HG3' ' HB3' ' A' ' 64' ' ' ASP . 0.6 OUTLIER -86.35 22.97 1.68 Allowed 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -179.076 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 1.04 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -133.7 99.96 4.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.206 0.527 . . . . 0.0 111.17 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.691 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 59.7 m95 -109.67 136.61 48.75 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.891 -178.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.44 HD11 ' HD3' ' A' ' 97' ' ' ARG . 20.4 pt -113.37 154.52 14.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.112 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.5 t -101.75 125.93 55.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.993 0.425 . . . . 0.0 111.057 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.9 t -118.74 93.87 4.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.338 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.41 -100.73 0.83 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.425 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.499 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -121.15 29.78 7.15 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.544 0.211 . . . . 0.0 110.842 -179.868 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.408 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.12 147.46 30.58 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -178.6 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.765 ' HB ' HD12 ' A' ' 101' ' ' LEU . 14.1 mm -93.86 119.17 41.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.492 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.964 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -123.27 146.68 47.67 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -178.501 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.572 ' NE2' ' CZ2' ' A' ' 84' ' ' TRP . 1.3 tp60 -64.78 149.18 49.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.599 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.04 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.7 pt? -64.61 -56.88 11.08 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.551 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.612 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 47.3 t -76.2 -2.3 30.57 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -178.463 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.555 ' O ' HG22 ' A' ' 99' ' ' ILE . 11.1 m-20 -145.85 90.85 2.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.029 0.442 . . . . 0.0 110.939 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.44 ' HD3' HD11 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -73.43 -13.7 61.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.546 179.351 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -86.15 10.44 14.49 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.486 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.854 HG12 ' HB1' ' A' ' 116' ' ' ALA . 3.2 tt -135.12 142.38 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.132 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.964 HG12 ' HB2' ' A' ' 92' ' ' ALA . 32.1 m -150.51 139.51 15.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.851 0.357 . . . . 0.0 111.871 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.765 HD12 ' HB ' ' A' ' 91' ' ' ILE . 11.9 mt -45.58 154.13 0.22 Allowed 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.8 0.809 . . . . 0.0 111.997 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.718 ' O ' HG22 ' A' ' 114' ' ' ILE . 9.4 t70 -157.51 167.71 29.41 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 114.18 -1.373 . . . . 0.0 110.563 -177.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.576 HD12 ' O ' ' A' ' 124' ' ' ASN . 4.5 mp -90.42 122.44 41.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.406 179.253 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.749 HG22 ' O ' ' A' ' 113' ' ' HIS . 8.9 tt -67.45 140.86 18.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.971 0.415 . . . . 0.0 111.379 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt 76.95 -7.32 1.87 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.935 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.6 m 46.56 28.85 0.82 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 120.76 0.314 . . . . 0.0 111.232 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.499 ' O ' ' ND2' ' A' ' 13' ' ' ASN . 5.9 t0 -99.63 159.96 14.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.052 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.503 ' HA ' ' ND2' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -80.36 -14.43 58.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.182 179.84 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -47.48 126.18 9.39 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.163 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.87 158.31 36.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.225 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.57 14.77 80.89 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.327 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.1 131.91 38.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.816 0.341 . . . . 0.0 110.872 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.749 ' O ' HG22 ' A' ' 104' ' ' ILE . 2.0 m-70 -65.1 173.52 2.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.024 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.718 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -136.35 161.5 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.367 179.928 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.579 ' HA ' HD11 ' A' ' 70' ' ' ILE . 7.4 t -152.47 166.57 31.55 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.854 ' HB1' HG12 ' A' ' 99' ' ' ILE . . . -93.92 125.02 38.3 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.038 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.46 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 68.2 t-105 -131.49 161.72 31.89 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.672 0.748 . . . . 0.0 112.455 -179.154 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.46 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.0 OUTLIER -63.85 121.13 13.3 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.792 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -60.43 124.11 19.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.977 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -136.18 8.4 3.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.503 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 79.53 57.16 3.18 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.479 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -116.51 143.31 18.01 Favored Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.488 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.82 -32.53 77.44 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.57 2.18 . . . . 0.0 112.326 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.576 ' O ' HD12 ' A' ' 103' ' ' ILE . 18.7 p-10 -73.71 -5.33 39.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.632 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.408 ' O ' ' CG2' ' A' ' 90' ' ' THR . 93.0 mt-30 -107.29 10.11 29.85 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.509 0.195 . . . . 0.0 111.362 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.445 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -106.21 140.86 38.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.864 0.364 . . . . 0.0 111.104 -179.627 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.428 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 7.9 m-85 -139.35 156.84 46.74 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.45 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.4 mt -113.79 139.17 40.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.095 0.474 . . . . 0.0 110.679 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.53 ' CD1' HG23 ' A' ' 8' ' ' ILE . 25.5 mm -114.6 139.96 37.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.62 -179.157 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -137.47 94.56 2.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.59 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 27.2 m -51.04 108.67 0.26 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.356 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.198 -0.906 . . . . 0.0 111.172 179.824 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.474 ' HA ' ' O ' ' A' ' 46' ' ' TRP . 17.0 m-85 . . . . . 0 C--O 1.231 0.087 0 N-CA-C 110.493 -0.188 . . . . 0.0 110.493 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.77 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -159.42 176.02 12.61 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.76 179.694 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.442 ' CE1' ' HB3' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -114.96 124.12 50.87 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.365 179.099 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.614 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -105.89 109.4 27.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.465 179.921 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 16' ' ' VAL . 1.3 tttm -105.82 136.61 45.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.064 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 79.3 p -76.51 107.76 9.02 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 178.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.419 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 2.2 tt0 -63.15 -10.33 14.57 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.467 -178.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 27.0 tp -83.16 -62.67 1.53 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.862 0.363 . . . . 0.0 110.911 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.573 HD21 ' HA ' ' A' ' 108' ' ' LYS . 3.3 m120 -86.25 -10.83 53.86 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -178.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.39 3.74 72.07 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.172 -1.014 . . . . 0.0 111.421 -178.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.0 mmmm -91.67 -177.73 4.86 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 122.583 0.353 . . . . 0.0 110.054 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.574 HG21 ' HA ' ' A' ' 35' ' ' GLN . 4.5 m -121.27 140.83 44.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.69 0.281 . . . . 0.0 110.484 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.1 mt -70.67 136.26 48.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.233 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -140.51 153.98 46.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.85 0.357 . . . . 0.0 111.147 -179.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.912 HD13 HG21 ' A' ' 72' ' ' THR . 1.6 mt . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.59 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.404 0 N-CA-C 112.7 -0.16 . . . . 0.0 112.7 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.7 m -71.75 137.47 47.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.903 0.382 . . . . 0.0 111.134 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.99 156.64 19.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.299 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.701 HD11 ' HB ' ' A' ' 70' ' ' ILE . 44.2 pt -116.42 145.59 21.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.913 0.387 . . . . 0.0 111.598 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.442 HG22 ' HA ' ' A' ' 113' ' ' HIS . 0.2 OUTLIER -155.93 -178.91 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.164 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.529 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.4 p -101.2 148.92 24.53 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.561 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 18.1 t-105 -156.81 171.67 19.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.721 0.296 . . . . 0.0 110.98 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.45 134.51 47.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.719 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.574 ' HA ' HG21 ' A' ' 16' ' ' VAL . 3.5 tt0 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.112 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.987 ' O ' HD12 ' A' ' 45' ' ' LEU . . . . . . . . 0 N--CA 1.457 -0.115 0 CA-C-O 120.722 0.296 . . . . 0.0 111.109 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 81.6 t -49.44 -33.24 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.103 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -66.26 -9.26 30.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.046 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.442 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 6.4 mt-30 -118.95 8.22 11.61 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.353 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.987 HD12 ' O ' ' A' ' 41' ' ' ALA . 0.9 OUTLIER -117.65 140.11 50.09 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.71 -178.943 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.627 ' CZ2' HD11 ' A' ' 19' ' ' ILE . 23.1 m95 -134.0 168.62 18.46 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.545 -178.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.531 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 5.3 p90 -136.53 160.29 39.21 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.081 179.031 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.427 HG22 HG23 ' A' ' 54' ' ' ILE . 29.1 p -105.72 134.55 48.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.708 0.29 . . . . 0.0 110.9 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 53' ' ' VAL . 28.2 t70 -77.42 165.68 24.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.88 0.371 . . . . 0.0 111.092 -179.347 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.1 mm-40 -55.45 -21.76 17.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.28 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -103.94 -1.26 27.9 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.414 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.62 -0.15 49.4 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.69 -0.766 . . . . 0.0 113.068 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.405 ' O ' ' HB2' ' A' ' 49' ' ' ASP . 19.0 t -78.95 113.62 18.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.817 0.342 . . . . 0.0 110.695 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.531 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.8 OUTLIER -79.55 147.14 6.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.407 0.622 . . . . 0.0 112.212 -179.537 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.776 ' CD ' ' HB2' ' A' ' 62' ' ' ALA . 0.1 OUTLIER -150.82 132.58 14.98 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.904 178.5 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.501 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 99.9 p . . . . . 0 CA--C 1.508 -0.639 0 CA-C-O 121.758 0.789 . . . . 0.0 111.818 -179.113 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.745 0.307 . . . . 0.0 110.816 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.776 ' HB2' ' CD ' ' A' ' 55' ' ' ARG . . . -104.94 151.22 24.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.514 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.839 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -79.79 151.82 4.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.465 179.607 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.618 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 7.4 p-10 -133.38 130.69 39.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.244 0.545 . . . . 0.0 111.776 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.676 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -93.33 43.48 1.12 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.245 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.0 m -75.48 -45.63 37.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.448 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -95.85 171.89 8.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.018 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -49.17 -41.77 37.68 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.91 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.24 144.23 32.32 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.801 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.839 HG22 HG22 ' A' ' 63' ' ' ILE . 2.5 mm -74.3 139.71 18.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.537 0.684 . . . . 0.0 111.441 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.406 ' O ' HG22 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -138.61 166.83 23.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.718 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.912 HG21 HD13 ' A' ' 19' ' ' ILE . 47.3 p -105.09 138.91 40.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.139 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.07 169.54 8.03 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.2 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -61.16 137.35 70.67 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.491 2.128 . . . . 0.0 112.028 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -54.84 128.0 31.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.074 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.444 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 8.9 t70 -116.9 129.33 25.39 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.64 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -68.52 -35.35 17.69 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.546 2.164 . . . . 0.0 113.01 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 56.4 m-20 -86.78 -1.59 57.88 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.444 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 1.6 t-20 -116.36 99.52 52.79 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-O 120.659 0.266 . . . . 0.0 110.795 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.542 ' O ' HD21 ' A' ' 94' ' ' LEU . 8.1 Cg_exo -72.51 32.63 0.28 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.068 2.512 . . . . 0.0 113.498 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.618 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 0.7 OUTLIER -118.89 -23.96 6.76 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 120.656 0.265 . . . . 0.0 111.171 -179.718 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.489 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 8.3 mtt-85 -85.13 18.71 2.44 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.144 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.998 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -127.76 99.26 5.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.201 0.524 . . . . 0.0 111.317 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.676 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 59.7 m95 -109.93 135.56 50.61 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.803 -179.075 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.9 pt -114.79 155.6 15.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.19 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.3 t -103.22 130.25 53.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.962 0.41 . . . . 0.0 111.143 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 30.5 t -123.04 94.99 4.44 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.286 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.25 -100.51 0.8 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.423 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.501 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.93 29.68 7.25 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.532 0.206 . . . . 0.0 110.919 -179.756 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.403 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.39 147.24 30.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.394 0.616 . . . . 0.0 112.648 -178.536 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.74 ' HB ' HD12 ' A' ' 101' ' ' LEU . 17.3 mm -94.12 119.87 42.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.2 178.5 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.977 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -122.54 144.88 48.8 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.487 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.582 ' NE2' ' CZ2' ' A' ' 84' ' ' TRP . 1.0 OUTLIER -64.99 147.74 52.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.52 179.452 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.998 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.6 pt? -62.73 -56.52 16.86 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.436 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.617 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 45.6 p -75.15 -4.59 39.62 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -178.619 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.583 ' O ' HG22 ' A' ' 99' ' ' ILE . 8.6 m-20 -140.1 89.03 2.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.815 0.34 . . . . 0.0 110.864 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.8 mmm-85 -70.78 -15.87 62.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.235 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.22 11.88 21.99 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.154 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.583 HG22 ' O ' ' A' ' 96' ' ' ASP . 1.0 OUTLIER -130.38 136.84 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.086 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.977 HG12 ' HB2' ' A' ' 92' ' ' ALA . 26.8 m -148.47 138.41 16.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.777 0.322 . . . . 0.0 111.643 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.74 HD12 ' HB ' ' A' ' 91' ' ' ILE . 10.7 mt -45.98 153.84 0.28 Allowed 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.723 0.773 . . . . 0.0 111.768 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.782 ' O ' HG22 ' A' ' 114' ' ' ILE . 10.3 t70 -157.51 167.7 29.43 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.789 -177.665 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.691 HD12 ' O ' ' A' ' 124' ' ' ASN . 4.3 mp -89.18 120.57 38.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.553 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.453 HG12 ' HA ' ' A' ' 114' ' ' ILE . 45.7 mm -69.2 143.25 15.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.823 0.344 . . . . 0.0 111.13 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 80.13 -9.82 1.36 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.689 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 46.76 29.51 0.99 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.749 0.309 . . . . 0.0 111.238 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.48 ' O ' ' ND2' ' A' ' 13' ' ' ASN . 54.0 p30 -105.46 163.54 12.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.033 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.573 ' HA ' HD21 ' A' ' 13' ' ' ASN . 1.4 tptm -80.56 -14.38 58.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.181 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -49.24 120.96 4.4 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.174 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.03 161.99 30.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.25 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 72.24 18.53 78.14 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.231 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -82.85 136.48 34.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.803 0.335 . . . . 0.0 111.112 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.442 ' HA ' HG22 ' A' ' 31' ' ' ILE . 5.5 m170 -62.61 168.08 3.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.939 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.782 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.7 OUTLIER -138.33 161.35 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.74 -179.772 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.65 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 5.2 t -155.15 169.67 23.62 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.667 ' HB2' ' HH2' ' A' ' 84' ' ' TRP . . . -94.08 125.91 38.99 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.046 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.459 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 76.3 t-105 -132.88 162.28 31.99 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.622 0.725 . . . . 0.0 112.311 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.459 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.1 OUTLIER -61.2 120.2 9.9 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.581 -1.191 . . . . 0.0 110.608 179.855 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -59.25 126.63 28.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.122 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -134.63 10.01 3.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.289 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 78.92 8.85 87.59 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.923 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.36 152.32 44.61 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.537 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.88 -27.09 59.06 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.606 2.204 . . . . 0.0 112.206 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.691 ' O ' HD12 ' A' ' 103' ' ' ILE . 25.4 p-10 -76.31 -1.93 29.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.479 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.403 ' O ' ' CG2' ' A' ' 90' ' ' THR . 0.0 OUTLIER -109.17 13.31 24.51 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 116.736 -0.211 . . . . 0.0 111.072 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.419 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 7.5 mmmt -104.61 132.53 50.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.789 0.328 . . . . 0.0 111.273 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.43 ' CD1' ' N ' ' A' ' 127' ' ' PHE . 1.7 m-85 -135.83 154.99 51.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.376 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 mt -114.33 139.82 38.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.163 0.506 . . . . 0.0 110.706 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.584 ' CD1' HG23 ' A' ' 8' ' ' ILE . 24.6 mm -114.54 140.73 33.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.707 -179.176 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -139.15 95.33 2.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.616 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.8 m -50.25 113.15 0.8 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.466 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.908 -179.986 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 46' ' ' TRP . 1.6 p90 . . . . . 0 C--O 1.231 0.087 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.766 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -159.9 176.16 12.21 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.746 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.457 ' CE1' ' HB3' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -113.71 123.91 51.01 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.26 179.195 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.696 ' HB ' HD21 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -105.09 109.42 27.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.912 0.386 . . . . 0.0 110.58 -179.983 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.41 ' HG3' ' O ' ' A' ' 15' ' ' LYS . 2.8 tttt -107.09 138.61 42.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.022 -0.535 . . . . 0.0 112.271 -178.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.1 p -77.54 109.29 11.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.658 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.429 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 4.1 tt0 -64.58 -10.14 24.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.598 -178.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.569 HD22 ' HA ' ' A' ' 124' ' ' ASN . 65.0 tp -84.0 -62.79 1.48 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.974 0.416 . . . . 0.0 110.906 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.534 ' ND2' ' HA ' ' A' ' 108' ' ' LYS . 2.7 m120 -85.53 -12.36 51.89 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -178.651 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.83 1.9 74.5 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.038 -1.077 . . . . 0.0 111.245 -178.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.432 ' HG2' ' HB2' ' A' ' 13' ' ' ASN . 6.6 mmmt -90.41 179.81 5.78 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.485 HG21 ' HA ' ' A' ' 35' ' ' GLN . 4.0 m -121.13 141.66 40.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.696 HD21 ' HB ' ' A' ' 8' ' ' ILE . 0.1 OUTLIER -71.89 136.62 46.99 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.374 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -142.1 150.37 41.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.948 0.404 . . . . 0.0 111.335 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.891 HD13 HG21 ' A' ' 72' ' ' THR . 23.7 mt . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.507 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 CA-C-O 120.361 -0.133 . . . . 0.0 113.09 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.23 129.71 37.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.942 0.401 . . . . 0.0 111.118 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.408 ' HA ' ' HG3' ' A' ' 71' ' ' GLU . 9.8 mmtt -81.16 159.51 24.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.554 179.638 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.626 HD11 ' HB ' ' A' ' 70' ' ' ILE . 48.2 pt -119.89 147.91 23.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.976 0.417 . . . . 0.0 111.729 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.431 HG22 ' HA ' ' A' ' 113' ' ' HIS . 0.2 OUTLIER -155.74 -179.34 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.176 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.581 -179.881 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.693 HG21 HD12 ' A' ' 103' ' ' ILE . 2.8 p -100.97 148.45 25.0 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.639 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 51.6 t-105 -156.77 170.92 21.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.681 0.277 . . . . 0.0 110.819 -179.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.62 135.53 48.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.744 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.485 ' HA ' HG21 ' A' ' 16' ' ' VAL . 28.2 tt0 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.019 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.93 ' O ' HD12 ' A' ' 45' ' ' LEU . . . . . . . . 0 CA--C 1.528 0.105 0 CA-C-O 120.684 0.278 . . . . 0.0 111.307 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 57.3 t -48.88 -27.12 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.272 179.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -64.38 -11.74 35.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.912 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.471 ' NE2' HG23 ' A' ' 16' ' ' VAL . 5.6 mt-30 -120.28 7.16 10.7 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.096 0.474 . . . . 0.0 109.784 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.93 HD12 ' O ' ' A' ' 41' ' ' ALA . 1.3 mp -118.18 140.21 50.12 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.949 -179.064 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.568 ' CZ2' HD11 ' A' ' 19' ' ' ILE . 25.5 m95 -135.12 169.88 16.77 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.019 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.567 ' CZ ' ' HB2' ' A' ' 55' ' ' ARG . 5.2 p90 -141.13 165.5 27.36 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.158 178.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.53 131.7 52.6 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.827 0.346 . . . . 0.0 111.195 -179.169 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -77.61 165.48 24.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.093 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -59.94 -25.26 65.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.12 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -91.84 -3.57 55.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.391 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.84 ' O ' HG22 ' A' ' 85' ' ' ILE . . . 97.75 10.4 52.9 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.891 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.639 HG13 ' HA ' ' A' ' 83' ' ' ALA . 5.5 t -98.23 121.22 48.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.778 0.323 . . . . 0.0 110.495 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.552 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -75.63 147.5 8.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.198 0.523 . . . . 0.0 111.884 -179.733 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.596 ' HD2' ' HB2' ' A' ' 62' ' ' ALA . 0.2 OUTLIER -151.79 135.59 16.36 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.62 179.063 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 73.1 m . . . . . 0 C--N 1.328 -0.368 0 CA-C-O 121.255 0.55 . . . . 0.0 112.047 -179.007 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.42 ' CZ ' ' HG3' ' A' ' 74' ' ' PRO . 2.3 m-85 . . . . . 0 C--O 1.233 0.185 0 CA-C-O 120.81 0.338 . . . . 0.0 110.725 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.596 ' HB2' ' HD2' ' A' ' 55' ' ' ARG . . . -109.4 150.96 27.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.458 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.857 HG22 HG22 ' A' ' 70' ' ' ILE . 0.3 OUTLIER -78.45 153.77 5.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.583 179.614 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.606 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 4.7 p-10 -133.28 130.19 38.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.226 0.536 . . . . 0.0 111.832 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.67 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -93.95 39.92 1.08 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.433 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.31 -44.73 51.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.172 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 50.6 m170 -94.11 169.44 10.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.928 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -46.9 -47.66 21.44 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.999 0.428 . . . . 0.0 110.956 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.98 145.17 29.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.623 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.857 HG22 HG22 ' A' ' 63' ' ' ILE . 2.3 mm -73.09 137.8 22.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-O 121.553 0.692 . . . . 0.0 111.489 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.408 ' HG3' ' HA ' ' A' ' 29' ' ' LYS . 3.7 tt0 -132.34 161.93 32.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.015 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.891 HG21 HD13 ' A' ' 19' ' ' ILE . 28.3 p -104.04 138.89 39.92 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.635 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.91 160.46 15.02 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.654 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.421 ' O ' ' HD3' ' A' ' 82' ' ' ARG . 51.1 Cg_exo -53.51 141.88 61.12 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.441 2.094 . . . . 0.0 111.785 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -55.13 134.6 49.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.875 0.369 . . . . 0.0 111.352 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -126.31 118.96 23.33 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.609 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -58.33 -36.66 97.41 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.633 2.222 . . . . 0.0 113.231 -179.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 29.1 m-20 -86.1 -0.68 56.2 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -106.5 103.54 46.65 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.6 0.238 . . . . 0.0 111.137 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.529 ' O ' HD21 ' A' ' 94' ' ' LEU . 79.1 Cg_endo -77.37 23.09 0.55 Allowed 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.649 2.233 . . . . 0.0 113.132 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.606 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 0.7 OUTLIER -119.87 -21.18 7.27 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.966 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.54 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 2.5 mtm180 -86.66 20.93 2.34 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.006 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.991 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -129.79 99.91 5.3 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.275 0.56 . . . . 0.0 111.066 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.67 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 63.4 m95 -110.47 136.8 49.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.846 -178.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.84 HG22 ' O ' ' A' ' 52' ' ' GLY . 1.2 pp -117.01 155.45 18.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.215 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.1 t -100.79 125.77 54.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.917 0.389 . . . . 0.0 111.054 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 12.7 t -118.5 93.62 4.18 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.487 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.22 -100.84 0.82 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.517 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.501 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.74 29.32 7.47 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.557 0.218 . . . . 0.0 110.939 -179.655 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.419 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.82 148.18 30.61 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.379 0.609 . . . . 0.0 112.552 -178.576 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.754 ' HB ' HD12 ' A' ' 101' ' ' LEU . 16.7 mm -93.41 119.98 42.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.303 178.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.953 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -123.55 145.29 48.99 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -178.348 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.584 ' NE2' ' CZ2' ' A' ' 84' ' ' TRP . 0.7 OUTLIER -66.67 147.05 53.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.723 179.713 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.991 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.6 pt? -60.81 -56.23 23.65 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.499 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.616 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 2.8 m -76.75 -3.95 40.83 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -178.324 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -139.04 87.88 2.24 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.88 0.371 . . . . 0.0 111.071 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -66.92 -18.25 65.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.173 179.001 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.27 10.42 32.03 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.509 179.28 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.839 ' CG2' ' HB1' ' A' ' 116' ' ' ALA . 12.1 mm -122.37 127.29 75.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.596 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.953 HG12 ' HB2' ' A' ' 92' ' ' ALA . 29.6 m -146.14 135.52 17.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.821 0.343 . . . . 0.0 111.796 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.754 HD12 ' HB ' ' A' ' 91' ' ' ILE . 10.8 mt -45.97 154.0 0.27 Allowed 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.66 0.743 . . . . 0.0 111.913 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.821 ' O ' HG22 ' A' ' 114' ' ' ILE . 10.8 t70 -157.92 168.59 26.74 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.88 -177.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.693 HD12 HG21 ' A' ' 32' ' ' THR . 34.6 mm -88.77 126.95 41.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.603 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.713 HG22 ' O ' ' A' ' 113' ' ' HIS . 0.5 OUTLIER -64.16 134.11 29.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.184 0.516 . . . . 0.0 111.449 -179.699 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 12.7 tttm 62.46 10.2 3.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.929 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.0 p 40.22 33.21 0.15 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.697 0.284 . . . . 0.0 111.587 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.468 ' O ' ' ND2' ' A' ' 13' ' ' ASN . 0.6 OUTLIER -91.93 154.73 18.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.931 0.396 . . . . 0.0 111.191 -179.672 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.534 ' HA ' ' ND2' ' A' ' 13' ' ' ASN . 0.1 OUTLIER -79.28 -16.17 56.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.322 179.926 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -49.36 126.52 13.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.791 0.329 . . . . 0.0 111.308 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -73.1 157.95 36.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.031 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.48 14.08 81.27 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.17 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.52 134.03 38.4 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.924 0.392 . . . . 0.0 111.035 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.713 ' O ' HG22 ' A' ' 104' ' ' ILE . 0.8 OUTLIER -60.91 167.08 3.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.878 -179.798 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.821 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.1 OUTLIER -139.48 161.41 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.728 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.673 ' HA ' HD11 ' A' ' 70' ' ' ILE . 5.7 p -157.6 173.3 17.07 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.839 ' HB1' ' CG2' ' A' ' 99' ' ' ILE . . . -95.27 129.47 42.38 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.349 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.456 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 75.7 t-105 -136.04 162.47 32.79 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.565 0.698 . . . . 0.0 112.096 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.456 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.0 OUTLIER -61.63 118.77 7.51 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.773 179.976 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -59.01 127.13 30.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.997 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -134.08 11.25 3.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.155 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 77.44 7.64 87.06 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.864 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.5 154.88 41.4 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.507 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.46 -28.4 53.99 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.625 2.216 . . . . 0.0 112.28 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.569 ' HA ' HD22 ' A' ' 12' ' ' LEU . 30.3 p-10 -74.52 -4.07 34.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.589 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.419 ' O ' ' CG2' ' A' ' 90' ' ' THR . 0.0 OUTLIER -108.34 15.81 23.69 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.571 0.224 . . . . 0.0 111.176 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.429 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 16.7 mmtt -107.06 134.01 50.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.765 0.317 . . . . 0.0 111.384 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.43 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 4.5 m-85 -137.05 155.29 49.85 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.303 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.4 mt -113.55 139.14 40.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.174 0.511 . . . . 0.0 110.587 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.575 HD12 HG23 ' A' ' 8' ' ' ILE . 24.0 mm -113.97 139.79 37.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.616 -179.092 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -136.77 94.68 3.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.628 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.3 p -52.48 110.81 0.54 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.253 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.448 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 5.2 tp10 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.996 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.471 ' CE2' ' HB3' ' A' ' 132' ' ' GLU . 2.3 p90 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.451 0.167 . . . . 0.0 110.7 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.723 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -161.08 177.8 9.94 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.628 179.73 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.75 ' OH ' ' HB1' ' A' ' 41' ' ' ALA . 1.0 OUTLIER -112.61 123.83 51.18 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.42 179.379 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.617 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -103.97 109.42 27.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.123 0.487 . . . . 0.0 109.802 179.552 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.506 ' HE2' HD12 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -102.89 130.84 50.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.579 -178.025 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.68 103.18 7.46 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 178.369 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.421 ' HB3' ' O ' ' A' ' 126' ' ' LYS . 3.3 tt0 -65.58 -8.22 18.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.768 -178.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.722 HD22 ' CB ' ' A' ' 124' ' ' ASN . 36.1 tp -83.16 -63.6 1.33 Allowed 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.44 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.44 HD21 HG21 ' A' ' 103' ' ' ILE . 3.3 m-80 -83.72 -7.78 59.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.862 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.78 4.85 72.54 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.11 -1.043 . . . . 0.0 111.234 -177.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm -94.43 -166.31 1.46 Allowed 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 122.809 0.444 . . . . 0.0 109.958 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.58 HG21 ' HA ' ' A' ' 35' ' ' GLN . 6.3 m -130.78 143.93 39.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.3 mt -70.19 135.11 48.76 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -145.15 155.97 43.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.915 0.388 . . . . 0.0 111.196 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.066 HD13 HG21 ' A' ' 72' ' ' THR . 17.4 mt . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.517 179.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 CA-C-O 120.285 -0.175 . . . . 0.0 113.3 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.55 125.24 26.97 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 117.102 0.451 . . . . 0.0 111.258 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -77.64 159.99 28.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.562 179.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.53 HD13 HG21 ' A' ' 63' ' ' ILE . 47.9 pt -121.1 148.27 24.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.885 0.374 . . . . 0.0 111.771 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.457 HG22 ' HA ' ' A' ' 113' ' ' HIS . 0.3 OUTLIER -156.01 -178.3 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.219 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.551 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.633 HG21 HD12 ' A' ' 103' ' ' ILE . 1.6 p -100.54 147.94 25.35 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.617 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 25.6 t-105 -159.15 173.79 15.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.66 0.267 . . . . 0.0 110.798 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -69.8 134.7 48.83 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.815 0.34 . . . . 0.0 110.762 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.58 ' HA ' HG21 ' A' ' 16' ' ' VAL . 6.6 tt0 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.125 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.775 ' O ' HD12 ' A' ' 45' ' ' LEU . . . . . . . . 0 N--CA 1.456 -0.151 0 CA-C-O 120.754 0.311 . . . . 0.0 110.447 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.413 ' HA ' ' CD1' ' A' ' 45' ' ' LEU . 28.3 t -50.32 -25.77 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.091 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -61.62 -11.33 11.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.712 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -120.13 8.43 10.95 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.015 0.436 . . . . 0.0 109.978 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.775 HD12 ' O ' ' A' ' 41' ' ' ALA . 1.5 mp -116.98 139.77 50.27 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.828 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.468 ' O ' ' HA ' ' A' ' 5' ' ' PHE . 23.9 m95 -134.38 168.04 19.65 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.027 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.526 ' CE1' ' HB2' ' A' ' 55' ' ' ARG . 26.5 p90 -140.11 164.2 30.69 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.101 178.652 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -106.45 133.74 50.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.859 0.361 . . . . 0.0 111.327 -179.014 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -77.69 166.03 23.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.063 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.28 -24.08 62.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.112 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -94.74 -3.23 49.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.42 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.555 ' O ' HG22 ' A' ' 85' ' ' ILE . . . 98.99 7.82 54.76 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.826 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.545 HG13 ' HA ' ' A' ' 83' ' ' ALA . 21.2 t -92.76 118.48 38.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.76 0.28 . . . . 0.0 110.549 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.523 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -76.11 146.98 8.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.294 0.568 . . . . 0.0 111.863 -179.786 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.792 ' CD ' ' HB2' ' A' ' 62' ' ' ALA . 7.7 mmm-85 -150.21 135.27 17.81 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.629 179.089 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 15.0 m . . . . . 0 C--N 1.327 -0.411 0 CA-C-O 121.369 0.604 . . . . 0.0 112.012 -179.008 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.874 0.368 . . . . 0.0 110.787 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.792 ' HB2' ' CD ' ' A' ' 55' ' ' ARG . . . -113.07 154.12 27.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.352 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.893 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -79.77 153.09 4.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.725 179.776 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.599 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 6.3 p-10 -132.33 132.8 43.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.126 0.489 . . . . 0.0 111.609 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.73 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -97.75 39.86 1.19 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.317 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.42 -43.52 60.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.252 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -96.29 172.08 8.18 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.018 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -47.73 -48.72 29.57 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.042 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.83 147.64 26.26 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.666 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.893 HG22 HG22 ' A' ' 63' ' ' ILE . 1.6 mm -78.62 144.01 11.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-O 121.649 0.738 . . . . 0.0 111.992 -179.138 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.73 166.07 25.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.799 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . 1.066 HG21 HD13 ' A' ' 19' ' ' ILE . 73.9 p -102.33 138.95 38.57 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.051 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.48 159.94 20.38 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.392 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.402 ' O ' ' HD3' ' A' ' 82' ' ' ARG . 52.2 Cg_exo -52.54 136.59 57.32 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.441 2.094 . . . . 0.0 111.887 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.478 ' CD2' HG11 ' A' ' 53' ' ' VAL . 17.4 t80 -57.09 132.19 52.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.223 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -121.75 134.46 24.64 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.608 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.3 -34.93 15.02 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.424 2.083 . . . . 0.0 112.608 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -87.4 -0.77 57.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.55 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -108.96 100.18 38.74 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-O 120.622 0.248 . . . . 0.0 111.021 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.826 ' O ' HD21 ' A' ' 94' ' ' LEU . 4.0 Cg_exo -76.73 25.14 0.45 Allowed 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.988 2.459 . . . . 0.0 113.02 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.707 ' HD2' ' HB3' ' A' ' 65' ' ' ALA . 42.7 mmtt -119.72 -21.06 7.41 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 120.635 0.255 . . . . 0.0 110.893 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.521 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 3.6 mtm180 -87.01 17.91 3.88 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.24 -179.249 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 1.102 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -127.25 99.29 5.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.166 0.508 . . . . 0.0 110.764 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.73 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 62.1 m95 -109.27 136.27 49.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.105 0.479 . . . . 0.0 111.77 -178.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.555 HG22 ' O ' ' A' ' 52' ' ' GLY . 2.6 pp -115.73 154.6 17.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.139 179.187 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.8 t -102.03 130.0 52.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.932 0.396 . . . . 0.0 111.184 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 36.7 t -122.61 95.18 4.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.447 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.45 -100.71 0.83 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.545 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.499 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.97 29.67 7.25 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.509 0.195 . . . . 0.0 110.789 -179.731 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.424 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.72 147.63 30.13 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -178.49 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.501 ' HB ' HD12 ' A' ' 101' ' ' LEU . 27.5 mm -94.03 120.47 43.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.421 178.459 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.95 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -124.27 146.11 48.97 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -178.394 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.583 ' NE2' ' CZ2' ' A' ' 84' ' ' TRP . 1.1 tp60 -65.42 150.06 48.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.673 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.102 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.7 pt? -62.81 -57.22 11.63 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.721 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.585 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 1.5 m -79.8 -2.06 41.64 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -178.459 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.526 ' O ' HG22 ' A' ' 99' ' ' ILE . 1.5 m-20 -137.48 85.54 2.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.842 0.353 . . . . 0.0 110.809 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 16.4 mmt85 -69.48 -16.68 63.51 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.158 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -90.35 11.29 21.87 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.138 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.526 HG22 ' O ' ' A' ' 96' ' ' ASP . 5.6 tt -130.21 136.42 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.151 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.95 HG12 ' HB2' ' A' ' 92' ' ' ALA . 19.8 m -148.57 137.36 15.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.455 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.509 ' HA ' ' O ' ' A' ' 115' ' ' CYS . 25.8 mt -45.31 153.99 0.19 Allowed 'General case' 0 CA--C 1.51 -0.596 0 CA-C-O 121.713 0.768 . . . . 0.0 111.622 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.825 ' O ' HG22 ' A' ' 114' ' ' ILE . 27.4 t70 -157.49 167.72 29.38 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.964 -177.424 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.633 HD12 HG21 ' A' ' 32' ' ' THR . 33.1 mm -86.46 123.34 39.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.232 179.063 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.82 HG22 ' O ' ' A' ' 113' ' ' HIS . 0.8 OUTLIER -68.26 139.3 20.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.1 0.476 . . . . 0.0 111.65 -179.549 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.12 18.36 3.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.815 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.405 ' HA ' HD21 ' A' ' 12' ' ' LEU . 13.4 m 45.1 -132.87 0.84 Allowed 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.918 -0.128 . . . . 0.0 111.041 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 65.45 162.9 0.15 Allowed 'General case' 0 CA--C 1.526 0.037 0 CA-C-O 120.772 0.32 . . . . 0.0 111.025 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -90.04 -12.4 38.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.448 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -44.81 132.54 6.56 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.391 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -89.22 164.74 14.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.245 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 71.61 19.01 77.61 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.048 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -86.18 138.34 31.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.841 0.353 . . . . 0.0 110.915 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.82 ' O ' HG22 ' A' ' 104' ' ' ILE . 34.7 m80 -62.12 170.52 2.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.749 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.825 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.6 OUTLIER -143.94 161.84 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.928 -179.497 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.673 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 6.0 p -156.65 173.49 16.86 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.673 ' HB2' ' HH2' ' A' ' 84' ' ' TRP . . . -95.99 128.71 43.13 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 178.351 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.451 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 75.0 t-105 -134.81 162.68 31.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.494 0.664 . . . . 0.0 112.059 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.451 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.3 OUTLIER -62.33 122.99 17.05 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.787 179.929 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -56.99 124.1 17.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.054 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -128.78 5.57 5.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.394 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 81.69 6.86 88.75 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.88 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -65.98 148.93 51.32 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.528 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.03 -27.01 57.91 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.564 2.176 . . . . 0.0 112.382 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.722 ' CB ' HD22 ' A' ' 12' ' ' LEU . 42.5 p-10 -66.95 -12.26 59.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.561 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.425 ' HG2' ' HB2' ' A' ' 102' ' ' ASP . 6.0 mt-30 -103.5 17.57 23.79 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.338 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.421 ' O ' ' HB3' ' A' ' 11' ' ' GLU . 12.3 mmtp -106.43 136.28 46.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.856 0.36 . . . . 0.0 111.568 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.432 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 3.0 m-85 -141.13 155.28 46.13 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.909 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.506 HD12 ' HE2' ' A' ' 9' ' ' LYS . 1.5 mt -110.65 139.68 33.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.146 0.498 . . . . 0.0 110.651 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.434 HD12 HG23 ' A' ' 8' ' ' ILE . 21.9 mm -112.98 139.69 36.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.648 -179.009 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -138.08 94.46 2.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.618 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.5 t -52.13 113.16 0.94 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.341 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.471 ' HB3' ' CE2' ' A' ' 5' ' ' PHE . 2.2 tm-20 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.272 -0.871 . . . . 0.0 110.932 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.593 0.235 . . . . 0.0 110.665 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.613 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -152.46 170.22 20.66 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 120.952 0.406 . . . . 0.0 111.14 179.303 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.458 ' O ' ' HA ' ' A' ' 129' ' ' ILE . 0.1 OUTLIER -108.62 123.74 49.42 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.932 178.942 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.629 ' HB ' HD21 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -107.72 106.12 20.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.341 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.434 ' HD3' HG13 ' A' ' 16' ' ' VAL . 1.3 tptp -104.92 134.63 47.71 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.508 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 54.2 m -75.82 107.13 7.79 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.218 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.45 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 4.3 tt0 -63.14 -10.49 15.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.61 -178.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 51.1 tp -81.84 -62.96 1.49 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.97 0.414 . . . . 0.0 110.869 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.463 HD21 HG21 ' A' ' 103' ' ' ILE . 6.5 m-20 -86.31 -7.46 58.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.244 -178.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.48 6.54 62.38 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.05 -1.071 . . . . 0.0 111.459 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.6 mmmm -94.94 -176.22 3.78 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.576 HG21 ' HA ' ' A' ' 35' ' ' GLN . 3.6 m -122.52 142.2 39.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.629 HD21 ' HB ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -72.56 138.23 46.74 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.174 179.52 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 19' ' ' ILE . 31.5 t0 -146.01 142.38 28.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.78 0.324 . . . . 0.0 111.033 -178.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.763 HD12 HG21 ' A' ' 72' ' ' THR . 7.9 mm . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.319 -0.4 . . . . 0.0 109.925 179.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 CA-C-O 120.236 -0.202 . . . . 0.0 113.066 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.5 m -72.55 138.61 47.01 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 117.085 0.443 . . . . 0.0 110.69 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.48 157.44 19.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.784 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.657 HD11 ' HB ' ' A' ' 70' ' ' ILE . 42.1 pt -115.74 145.9 20.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.377 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.435 ' HA ' ' CD1' ' A' ' 114' ' ' ILE . 0.3 OUTLIER -153.46 177.71 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.156 -179.741 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.8 p -102.03 148.89 24.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.759 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 41.0 t-105 -157.45 172.08 19.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.713 0.292 . . . . 0.0 110.826 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.65 134.21 48.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.732 0.301 . . . . 0.0 110.734 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.576 ' HA ' HG21 ' A' ' 16' ' ' VAL . 8.0 tt0 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.055 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.547 ' O ' HD12 ' A' ' 45' ' ' LEU . . . . . . . . 0 CA--C 1.524 -0.03 0 CA-C-O 120.545 0.212 . . . . 0.0 111.168 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.544 ' HA ' HD13 ' A' ' 45' ' ' LEU . 2.5 t -60.27 -17.29 14.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.761 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 29.7 p30 -60.36 -13.51 13.55 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.047 178.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -111.38 7.36 20.87 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.613 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 1.8 mp -120.09 147.63 44.61 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.469 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.634 ' CZ2' HD11 ' A' ' 19' ' ' ILE . 25.4 m95 -133.34 169.57 16.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.818 -179.055 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.505 ' CE2' ' HB2' ' A' ' 55' ' ' ARG . 1.5 p90 -136.14 159.19 42.47 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.007 178.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.509 HG22 ' CG2' ' A' ' 54' ' ' ILE . 40.0 p -106.22 132.88 51.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.763 0.316 . . . . 0.0 111.256 -179.199 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -77.67 165.36 24.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.108 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -60.94 -24.07 65.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.017 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -93.17 -3.35 54.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.44 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.95 8.75 53.69 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.883 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.555 HG11 ' CD2' ' A' ' 75' ' ' PHE . 33.8 t -95.5 119.74 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 116.946 0.373 . . . . 0.0 110.638 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.509 ' CG2' HG22 ' A' ' 48' ' ' THR . 0.8 OUTLIER -79.35 151.9 4.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.246 0.546 . . . . 0.0 111.863 -179.826 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.557 ' CD ' ' HB2' ' A' ' 62' ' ' ALA . 8.6 mmm-85 -148.11 133.3 18.36 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.289 179.063 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.48 0 CA-C-O 121.323 0.582 . . . . 0.0 111.968 -178.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.419 ' CE2' ' HA ' ' A' ' 73' ' ' GLN . 2.2 m-85 . . . . . 0 C--O 1.233 0.214 0 CA-C-O 121.121 0.486 . . . . 0.0 110.7 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.557 ' HB2' ' CD ' ' A' ' 55' ' ' ARG . . . -98.87 152.22 19.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.118 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.898 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -77.9 149.91 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.349 179.523 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.649 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 3.7 p-10 -131.51 133.16 44.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.133 0.492 . . . . 0.0 111.79 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.643 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -99.36 42.41 1.1 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.369 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 66.4 p -74.34 -44.53 52.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.15 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -96.72 172.53 7.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.963 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -48.86 -44.19 39.49 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.056 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.68 145.43 29.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.986 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.898 HG22 HG22 ' A' ' 63' ' ' ILE . 2.8 mm -75.77 141.8 15.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-O 121.555 0.693 . . . . 0.0 111.358 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -136.96 168.76 18.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.001 -0.999 . . . . 0.0 111.432 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.763 HG21 HD12 ' A' ' 19' ' ' ILE . 23.2 p -108.54 135.79 49.23 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.213 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.419 ' HA ' ' CE2' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -165.54 171.9 4.77 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.429 -179.725 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.415 ' HD3' ' CE2' ' A' ' 61' ' ' PHE . 75.6 Cg_exo -49.09 139.83 25.87 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.506 2.137 . . . . 0.0 111.957 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.555 ' CD2' HG11 ' A' ' 53' ' ' VAL . 48.4 t80 -47.74 -59.58 3.19 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -179.42 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.403 ' HB2' ' HD3' ' A' ' 82' ' ' ARG . 0.3 OUTLIER 63.56 118.83 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 -179.166 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.47 -28.65 21.6 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.527 2.151 . . . . 0.0 113.445 -179.183 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -87.25 0.58 55.15 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.45 ' CB ' ' HD2' ' A' ' 82' ' ' ARG . 1.9 m120 -104.42 101.97 30.68 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 120.63 0.253 . . . . 0.0 111.328 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.862 ' O ' HD21 ' A' ' 94' ' ' LEU . 94.8 Cg_endo -77.58 18.6 0.81 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.733 2.288 . . . . 0.0 113.319 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.649 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -118.97 -19.84 8.35 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 120.716 0.293 . . . . 0.0 110.905 179.818 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.509 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 36.5 mtt180 -91.01 25.62 2.38 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.227 -178.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 1.054 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -136.96 99.48 4.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.94 0.4 . . . . 0.0 110.898 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.672 ' HH2' ' HB2' ' A' ' 116' ' ' ALA . 38.6 m95 -109.58 139.13 44.97 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.246 0.546 . . . . 0.0 111.78 -178.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 pp -112.7 155.92 13.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.287 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.6 t -102.64 128.15 55.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.962 0.41 . . . . 0.0 111.246 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.9 t -120.92 94.6 4.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.209 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.41 -100.98 0.85 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.34 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.5 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.76 29.84 7.2 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.579 0.228 . . . . 0.0 110.843 -179.81 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.425 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.44 147.51 30.29 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.383 0.611 . . . . 0.0 112.64 -178.595 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.718 ' HB ' HD12 ' A' ' 101' ' ' LEU . 20.1 mm -94.02 120.29 43.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.292 178.593 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.9 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -122.2 144.11 49.16 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.441 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -64.82 148.14 51.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.435 179.566 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.054 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.5 pt? -62.79 -57.49 10.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.8 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.548 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 3.5 t -75.81 -3.91 37.69 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.489 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.477 ' O ' HG22 ' A' ' 99' ' ' ILE . 19.0 t0 -141.14 89.63 2.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.841 0.353 . . . . 0.0 110.891 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 8.8 mmt85 -70.79 -16.02 62.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.232 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -88.93 10.87 19.79 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.253 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.477 HG22 ' O ' ' A' ' 96' ' ' ASP . 5.3 tt -131.05 137.54 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.055 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.9 HG12 ' HB2' ' A' ' 92' ' ' ALA . 17.5 m -148.39 138.59 16.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.774 0.321 . . . . 0.0 111.536 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.718 HD12 ' HB ' ' A' ' 91' ' ' ILE . 10.9 mt -46.32 153.87 0.31 Allowed 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.634 0.731 . . . . 0.0 111.581 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.735 ' O ' HG22 ' A' ' 114' ' ' ILE . 9.8 t70 -158.85 168.08 27.75 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.46 -1.245 . . . . 0.0 110.669 -177.388 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.558 HD12 ' O ' ' A' ' 124' ' ' ASN . 4.6 mp -87.34 120.69 37.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.139 179.095 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.765 HD11 ' HB2' ' A' ' 115' ' ' CYS . 40.2 mm -70.03 136.39 26.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.883 0.373 . . . . 0.0 111.253 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 8.4 tttt 78.92 -6.1 1.94 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.764 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.1 m 46.45 29.7 0.94 Allowed 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 120.809 0.338 . . . . 0.0 111.27 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.39 155.01 17.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.039 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.1 -13.74 59.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.097 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -48.78 123.14 6.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.229 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.4 157.86 30.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.037 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.24 12.55 81.76 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.146 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.51 131.52 41.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.873 0.368 . . . . 0.0 111.052 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -64.87 172.44 2.84 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.111 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.735 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -136.71 161.67 36.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.349 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.765 ' HB2' HD11 ' A' ' 104' ' ' ILE . 6.3 t -153.38 167.47 29.29 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.672 ' HB2' ' HH2' ' A' ' 84' ' ' TRP . . . -94.75 125.24 39.28 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 177.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.459 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 76.1 t-105 -133.56 162.38 32.07 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.629 0.728 . . . . 0.0 112.291 -179.265 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.459 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.0 OUTLIER -61.79 119.82 9.49 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.621 179.836 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -59.74 126.05 26.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.1 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 14.2 p-80 -134.11 10.7 3.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.21 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 81.15 7.88 87.96 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.981 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.48 150.09 47.74 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.603 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.37 -27.02 55.29 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.561 2.174 . . . . 0.0 112.182 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.558 ' O ' HD12 ' A' ' 103' ' ' ILE . 32.1 p-10 -75.45 -4.42 39.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.425 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.425 ' O ' ' CG2' ' A' ' 90' ' ' THR . 0.0 OUTLIER -105.82 12.95 30.22 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.29 -179.741 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.45 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 5.9 mmtt -106.02 140.3 39.23 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.863 0.364 . . . . 0.0 111.367 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.414 ' CD1' ' O ' ' A' ' 126' ' ' LYS . 8.9 m-85 -138.67 155.27 48.42 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.162 179.615 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 mt -111.45 137.24 44.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.049 0.452 . . . . 0.0 110.41 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.458 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 36.6 mm -113.47 140.9 31.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.64 -179.031 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -140.83 106.2 5.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.596 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.61 109.11 0.94 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.044 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 34.5 tp10 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.232 -0.89 . . . . 0.0 111.127 179.888 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.474 ' HA ' ' O ' ' A' ' 46' ' ' TRP . 2.1 p90 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.484 0.183 . . . . 0.0 110.618 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.742 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -159.92 175.97 12.43 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.596 179.744 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.439 ' CE1' ' HB3' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -114.22 123.88 50.66 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.288 179.206 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.624 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -104.12 109.77 28.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.37 -179.924 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 16' ' ' VAL . 0.1 OUTLIER -105.63 135.42 47.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.464 -178.756 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.8 t -75.27 105.66 6.4 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -62.66 -11.88 19.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.594 -178.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.488 ' HB2' ' HA ' ' A' ' 124' ' ' ASN . 12.3 tp -84.51 -62.49 1.54 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.964 0.412 . . . . 0.0 110.967 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.626 HD21 HG21 ' A' ' 103' ' ' ILE . 12.9 m-20 -83.08 -12.81 56.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.48 -178.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.53 2.9 76.7 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.143 -1.027 . . . . 0.0 111.491 -178.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -91.86 -175.14 4.04 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.74 HG11 ' HG3' ' A' ' 35' ' ' GLN . 5.4 m -121.62 140.22 46.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.656 0.265 . . . . 0.0 110.437 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.5 mt -69.4 134.76 49.41 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -143.61 153.99 43.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.888 0.375 . . . . 0.0 111.196 -178.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.06 HD13 HG21 ' A' ' 72' ' ' THR . 34.0 mt . . . . . 0 C--N 1.327 -0.409 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.572 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.395 0 CA-C-O 120.332 -0.149 . . . . 0.0 113.08 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.75 138.61 48.58 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.946 0.403 . . . . 0.0 111.056 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.3 mptt -89.4 157.71 18.04 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.216 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.721 HD11 ' HB ' ' A' ' 70' ' ' ILE . 38.0 pt -116.34 145.91 21.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.799 0.333 . . . . 0.0 111.743 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.461 ' HA ' ' CD1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -155.32 178.17 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.192 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.537 -179.827 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.6 p -100.68 148.77 24.49 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 121.001 -0.279 . . . . 0.0 110.65 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 24.3 t-105 -157.69 172.57 18.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.706 0.289 . . . . 0.0 110.883 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -69.77 133.93 48.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.852 0.358 . . . . 0.0 110.706 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.74 ' HG3' HG11 ' A' ' 16' ' ' VAL . 6.9 tt0 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.112 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.956 ' O ' HD12 ' A' ' 45' ' ' LEU . . . . . . . . 0 CA--C 1.527 0.088 0 CA-C-O 120.765 0.317 . . . . 0.0 111.124 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 45.3 t -49.69 -29.77 4.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.113 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -65.69 -10.91 40.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.927 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.439 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 3.5 mt-30 -118.2 7.59 12.14 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.19 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.956 HD12 ' O ' ' A' ' 41' ' ' ALA . 1.1 mp -118.82 140.38 50.05 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.981 -179.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.76 ' CZ2' HD11 ' A' ' 19' ' ' ILE . 24.8 m95 -134.12 168.82 18.13 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.92 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.52 ' CZ ' ' HB2' ' A' ' 55' ' ' ARG . 32.0 p90 -140.73 164.93 28.87 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.219 178.692 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.454 HG22 ' CG2' ' A' ' 54' ' ' ILE . 81.1 p -107.6 134.32 50.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.833 0.349 . . . . 0.0 111.378 -178.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -77.81 170.25 16.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.15 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.17 -23.62 67.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.077 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.3 mm100 -94.04 -3.45 51.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.242 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.95 8.78 53.65 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.917 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.429 HG11 ' CE2' ' A' ' 75' ' ' PHE . 42.2 t -95.14 119.63 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-O 120.83 0.348 . . . . 0.0 110.693 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -76.68 147.85 7.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.341 0.591 . . . . 0.0 111.9 -179.792 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.612 ' CD ' ' HB2' ' A' ' 62' ' ' ALA . 8.2 mmm-85 -149.48 133.69 17.31 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.39 179.076 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.46 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 70.0 m . . . . . 0 C--N 1.326 -0.422 0 CA-C-O 121.463 0.649 . . . . 0.0 111.848 -178.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.416 ' CE2' ' HD3' ' A' ' 74' ' ' PRO . 2.8 m-85 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.828 0.347 . . . . 0.0 110.77 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.612 ' HB2' ' CD ' ' A' ' 55' ' ' ARG . . . -109.26 154.9 21.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.547 -179.715 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.85 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -80.37 150.79 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.466 179.587 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.575 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 6.4 p-10 -131.61 132.09 43.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.064 0.459 . . . . 0.0 111.419 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.666 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -97.51 41.66 1.11 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.192 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.4 t -74.83 -45.54 42.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.158 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 59.6 m80 -94.44 170.76 9.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.982 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -47.83 -48.02 31.0 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.106 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -99.6 143.86 29.35 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.099 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.85 HG22 HG22 ' A' ' 63' ' ' ILE . 3.0 mm -74.2 139.95 18.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 CA-C-O 121.554 0.692 . . . . 0.0 111.478 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -139.88 168.94 18.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.262 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . 1.06 HG21 HD13 ' A' ' 19' ' ' ILE . 63.4 p -108.59 139.2 43.7 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.281 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.6 163.02 16.72 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.485 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.416 ' HD3' ' CE2' ' A' ' 61' ' ' PHE . 50.7 Cg_exo -55.08 136.06 71.49 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.474 2.116 . . . . 0.0 111.729 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.429 ' CE2' HG11 ' A' ' 53' ' ' VAL . 32.7 t80 -52.77 134.72 36.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.97 0.414 . . . . 0.0 111.489 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.421 ' HB2' ' CZ ' ' A' ' 82' ' ' ARG . 21.6 t70 -124.21 116.8 27.03 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.477 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -56.98 -33.76 96.18 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.532 2.155 . . . . 0.0 113.045 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 33.5 m-20 -86.89 -0.07 55.86 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -179.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 -112.55 104.07 55.78 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 120.629 0.252 . . . . 0.0 111.114 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.828 ' O ' HD21 ' A' ' 94' ' ' LEU . 84.4 Cg_endo -76.84 27.11 0.43 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.733 2.289 . . . . 0.0 113.105 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.602 ' HD2' ' HB3' ' A' ' 65' ' ' ALA . 40.7 mmtt -120.29 -19.5 7.64 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 116.687 -0.233 . . . . 0.0 111.162 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.543 ' HG2' ' HB3' ' A' ' 64' ' ' ASP . 3.5 mtm180 -88.43 19.71 3.71 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.329 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 1.132 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -130.03 99.38 5.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.075 0.464 . . . . 0.0 110.784 179.445 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.666 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 58.8 m95 -109.05 135.77 49.66 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.146 0.498 . . . . 0.0 111.979 -178.721 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.796 HD11 ' HD3' ' A' ' 97' ' ' ARG . 1.1 pp -111.82 152.87 13.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.084 179.112 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.3 t -100.57 126.37 54.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.941 0.4 . . . . 0.0 111.133 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.3 t -119.39 94.85 4.56 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.577 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.81 -100.41 0.76 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.643 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.491 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.51 29.64 7.34 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.518 0.199 . . . . 0.0 110.977 -179.492 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -149.71 149.11 30.09 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.337 0.589 . . . . 0.0 112.493 -178.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.83 ' HB ' HD12 ' A' ' 101' ' ' LEU . 12.3 mm -94.01 120.71 43.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.449 178.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.882 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -121.38 144.54 48.61 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -178.454 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.419 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -66.33 149.02 51.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.929 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.132 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.6 pt? -64.26 -57.36 9.67 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.018 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.587 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 3.5 m -74.06 -4.12 33.54 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.192 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.586 ' O ' HG22 ' A' ' 99' ' ' ILE . 73.2 m-20 -146.73 93.01 2.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.099 0.476 . . . . 0.0 111.035 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.796 ' HD3' HD11 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -73.04 -13.12 61.15 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.587 179.37 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -87.89 12.02 14.23 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.481 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.824 HG12 ' HB1' ' A' ' 116' ' ' ALA . 2.6 tt -135.09 143.25 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.034 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.882 HG12 ' HB2' ' A' ' 92' ' ' ALA . 34.9 m -151.66 139.71 14.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.789 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.83 HD12 ' HB ' ' A' ' 91' ' ' ILE . 10.6 mt -46.2 154.31 0.27 Allowed 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 121.722 0.772 . . . . 0.0 111.706 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.733 ' O ' HG22 ' A' ' 114' ' ' ILE . 28.5 t70 -158.3 168.29 27.42 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.629 -177.491 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.626 HG21 HD21 ' A' ' 13' ' ' ASN . 26.8 mm -89.35 120.97 38.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.389 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.832 HG22 ' O ' ' A' ' 113' ' ' HIS . 7.9 tp -64.72 138.66 22.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.023 0.44 . . . . 0.0 111.457 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 73.54 -3.71 2.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.043 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 45.3 t 44.19 31.26 0.53 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.76 0.314 . . . . 0.0 111.428 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -97.36 158.12 15.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.194 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.99 -13.4 59.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.183 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -49.11 131.93 19.29 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.26 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -77.17 158.86 30.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.017 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 72.3 15.34 76.98 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.145 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.05 132.61 40.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.895 0.378 . . . . 0.0 110.929 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.832 ' O ' HG22 ' A' ' 104' ' ' ILE . 6.2 m80 -64.99 171.53 3.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.934 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.733 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -135.45 161.25 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.397 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.586 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 5.8 t -152.39 167.22 29.41 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.824 ' HB1' HG12 ' A' ' 99' ' ' ILE . . . -94.99 124.73 39.21 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.228 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.447 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 77.0 t-105 -133.49 161.4 34.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.619 0.723 . . . . 0.0 112.236 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.447 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.0 OUTLIER -61.03 123.0 16.38 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.57 -1.195 . . . . 0.0 110.806 -179.906 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -58.84 125.05 21.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.951 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 6.1 p-80 -136.98 6.32 2.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.595 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 78.26 57.1 3.49 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.273 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -112.0 138.73 15.18 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.509 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.67 -31.42 60.32 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.447 2.098 . . . . 0.0 112.18 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.488 ' HA ' ' HB2' ' A' ' 12' ' ' LEU . 10.9 p-10 -72.0 -8.0 52.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.575 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -101.9 -14.31 17.28 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.57 0.211 . . . . 0.0 111.57 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.428 ' O ' ' CD1' ' A' ' 127' ' ' PHE . 2.3 mmtt -78.27 136.73 37.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.811 0.339 . . . . 0.0 111.373 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.428 ' CD1' ' O ' ' A' ' 126' ' ' LYS . 6.8 m-85 -139.15 156.22 47.28 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.136 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 mt -112.33 137.77 43.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.176 0.513 . . . . 0.0 110.592 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.569 HD12 HG23 ' A' ' 8' ' ' ILE . 19.5 mm -114.36 138.7 43.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.527 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -134.52 94.29 3.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.54 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.15 108.06 0.48 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.134 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.295 -0.86 . . . . 0.0 111.358 179.726 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mmm . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.878 0.371 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.9 mmmt -116.02 91.22 30.77 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.948 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.0 -170.35 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.489 2.126 . . . . 0.0 112.253 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.402 ' O ' ' CB ' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -114.67 141.3 47.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.92 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.488 ' HD2' HD22 ' A' ' 45' ' ' LEU . 0.1 OUTLIER -104.05 175.82 5.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.351 179.821 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.793 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -155.24 171.28 20.08 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.613 179.815 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.81 ' OH ' ' HB1' ' A' ' 41' ' ' ALA . 2.0 m-85 -109.2 123.41 49.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.23 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.616 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -108.23 103.72 15.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.842 0.353 . . . . 0.0 110.275 179.674 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.855 ' HB3' HG12 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -127.98 126.84 42.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.763 -179.036 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.467 ' O ' ' HD2' ' A' ' 9' ' ' LYS . 0.9 OUTLIER -46.15 138.44 5.29 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.019 0.437 . . . . 0.0 111.575 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.543 ' HA ' HD11 ' A' ' 128' ' ' ILE . 3.2 tt0 -81.13 -11.28 59.5 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.082 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 61.4 tp -92.9 -56.54 2.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.165 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -83.24 -21.09 33.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.83 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.18 4.08 77.7 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.284 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.59 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 1.1 mmmm -85.26 164.25 18.15 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.855 HG12 ' HB3' ' A' ' 9' ' ' LYS . 12.6 m -106.95 137.0 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-O 120.769 0.318 . . . . 0.0 110.722 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 21.0 mt -68.31 136.57 53.65 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -138.26 152.01 48.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.841 0.353 . . . . 0.0 111.111 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.929 HD13 HG21 ' A' ' 72' ' ' THR . 1.5 mt -101.12 118.92 48.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.872 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.444 ' HG3' HD12 ' A' ' 31' ' ' ILE . 1.6 mt-10 -63.42 95.87 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.891 0.377 . . . . 0.0 110.444 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 157.24 -44.16 0.51 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.373 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 48.7 51.24 16.03 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.812 0.339 . . . . 0.0 111.323 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -177.17 171.98 0.86 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.053 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.56 -17.15 40.05 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.748 2.299 . . . . 0.0 112.418 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -45.51 99.49 0.21 Allowed Pre-proline 0 CA--C 1.531 0.215 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.329 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.422 ' HB3' ' HD3' ' A' ' 74' ' ' PRO . 14.9 Cg_exo -69.17 150.65 72.06 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.69 2.26 . . . . 0.0 112.134 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.55 8.66 55.88 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.588 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.37 132.91 37.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.945 0.403 . . . . 0.0 111.114 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.87 155.65 30.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.311 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.698 HG22 HG23 ' A' ' 19' ' ' ILE . 47.8 pt -115.31 144.59 22.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.921 0.391 . . . . 0.0 111.676 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.444 HD12 ' HG3' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -156.09 -176.68 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.581 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.513 HG21 HD12 ' A' ' 103' ' ' ILE . 1.2 p -101.75 148.56 25.14 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.343 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 10.4 t-105 -159.1 173.84 15.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.709 0.29 . . . . 0.0 111.009 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -71.85 138.32 48.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.815 0.341 . . . . 0.0 110.86 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.619 ' HA ' HG21 ' A' ' 16' ' ' VAL . 28.4 tt0 -64.79 137.28 57.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.176 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.9 mmmt -109.17 165.04 11.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.683 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.3 mtmt -128.14 112.19 14.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.983 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 146.05 -163.35 28.36 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.638 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -72.2 -1.18 9.7 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.983 2.455 . . . . 0.0 112.884 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.5 t -111.91 36.45 3.3 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.098 0.475 . . . . 0.0 110.666 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.898 ' O ' HD12 ' A' ' 45' ' ' LEU . . . -107.89 -18.95 13.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.885 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.97 HG13 ' HB3' ' A' ' 57' ' ' LYS . 99.6 t -49.73 -28.07 3.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.191 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -67.07 -9.0 34.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.804 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -119.6 6.14 11.05 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.153 0.501 . . . . 0.0 109.821 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.898 HD12 ' O ' ' A' ' 41' ' ' ALA . 1.2 mp -116.07 138.86 50.86 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.583 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.576 ' CZ2' HD11 ' A' ' 19' ' ' ILE . 21.1 m95 -132.54 167.92 19.15 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.035 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.509 ' CE1' ' HB2' ' A' ' 55' ' ' ARG . 41.2 p90 -140.44 163.93 31.48 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.146 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -105.1 132.6 51.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.849 0.357 . . . . 0.0 111.345 -178.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -77.65 165.85 23.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.154 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -62.71 -24.16 67.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.14 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -90.3 -4.1 57.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.328 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.738 ' O ' HG22 ' A' ' 85' ' ' ILE . . . 97.11 13.37 46.08 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.858 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.553 HG13 ' HA ' ' A' ' 83' ' ' ALA . 21.6 t -103.97 123.02 57.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.712 0.291 . . . . 0.0 110.533 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -75.71 149.23 6.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.369 0.604 . . . . 0.0 111.941 -179.828 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.684 ' CD ' ' HB2' ' A' ' 62' ' ' ALA . 7.5 mmm-85 -149.36 133.5 17.26 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.235 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 8.2 m -57.57 140.49 50.77 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.468 0.651 . . . . 0.0 111.862 -178.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.97 ' HB3' HG13 ' A' ' 42' ' ' VAL . 4.0 tttt -51.51 -24.32 5.04 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.838 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.465 HD12 ' N ' ' A' ' 59' ' ' ASN . 3.9 pp -56.46 -41.24 76.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.287 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.465 ' N ' HD12 ' A' ' 58' ' ' LEU . 3.2 t-20 177.91 178.67 0.34 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.921 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.74 84.0 0.19 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.759 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -145.85 128.13 15.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.872 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.684 ' HB2' ' CD ' ' A' ' 55' ' ' ARG . . . -114.0 153.2 29.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.265 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.762 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -78.54 153.65 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.475 179.742 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.56 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 6.9 p-10 -133.63 132.94 41.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.203 0.525 . . . . 0.0 111.554 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.647 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -97.28 43.63 1.06 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.27 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.7 m -74.54 -45.56 44.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.084 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -94.66 171.9 8.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.834 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -50.87 -41.94 58.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.086 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.77 144.3 31.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.967 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.762 HG22 HG22 ' A' ' 63' ' ' ILE . 2.8 mm -72.47 135.95 26.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-O 121.642 0.734 . . . . 0.0 111.516 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.417 ' O ' HG22 ' A' ' 63' ' ' ILE . 6.8 tt0 -135.99 163.25 30.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.724 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.929 HG21 HD13 ' A' ' 19' ' ' ILE . 31.7 p -105.73 140.03 39.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.965 0.412 . . . . 0.0 111.195 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.467 ' CB ' ' HD2' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -162.41 169.09 9.7 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.29 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.467 ' HD2' ' CB ' ' A' ' 73' ' ' GLN . 19.4 Cg_endo -60.54 139.31 85.47 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.307 2.005 . . . . 0.0 111.913 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.43 ' HE1' ' HB2' ' A' ' 83' ' ' ALA . 8.7 t80 -57.0 138.21 54.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.088 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.4 ' HB3' ' CB ' ' A' ' 79' ' ' ASN . 24.4 t0 -129.98 119.15 18.77 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.685 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -56.53 -34.64 95.57 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.538 2.159 . . . . 0.0 112.907 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -86.54 -1.39 57.59 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.4 ' CB ' ' HB3' ' A' ' 76' ' ' ASP . 2.8 t-20 -108.92 102.42 48.38 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.656 0.265 . . . . 0.0 110.957 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.833 ' O ' HD21 ' A' ' 94' ' ' LEU . 88.0 Cg_endo -76.78 24.57 0.47 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.725 2.283 . . . . 0.0 113.276 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.584 ' HD2' ' HB3' ' A' ' 65' ' ' ALA . 37.7 mmtt -120.03 -18.43 8.14 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 120.519 0.2 . . . . 0.0 111.195 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 2.0 mtt180 -89.14 20.06 3.91 Favored 'General case' 0 C--N 1.341 0.219 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 1.103 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -129.3 99.62 5.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.093 0.473 . . . . 0.0 110.691 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.647 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 60.5 m95 -108.99 134.92 51.0 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.123 0.487 . . . . 0.0 112.057 -178.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.738 HG22 ' O ' ' A' ' 52' ' ' GLY . 3.4 pt -112.82 153.76 14.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.296 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.2 t -101.76 127.0 55.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.898 0.38 . . . . 0.0 111.087 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 25.2 t -119.49 95.21 4.69 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.632 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.47 -100.03 0.7 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.677 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.501 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.32 29.67 7.36 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.575 0.226 . . . . 0.0 110.962 -179.449 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.6 149.98 30.58 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.315 0.579 . . . . 0.0 112.474 -178.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.835 ' HB ' HD12 ' A' ' 101' ' ' LEU . 12.6 mm -94.28 122.09 45.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.458 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.929 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -122.29 142.32 50.6 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.419 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -64.74 148.09 51.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.469 179.648 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.103 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.7 pt? -62.43 -56.79 14.84 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.918 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.58 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 7.0 p -75.99 -4.0 38.78 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -178.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.409 ' HB3' ' HB ' ' A' ' 99' ' ' ILE . 5.3 m-20 -141.16 89.82 2.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.866 0.365 . . . . 0.0 111.241 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -67.6 -16.4 64.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.259 178.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -92.5 10.03 31.93 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.476 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.812 ' CG2' ' HB1' ' A' ' 116' ' ' ALA . 11.6 mm -123.51 128.24 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.477 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.929 HG12 ' HB2' ' A' ' 92' ' ' ALA . 30.5 m -146.48 135.84 16.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.771 0.32 . . . . 0.0 111.667 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.835 HD12 ' HB ' ' A' ' 91' ' ' ILE . 8.6 mt -47.09 154.4 0.36 Allowed 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.639 0.733 . . . . 0.0 111.475 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.81 ' O ' HG22 ' A' ' 114' ' ' ILE . 30.0 t70 -155.85 166.89 32.15 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.875 -177.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.531 ' HA ' HG22 ' A' ' 114' ' ' ILE . 35.0 mm -89.73 120.54 38.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.426 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.805 HG22 ' O ' ' A' ' 113' ' ' HIS . 0.6 OUTLIER -64.84 138.89 22.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.038 0.447 . . . . 0.0 111.512 -179.622 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.402 ' N ' HG13 ' A' ' 104' ' ' ILE . 10.1 mmtp 76.01 -4.02 2.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.031 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 17.1 m 45.68 30.04 0.75 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.823 0.344 . . . . 0.0 111.285 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -100.41 165.09 11.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.215 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.54 -15.55 51.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.058 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -47.28 128.81 12.34 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.203 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -80.95 161.46 24.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.115 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 72.05 17.93 77.48 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.178 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.85 138.23 33.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.888 0.375 . . . . 0.0 110.967 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.805 ' O ' HG22 ' A' ' 104' ' ' ILE . 48.7 m-70 -62.87 171.07 2.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.787 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.81 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.7 OUTLIER -142.67 161.76 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.688 -179.657 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.648 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 28.4 p -155.71 171.4 20.06 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.812 ' HB1' ' CG2' ' A' ' 99' ' ' ILE . . . -95.83 126.84 41.36 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.459 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 76.1 t-105 -134.98 162.61 31.94 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.567 0.699 . . . . 0.0 112.123 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.459 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.0 OUTLIER -60.72 120.92 11.01 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.607 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -52.09 123.8 11.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.886 0.374 . . . . 0.0 111.277 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 22.3 p-80 -128.84 3.3 5.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.361 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.62 8.48 81.31 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.836 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.67 142.0 46.21 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.55 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.81 -31.2 71.36 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.528 2.152 . . . . 0.0 112.295 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -69.42 -11.95 61.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.319 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -101.68 13.5 34.73 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.703 0.287 . . . . 0.0 111.138 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.6 mmmm -100.34 126.27 46.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.351 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.449 ' HE2' HD11 ' A' ' 103' ' ' ILE . 32.6 m-85 -129.13 154.98 46.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.333 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.543 HD11 ' HA ' ' A' ' 11' ' ' GLU . 2.0 mt -116.21 141.57 33.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.295 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.587 HD12 HG23 ' A' ' 8' ' ' ILE . 26.1 mm -113.33 141.16 30.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.288 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -141.59 95.3 2.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.753 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 47.5 m -54.77 108.12 0.36 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.289 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.383 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.3 mtt . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.837 0.351 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ttpp -94.78 123.14 58.78 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.839 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.73 179.06 5.59 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.468 2.112 . . . . 0.0 112.402 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.414 ' O ' ' HB2' ' A' ' 47' ' ' TYR . 0.9 OUTLIER -95.87 122.46 38.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.78 179.907 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.425 ' HA ' ' O ' ' A' ' 46' ' ' TRP . 71.7 m-85 -96.22 174.24 6.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.691 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.681 ' C ' HD23 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -153.75 171.6 18.62 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 120.978 0.418 . . . . 0.0 111.178 179.118 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.439 ' O ' ' HA ' ' A' ' 129' ' ' ILE . 0.1 OUTLIER -111.66 123.6 50.58 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.213 179.044 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.61 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -106.97 106.55 20.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.886 0.374 . . . . 0.0 110.095 179.802 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -106.78 137.73 44.27 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.648 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.38 109.42 10.08 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.469 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 6.0 tt0 -62.88 -10.91 15.08 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.521 -178.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.609 HD22 ' HA ' ' A' ' 124' ' ' ASN . 43.0 tp -84.24 -62.32 1.59 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.938 0.399 . . . . 0.0 111.037 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.513 ' ND2' ' HA ' ' A' ' 108' ' ' LYS . 3.6 m120 -86.25 -12.32 49.93 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.23 3.98 71.9 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.071 -1.061 . . . . 0.0 111.545 -178.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.438 ' O ' ' HG3' ' A' ' 9' ' ' LYS . 5.1 mmtm -91.85 175.91 6.71 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.607 HG21 ' HA ' ' A' ' 35' ' ' GLN . 5.9 m -118.47 143.83 28.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.725 0.298 . . . . 0.0 110.603 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.3 mt -69.25 136.29 51.75 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.004 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.402 ' CB ' ' HG3' ' A' ' 44' ' ' GLN . 14.0 t0 -144.96 144.24 30.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.795 0.331 . . . . 0.0 111.146 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.831 HD12 HG21 ' A' ' 72' ' ' THR . 4.3 mm -75.65 131.26 35.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.93 115.72 3.04 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.771 0.32 . . . . 0.0 111.129 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 47.95 48.71 24.59 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.302 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 61.48 -168.69 0.18 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.633 0.254 . . . . 0.0 110.341 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.768 ' HB2' HG21 ' A' ' 19' ' ' ILE . 51.9 t30 -140.11 62.71 21.77 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.141 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.445 ' HD3' ' N ' ' A' ' 23' ' ' ASN . 21.0 Cg_exo -64.99 -28.94 57.54 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.502 2.134 . . . . 0.0 111.808 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.462 ' HB1' ' HD2' ' A' ' 26' ' ' PRO . . . -139.21 157.49 70.92 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.071 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.484 ' HB3' ' HD2' ' A' ' 74' ' ' PRO . 18.7 Cg_endo -60.38 146.71 96.12 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.763 2.309 . . . . 0.0 112.544 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.67 3.17 40.25 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.503 -0.856 . . . . 0.0 113.192 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.3 t -73.34 128.85 36.66 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 117.243 0.521 . . . . 0.0 110.994 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.1 mmtp -80.38 158.12 26.11 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.282 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.675 HD11 ' HB ' ' A' ' 70' ' ' ILE . 43.3 pt -117.0 145.97 22.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.613 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.466 ' HA ' ' CD1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -153.65 178.61 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.182 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.943 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.3 p -101.87 149.4 24.24 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.567 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 26.0 t-105 -159.27 173.89 15.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.635 0.255 . . . . 0.0 110.869 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -69.46 133.02 47.22 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.798 0.332 . . . . 0.0 110.776 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.607 ' HA ' HG21 ' A' ' 16' ' ' VAL . 27.9 pt20 -61.25 148.53 40.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.992 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -115.79 160.66 19.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.823 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.6 mmtm -119.66 107.32 13.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.949 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 150.34 176.41 23.33 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.525 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -71.06 -3.9 13.79 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.882 2.388 . . . . 0.0 112.735 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.6 p -106.07 29.53 6.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.769 0.319 . . . . 0.0 111.018 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.514 ' O ' HD12 ' A' ' 45' ' ' LEU . . . -121.92 4.97 9.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.566 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.692 HG12 ' HB3' ' A' ' 57' ' ' LYS . 1.6 t -59.26 -18.53 14.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.675 0.274 . . . . 0.0 110.821 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.415 ' HA ' ' HG2' ' A' ' 57' ' ' LYS . 2.2 t-20 -63.8 -10.65 21.26 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.755 0.312 . . . . 0.0 110.894 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.402 ' HG3' ' CB ' ' A' ' 18' ' ' ASP . 1.2 mt-30 -111.12 7.95 21.55 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.681 HD23 ' C ' ' A' ' 6' ' ' PHE . 1.1 mp -121.1 146.45 46.72 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 114.662 -1.153 . . . . 0.0 111.296 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.601 ' CZ2' HD11 ' A' ' 19' ' ' ILE . 26.0 m95 -133.46 170.46 15.46 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.678 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.54 ' CE2' ' HB2' ' A' ' 55' ' ' ARG . 1.5 p90 -136.62 160.39 38.94 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.039 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.556 HG22 HG23 ' A' ' 54' ' ' ILE . 33.2 p -107.77 134.41 50.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.71 0.29 . . . . 0.0 111.285 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -77.67 170.47 16.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.281 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -63.22 -22.79 67.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.038 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -97.35 -2.93 41.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.148 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.6 5.52 53.88 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.976 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.436 HG11 ' CE1' ' A' ' 75' ' ' PHE . 23.6 t -88.08 116.59 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 CA-C-O 120.864 0.364 . . . . 0.0 110.778 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.556 HG23 HG22 ' A' ' 48' ' ' THR . 0.7 OUTLIER -78.5 150.27 5.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.242 0.544 . . . . 0.0 111.821 -179.86 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.54 ' HB2' ' CE2' ' A' ' 47' ' ' TYR . 10.0 mmm-85 -147.16 133.14 19.17 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.454 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.517 ' HB2' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -66.88 -178.36 0.74 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.162 0.505 . . . . 0.0 111.877 -178.876 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.692 ' HB3' HG12 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -47.2 -23.09 0.47 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.448 179.806 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.641 ' H ' HD22 ' A' ' 58' ' ' LEU . 1.8 mm? -47.48 -23.66 0.67 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.508 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.444 ' CB ' ' O ' ' A' ' 58' ' ' LEU . 22.0 m-20 85.43 -9.15 0.81 Allowed 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -176.68 53.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.918 0.389 . . . . 0.0 111.466 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.491 ' HB2' ' HB2' ' A' ' 58' ' ' LEU . 23.2 m-85 -140.85 108.99 5.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.99 0.424 . . . . 0.0 110.642 179.15 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -97.17 150.19 21.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.807 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.895 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -78.07 150.23 5.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.283 179.903 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.583 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 15.7 p-10 -130.71 131.34 44.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.071 0.462 . . . . 0.0 111.583 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.674 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -96.83 42.77 1.08 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.175 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.8 -45.18 45.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.216 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -96.45 172.86 7.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.014 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -47.33 -49.41 24.28 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.923 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -98.96 146.96 25.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.929 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.895 HG22 HG22 ' A' ' 63' ' ' ILE . 2.6 mm -76.22 140.82 16.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-O 121.531 0.681 . . . . 0.0 111.441 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -133.05 166.54 22.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.618 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.831 HG21 HD12 ' A' ' 19' ' ' ILE . 24.8 p -112.13 137.06 50.73 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.717 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.487 ' HG2' ' C ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -163.57 165.63 13.74 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.062 179.655 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.484 ' HD2' ' HB3' ' A' ' 26' ' ' PRO . 54.1 Cg_exo -52.38 141.26 51.31 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.379 2.053 . . . . 0.0 111.935 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.436 ' CE1' HG11 ' A' ' 53' ' ' VAL . 36.0 t80 -60.5 132.55 54.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.388 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.405 ' HB2' ' NH1' ' A' ' 82' ' ' ARG . 20.2 t0 -123.49 132.13 24.29 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.411 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -68.79 -33.56 20.49 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.52 2.147 . . . . 0.0 113.283 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -87.14 1.04 54.28 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -105.57 103.69 44.53 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.56 0.219 . . . . 0.0 111.28 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.839 ' O ' HD21 ' A' ' 94' ' ' LEU . 6.1 Cg_exo -77.78 20.42 0.71 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.959 2.439 . . . . 0.0 112.828 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.583 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 11.3 mmtm -120.35 -17.89 8.09 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.993 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.509 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 39.2 mtt180 -89.08 19.59 4.13 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.305 -179.033 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 1.114 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -130.03 99.1 4.96 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.053 0.454 . . . . 0.0 110.937 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.674 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 54.3 m95 -108.58 134.9 50.7 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.14 0.495 . . . . 0.0 111.801 -178.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.4 pp -111.48 154.52 13.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.318 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.4 t -102.3 128.57 54.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.993 0.425 . . . . 0.0 111.139 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.6 t -121.33 94.23 4.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.398 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.16 -100.13 0.76 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.503 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.493 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.63 29.25 7.52 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.617 0.246 . . . . 0.0 110.974 -179.737 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.408 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.78 147.29 29.7 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.633 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.731 ' HB ' HD12 ' A' ' 101' ' ' LEU . 20.0 mm -94.29 120.52 43.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.384 178.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.903 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -121.91 145.07 48.45 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -178.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.441 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -65.4 149.09 50.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.493 179.568 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.114 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.6 pt? -62.91 -57.35 11.09 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.819 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.564 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -76.22 -3.89 38.86 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -178.559 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.561 ' O ' HG22 ' A' ' 99' ' ' ILE . 8.4 m-20 -139.84 88.6 2.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.783 0.325 . . . . 0.0 110.926 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.48 -16.34 62.9 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.181 179.034 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.86 11.76 19.31 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.216 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.561 HG22 ' O ' ' A' ' 96' ' ' ASP . 6.9 tt -131.53 137.78 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.903 HG12 ' HB2' ' A' ' 92' ' ' ALA . 18.6 m -148.66 138.5 16.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.819 0.343 . . . . 0.0 111.789 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.731 HD12 ' HB ' ' A' ' 91' ' ' ILE . 10.8 mt -45.96 153.24 0.31 Allowed 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 121.708 0.766 . . . . 0.0 111.791 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.731 ' O ' HG22 ' A' ' 114' ' ' ILE . 10.9 t70 -156.64 166.94 31.95 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.383 -1.28 . . . . 0.0 110.745 -177.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.621 HD12 ' O ' ' A' ' 124' ' ' ASN . 4.3 mp -89.73 120.58 38.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.33 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.816 HG22 ' O ' ' A' ' 113' ' ' HIS . 3.7 tp -64.66 139.05 22.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.999 0.428 . . . . 0.0 111.494 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 71.46 -2.13 2.54 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.165 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.4 m 41.91 32.23 0.27 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.803 0.335 . . . . 0.0 111.52 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.489 ' O ' ' ND2' ' A' ' 13' ' ' ASN . 3.1 m-20 -96.39 156.83 16.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.18 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.513 ' HA ' ' ND2' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -77.27 -13.92 59.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.097 179.675 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -52.0 124.51 12.98 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.157 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.4 159.76 33.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.086 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.86 14.0 81.96 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.288 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.46 132.33 39.56 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.853 0.359 . . . . 0.0 110.993 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.816 ' O ' HG22 ' A' ' 104' ' ' ILE . 75.8 m-70 -65.02 171.15 3.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.964 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.731 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -135.92 161.67 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.514 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.623 ' HA ' HD11 ' A' ' 70' ' ' ILE . 13.6 p -153.98 169.03 24.46 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.672 ' HB2' ' HH2' ' A' ' 84' ' ' TRP . . . -95.34 126.13 40.43 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.521 -0.471 . . . . 0.0 109.747 178.106 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.461 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 76.0 t-105 -133.92 162.47 31.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.566 0.698 . . . . 0.0 112.298 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.461 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 4.3 tmtm? -61.89 122.58 15.8 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.752 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.407 ' HA ' ' NE2' ' A' ' 125' ' ' GLN . 29.1 tt0 -60.54 125.52 24.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.346 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -134.68 9.0 3.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.631 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 80.82 7.45 88.56 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.486 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.54 152.93 44.34 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.505 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.71 -26.12 53.45 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.654 2.236 . . . . 0.0 112.324 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.621 ' O ' HD12 ' A' ' 103' ' ' ILE . 26.9 p-10 -75.39 -3.5 34.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.485 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.408 ' O ' ' CG2' ' A' ' 90' ' ' THR . 0.5 OUTLIER -108.95 14.41 24.13 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.194 -179.815 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.469 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 1.3 mmtp -105.53 133.22 50.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.768 0.318 . . . . 0.0 111.321 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.421 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 5.9 m-85 -136.41 155.77 49.56 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.544 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.4 mt -113.72 138.86 42.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.187 0.518 . . . . 0.0 110.409 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.524 ' CD1' HG23 ' A' ' 8' ' ' ILE . 36.4 mm -113.41 140.41 33.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.589 -179.12 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -139.16 111.48 7.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.509 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.35 110.63 2.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.118 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.957 -179.993 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.2 ttm . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.805 0.336 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.76 118.55 66.77 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.85 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.59 100.22 0.48 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.436 2.091 . . . . 0.0 112.302 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.72 74.29 1.4 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.005 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.462 ' CD1' ' HG3' ' A' ' 57' ' ' LYS . 1.3 p90 -97.64 175.79 6.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.31 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.754 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -158.84 175.57 13.42 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.795 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.447 ' CE1' ' HB3' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -114.74 123.81 50.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.24 179.196 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.616 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -104.56 109.88 28.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.926 0.393 . . . . 0.0 110.374 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -104.64 135.87 45.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.32 -178.824 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.702 ' OG ' HD11 ' A' ' 103' ' ' ILE . 0.6 OUTLIER -75.55 107.21 7.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.516 178.299 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.424 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 1.8 tt0 -63.82 -11.03 23.59 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.661 -178.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.689 HD22 ' CB ' ' A' ' 124' ' ' ASN . 37.7 tp -84.68 -62.77 1.47 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.898 0.38 . . . . 0.0 110.988 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -84.23 -11.48 56.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.333 -178.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.81 3.53 73.93 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.136 -1.03 . . . . 0.0 111.416 -178.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -91.28 -172.8 3.41 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.613 HG21 ' HA ' ' A' ' 35' ' ' GLN . 3.5 m -124.48 140.83 46.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.708 0.29 . . . . 0.0 110.469 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.4 mt -69.8 134.78 48.92 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.016 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -142.99 158.58 43.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.968 0.413 . . . . 0.0 111.239 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.949 HD13 HG21 ' A' ' 72' ' ' THR . 19.2 mt -100.91 133.72 43.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.419 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -40.51 96.77 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.769 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 49.03 64.27 3.4 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.61 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 59.47 -163.27 0.23 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.582 0.23 . . . . 0.0 110.421 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.459 ' N ' ' HD3' ' A' ' 24' ' ' PRO . 9.2 t-20 -138.96 62.2 25.44 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.71 0.29 . . . . 0.0 111.079 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.459 ' HD3' ' N ' ' A' ' 23' ' ' ASN . 16.7 Cg_exo -67.08 -37.59 18.43 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.524 2.15 . . . . 0.0 111.798 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.94 152.89 80.72 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.995 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.42 ' HB3' ' CD ' ' A' ' 74' ' ' PRO . 23.9 Cg_exo -63.66 139.96 72.25 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.645 2.23 . . . . 0.0 112.204 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.52 4.57 24.97 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.445 -0.883 . . . . 0.0 113.347 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.6 m -75.81 129.94 37.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.157 0.479 . . . . 0.0 111.258 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.2 mmtp -82.4 160.81 22.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.437 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.714 HD11 ' HB ' ' A' ' 70' ' ' ILE . 41.1 pt -119.4 147.09 23.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.78 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.46 ' HA ' ' CD1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -155.17 179.39 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.208 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.511 -179.777 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.49 HG21 HD12 ' A' ' 103' ' ' ILE . 1.6 p -101.77 149.07 24.55 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.622 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 24.3 t-105 -156.99 171.85 19.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.857 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -70.12 135.79 49.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.76 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.613 ' HA ' HG21 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -53.1 114.85 1.6 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.145 -179.835 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.63 161.99 22.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.813 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.9 mtpp -131.83 108.94 9.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.914 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 154.65 -163.6 31.3 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.517 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -76.86 4.27 5.84 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 123.09 2.526 . . . . 0.0 112.862 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.1 t -113.64 18.82 17.27 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.692 0.282 . . . . 0.0 111.207 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.862 ' O ' HD12 ' A' ' 45' ' ' LEU . . . -79.85 -19.44 48.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.189 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 1.009 HG13 ' HB3' ' A' ' 57' ' ' LYS . 47.7 t -49.38 -27.73 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.085 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -64.97 -9.59 22.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.791 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.447 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 6.0 mt-30 -120.45 7.42 10.64 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.099 0.476 . . . . 0.0 109.766 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.862 HD12 ' O ' ' A' ' 41' ' ' ALA . 1.3 mp -116.95 139.88 50.13 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.781 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.697 ' CZ2' HD11 ' A' ' 19' ' ' ILE . 24.7 m95 -133.95 168.82 18.09 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.127 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.524 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 30.1 p90 -140.71 165.0 28.69 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.112 178.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.559 HG22 HG23 ' A' ' 54' ' ' ILE . 15.0 p -107.76 134.0 51.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.813 0.34 . . . . 0.0 111.429 -178.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -77.8 169.89 17.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.192 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -63.49 -24.15 67.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.143 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -93.95 -2.82 52.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.136 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.49 8.49 54.66 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.84 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.469 HG12 ' HD3' ' A' ' 55' ' ' ARG . 40.4 t -93.98 119.43 41.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.89 0.345 . . . . 0.0 110.552 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.559 HG23 HG22 ' A' ' 48' ' ' THR . 0.7 OUTLIER -77.26 147.92 7.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.299 0.571 . . . . 0.0 111.763 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.7 ' CD ' ' HB2' ' A' ' 62' ' ' ALA . 9.0 mmm-85 -149.85 133.74 16.95 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.474 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.466 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 37.9 m -54.83 143.48 25.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.476 0.655 . . . . 0.0 111.863 -178.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 1.009 ' HB3' HG13 ' A' ' 42' ' ' VAL . 11.7 tttm -53.45 -23.82 11.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.719 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.537 HD12 ' N ' ' A' ' 59' ' ' ASN . 3.6 pp -56.15 -43.62 78.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.202 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.537 ' N ' HD12 ' A' ' 58' ' ' LEU . 1.4 t30 178.34 -171.15 0.11 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.862 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.81 83.16 1.65 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.835 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.413 ' CD1' ' OD1' ' A' ' 23' ' ' ASN . 31.9 m-85 -144.94 122.0 11.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.825 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.7 ' HB2' ' CD ' ' A' ' 55' ' ' ARG . . . -110.55 155.85 21.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.492 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.848 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -82.89 151.76 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.636 179.6 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.598 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 10.0 p-10 -132.44 130.31 40.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.106 0.479 . . . . 0.0 111.429 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.67 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -94.3 39.62 1.08 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.467 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.3 m -74.34 -45.89 44.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.141 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 15.3 m170 -91.13 167.91 12.01 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.943 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -46.74 -47.19 20.71 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.928 0.394 . . . . 0.0 110.833 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.34 146.18 27.92 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.701 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.848 HG22 HG22 ' A' ' 63' ' ' ILE . 2.7 mm -73.51 136.45 25.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 CA-C-O 121.738 0.78 . . . . 0.0 111.595 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -132.34 163.82 27.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.094 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.949 HG21 HD13 ' A' ' 19' ' ' ILE . 41.6 p -109.33 136.71 48.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.591 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.466 ' HG2' ' C ' ' A' ' 72' ' ' THR . 0.5 OUTLIER -163.1 167.32 11.9 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.452 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.432 ' O ' ' HD3' ' A' ' 82' ' ' ARG . 50.4 Cg_exo -53.46 137.0 65.04 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.432 2.088 . . . . 0.0 111.759 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -65.47 141.6 58.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.964 0.411 . . . . 0.0 111.412 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.12 139.62 35.51 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.59 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.02 -30.53 20.91 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.511 2.141 . . . . 0.0 112.864 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -89.57 0.05 57.18 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -106.19 102.57 40.81 Favored Pre-proline 0 CA--C 1.529 0.17 0 CA-C-O 120.568 0.223 . . . . 0.0 111.187 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.853 ' O ' HD21 ' A' ' 94' ' ' LEU . 5.8 Cg_exo -77.27 20.1 0.68 Allowed 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.94 2.427 . . . . 0.0 113.034 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.598 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 0.1 OUTLIER -117.85 -20.42 8.83 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 120.634 0.254 . . . . 0.0 110.96 -179.859 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.503 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 6.8 mtm-85 -88.41 19.76 3.66 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.414 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 1.131 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -128.58 99.2 5.28 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.089 0.471 . . . . 0.0 110.696 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.67 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 62.7 m95 -108.85 134.63 51.28 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.216 0.531 . . . . 0.0 112.016 -178.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.6 pt -112.12 153.23 13.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.201 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.4 t -101.75 127.02 55.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.943 0.402 . . . . 0.0 110.98 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.9 t -119.82 95.06 4.61 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.566 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.87 -100.27 0.75 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.557 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.499 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.79 29.82 7.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.603 0.239 . . . . 0.0 110.864 -179.668 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.413 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -148.76 148.43 29.97 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 121.358 0.599 . . . . 0.0 112.595 -178.548 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.809 ' HB ' HD12 ' A' ' 101' ' ' LEU . 14.6 mm -93.93 120.93 44.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.393 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.966 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -123.71 144.06 49.89 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.411 ' HB3' ' HB2' ' A' ' 96' ' ' ASP . 1.6 tt0 -62.83 152.34 36.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.476 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.131 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.7 pt? -65.73 -56.9 9.59 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.402 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.577 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 1.2 m -79.34 -1.93 39.16 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.411 ' HB2' ' HB3' ' A' ' 93' ' ' GLN . 9.6 m-20 -138.07 85.03 2.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.891 0.377 . . . . 0.0 110.998 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.45 -17.79 64.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.221 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' A' ' 118' ' ' LYS . 4.6 m-20 -92.7 10.28 31.35 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.466 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.848 ' CG2' ' HB1' ' A' ' 116' ' ' ALA . 11.9 mm -123.07 128.66 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.501 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.966 HG12 ' HB2' ' A' ' 92' ' ' ALA . 28.5 m -146.39 135.17 16.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.809 HD12 ' HB ' ' A' ' 91' ' ' ILE . 11.3 mt -45.62 154.21 0.22 Allowed 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.746 0.784 . . . . 0.0 111.861 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.607 ' O ' HG22 ' A' ' 114' ' ' ILE . 13.6 t70 -159.55 169.39 23.93 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.65 -177.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.702 HD11 ' OG ' ' A' ' 10' ' ' SER . 17.6 mm -88.07 121.11 38.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.168 179.176 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.437 HD12 ' CB ' ' A' ' 113' ' ' HIS . 52.7 mt -70.42 136.83 25.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.841 0.353 . . . . 0.0 111.215 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.403 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 0.2 OUTLIER 80.88 -9.03 1.38 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.802 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 38.2 m 47.39 30.49 1.58 Allowed 'General case' 0 N--CA 1.461 0.108 0 CA-C-O 120.785 0.326 . . . . 0.0 111.289 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -98.55 154.05 18.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.015 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.25 -11.56 60.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.316 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -52.36 129.12 27.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.206 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.95 161.51 29.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.008 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 70.64 15.62 73.47 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.867 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.92 133.41 39.25 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.824 0.345 . . . . 0.0 110.793 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.437 ' CB ' HD12 ' A' ' 104' ' ' ILE . 40.4 m-70 -64.0 170.43 3.56 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.019 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.607 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -135.89 161.71 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.425 179.779 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.631 ' HA ' HD11 ' A' ' 70' ' ' ILE . 29.1 p -154.53 169.06 24.69 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.848 ' HB1' ' CG2' ' A' ' 99' ' ' ILE . . . -94.84 127.63 41.0 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.459 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 75.8 t-105 -135.9 162.75 31.95 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.608 0.718 . . . . 0.0 112.212 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.459 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 12.2 tptt -61.95 117.14 5.54 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.625 -1.171 . . . . 0.0 110.875 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.56 127.59 32.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.772 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -139.08 12.02 2.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.27 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 75.86 60.46 3.15 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.266 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -116.15 144.26 18.36 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.557 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.78 -33.89 72.57 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.5 2.134 . . . . 0.0 112.226 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.689 ' CB ' HD22 ' A' ' 12' ' ' LEU . 12.9 p-10 -76.68 -2.22 31.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.508 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.413 ' O ' ' CG2' ' A' ' 90' ' ' THR . 0.0 OUTLIER -107.97 9.82 28.51 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.745 -0.207 . . . . 0.0 111.184 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.424 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 9.8 mmtp -106.5 139.43 40.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.762 0.315 . . . . 0.0 111.439 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.43 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 7.5 m-85 -138.61 156.34 47.54 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.244 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.4 mt -113.17 138.64 41.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.158 0.504 . . . . 0.0 110.65 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.557 ' CD1' HG23 ' A' ' 8' ' ' ILE . 25.2 mm -114.17 140.36 35.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.62 -179.161 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.95 96.04 3.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.588 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.2 t -51.91 111.48 0.62 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.313 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.444 ' HB3' ' CD2' ' A' ' 5' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.898 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.825 0.345 . . . . 0.0 111.189 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.76 132.46 24.19 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.803 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.6 173.24 14.67 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.47 2.113 . . . . 0.0 112.397 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.44 148.01 49.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.684 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.5 ' HA ' ' O ' ' A' ' 46' ' ' TRP . 3.1 p90 -89.72 173.04 8.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.851 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.743 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -159.48 173.75 15.71 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.204 179.693 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.549 ' OH ' ' HB1' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -109.41 123.47 49.4 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.359 179.091 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.62 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -107.92 104.11 16.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.847 -179.709 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.837 ' HB3' HG12 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -127.22 125.44 41.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.471 -179.504 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.473 ' O ' ' HD2' ' A' ' 9' ' ' LYS . 28.7 t -46.24 139.7 4.52 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.04 0.447 . . . . 0.0 111.474 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.551 ' HA ' HD11 ' A' ' 128' ' ' ILE . 3.9 tt0 -82.64 -10.73 58.82 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.02 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 38.1 tp -90.25 -58.31 2.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.804 0.335 . . . . 0.0 111.034 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -84.1 -19.09 34.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.846 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.13 5.28 75.71 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.306 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.585 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 2.9 mmmm -85.74 165.49 16.88 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.837 HG12 ' HB3' ' A' ' 9' ' ' LYS . 15.4 m -107.2 136.43 42.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.823 0.344 . . . . 0.0 110.754 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.7 mt -69.99 137.91 51.8 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -140.05 149.95 43.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.836 0.35 . . . . 0.0 111.157 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.856 HD13 HG21 ' A' ' 72' ' ' THR . 1.1 mt -99.33 116.25 42.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.839 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -61.72 96.13 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.864 0.364 . . . . 0.0 110.611 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 158.21 -45.01 0.47 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.372 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 52.12 48.64 22.3 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.832 0.349 . . . . 0.0 111.176 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.403 ' CB ' ' CD ' ' A' ' 24' ' ' PRO . 1.0 OUTLIER -177.65 175.66 0.54 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.996 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.403 ' CD ' ' CB ' ' A' ' 23' ' ' ASN . 25.3 Cg_exo -62.89 -12.64 30.29 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.824 2.349 . . . . 0.0 112.605 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -43.35 102.43 0.28 Allowed Pre-proline 0 CA--C 1.53 0.176 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.497 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.457 ' HB3' ' HD3' ' A' ' 74' ' ' PRO . 70.1 Cg_endo -72.96 143.96 37.43 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.585 2.19 . . . . 0.0 112.272 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.68 6.68 52.34 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.515 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.8 m -77.22 137.48 38.87 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.039 0.447 . . . . 0.0 111.171 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.3 mmtm -83.86 157.62 21.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.219 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.824 HG22 HG23 ' A' ' 19' ' ' ILE . 44.1 pt -115.95 145.68 21.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.889 0.376 . . . . 0.0 111.633 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.453 ' HA ' ' CD1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -155.4 -179.5 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.126 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.779 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.8 p -103.18 150.73 23.39 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.579 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 28.0 t-105 -155.47 170.59 21.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.657 0.265 . . . . 0.0 110.979 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -71.83 137.27 47.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.831 0.348 . . . . 0.0 110.763 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -56.63 135.19 54.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.008 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.9 168.12 9.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.83 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.26 103.29 6.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.926 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 163.94 -164.8 36.69 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.593 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -80.92 7.39 4.94 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.801 2.334 . . . . 0.0 113.102 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.1 17.55 21.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.652 0.263 . . . . 0.0 111.184 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.972 ' O ' HD12 ' A' ' 45' ' ' LEU . . . -82.17 -18.52 42.45 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.308 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.945 HG13 ' HB3' ' A' ' 57' ' ' LYS . 65.8 t -51.26 -31.25 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.937 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -66.99 -10.62 51.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.696 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -116.09 7.41 14.23 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.972 HD12 ' O ' ' A' ' 41' ' ' ALA . 0.9 OUTLIER -117.66 141.29 48.56 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.713 -179.083 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.634 ' CZ2' HD11 ' A' ' 19' ' ' ILE . 24.4 m95 -133.27 167.69 19.91 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.041 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.518 ' CE1' ' HB2' ' A' ' 55' ' ' ARG . 37.6 p90 -140.56 165.03 28.55 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.106 178.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 46.0 p -105.6 132.63 51.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.828 0.346 . . . . 0.0 111.336 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -77.79 165.84 23.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.117 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.13 -25.49 67.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.234 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -90.86 -4.05 56.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.469 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.563 ' O ' HG22 ' A' ' 85' ' ' ILE . . . 97.96 11.87 48.28 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.845 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.451 HG13 ' HA ' ' A' ' 83' ' ' ALA . 30.9 t -100.7 121.44 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-O 120.744 0.307 . . . . 0.0 110.488 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.482 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -76.07 148.43 7.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.31 0.576 . . . . 0.0 111.889 -179.751 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.734 ' CD ' ' HB2' ' A' ' 62' ' ' ALA . 12.3 mmm-85 -149.23 133.74 17.61 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.408 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.506 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -56.51 142.12 40.22 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.54 0.686 . . . . 0.0 111.893 -178.873 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.945 ' HB3' HG13 ' A' ' 42' ' ' VAL . 21.0 tttt -54.09 -22.31 10.65 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.715 -1.13 . . . . 0.0 111.673 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.467 ' HA ' HG11 ' A' ' 42' ' ' VAL . 3.4 pp -58.93 -41.87 88.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.777 0.322 . . . . 0.0 111.12 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.434 ' N ' HD12 ' A' ' 58' ' ' LEU . 1.2 t-20 -179.36 -179.69 0.56 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.791 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -70.99 84.4 0.69 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.806 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.402 ' CZ ' ' O ' ' A' ' 24' ' ' PRO . 1.9 m-85 -145.92 123.5 11.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.899 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.734 ' HB2' ' CD ' ' A' ' 55' ' ' ARG . . . -108.83 152.59 24.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.081 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.786 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -78.66 152.99 4.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.68 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.537 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 6.7 p-10 -134.2 133.42 40.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.277 0.56 . . . . 0.0 111.69 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.674 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -97.42 43.49 1.07 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.217 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.0 t -74.71 -43.98 52.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.087 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 65.8 m170 -97.2 172.47 7.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.925 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -48.32 -48.81 35.92 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.14 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -99.0 145.62 26.88 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.126 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.786 HG22 HG22 ' A' ' 63' ' ' ILE . 3.1 mm -73.93 138.54 20.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.552 0.692 . . . . 0.0 111.455 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.43 ' O ' HG22 ' A' ' 63' ' ' ILE . 1.3 pt-20 -139.2 167.75 21.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.799 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.856 HG21 HD13 ' A' ' 19' ' ' ILE . 57.0 p -106.77 139.41 41.24 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.052 0.453 . . . . 0.0 111.528 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.403 ' CB ' ' CD ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -159.46 175.07 3.44 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.993 179.643 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.457 ' HD3' ' HB3' ' A' ' 26' ' ' PRO . 17.3 Cg_exo -66.65 138.86 50.91 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.513 2.142 . . . . 0.0 111.583 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -62.29 128.82 37.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.814 0.34 . . . . 0.0 111.031 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.409 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 0.4 OUTLIER -122.18 125.85 26.46 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.674 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -56.92 -35.4 98.55 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.457 2.105 . . . . 0.0 112.794 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 21.3 m-20 -86.35 -2.73 58.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.777 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.41 ' CB ' ' HD2' ' A' ' 82' ' ' ARG . 8.7 t-20 -101.19 100.6 13.77 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-O 120.611 0.243 . . . . 0.0 110.786 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.555 ' O ' HD21 ' A' ' 94' ' ' LEU . 82.9 Cg_endo -76.66 21.16 0.58 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.638 2.225 . . . . 0.0 113.48 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.659 ' HD2' ' HB3' ' A' ' 65' ' ' ALA . 40.3 mmtt -120.94 -18.37 7.58 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 120.689 0.28 . . . . 0.0 111.134 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.495 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 40.3 mtt180 -88.09 21.42 2.76 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -178.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 1.003 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -130.25 99.84 5.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.203 0.525 . . . . 0.0 111.051 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.674 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 60.4 m95 -110.21 135.06 51.57 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.227 0.537 . . . . 0.0 111.914 -178.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.563 HG22 ' O ' ' A' ' 52' ' ' GLY . 2.4 pt -113.86 154.24 15.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.125 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.9 t -102.14 127.99 55.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.912 0.387 . . . . 0.0 111.115 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 46.6 t -121.07 95.1 4.56 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.553 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.28 -100.66 0.81 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.554 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.504 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.94 29.86 7.16 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.587 0.232 . . . . 0.0 110.735 -179.76 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -149.16 148.36 29.54 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 121.358 0.599 . . . . 0.0 112.348 -178.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.768 ' HB ' HD12 ' A' ' 101' ' ' LEU . 14.3 mm -94.32 121.08 44.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.629 178.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.833 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -120.84 143.0 49.12 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -178.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.438 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -67.31 146.05 54.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.699 179.763 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.003 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.6 pt? -61.05 -56.13 24.55 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.664 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.628 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 7.9 m -73.72 -6.68 48.36 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -178.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.533 ' O ' HG22 ' A' ' 99' ' ' ILE . 0.6 OUTLIER -139.75 89.65 2.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.881 0.372 . . . . 0.0 111.071 -179.777 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.26 -16.23 63.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.182 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.73 12.86 21.95 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.096 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.533 HG22 ' O ' ' A' ' 96' ' ' ASP . 6.8 tt -131.08 137.16 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.833 HG12 ' HB2' ' A' ' 92' ' ' ALA . 15.9 m -148.9 138.46 15.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.855 0.359 . . . . 0.0 111.637 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.768 HD12 ' HB ' ' A' ' 91' ' ' ILE . 10.5 mt -46.39 155.19 0.23 Allowed 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.593 0.711 . . . . 0.0 111.71 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.71 ' O ' HG22 ' A' ' 114' ' ' ILE . 35.6 t70 -157.49 166.71 32.23 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.588 -177.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.528 ' HA ' HG22 ' A' ' 114' ' ' ILE . 3.0 mp -92.8 118.33 38.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.461 179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.773 HG22 ' O ' ' A' ' 113' ' ' HIS . 8.5 tt -62.45 141.98 17.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.791 0.329 . . . . 0.0 111.164 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.425 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 10.5 tptt 82.43 -20.81 0.33 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.71 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.6 m 53.9 39.41 30.41 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.917 0.389 . . . . 0.0 111.013 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -113.36 167.01 10.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.029 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.75 -13.83 58.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.984 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -48.29 142.41 5.54 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.098 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.476 ' HB2' ' NZ ' ' A' ' 15' ' ' LYS . . . -90.1 158.16 17.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.2 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 76.35 12.84 83.91 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.543 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.5 132.9 39.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.878 0.37 . . . . 0.0 111.01 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.773 ' O ' HG22 ' A' ' 104' ' ' ILE . 12.9 m80 -65.52 173.33 2.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.029 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.71 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -137.36 161.5 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.513 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.598 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 7.2 t -152.52 166.14 32.93 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.638 ' HB2' ' HH2' ' A' ' 84' ' ' TRP . . . -92.91 121.54 34.37 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.471 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 76.2 t-105 -128.73 162.19 27.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.67 0.747 . . . . 0.0 112.241 -179.14 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.471 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.8 OUTLIER -64.8 123.38 19.22 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.7 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -58.48 123.29 15.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.045 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -134.2 4.44 3.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.493 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 79.39 56.56 3.37 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.286 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -109.28 147.47 16.91 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.519 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.74 -29.3 59.63 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.57 2.18 . . . . 0.0 112.083 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -76.91 -4.35 43.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.234 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.421 ' NE2' ' CG2' ' A' ' 100' ' ' VAL . 3.2 mt-30 -102.73 -7.14 21.92 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.463 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.44 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 8.6 mmtm -83.73 132.66 34.83 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.772 0.32 . . . . 0.0 111.295 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -131.11 153.64 49.14 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.344 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.813 HD12 ' CE ' ' A' ' 9' ' ' LYS . 1.4 mt -113.68 137.48 46.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.163 0.506 . . . . 0.0 110.644 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.575 HD12 HG23 ' A' ' 8' ' ' ILE . 20.8 mm -114.26 142.05 28.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.593 -179.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -137.02 110.41 7.91 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.285 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 44.1 m -60.02 114.41 2.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.322 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.23 -0.89 . . . . 0.0 111.494 179.714 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.6 ttt . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.786 0.327 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 63.59 126.21 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.863 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.6 148.21 36.24 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.466 2.11 . . . . 0.0 112.343 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -118.92 139.94 50.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.826 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.493 ' CD1' ' HG3' ' A' ' 57' ' ' LYS . 1.5 p90 -95.1 175.04 6.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.501 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.746 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -160.38 176.45 11.66 Favored 'General case' 0 CA--C 1.512 -0.512 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.774 179.919 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.449 ' CE1' ' HB3' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -114.86 123.78 50.04 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.297 179.228 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.623 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -104.14 109.89 28.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.23 179.904 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.29 136.85 45.28 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.273 -178.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.54 ' OG ' HD21 ' A' ' 17' ' ' LEU . 48.7 m -75.95 107.82 8.41 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 5.2 tt0 -63.19 -11.15 18.72 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.47 -178.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.568 HD22 ' HA ' ' A' ' 124' ' ' ASN . 56.3 tp -84.66 -62.49 1.53 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.848 0.356 . . . . 0.0 110.973 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.503 ' ND2' ' HA ' ' A' ' 108' ' ' LYS . 3.0 m120 -84.97 -12.94 52.19 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.69 2.57 76.45 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.214 -0.993 . . . . 0.0 111.513 -178.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.41 -178.64 5.65 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.601 HG21 ' HA ' ' A' ' 35' ' ' GLN . 7.9 m -120.37 140.34 44.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.673 0.273 . . . . 0.0 110.527 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.54 HD21 ' OG ' ' A' ' 10' ' ' SER . 10.6 mt -70.19 134.8 48.45 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -142.61 158.21 43.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.901 0.381 . . . . 0.0 111.204 -179.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.119 HD13 HG21 ' A' ' 72' ' ' THR . 31.3 mt -100.19 137.86 26.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.458 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -41.16 96.0 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.73 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' A' ' 23' ' ' ASN . . . 45.12 39.13 6.58 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.182 -0.532 . . . . 0.0 112.987 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.74 -74.31 0.06 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.85 0.357 . . . . 0.0 110.766 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 21' ' ' GLY . 1.7 t30 59.8 92.52 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.025 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -64.96 -9.39 21.3 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.705 2.27 . . . . 0.0 112.571 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -93.5 151.84 40.47 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-O 120.724 0.297 . . . . 0.0 111.078 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.449 ' HB3' ' HB3' ' A' ' 73' ' ' GLN . 16.2 Cg_exo -68.41 135.73 34.7 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.832 2.355 . . . . 0.0 112.468 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.21 1.29 16.36 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.604 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.85 136.25 43.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 117.316 0.558 . . . . 0.0 111.0 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.2 159.78 18.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.694 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.664 HG22 HG12 ' A' ' 19' ' ' ILE . 46.4 pt -120.33 148.03 23.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.821 0.343 . . . . 0.0 111.637 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.465 HG22 ' HA ' ' A' ' 113' ' ' HIS . 0.3 OUTLIER -156.26 -178.39 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.243 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.425 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.531 HG21 HD12 ' A' ' 103' ' ' ILE . 1.6 p -100.87 148.55 24.84 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.585 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 28.0 t-105 -158.42 172.63 17.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.689 0.28 . . . . 0.0 110.91 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -70.86 135.76 48.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.765 0.317 . . . . 0.0 110.708 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.601 ' HA ' HG21 ' A' ' 16' ' ' VAL . 5.7 tm0? -56.73 125.96 24.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.007 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.25 164.55 12.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.951 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.7 mmmt -131.68 111.22 11.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.961 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 154.23 -165.76 31.9 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.635 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.64 2.52 6.84 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.131 2.554 . . . . 0.0 112.859 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.12 16.95 19.08 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.653 0.263 . . . . 0.0 111.153 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.846 ' O ' HD12 ' A' ' 45' ' ' LEU . . . -80.35 -18.1 50.04 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.412 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.967 HG13 ' HB3' ' A' ' 57' ' ' LYS . 49.4 t -50.08 -27.39 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.055 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -64.57 -10.27 25.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.718 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.449 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 1.6 mt-30 -118.92 7.76 11.55 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.846 HD12 ' O ' ' A' ' 41' ' ' ALA . 1.3 mp -117.65 140.7 49.3 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.8 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.719 ' CZ2' HD11 ' A' ' 19' ' ' ILE . 26.9 m95 -134.12 168.77 18.23 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.938 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.555 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 15.7 p90 -141.69 165.93 26.13 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.1 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 72.8 p -106.79 132.4 52.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.768 0.318 . . . . 0.0 111.313 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -77.63 165.62 24.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.09 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -58.69 -25.49 62.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.027 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -93.55 -3.52 52.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.324 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.34 6.8 55.1 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.874 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.3 t -90.43 117.65 34.13 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-O 120.771 0.319 . . . . 0.0 110.687 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.563 ' O ' ' HG3' ' A' ' 55' ' ' ARG . 0.6 OUTLIER -75.99 144.08 12.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.076 0.465 . . . . 0.0 111.049 179.596 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.563 ' HG3' ' O ' ' A' ' 54' ' ' ILE . 0.4 OUTLIER -149.75 133.54 16.89 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.88 179.222 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 72.7 m -51.5 144.74 9.81 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.582 0.706 . . . . 0.0 112.127 -178.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.967 ' HB3' HG13 ' A' ' 42' ' ' VAL . 10.0 tttt -57.96 -20.26 36.67 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.877 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.548 ' HA ' HG11 ' A' ' 42' ' ' VAL . 0.5 OUTLIER -47.58 -45.81 27.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.794 -179.253 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -171.24 -72.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.66 0.266 . . . . 0.0 111.282 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -176.42 81.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.913 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.414 ' CE2' ' HD3' ' A' ' 74' ' ' PRO . 1.5 m-85 -140.84 122.99 15.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.874 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -101.68 148.3 25.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.201 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.874 HG22 HG22 ' A' ' 70' ' ' ILE . 0.3 OUTLIER -77.99 152.45 5.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.684 179.786 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.634 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 6.6 p-10 -133.18 130.72 39.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.191 0.52 . . . . 0.0 111.682 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.675 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -95.07 42.05 1.09 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.418 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 60.4 p -74.62 -43.18 56.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.369 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 23.4 m80 -97.89 171.81 8.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.102 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -48.82 -44.01 38.88 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.916 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.06 144.49 31.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.641 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.874 HG22 HG22 ' A' ' 63' ' ' ILE . 1.7 mm -76.37 141.95 15.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.666 0.746 . . . . 0.0 111.8 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -139.26 166.59 24.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.863 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . 1.119 HG21 HD13 ' A' ' 19' ' ' ILE . 41.6 p -104.27 138.18 41.1 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.861 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.449 ' HB3' ' HB3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -163.53 167.54 11.14 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.26 179.755 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.415 ' CD ' ' HB3' ' A' ' 26' ' ' PRO . 32.2 Cg_exo -57.88 137.33 80.46 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.415 2.077 . . . . 0.0 111.861 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.536 ' CE1' ' HB2' ' A' ' 83' ' ' ALA . 16.8 t80 -67.18 127.2 31.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.855 0.359 . . . . 0.0 110.886 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -117.48 139.55 26.3 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.48 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.4 -32.26 41.01 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.527 2.151 . . . . 0.0 112.905 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 32.3 m-20 -88.79 -1.59 58.16 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -107.11 101.12 36.4 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.571 0.224 . . . . 0.0 111.007 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.85 ' O ' HD21 ' A' ' 94' ' ' LEU . 5.6 Cg_exo -77.16 21.28 0.61 Allowed 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.869 2.379 . . . . 0.0 112.98 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.634 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -116.47 -21.92 8.98 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.94 -179.827 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.477 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 41.7 mtt180 -87.62 20.28 3.02 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.47 -179.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 1.071 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -130.01 99.33 5.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.074 0.464 . . . . 0.0 110.854 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.675 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 58.9 m95 -109.45 137.26 47.56 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.223 0.535 . . . . 0.0 111.89 -178.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.3 pt -115.1 153.63 16.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.237 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.9 t -100.21 125.39 53.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.905 0.383 . . . . 0.0 110.948 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 21.5 t -117.85 93.89 4.32 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.526 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.89 -100.57 0.78 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.601 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.499 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.55 29.36 7.48 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.568 0.223 . . . . 0.0 110.921 -179.549 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -148.76 148.55 30.11 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.314 0.578 . . . . 0.0 112.522 -178.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.639 ' HB ' HD12 ' A' ' 101' ' ' LEU . 17.6 mm -93.38 121.28 43.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.44 178.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.99 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -124.67 145.3 49.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.32 0.581 . . . . 0.0 112.557 -178.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.421 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -65.26 149.53 49.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.508 179.729 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.071 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.7 pt? -62.2 -56.88 14.27 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.717 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.575 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 35.7 m -79.65 -1.61 38.99 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.405 ' HB2' ' HB3' ' A' ' 93' ' ' GLN . 72.9 m-20 -138.5 85.9 2.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.875 0.369 . . . . 0.0 111.009 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.63 -18.32 65.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.072 178.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -91.51 8.73 35.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.445 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.822 ' CG2' ' HB1' ' A' ' 116' ' ' ALA . 12.7 mm -121.15 126.29 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.494 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.99 HG12 ' HB2' ' A' ' 92' ' ' ALA . 22.3 m -145.98 134.49 16.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.836 0.351 . . . . 0.0 111.892 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.639 HD12 ' HB ' ' A' ' 91' ' ' ILE . 16.2 mt -46.26 154.09 0.29 Allowed 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 121.755 0.788 . . . . 0.0 111.964 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.826 ' O ' HG22 ' A' ' 114' ' ' ILE . 25.6 t70 -156.85 167.41 30.56 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.293 -1.321 . . . . 0.0 110.752 -177.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.531 HD12 HG21 ' A' ' 32' ' ' THR . 34.0 mm -89.0 126.08 42.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.566 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.787 HG22 ' O ' ' A' ' 113' ' ' HIS . 1.2 tt -68.05 137.99 23.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.01 0.434 . . . . 0.0 111.558 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 29.7 mtpt 67.44 3.41 3.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.114 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 40.0 t 40.9 32.33 0.16 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.744 0.307 . . . . 0.0 111.454 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.49 ' O ' ' ND2' ' A' ' 13' ' ' ASN . 26.1 p30 -96.08 157.41 15.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.181 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.503 ' HA ' ' ND2' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -78.93 -14.97 58.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.199 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -51.1 123.07 8.62 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.847 0.356 . . . . 0.0 111.107 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.18 161.15 31.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.172 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 73.29 16.64 78.7 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.181 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.85 135.58 35.95 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 120.875 0.369 . . . . 0.0 111.056 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.787 ' O ' HG22 ' A' ' 104' ' ' ILE . 1.4 m80 -61.86 170.29 2.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.783 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.826 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.5 OUTLIER -143.22 161.8 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.872 -179.698 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.655 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 12.8 p -157.15 174.16 15.9 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.822 ' HB1' ' CG2' ' A' ' 99' ' ' ILE . . . -95.81 129.67 42.98 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 178.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.458 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 75.8 t-105 -136.05 162.38 33.04 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.602 0.715 . . . . 0.0 112.051 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.458 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.2 OUTLIER -60.36 119.74 8.54 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.689 179.928 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.414 ' HA ' ' NE2' ' A' ' 125' ' ' GLN . 12.2 tt0 -60.1 127.3 31.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.081 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -137.52 11.0 2.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.207 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 78.4 10.28 86.34 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.882 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.78 139.78 46.82 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.521 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.5 -28.92 57.14 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.495 2.13 . . . . 0.0 112.24 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.568 ' HA ' HD22 ' A' ' 12' ' ' LEU . 30.6 p-10 -74.55 -5.42 42.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.423 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.414 ' NE2' ' HA ' ' A' ' 119' ' ' GLN . 0.1 OUTLIER -106.57 16.36 24.69 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.096 -179.829 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.443 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 2.7 mmmt -105.91 132.95 51.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.743 0.306 . . . . 0.0 111.398 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.436 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 5.2 m-85 -136.12 155.1 50.67 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.417 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 mt -114.27 140.32 35.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.179 0.514 . . . . 0.0 110.67 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.543 HD12 HG23 ' A' ' 8' ' ' ILE . 20.1 mm -114.04 139.78 38.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.617 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.21 96.14 3.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.614 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.4 m -50.76 111.71 0.59 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.405 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.435 ' HB3' ' CD2' ' A' ' 5' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.918 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.5 mtp . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 120.807 0.337 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -115.92 105.37 51.41 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.92 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.45 ' HG2' ' CD1' ' A' ' 47' ' ' TYR . 39.3 Cg_endo -67.04 161.07 44.32 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.37 2.047 . . . . 0.0 112.322 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -47.94 151.35 0.95 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.673 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.485 ' CD1' ' HG3' ' A' ' 57' ' ' LYS . 0.2 OUTLIER -105.85 176.46 5.16 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.139 179.666 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.761 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -156.41 172.76 17.95 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.735 179.878 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.487 ' OH ' ' HB1' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -112.22 123.86 51.2 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.103 179.04 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.619 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -105.1 109.29 27.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.004 0.431 . . . . 0.0 110.693 -179.73 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 16' ' ' VAL . 0.1 OUTLIER -102.15 132.49 48.02 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.008 -179.065 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.1 p -74.16 107.29 6.25 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.415 ' HB3' ' O ' ' A' ' 126' ' ' LYS . 3.6 tt0 -63.8 -9.86 16.96 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.537 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.502 HD13 ' HA ' ' A' ' 124' ' ' ASN . 28.7 tp -83.44 -62.99 1.44 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.815 0.34 . . . . 0.0 110.752 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.555 HD21 HG21 ' A' ' 103' ' ' ILE . 5.0 m-80 -85.59 -7.87 58.61 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.79 6.65 67.75 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.071 -1.062 . . . . 0.0 111.558 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -94.11 -171.97 2.69 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 4.8 m -121.84 140.65 45.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.755 0.312 . . . . 0.0 110.528 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.1 mt -69.79 133.47 47.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.329 -0.396 . . . . 0.0 109.95 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -144.04 147.79 34.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.827 0.346 . . . . 0.0 111.144 -179.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.1 HD13 HG21 ' A' ' 72' ' ' THR . 22.3 mt -89.52 133.77 30.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.42 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -41.85 101.57 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.196 -0.456 . . . . 0.0 112.025 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 23' ' ' ASN . . . 42.6 31.41 1.07 Allowed Glycine 0 C--N 1.332 0.32 0 CA-C-N 115.927 -0.579 . . . . 0.0 113.351 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.2 mp0 63.48 -76.06 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.746 0.308 . . . . 0.0 111.332 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.404 ' N ' ' O ' ' A' ' 21' ' ' GLY . 3.0 m120 63.32 100.44 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.819 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -62.43 -11.01 20.87 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.625 2.217 . . . . 0.0 112.631 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . . . -95.58 147.94 33.8 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-O 120.68 0.276 . . . . 0.0 111.048 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.452 ' HB3' ' HB3' ' A' ' 73' ' ' GLN . 19.6 Cg_exo -66.31 144.19 73.3 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.738 2.292 . . . . 0.0 112.476 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.07 2.19 22.06 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.454 -0.879 . . . . 0.0 113.439 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.2 t -73.17 139.29 46.23 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 117.22 0.51 . . . . 0.0 111.121 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.3 mptm? -90.65 158.49 16.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.487 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.704 HD11 ' HB ' ' A' ' 70' ' ' ILE . 36.8 pt -116.88 145.53 22.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.854 0.359 . . . . 0.0 111.708 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.46 ' HA ' ' CD1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -154.97 177.92 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.458 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.5 p -100.94 149.57 23.76 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.498 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 9.0 t-105 -155.47 170.66 21.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.745 0.307 . . . . 0.0 110.993 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.09 135.43 47.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.827 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -58.98 130.03 45.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.906 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.23 176.43 5.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.838 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.0 mttp -127.9 156.67 42.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.823 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 110.3 -164.04 12.32 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.501 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -80.89 7.84 4.66 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.746 2.297 . . . . 0.0 113.13 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 43.1 p -106.25 16.27 25.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.635 0.255 . . . . 0.0 111.244 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.981 ' O ' HD12 ' A' ' 45' ' ' LEU . . . -84.11 -19.85 33.54 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.311 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 1.012 HG13 ' HB3' ' A' ' 57' ' ' LYS . 53.2 t -50.6 -31.9 9.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.915 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -65.19 -11.25 38.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.889 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.454 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 3.7 mt-30 -117.6 8.78 12.95 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.981 HD12 ' O ' ' A' ' 41' ' ' ALA . 0.9 OUTLIER -118.43 141.15 48.83 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.861 -179.143 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.746 ' CZ2' HD11 ' A' ' 19' ' ' ILE . 26.1 m95 -134.23 169.49 17.1 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.052 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.523 ' CZ ' ' HB2' ' A' ' 55' ' ' ARG . 28.3 p90 -141.45 164.47 30.15 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.143 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.493 HG22 HG23 ' A' ' 54' ' ' ILE . 0.7 OUTLIER -109.11 136.41 48.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.829 0.347 . . . . 0.0 111.397 -178.953 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -77.75 170.7 16.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.2 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -62.31 -22.48 66.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.089 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -98.77 -2.46 37.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.167 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.8 3.77 54.82 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.884 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.669 HG11 ' CD2' ' A' ' 75' ' ' PHE . 21.8 t -85.99 116.24 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 CA-C-N 116.977 0.389 . . . . 0.0 110.693 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.515 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -78.21 147.8 6.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.383 0.611 . . . . 0.0 112.034 -179.59 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.802 ' CD ' ' HB2' ' A' ' 62' ' ' ALA . 8.8 mmm-85 -150.62 133.67 16.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.152 178.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.638 ' HB2' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -55.27 146.05 20.15 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.456 0.646 . . . . 0.0 112.055 -178.721 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 1.012 ' HB3' HG13 ' A' ' 42' ' ' VAL . 8.2 tttm -57.89 -20.7 38.82 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.81 -1.087 . . . . 0.0 111.886 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.704 HD23 ' H ' ' A' ' 59' ' ' ASN . 0.8 OUTLIER -59.49 -33.1 70.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.832 0.349 . . . . 0.0 111.087 -179.533 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.704 ' H ' HD23 ' A' ' 58' ' ' LEU . 0.4 OUTLIER 174.74 -169.82 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.712 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -82.34 82.78 7.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.721 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -144.23 124.97 14.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.979 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.802 ' HB2' ' CD ' ' A' ' 55' ' ' ARG . . . -107.46 153.19 23.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.524 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.797 HG22 HG22 ' A' ' 70' ' ' ILE . 0.3 OUTLIER -78.85 152.05 5.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.778 179.667 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.568 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 4.1 p-10 -132.78 137.83 46.95 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.964 0.411 . . . . 0.0 111.368 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.635 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -104.06 42.37 1.19 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.429 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.37 -44.82 50.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.833 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 7.2 m80 -93.84 169.22 10.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.934 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -48.4 -46.0 36.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.956 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -99.73 142.74 30.82 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.138 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.797 HG22 HG22 ' A' ' 63' ' ' ILE . 3.5 mm -73.44 139.53 19.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-O 121.55 0.691 . . . . 0.0 111.382 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -140.56 169.35 17.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.944 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . 1.1 HG21 HD13 ' A' ' 19' ' ' ILE . 49.9 p -106.28 138.65 42.09 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.262 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.475 ' HG2' ' C ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -164.92 169.36 7.65 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.033 179.684 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.433 ' HD3' ' HB3' ' A' ' 26' ' ' PRO . 77.1 Cg_exo -49.56 141.82 25.38 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.416 2.077 . . . . 0.0 112.08 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.669 ' CD2' HG11 ' A' ' 53' ' ' VAL . 53.1 t80 -47.94 -56.62 7.19 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.3 t70 61.29 118.15 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.67 0.272 . . . . 0.0 110.346 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.08 -27.32 25.06 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.488 2.125 . . . . 0.0 113.546 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -88.43 0.85 55.81 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.46 ' CB ' ' HD2' ' A' ' 82' ' ' ARG . 1.7 m-80 -105.96 103.76 46.04 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.586 0.232 . . . . 0.0 111.331 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.88 ' O ' HD21 ' A' ' 94' ' ' LEU . 5.6 Cg_exo -77.33 18.79 0.76 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.996 2.464 . . . . 0.0 113.105 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.568 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 8.2 mmtt -119.95 -18.27 8.23 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 120.648 0.261 . . . . 0.0 110.91 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.487 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 32.2 mtt180 -90.97 23.13 3.31 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.15 -179.081 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 1.149 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -131.23 99.8 4.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.983 0.421 . . . . 0.0 110.765 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.635 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 51.3 m95 -110.35 136.94 48.75 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.246 0.546 . . . . 0.0 112.106 -178.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.409 ' C ' HD12 ' A' ' 85' ' ' ILE . 2.7 pp -114.13 154.71 15.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.198 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.2 t -101.47 127.21 55.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.95 0.405 . . . . 0.0 111.105 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.3 t -119.51 94.38 4.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.347 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.19 -100.43 0.79 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.497 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.502 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.89 29.77 7.21 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.56 0.219 . . . . 0.0 110.871 -179.692 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.411 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -148.03 148.05 30.28 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.502 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.775 ' HB ' HD12 ' A' ' 101' ' ' LEU . 15.2 mm -93.69 120.09 42.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.131 -0.941 . . . . 0.0 109.336 178.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.919 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -121.94 143.73 49.29 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.432 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -67.28 147.34 53.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.732 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.149 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.6 pt? -60.97 -56.86 16.13 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.798 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.569 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 2.2 m -75.17 -4.63 39.92 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -139.6 87.61 2.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.789 0.328 . . . . 0.0 110.967 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 16.3 mmt85 -67.6 -17.42 64.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.117 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.41 ' O ' ' HA ' ' A' ' 118' ' ' LYS . 0.8 OUTLIER -94.05 11.78 28.61 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.486 179.165 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.848 ' CG2' ' HB1' ' A' ' 116' ' ' ALA . 10.2 mm -124.4 130.83 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.919 HG12 ' HB2' ' A' ' 92' ' ' ALA . 34.7 m -147.64 136.75 15.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.836 0.351 . . . . 0.0 111.91 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.775 HD12 ' HB ' ' A' ' 91' ' ' ILE . 11.2 mt -46.06 154.29 0.26 Allowed 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.693 0.758 . . . . 0.0 111.867 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.731 ' O ' HG22 ' A' ' 114' ' ' ILE . 10.3 t70 -159.59 168.57 25.78 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 114.375 -1.284 . . . . 0.0 110.666 -177.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.695 HD12 ' O ' ' A' ' 124' ' ' ASN . 4.4 mp -87.41 119.46 35.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.031 179.031 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.595 HG22 ' HG2' ' A' ' 105' ' ' LYS . 52.9 mt -70.24 137.51 23.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.913 0.387 . . . . 0.0 111.525 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.595 ' HG2' HG22 ' A' ' 104' ' ' ILE . 0.0 OUTLIER 67.0 10.77 7.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.714 179.763 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.3 m 45.69 -139.18 0.47 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.938 -0.119 . . . . 0.0 110.94 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 68.84 162.88 0.22 Allowed 'General case' 0 N--CA 1.46 0.067 0 CA-C-O 120.803 0.335 . . . . 0.0 110.878 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 4.3 tttp -89.32 -11.57 43.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.533 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -41.94 135.74 2.28 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.812 0.339 . . . . 0.0 111.62 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -88.46 161.31 17.1 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.303 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 71.94 17.2 76.83 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.027 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.79 135.08 35.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.801 0.334 . . . . 0.0 110.896 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 15.5 m170 -65.14 173.96 2.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.012 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.731 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -137.77 161.94 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.476 -179.917 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.599 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 4.9 t -152.77 167.3 29.48 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.848 ' HB1' ' CG2' ' A' ' 99' ' ' ILE . . . -94.93 126.08 40.03 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.145 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.458 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 75.8 t-105 -136.92 162.65 32.68 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.589 0.709 . . . . 0.0 112.304 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.458 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.1 OUTLIER -59.6 119.73 8.11 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.884 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -66.68 130.35 42.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.013 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -142.54 16.07 2.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.88 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 81.95 13.11 80.12 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.83 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.62 136.84 41.83 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.433 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.46 -31.79 70.29 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.465 2.11 . . . . 0.0 112.115 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.695 ' O ' HD12 ' A' ' 103' ' ' ILE . 22.7 p-10 -75.45 -4.21 38.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.323 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.411 ' O ' ' CG2' ' A' ' 90' ' ' THR . 0.0 OUTLIER -105.53 13.63 29.76 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.244 -179.812 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.415 ' O ' ' HB3' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -107.96 142.69 37.69 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.871 0.367 . . . . 0.0 111.373 -179.432 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.443 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 6.6 m-85 -140.84 156.45 46.13 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.118 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 mt -112.4 139.62 36.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.109 0.481 . . . . 0.0 110.75 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.495 ' CD1' HG23 ' A' ' 8' ' ' ILE . 24.4 mm -114.63 141.74 29.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.67 -179.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -139.17 94.37 2.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.7 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.8 m -54.29 107.09 0.24 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.227 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.888 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mtp . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.867 0.365 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.411 ' CB ' ' CD ' ' A' ' 3' ' ' PRO . 17.7 mttt -76.47 -61.24 0.8 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.041 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.411 ' CD ' ' CB ' ' A' ' 2' ' ' LYS . 65.7 Cg_endo -73.86 143.3 33.0 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.503 2.135 . . . . 0.0 112.405 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -87.31 118.42 26.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.93 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.469 ' CG ' ' HD2' ' A' ' 57' ' ' LYS . 0.8 OUTLIER -99.61 176.19 5.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.495 179.875 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.739 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -157.5 174.49 15.3 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 120.49 -0.484 . . . . 0.0 111.648 179.634 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.495 ' OH ' ' HB1' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -113.13 123.76 51.01 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.132 179.17 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.621 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -105.53 109.78 28.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.891 0.377 . . . . 0.0 110.387 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.423 ' HA ' ' HA ' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -105.81 134.63 48.61 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.325 -178.709 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.6 p -75.74 106.29 7.23 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.433 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 4.3 tt0 -62.66 -10.68 13.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.539 -178.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.583 HD22 ' CB ' ' A' ' 124' ' ' ASN . 51.2 tp -82.79 -62.82 1.5 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.894 0.378 . . . . 0.0 110.856 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.549 HD21 HG21 ' A' ' 103' ' ' ILE . 6.4 m-20 -85.98 -9.78 56.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.319 -178.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.12 5.0 69.7 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.139 -1.029 . . . . 0.0 111.48 -178.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.592 ' HE2' ' HB2' ' A' ' 110' ' ' ALA . 8.4 mmtm -91.76 -177.98 4.91 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.585 HG11 ' HG3' ' A' ' 35' ' ' GLN . 10.8 m -120.85 141.39 41.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.703 0.287 . . . . 0.0 110.538 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.9 mt -69.33 134.26 48.87 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.038 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.461 ' HB2' ' HG3' ' A' ' 44' ' ' GLN . 9.7 t70 -146.62 153.74 40.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.864 0.364 . . . . 0.0 111.108 -179.051 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.569 HD12 HG21 ' A' ' 72' ' ' THR . 6.9 mm -74.9 143.39 13.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.431 ' HG2' ' N ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -69.85 128.81 37.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.967 0.413 . . . . 0.0 111.659 -179.116 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 60.89 15.4 42.17 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.823 -0.626 . . . . 0.0 113.193 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 45.84 29.81 0.77 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.907 0.354 . . . . 0.0 111.215 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.479 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 9.4 t-20 -76.62 111.14 14.12 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.093 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 23' ' ' ASN . 6.5 Cg_exo -73.66 0.41 8.21 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.696 2.264 . . . . 0.0 112.686 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.479 ' HB3' ' OD1' ' A' ' 23' ' ' ASN . . . -84.12 144.78 44.76 Favored Pre-proline 0 C--N 1.332 -0.165 0 CA-C-O 120.675 0.274 . . . . 0.0 111.216 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.445 ' HB3' ' CD ' ' A' ' 74' ' ' PRO . 50.1 Cg_exo -54.35 141.43 71.79 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.65 2.233 . . . . 0.0 112.445 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.25 3.45 55.55 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.762 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.3 m -73.64 124.96 26.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.974 0.416 . . . . 0.0 111.105 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.431 ' N ' ' HG2' ' A' ' 20' ' ' GLU . 0.3 OUTLIER -75.08 161.45 29.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.045 179.479 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.546 HD11 ' HB ' ' A' ' 70' ' ' ILE . 41.6 pt -118.88 146.56 23.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.853 0.359 . . . . 0.0 111.928 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.459 ' HA ' ' CD1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -153.56 178.01 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.139 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.686 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.4 p -103.73 151.14 23.37 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.695 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 27.0 t-105 -154.86 169.64 23.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.735 0.303 . . . . 0.0 110.884 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.56 132.68 46.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.767 0.318 . . . . 0.0 110.666 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.585 ' HG3' HG11 ' A' ' 16' ' ' VAL . 9.4 tt0 -55.08 114.84 1.92 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.217 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.19 170.29 10.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.678 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.6 mtmm -130.94 112.89 13.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.915 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 151.1 -162.82 29.59 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.594 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -74.95 1.01 8.18 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 123.013 2.475 . . . . 0.0 112.866 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.0 t -104.41 26.11 9.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.709 0.29 . . . . 0.0 111.123 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.988 ' O ' HD12 ' A' ' 45' ' ' LEU . . . -93.93 -20.58 19.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.975 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.665 HG13 ' HB3' ' A' ' 57' ' ' LYS . 50.0 t -51.21 -33.93 14.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.301 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -68.91 -7.86 38.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.6 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.461 ' HG3' ' HB2' ' A' ' 18' ' ' ASP . 1.8 mt-30 -114.5 6.27 15.82 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.988 HD12 ' O ' ' A' ' 41' ' ' ALA . 0.9 OUTLIER -118.67 142.34 47.76 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.157 -0.928 . . . . 0.0 111.567 -178.913 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.498 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 26.1 m95 -134.51 169.47 17.23 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.187 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.516 ' CE2' ' HB2' ' A' ' 55' ' ' ARG . 42.1 p90 -141.25 164.14 31.05 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.533 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.593 HG22 HG23 ' A' ' 54' ' ' ILE . 0.7 OUTLIER -108.58 135.18 50.26 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.784 0.326 . . . . 0.0 111.443 -178.876 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -78.19 170.93 15.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.144 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -66.33 -24.3 66.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.097 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.505 ' HG3' HG23 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -91.8 -4.09 55.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.253 179.846 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.38 9.78 49.8 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.875 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.505 HG23 ' HG3' ' A' ' 51' ' ' GLN . 40.1 t -97.48 119.73 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 CA-C-N 116.883 0.341 . . . . 0.0 110.512 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.593 HG23 HG22 ' A' ' 48' ' ' THR . 0.6 OUTLIER -78.77 150.86 5.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.495 0.664 . . . . 0.0 111.951 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.733 ' HD3' ' HB2' ' A' ' 62' ' ' ALA . 11.2 mmm-85 -147.36 132.94 18.76 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.628 178.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.791 ' HB2' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -60.83 141.97 56.57 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.713 0.768 . . . . 0.0 111.981 -178.481 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.665 ' HB3' HG13 ' A' ' 42' ' ' VAL . 21.9 tttm -56.64 -20.58 22.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.445 -1.252 . . . . 0.0 111.69 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.791 HD22 ' HB2' ' A' ' 56' ' ' SER . 1.0 OUTLIER -48.19 -31.7 6.11 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.736 -179.188 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.661 ' H ' HD23 ' A' ' 58' ' ' LEU . 0.3 OUTLIER -179.86 -81.46 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.735 0.303 . . . . 0.0 111.036 179.897 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 32.0 p-10 -176.44 77.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.897 0.38 . . . . 0.0 110.926 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -145.22 132.26 20.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.838 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.733 ' HB2' ' HD3' ' A' ' 55' ' ' ARG . . . -98.29 150.71 21.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.938 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.863 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -80.82 150.89 4.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.273 179.476 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.58 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 8.6 p-10 -133.06 131.58 40.79 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.215 0.531 . . . . 0.0 111.603 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.631 ' HB2' ' CZ2' ' A' ' 84' ' ' TRP . . . -96.18 40.96 1.11 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.256 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 68.2 m -73.91 -43.41 58.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.342 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 65.0 m80 -97.59 172.56 7.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.11 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -48.04 -47.15 33.79 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.136 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -102.33 146.5 27.94 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.912 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.863 HG22 HG22 ' A' ' 63' ' ' ILE . 1.9 mm -78.1 144.15 11.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-O 121.614 0.721 . . . . 0.0 111.755 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -144.51 168.75 19.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.001 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.569 HG21 HD12 ' A' ' 19' ' ' ILE . 80.9 p -105.44 136.98 44.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.993 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.451 ' CB ' ' HD2' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -161.2 168.06 12.21 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.136 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.451 ' HD2' ' CB ' ' A' ' 73' ' ' GLN . 13.9 Cg_endo -57.37 134.49 64.08 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.404 2.07 . . . . 0.0 112.055 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.477 ' CE1' ' HB2' ' A' ' 83' ' ' ALA . 19.6 t80 -62.46 132.61 53.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.864 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -121.62 139.22 29.54 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.775 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.12 -34.05 17.63 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.515 2.143 . . . . 0.0 112.67 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -88.13 -0.72 57.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.653 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.442 ' HB3' ' HD2' ' A' ' 82' ' ' ARG . 1.7 m120 -109.31 100.02 39.23 Favored Pre-proline 0 C--O 1.232 0.175 0 CA-C-O 120.583 0.23 . . . . 0.0 111.029 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.849 ' O ' HD21 ' A' ' 94' ' ' LEU . 4.0 Cg_exo -76.44 25.48 0.43 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.923 2.415 . . . . 0.0 113.027 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.58 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 0.1 OUTLIER -118.71 -21.33 7.92 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 120.616 0.246 . . . . 0.0 111.19 -179.721 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.487 ' HG3' ' HB3' ' A' ' 64' ' ' ASP . 0.4 OUTLIER -88.56 18.94 4.18 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.064 -0.517 . . . . 0.0 112.365 -179.028 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 1.155 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -128.41 99.26 5.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.097 0.475 . . . . 0.0 110.775 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.631 ' CZ2' ' HB2' ' A' ' 65' ' ' ALA . 58.3 m95 -108.84 136.45 48.37 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.15 0.5 . . . . 0.0 111.907 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.9 pt -113.81 154.47 15.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.085 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.7 t -102.53 127.84 55.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.988 0.423 . . . . 0.0 111.111 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 30.5 t -120.88 95.14 4.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.35 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.2 -101.07 0.84 Allowed Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.477 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.498 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -121.02 30.15 7.0 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.496 0.189 . . . . 0.0 110.867 -179.802 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.421 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.34 147.49 30.38 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.597 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.709 ' HB ' HD12 ' A' ' 101' ' ' LEU . 19.1 mm -94.06 119.98 42.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.336 178.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.935 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -123.98 144.57 49.74 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.404 ' HB3' ' HB2' ' A' ' 96' ' ' ASP . 1.7 tt0 -63.86 149.53 46.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.661 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.155 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.6 pt? -62.33 -57.11 12.54 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.672 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.566 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 92.6 p -79.8 -2.64 44.19 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.404 ' HB2' ' HB3' ' A' ' 93' ' ' GLN . 49.0 m-20 -137.52 84.65 2.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.841 0.353 . . . . 0.0 111.004 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.6 mpp_? -66.34 -18.18 65.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.174 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.407 ' O ' ' HA ' ' A' ' 118' ' ' LYS . 0.4 OUTLIER -91.46 10.29 28.32 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.538 179.316 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.857 ' CG2' ' HB1' ' A' ' 116' ' ' ALA . 11.2 mm -124.36 129.39 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.466 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.935 HG12 ' HB2' ' A' ' 92' ' ' ALA . 30.8 m -146.68 136.01 16.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.709 HD12 ' HB ' ' A' ' 91' ' ' ILE . 12.7 mt -46.47 153.79 0.34 Allowed 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 121.753 0.787 . . . . 0.0 111.837 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.748 ' O ' HG22 ' A' ' 114' ' ' ILE . 9.9 t70 -158.36 168.02 28.11 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.587 -177.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.664 HD12 ' O ' ' A' ' 124' ' ' ASN . 4.4 mp -87.26 122.38 39.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.194 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.8 HG22 ' O ' ' A' ' 113' ' ' HIS . 3.1 tt -65.37 136.73 26.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.072 0.463 . . . . 0.0 111.482 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 70.63 1.22 3.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.997 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 51.4 p 43.68 31.39 0.45 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.761 0.315 . . . . 0.0 111.365 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -94.7 154.29 17.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.267 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.91 -14.14 58.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.156 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -49.03 118.51 2.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.265 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.592 ' HB2' ' HE2' ' A' ' 15' ' ' LYS . . . -62.1 157.93 17.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.054 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 73.25 15.67 78.79 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.214 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.94 132.86 39.28 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.834 0.349 . . . . 0.0 110.95 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.8 ' O ' HG22 ' A' ' 104' ' ' ILE . 17.1 m170 -65.58 172.02 3.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.925 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.748 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -136.42 161.63 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.517 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.597 ' HA ' HD11 ' A' ' 70' ' ' ILE . 95.7 m -153.77 168.96 24.56 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.857 ' HB1' ' CG2' ' A' ' 99' ' ' ILE . . . -95.7 126.62 41.1 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.467 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 76.1 t-105 -134.49 162.57 31.88 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.603 0.716 . . . . 0.0 112.129 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.467 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.1 OUTLIER -62.43 117.43 6.15 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.596 -1.183 . . . . 0.0 110.781 179.885 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -62.4 126.65 28.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.962 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -138.18 13.72 2.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.165 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 76.19 60.8 2.98 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.518 -0.848 . . . . 0.0 112.315 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -117.3 145.99 18.7 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.551 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.68 -32.39 75.36 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.403 2.069 . . . . 0.0 112.013 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.664 ' O ' HD12 ' A' ' 103' ' ' ILE . 30.3 p-10 -76.29 -2.69 32.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.586 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.421 ' O ' ' CG2' ' A' ' 90' ' ' THR . 0.9 OUTLIER -107.8 11.06 28.55 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.466 0.174 . . . . 0.0 111.172 180.0 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.433 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 1.7 mmmm -106.76 138.21 43.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.846 0.355 . . . . 0.0 111.529 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.413 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 7.0 m-85 -138.59 155.77 48.05 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.246 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.3 mt -113.36 138.64 42.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.149 0.5 . . . . 0.0 110.776 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.471 ' CD1' HG23 ' A' ' 8' ' ' ILE . 26.4 mm -113.86 139.71 38.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.524 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -139.5 94.68 2.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.655 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 18.6 p -51.34 110.73 0.47 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.327 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.614 ' HG3' HD21 ' A' ' 45' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.948 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 mtt . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.796 0.331 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.4 mttt 60.33 82.12 0.23 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.837 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.62 106.78 1.88 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.547 2.164 . . . . 0.0 112.327 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 11.4 mttm -96.46 121.16 37.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.817 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.507 ' CD1' ' HG3' ' A' ' 57' ' ' LYS . 0.9 OUTLIER -100.64 175.93 5.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.476 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.758 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -158.84 173.95 15.74 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 120.469 -0.492 . . . . 0.0 111.496 179.883 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.836 ' OH ' ' HB1' ' A' ' 41' ' ' ALA . 0.4 OUTLIER -109.46 123.79 49.96 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.204 179.13 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.611 HG23 ' CD1' ' A' ' 129' ' ' ILE . 0.0 OUTLIER -109.02 104.56 17.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.939 -179.755 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.86 ' HE2' HD12 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -122.81 140.11 53.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.453 -179.751 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.41 ' O ' ' HD2' ' A' ' 9' ' ' LYS . 1.9 m -60.69 135.45 57.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.925 0.393 . . . . 0.0 110.744 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 4.2 tt0 -77.99 -11.84 59.94 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.961 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 41.1 tp -89.03 -58.64 2.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.793 0.33 . . . . 0.0 110.986 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.572 HD21 HG21 ' A' ' 103' ' ' ILE . 6.2 m-20 -84.94 -17.74 36.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.262 -0.426 . . . . 0.0 112.017 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.4 5.81 73.72 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.308 -0.949 . . . . 0.0 112.231 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.649 ' HE2' ' HB2' ' A' ' 110' ' ' ALA . 1.5 mmmt -86.29 165.64 16.28 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.765 HG12 ' HB3' ' A' ' 9' ' ' LYS . 9.5 m -106.5 137.15 38.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.822 0.344 . . . . 0.0 110.723 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.3 mt -69.13 137.58 53.52 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -143.7 151.19 39.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.018 0.437 . . . . 0.0 111.439 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.062 HD13 HG21 ' A' ' 72' ' ' THR . 23.1 mt -92.73 133.64 33.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.459 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -40.64 96.3 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.962 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 44.43 32.94 2.92 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.925 -0.58 . . . . 0.0 113.302 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 67.67 -66.06 0.22 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.784 0.326 . . . . 0.0 111.021 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 63.55 90.75 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.847 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.63 -21.09 13.7 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.579 2.186 . . . . 0.0 112.505 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -96.23 153.94 38.9 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.066 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.477 ' HB3' ' HB3' ' A' ' 73' ' ' GLN . 10.7 Cg_exo -70.81 146.48 53.79 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.772 2.315 . . . . 0.0 112.092 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.98 3.38 23.25 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.52 -0.847 . . . . 0.0 113.239 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.7 t -77.2 132.54 38.8 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 117.093 0.446 . . . . 0.0 111.345 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.6 mmtt -81.46 160.53 23.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.645 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.572 HD13 HG21 ' A' ' 63' ' ' ILE . 47.3 pt -120.98 149.03 23.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.445 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.423 HG22 ' HA ' ' A' ' 113' ' ' HIS . 0.2 OUTLIER -155.73 -178.98 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.173 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.75 -179.812 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 p -101.36 149.19 24.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.419 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 19.5 t-105 -156.81 171.49 20.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.732 0.301 . . . . 0.0 110.989 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -71.33 138.54 49.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.705 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.529 ' HA ' HG21 ' A' ' 16' ' ' VAL . 4.6 tt0 -52.1 112.14 0.74 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.284 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.0 168.01 13.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.902 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.98 151.6 51.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.877 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.96 -162.81 12.3 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.496 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -79.13 7.9 4.13 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.169 2.579 . . . . 0.0 112.849 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -114.07 18.0 17.44 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.655 0.264 . . . . 0.0 111.208 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.844 ' O ' HD12 ' A' ' 45' ' ' LEU . . . -82.42 -22.37 35.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.951 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.922 HG13 ' HB3' ' A' ' 57' ' ' LYS . 17.5 t -50.33 -27.65 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.961 179.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -64.65 -10.56 27.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.619 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -118.56 7.79 11.87 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.135 0.493 . . . . 0.0 109.675 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.844 HD12 ' O ' ' A' ' 41' ' ' ALA . 1.3 mp -117.05 140.37 49.57 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.664 -179.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.661 ' CZ2' HD11 ' A' ' 19' ' ' ILE . 25.9 m95 -134.43 169.4 17.31 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.035 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.587 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 15.1 p90 -141.42 165.51 27.32 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.954 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.599 HG22 HG23 ' A' ' 54' ' ' ILE . 4.2 p -109.68 136.67 48.66 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.902 0.382 . . . . 0.0 111.475 -178.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.0 173.39 12.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.327 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -63.29 -21.24 66.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.12 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -101.36 -2.8 30.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.168 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.21 2.6 51.28 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.868 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.554 HG12 ' HD3' ' A' ' 55' ' ' ARG . 21.8 t -83.06 114.26 23.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.873 0.368 . . . . 0.0 110.82 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.599 HG23 HG22 ' A' ' 48' ' ' THR . 0.7 OUTLIER -76.78 146.72 8.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.253 0.549 . . . . 0.0 111.766 -179.795 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.659 ' HD2' ' HB2' ' A' ' 62' ' ' ALA . 2.7 mmm-85 -151.56 133.68 15.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.539 178.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.532 ' CB ' HD22 ' A' ' 58' ' ' LEU . 12.5 m -52.78 150.2 5.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.271 0.558 . . . . 0.0 111.903 -179.054 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.922 ' HB3' HG13 ' A' ' 42' ' ' VAL . 1.1 ttpt -60.33 -26.56 66.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.763 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.728 HD23 ' H ' ' A' ' 59' ' ' ASN . 0.8 OUTLIER -56.29 -32.91 65.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.282 -179.316 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.728 ' H ' HD23 ' A' ' 58' ' ' LEU . 1.3 m-20 170.77 -171.87 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.775 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -76.4 84.78 3.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.705 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.41 ' CE2' ' HD3' ' A' ' 74' ' ' PRO . 1.1 m-85 -141.06 115.17 9.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.759 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.659 ' HB2' ' HD2' ' A' ' 55' ' ' ARG . . . -105.73 150.03 25.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.081 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.824 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -78.64 153.76 4.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.92 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.564 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 5.1 p-10 -133.6 132.91 41.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.227 0.537 . . . . 0.0 111.569 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.668 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -96.73 41.78 1.1 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.197 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.4 m -74.53 -46.36 39.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.225 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -93.95 170.66 9.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.952 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -47.29 -48.06 25.04 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.944 0.402 . . . . 0.0 110.959 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -99.73 144.24 29.04 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.917 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.824 HG22 HG22 ' A' ' 63' ' ' ILE . 2.7 mm -71.05 136.13 26.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-O 121.527 0.679 . . . . 0.0 111.366 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -130.33 162.76 28.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.237 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . 1.062 HG21 HD13 ' A' ' 19' ' ' ILE . 18.0 p -105.5 138.71 41.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.549 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.477 ' HB3' ' HB3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -162.82 159.16 19.3 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.668 -179.769 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.423 ' O ' ' HD3' ' A' ' 82' ' ' ARG . 53.7 Cg_exo -52.03 143.29 41.27 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.429 2.086 . . . . 0.0 111.737 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.532 ' CE1' HG11 ' A' ' 53' ' ' VAL . 66.7 t80 -59.07 126.03 26.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.915 0.388 . . . . 0.0 111.354 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.422 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 8.1 t70 -119.54 130.32 24.9 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.166 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.6 -33.82 21.07 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.602 2.202 . . . . 0.0 113.47 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -85.71 0.25 53.29 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.422 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 3.2 m120 -106.49 104.33 50.13 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.563 0.221 . . . . 0.0 111.343 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.842 ' O ' HD21 ' A' ' 94' ' ' LEU . 5.6 Cg_exo -77.34 20.07 0.69 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.868 2.379 . . . . 0.0 112.697 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.579 ' HD2' ' HB3' ' A' ' 65' ' ' ALA . 24.6 mmtp -120.15 -18.34 8.09 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.038 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.525 ' HG2' ' HB3' ' A' ' 64' ' ' ASP . 6.4 mtt180 -88.66 18.73 4.42 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.943 -0.572 . . . . 0.0 112.187 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 1.132 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -127.79 99.27 5.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.131 0.491 . . . . 0.0 110.647 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.668 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 61.8 m95 -108.55 136.42 48.18 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.114 0.483 . . . . 0.0 111.859 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 pt -115.21 154.24 16.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.272 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.5 t -101.2 124.41 54.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.012 0.434 . . . . 0.0 110.987 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 23.1 t -116.8 94.43 4.6 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.437 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.66 -100.95 0.79 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.505 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.51 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.79 30.17 7.03 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.587 0.232 . . . . 0.0 110.915 -179.63 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.92 148.0 30.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.394 0.616 . . . . 0.0 112.537 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.751 ' HB ' HD12 ' A' ' 101' ' ' LEU . 13.6 mm -93.94 120.15 42.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.411 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.989 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -124.89 146.67 49.2 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -178.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.437 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -67.17 148.83 51.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.811 179.808 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.132 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.7 pt? -61.07 -56.54 19.75 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.719 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.578 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 57.9 m -80.17 -3.44 48.98 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -136.56 85.44 2.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.838 0.351 . . . . 0.0 111.075 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -66.83 -17.97 65.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.155 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -92.08 9.83 31.75 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.521 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.823 ' CG2' ' HB1' ' A' ' 116' ' ' ALA . 12.2 mm -123.14 127.4 74.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.531 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.989 HG12 ' HB2' ' A' ' 92' ' ' ALA . 23.5 m -146.17 135.04 16.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.86 0.362 . . . . 0.0 111.862 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.751 HD12 ' HB ' ' A' ' 91' ' ' ILE . 11.0 mt -46.72 154.37 0.32 Allowed 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.7 0.762 . . . . 0.0 112.008 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.804 ' O ' HG22 ' A' ' 114' ' ' ILE . 9.8 t70 -155.63 167.78 29.29 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.319 -1.31 . . . . 0.0 110.694 -177.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.572 HG21 HD21 ' A' ' 13' ' ' ASN . 3.7 mp -92.94 124.52 45.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.509 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.8 HG22 ' O ' ' A' ' 113' ' ' HIS . 0.9 OUTLIER -68.24 139.6 20.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.961 0.41 . . . . 0.0 111.324 -179.83 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.422 ' N ' HG13 ' A' ' 104' ' ' ILE . 0.0 OUTLIER 78.4 -9.8 1.45 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.851 179.745 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.4 m 47.13 34.94 3.19 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.806 0.336 . . . . 0.0 111.188 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -106.94 166.92 10.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.195 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.4 -14.39 58.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.037 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -50.47 135.84 21.73 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.202 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.649 ' HB2' ' HE2' ' A' ' 15' ' ' LYS . . . -88.97 162.3 16.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.095 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.01 16.45 79.51 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.233 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.43 137.87 33.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.897 0.379 . . . . 0.0 110.967 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.8 ' O ' HG22 ' A' ' 104' ' ' ILE . 3.1 m170 -61.9 167.98 3.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.847 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.804 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -138.74 161.01 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.582 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.672 ' HA ' HD11 ' A' ' 70' ' ' ILE . 25.7 p -156.75 170.68 21.88 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.823 ' HB1' ' CG2' ' A' ' 99' ' ' ILE . . . -95.49 127.01 41.18 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 178.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.456 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 70.7 t-105 -132.37 162.88 29.98 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.529 0.68 . . . . 0.0 112.282 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.456 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.5 OUTLIER -63.55 120.78 12.39 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.659 179.843 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -58.91 124.45 19.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.177 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -132.68 8.1 4.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.631 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 82.38 6.74 88.42 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.164 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -66.0 142.62 43.55 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.401 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -56.86 -25.15 60.16 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.457 2.105 . . . . 0.0 112.508 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 34.5 p-10 -70.46 -9.09 55.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.706 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -107.02 17.99 22.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.698 0.285 . . . . 0.0 111.014 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.427 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 4.5 mmtp -103.59 123.78 47.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.793 0.33 . . . . 0.0 111.157 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.431 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 4.3 m-85 -127.96 153.0 47.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.632 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.86 HD12 ' HE2' ' A' ' 9' ' ' LYS . 1.6 mt -115.61 139.47 41.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.452 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.611 ' CD1' HG23 ' A' ' 8' ' ' ILE . 32.3 mm -113.94 144.05 22.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.677 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -136.07 94.18 3.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.609 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.47 109.3 0.43 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.312 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.913 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.83 0.348 . . . . 0.0 111.166 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.457 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 0.1 OUTLIER -80.17 -47.78 1.33 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.2 -179.977 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.457 ' CD ' ' N ' ' A' ' 2' ' ' LYS . 85.0 Cg_endo -82.56 111.4 2.04 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.405 2.07 . . . . 0.0 112.539 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.426 ' O ' ' HB2' ' A' ' 47' ' ' TYR . 0.5 OUTLIER -102.76 76.84 1.54 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.773 179.876 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.4 ' HA ' ' O ' ' A' ' 46' ' ' TRP . 97.9 m-85 -99.21 175.04 6.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.757 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.636 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -151.92 170.71 19.19 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 120.97 0.414 . . . . 0.0 111.213 178.982 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.432 ' O ' ' HA ' ' A' ' 129' ' ' ILE . 0.1 OUTLIER -111.45 123.82 50.99 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.143 179.173 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.616 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -107.12 106.36 20.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.245 179.879 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.424 ' HG3' ' O ' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -106.77 137.06 45.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.384 -178.7 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.9 108.67 10.11 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.421 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 3.1 tt0 -62.69 -10.53 12.92 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.483 -178.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.638 HD22 ' HA ' ' A' ' 124' ' ' ASN . 30.3 tp -83.36 -62.47 1.58 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.865 0.364 . . . . 0.0 111.039 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.506 ' ND2' ' O ' ' A' ' 107' ' ' ASP . 3.0 m120 -86.83 -10.65 52.98 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.1 5.03 69.7 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.086 -1.054 . . . . 0.0 111.398 -178.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.424 ' O ' ' HG3' ' A' ' 9' ' ' LYS . 1.7 mmmm -91.78 178.22 5.97 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.625 HG21 ' HA ' ' A' ' 35' ' ' GLN . 5.9 m -119.93 142.59 34.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.689 0.281 . . . . 0.0 110.507 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.3 mt -68.11 135.93 52.94 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.453 ' CB ' ' HG3' ' A' ' 44' ' ' GLN . 19.9 t0 -145.33 142.44 29.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.719 0.295 . . . . 0.0 111.114 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.737 HD12 HG21 ' A' ' 72' ' ' THR . 14.0 mm -66.28 145.78 13.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -51.04 109.2 0.3 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.911 0.386 . . . . 0.0 111.511 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 49.76 26.38 7.97 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.97 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 50.75 68.94 0.7 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.848 0.356 . . . . 0.0 110.985 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.457 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 2.1 t-20 -102.37 106.25 47.76 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.927 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.27 -7.92 20.42 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.739 2.293 . . . . 0.0 112.68 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.514 ' HB1' ' HD2' ' A' ' 26' ' ' PRO . . . -82.08 160.46 63.02 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.787 0.327 . . . . 0.0 111.088 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.514 ' HD2' ' HB1' ' A' ' 25' ' ' ALA . 72.1 Cg_endo -75.49 141.07 24.83 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.742 2.294 . . . . 0.0 112.387 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.14 5.5 52.85 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.806 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.91 134.56 41.57 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.96 0.409 . . . . 0.0 111.213 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.417 ' HD3' ' HB3' ' A' ' 71' ' ' GLU . 45.9 mmtt -81.72 157.03 24.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.213 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.595 HD13 HG21 ' A' ' 63' ' ' ILE . 47.5 pt -116.63 145.96 21.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.906 -0.317 . . . . 0.0 111.483 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.447 HG22 ' HA ' ' A' ' 113' ' ' HIS . 0.2 OUTLIER -155.49 -178.85 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.196 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.982 -179.667 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.5 p -101.98 148.88 24.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.551 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 32.4 t-105 -159.13 173.28 16.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.686 0.279 . . . . 0.0 110.845 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -70.14 134.58 48.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.813 0.339 . . . . 0.0 110.757 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.625 ' HA ' HG21 ' A' ' 16' ' ' VAL . 20.4 tt0 -61.36 130.51 46.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.01 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.71 159.97 14.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.784 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -122.45 105.76 10.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.967 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 159.31 -178.12 35.58 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.51 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -77.19 4.57 5.73 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.04 2.493 . . . . 0.0 112.782 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.2 t -119.98 30.02 7.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.797 0.332 . . . . 0.0 110.917 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.52 ' O ' HD12 ' A' ' 45' ' ' LEU . . . -109.29 2.52 20.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.525 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.691 HG12 ' HB3' ' A' ' 57' ' ' LYS . 2.2 t -58.95 -18.21 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-O 120.706 0.289 . . . . 0.0 110.596 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.41 ' HA ' ' HG2' ' A' ' 57' ' ' LYS . 64.0 t30 -61.84 -11.86 14.72 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.928 178.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.453 ' HG3' ' CB ' ' A' ' 18' ' ' ASP . 7.7 mp0 -111.56 7.76 20.72 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.636 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 1.4 mp -121.06 146.44 46.72 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.232 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.461 ' CH2' ' CG1' ' A' ' 63' ' ' ILE . 25.4 m95 -133.27 170.11 15.93 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.65 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.549 ' CE2' ' HB2' ' A' ' 55' ' ' ARG . 1.5 p90 -136.09 159.46 41.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.92 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.529 HG22 HG23 ' A' ' 54' ' ' ILE . 17.8 p -107.17 134.18 50.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.786 0.327 . . . . 0.0 111.303 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 53' ' ' VAL . 14.7 t70 -77.87 166.53 22.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.147 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -59.37 -22.69 61.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.164 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -97.4 -2.83 41.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.281 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.91 5.45 55.0 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.873 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.412 HG12 ' HD3' ' A' ' 55' ' ' ARG . 21.2 t -87.84 116.67 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-O 120.8 0.333 . . . . 0.0 110.635 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.529 HG23 HG22 ' A' ' 48' ' ' THR . 0.8 OUTLIER -78.55 150.49 5.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.326 0.584 . . . . 0.0 111.942 -179.758 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.549 ' HB2' ' CE2' ' A' ' 47' ' ' TYR . 2.9 mmm-85 -147.44 133.18 18.93 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.207 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.426 ' HB3' ' CD2' ' A' ' 58' ' ' LEU . 47.2 t -68.8 -177.2 0.94 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.307 0.575 . . . . 0.0 112.138 -178.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.691 ' HB3' HG12 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -46.05 -23.56 0.33 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.838 -179.761 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.537 ' HB2' ' HB2' ' A' ' 61' ' ' PHE . 0.9 OUTLIER -50.45 -21.3 1.41 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.652 -179.315 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 58' ' ' LEU . 8.0 t30 84.44 -10.24 0.88 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 179.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -175.36 53.49 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.861 0.362 . . . . 0.0 111.546 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.537 ' HB2' ' HB2' ' A' ' 58' ' ' LEU . 3.8 m-85 -141.07 110.5 6.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.018 0.437 . . . . 0.0 110.597 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.417 ' HB2' ' CD ' ' A' ' 55' ' ' ARG . . . -98.46 150.06 22.04 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.894 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.836 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -77.92 150.8 5.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.214 179.713 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.583 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 7.8 p-10 -131.59 133.02 44.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.156 0.503 . . . . 0.0 111.558 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.638 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -99.65 41.44 1.16 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.178 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.4 m -73.49 -42.62 61.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.061 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -98.2 172.83 7.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.936 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -49.47 -47.82 48.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.181 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -99.74 144.33 28.94 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.141 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.836 HG22 HG22 ' A' ' 63' ' ' ILE . 2.3 mm -76.31 142.86 13.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 CA-C-O 121.541 0.686 . . . . 0.0 111.764 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.417 ' HB3' ' HD3' ' A' ' 29' ' ' LYS . 0.5 OUTLIER -141.8 168.41 19.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.196 -179.835 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.737 HG21 HD12 ' A' ' 19' ' ' ILE . 49.4 p -108.24 139.88 42.29 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.085 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.49 165.17 14.51 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.304 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.468 ' CD ' ' HB3' ' A' ' 26' ' ' PRO . 10.6 Cg_endo -53.6 139.37 66.81 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.533 2.155 . . . . 0.0 111.92 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -61.5 131.74 51.13 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.881 0.372 . . . . 0.0 111.232 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.405 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 0.3 OUTLIER -120.92 133.84 24.21 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.555 179.729 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -69.05 -34.48 16.86 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.451 2.101 . . . . 0.0 112.664 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -88.04 0.31 56.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.77 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.405 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 1.3 t-20 -105.71 102.21 37.04 Favored Pre-proline 0 C--O 1.233 0.2 0 CA-C-O 120.517 0.199 . . . . 0.0 111.051 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.852 ' O ' HD21 ' A' ' 94' ' ' LEU . 5.9 Cg_exo -77.62 22.05 0.61 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.921 2.414 . . . . 0.0 112.994 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.583 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 33.7 mmtt -119.93 -18.54 8.18 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 120.599 0.238 . . . . 0.0 111.139 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.527 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 3.1 mtm180 -89.63 18.84 5.06 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.357 -179.085 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 1.087 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -127.8 99.06 5.39 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.054 0.454 . . . . 0.0 110.802 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.638 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 58.0 m95 -108.77 135.53 49.84 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.192 0.52 . . . . 0.0 111.938 -178.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.3 pt -113.58 154.41 14.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.254 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.3 t -101.32 125.83 55.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.967 0.413 . . . . 0.0 111.045 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 47.0 t -118.44 93.68 4.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.456 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.9 -100.41 0.77 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.519 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.495 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.42 29.19 7.58 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.532 0.206 . . . . 0.0 111.017 -179.578 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.426 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.57 147.56 30.21 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.607 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.627 ' HB ' HD12 ' A' ' 101' ' ' LEU . 18.9 mm -93.76 120.47 43.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.127 178.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.967 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -123.87 145.31 49.19 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.423 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -66.22 148.45 51.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.648 179.786 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.087 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.6 pt? -60.77 -57.02 14.44 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.804 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.566 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 66.9 p -78.99 -3.7 46.33 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -137.09 86.59 2.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.877 0.37 . . . . 0.0 111.001 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.59 -18.68 65.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.082 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.402 ' O ' ' HA ' ' A' ' 118' ' ' LYS . 9.5 m-20 -91.96 9.87 31.28 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.459 179.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.817 ' CG2' ' HB1' ' A' ' 116' ' ' ALA . 13.3 mm -121.84 126.46 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.47 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.967 HG12 ' HB2' ' A' ' 92' ' ' ALA . 25.4 m -146.14 134.9 16.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.96 0.41 . . . . 0.0 111.973 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.627 HD12 ' HB ' ' A' ' 91' ' ' ILE . 13.6 mt -47.94 154.22 0.56 Allowed 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 121.782 0.801 . . . . 0.0 112.095 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.783 ' O ' HG22 ' A' ' 114' ' ' ILE . 9.9 t70 -156.2 167.02 31.74 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.271 -1.331 . . . . 0.0 110.78 -177.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.704 HD12 ' O ' ' A' ' 124' ' ' ASN . 4.4 mp -88.62 122.92 40.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.256 179.256 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.834 HG22 ' O ' ' A' ' 113' ' ' HIS . 2.8 tt -69.03 139.47 20.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.066 0.46 . . . . 0.0 111.675 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 75.61 -7.21 1.83 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.074 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.1 m 46.61 29.15 0.88 Allowed 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.766 0.317 . . . . 0.0 111.179 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.506 ' O ' ' ND2' ' A' ' 13' ' ' ASN . 0.6 OUTLIER -99.43 161.53 13.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.071 -179.816 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.489 ' HA ' ' ND2' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -78.64 -14.36 59.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.202 179.769 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -49.06 123.6 7.45 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.895 0.379 . . . . 0.0 111.252 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.59 162.17 29.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.103 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 70.63 18.96 76.13 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.0 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.37 136.41 35.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.903 0.382 . . . . 0.0 111.0 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.834 ' O ' HG22 ' A' ' 104' ' ' ILE . 1.2 m170 -63.61 171.39 2.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.751 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.783 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.7 OUTLIER -142.44 162.02 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.806 -179.681 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.652 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 5.0 p -155.51 172.02 18.95 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.817 ' HB1' ' CG2' ' A' ' 99' ' ' ILE . . . -96.02 126.99 41.64 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 178.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.458 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 69.8 t-105 -132.77 162.01 32.58 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.567 0.699 . . . . 0.0 112.158 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.458 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 2.4 tptt -61.21 121.14 11.79 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.637 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -62.0 125.28 23.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.896 0.379 . . . . 0.0 111.211 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -134.92 12.17 3.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.169 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 79.62 8.16 87.94 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.927 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -60.47 149.76 42.52 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.52 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.21 -25.2 57.8 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.639 2.226 . . . . 0.0 112.206 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.704 ' O ' HD12 ' A' ' 103' ' ' ILE . 13.3 p-10 -74.0 -5.16 39.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.426 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.426 ' O ' ' CG2' ' A' ' 90' ' ' THR . 83.8 mt-30 -108.14 18.69 20.85 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.615 0.245 . . . . 0.0 111.19 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.421 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 1.5 mmmt -104.74 127.69 52.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.798 0.332 . . . . 0.0 111.273 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.432 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 15.1 m-85 -134.04 154.38 51.19 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 120.939 0.4 . . . . 0.0 110.399 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.4 mt -113.56 138.98 41.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.456 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.513 ' CD1' HG23 ' A' ' 8' ' ' ILE . 36.2 mm -113.64 140.85 31.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.613 -179.135 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -138.45 112.15 8.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.512 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.82 109.07 3.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.047 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.905 179.958 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.6 mmt . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.799 0.333 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.411 ' CB ' ' HD3' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -87.66 -52.98 0.39 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.943 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.411 ' HD3' ' CB ' ' A' ' 2' ' ' LYS . 50.2 Cg_exo -53.63 132.12 47.42 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.487 2.125 . . . . 0.0 112.246 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -78.69 109.61 13.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.911 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.51 ' CD1' ' HG3' ' A' ' 57' ' ' LYS . 25.3 m-85 -92.39 175.2 6.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.516 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.722 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -159.46 176.34 12.21 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.793 179.764 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.839 ' CE2' HD21 ' A' ' 45' ' ' LEU . 21.5 m-85 -111.84 124.29 52.06 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.276 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.611 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -107.61 107.07 21.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.818 0.342 . . . . 0.0 110.275 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 15' ' ' LYS . 6.0 tttt -106.5 137.07 45.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.099 -0.501 . . . . 0.0 112.322 -178.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.0 m -75.94 109.83 9.89 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 178.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.411 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 3.8 tt0 -64.46 -11.38 32.95 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.492 -178.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.455 HD22 ' CB ' ' A' ' 124' ' ' ASN . 24.0 tp -84.34 -62.3 1.59 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.939 0.399 . . . . 0.0 111.034 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.513 ' ND2' ' HA ' ' A' ' 108' ' ' LYS . 3.4 m120 -85.28 -12.6 52.05 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.79 3.07 72.43 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.095 -1.05 . . . . 0.0 111.485 -178.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.432 ' HG2' ' HB2' ' A' ' 13' ' ' ASN . 1.7 mmtt -90.43 -179.2 5.54 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.541 HG21 ' HA ' ' A' ' 35' ' ' GLN . 4.3 m -121.93 142.44 38.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.728 0.299 . . . . 0.0 110.586 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.3 mt -67.23 135.08 52.87 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.44 ' O ' HD13 ' A' ' 31' ' ' ILE . 12.7 t70 -145.41 146.64 31.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.683 0.278 . . . . 0.0 111.13 -178.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.405 HD11 ' CZ2' ' A' ' 46' ' ' TRP . 3.0 mm -74.32 144.9 11.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.662 ' HG2' HD12 ' A' ' 31' ' ' ILE . 1.7 mt-10 -62.28 128.68 37.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.013 0.435 . . . . 0.0 111.909 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 47.35 24.94 2.67 Favored Glycine 0 C--N 1.331 0.298 0 CA-C-N 115.825 -0.625 . . . . 0.0 113.671 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 47.63 27.49 1.04 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.851 0.326 . . . . 0.0 111.333 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -66.03 108.02 1.96 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.064 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -76.0 -2.82 13.07 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.727 2.285 . . . . 0.0 112.489 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -85.32 147.97 48.61 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 120.725 0.298 . . . . 0.0 111.232 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -56.94 134.35 63.97 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.532 2.155 . . . . 0.0 112.372 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.32 5.44 32.33 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.99 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.3 m -76.67 126.59 31.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.901 0.381 . . . . 0.0 111.259 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -76.14 159.94 30.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.282 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.605 HD13 HG21 ' A' ' 63' ' ' ILE . 50.9 pt -119.96 147.4 23.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.892 0.377 . . . . 0.0 111.824 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.662 HD12 ' HG2' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -155.9 -177.81 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.163 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.495 -179.901 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 p -103.36 150.38 23.86 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.648 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 27.2 t-105 -156.53 170.74 21.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.668 0.27 . . . . 0.0 110.849 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -69.6 132.9 46.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.758 0.313 . . . . 0.0 110.665 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.541 ' HA ' HG21 ' A' ' 16' ' ' VAL . 4.5 pt20 -57.27 147.4 25.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.16 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.53 165.45 15.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.775 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.9 mttm -125.6 109.61 12.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 144.29 -160.8 27.9 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.623 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -72.73 -1.91 11.09 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 123.005 2.47 . . . . 0.0 112.861 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.7 p -102.14 30.49 4.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.94 0.4 . . . . 0.0 111.033 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.985 ' O ' HD12 ' A' ' 45' ' ' LEU . . . -106.62 -17.11 14.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.908 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.871 HG13 ' HB3' ' A' ' 57' ' ' LYS . 73.4 t -50.06 -35.12 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.965 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.438 ' HB3' ' OD1' ' A' ' 18' ' ' ASP . 17.8 t30 -69.13 -7.82 39.68 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.995 -179.301 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -118.01 7.75 12.34 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.985 HD12 ' O ' ' A' ' 41' ' ' ALA . 0.9 OUTLIER -117.68 140.72 49.27 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.312 -179.096 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.524 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 25.4 m95 -134.67 169.29 17.55 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.813 -178.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.498 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 6.3 p90 -137.86 161.18 37.3 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.296 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.61 HG22 ' CG2' ' A' ' 54' ' ' ILE . 65.1 p -107.58 136.32 47.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.729 0.299 . . . . 0.0 111.003 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.424 ' HB2' ' O ' ' A' ' 53' ' ' VAL . 25.4 t70 -77.77 166.59 22.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.938 0.399 . . . . 0.0 111.168 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -57.81 -20.93 39.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.189 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -102.79 -2.45 28.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.386 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.24 0.47 47.54 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.043 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.48 HG13 ' HA ' ' A' ' 83' ' ' ALA . 23.2 t -81.24 113.32 20.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.921 0.36 . . . . 0.0 110.58 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.61 ' CG2' HG22 ' A' ' 48' ' ' THR . 0.6 OUTLIER -79.59 150.33 5.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.439 0.638 . . . . 0.0 112.089 -179.602 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.851 ' CD ' ' HB2' ' A' ' 62' ' ' ALA . 9.0 mmm-85 -151.02 132.59 14.79 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.834 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.524 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 66.2 p -57.42 156.59 7.67 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.648 0.737 . . . . 0.0 111.384 -179.225 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.871 ' HB3' HG13 ' A' ' 42' ' ' VAL . 58.7 tttm -61.25 -9.32 4.81 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.686 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.506 HD13 ' HB2' ' A' ' 56' ' ' SER . 4.6 mp -42.13 -49.86 4.81 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.059 0.457 . . . . 0.0 111.035 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.7 p30 172.52 -53.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.534 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.5 t0 179.71 76.82 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.668 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.441 ' CE2' ' HD3' ' A' ' 74' ' ' PRO . 3.7 m-85 -143.49 126.88 16.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.054 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.851 ' HB2' ' CD ' ' A' ' 55' ' ' ARG . . . -103.61 150.85 23.58 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.21 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.954 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -80.49 152.04 4.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.178 179.499 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.558 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 6.9 p-10 -133.36 135.72 44.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.17 0.51 . . . . 0.0 111.653 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.653 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -98.13 44.08 1.05 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.205 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 94.2 p -74.12 -43.64 56.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.462 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -100.89 176.06 5.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.084 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -49.03 -44.71 41.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.823 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.74 148.87 26.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.602 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.954 HG22 HG22 ' A' ' 63' ' ' ILE . 1.3 mm -77.93 140.84 16.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 CA-C-O 121.651 0.738 . . . . 0.0 111.612 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -133.31 159.84 39.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.766 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 39.2 p -102.29 137.53 40.43 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.34 179.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.496 ' CB ' ' HD2' ' A' ' 74' ' ' PRO . 0.3 OUTLIER -164.47 170.95 6.12 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.253 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.496 ' HD2' ' CB ' ' A' ' 73' ' ' GLN . 20.0 Cg_endo -60.45 133.35 48.48 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.19 1.927 . . . . 0.0 111.815 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.416 ' CE1' ' HB2' ' A' ' 83' ' ' ALA . 28.8 t80 -57.63 135.71 56.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.953 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.08 122.96 26.82 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.787 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -56.39 -34.58 94.72 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.467 2.111 . . . . 0.0 112.698 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -87.94 -0.67 57.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.761 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.402 ' HB3' ' HD2' ' A' ' 82' ' ' ARG . 3.0 m120 -108.74 100.31 38.46 Favored Pre-proline 0 C--O 1.232 0.183 0 CA-C-O 120.603 0.24 . . . . 0.0 110.922 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.85 ' O ' HD21 ' A' ' 94' ' ' LEU . 3.8 Cg_exo -76.47 25.37 0.44 Allowed 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.91 2.407 . . . . 0.0 113.236 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.561 ' HD2' ' HB3' ' A' ' 65' ' ' ALA . 21.0 mmtp -120.01 -19.91 7.66 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 120.581 0.229 . . . . 0.0 111.066 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.469 ' HG3' ' HB3' ' A' ' 64' ' ' ASP . 0.2 OUTLIER -88.89 18.75 4.55 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.162 -179.304 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 1.127 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -127.56 99.16 5.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.13 0.491 . . . . 0.0 110.738 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.695 ' HH2' ' HB2' ' A' ' 116' ' ' ALA . 58.8 m95 -108.48 135.39 49.84 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.138 0.494 . . . . 0.0 111.734 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 pt -113.55 155.27 14.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.257 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.7 t -103.38 129.06 55.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.965 0.412 . . . . 0.0 111.139 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 40.3 t -121.74 95.72 4.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.308 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.13 -101.14 0.85 Allowed Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.274 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.5 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.85 30.41 6.9 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.573 0.225 . . . . 0.0 110.811 -179.797 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.405 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.66 147.44 29.99 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.621 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.461 ' HB ' HD12 ' A' ' 101' ' ' LEU . 18.4 mm -94.38 120.24 43.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.385 178.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.901 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -123.66 145.34 49.03 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -178.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.588 ' NE2' ' CZ2' ' A' ' 84' ' ' TRP . 0.8 OUTLIER -65.65 148.38 51.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.513 179.646 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.127 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.6 pt? -62.19 -56.77 15.42 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.836 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.563 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 20.6 p -77.91 -4.13 45.22 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -178.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.568 ' O ' HG22 ' A' ' 99' ' ' ILE . 2.1 m-20 -138.05 87.0 2.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.777 0.322 . . . . 0.0 110.863 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.11 -16.16 63.07 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.204 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -90.35 11.83 20.2 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.182 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.568 HG22 ' O ' ' A' ' 96' ' ' ASP . 6.3 tt -130.94 137.92 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.061 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.901 HG12 ' HB2' ' A' ' 92' ' ' ALA . 23.9 m -148.86 137.12 14.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.763 0.316 . . . . 0.0 111.729 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.557 ' HA ' ' O ' ' A' ' 115' ' ' CYS . 24.8 mt -45.53 153.4 0.25 Allowed 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.705 0.764 . . . . 0.0 111.788 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.437 ' O ' HG22 ' A' ' 114' ' ' ILE . 10.0 t70 -158.46 168.4 27.06 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.381 -1.282 . . . . 0.0 110.763 -177.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.544 HD12 ' O ' ' A' ' 124' ' ' ASN . 4.5 mp -90.48 123.55 42.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.452 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.85 HG22 ' O ' ' A' ' 113' ' ' HIS . 6.2 tp -67.9 140.73 18.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.938 0.399 . . . . 0.0 111.332 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 76.56 -5.83 2.11 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.945 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.7 t 46.36 29.69 0.91 Allowed 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.77 0.319 . . . . 0.0 111.194 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.5 ' O ' ' ND2' ' A' ' 13' ' ' ASN . 5.6 m-20 -100.79 161.75 13.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.105 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.513 ' HA ' ' ND2' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -80.9 -13.98 58.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.141 179.838 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -48.6 123.43 6.74 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.237 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.88 160.27 32.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.063 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 72.56 16.32 77.63 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.092 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -79.26 135.09 36.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.816 0.341 . . . . 0.0 110.886 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.85 ' O ' HG22 ' A' ' 104' ' ' ILE . 18.8 m170 -61.83 166.6 4.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.911 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.454 HG22 ' HA ' ' A' ' 103' ' ' ILE . 0.0 OUTLIER -136.35 160.44 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.476 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.735 ' HA ' HD11 ' A' ' 70' ' ' ILE . 26.2 p -157.8 172.29 18.74 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.695 ' HB2' ' HH2' ' A' ' 84' ' ' TRP . . . -95.51 127.67 41.74 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.625 -0.43 . . . . 0.0 109.922 178.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.461 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 75.7 t-105 -133.23 163.04 30.19 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.578 0.704 . . . . 0.0 111.97 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.461 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.0 OUTLIER -64.23 123.11 18.26 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.727 179.93 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.93 121.83 9.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.157 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.429 ' CE1' ' HA3' ' A' ' 122' ' ' GLY . 6.9 p80 -126.59 3.01 6.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.434 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 80.82 5.92 89.74 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.973 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.429 ' HA3' ' CE1' ' A' ' 120' ' ' HIS . . . -64.8 154.0 49.5 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.575 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.9 -23.58 54.58 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.616 2.211 . . . . 0.0 112.348 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.544 ' O ' HD12 ' A' ' 103' ' ' ILE . 27.1 p-10 -76.76 -2.17 31.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.56 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.405 ' O ' ' CG2' ' A' ' 90' ' ' THR . 0.0 OUTLIER -108.97 9.6 26.47 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.219 -179.961 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.411 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 19.9 mmmt -103.38 136.92 42.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.773 0.32 . . . . 0.0 111.249 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.42 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 6.6 m-85 -137.57 155.61 49.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.45 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.3 mt -113.47 138.89 41.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.098 0.475 . . . . 0.0 110.559 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.477 HD12 HG23 ' A' ' 8' ' ' ILE . 27.1 mm -114.17 141.34 30.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.661 -179.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -138.95 94.64 2.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.611 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.75 113.41 0.9 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.422 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.964 179.989 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.863 0.363 . . . . 0.0 111.165 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 58.1 mttt 61.92 153.77 0.11 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.93 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.7 -178.01 0.12 Allowed 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.703 2.269 . . . . 0.0 112.274 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.4 mmmm -147.59 80.91 1.51 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.103 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.454 ' CG ' ' HD2' ' A' ' 57' ' ' LYS . 1.4 p90 -100.27 176.73 5.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.422 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.703 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -156.89 175.26 14.31 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 120.481 -0.487 . . . . 0.0 111.731 179.806 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.59 ' CZ ' HD11 ' A' ' 45' ' ' LEU . 9.9 m-85 -109.33 124.58 51.18 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.157 179.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.607 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -108.51 106.24 20.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.871 0.367 . . . . 0.0 110.296 179.735 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -105.76 134.6 48.63 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -178.566 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 57.9 p -75.78 106.55 7.42 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.404 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 3.6 tt0 -63.4 -10.54 17.43 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.591 -178.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.427 HD22 ' CB ' ' A' ' 124' ' ' ASN . 33.1 tp -83.5 -62.91 1.46 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.924 0.392 . . . . 0.0 110.794 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.525 HD21 HG21 ' A' ' 103' ' ' ILE . 4.9 m-20 -84.23 -10.27 57.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.313 -178.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.45 3.75 67.33 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.129 -1.034 . . . . 0.0 111.382 -178.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.1 mmmt -92.66 -176.59 4.31 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.659 HG21 ' HA ' ' A' ' 35' ' ' GLN . 7.5 m -121.78 142.44 38.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.708 0.29 . . . . 0.0 110.58 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.7 mt -70.05 134.63 48.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.014 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.405 ' HB2' ' HG3' ' A' ' 44' ' ' GLN . 9.5 t0 -146.71 150.36 35.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.707 0.289 . . . . 0.0 111.033 -179.031 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.518 HD12 HG21 ' A' ' 72' ' ' THR . 2.7 mm -73.32 147.37 9.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.006 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.44 ' HG2' HD12 ' A' ' 31' ' ' ILE . 0.4 OUTLIER -58.58 122.96 14.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.925 0.393 . . . . 0.0 111.485 -179.455 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 45.9 28.26 2.72 Favored Glycine 0 C--N 1.332 0.36 0 CA-C-N 115.986 -0.552 . . . . 0.0 113.104 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 43.2 60.53 2.51 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.934 0.397 . . . . 0.0 111.428 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.95 106.0 48.31 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.922 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -71.24 1.01 5.85 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.75 2.3 . . . . 0.0 112.853 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.402 ' HB1' ' HD2' ' A' ' 26' ' ' PRO . . . -82.96 155.8 67.49 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-O 120.796 0.331 . . . . 0.0 111.174 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.419 ' HB3' ' CD ' ' A' ' 74' ' ' PRO . 35.9 Cg_endo -65.21 131.31 28.04 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.735 2.29 . . . . 0.0 112.46 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.04 2.59 36.23 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.477 -0.868 . . . . 0.0 113.188 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.52 127.51 32.76 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 117.027 0.414 . . . . 0.0 111.037 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -78.75 159.83 27.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.189 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.654 HD11 ' HB ' ' A' ' 70' ' ' ILE . 42.6 pt -117.89 146.29 22.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.771 0.32 . . . . 0.0 111.783 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.453 ' HA ' ' CD1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -154.44 178.01 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.17 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.78 -179.806 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.2 p -101.13 148.69 24.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.623 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 34.9 t-105 -158.23 172.9 17.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.708 0.289 . . . . 0.0 110.918 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -69.01 132.93 47.44 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.758 0.313 . . . . 0.0 110.738 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.659 ' HA ' HG21 ' A' ' 16' ' ' VAL . 2.4 pt20 -58.55 138.95 56.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.019 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.1 mmmm -102.79 157.67 16.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.771 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.16 101.72 8.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.845 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 146.3 -164.61 28.33 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.631 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -72.08 -2.44 11.58 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.968 2.445 . . . . 0.0 112.853 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.4 p -94.6 0.96 55.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.535 0.207 . . . . 0.0 111.346 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.994 ' O ' HD12 ' A' ' 45' ' ' LEU . . . -82.09 -9.44 59.54 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.619 0.229 . . . . 0.0 111.619 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.74 HG13 ' HB3' ' A' ' 57' ' ' LYS . 59.4 t -50.92 -33.57 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.116 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.406 ' OD1' ' HB ' ' A' ' 19' ' ' ILE . 0.6 OUTLIER -69.73 -7.51 40.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.76 -179.649 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.405 ' HG3' ' HB2' ' A' ' 18' ' ' ASP . 2.6 mt-30 -115.79 6.26 14.32 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.994 HD12 ' O ' ' A' ' 41' ' ' ALA . 0.9 OUTLIER -117.8 142.22 47.54 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.216 -179.273 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.478 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 26.3 m95 -133.74 168.71 18.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.541 -179.109 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.526 ' CZ ' ' HB2' ' A' ' 55' ' ' ARG . 43.1 p90 -141.32 164.16 31.01 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.382 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.671 HG22 ' CG2' ' A' ' 54' ' ' ILE . 67.5 p -109.19 135.37 50.42 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.783 0.325 . . . . 0.0 111.539 -178.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -78.36 170.88 15.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.12 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.34 -25.15 65.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.999 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -89.3 -5.02 57.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.201 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.24 11.74 44.45 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.837 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.658 HG13 ' HA ' ' A' ' 83' ' ' ALA . 37.2 t -100.68 120.43 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-O 120.779 0.323 . . . . 0.0 110.489 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.671 ' CG2' HG22 ' A' ' 48' ' ' THR . 0.6 OUTLIER -78.78 149.75 5.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.541 0.686 . . . . 0.0 111.883 -179.806 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.657 ' HD3' ' HB2' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -147.0 132.53 18.71 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.647 178.612 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.478 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -57.64 143.06 42.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.569 0.699 . . . . 0.0 111.857 -178.679 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.74 ' HB3' HG13 ' A' ' 42' ' ' VAL . 5.4 tttp -53.96 -22.18 9.74 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 114.634 -1.166 . . . . 0.0 111.471 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.543 HD12 ' HB2' ' A' ' 59' ' ' ASN . 3.6 pp -56.74 -39.04 73.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.857 0.36 . . . . 0.0 111.089 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.543 ' HB2' HD12 ' A' ' 58' ' ' LEU . 1.3 t30 176.31 172.82 0.39 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.669 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.41 79.24 0.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.817 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.409 ' CE2' ' HG3' ' A' ' 74' ' ' PRO . 32.7 m-85 -145.08 123.97 12.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.858 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.657 ' HB2' ' HD3' ' A' ' 55' ' ' ARG . . . -104.4 154.16 20.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.397 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.858 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -79.86 150.37 5.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.59 179.665 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.573 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 6.3 p-10 -132.6 134.75 45.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.138 0.494 . . . . 0.0 111.501 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.673 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -99.06 43.29 1.06 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.334 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.1 m -74.06 -43.07 59.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.142 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 57.2 m80 -98.78 173.1 7.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.931 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -49.32 -46.96 47.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.983 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -99.69 145.03 28.09 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.936 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.858 HG22 HG22 ' A' ' 63' ' ' ILE . 2.4 mm -76.8 142.38 14.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-O 121.591 0.71 . . . . 0.0 111.511 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -140.31 168.61 19.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.062 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.518 HG21 HD12 ' A' ' 19' ' ' ILE . 58.8 p -106.87 138.51 42.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.97 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.48 161.11 17.9 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.329 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.419 ' CD ' ' HB3' ' A' ' 26' ' ' PRO . 57.3 Cg_exo -51.44 139.19 46.58 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.449 2.099 . . . . 0.0 112.074 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.576 ' HE1' ' HB2' ' A' ' 83' ' ' ALA . 90.6 t80 -62.94 127.8 32.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.129 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.412 ' HB2' ' HD3' ' A' ' 82' ' ' ARG . 0.1 OUTLIER -117.56 136.32 23.54 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.597 179.68 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -68.96 -34.81 16.5 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.56 2.173 . . . . 0.0 112.93 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -87.34 0.15 55.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.8 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.409 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 0.7 OUTLIER -108.53 101.03 41.26 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 120.588 0.232 . . . . 0.0 111.147 -179.818 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.854 ' O ' HD21 ' A' ' 94' ' ' LEU . 4.8 Cg_exo -77.09 24.7 0.48 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.989 2.459 . . . . 0.0 113.043 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.573 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 21.0 mmtp -120.26 -19.72 7.57 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 120.568 0.223 . . . . 0.0 111.101 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.481 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 0.4 OUTLIER -88.72 17.07 5.85 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.09 -0.505 . . . . 0.0 112.285 -179.208 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 1.091 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -126.61 98.85 5.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.081 0.467 . . . . 0.0 110.823 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.673 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 56.2 m95 -107.94 136.05 48.29 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.157 0.503 . . . . 0.0 111.81 -178.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.5 pt -111.25 153.5 13.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.197 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.2 t -102.28 127.69 55.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.008 0.432 . . . . 0.0 111.042 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.4 t -120.59 94.75 4.46 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.448 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.99 -100.13 0.75 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.531 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.499 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.85 29.74 7.23 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.52 0.2 . . . . 0.0 110.868 -179.676 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.425 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -148.14 147.77 29.84 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.577 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.813 ' HB ' HD12 ' A' ' 101' ' ' LEU . 11.9 mm -94.13 120.34 43.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.047 -0.978 . . . . 0.0 109.351 178.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.875 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -122.26 144.01 49.25 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -178.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.415 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -64.61 148.91 49.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.527 179.834 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.091 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.6 pt? -64.34 -57.23 9.96 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.688 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.561 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 13.5 t -74.22 -4.1 33.9 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -178.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.555 ' O ' HG22 ' A' ' 99' ' ' ILE . 56.7 m-20 -143.46 92.22 2.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.919 0.39 . . . . 0.0 111.025 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -72.89 -14.32 61.46 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.287 179.127 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -90.25 11.19 21.91 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.297 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.555 HG22 ' O ' ' A' ' 96' ' ' ASP . 9.0 tt -130.64 138.27 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.875 HG12 ' HB2' ' A' ' 92' ' ' ALA . 26.7 m -148.99 138.15 15.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.837 0.351 . . . . 0.0 111.907 -179.321 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.813 HD12 ' HB ' ' A' ' 91' ' ' ILE . 11.1 mt -45.53 153.3 0.26 Allowed 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 121.754 0.788 . . . . 0.0 111.772 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.713 ' O ' HG22 ' A' ' 114' ' ' ILE . 9.8 t70 -158.63 168.24 27.42 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.833 -177.442 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.664 HD12 ' O ' ' A' ' 124' ' ' ASN . 4.4 mp -88.0 122.96 40.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.204 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.826 HG22 ' O ' ' A' ' 113' ' ' HIS . 7.8 tp -66.63 138.27 23.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.057 0.456 . . . . 0.0 111.476 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.4 1.06 3.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.983 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.4 t 44.17 30.88 0.48 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.781 0.324 . . . . 0.0 111.344 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.7 p30 -96.67 155.79 16.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.152 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -82.24 -17.17 46.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.106 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -45.28 116.12 1.06 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.279 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.4 156.74 9.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.247 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.63 14.47 81.2 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.312 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.88 131.81 39.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.902 0.382 . . . . 0.0 110.985 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.826 ' O ' HG22 ' A' ' 104' ' ' ILE . 0.8 OUTLIER -64.87 171.25 3.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.014 -179.814 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.713 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -136.38 161.75 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.445 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.605 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 26.5 p -153.51 168.45 26.11 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.663 ' HB2' ' HH2' ' A' ' 84' ' ' TRP . . . -95.06 126.71 40.59 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 178.041 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.468 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 76.5 t-105 -134.71 162.49 32.2 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.63 0.729 . . . . 0.0 112.196 -179.226 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.468 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.9 OUTLIER -62.53 120.87 11.96 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.646 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -58.55 125.5 23.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.089 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 20.9 p-80 -132.97 8.51 4.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.357 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 81.82 7.17 88.34 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.086 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.73 152.15 48.44 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.58 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.59 -26.35 54.14 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.604 2.203 . . . . 0.0 112.33 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.664 ' O ' HD12 ' A' ' 103' ' ' ILE . 30.6 p-10 -75.05 -4.11 36.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.506 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.425 ' O ' ' CG2' ' A' ' 90' ' ' THR . 0.0 OUTLIER -107.5 14.38 25.89 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.183 -179.811 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.404 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 2.3 mmmm -107.08 136.92 46.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.793 0.33 . . . . 0.0 111.472 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.435 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 6.1 m-85 -138.2 155.23 48.88 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.21 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.3 mt -112.03 138.43 40.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.091 0.472 . . . . 0.0 110.392 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 27.9 mm -112.99 140.19 34.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.563 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.7 112.02 8.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.457 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 5.7 t -66.4 109.95 2.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.13 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.477 ' HG3' HD21 ' A' ' 45' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.188 -0.911 . . . . 0.0 110.898 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.792 0.329 . . . . 0.0 111.147 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.75 68.9 82.21 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.889 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.12 105.55 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.623 2.215 . . . . 0.0 112.304 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.51 121.86 42.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.993 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.502 ' CD1' ' HG3' ' A' ' 57' ' ' LYS . 1.4 p90 -95.79 175.21 6.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.254 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.691 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -159.01 175.61 13.32 Favored 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.94 179.889 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.582 ' CZ ' HD11 ' A' ' 45' ' ' LEU . 4.7 m-85 -110.6 124.01 51.06 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.055 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.768 HG13 HD11 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -106.5 106.87 21.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.844 0.354 . . . . 0.0 110.436 179.824 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 15' ' ' LYS . 8.7 tttt -107.85 138.54 43.91 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.305 -178.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.91 109.2 10.53 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -64.01 -10.95 24.7 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.579 -178.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.618 HD22 ' HA ' ' A' ' 124' ' ' ASN . 56.8 tp -84.26 -62.48 1.55 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.88 0.371 . . . . 0.0 111.026 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.533 ' ND2' ' HA ' ' A' ' 108' ' ' LYS . 2.8 m120 -85.43 -12.93 50.79 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 77.17 0.84 72.18 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.103 -1.046 . . . . 0.0 111.413 -177.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.421 ' HG2' ' HB2' ' A' ' 13' ' ' ASN . 0.5 OUTLIER -89.01 179.74 6.1 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.503 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.418 HG11 ' HG2' ' A' ' 35' ' ' GLN . 4.2 m -121.36 141.46 41.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.768 HD11 HG13 ' A' ' 8' ' ' ILE . 0.4 OUTLIER -73.49 137.61 44.57 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.123 179.475 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -142.6 153.09 43.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.873 0.368 . . . . 0.0 111.127 -179.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.051 HD13 HG21 ' A' ' 72' ' ' THR . 25.3 mt -93.03 134.66 30.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.662 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -43.6 96.25 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.917 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 43.23 32.93 1.8 Allowed Glycine 0 C--N 1.331 0.28 0 CA-C-N 115.981 -0.554 . . . . 0.0 113.363 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.42 ' HG2' ' ND2' ' A' ' 43' ' ' ASN . 3.2 mp0 68.41 -66.54 0.23 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.835 0.35 . . . . 0.0 110.931 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 64.82 90.73 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.79 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -51.94 -22.08 13.47 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.649 2.233 . . . . 0.0 112.482 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.3 149.36 35.62 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.115 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.445 ' HB3' ' CD ' ' A' ' 74' ' ' PRO . 33.7 Cg_endo -64.63 151.85 84.08 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.654 2.236 . . . . 0.0 112.371 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 109.12 0.59 31.54 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.475 -0.869 . . . . 0.0 113.108 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.11 137.04 50.8 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 117.122 0.461 . . . . 0.0 110.918 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.3 mmtp -88.32 157.6 18.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.606 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.668 HD11 ' HB ' ' A' ' 70' ' ' ILE . 44.2 pt -117.96 146.77 22.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.348 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.444 HG22 ' HA ' ' A' ' 113' ' ' HIS . 0.2 OUTLIER -155.19 179.73 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.182 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.885 -179.737 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.1 p -101.6 149.0 24.56 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.48 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 35.4 t-105 -157.81 172.21 18.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.711 0.291 . . . . 0.0 110.965 -179.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -72.48 139.08 47.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.81 0.338 . . . . 0.0 110.805 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.418 ' HG2' HG11 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -58.89 137.43 57.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.939 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.94 168.02 9.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.86 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.04 95.98 4.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.969 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 166.52 170.17 31.06 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.488 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -51.32 -24.93 16.81 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.595 2.197 . . . . 0.0 112.335 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 43.1 p -78.09 9.84 3.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.035 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.882 ' O ' HD12 ' A' ' 45' ' ' LEU . . . -77.41 -17.23 58.32 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.657 0.265 . . . . 0.0 111.037 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.974 HG13 ' HB3' ' A' ' 57' ' ' LYS . 48.5 t -50.29 -27.48 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.065 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.42 ' ND2' ' HG2' ' A' ' 22' ' ' GLN . 1.5 m120 -66.83 -9.45 37.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.582 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -118.46 5.89 11.76 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.882 HD12 ' O ' ' A' ' 41' ' ' ALA . 1.3 mp -116.98 141.44 48.23 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.531 -179.347 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.57 ' CZ2' HD11 ' A' ' 19' ' ' ILE . 26.1 m95 -134.18 169.01 17.81 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.249 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.55 ' CZ ' ' HB2' ' A' ' 55' ' ' ARG . 11.3 p90 -141.98 166.22 25.31 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.981 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.405 HG22 ' CG2' ' A' ' 54' ' ' ILE . 39.7 p -108.38 133.87 51.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.882 0.372 . . . . 0.0 111.559 -178.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 53' ' ' VAL . 42.9 t0 -77.96 167.78 20.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.026 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -60.9 -24.85 66.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.138 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.2 tp60 -92.74 -3.34 54.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.269 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.96 8.79 55.16 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.765 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.421 ' O ' ' HB2' ' A' ' 49' ' ' ASP . 31.1 t -93.83 119.68 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-O 120.744 0.307 . . . . 0.0 110.587 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.535 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -75.96 145.64 10.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.168 0.509 . . . . 0.0 111.779 -179.835 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.742 ' CD ' ' HB2' ' A' ' 62' ' ' ALA . 13.5 mmm-85 -149.47 133.73 17.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.719 179.046 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.405 ' HB2' HD21 ' A' ' 58' ' ' LEU . 74.5 m -50.5 147.1 4.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.598 0.714 . . . . 0.0 111.984 -179.087 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.974 ' HB3' HG13 ' A' ' 42' ' ' VAL . 17.6 tttm -60.26 -18.24 47.67 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 114.658 -1.156 . . . . 0.0 112.022 -179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.504 ' HA ' HG11 ' A' ' 42' ' ' VAL . 0.6 OUTLIER -51.08 -49.62 60.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.747 -179.325 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.416 ' N ' HD12 ' A' ' 58' ' ' LEU . 22.6 m-20 -166.06 -69.24 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.745 0.307 . . . . 0.0 111.062 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.2 p30 179.65 82.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.733 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.411 ' CZ ' ' HG3' ' A' ' 74' ' ' PRO . 2.7 m-85 -138.05 119.95 15.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.899 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.742 ' HB2' ' CD ' ' A' ' 55' ' ' ARG . . . -99.42 145.55 27.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.205 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.826 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -76.95 152.64 5.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.6 179.733 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.626 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 5.0 p-10 -132.37 129.87 39.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.249 0.547 . . . . 0.0 111.777 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.745 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -94.29 40.8 1.09 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.272 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.4 t -75.11 -45.5 40.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.543 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -94.7 170.33 9.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.962 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -49.16 -42.18 38.89 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.014 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.59 140.05 38.57 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.813 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.826 HG22 HG22 ' A' ' 63' ' ' ILE . 3.1 mm -69.94 137.12 24.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-O 121.464 0.649 . . . . 0.0 111.367 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.401 ' O ' HG22 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -134.54 165.68 24.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.118 -0.947 . . . . 0.0 111.17 -179.708 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . 1.051 HG21 HD13 ' A' ' 19' ' ' ILE . 23.9 p -106.62 140.25 39.79 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.238 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.11 163.79 13.33 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.481 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.461 ' O ' ' HD3' ' A' ' 82' ' ' ARG . 40.4 Cg_exo -56.73 142.81 91.54 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.451 2.1 . . . . 0.0 111.673 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.421 ' CD2' HG11 ' A' ' 53' ' ' VAL . 58.2 t80 -57.13 128.77 38.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.859 0.362 . . . . 0.0 111.358 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -118.17 131.02 24.38 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.532 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -68.14 -36.77 16.02 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.453 2.102 . . . . 0.0 112.758 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -87.55 0.31 55.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.812 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -105.19 102.65 37.78 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-O 120.53 0.205 . . . . 0.0 111.086 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.566 ' O ' HD21 ' A' ' 94' ' ' LEU . 5.7 Cg_exo -77.32 21.63 0.61 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.887 2.391 . . . . 0.0 112.978 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.626 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 7.6 mptt -119.92 -21.03 7.3 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 120.753 0.311 . . . . 0.0 111.001 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.546 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 2.7 mtt180 -86.85 20.84 2.44 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 1.033 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -130.68 99.58 5.01 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.276 0.56 . . . . 0.0 110.937 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.745 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 61.0 m95 -109.39 136.07 49.41 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.923 -178.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 27.8 pt -113.17 153.45 14.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.196 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.0 t -100.2 123.0 52.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.901 0.382 . . . . 0.0 110.948 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 37.6 t -115.8 93.49 4.28 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.438 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.97 -100.56 0.78 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.533 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.502 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.73 29.67 7.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.496 0.189 . . . . 0.0 110.923 -179.594 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.406 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -148.05 148.23 30.45 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.36 0.6 . . . . 0.0 112.583 -178.63 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.508 ' HB ' HD12 ' A' ' 101' ' ' LEU . 23.9 mm -93.65 119.47 41.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.542 178.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.981 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -123.99 147.56 47.68 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.566 ' NE2' ' CZ2' ' A' ' 84' ' ' TRP . 1.8 tp60 -65.17 149.88 49.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.849 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.033 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.7 pt? -64.29 -56.88 11.48 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.444 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.612 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 0.3 OUTLIER -77.25 -1.77 31.3 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.363 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.554 ' O ' HG22 ' A' ' 99' ' ' ILE . 49.7 t0 -145.09 91.14 2.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.165 0.507 . . . . 0.0 110.942 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 3.8 mmm180 -74.09 -13.69 60.87 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.526 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -87.35 9.81 19.32 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.518 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.831 HG12 ' HB1' ' A' ' 116' ' ' ALA . 6.8 tt -132.89 140.24 47.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 179.064 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.981 HG12 ' HB2' ' A' ' 92' ' ' ALA . 20.0 m -149.77 138.84 15.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.77 0.319 . . . . 0.0 111.826 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.508 HD12 ' HB ' ' A' ' 91' ' ' ILE . 21.8 mt -46.15 154.89 0.23 Allowed 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 121.733 0.778 . . . . 0.0 111.948 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.805 ' O ' HG22 ' A' ' 114' ' ' ILE . 11.0 t70 -156.97 167.67 29.77 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.792 -177.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.612 HD12 ' O ' ' A' ' 124' ' ' ASN . 4.6 mp -89.38 123.96 41.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.427 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.788 HG22 ' O ' ' A' ' 113' ' ' HIS . 3.9 tt -68.04 144.48 14.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.947 0.403 . . . . 0.0 111.421 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 5.2 mttt 70.34 -0.8 2.71 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.015 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.1 m 42.09 31.61 0.25 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.734 0.302 . . . . 0.0 111.474 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.477 ' O ' ' ND2' ' A' ' 13' ' ' ASN . 14.6 t0 -102.78 162.39 12.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.068 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.533 ' HA ' ' ND2' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -81.23 -14.5 57.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.255 179.918 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -48.21 133.11 15.8 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.21 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -81.91 159.37 23.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.147 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.49 16.37 80.05 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.287 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -82.0 135.79 35.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.841 0.353 . . . . 0.0 111.124 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.788 ' O ' HG22 ' A' ' 104' ' ' ILE . 6.7 m80 -61.86 172.85 1.19 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.962 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.805 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.7 OUTLIER -143.28 161.6 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.758 -179.777 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.645 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 4.6 t -155.43 169.95 23.07 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.831 ' HB1' HG12 ' A' ' 99' ' ' ILE . . . -93.6 126.53 38.81 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.228 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.458 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 75.9 t-105 -131.47 160.98 33.58 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.635 0.731 . . . . 0.0 112.361 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.458 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.3 OUTLIER -62.87 124.77 21.91 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.764 -179.885 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.88 121.28 8.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.127 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.438 ' CE1' ' HA3' ' A' ' 122' ' ' GLY . 6.6 p80 -127.34 2.4 6.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.493 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 79.4 5.23 89.26 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.881 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.438 ' HA3' ' CE1' ' A' ' 120' ' ' HIS . . . -63.34 156.28 42.32 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.536 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.75 -25.04 46.54 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.589 2.193 . . . . 0.0 112.365 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.618 ' HA ' HD22 ' A' ' 12' ' ' LEU . 36.3 p-10 -74.53 -3.8 33.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.644 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.406 ' O ' ' CG2' ' A' ' 90' ' ' THR . 0.0 OUTLIER -108.88 15.81 23.2 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.533 0.206 . . . . 0.0 111.116 -179.978 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -106.3 131.29 53.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.835 0.35 . . . . 0.0 111.465 -179.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.435 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 3.0 m-85 -134.9 154.6 51.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.285 179.459 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 mt -114.07 140.04 36.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.131 0.491 . . . . 0.0 110.677 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.472 HD12 HG23 ' A' ' 8' ' ' ILE . 20.8 mm -113.38 141.4 29.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.602 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.46 94.66 2.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.711 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 5.0 t -49.96 109.64 0.31 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.426 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.433 179.751 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.715 0.293 . . . . 0.0 111.183 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.486 ' HB2' ' HD3' ' A' ' 3' ' ' PRO . 75.1 mmtt -91.97 -46.91 0.34 Allowed Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.765 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.486 ' HD3' ' HB2' ' A' ' 2' ' ' LYS . 87.7 Cg_endo -83.64 112.82 1.89 Allowed 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.374 2.05 . . . . 0.0 112.667 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.8 tppt? -63.75 117.03 6.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.743 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.504 ' CD1' ' HG3' ' A' ' 57' ' ' LYS . 1.1 p90 -96.67 176.06 6.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.629 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.743 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -159.87 176.57 11.75 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.861 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.822 ' OH ' ' HB1' ' A' ' 41' ' ' ALA . 0.7 OUTLIER -112.64 124.16 51.94 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.299 179.371 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.616 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -105.54 108.48 25.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.914 0.387 . . . . 0.0 110.339 179.873 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.456 ' HG2' ' HZ2' ' A' ' 9' ' ' LYS . 1.5 tptp -105.27 135.3 46.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.422 -178.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.7 t -75.65 108.04 8.21 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.448 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 2.7 tt0 -63.84 -10.76 22.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.633 -178.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.567 HD22 ' CB ' ' A' ' 124' ' ' ASN . 52.5 tp -83.25 -62.71 1.52 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.92 0.391 . . . . 0.0 110.924 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.534 HD21 ' HA ' ' A' ' 108' ' ' LYS . 2.8 m120 -86.32 -9.85 55.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.429 -178.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.86 5.01 68.41 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.145 -1.026 . . . . 0.0 111.369 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.41 ' HG2' ' HB2' ' A' ' 13' ' ' ASN . 1.8 mmmt -91.57 -177.18 4.73 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.537 HG11 ' HG2' ' A' ' 35' ' ' GLN . 2.9 m -120.3 140.28 44.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.784 0.326 . . . . 0.0 110.513 179.401 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.3 mt -70.89 136.06 48.39 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -143.83 158.57 43.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.936 0.398 . . . . 0.0 111.345 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.014 HD13 HG21 ' A' ' 72' ' ' THR . 27.5 mt -98.92 136.13 31.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.406 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -39.67 95.97 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.983 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 42.28 33.58 1.38 Allowed Glycine 0 C--N 1.333 0.389 0 CA-C-N 115.925 -0.58 . . . . 0.0 113.225 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.41 ' CG ' HD13 ' A' ' 58' ' ' LEU . 17.5 tt0 68.31 -66.33 0.23 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.787 0.327 . . . . 0.0 110.771 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 50.0 t30 61.83 92.53 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.992 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.18 -22.02 18.52 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.502 2.135 . . . . 0.0 112.406 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -93.47 145.01 29.18 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.094 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.516 ' HB3' ' HD2' ' A' ' 74' ' ' PRO . 24.4 Cg_exo -63.24 155.86 59.07 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.535 2.157 . . . . 0.0 112.13 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.22 3.87 47.68 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.951 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.71 130.05 38.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.987 0.422 . . . . 0.0 111.198 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -80.73 161.83 24.39 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.422 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.626 HG22 HG12 ' A' ' 19' ' ' ILE . 48.4 pt -122.82 150.29 26.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.783 0.325 . . . . 0.0 111.705 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.455 HG22 ' HA ' ' A' ' 113' ' ' HIS . 0.3 OUTLIER -156.39 -178.62 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.785 -179.738 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.2 p -100.29 148.59 24.5 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.468 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 30.6 t-105 -157.16 171.9 19.62 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.77 0.319 . . . . 0.0 111.109 -179.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.7 140.6 47.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.799 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.537 ' HG2' HG11 ' A' ' 16' ' ' VAL . 6.0 mt-30 -57.76 154.6 11.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.946 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -137.11 173.29 11.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.856 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.7 mmtp -135.84 116.42 13.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.98 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 157.24 -169.05 34.22 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.606 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -77.19 4.68 5.63 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.145 2.563 . . . . 0.0 112.83 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.6 t -114.49 16.44 17.69 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.654 0.264 . . . . 0.0 111.164 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.858 ' O ' HD12 ' A' ' 45' ' ' LEU . . . -79.23 -20.14 48.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.163 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.877 HG13 ' HB3' ' A' ' 57' ' ' LYS . 15.7 t -49.34 -26.2 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.19 179.226 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -65.74 -10.02 33.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.738 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -119.6 6.04 11.05 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.103 0.478 . . . . 0.0 109.772 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.858 HD12 ' O ' ' A' ' 41' ' ' ALA . 1.4 mp -116.59 139.8 50.1 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.617 -179.1 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.555 ' CZ2' HD11 ' A' ' 19' ' ' ILE . 25.5 m95 -133.73 168.09 19.34 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.228 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.567 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 6.4 p90 -139.61 163.51 32.37 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.009 178.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.547 HG22 ' CG2' ' A' ' 54' ' ' ILE . 81.1 p -109.13 136.41 48.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.786 0.327 . . . . 0.0 111.4 -178.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.83 173.2 12.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.288 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.85 -20.93 65.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.063 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -101.74 -2.14 30.87 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.221 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.75 1.91 52.61 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.929 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.695 HG12 ' HD3' ' A' ' 55' ' ' ARG . 21.7 t -81.8 114.41 22.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.915 0.358 . . . . 0.0 110.767 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.567 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -77.5 148.02 6.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.263 0.554 . . . . 0.0 111.783 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.695 ' HD3' HG12 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -154.4 133.85 12.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.608 179.139 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.552 ' CB ' HD22 ' A' ' 58' ' ' LEU . 1.9 m -51.1 153.35 1.94 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.356 0.598 . . . . 0.0 111.913 -179.038 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.877 ' HB3' HG13 ' A' ' 42' ' ' VAL . 0.4 OUTLIER -61.84 -24.08 66.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.841 -179.513 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.66 HD23 ' H ' ' A' ' 59' ' ' ASN . 1.3 pt? -57.64 -37.0 72.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.325 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.66 ' H ' HD23 ' A' ' 58' ' ' LEU . 0.3 OUTLIER 170.89 -173.96 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.751 179.943 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -69.38 84.58 0.4 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.733 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -142.31 114.0 7.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.908 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.582 ' HB2' ' HD2' ' A' ' 55' ' ' ARG . . . -105.04 150.79 24.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.348 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.843 HG22 HG22 ' A' ' 70' ' ' ILE . 0.3 OUTLIER -77.08 155.07 5.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.527 179.76 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.55 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 4.4 p-10 -134.48 133.48 40.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.173 0.511 . . . . 0.0 111.873 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.597 ' HB2' ' CZ2' ' A' ' 84' ' ' TRP . . . -100.25 40.09 1.29 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.367 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.0 p -74.27 -43.87 55.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.458 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -98.43 173.48 6.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.117 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -46.08 -48.77 17.01 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.816 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -104.59 149.84 25.17 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.843 HG22 HG22 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -78.39 144.65 10.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 CA-C-O 121.729 0.776 . . . . 0.0 111.805 -179.203 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -135.91 158.61 43.98 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.052 179.056 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . 1.014 HG21 HD13 ' A' ' 19' ' ' ILE . 36.4 p -101.15 140.81 34.92 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.541 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.456 ' HG2' ' C ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -163.67 164.24 15.28 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.896 179.8 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.516 ' HD2' ' HB3' ' A' ' 26' ' ' PRO . 10.8 Cg_endo -54.49 139.99 74.81 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.341 2.027 . . . . 0.0 111.754 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -56.16 122.84 12.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.911 0.386 . . . . 0.0 111.007 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.401 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 9.9 t70 -112.69 129.44 24.43 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.58 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.96 -34.81 22.32 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.449 2.099 . . . . 0.0 112.971 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -88.0 -0.64 57.27 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.401 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 4.3 t-20 -102.88 103.95 36.52 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 120.509 0.195 . . . . 0.0 110.957 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.581 ' O ' HD21 ' A' ' 94' ' ' LEU . 4.9 Cg_exo -77.1 19.95 0.67 Allowed 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.87 2.38 . . . . 0.0 113.246 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 11.5 mptt -120.45 -18.08 7.97 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 120.584 0.23 . . . . 0.0 111.27 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.487 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 4.4 mtt180 -90.3 21.59 3.76 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.642 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 1.111 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -129.32 99.5 5.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.231 0.539 . . . . 0.0 110.928 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.632 ' HH2' ' HB2' ' A' ' 116' ' ' ALA . 59.1 m95 -109.91 133.96 52.6 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.271 0.558 . . . . 0.0 112.151 -178.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.9 pt -113.23 154.57 14.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.066 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.8 t -103.24 131.07 52.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.965 0.412 . . . . 0.0 111.228 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 43.7 t -124.43 94.87 4.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.406 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.02 -100.71 0.87 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.449 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.496 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -121.13 28.98 7.55 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.603 0.24 . . . . 0.0 110.703 -179.933 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.433 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.2 146.97 30.02 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.321 0.582 . . . . 0.0 112.446 -178.642 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.849 ' HB ' HD12 ' A' ' 101' ' ' LEU . 10.6 mm -94.56 121.24 44.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.338 178.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.815 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -120.96 141.49 50.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.247 0.546 . . . . 0.0 112.462 -178.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.68 146.56 54.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.545 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.111 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.7 pt? -61.04 -56.6 19.16 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.826 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.601 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 97.2 p -73.81 -6.73 48.85 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -178.061 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.411 ' CB ' ' HB ' ' A' ' 99' ' ' ILE . 61.9 m-20 -139.63 91.06 2.45 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.869 -0.333 . . . . 0.0 111.203 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -66.6 -17.8 65.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.093 178.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.31 12.51 26.64 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.467 179.15 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.84 ' CG2' ' HB1' ' A' ' 116' ' ' ALA . 10.2 mm -124.5 128.49 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.412 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.815 HG12 ' HB2' ' A' ' 92' ' ' ALA . 19.3 m -146.31 135.54 16.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.832 0.348 . . . . 0.0 111.93 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.849 HD12 ' HB ' ' A' ' 91' ' ' ILE . 6.7 mt -45.55 152.2 0.34 Allowed 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.728 0.775 . . . . 0.0 111.781 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.821 ' O ' HG22 ' A' ' 114' ' ' ILE . 10.6 t70 -157.46 167.65 29.61 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.88 -177.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.553 HD12 ' O ' ' A' ' 124' ' ' ASN . 4.6 mp -88.57 121.12 38.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.278 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.826 HG22 ' HG2' ' A' ' 105' ' ' LYS . 56.1 mt -70.48 138.33 22.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.748 0.309 . . . . 0.0 111.161 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.826 ' HG2' HG22 ' A' ' 104' ' ' ILE . 0.1 OUTLIER 81.34 -9.68 1.26 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.7 179.893 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 46.76 29.99 1.09 Allowed 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 120.757 0.313 . . . . 0.0 111.425 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.528 ' O ' ' ND2' ' A' ' 13' ' ' ASN . 5.5 p30 -102.34 160.41 14.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.931 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.534 ' HA ' HD21 ' A' ' 13' ' ' ASN . 0.0 OUTLIER -79.69 -14.28 58.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.484 -179.86 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -51.95 118.95 3.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.83 0.348 . . . . 0.0 111.158 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.44 161.07 23.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.114 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.33 14.74 80.56 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.202 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.38 133.84 38.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.82 0.343 . . . . 0.0 111.063 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.572 ' HB2' HD12 ' A' ' 104' ' ' ILE . 35.9 m80 -61.38 163.25 6.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.06 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.821 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.6 OUTLIER -135.6 161.7 38.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.708 -179.836 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.608 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 26.2 p -162.3 176.94 10.05 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.248 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.84 ' HB1' ' CG2' ' A' ' 99' ' ' ILE . . . -96.91 132.24 42.89 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.826 -0.349 . . . . 0.0 110.261 178.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.467 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 75.9 t-105 -136.32 163.23 30.91 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.422 0.629 . . . . 0.0 111.756 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.467 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.1 OUTLIER -64.98 117.18 7.25 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.774 179.956 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -62.8 125.62 24.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.877 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -136.1 13.17 3.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.215 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 77.49 59.74 2.99 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.354 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -116.16 152.55 17.91 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.486 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.55 -30.67 79.76 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.51 2.14 . . . . 0.0 111.976 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.567 ' CB ' HD22 ' A' ' 12' ' ' LEU . 28.6 p-10 -77.21 -2.05 32.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.403 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.433 ' O ' ' CG2' ' A' ' 90' ' ' THR . 5.2 mm-40 -107.82 9.69 28.84 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.746 -0.206 . . . . 0.0 111.276 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.448 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 10.0 mmtt -106.5 140.99 38.52 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.872 0.368 . . . . 0.0 111.39 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -141.12 156.27 45.99 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.234 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.3 mt -112.14 138.45 41.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.072 0.463 . . . . 0.0 110.639 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.492 HD12 HG23 ' A' ' 8' ' ' ILE . 23.7 mm -113.73 140.29 34.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.599 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -139.58 94.84 2.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.668 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 53.0 m -53.0 111.14 0.62 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.35 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.739 ' OE2' HD21 ' A' ' 45' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.884 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 ttt . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.769 0.319 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.72 94.13 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.923 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.09 178.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.538 2.158 . . . . 0.0 112.315 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.89 117.85 21.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.951 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.505 ' CE1' ' HA ' ' A' ' 57' ' ' LYS . 27.8 m-85 -97.63 173.13 7.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.488 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.613 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -152.66 170.53 20.02 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.405 179.302 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.426 ' O ' ' HA ' ' A' ' 129' ' ' ILE . 0.1 OUTLIER -112.06 123.6 50.62 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.815 178.863 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.672 ' HB ' HD21 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -106.56 108.67 25.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.892 0.377 . . . . 0.0 110.488 -179.866 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -107.81 137.14 46.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.252 -178.907 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.3 t -75.13 107.76 7.42 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.403 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 5.4 tt0 -62.4 -12.05 19.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.451 -178.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.8 tp -82.92 -62.15 1.68 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.871 0.367 . . . . 0.0 111.163 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.404 ' HB2' ' HG2' ' A' ' 15' ' ' LYS . 8.9 m-20 -86.79 -11.85 49.76 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -178.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.64 0.68 68.78 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.041 -1.076 . . . . 0.0 111.46 -178.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.407 ' O ' ' HG3' ' A' ' 9' ' ' LYS . 7.6 mmtm -89.06 177.69 6.58 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.556 HG21 ' HA ' ' A' ' 35' ' ' GLN . 4.5 m -119.72 141.26 40.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 179.252 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.672 HD21 ' HB ' ' A' ' 8' ' ' ILE . 0.1 OUTLIER -72.24 136.51 46.36 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.242 179.613 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.478 ' OD1' ' ND2' ' A' ' 43' ' ' ASN . 25.8 t0 -140.97 148.7 40.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.899 -179.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.078 HD13 HG21 ' A' ' 72' ' ' THR . 1.1 mt -89.03 122.02 39.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.128 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.65 117.86 9.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.923 0.392 . . . . 0.0 110.904 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 128.12 -32.39 3.44 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.537 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 53.01 24.74 3.6 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.828 0.346 . . . . 0.0 111.024 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.408 ' HA ' ' HD3' ' A' ' 24' ' ' PRO . 67.6 m-20 -125.16 153.7 71.66 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.567 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.414 ' O ' ' CZ ' ' A' ' 61' ' ' PHE . 3.9 Cg_endo -86.18 36.98 0.52 Allowed 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.019 2.48 . . . . 0.0 112.865 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -99.28 143.14 25.87 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-O 120.594 0.235 . . . . 0.0 110.986 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.407 ' HB3' ' CD ' ' A' ' 74' ' ' PRO . 16.7 Cg_exo -67.9 131.96 25.33 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.676 2.251 . . . . 0.0 112.698 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.4 0.71 27.95 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.623 -0.798 . . . . 0.0 113.665 179.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.437 ' HB3' HG22 ' A' ' 19' ' ' ILE . 5.2 m -71.52 122.41 20.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.316 0.558 . . . . 0.0 111.141 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -76.6 160.56 29.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.586 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.585 HG22 HG23 ' A' ' 19' ' ' ILE . 44.5 pt -121.37 147.63 25.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.902 0.382 . . . . 0.0 111.992 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.427 HG22 ' HA ' ' A' ' 113' ' ' HIS . 0.3 OUTLIER -155.77 -178.29 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.219 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.386 179.805 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.5 p -102.31 149.48 24.29 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.603 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 20.8 t-105 -160.38 174.56 13.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.676 0.274 . . . . 0.0 110.843 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -71.12 136.29 48.11 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.814 0.34 . . . . 0.0 110.729 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.556 ' HA ' HG21 ' A' ' 16' ' ' VAL . 0.7 OUTLIER -63.24 159.78 17.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.947 -179.964 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -128.9 163.62 24.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.848 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 47.7 mmtt -122.78 107.67 12.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.921 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 156.73 178.77 31.15 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.493 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -77.35 0.93 9.27 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.703 2.269 . . . . 0.0 112.904 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 41.5 p -111.67 29.66 7.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.744 0.306 . . . . 0.0 111.036 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.55 ' O ' HD12 ' A' ' 45' ' ' LEU . . . -116.44 4.19 13.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.525 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.691 HG12 ' HB3' ' A' ' 57' ' ' LYS . 1.6 t -58.62 -18.48 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 120.686 0.279 . . . . 0.0 110.79 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.478 ' ND2' ' OD1' ' A' ' 18' ' ' ASP . 44.9 t30 -62.57 -9.93 10.42 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.12 178.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.406 ' HG3' ' CB ' ' A' ' 18' ' ' ASP . 1.1 mt-30 -114.55 7.46 16.13 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.622 HD22 ' OE1' ' A' ' 132' ' ' GLU . 1.7 mp -119.12 145.72 45.72 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.159 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.462 ' CH2' ' CG1' ' A' ' 63' ' ' ILE . 22.8 m95 -133.22 170.65 15.11 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.882 -178.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.54 ' CE2' ' HB2' ' A' ' 55' ' ' ARG . 1.1 p90 -135.85 159.8 40.55 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.856 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.43 HG22 HG23 ' A' ' 54' ' ' ILE . 11.8 p -106.15 132.98 51.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.732 0.301 . . . . 0.0 111.196 -179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -77.57 164.64 25.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.949 0.404 . . . . 0.0 111.268 -179.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 22.2 mm100 -57.77 -23.3 51.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.13 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.61 -1.84 42.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.292 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.31 4.67 56.24 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.987 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.604 HG11 ' CE1' ' A' ' 75' ' ' PHE . 23.9 t -87.72 117.68 32.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.921 0.361 . . . . 0.0 110.544 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.526 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.9 OUTLIER -78.62 150.03 5.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.278 0.561 . . . . 0.0 111.939 -179.77 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.54 ' HB2' ' CE2' ' A' ' 47' ' ' TYR . 8.8 mmm-85 -146.9 133.2 19.5 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.308 178.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.654 ' HB3' HD22 ' A' ' 58' ' ' LEU . 0.1 OUTLIER -69.51 -177.53 1.21 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.333 0.587 . . . . 0.0 112.098 -178.621 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.691 ' HB3' HG12 ' A' ' 42' ' ' VAL . 17.9 pttt -46.78 -22.56 0.32 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.742 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.654 HD22 ' HB3' ' A' ' 56' ' ' SER . 1.4 mm? -50.39 -21.62 1.51 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.555 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.503 ' CB ' ' O ' ' A' ' 58' ' ' LEU . 7.8 t30 91.91 -34.54 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 122.729 0.412 . . . . 0.0 111.686 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -156.51 60.33 0.55 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.854 0.359 . . . . 0.0 111.423 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.541 ' HB2' ' HB2' ' A' ' 58' ' ' LEU . 3.7 m-85 -142.53 114.07 7.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.627 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.406 ' HB2' ' CD ' ' A' ' 55' ' ' ARG . . . -102.15 151.27 22.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.042 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.838 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -78.61 151.19 5.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.484 179.692 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.591 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 7.7 p-10 -131.95 129.87 40.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.084 0.469 . . . . 0.0 111.646 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.623 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -95.32 41.42 1.1 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.363 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.9 m -74.51 -44.65 50.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.218 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 33.6 m170 -94.94 170.73 9.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.976 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -48.59 -44.62 37.07 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.939 0.399 . . . . 0.0 110.951 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.13 144.67 31.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.659 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.838 HG22 HG22 ' A' ' 63' ' ' ILE . 2.1 mm -76.35 143.9 12.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.521 0.677 . . . . 0.0 111.649 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -143.31 167.86 21.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.947 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . 1.078 HG21 HD13 ' A' ' 19' ' ' ILE . 71.6 p -107.49 140.31 40.66 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.296 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.33 164.76 15.25 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.309 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.422 ' HD3' ' CE2' ' A' ' 61' ' ' PHE . 51.4 Cg_exo -52.82 138.34 60.34 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.399 2.066 . . . . 0.0 111.844 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.604 ' CE1' HG11 ' A' ' 53' ' ' VAL . 41.4 t80 -60.74 133.48 56.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.85 0.357 . . . . 0.0 111.113 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.408 ' CB ' ' HB2' ' A' ' 79' ' ' ASN . 0.5 OUTLIER -123.86 134.79 25.61 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.639 179.724 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.03 -34.78 16.22 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.46 2.106 . . . . 0.0 112.847 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 36.6 m-20 -86.87 -0.52 56.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.735 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.408 ' HB2' ' CB ' ' A' ' 76' ' ' ASP . 0.3 OUTLIER -105.8 101.38 32.68 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-O 120.639 0.257 . . . . 0.0 111.078 -179.859 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.856 ' O ' HD21 ' A' ' 94' ' ' LEU . 74.1 Cg_endo -77.2 21.45 0.61 Allowed 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.63 2.22 . . . . 0.0 113.091 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.591 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 6.6 mptt -117.97 -19.86 8.98 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.127 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.531 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 3.2 mtm180 -88.88 19.99 3.79 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -178.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 1.1 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -128.86 99.23 5.23 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.091 0.472 . . . . 0.0 110.81 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.623 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 59.5 m95 -109.54 135.5 50.44 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.148 0.499 . . . . 0.0 111.91 -178.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.2 pp -114.05 154.37 15.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.297 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.5 t -100.53 125.05 54.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.919 0.39 . . . . 0.0 111.085 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 12.9 t -117.62 93.55 4.2 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.433 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.12 -100.52 0.79 Allowed Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.538 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.492 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.64 29.42 7.43 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.534 0.207 . . . . 0.0 110.927 -179.658 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.488 HG22 ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.87 147.83 30.19 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.334 0.588 . . . . 0.0 112.473 -178.729 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.77 ' HB ' HD12 ' A' ' 101' ' ' LEU . 14.7 mm -93.49 119.88 42.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.144 178.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.982 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -122.25 145.17 48.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.236 0.541 . . . . 0.0 112.434 -178.417 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.434 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -66.84 148.3 52.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.627 179.719 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.1 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.7 pt? -60.6 -56.74 17.7 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.554 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.572 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 0.3 OUTLIER -77.74 -3.51 41.6 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 -178.428 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.407 ' HB2' ' HB3' ' A' ' 93' ' ' GLN . 4.9 m-20 -138.1 86.33 2.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.799 0.333 . . . . 0.0 110.961 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 14.7 mmt180 -67.74 -18.04 64.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.21 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -92.93 11.33 27.67 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.43 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.846 ' CG2' ' HB1' ' A' ' 116' ' ' ALA . 9.8 mm -124.93 130.25 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.569 179.433 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.982 HG12 ' HB2' ' A' ' 92' ' ' ALA . 27.7 m -147.34 136.91 16.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.84 0.352 . . . . 0.0 111.783 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.77 HD12 ' HB ' ' A' ' 91' ' ' ILE . 9.4 mt -46.71 154.7 0.3 Allowed 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.674 0.749 . . . . 0.0 111.909 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.771 ' O ' HG22 ' A' ' 114' ' ' ILE . 10.1 t70 -160.49 169.74 22.39 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.493 -1.231 . . . . 0.0 110.746 -177.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.803 HD12 ' O ' ' A' ' 124' ' ' ASN . 4.0 mp -86.48 124.13 40.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.238 179.2 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.799 HG22 ' O ' ' A' ' 113' ' ' HIS . 1.1 tt -63.57 138.38 23.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.066 0.46 . . . . 0.0 111.582 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 25.5 mttp 48.62 24.99 0.86 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.6 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 33.2 t 44.48 -121.32 0.82 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.98 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 61.11 150.26 0.02 OUTLIER 'General case' 0 C--N 1.334 -0.079 0 CA-C-O 120.923 0.392 . . . . 0.0 111.203 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.22 -13.5 55.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.182 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -45.74 136.5 6.07 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.369 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -89.84 162.2 15.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.21 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 73.36 18.03 79.15 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.192 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -85.03 136.67 33.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.805 0.336 . . . . 0.0 110.885 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.799 ' O ' HG22 ' A' ' 104' ' ' ILE . 2.6 m80 -61.07 170.84 1.45 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.888 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.771 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.7 OUTLIER -142.11 161.63 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.685 -179.859 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.666 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 20.8 p -156.84 173.75 16.53 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.545 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.846 ' HB1' ' CG2' ' A' ' 99' ' ' ILE . . . -95.47 128.79 42.61 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.436 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.464 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 73.9 t-105 -136.61 162.44 33.13 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.585 0.707 . . . . 0.0 112.128 -179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.464 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.1 OUTLIER -60.26 119.43 7.9 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.663 179.887 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -62.45 129.04 38.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.095 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -139.35 12.88 2.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.107 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 80.64 11.79 83.62 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.833 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.25 139.08 41.67 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.497 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.51 -28.37 54.54 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.472 2.115 . . . . 0.0 112.326 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.803 ' O ' HD12 ' A' ' 103' ' ' ILE . 14.5 p-10 -74.66 -2.15 24.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.622 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.488 ' O ' HG22 ' A' ' 90' ' ' THR . 91.5 mt-30 -104.45 -15.53 15.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.745 -0.207 . . . . 0.0 111.441 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.415 ' O ' ' CD1' ' A' ' 127' ' ' PHE . 0.2 OUTLIER -78.07 137.87 38.47 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.899 0.38 . . . . 0.0 111.361 -179.29 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.415 ' CD1' ' O ' ' A' ' 126' ' ' LYS . 8.4 m-85 -137.5 156.26 48.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.155 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 mt -114.32 137.03 48.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.151 0.501 . . . . 0.0 110.57 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.507 ' CD1' HG23 ' A' ' 8' ' ' ILE . 33.5 mm -113.59 139.49 38.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.574 -179.215 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -138.82 109.39 6.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.501 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.76 110.24 1.11 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.047 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.622 ' OE1' HD22 ' A' ' 45' ' ' LEU . 3.4 tt0 . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.894 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.824 0.345 . . . . 0.0 111.172 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.406 ' N ' ' HD3' ' A' ' 3' ' ' PRO . 4.3 mttp 59.77 64.81 2.7 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.921 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.406 ' HD3' ' N ' ' A' ' 2' ' ' LYS . 33.8 Cg_exo -61.14 79.71 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.616 2.211 . . . . 0.0 112.175 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.76 126.65 41.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.041 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.465 ' CD1' ' HG3' ' A' ' 57' ' ' LYS . 0.1 OUTLIER -105.17 175.22 5.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.07 179.683 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.762 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -155.89 172.39 18.44 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.804 179.638 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.458 ' CE1' ' HB3' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -112.95 123.85 51.27 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.13 179.135 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.621 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -105.18 108.96 26.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.906 0.384 . . . . 0.0 110.389 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.423 ' HG3' ' O ' ' A' ' 15' ' ' LYS . 7.7 tttt -105.82 136.14 45.99 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.235 -178.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.514 ' OG ' HD21 ' A' ' 17' ' ' LEU . 70.3 m -73.85 109.17 7.15 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.445 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 3.8 tt0 -63.14 -12.39 27.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.521 -178.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.494 HD22 ' CB ' ' A' ' 124' ' ' ASN . 43.5 tp -84.8 -62.12 1.62 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.894 0.378 . . . . 0.0 111.115 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.503 ' ND2' ' HA ' ' A' ' 108' ' ' LYS . 3.8 m120 -84.33 -12.71 54.1 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -178.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.5 3.02 70.4 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.007 -1.092 . . . . 0.0 111.632 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.44 ' HG2' ' HB2' ' A' ' 13' ' ' ASN . 13.2 mmtp -91.58 -177.26 4.75 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.643 HG21 ' HA ' ' A' ' 35' ' ' GLN . 4.3 m -121.7 142.21 38.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.787 0.327 . . . . 0.0 110.614 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.514 HD21 ' OG ' ' A' ' 10' ' ' SER . 9.2 mt -70.56 134.94 48.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.276 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 19' ' ' ILE . 61.5 t0 -142.51 141.72 32.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.767 0.318 . . . . 0.0 111.043 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.028 HD13 HG21 ' A' ' 72' ' ' THR . 25.1 mt -84.03 134.8 26.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.564 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -39.39 104.79 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 41.04 34.19 0.8 Allowed Glycine 0 C--N 1.332 0.315 0 CA-C-N 115.74 -0.664 . . . . 0.0 113.841 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.645 ' HG3' HD22 ' A' ' 58' ' ' LEU . 10.3 tt0 48.71 35.1 5.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.911 0.355 . . . . 0.0 111.217 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -46.28 102.63 0.31 Allowed Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.262 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -62.65 -14.63 41.18 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.658 2.239 . . . . 0.0 112.526 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -91.98 147.71 35.42 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.203 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.434 ' HB3' ' HB3' ' A' ' 73' ' ' GLN . 25.5 Cg_exo -62.52 145.56 95.45 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.675 2.25 . . . . 0.0 112.169 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.51 1.6 40.54 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.411 -0.9 . . . . 0.0 112.912 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.88 139.73 50.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 117.028 0.414 . . . . 0.0 110.784 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.88 158.38 16.33 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.485 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.718 HD11 ' HB ' ' A' ' 70' ' ' ILE . 37.3 pt -117.53 147.56 20.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.548 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.463 ' HA ' ' CD1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -155.44 -179.72 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.728 -179.84 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 p -103.77 150.55 23.98 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.667 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 31.4 t-105 -158.8 173.49 16.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.643 0.259 . . . . 0.0 110.922 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -68.89 131.68 45.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.82 0.343 . . . . 0.0 110.693 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.643 ' HA ' HG21 ' A' ' 16' ' ' VAL . 5.3 tt0 -59.71 141.13 55.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.348 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.78 158.35 17.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.414 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.59 108.71 13.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.837 0.351 . . . . 0.0 111.234 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 41' ' ' ALA . . . 109.28 -139.2 15.19 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.526 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.441 ' O ' HG22 ' A' ' 40' ' ' THR . 74.6 Cg_exo -48.12 166.72 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.451 2.101 . . . . 0.0 112.414 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.441 HG22 ' O ' ' A' ' 39' ' ' PRO . 14.4 t 44.34 23.14 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.536 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.827 ' O ' HD12 ' A' ' 45' ' ' LEU . . . -86.33 -26.59 24.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.767 0.317 . . . . 0.0 110.443 178.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 1.015 HG13 ' HB3' ' A' ' 57' ' ' LYS . 60.4 t -50.48 -28.84 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.817 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -57.65 -13.75 4.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.144 -179.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.458 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -121.31 12.24 10.91 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 120.926 0.393 . . . . 0.0 110.364 -179.909 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.827 HD12 ' O ' ' A' ' 41' ' ' ALA . 1.2 mp -118.32 140.13 50.29 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.062 -179.074 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.707 ' CZ2' HD11 ' A' ' 19' ' ' ILE . 23.8 m95 -133.3 169.19 17.27 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.098 -179.559 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.53 ' CZ ' ' HB2' ' A' ' 55' ' ' ARG . 31.1 p90 -142.39 165.71 26.67 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.317 179.135 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.442 HG22 ' CG2' ' A' ' 54' ' ' ILE . 74.6 p -106.84 131.79 53.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.81 0.338 . . . . 0.0 111.272 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -77.44 165.6 24.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.077 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -63.12 -26.9 69.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.951 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -85.97 -4.64 59.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.277 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.431 ' O ' HG22 ' A' ' 85' ' ' ILE . . . 96.48 15.08 41.97 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.82 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.507 HG12 ' HD3' ' A' ' 55' ' ' ARG . 40.2 t -106.09 123.74 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-O 120.662 0.267 . . . . 0.0 110.495 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.464 HD11 ' HB2' ' A' ' 84' ' ' TRP . 0.6 OUTLIER -77.5 148.74 6.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.289 0.566 . . . . 0.0 111.828 -179.963 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.552 ' CD ' ' HB2' ' A' ' 62' ' ' ALA . 0.2 OUTLIER -150.06 133.28 16.34 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.323 178.903 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.518 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 16.5 m -54.76 141.75 31.41 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.512 0.673 . . . . 0.0 112.029 -178.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 1.015 ' HB3' HG13 ' A' ' 42' ' ' VAL . 25.5 tttt -54.02 -23.24 12.75 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.427 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.645 HD22 ' HG3' ' A' ' 22' ' ' GLN . 3.6 pp -57.74 -38.97 76.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.007 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 178.93 -178.0 0.3 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.746 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -74.83 82.45 2.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.813 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.443 ' CE2' ' HD3' ' A' ' 74' ' ' PRO . 2.9 m-85 -144.64 125.58 14.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.903 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.552 ' HB2' ' CD ' ' A' ' 55' ' ' ARG . . . -109.51 153.24 24.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.405 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.817 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -79.15 151.82 4.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.595 179.647 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.633 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 10.5 p-10 -133.42 130.54 38.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.261 0.553 . . . . 0.0 111.787 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.691 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -93.58 41.26 1.08 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.398 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 77.7 p -74.73 -42.87 57.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.379 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -98.11 171.04 8.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.096 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -47.6 -46.34 28.26 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.095 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.05 143.98 31.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.029 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.817 HG22 HG22 ' A' ' 63' ' ' ILE . 3.0 mm -71.38 136.38 25.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 CA-C-O 121.605 0.717 . . . . 0.0 111.454 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.438 ' O ' HG22 ' A' ' 63' ' ' ILE . 18.3 mt-10 -133.07 165.59 24.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.351 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . 1.028 HG21 HD13 ' A' ' 19' ' ' ILE . 27.5 p -105.21 134.45 48.29 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.212 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.462 ' HG2' ' C ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -161.75 167.82 12.22 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.181 -179.681 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.443 ' HD3' ' CE2' ' A' ' 61' ' ' PHE . 21.4 Cg_endo -61.11 139.44 84.12 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.308 2.005 . . . . 0.0 112.015 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.466 ' CE1' ' HB2' ' A' ' 83' ' ' ALA . 16.9 t80 -59.58 139.65 56.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.935 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.406 ' HB3' ' CB ' ' A' ' 79' ' ' ASN . 1.1 t0 -129.38 135.0 26.89 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.791 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -68.24 -35.63 18.52 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.505 2.137 . . . . 0.0 112.762 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -88.79 -1.25 57.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.699 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.427 ' HB3' ' HD2' ' A' ' 82' ' ' ARG . 2.9 t-20 -110.91 99.05 41.02 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-O 120.611 0.243 . . . . 0.0 110.846 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.532 ' O ' HD21 ' A' ' 94' ' ' LEU . 4.4 Cg_exo -74.94 27.98 0.36 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.878 2.385 . . . . 0.0 113.387 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.633 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -119.03 -23.63 6.8 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-O 120.673 0.273 . . . . 0.0 111.036 -179.833 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.47 ' HG3' ' HB3' ' A' ' 64' ' ' ASP . 0.6 OUTLIER -86.35 22.97 1.68 Allowed 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -179.076 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 1.04 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -133.7 99.96 4.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.206 0.527 . . . . 0.0 111.17 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.691 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 59.7 m95 -109.67 136.61 48.75 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.891 -178.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.44 HD11 ' HD3' ' A' ' 97' ' ' ARG . 20.4 pt -113.37 154.52 14.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.112 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.5 t -101.75 125.93 55.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.993 0.425 . . . . 0.0 111.057 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.9 t -118.74 93.87 4.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.338 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.41 -100.73 0.83 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.425 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.499 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -121.15 29.78 7.15 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.544 0.211 . . . . 0.0 110.842 -179.868 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.408 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.12 147.46 30.58 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -178.6 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.765 ' HB ' HD12 ' A' ' 101' ' ' LEU . 14.1 mm -93.86 119.17 41.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.492 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.964 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -123.27 146.68 47.67 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -178.501 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.572 ' NE2' ' CZ2' ' A' ' 84' ' ' TRP . 1.3 tp60 -64.78 149.18 49.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.599 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.04 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.7 pt? -64.61 -56.88 11.08 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.551 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.612 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 47.3 t -76.2 -2.3 30.57 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -178.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.555 ' O ' HG22 ' A' ' 99' ' ' ILE . 11.1 m-20 -145.85 90.85 2.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.029 0.442 . . . . 0.0 110.939 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.44 ' HD3' HD11 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -73.43 -13.7 61.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.546 179.351 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -86.15 10.44 14.49 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.486 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.854 HG12 ' HB1' ' A' ' 116' ' ' ALA . 3.2 tt -135.12 142.38 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.132 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.964 HG12 ' HB2' ' A' ' 92' ' ' ALA . 32.1 m -150.51 139.51 15.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.851 0.357 . . . . 0.0 111.871 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.765 HD12 ' HB ' ' A' ' 91' ' ' ILE . 11.9 mt -45.58 154.13 0.22 Allowed 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.8 0.809 . . . . 0.0 111.997 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.718 ' O ' HG22 ' A' ' 114' ' ' ILE . 9.4 t70 -157.51 167.71 29.41 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 114.18 -1.373 . . . . 0.0 110.563 -177.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.576 HD12 ' O ' ' A' ' 124' ' ' ASN . 4.5 mp -90.42 122.44 41.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.406 179.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.749 HG22 ' O ' ' A' ' 113' ' ' HIS . 8.9 tt -67.45 140.86 18.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.971 0.415 . . . . 0.0 111.379 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt 76.95 -7.32 1.87 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.935 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.6 m 46.56 28.85 0.82 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 120.76 0.314 . . . . 0.0 111.232 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.499 ' O ' ' ND2' ' A' ' 13' ' ' ASN . 5.9 t0 -99.63 159.96 14.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.052 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.503 ' HA ' ' ND2' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -80.36 -14.43 58.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.182 179.84 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -47.48 126.18 9.39 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.163 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.87 158.31 36.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.225 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.57 14.77 80.89 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.327 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.1 131.91 38.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.816 0.341 . . . . 0.0 110.872 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.749 ' O ' HG22 ' A' ' 104' ' ' ILE . 2.0 m-70 -65.1 173.52 2.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.024 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.718 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -136.35 161.5 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.367 179.928 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.579 ' HA ' HD11 ' A' ' 70' ' ' ILE . 7.4 t -152.47 166.57 31.55 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.854 ' HB1' HG12 ' A' ' 99' ' ' ILE . . . -93.92 125.02 38.3 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.038 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.46 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 68.2 t-105 -131.49 161.72 31.89 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.672 0.748 . . . . 0.0 112.455 -179.154 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.46 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.0 OUTLIER -63.85 121.13 13.3 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.792 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -60.43 124.11 19.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.977 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -136.18 8.4 3.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.503 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 79.53 57.16 3.18 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.479 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -116.51 143.31 18.01 Favored Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.488 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.82 -32.53 77.44 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.57 2.18 . . . . 0.0 112.326 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.576 ' O ' HD12 ' A' ' 103' ' ' ILE . 18.7 p-10 -73.71 -5.33 39.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.632 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.408 ' O ' ' CG2' ' A' ' 90' ' ' THR . 93.0 mt-30 -107.29 10.11 29.85 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.509 0.195 . . . . 0.0 111.362 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.445 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -106.21 140.86 38.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.864 0.364 . . . . 0.0 111.104 -179.627 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.428 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 7.9 m-85 -139.35 156.84 46.74 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.45 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.4 mt -113.79 139.17 40.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.095 0.474 . . . . 0.0 110.679 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.53 ' CD1' HG23 ' A' ' 8' ' ' ILE . 25.5 mm -114.6 139.96 37.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.62 -179.157 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -137.47 94.56 2.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.59 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 27.2 m -51.04 108.67 0.26 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.356 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.198 -0.906 . . . . 0.0 111.172 179.824 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mtt . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.819 0.343 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.411 ' N ' ' HD2' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -60.13 -61.12 8.56 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.972 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.411 ' HD2' ' N ' ' A' ' 2' ' ' LYS . 48.2 Cg_endo -68.84 141.03 47.89 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.472 2.115 . . . . 0.0 112.356 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.8 pttp -118.44 138.55 52.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.933 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.475 ' CE1' ' HG3' ' A' ' 57' ' ' LYS . 17.0 m-85 -94.08 175.29 6.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.493 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.77 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -159.42 176.02 12.61 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.76 179.694 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.442 ' CE1' ' HB3' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -114.96 124.12 50.87 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.365 179.099 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.614 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -105.89 109.4 27.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.465 179.921 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 16' ' ' VAL . 1.3 tttm -105.82 136.61 45.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.064 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 79.3 p -76.51 107.76 9.02 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 178.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.419 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 2.2 tt0 -63.15 -10.33 14.57 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.467 -178.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 27.0 tp -83.16 -62.67 1.53 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.862 0.363 . . . . 0.0 110.911 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.573 HD21 ' HA ' ' A' ' 108' ' ' LYS . 3.3 m120 -86.25 -10.83 53.86 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -178.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.39 3.74 72.07 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.172 -1.014 . . . . 0.0 111.421 -178.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.0 mmmm -91.67 -177.73 4.86 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 122.583 0.353 . . . . 0.0 110.054 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.574 HG21 ' HA ' ' A' ' 35' ' ' GLN . 4.5 m -121.27 140.83 44.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.69 0.281 . . . . 0.0 110.484 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.1 mt -70.67 136.26 48.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.233 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -140.51 153.98 46.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.85 0.357 . . . . 0.0 111.147 -179.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.912 HD13 HG21 ' A' ' 72' ' ' THR . 1.6 mt -100.43 118.35 46.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.59 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -65.26 96.13 0.21 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.876 0.369 . . . . 0.0 110.602 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 156.16 -41.29 0.57 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.379 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 53.37 49.23 20.17 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.796 0.331 . . . . 0.0 111.124 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -176.97 170.69 1.01 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.064 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.428 ' O ' ' CZ ' ' A' ' 61' ' ' PHE . 24.2 Cg_exo -63.78 -12.34 31.13 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.834 2.356 . . . . 0.0 112.627 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -40.39 97.8 0.15 Allowed Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.657 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.429 ' HB3' ' HD3' ' A' ' 74' ' ' PRO . 37.9 Cg_exo -61.11 142.33 96.6 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.652 2.235 . . . . 0.0 112.327 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.98 3.26 55.91 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.7 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.7 m -71.75 137.47 47.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.903 0.382 . . . . 0.0 111.134 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.99 156.64 19.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.299 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.701 HD11 ' HB ' ' A' ' 70' ' ' ILE . 44.2 pt -116.42 145.59 21.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.913 0.387 . . . . 0.0 111.598 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.442 HG22 ' HA ' ' A' ' 113' ' ' HIS . 0.2 OUTLIER -155.93 -178.91 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.164 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.529 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.4 p -101.2 148.92 24.53 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.561 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 18.1 t-105 -156.81 171.67 19.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.721 0.296 . . . . 0.0 110.98 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.45 134.51 47.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.719 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.574 ' HA ' HG21 ' A' ' 16' ' ' VAL . 3.5 tt0 -56.18 126.41 25.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.112 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.8 mmmt -92.43 160.99 14.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.926 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -126.03 102.52 7.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.869 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 151.02 -159.52 28.2 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.651 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -74.15 0.14 8.83 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.082 2.521 . . . . 0.0 112.904 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.2 t -103.99 22.22 15.0 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.806 0.336 . . . . 0.0 111.082 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.987 ' O ' HD12 ' A' ' 45' ' ' LEU . . . -89.96 -20.9 22.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.109 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.884 HG13 ' HB3' ' A' ' 57' ' ' LYS . 81.6 t -49.44 -33.24 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.103 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -66.26 -9.26 30.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.046 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.442 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 6.4 mt-30 -118.95 8.22 11.61 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.353 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.987 HD12 ' O ' ' A' ' 41' ' ' ALA . 0.9 OUTLIER -117.65 140.11 50.09 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.71 -178.943 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.627 ' CZ2' HD11 ' A' ' 19' ' ' ILE . 23.1 m95 -134.0 168.62 18.46 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.545 -178.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.531 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 5.3 p90 -136.53 160.29 39.21 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.081 179.031 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.427 HG22 HG23 ' A' ' 54' ' ' ILE . 29.1 p -105.72 134.55 48.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.708 0.29 . . . . 0.0 110.9 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 53' ' ' VAL . 28.2 t70 -77.42 165.68 24.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.88 0.371 . . . . 0.0 111.092 -179.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.1 mm-40 -55.45 -21.76 17.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.28 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -103.94 -1.26 27.9 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.414 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.62 -0.15 49.4 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.69 -0.766 . . . . 0.0 113.068 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.405 ' O ' ' HB2' ' A' ' 49' ' ' ASP . 19.0 t -78.95 113.62 18.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.817 0.342 . . . . 0.0 110.695 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.531 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.8 OUTLIER -79.55 147.14 6.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.407 0.622 . . . . 0.0 112.212 -179.537 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.776 ' CD ' ' HB2' ' A' ' 62' ' ' ALA . 0.1 OUTLIER -150.82 132.58 14.98 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.904 178.5 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.783 ' OG ' HD22 ' A' ' 58' ' ' LEU . 99.9 p -53.88 153.59 4.62 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 121.758 0.789 . . . . 0.0 111.818 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.884 ' HB3' HG13 ' A' ' 42' ' ' VAL . 79.5 tttt -59.69 -10.74 3.96 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 114.358 -1.292 . . . . 0.0 111.271 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.783 HD22 ' OG ' ' A' ' 56' ' ' SER . 0.7 OUTLIER -43.85 -50.53 7.89 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.956 0.408 . . . . 0.0 111.19 179.612 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 175.43 -55.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.548 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 179.55 77.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.947 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.428 ' CZ ' ' O ' ' A' ' 24' ' ' PRO . 1.8 m-85 -142.15 125.61 16.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.816 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.776 ' HB2' ' CD ' ' A' ' 55' ' ' ARG . . . -104.94 151.22 24.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.514 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.839 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -79.79 151.82 4.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.465 179.607 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.618 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 7.4 p-10 -133.38 130.69 39.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.244 0.545 . . . . 0.0 111.776 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.676 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -93.33 43.48 1.12 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.245 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.0 m -75.48 -45.63 37.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.448 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -95.85 171.89 8.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.018 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -49.17 -41.77 37.68 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.91 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.24 144.23 32.32 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.801 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.839 HG22 HG22 ' A' ' 63' ' ' ILE . 2.5 mm -74.3 139.71 18.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.537 0.684 . . . . 0.0 111.441 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.406 ' O ' HG22 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -138.61 166.83 23.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.718 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.912 HG21 HD13 ' A' ' 19' ' ' ILE . 47.3 p -105.09 138.91 40.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.139 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.07 169.54 8.03 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.2 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.429 ' HD3' ' HB3' ' A' ' 26' ' ' PRO . 32.6 Cg_exo -61.16 137.35 70.67 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.491 2.128 . . . . 0.0 112.028 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -54.84 128.0 31.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.074 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.444 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 8.9 t70 -116.9 129.33 25.39 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.64 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -68.52 -35.35 17.69 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.546 2.164 . . . . 0.0 113.01 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 56.4 m-20 -86.78 -1.59 57.88 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.444 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 1.6 t-20 -116.36 99.52 52.79 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-O 120.659 0.266 . . . . 0.0 110.795 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.542 ' O ' HD21 ' A' ' 94' ' ' LEU . 8.1 Cg_exo -72.51 32.63 0.28 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.068 2.512 . . . . 0.0 113.498 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.618 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 0.7 OUTLIER -118.89 -23.96 6.76 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 120.656 0.265 . . . . 0.0 111.171 -179.718 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.489 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 8.3 mtt-85 -85.13 18.71 2.44 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.144 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.998 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -127.76 99.26 5.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.201 0.524 . . . . 0.0 111.317 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.676 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 59.7 m95 -109.93 135.56 50.61 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.803 -179.075 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.9 pt -114.79 155.6 15.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.19 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.3 t -103.22 130.25 53.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.962 0.41 . . . . 0.0 111.143 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 30.5 t -123.04 94.99 4.44 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.286 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.25 -100.51 0.8 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.423 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.501 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.93 29.68 7.25 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.532 0.206 . . . . 0.0 110.919 -179.756 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.403 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.39 147.24 30.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.394 0.616 . . . . 0.0 112.648 -178.536 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.74 ' HB ' HD12 ' A' ' 101' ' ' LEU . 17.3 mm -94.12 119.87 42.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.2 178.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.977 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -122.54 144.88 48.8 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.487 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.582 ' NE2' ' CZ2' ' A' ' 84' ' ' TRP . 1.0 OUTLIER -64.99 147.74 52.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.52 179.452 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.998 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.6 pt? -62.73 -56.52 16.86 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.436 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.617 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 45.6 p -75.15 -4.59 39.62 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -178.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.583 ' O ' HG22 ' A' ' 99' ' ' ILE . 8.6 m-20 -140.1 89.03 2.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.815 0.34 . . . . 0.0 110.864 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.8 mmm-85 -70.78 -15.87 62.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.235 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.22 11.88 21.99 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.154 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.583 HG22 ' O ' ' A' ' 96' ' ' ASP . 1.0 OUTLIER -130.38 136.84 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.086 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.977 HG12 ' HB2' ' A' ' 92' ' ' ALA . 26.8 m -148.47 138.41 16.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.777 0.322 . . . . 0.0 111.643 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.74 HD12 ' HB ' ' A' ' 91' ' ' ILE . 10.7 mt -45.98 153.84 0.28 Allowed 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.723 0.773 . . . . 0.0 111.768 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.782 ' O ' HG22 ' A' ' 114' ' ' ILE . 10.3 t70 -157.51 167.7 29.43 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.789 -177.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.691 HD12 ' O ' ' A' ' 124' ' ' ASN . 4.3 mp -89.18 120.57 38.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.553 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.453 HG12 ' HA ' ' A' ' 114' ' ' ILE . 45.7 mm -69.2 143.25 15.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.823 0.344 . . . . 0.0 111.13 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 80.13 -9.82 1.36 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.689 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 46.76 29.51 0.99 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.749 0.309 . . . . 0.0 111.238 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.48 ' O ' ' ND2' ' A' ' 13' ' ' ASN . 54.0 p30 -105.46 163.54 12.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.033 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.573 ' HA ' HD21 ' A' ' 13' ' ' ASN . 1.4 tptm -80.56 -14.38 58.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.181 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -49.24 120.96 4.4 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.174 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.03 161.99 30.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.25 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 72.24 18.53 78.14 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.231 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -82.85 136.48 34.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.803 0.335 . . . . 0.0 111.112 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.442 ' HA ' HG22 ' A' ' 31' ' ' ILE . 5.5 m170 -62.61 168.08 3.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.939 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.782 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.7 OUTLIER -138.33 161.35 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.74 -179.772 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.65 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 5.2 t -155.15 169.67 23.62 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.667 ' HB2' ' HH2' ' A' ' 84' ' ' TRP . . . -94.08 125.91 38.99 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.046 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.459 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 76.3 t-105 -132.88 162.28 31.99 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.622 0.725 . . . . 0.0 112.311 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.459 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.1 OUTLIER -61.2 120.2 9.9 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.581 -1.191 . . . . 0.0 110.608 179.855 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -59.25 126.63 28.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.122 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -134.63 10.01 3.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.289 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 78.92 8.85 87.59 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.923 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.36 152.32 44.61 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.537 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.88 -27.09 59.06 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.606 2.204 . . . . 0.0 112.206 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.691 ' O ' HD12 ' A' ' 103' ' ' ILE . 25.4 p-10 -76.31 -1.93 29.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.479 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.403 ' O ' ' CG2' ' A' ' 90' ' ' THR . 0.0 OUTLIER -109.17 13.31 24.51 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 116.736 -0.211 . . . . 0.0 111.072 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.419 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 7.5 mmmt -104.61 132.53 50.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.789 0.328 . . . . 0.0 111.273 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.43 ' CD1' ' N ' ' A' ' 127' ' ' PHE . 1.7 m-85 -135.83 154.99 51.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.376 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 mt -114.33 139.82 38.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.163 0.506 . . . . 0.0 110.706 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.584 ' CD1' HG23 ' A' ' 8' ' ' ILE . 24.6 mm -114.54 140.73 33.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.707 -179.176 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -139.15 95.33 2.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.616 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.8 m -50.25 113.15 0.8 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.466 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.908 -179.986 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 ttm . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.764 0.316 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.18 127.55 71.1 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.898 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.16 175.2 5.04 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.438 2.092 . . . . 0.0 112.248 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -140.38 76.4 1.55 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.015 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 46' ' ' TRP . 1.6 p90 -98.13 176.36 5.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.438 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.766 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -159.9 176.16 12.21 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.746 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.457 ' CE1' ' HB3' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -113.71 123.91 51.01 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.26 179.195 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.696 ' HB ' HD21 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -105.09 109.42 27.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.912 0.386 . . . . 0.0 110.58 -179.983 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.41 ' HG3' ' O ' ' A' ' 15' ' ' LYS . 2.8 tttt -107.09 138.61 42.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.022 -0.535 . . . . 0.0 112.271 -178.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.1 p -77.54 109.29 11.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.658 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.429 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 4.1 tt0 -64.58 -10.14 24.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.598 -178.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.569 HD22 ' HA ' ' A' ' 124' ' ' ASN . 65.0 tp -84.0 -62.79 1.48 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.974 0.416 . . . . 0.0 110.906 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.534 ' ND2' ' HA ' ' A' ' 108' ' ' LYS . 2.7 m120 -85.53 -12.36 51.89 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -178.651 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.83 1.9 74.5 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.038 -1.077 . . . . 0.0 111.245 -178.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.432 ' HG2' ' HB2' ' A' ' 13' ' ' ASN . 6.6 mmmt -90.41 179.81 5.78 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.485 HG21 ' HA ' ' A' ' 35' ' ' GLN . 4.0 m -121.13 141.66 40.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.696 HD21 ' HB ' ' A' ' 8' ' ' ILE . 0.1 OUTLIER -71.89 136.62 46.99 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.374 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -142.1 150.37 41.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.948 0.404 . . . . 0.0 111.335 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.891 HD13 HG21 ' A' ' 72' ' ' THR . 23.7 mt -89.98 135.58 25.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.507 179.44 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -41.26 96.08 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.857 -179.444 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 44.24 35.07 3.56 Favored Glycine 0 C--N 1.331 0.304 0 CA-C-N 115.924 -0.58 . . . . 0.0 113.303 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 37.52 48.09 0.85 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.808 0.337 . . . . 0.0 111.726 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -48.34 105.85 0.54 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.069 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -49.95 -24.28 10.32 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.538 2.159 . . . . 0.0 112.486 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -91.99 147.98 35.96 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.983 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -63.11 144.92 93.42 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.55 2.167 . . . . 0.0 112.058 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.59 4.42 24.92 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.496 -0.859 . . . . 0.0 113.09 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.23 129.71 37.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.942 0.401 . . . . 0.0 111.118 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.408 ' HA ' ' HG3' ' A' ' 71' ' ' GLU . 9.8 mmtt -81.16 159.51 24.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.554 179.638 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.626 HD11 ' HB ' ' A' ' 70' ' ' ILE . 48.2 pt -119.89 147.91 23.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.976 0.417 . . . . 0.0 111.729 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.431 HG22 ' HA ' ' A' ' 113' ' ' HIS . 0.2 OUTLIER -155.74 -179.34 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.176 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.581 -179.881 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.693 HG21 HD12 ' A' ' 103' ' ' ILE . 2.8 p -100.97 148.45 25.0 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.639 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 51.6 t-105 -156.77 170.92 21.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.681 0.277 . . . . 0.0 110.819 -179.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.62 135.53 48.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.744 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.485 ' HA ' HG21 ' A' ' 16' ' ' VAL . 28.2 tt0 -56.79 133.96 54.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.019 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.34 168.15 9.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.851 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.5 mttp -128.19 104.77 7.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.878 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 167.75 165.02 24.45 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.56 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.24 -27.5 30.54 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.609 2.206 . . . . 0.0 112.347 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.9 t -81.44 13.13 3.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.928 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.93 ' O ' HD12 ' A' ' 45' ' ' LEU . . . -72.8 -10.4 59.75 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.684 0.278 . . . . 0.0 111.307 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.806 HG13 ' CG ' ' A' ' 57' ' ' LYS . 57.3 t -48.88 -27.12 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.272 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -64.38 -11.74 35.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.912 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.471 ' NE2' HG23 ' A' ' 16' ' ' VAL . 5.6 mt-30 -120.28 7.16 10.7 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.096 0.474 . . . . 0.0 109.784 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.93 HD12 ' O ' ' A' ' 41' ' ' ALA . 1.3 mp -118.18 140.21 50.12 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.949 -179.064 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.568 ' CZ2' HD11 ' A' ' 19' ' ' ILE . 25.5 m95 -135.12 169.88 16.77 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.019 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.567 ' CZ ' ' HB2' ' A' ' 55' ' ' ARG . 5.2 p90 -141.13 165.5 27.36 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.158 178.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.53 131.7 52.6 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.827 0.346 . . . . 0.0 111.195 -179.169 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -77.61 165.48 24.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.093 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -59.94 -25.26 65.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.12 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -91.84 -3.57 55.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.391 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.84 ' O ' HG22 ' A' ' 85' ' ' ILE . . . 97.75 10.4 52.9 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.891 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.639 HG13 ' HA ' ' A' ' 83' ' ' ALA . 5.5 t -98.23 121.22 48.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.778 0.323 . . . . 0.0 110.495 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.552 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -75.63 147.5 8.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.198 0.523 . . . . 0.0 111.884 -179.733 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.596 ' HD2' ' HB2' ' A' ' 62' ' ' ALA . 0.2 OUTLIER -151.79 135.59 16.36 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.62 179.063 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 73.1 m -49.9 149.32 2.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.255 0.55 . . . . 0.0 112.047 -179.007 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.806 ' CG ' HG13 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -59.49 -20.07 52.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.996 179.914 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.641 HD12 ' OD1' ' A' ' 59' ' ' ASN . 0.5 OUTLIER -61.35 -49.59 76.33 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.241 -179.665 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.641 ' OD1' HD12 ' A' ' 58' ' ' LEU . 32.2 p30 -176.56 -173.82 0.54 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.959 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -68.02 82.55 0.22 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.174 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.42 ' CZ ' ' HG3' ' A' ' 74' ' ' PRO . 2.3 m-85 -141.39 116.15 9.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.725 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.596 ' HB2' ' HD2' ' A' ' 55' ' ' ARG . . . -109.4 150.96 27.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.458 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.857 HG22 HG22 ' A' ' 70' ' ' ILE . 0.3 OUTLIER -78.45 153.77 5.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.583 179.614 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.606 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 4.7 p-10 -133.28 130.19 38.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.226 0.536 . . . . 0.0 111.832 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.67 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -93.95 39.92 1.08 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.433 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.31 -44.73 51.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.172 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 50.6 m170 -94.11 169.44 10.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.928 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -46.9 -47.66 21.44 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.999 0.428 . . . . 0.0 110.956 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.98 145.17 29.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.623 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.857 HG22 HG22 ' A' ' 63' ' ' ILE . 2.3 mm -73.09 137.8 22.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-O 121.553 0.692 . . . . 0.0 111.489 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.408 ' HG3' ' HA ' ' A' ' 29' ' ' LYS . 3.7 tt0 -132.34 161.93 32.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.015 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.891 HG21 HD13 ' A' ' 19' ' ' ILE . 28.3 p -104.04 138.89 39.92 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.635 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.91 160.46 15.02 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.654 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.421 ' O ' ' HD3' ' A' ' 82' ' ' ARG . 51.1 Cg_exo -53.51 141.88 61.12 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.441 2.094 . . . . 0.0 111.785 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -55.13 134.6 49.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.875 0.369 . . . . 0.0 111.352 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -126.31 118.96 23.33 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.609 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -58.33 -36.66 97.41 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.633 2.222 . . . . 0.0 113.231 -179.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 29.1 m-20 -86.1 -0.68 56.2 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -106.5 103.54 46.65 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.6 0.238 . . . . 0.0 111.137 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.529 ' O ' HD21 ' A' ' 94' ' ' LEU . 79.1 Cg_endo -77.37 23.09 0.55 Allowed 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.649 2.233 . . . . 0.0 113.132 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.606 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 0.7 OUTLIER -119.87 -21.18 7.27 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.966 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.54 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 2.5 mtm180 -86.66 20.93 2.34 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.006 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.991 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -129.79 99.91 5.3 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.275 0.56 . . . . 0.0 111.066 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.67 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 63.4 m95 -110.47 136.8 49.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.846 -178.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.84 HG22 ' O ' ' A' ' 52' ' ' GLY . 1.2 pp -117.01 155.45 18.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.215 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.1 t -100.79 125.77 54.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.917 0.389 . . . . 0.0 111.054 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 12.7 t -118.5 93.62 4.18 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.487 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.22 -100.84 0.82 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.517 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.501 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.74 29.32 7.47 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.557 0.218 . . . . 0.0 110.939 -179.655 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.419 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.82 148.18 30.61 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.379 0.609 . . . . 0.0 112.552 -178.576 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.754 ' HB ' HD12 ' A' ' 101' ' ' LEU . 16.7 mm -93.41 119.98 42.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.303 178.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.953 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -123.55 145.29 48.99 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -178.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.584 ' NE2' ' CZ2' ' A' ' 84' ' ' TRP . 0.7 OUTLIER -66.67 147.05 53.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.723 179.713 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.991 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.6 pt? -60.81 -56.23 23.65 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.499 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.616 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 2.8 m -76.75 -3.95 40.83 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -178.324 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -139.04 87.88 2.24 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.88 0.371 . . . . 0.0 111.071 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -66.92 -18.25 65.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.173 179.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.27 10.42 32.03 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.509 179.28 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.839 ' CG2' ' HB1' ' A' ' 116' ' ' ALA . 12.1 mm -122.37 127.29 75.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.596 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.953 HG12 ' HB2' ' A' ' 92' ' ' ALA . 29.6 m -146.14 135.52 17.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.821 0.343 . . . . 0.0 111.796 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.754 HD12 ' HB ' ' A' ' 91' ' ' ILE . 10.8 mt -45.97 154.0 0.27 Allowed 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.66 0.743 . . . . 0.0 111.913 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.821 ' O ' HG22 ' A' ' 114' ' ' ILE . 10.8 t70 -157.92 168.59 26.74 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.88 -177.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.693 HD12 HG21 ' A' ' 32' ' ' THR . 34.6 mm -88.77 126.95 41.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.603 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.713 HG22 ' O ' ' A' ' 113' ' ' HIS . 0.5 OUTLIER -64.16 134.11 29.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.184 0.516 . . . . 0.0 111.449 -179.699 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 12.7 tttm 62.46 10.2 3.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.929 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.0 p 40.22 33.21 0.15 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.697 0.284 . . . . 0.0 111.587 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.468 ' O ' ' ND2' ' A' ' 13' ' ' ASN . 0.6 OUTLIER -91.93 154.73 18.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.931 0.396 . . . . 0.0 111.191 -179.672 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.534 ' HA ' ' ND2' ' A' ' 13' ' ' ASN . 0.1 OUTLIER -79.28 -16.17 56.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.322 179.926 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -49.36 126.52 13.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.791 0.329 . . . . 0.0 111.308 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -73.1 157.95 36.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.031 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.48 14.08 81.27 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.17 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.52 134.03 38.4 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.924 0.392 . . . . 0.0 111.035 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.713 ' O ' HG22 ' A' ' 104' ' ' ILE . 0.8 OUTLIER -60.91 167.08 3.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.878 -179.798 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.821 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.1 OUTLIER -139.48 161.41 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.728 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.673 ' HA ' HD11 ' A' ' 70' ' ' ILE . 5.7 p -157.6 173.3 17.07 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.839 ' HB1' ' CG2' ' A' ' 99' ' ' ILE . . . -95.27 129.47 42.38 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.349 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.456 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 75.7 t-105 -136.04 162.47 32.79 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.565 0.698 . . . . 0.0 112.096 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.456 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.0 OUTLIER -61.63 118.77 7.51 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.773 179.976 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -59.01 127.13 30.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.997 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -134.08 11.25 3.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.155 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 77.44 7.64 87.06 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.864 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.5 154.88 41.4 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.507 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.46 -28.4 53.99 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.625 2.216 . . . . 0.0 112.28 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.569 ' HA ' HD22 ' A' ' 12' ' ' LEU . 30.3 p-10 -74.52 -4.07 34.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.589 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.419 ' O ' ' CG2' ' A' ' 90' ' ' THR . 0.0 OUTLIER -108.34 15.81 23.69 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.571 0.224 . . . . 0.0 111.176 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.429 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 16.7 mmtt -107.06 134.01 50.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.765 0.317 . . . . 0.0 111.384 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.43 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 4.5 m-85 -137.05 155.29 49.85 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.303 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.4 mt -113.55 139.14 40.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.174 0.511 . . . . 0.0 110.587 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.575 HD12 HG23 ' A' ' 8' ' ' ILE . 24.0 mm -113.97 139.79 37.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.616 -179.092 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -136.77 94.68 3.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.628 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.3 p -52.48 110.81 0.54 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.253 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.448 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 5.2 tp10 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.996 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 ptp . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 120.894 0.378 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.48 143.9 27.5 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.85 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.05 133.9 17.07 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.516 2.144 . . . . 0.0 112.473 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.0 tttt -96.96 116.88 29.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.654 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.492 ' CD1' ' HG3' ' A' ' 57' ' ' LYS . 2.3 p90 -91.44 174.94 7.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.7 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.723 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -161.08 177.8 9.94 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.628 179.73 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.75 ' OH ' ' HB1' ' A' ' 41' ' ' ALA . 1.0 OUTLIER -112.61 123.83 51.18 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.42 179.379 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.617 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -103.97 109.42 27.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.123 0.487 . . . . 0.0 109.802 179.552 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.506 ' HE2' HD12 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -102.89 130.84 50.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.579 -178.025 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.68 103.18 7.46 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 178.369 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.421 ' HB3' ' O ' ' A' ' 126' ' ' LYS . 3.3 tt0 -65.58 -8.22 18.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.768 -178.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.722 HD22 ' CB ' ' A' ' 124' ' ' ASN . 36.1 tp -83.16 -63.6 1.33 Allowed 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.44 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.44 HD21 HG21 ' A' ' 103' ' ' ILE . 3.3 m-80 -83.72 -7.78 59.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.862 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.78 4.85 72.54 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.11 -1.043 . . . . 0.0 111.234 -177.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm -94.43 -166.31 1.46 Allowed 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 122.809 0.444 . . . . 0.0 109.958 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.58 HG21 ' HA ' ' A' ' 35' ' ' GLN . 6.3 m -130.78 143.93 39.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.3 mt -70.19 135.11 48.76 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -145.15 155.97 43.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.915 0.388 . . . . 0.0 111.196 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.066 HD13 HG21 ' A' ' 72' ' ' THR . 17.4 mt -97.53 130.77 45.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.517 179.295 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.45 104.27 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.042 -178.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 23' ' ' ASN . . . 44.83 29.41 2.01 Favored Glycine 0 C--N 1.332 0.334 0 CA-C-N 115.824 -0.625 . . . . 0.0 113.406 179.384 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.817 ' HG2' HD22 ' A' ' 58' ' ' LEU . 0.2 OUTLIER 65.82 -71.17 0.09 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.789 0.328 . . . . 0.0 111.063 179.877 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 21' ' ' GLY . 49.4 t30 68.25 91.71 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.866 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.38 -20.42 20.18 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.6 2.2 . . . . 0.0 112.487 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -94.63 153.86 40.14 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.083 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.421 ' HB3' ' CD ' ' A' ' 74' ' ' PRO . 17.1 Cg_exo -66.96 151.42 82.16 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.672 2.248 . . . . 0.0 112.11 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.53 2.33 35.09 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.463 -0.875 . . . . 0.0 113.3 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.55 125.24 26.97 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 117.102 0.451 . . . . 0.0 111.258 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -77.64 159.99 28.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.562 179.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.53 HD13 HG21 ' A' ' 63' ' ' ILE . 47.9 pt -121.1 148.27 24.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.885 0.374 . . . . 0.0 111.771 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.457 HG22 ' HA ' ' A' ' 113' ' ' HIS . 0.3 OUTLIER -156.01 -178.3 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.219 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.551 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.633 HG21 HD12 ' A' ' 103' ' ' ILE . 1.6 p -100.54 147.94 25.35 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.617 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 25.6 t-105 -159.15 173.79 15.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.66 0.267 . . . . 0.0 110.798 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -69.8 134.7 48.83 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.815 0.34 . . . . 0.0 110.762 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.58 ' HA ' HG21 ' A' ' 16' ' ' VAL . 6.6 tt0 -62.86 137.45 58.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.125 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.7 mmmt -99.66 157.12 16.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.824 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.63 106.27 11.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.302 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 113.82 -123.87 6.28 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.507 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -66.52 169.4 14.3 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.354 2.036 . . . . 0.0 112.153 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.1 p 43.85 23.99 0.06 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.775 ' O ' HD12 ' A' ' 45' ' ' LEU . . . -87.26 -26.36 23.5 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.916 -0.314 . . . . 0.0 110.447 178.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.94 HG13 ' HB3' ' A' ' 57' ' ' LYS . 28.3 t -50.32 -25.77 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.091 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -61.62 -11.33 11.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.712 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -120.13 8.43 10.95 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.015 0.436 . . . . 0.0 109.978 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.775 HD12 ' O ' ' A' ' 41' ' ' ALA . 1.5 mp -116.98 139.77 50.27 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.828 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.468 ' O ' ' HA ' ' A' ' 5' ' ' PHE . 23.9 m95 -134.38 168.04 19.65 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.027 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.526 ' CE1' ' HB2' ' A' ' 55' ' ' ARG . 26.5 p90 -140.11 164.2 30.69 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.101 178.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -106.45 133.74 50.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.859 0.361 . . . . 0.0 111.327 -179.014 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -77.69 166.03 23.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.063 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.28 -24.08 62.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.112 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -94.74 -3.23 49.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.42 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.555 ' O ' HG22 ' A' ' 85' ' ' ILE . . . 98.99 7.82 54.76 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.826 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.545 HG13 ' HA ' ' A' ' 83' ' ' ALA . 21.2 t -92.76 118.48 38.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.76 0.28 . . . . 0.0 110.549 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.523 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -76.11 146.98 8.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.294 0.568 . . . . 0.0 111.863 -179.786 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.792 ' CD ' ' HB2' ' A' ' 62' ' ' ALA . 7.7 mmm-85 -150.21 135.27 17.81 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.629 179.089 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 15.0 m -55.6 143.75 28.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.369 0.604 . . . . 0.0 112.012 -179.008 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.94 ' HB3' HG13 ' A' ' 42' ' ' VAL . 4.6 tttt -54.15 -25.45 22.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.052 -179.484 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.817 HD22 ' HG2' ' A' ' 22' ' ' GLN . 1.9 pp -56.58 -48.52 77.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.763 0.316 . . . . 0.0 111.351 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.538 ' N ' HD12 ' A' ' 58' ' ' LEU . 0.8 OUTLIER -172.12 -179.74 2.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.9 -179.941 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.83 84.77 0.48 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.944 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -145.91 125.17 12.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.787 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.792 ' HB2' ' CD ' ' A' ' 55' ' ' ARG . . . -113.07 154.12 27.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.352 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.893 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -79.77 153.09 4.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.725 179.776 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.599 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 6.3 p-10 -132.33 132.8 43.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.126 0.489 . . . . 0.0 111.609 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.73 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -97.75 39.86 1.19 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.317 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.42 -43.52 60.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.252 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -96.29 172.08 8.18 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.018 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -47.73 -48.72 29.57 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.042 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.83 147.64 26.26 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.666 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.893 HG22 HG22 ' A' ' 63' ' ' ILE . 1.6 mm -78.62 144.01 11.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-O 121.649 0.738 . . . . 0.0 111.992 -179.138 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.73 166.07 25.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.799 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . 1.066 HG21 HD13 ' A' ' 19' ' ' ILE . 73.9 p -102.33 138.95 38.57 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.051 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.48 159.94 20.38 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.392 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.421 ' CD ' ' HB3' ' A' ' 26' ' ' PRO . 52.2 Cg_exo -52.54 136.59 57.32 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.441 2.094 . . . . 0.0 111.887 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.478 ' CD2' HG11 ' A' ' 53' ' ' VAL . 17.4 t80 -57.09 132.19 52.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.223 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -121.75 134.46 24.64 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.608 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.3 -34.93 15.02 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.424 2.083 . . . . 0.0 112.608 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -87.4 -0.77 57.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.55 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -108.96 100.18 38.74 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-O 120.622 0.248 . . . . 0.0 111.021 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.826 ' O ' HD21 ' A' ' 94' ' ' LEU . 4.0 Cg_exo -76.73 25.14 0.45 Allowed 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.988 2.459 . . . . 0.0 113.02 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.707 ' HD2' ' HB3' ' A' ' 65' ' ' ALA . 42.7 mmtt -119.72 -21.06 7.41 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 120.635 0.255 . . . . 0.0 110.893 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.521 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 3.6 mtm180 -87.01 17.91 3.88 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.24 -179.249 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 1.102 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -127.25 99.29 5.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.166 0.508 . . . . 0.0 110.764 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.73 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 62.1 m95 -109.27 136.27 49.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.105 0.479 . . . . 0.0 111.77 -178.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.555 HG22 ' O ' ' A' ' 52' ' ' GLY . 2.6 pp -115.73 154.6 17.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.139 179.187 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.8 t -102.03 130.0 52.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.932 0.396 . . . . 0.0 111.184 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 36.7 t -122.61 95.18 4.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.447 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.45 -100.71 0.83 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.545 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.499 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.97 29.67 7.25 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.509 0.195 . . . . 0.0 110.789 -179.731 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.424 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.72 147.63 30.13 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -178.49 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.501 ' HB ' HD12 ' A' ' 101' ' ' LEU . 27.5 mm -94.03 120.47 43.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.421 178.459 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.95 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -124.27 146.11 48.97 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -178.394 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.583 ' NE2' ' CZ2' ' A' ' 84' ' ' TRP . 1.1 tp60 -65.42 150.06 48.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.673 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.102 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.7 pt? -62.81 -57.22 11.63 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.721 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.585 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 1.5 m -79.8 -2.06 41.64 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -178.459 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.526 ' O ' HG22 ' A' ' 99' ' ' ILE . 1.5 m-20 -137.48 85.54 2.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.842 0.353 . . . . 0.0 110.809 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 16.4 mmt85 -69.48 -16.68 63.51 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.158 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -90.35 11.29 21.87 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.138 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.526 HG22 ' O ' ' A' ' 96' ' ' ASP . 5.6 tt -130.21 136.42 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.151 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.95 HG12 ' HB2' ' A' ' 92' ' ' ALA . 19.8 m -148.57 137.36 15.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.455 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.509 ' HA ' ' O ' ' A' ' 115' ' ' CYS . 25.8 mt -45.31 153.99 0.19 Allowed 'General case' 0 CA--C 1.51 -0.596 0 CA-C-O 121.713 0.768 . . . . 0.0 111.622 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.825 ' O ' HG22 ' A' ' 114' ' ' ILE . 27.4 t70 -157.49 167.72 29.38 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.964 -177.424 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.633 HD12 HG21 ' A' ' 32' ' ' THR . 33.1 mm -86.46 123.34 39.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.232 179.063 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.82 HG22 ' O ' ' A' ' 113' ' ' HIS . 0.8 OUTLIER -68.26 139.3 20.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.1 0.476 . . . . 0.0 111.65 -179.549 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.12 18.36 3.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.815 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.405 ' HA ' HD21 ' A' ' 12' ' ' LEU . 13.4 m 45.1 -132.87 0.84 Allowed 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.918 -0.128 . . . . 0.0 111.041 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 65.45 162.9 0.15 Allowed 'General case' 0 CA--C 1.526 0.037 0 CA-C-O 120.772 0.32 . . . . 0.0 111.025 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -90.04 -12.4 38.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.448 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -44.81 132.54 6.56 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.391 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -89.22 164.74 14.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.245 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 71.61 19.01 77.61 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.048 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -86.18 138.34 31.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.841 0.353 . . . . 0.0 110.915 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.82 ' O ' HG22 ' A' ' 104' ' ' ILE . 34.7 m80 -62.12 170.52 2.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.749 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.825 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.6 OUTLIER -143.94 161.84 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.928 -179.497 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.673 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 6.0 p -156.65 173.49 16.86 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.673 ' HB2' ' HH2' ' A' ' 84' ' ' TRP . . . -95.99 128.71 43.13 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 178.351 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.451 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 75.0 t-105 -134.81 162.68 31.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.494 0.664 . . . . 0.0 112.059 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.451 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.3 OUTLIER -62.33 122.99 17.05 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.787 179.929 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -56.99 124.1 17.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.054 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -128.78 5.57 5.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.394 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 81.69 6.86 88.75 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.88 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -65.98 148.93 51.32 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.528 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.03 -27.01 57.91 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.564 2.176 . . . . 0.0 112.382 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.722 ' CB ' HD22 ' A' ' 12' ' ' LEU . 42.5 p-10 -66.95 -12.26 59.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.561 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.425 ' HG2' ' HB2' ' A' ' 102' ' ' ASP . 6.0 mt-30 -103.5 17.57 23.79 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.338 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.421 ' O ' ' HB3' ' A' ' 11' ' ' GLU . 12.3 mmtp -106.43 136.28 46.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.856 0.36 . . . . 0.0 111.568 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.432 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 3.0 m-85 -141.13 155.28 46.13 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.909 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.506 HD12 ' HE2' ' A' ' 9' ' ' LYS . 1.5 mt -110.65 139.68 33.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.146 0.498 . . . . 0.0 110.651 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.434 HD12 HG23 ' A' ' 8' ' ' ILE . 21.9 mm -112.98 139.69 36.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.648 -179.009 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -138.08 94.46 2.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.618 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.5 t -52.13 113.16 0.94 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.341 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.471 ' HB3' ' CE2' ' A' ' 5' ' ' PHE . 2.2 tm-20 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.272 -0.871 . . . . 0.0 110.932 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.827 0.346 . . . . 0.0 111.203 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.7 mttp -128.67 89.44 49.24 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.849 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.02 60.35 3.75 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.595 2.197 . . . . 0.0 112.381 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -92.9 122.94 35.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.886 179.982 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -98.76 175.05 6.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.665 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.613 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -152.46 170.22 20.66 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 120.952 0.406 . . . . 0.0 111.14 179.303 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.458 ' O ' ' HA ' ' A' ' 129' ' ' ILE . 0.1 OUTLIER -108.62 123.74 49.42 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.932 178.942 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.629 ' HB ' HD21 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -107.72 106.12 20.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.341 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.434 ' HD3' HG13 ' A' ' 16' ' ' VAL . 1.3 tptp -104.92 134.63 47.71 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 54.2 m -75.82 107.13 7.79 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.45 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 4.3 tt0 -63.14 -10.49 15.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.61 -178.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 51.1 tp -81.84 -62.96 1.49 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.97 0.414 . . . . 0.0 110.869 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.463 HD21 HG21 ' A' ' 103' ' ' ILE . 6.5 m-20 -86.31 -7.46 58.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.244 -178.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.48 6.54 62.38 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.05 -1.071 . . . . 0.0 111.459 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.6 mmmm -94.94 -176.22 3.78 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.576 HG21 ' HA ' ' A' ' 35' ' ' GLN . 3.6 m -122.52 142.2 39.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.629 HD21 ' HB ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -72.56 138.23 46.74 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.174 179.52 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 19' ' ' ILE . 31.5 t0 -146.01 142.38 28.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.78 0.324 . . . . 0.0 111.033 -178.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.763 HD12 HG21 ' A' ' 72' ' ' THR . 7.9 mm -69.06 141.94 16.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.319 -0.4 . . . . 0.0 109.925 179.011 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -52.67 105.9 0.14 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.951 0.405 . . . . 0.0 111.468 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 53.46 31.77 44.27 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.993 -0.623 . . . . 0.0 113.01 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 43.91 30.5 0.41 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.728 0.299 . . . . 0.0 111.591 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -58.77 108.46 1.33 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.676 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -78.52 36.61 0.6 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.858 2.372 . . . . 0.0 112.928 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -124.72 150.04 64.24 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.655 0.264 . . . . 0.0 110.877 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.4 ' HG3' ' HD3' ' A' ' 74' ' ' PRO . 23.1 Cg_exo -63.22 130.91 30.22 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.513 2.142 . . . . 0.0 112.026 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.72 1.49 32.39 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.442 -0.885 . . . . 0.0 113.066 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.5 m -72.55 138.61 47.01 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 117.085 0.443 . . . . 0.0 110.69 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.48 157.44 19.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.784 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.657 HD11 ' HB ' ' A' ' 70' ' ' ILE . 42.1 pt -115.74 145.9 20.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.377 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.435 ' HA ' ' CD1' ' A' ' 114' ' ' ILE . 0.3 OUTLIER -153.46 177.71 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.156 -179.741 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.8 p -102.03 148.89 24.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.759 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 41.0 t-105 -157.45 172.08 19.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.713 0.292 . . . . 0.0 110.826 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.65 134.21 48.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.732 0.301 . . . . 0.0 110.734 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.576 ' HA ' HG21 ' A' ' 16' ' ' VAL . 8.0 tt0 -56.88 127.7 33.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.055 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.87 162.47 13.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.868 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.18 101.87 7.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.878 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 166.84 158.78 11.6 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.461 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.49 -28.54 36.43 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.644 2.229 . . . . 0.0 112.348 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.8 t -90.12 28.86 1.31 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.476 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.547 ' O ' HD12 ' A' ' 45' ' ' LEU . . . -101.94 2.73 38.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.168 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.697 HG12 ' HB3' ' A' ' 57' ' ' LYS . 2.5 t -60.27 -17.29 14.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.761 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 29.7 p30 -60.36 -13.51 13.55 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.047 178.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -111.38 7.36 20.87 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.613 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 1.8 mp -120.09 147.63 44.61 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.469 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.634 ' CZ2' HD11 ' A' ' 19' ' ' ILE . 25.4 m95 -133.34 169.57 16.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.818 -179.055 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.505 ' CE2' ' HB2' ' A' ' 55' ' ' ARG . 1.5 p90 -136.14 159.19 42.47 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.007 178.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.509 HG22 ' CG2' ' A' ' 54' ' ' ILE . 40.0 p -106.22 132.88 51.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.763 0.316 . . . . 0.0 111.256 -179.199 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -77.67 165.36 24.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.108 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -60.94 -24.07 65.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.017 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -93.17 -3.35 54.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.44 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.95 8.75 53.69 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.883 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.555 HG11 ' CD2' ' A' ' 75' ' ' PHE . 33.8 t -95.5 119.74 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 116.946 0.373 . . . . 0.0 110.638 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.509 ' CG2' HG22 ' A' ' 48' ' ' THR . 0.8 OUTLIER -79.35 151.9 4.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.246 0.546 . . . . 0.0 111.863 -179.826 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.557 ' CD ' ' HB2' ' A' ' 62' ' ' ALA . 8.6 mmm-85 -148.11 133.3 18.36 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.289 179.063 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.598 ' HB3' HD22 ' A' ' 58' ' ' LEU . 0.1 OUTLIER -69.58 -176.77 1.07 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.323 0.582 . . . . 0.0 111.968 -178.708 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.697 ' HB3' HG12 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -46.09 -23.54 0.33 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.714 -179.876 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.599 ' H ' HD22 ' A' ' 58' ' ' LEU . 1.5 mm? -49.08 -21.65 0.76 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.728 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.493 ' CB ' ' O ' ' A' ' 58' ' ' LEU . 10.9 t30 89.53 -25.64 0.07 Allowed 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 179.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -164.93 58.2 0.13 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.934 0.397 . . . . 0.0 111.419 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.475 ' HB2' ' HB2' ' A' ' 58' ' ' LEU . 2.2 m-85 -143.39 113.36 7.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.121 0.486 . . . . 0.0 110.7 179.25 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.557 ' HB2' ' CD ' ' A' ' 55' ' ' ARG . . . -98.87 152.22 19.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.118 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.898 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -77.9 149.91 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.349 179.523 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.649 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 3.7 p-10 -131.51 133.16 44.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.133 0.492 . . . . 0.0 111.79 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.643 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -99.36 42.41 1.1 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.369 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 66.4 p -74.34 -44.53 52.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.15 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -96.72 172.53 7.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.963 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -48.86 -44.19 39.49 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.056 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.68 145.43 29.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.986 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.898 HG22 HG22 ' A' ' 63' ' ' ILE . 2.8 mm -75.77 141.8 15.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-O 121.555 0.693 . . . . 0.0 111.358 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -136.96 168.76 18.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.001 -0.999 . . . . 0.0 111.432 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.763 HG21 HD12 ' A' ' 19' ' ' ILE . 23.2 p -108.54 135.79 49.23 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.213 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.419 ' HA ' ' CE2' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -165.54 171.9 4.77 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.429 -179.725 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.415 ' HD3' ' CE2' ' A' ' 61' ' ' PHE . 75.6 Cg_exo -49.09 139.83 25.87 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.506 2.137 . . . . 0.0 111.957 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.555 ' CD2' HG11 ' A' ' 53' ' ' VAL . 48.4 t80 -47.74 -59.58 3.19 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -179.42 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.403 ' HB2' ' HD3' ' A' ' 82' ' ' ARG . 0.3 OUTLIER 63.56 118.83 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 -179.166 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.47 -28.65 21.6 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.527 2.151 . . . . 0.0 113.445 -179.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -87.25 0.58 55.15 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.45 ' CB ' ' HD2' ' A' ' 82' ' ' ARG . 1.9 m120 -104.42 101.97 30.68 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 120.63 0.253 . . . . 0.0 111.328 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.862 ' O ' HD21 ' A' ' 94' ' ' LEU . 94.8 Cg_endo -77.58 18.6 0.81 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.733 2.288 . . . . 0.0 113.319 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.649 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -118.97 -19.84 8.35 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 120.716 0.293 . . . . 0.0 110.905 179.818 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.509 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 36.5 mtt180 -91.01 25.62 2.38 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.227 -178.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 1.054 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -136.96 99.48 4.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.94 0.4 . . . . 0.0 110.898 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.672 ' HH2' ' HB2' ' A' ' 116' ' ' ALA . 38.6 m95 -109.58 139.13 44.97 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.246 0.546 . . . . 0.0 111.78 -178.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 pp -112.7 155.92 13.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.287 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.6 t -102.64 128.15 55.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.962 0.41 . . . . 0.0 111.246 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.9 t -120.92 94.6 4.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.209 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.41 -100.98 0.85 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.34 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.5 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.76 29.84 7.2 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.579 0.228 . . . . 0.0 110.843 -179.81 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.425 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.44 147.51 30.29 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.383 0.611 . . . . 0.0 112.64 -178.595 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.718 ' HB ' HD12 ' A' ' 101' ' ' LEU . 20.1 mm -94.02 120.29 43.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.292 178.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.9 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -122.2 144.11 49.16 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.441 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -64.82 148.14 51.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.435 179.566 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.054 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.5 pt? -62.79 -57.49 10.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.8 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.548 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 3.5 t -75.81 -3.91 37.69 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.489 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.477 ' O ' HG22 ' A' ' 99' ' ' ILE . 19.0 t0 -141.14 89.63 2.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.841 0.353 . . . . 0.0 110.891 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 8.8 mmt85 -70.79 -16.02 62.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.232 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -88.93 10.87 19.79 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.253 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.477 HG22 ' O ' ' A' ' 96' ' ' ASP . 5.3 tt -131.05 137.54 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.055 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.9 HG12 ' HB2' ' A' ' 92' ' ' ALA . 17.5 m -148.39 138.59 16.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.774 0.321 . . . . 0.0 111.536 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.718 HD12 ' HB ' ' A' ' 91' ' ' ILE . 10.9 mt -46.32 153.87 0.31 Allowed 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.634 0.731 . . . . 0.0 111.581 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.735 ' O ' HG22 ' A' ' 114' ' ' ILE . 9.8 t70 -158.85 168.08 27.75 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.46 -1.245 . . . . 0.0 110.669 -177.388 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.558 HD12 ' O ' ' A' ' 124' ' ' ASN . 4.6 mp -87.34 120.69 37.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.139 179.095 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.765 HD11 ' HB2' ' A' ' 115' ' ' CYS . 40.2 mm -70.03 136.39 26.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.883 0.373 . . . . 0.0 111.253 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 8.4 tttt 78.92 -6.1 1.94 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.764 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.1 m 46.45 29.7 0.94 Allowed 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 120.809 0.338 . . . . 0.0 111.27 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.39 155.01 17.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.039 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.1 -13.74 59.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.097 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -48.78 123.14 6.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.229 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.4 157.86 30.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.037 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.24 12.55 81.76 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.146 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.51 131.52 41.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.873 0.368 . . . . 0.0 111.052 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -64.87 172.44 2.84 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.111 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.735 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -136.71 161.67 36.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.349 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.765 ' HB2' HD11 ' A' ' 104' ' ' ILE . 6.3 t -153.38 167.47 29.29 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.672 ' HB2' ' HH2' ' A' ' 84' ' ' TRP . . . -94.75 125.24 39.28 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 177.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.459 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 76.1 t-105 -133.56 162.38 32.07 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.629 0.728 . . . . 0.0 112.291 -179.265 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.459 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.0 OUTLIER -61.79 119.82 9.49 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.621 179.836 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -59.74 126.05 26.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.1 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 14.2 p-80 -134.11 10.7 3.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.21 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 81.15 7.88 87.96 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.981 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.48 150.09 47.74 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.603 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.37 -27.02 55.29 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.561 2.174 . . . . 0.0 112.182 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.558 ' O ' HD12 ' A' ' 103' ' ' ILE . 32.1 p-10 -75.45 -4.42 39.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.425 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.425 ' O ' ' CG2' ' A' ' 90' ' ' THR . 0.0 OUTLIER -105.82 12.95 30.22 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.29 -179.741 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.45 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 5.9 mmtt -106.02 140.3 39.23 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.863 0.364 . . . . 0.0 111.367 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.414 ' CD1' ' O ' ' A' ' 126' ' ' LYS . 8.9 m-85 -138.67 155.27 48.42 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.162 179.615 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 mt -111.45 137.24 44.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.049 0.452 . . . . 0.0 110.41 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.458 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 36.6 mm -113.47 140.9 31.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.64 -179.031 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -140.83 106.2 5.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.596 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.61 109.11 0.94 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.044 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 34.5 tp10 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.232 -0.89 . . . . 0.0 111.127 179.888 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 mmt . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 120.795 0.331 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -145.04 117.39 5.33 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.802 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.39 -173.92 0.91 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.389 2.059 . . . . 0.0 112.391 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.58 112.36 23.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.831 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.474 ' HA ' ' O ' ' A' ' 46' ' ' TRP . 2.1 p90 -92.8 174.97 6.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.618 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.742 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -159.92 175.97 12.43 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.596 179.744 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.439 ' CE1' ' HB3' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -114.22 123.88 50.66 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.288 179.206 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.624 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -104.12 109.77 28.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.37 -179.924 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 16' ' ' VAL . 0.1 OUTLIER -105.63 135.42 47.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.464 -178.756 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.8 t -75.27 105.66 6.4 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -62.66 -11.88 19.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.594 -178.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.488 ' HB2' ' HA ' ' A' ' 124' ' ' ASN . 12.3 tp -84.51 -62.49 1.54 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.964 0.412 . . . . 0.0 110.967 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.626 HD21 HG21 ' A' ' 103' ' ' ILE . 12.9 m-20 -83.08 -12.81 56.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.48 -178.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.53 2.9 76.7 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.143 -1.027 . . . . 0.0 111.491 -178.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -91.86 -175.14 4.04 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.74 HG11 ' HG3' ' A' ' 35' ' ' GLN . 5.4 m -121.62 140.22 46.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.656 0.265 . . . . 0.0 110.437 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.5 mt -69.4 134.76 49.41 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -143.61 153.99 43.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.888 0.375 . . . . 0.0 111.196 -178.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.06 HD13 HG21 ' A' ' 72' ' ' THR . 34.0 mt -95.98 137.24 24.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.572 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -34.14 97.85 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -179.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 44.1 39.52 5.29 Favored Glycine 0 C--N 1.332 0.309 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.498 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 46.77 30.72 1.24 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.707 0.289 . . . . 0.0 111.348 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -47.11 102.87 0.33 Allowed Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.147 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.11 -12.21 31.31 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.644 2.229 . . . . 0.0 112.635 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . . . -88.46 145.0 34.61 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.642 0.258 . . . . 0.0 111.121 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.418 ' HB3' ' CD ' ' A' ' 74' ' ' PRO . 29.3 Cg_exo -61.55 142.67 95.6 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.599 2.2 . . . . 0.0 112.143 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.82 3.44 39.72 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.477 -0.868 . . . . 0.0 113.08 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.75 138.61 48.58 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.946 0.403 . . . . 0.0 111.056 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.3 mptt -89.4 157.71 18.04 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.216 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.721 HD11 ' HB ' ' A' ' 70' ' ' ILE . 38.0 pt -116.34 145.91 21.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.799 0.333 . . . . 0.0 111.743 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.461 ' HA ' ' CD1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -155.32 178.17 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.192 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.537 -179.827 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.6 p -100.68 148.77 24.49 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 121.001 -0.279 . . . . 0.0 110.65 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 24.3 t-105 -157.69 172.57 18.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.706 0.289 . . . . 0.0 110.883 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -69.77 133.93 48.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.852 0.358 . . . . 0.0 110.706 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.74 ' HG3' HG11 ' A' ' 16' ' ' VAL . 6.9 tt0 -56.68 119.51 6.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.112 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.34 164.83 13.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.795 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.0 mtpm? -131.68 116.85 17.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.94 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 149.2 -162.56 29.01 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.585 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -74.84 1.16 7.95 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.026 2.484 . . . . 0.0 112.827 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.09 19.13 18.72 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.661 0.267 . . . . 0.0 111.202 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.956 ' O ' HD12 ' A' ' 45' ' ' LEU . . . -81.89 -20.51 38.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.124 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.996 HG13 ' HB3' ' A' ' 57' ' ' LYS . 45.3 t -49.69 -29.77 4.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.113 179.322 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -65.69 -10.91 40.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.927 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.439 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 3.5 mt-30 -118.2 7.59 12.14 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.19 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.956 HD12 ' O ' ' A' ' 41' ' ' ALA . 1.1 mp -118.82 140.38 50.05 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.981 -179.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.76 ' CZ2' HD11 ' A' ' 19' ' ' ILE . 24.8 m95 -134.12 168.82 18.13 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.92 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.52 ' CZ ' ' HB2' ' A' ' 55' ' ' ARG . 32.0 p90 -140.73 164.93 28.87 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.219 178.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.454 HG22 ' CG2' ' A' ' 54' ' ' ILE . 81.1 p -107.6 134.32 50.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.833 0.349 . . . . 0.0 111.378 -178.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -77.81 170.25 16.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.15 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.17 -23.62 67.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.077 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.3 mm100 -94.04 -3.45 51.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.242 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.95 8.78 53.65 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.917 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.429 HG11 ' CE2' ' A' ' 75' ' ' PHE . 42.2 t -95.14 119.63 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-O 120.83 0.348 . . . . 0.0 110.693 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -76.68 147.85 7.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.341 0.591 . . . . 0.0 111.9 -179.792 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.612 ' CD ' ' HB2' ' A' ' 62' ' ' ALA . 8.2 mmm-85 -149.48 133.69 17.31 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.39 179.076 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.46 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 70.0 m -55.07 143.8 25.76 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.463 0.649 . . . . 0.0 111.848 -178.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.996 ' HB3' HG13 ' A' ' 42' ' ' VAL . 12.9 tttt -52.69 -24.07 7.87 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.7 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.742 HD12 ' N ' ' A' ' 59' ' ' ASN . 3.5 pp -56.59 -49.21 75.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.183 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.742 ' N ' HD12 ' A' ' 58' ' ' LEU . 1.8 t-20 -178.12 -176.47 0.54 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.871 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.75 83.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.855 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.416 ' CE2' ' HD3' ' A' ' 74' ' ' PRO . 2.8 m-85 -144.18 119.38 10.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.77 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.612 ' HB2' ' CD ' ' A' ' 55' ' ' ARG . . . -109.26 154.9 21.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.547 -179.715 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.85 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -80.37 150.79 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.466 179.587 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.575 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 6.4 p-10 -131.61 132.09 43.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.064 0.459 . . . . 0.0 111.419 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.666 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -97.51 41.66 1.11 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.192 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.4 t -74.83 -45.54 42.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.158 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 59.6 m80 -94.44 170.76 9.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.982 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -47.83 -48.02 31.0 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.106 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -99.6 143.86 29.35 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.099 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.85 HG22 HG22 ' A' ' 63' ' ' ILE . 3.0 mm -74.2 139.95 18.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 CA-C-O 121.554 0.692 . . . . 0.0 111.478 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -139.88 168.94 18.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.262 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . 1.06 HG21 HD13 ' A' ' 19' ' ' ILE . 63.4 p -108.59 139.2 43.7 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.281 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.6 163.02 16.72 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.485 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.418 ' CD ' ' HB3' ' A' ' 26' ' ' PRO . 50.7 Cg_exo -55.08 136.06 71.49 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.474 2.116 . . . . 0.0 111.729 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.429 ' CE2' HG11 ' A' ' 53' ' ' VAL . 32.7 t80 -52.77 134.72 36.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.97 0.414 . . . . 0.0 111.489 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.421 ' HB2' ' CZ ' ' A' ' 82' ' ' ARG . 21.6 t70 -124.21 116.8 27.03 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.477 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -56.98 -33.76 96.18 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.532 2.155 . . . . 0.0 113.045 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 33.5 m-20 -86.89 -0.07 55.86 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -179.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 -112.55 104.07 55.78 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 120.629 0.252 . . . . 0.0 111.114 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.828 ' O ' HD21 ' A' ' 94' ' ' LEU . 84.4 Cg_endo -76.84 27.11 0.43 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.733 2.289 . . . . 0.0 113.105 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.602 ' HD2' ' HB3' ' A' ' 65' ' ' ALA . 40.7 mmtt -120.29 -19.5 7.64 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 116.687 -0.233 . . . . 0.0 111.162 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.543 ' HG2' ' HB3' ' A' ' 64' ' ' ASP . 3.5 mtm180 -88.43 19.71 3.71 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.329 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 1.132 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -130.03 99.38 5.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.075 0.464 . . . . 0.0 110.784 179.445 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.666 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 58.8 m95 -109.05 135.77 49.66 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.146 0.498 . . . . 0.0 111.979 -178.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.796 HD11 ' HD3' ' A' ' 97' ' ' ARG . 1.1 pp -111.82 152.87 13.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.084 179.112 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.3 t -100.57 126.37 54.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.941 0.4 . . . . 0.0 111.133 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.3 t -119.39 94.85 4.56 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.577 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.81 -100.41 0.76 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.643 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.491 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.51 29.64 7.34 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.518 0.199 . . . . 0.0 110.977 -179.492 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -149.71 149.11 30.09 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.337 0.589 . . . . 0.0 112.493 -178.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.83 ' HB ' HD12 ' A' ' 101' ' ' LEU . 12.3 mm -94.01 120.71 43.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.449 178.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.882 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -121.38 144.54 48.61 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -178.454 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.419 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -66.33 149.02 51.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.929 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.132 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.6 pt? -64.26 -57.36 9.67 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.018 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.587 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 3.5 m -74.06 -4.12 33.54 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.192 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.586 ' O ' HG22 ' A' ' 99' ' ' ILE . 73.2 m-20 -146.73 93.01 2.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.099 0.476 . . . . 0.0 111.035 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.796 ' HD3' HD11 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -73.04 -13.12 61.15 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.587 179.37 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -87.89 12.02 14.23 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.481 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.824 HG12 ' HB1' ' A' ' 116' ' ' ALA . 2.6 tt -135.09 143.25 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.034 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.882 HG12 ' HB2' ' A' ' 92' ' ' ALA . 34.9 m -151.66 139.71 14.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.789 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.83 HD12 ' HB ' ' A' ' 91' ' ' ILE . 10.6 mt -46.2 154.31 0.27 Allowed 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 121.722 0.772 . . . . 0.0 111.706 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.733 ' O ' HG22 ' A' ' 114' ' ' ILE . 28.5 t70 -158.3 168.29 27.42 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.629 -177.491 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.626 HG21 HD21 ' A' ' 13' ' ' ASN . 26.8 mm -89.35 120.97 38.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.389 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.832 HG22 ' O ' ' A' ' 113' ' ' HIS . 7.9 tp -64.72 138.66 22.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.023 0.44 . . . . 0.0 111.457 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 73.54 -3.71 2.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.043 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 45.3 t 44.19 31.26 0.53 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.76 0.314 . . . . 0.0 111.428 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -97.36 158.12 15.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.194 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.99 -13.4 59.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.183 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -49.11 131.93 19.29 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.26 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -77.17 158.86 30.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.017 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 72.3 15.34 76.98 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.145 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.05 132.61 40.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.895 0.378 . . . . 0.0 110.929 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.832 ' O ' HG22 ' A' ' 104' ' ' ILE . 6.2 m80 -64.99 171.53 3.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.934 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.733 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -135.45 161.25 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.397 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.586 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 5.8 t -152.39 167.22 29.41 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.824 ' HB1' HG12 ' A' ' 99' ' ' ILE . . . -94.99 124.73 39.21 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.228 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.447 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 77.0 t-105 -133.49 161.4 34.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.619 0.723 . . . . 0.0 112.236 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.447 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.0 OUTLIER -61.03 123.0 16.38 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.57 -1.195 . . . . 0.0 110.806 -179.906 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -58.84 125.05 21.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.951 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 6.1 p-80 -136.98 6.32 2.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.595 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 78.26 57.1 3.49 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.273 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -112.0 138.73 15.18 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.509 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.67 -31.42 60.32 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.447 2.098 . . . . 0.0 112.18 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.488 ' HA ' ' HB2' ' A' ' 12' ' ' LEU . 10.9 p-10 -72.0 -8.0 52.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.575 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -101.9 -14.31 17.28 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.57 0.211 . . . . 0.0 111.57 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.428 ' O ' ' CD1' ' A' ' 127' ' ' PHE . 2.3 mmtt -78.27 136.73 37.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.811 0.339 . . . . 0.0 111.373 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.428 ' CD1' ' O ' ' A' ' 126' ' ' LYS . 6.8 m-85 -139.15 156.22 47.28 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.136 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 mt -112.33 137.77 43.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.176 0.513 . . . . 0.0 110.592 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.569 HD12 HG23 ' A' ' 8' ' ' ILE . 19.5 mm -114.36 138.7 43.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.527 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -134.52 94.29 3.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.54 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.15 108.06 0.48 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.134 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.295 -0.86 . . . . 0.0 111.358 179.726 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.488 ' HD2' HD22 ' A' ' 45' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.461 0.11 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.793 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -155.24 171.28 20.08 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.613 179.815 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.81 ' OH ' ' HB1' ' A' ' 41' ' ' ALA . 2.0 m-85 -109.2 123.41 49.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.23 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.616 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -108.23 103.72 15.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.842 0.353 . . . . 0.0 110.275 179.674 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.855 ' HB3' HG12 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -127.98 126.84 42.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.763 -179.036 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.467 ' O ' ' HD2' ' A' ' 9' ' ' LYS . 0.9 OUTLIER -46.15 138.44 5.29 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.019 0.437 . . . . 0.0 111.575 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.543 ' HA ' HD11 ' A' ' 128' ' ' ILE . 3.2 tt0 -81.13 -11.28 59.5 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.082 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 61.4 tp -92.9 -56.54 2.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.165 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -83.24 -21.09 33.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.83 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.18 4.08 77.7 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.284 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.59 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 1.1 mmmm -85.26 164.25 18.15 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.855 HG12 ' HB3' ' A' ' 9' ' ' LYS . 12.6 m -106.95 137.0 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-O 120.769 0.318 . . . . 0.0 110.722 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 21.0 mt -68.31 136.57 53.65 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -138.26 152.01 48.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.841 0.353 . . . . 0.0 111.111 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.929 HD13 HG21 ' A' ' 72' ' ' THR . 1.5 mt . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.872 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 N-CA-C 112.588 -0.205 . . . . 0.0 112.588 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.37 132.91 37.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.945 0.403 . . . . 0.0 111.114 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.87 155.65 30.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.311 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.698 HG22 HG23 ' A' ' 19' ' ' ILE . 47.8 pt -115.31 144.59 22.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.921 0.391 . . . . 0.0 111.676 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.442 HG22 ' HA ' ' A' ' 113' ' ' HIS . 0.2 OUTLIER -156.09 -176.68 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.581 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.513 HG21 HD12 ' A' ' 103' ' ' ILE . 1.2 p -101.75 148.56 25.14 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.343 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 10.4 t-105 -159.1 173.84 15.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.709 0.29 . . . . 0.0 111.009 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -71.85 138.32 48.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.815 0.341 . . . . 0.0 110.86 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.619 ' HA ' HG21 ' A' ' 16' ' ' VAL . 28.4 tt0 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.176 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.898 ' O ' HD12 ' A' ' 45' ' ' LEU . . . . . . . . 0 N--CA 1.457 -0.116 0 CA-C-O 120.758 0.314 . . . . 0.0 110.885 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 99.6 t -49.73 -28.07 3.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.191 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -67.07 -9.0 34.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.804 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -119.6 6.14 11.05 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.153 0.501 . . . . 0.0 109.821 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.898 HD12 ' O ' ' A' ' 41' ' ' ALA . 1.2 mp -116.07 138.86 50.86 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.583 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.576 ' CZ2' HD11 ' A' ' 19' ' ' ILE . 21.1 m95 -132.54 167.92 19.15 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.035 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.509 ' CE1' ' HB2' ' A' ' 55' ' ' ARG . 41.2 p90 -140.44 163.93 31.48 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.146 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -105.1 132.6 51.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.849 0.357 . . . . 0.0 111.345 -178.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -77.65 165.85 23.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.154 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -62.71 -24.16 67.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.14 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -90.3 -4.1 57.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.328 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.738 ' O ' HG22 ' A' ' 85' ' ' ILE . . . 97.11 13.37 46.08 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.858 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.553 HG13 ' HA ' ' A' ' 83' ' ' ALA . 21.6 t -103.97 123.02 57.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.712 0.291 . . . . 0.0 110.533 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -75.71 149.23 6.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.369 0.604 . . . . 0.0 111.941 -179.828 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.684 ' CD ' ' HB2' ' A' ' 62' ' ' ALA . 7.5 mmm-85 -149.36 133.5 17.26 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.235 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 8.2 m . . . . . 0 C--N 1.326 -0.444 0 CA-C-O 121.468 0.651 . . . . 0.0 111.862 -178.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.846 0.355 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.684 ' HB2' ' CD ' ' A' ' 55' ' ' ARG . . . -114.0 153.2 29.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.265 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.762 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -78.54 153.65 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.475 179.742 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.56 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 6.9 p-10 -133.63 132.94 41.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.203 0.525 . . . . 0.0 111.554 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.647 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -97.28 43.63 1.06 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.27 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.7 m -74.54 -45.56 44.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.084 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -94.66 171.9 8.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.834 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -50.87 -41.94 58.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.086 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.77 144.3 31.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.967 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.762 HG22 HG22 ' A' ' 63' ' ' ILE . 2.8 mm -72.47 135.95 26.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-O 121.642 0.734 . . . . 0.0 111.516 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.417 ' O ' HG22 ' A' ' 63' ' ' ILE . 6.8 tt0 -135.99 163.25 30.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.724 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.929 HG21 HD13 ' A' ' 19' ' ' ILE . 31.7 p -105.73 140.03 39.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.965 0.412 . . . . 0.0 111.195 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.467 ' CB ' ' HD2' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -162.41 169.09 9.7 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.29 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.467 ' HD2' ' CB ' ' A' ' 73' ' ' GLN . 19.4 Cg_endo -60.54 139.31 85.47 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.307 2.005 . . . . 0.0 111.913 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.43 ' HE1' ' HB2' ' A' ' 83' ' ' ALA . 8.7 t80 -57.0 138.21 54.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.088 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.4 ' HB3' ' CB ' ' A' ' 79' ' ' ASN . 24.4 t0 -129.98 119.15 18.77 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.685 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -56.53 -34.64 95.57 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.538 2.159 . . . . 0.0 112.907 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -86.54 -1.39 57.59 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.4 ' CB ' ' HB3' ' A' ' 76' ' ' ASP . 2.8 t-20 -108.92 102.42 48.38 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.656 0.265 . . . . 0.0 110.957 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.833 ' O ' HD21 ' A' ' 94' ' ' LEU . 88.0 Cg_endo -76.78 24.57 0.47 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.725 2.283 . . . . 0.0 113.276 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.584 ' HD2' ' HB3' ' A' ' 65' ' ' ALA . 37.7 mmtt -120.03 -18.43 8.14 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 120.519 0.2 . . . . 0.0 111.195 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 2.0 mtt180 -89.14 20.06 3.91 Favored 'General case' 0 C--N 1.341 0.219 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 1.103 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -129.3 99.62 5.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.093 0.473 . . . . 0.0 110.691 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.647 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 60.5 m95 -108.99 134.92 51.0 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.123 0.487 . . . . 0.0 112.057 -178.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.738 HG22 ' O ' ' A' ' 52' ' ' GLY . 3.4 pt -112.82 153.76 14.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.296 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.2 t -101.76 127.0 55.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.898 0.38 . . . . 0.0 111.087 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 25.2 t -119.49 95.21 4.69 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.632 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.47 -100.03 0.7 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.677 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.501 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.32 29.67 7.36 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.575 0.226 . . . . 0.0 110.962 -179.449 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.6 149.98 30.58 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.315 0.579 . . . . 0.0 112.474 -178.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.835 ' HB ' HD12 ' A' ' 101' ' ' LEU . 12.6 mm -94.28 122.09 45.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.458 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.929 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -122.29 142.32 50.6 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.419 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -64.74 148.09 51.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.469 179.648 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.103 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.7 pt? -62.43 -56.79 14.84 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.918 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.58 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 7.0 p -75.99 -4.0 38.78 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -178.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.409 ' HB3' ' HB ' ' A' ' 99' ' ' ILE . 5.3 m-20 -141.16 89.82 2.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.866 0.365 . . . . 0.0 111.241 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -67.6 -16.4 64.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.259 178.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -92.5 10.03 31.93 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.476 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.812 ' CG2' ' HB1' ' A' ' 116' ' ' ALA . 11.6 mm -123.51 128.24 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.477 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.929 HG12 ' HB2' ' A' ' 92' ' ' ALA . 30.5 m -146.48 135.84 16.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.771 0.32 . . . . 0.0 111.667 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.835 HD12 ' HB ' ' A' ' 91' ' ' ILE . 8.6 mt -47.09 154.4 0.36 Allowed 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.639 0.733 . . . . 0.0 111.475 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.81 ' O ' HG22 ' A' ' 114' ' ' ILE . 30.0 t70 -155.85 166.89 32.15 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.875 -177.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.531 ' HA ' HG22 ' A' ' 114' ' ' ILE . 35.0 mm -89.73 120.54 38.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.426 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.805 HG22 ' O ' ' A' ' 113' ' ' HIS . 0.6 OUTLIER -64.84 138.89 22.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.038 0.447 . . . . 0.0 111.512 -179.622 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.402 ' N ' HG13 ' A' ' 104' ' ' ILE . 10.1 mmtp 76.01 -4.02 2.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.031 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 17.1 m 45.68 30.04 0.75 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.823 0.344 . . . . 0.0 111.285 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -100.41 165.09 11.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.215 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.54 -15.55 51.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.058 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -47.28 128.81 12.34 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.203 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -80.95 161.46 24.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.115 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 72.05 17.93 77.48 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.178 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.85 138.23 33.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.888 0.375 . . . . 0.0 110.967 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.805 ' O ' HG22 ' A' ' 104' ' ' ILE . 28.9 m170 -62.87 171.07 2.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.787 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.81 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.7 OUTLIER -142.67 161.76 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.688 -179.657 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.648 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 28.4 p -155.71 171.4 20.06 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.812 ' HB1' ' CG2' ' A' ' 99' ' ' ILE . . . -95.83 126.84 41.36 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.459 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 76.1 t-105 -134.98 162.61 31.94 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.567 0.699 . . . . 0.0 112.123 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.459 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.0 OUTLIER -60.72 120.92 11.01 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.607 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -52.09 123.8 11.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.886 0.374 . . . . 0.0 111.277 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.416 ' CE1' ' HA3' ' A' ' 122' ' ' GLY . 6.6 p80 -128.84 3.3 5.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.361 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.62 8.48 81.31 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.836 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.416 ' HA3' ' CE1' ' A' ' 120' ' ' HIS . . . -63.67 142.0 46.21 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.55 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.81 -31.2 71.36 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.528 2.152 . . . . 0.0 112.295 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -69.42 -11.95 61.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.319 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -101.68 13.5 34.73 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.703 0.287 . . . . 0.0 111.138 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.6 mmmm -100.34 126.27 46.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.351 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.449 ' HE2' HD11 ' A' ' 103' ' ' ILE . 32.6 m-85 -129.13 154.98 46.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.333 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.543 HD11 ' HA ' ' A' ' 11' ' ' GLU . 2.0 mt -116.21 141.57 33.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.295 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.587 HD12 HG23 ' A' ' 8' ' ' ILE . 26.1 mm -113.33 141.16 30.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.288 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -141.59 95.3 2.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.753 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 47.5 m -54.77 108.12 0.36 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.289 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.383 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.425 ' HA ' ' O ' ' A' ' 46' ' ' TRP . 71.7 m-85 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.647 0.261 . . . . 0.0 110.691 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.681 ' C ' HD23 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -153.75 171.6 18.62 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 120.978 0.418 . . . . 0.0 111.178 179.118 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.439 ' O ' ' HA ' ' A' ' 129' ' ' ILE . 0.1 OUTLIER -111.66 123.6 50.58 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.213 179.044 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.61 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -106.97 106.55 20.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.886 0.374 . . . . 0.0 110.095 179.802 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -106.78 137.73 44.27 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.648 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.38 109.42 10.08 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.469 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 6.0 tt0 -62.88 -10.91 15.08 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.521 -178.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.609 HD22 ' HA ' ' A' ' 124' ' ' ASN . 43.0 tp -84.24 -62.32 1.59 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.938 0.399 . . . . 0.0 111.037 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.718 HD21 HG21 ' A' ' 103' ' ' ILE . 8.6 m-20 -86.25 -12.32 49.93 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.23 3.98 71.9 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.071 -1.061 . . . . 0.0 111.545 -178.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.438 ' O ' ' HG3' ' A' ' 9' ' ' LYS . 5.1 mmtm -91.85 175.91 6.71 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.607 HG21 ' HA ' ' A' ' 35' ' ' GLN . 5.9 m -118.47 143.83 28.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.725 0.298 . . . . 0.0 110.603 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.3 mt -69.25 136.29 51.75 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.004 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.402 ' CB ' ' HG3' ' A' ' 44' ' ' GLN . 14.0 t0 -144.96 144.24 30.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.795 0.331 . . . . 0.0 111.146 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.831 HD12 HG21 ' A' ' 72' ' ' THR . 4.3 mm . . . . . 0 C--N 1.327 -0.37 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.518 0 CA-C-O 120.185 -0.231 . . . . 0.0 113.192 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.3 t -73.34 128.85 36.66 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 117.243 0.521 . . . . 0.0 110.994 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.1 mmtp -80.38 158.12 26.11 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.282 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.675 HD11 ' HB ' ' A' ' 70' ' ' ILE . 43.3 pt -117.0 145.97 22.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.613 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.466 ' HA ' ' CD1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -153.65 178.61 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.182 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.943 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.3 p -101.87 149.4 24.24 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.567 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 26.0 t-105 -159.27 173.89 15.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.635 0.255 . . . . 0.0 110.869 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -69.46 133.02 47.22 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.798 0.332 . . . . 0.0 110.776 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.607 ' HA ' HG21 ' A' ' 16' ' ' VAL . 27.9 pt20 . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.992 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.514 ' O ' HD12 ' A' ' 45' ' ' LEU . . . . . . . . 0 C--O 1.23 0.07 0 N-CA-C 111.566 0.21 . . . . 0.0 111.566 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.476 ' HA ' ' CD1' ' A' ' 45' ' ' LEU . 1.6 t -59.26 -18.53 14.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.675 0.274 . . . . 0.0 110.821 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -63.8 -10.65 21.26 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.755 0.312 . . . . 0.0 110.894 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.402 ' HG3' ' CB ' ' A' ' 18' ' ' ASP . 1.2 mt-30 -111.12 7.95 21.55 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.681 HD23 ' C ' ' A' ' 6' ' ' PHE . 1.1 mp -121.1 146.45 46.72 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 114.662 -1.153 . . . . 0.0 111.296 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.601 ' CZ2' HD11 ' A' ' 19' ' ' ILE . 26.0 m95 -133.46 170.46 15.46 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.678 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.54 ' CE2' ' HB2' ' A' ' 55' ' ' ARG . 1.5 p90 -136.62 160.39 38.94 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.039 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.556 HG22 HG23 ' A' ' 54' ' ' ILE . 33.2 p -107.77 134.41 50.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.71 0.29 . . . . 0.0 111.285 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -77.67 170.47 16.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.281 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -63.22 -22.79 67.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.038 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -97.35 -2.93 41.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.148 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.6 5.52 53.88 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.976 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.436 HG11 ' CE1' ' A' ' 75' ' ' PHE . 23.6 t -88.08 116.59 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 CA-C-O 120.864 0.364 . . . . 0.0 110.778 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.556 HG23 HG22 ' A' ' 48' ' ' THR . 0.7 OUTLIER -78.5 150.27 5.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.242 0.544 . . . . 0.0 111.821 -179.86 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.54 ' HB2' ' CE2' ' A' ' 47' ' ' TYR . 10.0 mmm-85 -147.16 133.14 19.17 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.454 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.464 0 CA-C-O 121.162 0.505 . . . . 0.0 111.877 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.99 0.424 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -97.17 150.19 21.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.807 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.895 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -78.07 150.23 5.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.283 179.903 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.583 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 15.7 p-10 -130.71 131.34 44.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.071 0.462 . . . . 0.0 111.583 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.674 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -96.83 42.77 1.08 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.175 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.8 -45.18 45.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.216 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -96.45 172.86 7.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.014 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -47.33 -49.41 24.28 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.923 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -98.96 146.96 25.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.929 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.895 HG22 HG22 ' A' ' 63' ' ' ILE . 2.6 mm -76.22 140.82 16.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-O 121.531 0.681 . . . . 0.0 111.441 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -133.05 166.54 22.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.618 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.831 HG21 HD12 ' A' ' 19' ' ' ILE . 24.8 p -112.13 137.06 50.73 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.717 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.487 ' HG2' ' C ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -163.57 165.63 13.74 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.062 179.655 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.416 ' O ' ' HD3' ' A' ' 82' ' ' ARG . 54.1 Cg_exo -52.38 141.26 51.31 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.379 2.053 . . . . 0.0 111.935 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.436 ' CE1' HG11 ' A' ' 53' ' ' VAL . 36.0 t80 -60.5 132.55 54.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.388 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.405 ' HB2' ' NH1' ' A' ' 82' ' ' ARG . 20.2 t0 -123.49 132.13 24.29 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.411 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -68.79 -33.56 20.49 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.52 2.147 . . . . 0.0 113.283 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -87.14 1.04 54.28 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -105.57 103.69 44.53 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.56 0.219 . . . . 0.0 111.28 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.839 ' O ' HD21 ' A' ' 94' ' ' LEU . 6.1 Cg_exo -77.78 20.42 0.71 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.959 2.439 . . . . 0.0 112.828 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.583 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 11.3 mmtm -120.35 -17.89 8.09 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.993 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.509 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 39.2 mtt180 -89.08 19.59 4.13 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.305 -179.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 1.114 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -130.03 99.1 4.96 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.053 0.454 . . . . 0.0 110.937 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.674 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 54.3 m95 -108.58 134.9 50.7 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.14 0.495 . . . . 0.0 111.801 -178.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.4 pp -111.48 154.52 13.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.318 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.4 t -102.3 128.57 54.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.993 0.425 . . . . 0.0 111.139 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.6 t -121.33 94.23 4.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.398 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.16 -100.13 0.76 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.503 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.493 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.63 29.25 7.52 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.617 0.246 . . . . 0.0 110.974 -179.737 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.408 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.78 147.29 29.7 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.633 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.731 ' HB ' HD12 ' A' ' 101' ' ' LEU . 20.0 mm -94.29 120.52 43.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.384 178.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.903 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -121.91 145.07 48.45 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -178.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.441 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -65.4 149.09 50.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.493 179.568 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.114 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.6 pt? -62.91 -57.35 11.09 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.819 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.564 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -76.22 -3.89 38.86 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -178.559 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.561 ' O ' HG22 ' A' ' 99' ' ' ILE . 8.4 m-20 -139.84 88.6 2.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.783 0.325 . . . . 0.0 110.926 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.48 -16.34 62.9 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.181 179.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.86 11.76 19.31 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.216 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.561 HG22 ' O ' ' A' ' 96' ' ' ASP . 6.9 tt -131.53 137.78 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.903 HG12 ' HB2' ' A' ' 92' ' ' ALA . 18.6 m -148.66 138.5 16.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.819 0.343 . . . . 0.0 111.789 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.731 HD12 ' HB ' ' A' ' 91' ' ' ILE . 10.8 mt -45.96 153.24 0.31 Allowed 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 121.708 0.766 . . . . 0.0 111.791 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.731 ' O ' HG22 ' A' ' 114' ' ' ILE . 10.9 t70 -156.64 166.94 31.95 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.383 -1.28 . . . . 0.0 110.745 -177.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.718 HG21 HD21 ' A' ' 13' ' ' ASN . 4.3 mp -89.73 120.58 38.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.33 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.816 HG22 ' O ' ' A' ' 113' ' ' HIS . 3.7 tp -64.66 139.05 22.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.999 0.428 . . . . 0.0 111.494 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 71.46 -2.13 2.54 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.165 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.4 m 41.91 32.23 0.27 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.803 0.335 . . . . 0.0 111.52 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -96.39 156.83 16.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.18 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.27 -13.92 59.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.097 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -52.0 124.51 12.98 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.157 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.4 159.76 33.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.086 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.86 14.0 81.96 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.288 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.46 132.33 39.56 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.853 0.359 . . . . 0.0 110.993 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.816 ' O ' HG22 ' A' ' 104' ' ' ILE . 37.5 m80 -65.02 171.15 3.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.964 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.731 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -135.92 161.67 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.514 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.623 ' HA ' HD11 ' A' ' 70' ' ' ILE . 13.6 p -153.98 169.03 24.46 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.672 ' HB2' ' HH2' ' A' ' 84' ' ' TRP . . . -95.34 126.13 40.43 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.521 -0.471 . . . . 0.0 109.747 178.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.461 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 76.0 t-105 -133.92 162.47 31.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.566 0.698 . . . . 0.0 112.298 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.461 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 4.3 tmtm? -61.89 122.58 15.8 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.752 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.407 ' HA ' ' NE2' ' A' ' 125' ' ' GLN . 29.1 tt0 -60.54 125.52 24.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.346 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -134.68 9.0 3.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.631 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 80.82 7.45 88.56 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.486 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.54 152.93 44.34 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.505 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.71 -26.12 53.45 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.654 2.236 . . . . 0.0 112.324 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.621 ' O ' HD12 ' A' ' 103' ' ' ILE . 26.9 p-10 -75.39 -3.5 34.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.485 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.408 ' O ' ' CG2' ' A' ' 90' ' ' THR . 0.5 OUTLIER -108.95 14.41 24.13 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.194 -179.815 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.469 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 1.3 mmtp -105.53 133.22 50.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.768 0.318 . . . . 0.0 111.321 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.421 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 5.9 m-85 -136.41 155.77 49.56 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.544 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.4 mt -113.72 138.86 42.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.187 0.518 . . . . 0.0 110.409 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.524 ' CD1' HG23 ' A' ' 8' ' ' ILE . 36.4 mm -113.41 140.41 33.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.589 -179.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -139.16 111.48 7.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.509 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.35 110.63 2.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.118 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.957 -179.993 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.445 ' HA ' ' O ' ' A' ' 46' ' ' TRP . 1.3 p90 . . . . . 0 C--O 1.23 0.068 0 N-CA-C 110.31 -0.256 . . . . 0.0 110.31 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.754 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -158.84 175.57 13.42 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.795 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.447 ' CE1' ' HB3' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -114.74 123.81 50.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.24 179.196 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.616 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -104.56 109.88 28.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.926 0.393 . . . . 0.0 110.374 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -104.64 135.87 45.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.32 -178.824 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.702 ' OG ' HD11 ' A' ' 103' ' ' ILE . 0.6 OUTLIER -75.55 107.21 7.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.516 178.299 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.424 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 1.8 tt0 -63.82 -11.03 23.59 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.661 -178.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.689 HD22 ' CB ' ' A' ' 124' ' ' ASN . 37.7 tp -84.68 -62.77 1.47 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.898 0.38 . . . . 0.0 110.988 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -84.23 -11.48 56.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.333 -178.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.81 3.53 73.93 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.136 -1.03 . . . . 0.0 111.416 -178.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -91.28 -172.8 3.41 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.613 HG21 ' HA ' ' A' ' 35' ' ' GLN . 3.5 m -124.48 140.83 46.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.708 0.29 . . . . 0.0 110.469 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.4 mt -69.8 134.78 48.92 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.016 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -142.99 158.58 43.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.968 0.413 . . . . 0.0 111.239 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.949 HD13 HG21 ' A' ' 72' ' ' THR . 19.2 mt . . . . . 0 C--N 1.326 -0.416 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.419 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 CA-C-O 120.272 -0.182 . . . . 0.0 113.347 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.6 m -75.81 129.94 37.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.157 0.479 . . . . 0.0 111.258 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.2 mmtp -82.4 160.81 22.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.437 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.714 HD11 ' HB ' ' A' ' 70' ' ' ILE . 41.1 pt -119.4 147.09 23.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.78 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.46 ' HA ' ' CD1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -155.17 179.39 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.208 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.511 -179.777 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.49 HG21 HD12 ' A' ' 103' ' ' ILE . 1.6 p -101.77 149.07 24.55 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.622 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 24.3 t-105 -156.99 171.85 19.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.857 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -70.12 135.79 49.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.76 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.613 ' HA ' HG21 ' A' ' 16' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.145 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.862 ' O ' HD12 ' A' ' 45' ' ' LEU . . . . . . . . 0 N--CA 1.457 -0.081 0 CA-C-O 120.678 0.275 . . . . 0.0 111.189 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.7 t -49.38 -27.73 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.085 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -64.97 -9.59 22.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.791 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.447 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 6.0 mt-30 -120.45 7.42 10.64 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.099 0.476 . . . . 0.0 109.766 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.862 HD12 ' O ' ' A' ' 41' ' ' ALA . 1.3 mp -116.95 139.88 50.13 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.781 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.697 ' CZ2' HD11 ' A' ' 19' ' ' ILE . 24.7 m95 -133.95 168.82 18.09 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.127 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.524 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 30.1 p90 -140.71 165.0 28.69 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.112 178.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.559 HG22 HG23 ' A' ' 54' ' ' ILE . 15.0 p -107.76 134.0 51.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.813 0.34 . . . . 0.0 111.429 -178.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -77.8 169.89 17.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.192 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -63.49 -24.15 67.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.143 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -93.95 -2.82 52.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.136 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.49 8.49 54.66 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.84 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.469 HG12 ' HD3' ' A' ' 55' ' ' ARG . 40.4 t -93.98 119.43 41.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.89 0.345 . . . . 0.0 110.552 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.559 HG23 HG22 ' A' ' 48' ' ' THR . 0.7 OUTLIER -77.26 147.92 7.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.299 0.571 . . . . 0.0 111.763 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.7 ' CD ' ' HB2' ' A' ' 62' ' ' ALA . 9.0 mmm-85 -149.85 133.74 16.95 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.474 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.466 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 37.9 m . . . . . 0 C--N 1.326 -0.448 0 CA-C-O 121.476 0.655 . . . . 0.0 111.863 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.893 0.378 . . . . 0.0 110.825 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.7 ' HB2' ' CD ' ' A' ' 55' ' ' ARG . . . -110.55 155.85 21.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.492 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.848 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -82.89 151.76 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.636 179.6 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.598 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 10.0 p-10 -132.44 130.31 40.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.106 0.479 . . . . 0.0 111.429 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.67 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -94.3 39.62 1.08 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.467 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.3 m -74.34 -45.89 44.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.141 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 15.3 m170 -91.13 167.91 12.01 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.943 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -46.74 -47.19 20.71 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.928 0.394 . . . . 0.0 110.833 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.34 146.18 27.92 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.701 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.848 HG22 HG22 ' A' ' 63' ' ' ILE . 2.7 mm -73.51 136.45 25.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 CA-C-O 121.738 0.78 . . . . 0.0 111.595 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -132.34 163.82 27.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.094 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.949 HG21 HD13 ' A' ' 19' ' ' ILE . 41.6 p -109.33 136.71 48.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.591 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.466 ' HG2' ' C ' ' A' ' 72' ' ' THR . 0.5 OUTLIER -163.1 167.32 11.9 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.452 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.432 ' O ' ' HD3' ' A' ' 82' ' ' ARG . 50.4 Cg_exo -53.46 137.0 65.04 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.432 2.088 . . . . 0.0 111.759 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -65.47 141.6 58.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.964 0.411 . . . . 0.0 111.412 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.12 139.62 35.51 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.59 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.02 -30.53 20.91 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.511 2.141 . . . . 0.0 112.864 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -89.57 0.05 57.18 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -106.19 102.57 40.81 Favored Pre-proline 0 CA--C 1.529 0.17 0 CA-C-O 120.568 0.223 . . . . 0.0 111.187 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.853 ' O ' HD21 ' A' ' 94' ' ' LEU . 5.8 Cg_exo -77.27 20.1 0.68 Allowed 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.94 2.427 . . . . 0.0 113.034 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.598 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 0.1 OUTLIER -117.85 -20.42 8.83 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 120.634 0.254 . . . . 0.0 110.96 -179.859 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.503 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 6.8 mtm-85 -88.41 19.76 3.66 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.414 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 1.131 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -128.58 99.2 5.28 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.089 0.471 . . . . 0.0 110.696 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.67 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 62.7 m95 -108.85 134.63 51.28 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.216 0.531 . . . . 0.0 112.016 -178.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.6 pt -112.12 153.23 13.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.201 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.4 t -101.75 127.02 55.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.943 0.402 . . . . 0.0 110.98 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.9 t -119.82 95.06 4.61 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.566 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.87 -100.27 0.75 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.557 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.499 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.79 29.82 7.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.603 0.239 . . . . 0.0 110.864 -179.668 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.413 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -148.76 148.43 29.97 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 121.358 0.599 . . . . 0.0 112.595 -178.548 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.809 ' HB ' HD12 ' A' ' 101' ' ' LEU . 14.6 mm -93.93 120.93 44.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.393 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.966 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -123.71 144.06 49.89 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.411 ' HB3' ' HB2' ' A' ' 96' ' ' ASP . 0.6 OUTLIER -62.83 152.34 36.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.476 179.605 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.131 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.7 pt? -65.73 -56.9 9.59 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.402 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.577 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 1.2 m -79.34 -1.93 39.16 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.411 ' HB2' ' HB3' ' A' ' 93' ' ' GLN . 9.6 m-20 -138.07 85.03 2.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.891 0.377 . . . . 0.0 110.998 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.45 -17.79 64.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.221 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' A' ' 118' ' ' LYS . 4.6 m-20 -92.7 10.28 31.35 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.466 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.848 ' CG2' ' HB1' ' A' ' 116' ' ' ALA . 11.9 mm -123.07 128.66 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.501 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.966 HG12 ' HB2' ' A' ' 92' ' ' ALA . 28.5 m -146.39 135.17 16.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.809 HD12 ' HB ' ' A' ' 91' ' ' ILE . 11.3 mt -45.62 154.21 0.22 Allowed 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.746 0.784 . . . . 0.0 111.861 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.607 ' O ' HG22 ' A' ' 114' ' ' ILE . 13.6 t70 -159.55 169.39 23.93 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.65 -177.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.702 HD11 ' OG ' ' A' ' 10' ' ' SER . 17.6 mm -88.07 121.11 38.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.168 179.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.437 HD12 ' CB ' ' A' ' 113' ' ' HIS . 52.7 mt -70.42 136.83 25.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.841 0.353 . . . . 0.0 111.215 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.403 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 0.2 OUTLIER 80.88 -9.03 1.38 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.802 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 38.2 m 47.39 30.49 1.58 Allowed 'General case' 0 N--CA 1.461 0.108 0 CA-C-O 120.785 0.326 . . . . 0.0 111.289 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -98.55 154.05 18.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.015 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.25 -11.56 60.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.316 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -52.36 129.12 27.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.206 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.95 161.51 29.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.008 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 70.64 15.62 73.47 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.867 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.92 133.41 39.25 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.824 0.345 . . . . 0.0 110.793 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.437 ' CB ' HD12 ' A' ' 104' ' ' ILE . 14.8 m80 -64.0 170.43 3.56 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.019 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.607 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -135.89 161.71 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.425 179.779 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.631 ' HA ' HD11 ' A' ' 70' ' ' ILE . 29.1 p -154.53 169.06 24.69 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.848 ' HB1' ' CG2' ' A' ' 99' ' ' ILE . . . -94.84 127.63 41.0 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.459 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 75.8 t-105 -135.9 162.75 31.95 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.608 0.718 . . . . 0.0 112.212 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.459 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 12.2 tptt -61.95 117.14 5.54 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.625 -1.171 . . . . 0.0 110.875 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.56 127.59 32.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.772 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -139.08 12.02 2.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.27 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 75.86 60.46 3.15 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.266 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -116.15 144.26 18.36 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.557 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.78 -33.89 72.57 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.5 2.134 . . . . 0.0 112.226 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.689 ' CB ' HD22 ' A' ' 12' ' ' LEU . 12.9 p-10 -76.68 -2.22 31.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.508 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.413 ' O ' ' CG2' ' A' ' 90' ' ' THR . 0.0 OUTLIER -107.97 9.82 28.51 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.745 -0.207 . . . . 0.0 111.184 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.424 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 9.8 mmtp -106.5 139.43 40.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.762 0.315 . . . . 0.0 111.439 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.43 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 7.5 m-85 -138.61 156.34 47.54 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.244 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.4 mt -113.17 138.64 41.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.158 0.504 . . . . 0.0 110.65 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.557 ' CD1' HG23 ' A' ' 8' ' ' ILE . 25.2 mm -114.17 140.36 35.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.62 -179.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.95 96.04 3.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.588 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.2 t -51.91 111.48 0.62 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.313 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.444 ' HB3' ' CD2' ' A' ' 5' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.898 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.5 ' HA ' ' O ' ' A' ' 46' ' ' TRP . 3.1 p90 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.649 0.261 . . . . 0.0 110.851 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.743 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -159.48 173.75 15.71 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.204 179.693 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.549 ' OH ' ' HB1' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -109.41 123.47 49.4 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.359 179.091 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.62 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -107.92 104.11 16.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.847 -179.709 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.837 ' HB3' HG12 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -127.22 125.44 41.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.471 -179.504 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.473 ' O ' ' HD2' ' A' ' 9' ' ' LYS . 28.7 t -46.24 139.7 4.52 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.04 0.447 . . . . 0.0 111.474 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.551 ' HA ' HD11 ' A' ' 128' ' ' ILE . 3.9 tt0 -82.64 -10.73 58.82 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.02 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 38.1 tp -90.25 -58.31 2.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.804 0.335 . . . . 0.0 111.034 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -84.1 -19.09 34.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.846 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.13 5.28 75.71 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.306 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.585 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 2.9 mmmm -85.74 165.49 16.88 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.837 HG12 ' HB3' ' A' ' 9' ' ' LYS . 15.4 m -107.2 136.43 42.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.823 0.344 . . . . 0.0 110.754 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.7 mt -69.99 137.91 51.8 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -140.05 149.95 43.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.836 0.35 . . . . 0.0 111.157 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.856 HD13 HG21 ' A' ' 72' ' ' THR . 1.1 mt . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.839 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.411 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.8 m -77.22 137.48 38.87 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.039 0.447 . . . . 0.0 111.171 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.3 mmtm -83.86 157.62 21.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.219 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.824 HG22 HG23 ' A' ' 19' ' ' ILE . 44.1 pt -115.95 145.68 21.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.889 0.376 . . . . 0.0 111.633 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.453 ' HA ' ' CD1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -155.4 -179.5 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.126 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.779 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.8 p -103.18 150.73 23.39 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.579 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 28.0 t-105 -155.47 170.59 21.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.657 0.265 . . . . 0.0 110.979 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -71.83 137.27 47.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.831 0.348 . . . . 0.0 110.763 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.008 -179.919 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.972 ' O ' HD12 ' A' ' 45' ' ' LEU . . . . . . . . 0 CA--C 1.527 0.091 0 CA-C-O 120.646 0.26 . . . . 0.0 111.308 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 65.8 t -51.26 -31.25 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.937 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -66.99 -10.62 51.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.696 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -116.09 7.41 14.23 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.972 HD12 ' O ' ' A' ' 41' ' ' ALA . 0.9 OUTLIER -117.66 141.29 48.56 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.713 -179.083 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.634 ' CZ2' HD11 ' A' ' 19' ' ' ILE . 24.4 m95 -133.27 167.69 19.91 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.041 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.518 ' CE1' ' HB2' ' A' ' 55' ' ' ARG . 37.6 p90 -140.56 165.03 28.55 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.106 178.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 46.0 p -105.6 132.63 51.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.828 0.346 . . . . 0.0 111.336 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -77.79 165.84 23.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.117 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.13 -25.49 67.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.234 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -90.86 -4.05 56.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.469 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.563 ' O ' HG22 ' A' ' 85' ' ' ILE . . . 97.96 11.87 48.28 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.845 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.451 HG13 ' HA ' ' A' ' 83' ' ' ALA . 30.9 t -100.7 121.44 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-O 120.744 0.307 . . . . 0.0 110.488 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.482 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -76.07 148.43 7.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.31 0.576 . . . . 0.0 111.889 -179.751 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.734 ' CD ' ' HB2' ' A' ' 62' ' ' ALA . 12.3 mmm-85 -149.23 133.74 17.61 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.408 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.506 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.455 0 CA-C-O 121.54 0.686 . . . . 0.0 111.893 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 . . . . . 0 C--O 1.233 0.22 0 CA-C-O 120.892 0.377 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.734 ' HB2' ' CD ' ' A' ' 55' ' ' ARG . . . -108.83 152.59 24.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.081 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.786 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -78.66 152.99 4.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.68 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.537 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 6.7 p-10 -134.2 133.42 40.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.277 0.56 . . . . 0.0 111.69 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.674 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -97.42 43.49 1.07 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.217 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.0 t -74.71 -43.98 52.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.087 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 65.8 m170 -97.2 172.47 7.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.925 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -48.32 -48.81 35.92 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.14 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -99.0 145.62 26.88 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.126 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.786 HG22 HG22 ' A' ' 63' ' ' ILE . 3.1 mm -73.93 138.54 20.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.552 0.692 . . . . 0.0 111.455 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.43 ' O ' HG22 ' A' ' 63' ' ' ILE . 1.3 pt-20 -139.2 167.75 21.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.799 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.856 HG21 HD13 ' A' ' 19' ' ' ILE . 57.0 p -106.77 139.41 41.24 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.052 0.453 . . . . 0.0 111.528 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.403 ' CB ' ' CD ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -159.46 175.07 3.44 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.993 179.643 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.403 ' CD ' ' CB ' ' A' ' 73' ' ' GLN . 17.3 Cg_exo -66.65 138.86 50.91 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.513 2.142 . . . . 0.0 111.583 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -62.29 128.82 37.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.814 0.34 . . . . 0.0 111.031 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.409 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 0.4 OUTLIER -122.18 125.85 26.46 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.674 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -56.92 -35.4 98.55 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.457 2.105 . . . . 0.0 112.794 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 21.3 m-20 -86.35 -2.73 58.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.777 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.41 ' CB ' ' HD2' ' A' ' 82' ' ' ARG . 8.7 t-20 -101.19 100.6 13.77 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-O 120.611 0.243 . . . . 0.0 110.786 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.555 ' O ' HD21 ' A' ' 94' ' ' LEU . 82.9 Cg_endo -76.66 21.16 0.58 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.638 2.225 . . . . 0.0 113.48 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.659 ' HD2' ' HB3' ' A' ' 65' ' ' ALA . 40.3 mmtt -120.94 -18.37 7.58 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 120.689 0.28 . . . . 0.0 111.134 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.495 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 40.3 mtt180 -88.09 21.42 2.76 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -178.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 1.003 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -130.25 99.84 5.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.203 0.525 . . . . 0.0 111.051 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.674 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 60.4 m95 -110.21 135.06 51.57 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.227 0.537 . . . . 0.0 111.914 -178.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.563 HG22 ' O ' ' A' ' 52' ' ' GLY . 2.4 pt -113.86 154.24 15.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.125 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.9 t -102.14 127.99 55.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.912 0.387 . . . . 0.0 111.115 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 46.6 t -121.07 95.1 4.56 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.553 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.28 -100.66 0.81 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.554 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.504 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.94 29.86 7.16 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.587 0.232 . . . . 0.0 110.735 -179.76 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -149.16 148.36 29.54 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 121.358 0.599 . . . . 0.0 112.348 -178.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.768 ' HB ' HD12 ' A' ' 101' ' ' LEU . 14.3 mm -94.32 121.08 44.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.629 178.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.833 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -120.84 143.0 49.12 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -178.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.438 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -67.31 146.05 54.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.699 179.763 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.003 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.6 pt? -61.05 -56.13 24.55 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.664 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.628 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 7.9 m -73.72 -6.68 48.36 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -178.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.533 ' O ' HG22 ' A' ' 99' ' ' ILE . 0.6 OUTLIER -139.75 89.65 2.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.881 0.372 . . . . 0.0 111.071 -179.777 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.26 -16.23 63.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.182 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.73 12.86 21.95 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.096 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.533 HG22 ' O ' ' A' ' 96' ' ' ASP . 6.8 tt -131.08 137.16 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.833 HG12 ' HB2' ' A' ' 92' ' ' ALA . 15.9 m -148.9 138.46 15.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.855 0.359 . . . . 0.0 111.637 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.768 HD12 ' HB ' ' A' ' 91' ' ' ILE . 10.5 mt -46.39 155.19 0.23 Allowed 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.593 0.711 . . . . 0.0 111.71 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.71 ' O ' HG22 ' A' ' 114' ' ' ILE . 35.6 t70 -157.49 166.71 32.23 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.588 -177.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.528 ' HA ' HG22 ' A' ' 114' ' ' ILE . 3.0 mp -92.8 118.33 38.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.461 179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.773 HG22 ' O ' ' A' ' 113' ' ' HIS . 8.5 tt -62.45 141.98 17.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.791 0.329 . . . . 0.0 111.164 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.425 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 10.5 tptt 82.43 -20.81 0.33 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.71 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.6 m 53.9 39.41 30.41 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.917 0.389 . . . . 0.0 111.013 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -113.36 167.01 10.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.029 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.75 -13.83 58.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.984 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -48.29 142.41 5.54 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.098 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.476 ' HB2' ' NZ ' ' A' ' 15' ' ' LYS . . . -90.1 158.16 17.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.2 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 76.35 12.84 83.91 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.543 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.5 132.9 39.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.878 0.37 . . . . 0.0 111.01 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.773 ' O ' HG22 ' A' ' 104' ' ' ILE . 12.9 m80 -65.52 173.33 2.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.029 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.71 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -137.36 161.5 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.513 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.598 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 7.2 t -152.52 166.14 32.93 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.638 ' HB2' ' HH2' ' A' ' 84' ' ' TRP . . . -92.91 121.54 34.37 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.471 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 76.2 t-105 -128.73 162.19 27.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.67 0.747 . . . . 0.0 112.241 -179.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.471 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.8 OUTLIER -64.8 123.38 19.22 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.7 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -58.48 123.29 15.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.045 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -134.2 4.44 3.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.493 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 79.39 56.56 3.37 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.286 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -109.28 147.47 16.91 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.519 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.74 -29.3 59.63 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.57 2.18 . . . . 0.0 112.083 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -76.91 -4.35 43.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.234 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.421 ' NE2' ' CG2' ' A' ' 100' ' ' VAL . 3.2 mt-30 -102.73 -7.14 21.92 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.463 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.44 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 8.6 mmtm -83.73 132.66 34.83 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.772 0.32 . . . . 0.0 111.295 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -131.11 153.64 49.14 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.344 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.813 HD12 ' CE ' ' A' ' 9' ' ' LYS . 1.4 mt -113.68 137.48 46.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.163 0.506 . . . . 0.0 110.644 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.575 HD12 HG23 ' A' ' 8' ' ' ILE . 20.8 mm -114.26 142.05 28.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.593 -179.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -137.02 110.41 7.91 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.285 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 44.1 m -60.02 114.41 2.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.322 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.23 -0.89 . . . . 0.0 111.494 179.714 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.49 ' HA ' ' O ' ' A' ' 46' ' ' TRP . 1.5 p90 . . . . . 0 C--O 1.231 0.117 0 N-CA-C 110.501 -0.185 . . . . 0.0 110.501 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.746 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -160.38 176.45 11.66 Favored 'General case' 0 CA--C 1.512 -0.512 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.774 179.919 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.449 ' CE1' ' HB3' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -114.86 123.78 50.04 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.297 179.228 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.623 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -104.14 109.89 28.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.23 179.904 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.29 136.85 45.28 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.273 -178.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.54 ' OG ' HD21 ' A' ' 17' ' ' LEU . 48.7 m -75.95 107.82 8.41 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 5.2 tt0 -63.19 -11.15 18.72 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.47 -178.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.568 HD22 ' HA ' ' A' ' 124' ' ' ASN . 56.3 tp -84.66 -62.49 1.53 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.848 0.356 . . . . 0.0 110.973 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.65 HD21 HG21 ' A' ' 103' ' ' ILE . 6.7 m-20 -84.97 -12.94 52.19 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.69 2.57 76.45 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.214 -0.993 . . . . 0.0 111.513 -178.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.41 -178.64 5.65 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.601 HG21 ' HA ' ' A' ' 35' ' ' GLN . 7.9 m -120.37 140.34 44.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.673 0.273 . . . . 0.0 110.527 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.54 HD21 ' OG ' ' A' ' 10' ' ' SER . 10.6 mt -70.19 134.8 48.45 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -142.61 158.21 43.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.901 0.381 . . . . 0.0 111.204 -179.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.119 HD13 HG21 ' A' ' 72' ' ' THR . 31.3 mt . . . . . 0 C--N 1.327 -0.398 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.458 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 CA-C-O 120.154 -0.248 . . . . 0.0 113.604 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.85 136.25 43.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 117.316 0.558 . . . . 0.0 111.0 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.2 159.78 18.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.694 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.664 HG22 HG12 ' A' ' 19' ' ' ILE . 46.4 pt -120.33 148.03 23.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.821 0.343 . . . . 0.0 111.637 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.465 HG22 ' HA ' ' A' ' 113' ' ' HIS . 0.3 OUTLIER -156.26 -178.39 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.243 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.425 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.531 HG21 HD12 ' A' ' 103' ' ' ILE . 1.6 p -100.87 148.55 24.84 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.585 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 28.0 t-105 -158.42 172.63 17.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.689 0.28 . . . . 0.0 110.91 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -70.86 135.76 48.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.765 0.317 . . . . 0.0 110.708 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.601 ' HA ' HG21 ' A' ' 16' ' ' VAL . 5.7 tm0? . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.007 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.846 ' O ' HD12 ' A' ' 45' ' ' LEU . . . . . . . . 0 CA--C 1.527 0.084 0 CA-C-O 120.617 0.246 . . . . 0.0 111.412 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 49.4 t -50.08 -27.39 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.055 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -64.57 -10.27 25.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.718 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.449 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 1.6 mt-30 -118.92 7.76 11.55 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.846 HD12 ' O ' ' A' ' 41' ' ' ALA . 1.3 mp -117.65 140.7 49.3 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.8 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.719 ' CZ2' HD11 ' A' ' 19' ' ' ILE . 26.9 m95 -134.12 168.77 18.23 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.938 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.555 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 15.7 p90 -141.69 165.93 26.13 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.1 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 72.8 p -106.79 132.4 52.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.768 0.318 . . . . 0.0 111.313 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -77.63 165.62 24.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.09 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -58.69 -25.49 62.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.027 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -93.55 -3.52 52.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.324 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.34 6.8 55.1 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.874 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.3 t -90.43 117.65 34.13 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-O 120.771 0.319 . . . . 0.0 110.687 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.563 ' O ' ' HG3' ' A' ' 55' ' ' ARG . 0.6 OUTLIER -75.99 144.08 12.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.076 0.465 . . . . 0.0 111.049 179.596 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.563 ' HG3' ' O ' ' A' ' 54' ' ' ILE . 0.4 OUTLIER -149.75 133.54 16.89 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.88 179.222 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 72.7 m . . . . . 0 C--N 1.327 -0.392 0 CA-C-O 121.582 0.706 . . . . 0.0 112.127 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.414 ' CE2' ' HD3' ' A' ' 74' ' ' PRO . 1.5 m-85 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.863 0.363 . . . . 0.0 110.874 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -101.68 148.3 25.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.201 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.874 HG22 HG22 ' A' ' 70' ' ' ILE . 0.3 OUTLIER -77.99 152.45 5.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.684 179.786 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.634 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 6.6 p-10 -133.18 130.72 39.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.191 0.52 . . . . 0.0 111.682 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.675 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -95.07 42.05 1.09 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.418 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 60.4 p -74.62 -43.18 56.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.369 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 23.4 m80 -97.89 171.81 8.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.102 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -48.82 -44.01 38.88 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.916 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.06 144.49 31.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.641 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.874 HG22 HG22 ' A' ' 63' ' ' ILE . 1.7 mm -76.37 141.95 15.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.666 0.746 . . . . 0.0 111.8 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -139.26 166.59 24.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.863 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 1.119 HG21 HD13 ' A' ' 19' ' ' ILE . 41.6 p -104.27 138.18 41.1 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.861 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.426 ' HG2' ' C ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -163.53 167.54 11.14 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.26 179.755 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.414 ' HD3' ' CE2' ' A' ' 61' ' ' PHE . 32.2 Cg_exo -57.88 137.33 80.46 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.415 2.077 . . . . 0.0 111.861 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.536 ' CE1' ' HB2' ' A' ' 83' ' ' ALA . 16.8 t80 -67.18 127.2 31.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.855 0.359 . . . . 0.0 110.886 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -117.48 139.55 26.3 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.48 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.4 -32.26 41.01 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.527 2.151 . . . . 0.0 112.905 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 32.3 m-20 -88.79 -1.59 58.16 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -107.11 101.12 36.4 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.571 0.224 . . . . 0.0 111.007 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.85 ' O ' HD21 ' A' ' 94' ' ' LEU . 5.6 Cg_exo -77.16 21.28 0.61 Allowed 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.869 2.379 . . . . 0.0 112.98 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.634 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -116.47 -21.92 8.98 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.94 -179.827 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.477 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 41.7 mtt180 -87.62 20.28 3.02 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.47 -179.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 1.071 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -130.01 99.33 5.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.074 0.464 . . . . 0.0 110.854 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.675 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 58.9 m95 -109.45 137.26 47.56 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.223 0.535 . . . . 0.0 111.89 -178.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.3 pt -115.1 153.63 16.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.237 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.9 t -100.21 125.39 53.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.905 0.383 . . . . 0.0 110.948 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 21.5 t -117.85 93.89 4.32 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.526 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.89 -100.57 0.78 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.601 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.499 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.55 29.36 7.48 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.568 0.223 . . . . 0.0 110.921 -179.549 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -148.76 148.55 30.11 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.314 0.578 . . . . 0.0 112.522 -178.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.639 ' HB ' HD12 ' A' ' 101' ' ' LEU . 17.6 mm -93.38 121.28 43.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.44 178.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.99 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -124.67 145.3 49.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.32 0.581 . . . . 0.0 112.557 -178.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.421 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -65.26 149.53 49.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.508 179.729 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.071 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.7 pt? -62.2 -56.88 14.27 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.717 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.575 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 35.7 m -79.65 -1.61 38.99 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.405 ' HB2' ' HB3' ' A' ' 93' ' ' GLN . 72.9 m-20 -138.5 85.9 2.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.875 0.369 . . . . 0.0 111.009 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.63 -18.32 65.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.072 178.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -91.51 8.73 35.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.445 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.822 ' CG2' ' HB1' ' A' ' 116' ' ' ALA . 12.7 mm -121.15 126.29 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.494 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.99 HG12 ' HB2' ' A' ' 92' ' ' ALA . 22.3 m -145.98 134.49 16.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.836 0.351 . . . . 0.0 111.892 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.639 HD12 ' HB ' ' A' ' 91' ' ' ILE . 16.2 mt -46.26 154.09 0.29 Allowed 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 121.755 0.788 . . . . 0.0 111.964 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.826 ' O ' HG22 ' A' ' 114' ' ' ILE . 25.6 t70 -156.85 167.41 30.56 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.293 -1.321 . . . . 0.0 110.752 -177.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.65 HG21 HD21 ' A' ' 13' ' ' ASN . 34.0 mm -89.0 126.08 42.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.566 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.787 HG22 ' O ' ' A' ' 113' ' ' HIS . 1.2 tt -68.05 137.99 23.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.01 0.434 . . . . 0.0 111.558 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 29.7 mtpt 67.44 3.41 3.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.114 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 40.0 t 40.9 32.33 0.16 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.744 0.307 . . . . 0.0 111.454 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.1 p30 -96.08 157.41 15.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.181 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.93 -14.97 58.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.199 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -51.1 123.07 8.62 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.847 0.356 . . . . 0.0 111.107 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.18 161.15 31.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.172 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 73.29 16.64 78.7 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.181 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.85 135.58 35.95 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 120.875 0.369 . . . . 0.0 111.056 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.787 ' O ' HG22 ' A' ' 104' ' ' ILE . 1.4 m80 -61.86 170.29 2.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.783 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.826 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.5 OUTLIER -143.22 161.8 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.872 -179.698 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.655 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 12.8 p -157.15 174.16 15.9 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.822 ' HB1' ' CG2' ' A' ' 99' ' ' ILE . . . -95.81 129.67 42.98 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 178.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.458 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 75.8 t-105 -136.05 162.38 33.04 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.602 0.715 . . . . 0.0 112.051 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.458 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.2 OUTLIER -60.36 119.74 8.54 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.689 179.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.414 ' HA ' ' NE2' ' A' ' 125' ' ' GLN . 12.2 tt0 -60.1 127.3 31.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.081 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -137.52 11.0 2.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.207 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 78.4 10.28 86.34 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.882 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.78 139.78 46.82 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.521 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.5 -28.92 57.14 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.495 2.13 . . . . 0.0 112.24 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.568 ' HA ' HD22 ' A' ' 12' ' ' LEU . 30.6 p-10 -74.55 -5.42 42.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.423 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.414 ' NE2' ' HA ' ' A' ' 119' ' ' GLN . 0.1 OUTLIER -106.57 16.36 24.69 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.096 -179.829 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.443 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 2.7 mmmt -105.91 132.95 51.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.743 0.306 . . . . 0.0 111.398 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.436 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 5.2 m-85 -136.12 155.1 50.67 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.417 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 mt -114.27 140.32 35.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.179 0.514 . . . . 0.0 110.67 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.543 HD12 HG23 ' A' ' 8' ' ' ILE . 20.1 mm -114.04 139.78 38.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.617 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.21 96.14 3.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.614 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.4 m -50.76 111.71 0.59 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.405 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.435 ' HB3' ' CD2' ' A' ' 5' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.918 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.461 ' HD2' HD22 ' A' ' 45' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.137 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.761 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -156.41 172.76 17.95 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.735 179.878 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.487 ' OH ' ' HB1' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -112.22 123.86 51.2 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.103 179.04 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.619 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -105.1 109.29 27.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.004 0.431 . . . . 0.0 110.693 -179.73 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 16' ' ' VAL . 0.1 OUTLIER -102.15 132.49 48.02 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.008 -179.065 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.1 p -74.16 107.29 6.25 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.415 ' HB3' ' O ' ' A' ' 126' ' ' LYS . 3.6 tt0 -63.8 -9.86 16.96 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.537 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.502 HD13 ' HA ' ' A' ' 124' ' ' ASN . 28.7 tp -83.44 -62.99 1.44 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.815 0.34 . . . . 0.0 110.752 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.555 HD21 HG21 ' A' ' 103' ' ' ILE . 5.0 m-80 -85.59 -7.87 58.61 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.79 6.65 67.75 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.071 -1.062 . . . . 0.0 111.558 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -94.11 -171.97 2.69 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 4.8 m -121.84 140.65 45.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.755 0.312 . . . . 0.0 110.528 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.1 mt -69.79 133.47 47.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.329 -0.396 . . . . 0.0 109.95 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -144.04 147.79 34.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.827 0.346 . . . . 0.0 111.144 -179.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.1 HD13 HG21 ' A' ' 72' ' ' THR . 22.3 mt . . . . . 0 C--N 1.327 -0.38 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.42 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.26 0 CA-C-O 120.214 -0.214 . . . . 0.0 113.439 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.2 t -73.17 139.29 46.23 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 117.22 0.51 . . . . 0.0 111.121 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.3 mptm? -90.65 158.49 16.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.487 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.704 HD11 ' HB ' ' A' ' 70' ' ' ILE . 36.8 pt -116.88 145.53 22.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.854 0.359 . . . . 0.0 111.708 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.46 ' HA ' ' CD1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -154.97 177.92 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.458 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.5 p -100.94 149.57 23.76 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.498 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 9.0 t-105 -155.47 170.66 21.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.745 0.307 . . . . 0.0 110.993 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.09 135.43 47.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.827 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.906 -179.969 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.981 ' O ' HD12 ' A' ' 45' ' ' LEU . . . . . . . . 0 CA--C 1.527 0.064 0 CA-C-O 120.621 0.248 . . . . 0.0 111.311 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 53.2 t -50.6 -31.9 9.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.915 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -65.19 -11.25 38.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.889 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.454 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 3.7 mt-30 -117.6 8.78 12.95 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.981 HD12 ' O ' ' A' ' 41' ' ' ALA . 0.9 OUTLIER -118.43 141.15 48.83 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.861 -179.143 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.746 ' CZ2' HD11 ' A' ' 19' ' ' ILE . 26.1 m95 -134.23 169.49 17.1 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.052 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.523 ' CZ ' ' HB2' ' A' ' 55' ' ' ARG . 28.3 p90 -141.45 164.47 30.15 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.143 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.493 HG22 HG23 ' A' ' 54' ' ' ILE . 0.7 OUTLIER -109.11 136.41 48.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.829 0.347 . . . . 0.0 111.397 -178.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -77.75 170.7 16.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.2 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -62.31 -22.48 66.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.089 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -98.77 -2.46 37.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.167 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.8 3.77 54.82 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.884 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.669 HG11 ' CD2' ' A' ' 75' ' ' PHE . 21.8 t -85.99 116.24 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 CA-C-N 116.977 0.389 . . . . 0.0 110.693 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.515 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -78.21 147.8 6.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.383 0.611 . . . . 0.0 112.034 -179.59 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.802 ' CD ' ' HB2' ' A' ' 62' ' ' ALA . 8.8 mmm-85 -150.62 133.67 16.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.152 178.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.487 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.413 0 CA-C-O 121.456 0.646 . . . . 0.0 112.055 -178.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 . . . . . 0 C--O 1.234 0.265 0 CA-C-O 120.909 0.385 . . . . 0.0 110.979 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.802 ' HB2' ' CD ' ' A' ' 55' ' ' ARG . . . -107.46 153.19 23.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.524 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.797 HG22 HG22 ' A' ' 70' ' ' ILE . 0.3 OUTLIER -78.85 152.05 5.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.778 179.667 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.568 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 4.1 p-10 -132.78 137.83 46.95 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.964 0.411 . . . . 0.0 111.368 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.635 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -104.06 42.37 1.19 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.429 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.37 -44.82 50.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.833 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 7.2 m80 -93.84 169.22 10.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.934 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -48.4 -46.0 36.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.956 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -99.73 142.74 30.82 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.138 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.797 HG22 HG22 ' A' ' 63' ' ' ILE . 3.5 mm -73.44 139.53 19.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-O 121.55 0.691 . . . . 0.0 111.382 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -140.56 169.35 17.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.944 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 1.1 HG21 HD13 ' A' ' 19' ' ' ILE . 49.9 p -106.28 138.65 42.09 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.262 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.475 ' HG2' ' C ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -164.92 169.36 7.65 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.033 179.684 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -49.56 141.82 25.38 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.416 2.077 . . . . 0.0 112.08 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.669 ' CD2' HG11 ' A' ' 53' ' ' VAL . 53.1 t80 -47.94 -56.62 7.19 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.3 t70 61.29 118.15 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.67 0.272 . . . . 0.0 110.346 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.08 -27.32 25.06 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.488 2.125 . . . . 0.0 113.546 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -88.43 0.85 55.81 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.46 ' CB ' ' HD2' ' A' ' 82' ' ' ARG . 1.7 m-80 -105.96 103.76 46.04 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.586 0.232 . . . . 0.0 111.331 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.88 ' O ' HD21 ' A' ' 94' ' ' LEU . 5.6 Cg_exo -77.33 18.79 0.76 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.996 2.464 . . . . 0.0 113.105 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.568 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 8.2 mmtt -119.95 -18.27 8.23 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 120.648 0.261 . . . . 0.0 110.91 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.487 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 32.2 mtt180 -90.97 23.13 3.31 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.15 -179.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 1.149 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -131.23 99.8 4.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.983 0.421 . . . . 0.0 110.765 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.635 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 51.3 m95 -110.35 136.94 48.75 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.246 0.546 . . . . 0.0 112.106 -178.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.409 ' C ' HD12 ' A' ' 85' ' ' ILE . 2.7 pp -114.13 154.71 15.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.198 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.2 t -101.47 127.21 55.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.95 0.405 . . . . 0.0 111.105 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.3 t -119.51 94.38 4.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.347 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.19 -100.43 0.79 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.497 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.502 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.89 29.77 7.21 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.56 0.219 . . . . 0.0 110.871 -179.692 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.411 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -148.03 148.05 30.28 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.502 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.775 ' HB ' HD12 ' A' ' 101' ' ' LEU . 15.2 mm -93.69 120.09 42.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.131 -0.941 . . . . 0.0 109.336 178.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.919 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -121.94 143.73 49.29 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.432 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -67.28 147.34 53.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.732 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.149 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.6 pt? -60.97 -56.86 16.13 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.798 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.569 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 2.2 m -75.17 -4.63 39.92 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -139.6 87.61 2.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.789 0.328 . . . . 0.0 110.967 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 16.3 mmt85 -67.6 -17.42 64.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.117 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.41 ' O ' ' HA ' ' A' ' 118' ' ' LYS . 0.8 OUTLIER -94.05 11.78 28.61 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.486 179.165 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.848 ' CG2' ' HB1' ' A' ' 116' ' ' ALA . 10.2 mm -124.4 130.83 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.919 HG12 ' HB2' ' A' ' 92' ' ' ALA . 34.7 m -147.64 136.75 15.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.836 0.351 . . . . 0.0 111.91 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.775 HD12 ' HB ' ' A' ' 91' ' ' ILE . 11.2 mt -46.06 154.29 0.26 Allowed 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.693 0.758 . . . . 0.0 111.867 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.731 ' O ' HG22 ' A' ' 114' ' ' ILE . 10.3 t70 -159.59 168.57 25.78 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 114.375 -1.284 . . . . 0.0 110.666 -177.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.695 HD12 ' O ' ' A' ' 124' ' ' ASN . 4.4 mp -87.41 119.46 35.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.031 179.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.595 HG22 ' HG2' ' A' ' 105' ' ' LYS . 52.9 mt -70.24 137.51 23.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.913 0.387 . . . . 0.0 111.525 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.595 ' HG2' HG22 ' A' ' 104' ' ' ILE . 0.0 OUTLIER 67.0 10.77 7.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.714 179.763 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.3 m 45.69 -139.18 0.47 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.938 -0.119 . . . . 0.0 110.94 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 68.84 162.88 0.22 Allowed 'General case' 0 N--CA 1.46 0.067 0 CA-C-O 120.803 0.335 . . . . 0.0 110.878 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 4.3 tttp -89.32 -11.57 43.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.533 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -41.94 135.74 2.28 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.812 0.339 . . . . 0.0 111.62 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -88.46 161.31 17.1 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.303 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 71.94 17.2 76.83 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.027 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.79 135.08 35.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.801 0.334 . . . . 0.0 110.896 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 15.5 m170 -65.14 173.96 2.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.012 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.731 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -137.77 161.94 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.476 -179.917 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.599 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 4.9 t -152.77 167.3 29.48 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.848 ' HB1' ' CG2' ' A' ' 99' ' ' ILE . . . -94.93 126.08 40.03 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.458 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 75.8 t-105 -136.92 162.65 32.68 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.589 0.709 . . . . 0.0 112.304 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.458 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.1 OUTLIER -59.6 119.73 8.11 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.884 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -66.68 130.35 42.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.013 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -142.54 16.07 2.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.88 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 81.95 13.11 80.12 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.83 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.62 136.84 41.83 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.433 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.46 -31.79 70.29 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.465 2.11 . . . . 0.0 112.115 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.695 ' O ' HD12 ' A' ' 103' ' ' ILE . 22.7 p-10 -75.45 -4.21 38.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.323 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.411 ' O ' ' CG2' ' A' ' 90' ' ' THR . 0.0 OUTLIER -105.53 13.63 29.76 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.244 -179.812 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.415 ' O ' ' HB3' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -107.96 142.69 37.69 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.871 0.367 . . . . 0.0 111.373 -179.432 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.443 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 6.6 m-85 -140.84 156.45 46.13 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.118 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 mt -112.4 139.62 36.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.109 0.481 . . . . 0.0 110.75 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.495 ' CD1' HG23 ' A' ' 8' ' ' ILE . 24.4 mm -114.63 141.74 29.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.67 -179.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -139.17 94.37 2.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.7 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.8 m -54.29 107.09 0.24 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.227 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.888 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.421 ' HA ' ' O ' ' A' ' 46' ' ' TRP . 0.8 OUTLIER . . . . . 0 N--CA 1.461 0.081 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.739 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -157.5 174.49 15.3 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 120.49 -0.484 . . . . 0.0 111.648 179.634 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.495 ' OH ' ' HB1' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -113.13 123.76 51.01 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.132 179.17 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.621 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -105.53 109.78 28.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.891 0.377 . . . . 0.0 110.387 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.423 ' HA ' ' HA ' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -105.81 134.63 48.61 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.325 -178.709 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.6 p -75.74 106.29 7.23 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.433 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 4.3 tt0 -62.66 -10.68 13.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.539 -178.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.583 HD22 ' CB ' ' A' ' 124' ' ' ASN . 51.2 tp -82.79 -62.82 1.5 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.894 0.378 . . . . 0.0 110.856 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.549 HD21 HG21 ' A' ' 103' ' ' ILE . 6.4 m-20 -85.98 -9.78 56.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.319 -178.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.12 5.0 69.7 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.139 -1.029 . . . . 0.0 111.48 -178.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.592 ' HE2' ' HB2' ' A' ' 110' ' ' ALA . 8.4 mmtm -91.76 -177.98 4.91 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.585 HG11 ' HG3' ' A' ' 35' ' ' GLN . 10.8 m -120.85 141.39 41.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.703 0.287 . . . . 0.0 110.538 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.9 mt -69.33 134.26 48.87 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.038 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.461 ' HB2' ' HG3' ' A' ' 44' ' ' GLN . 9.7 t70 -146.62 153.74 40.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.864 0.364 . . . . 0.0 111.108 -179.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.569 HD12 HG21 ' A' ' 72' ' ' THR . 6.9 mm . . . . . 0 C--N 1.328 -0.35 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.446 0 N-CA-C 112.762 -0.135 . . . . 0.0 112.762 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.3 m -73.64 124.96 26.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.974 0.416 . . . . 0.0 111.105 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -75.08 161.45 29.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.045 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.546 HD11 ' HB ' ' A' ' 70' ' ' ILE . 41.6 pt -118.88 146.56 23.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.853 0.359 . . . . 0.0 111.928 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.459 ' HA ' ' CD1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -153.56 178.01 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.139 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.686 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.4 p -103.73 151.14 23.37 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.695 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 27.0 t-105 -154.86 169.64 23.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.735 0.303 . . . . 0.0 110.884 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.56 132.68 46.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.767 0.318 . . . . 0.0 110.666 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.585 ' HG3' HG11 ' A' ' 16' ' ' VAL . 9.4 tt0 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.217 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.988 ' O ' HD12 ' A' ' 45' ' ' LEU . . . . . . . . 0 N--CA 1.458 -0.053 0 CA-C-O 120.756 0.312 . . . . 0.0 110.975 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 50.0 t -51.21 -33.93 14.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.301 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -68.91 -7.86 38.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.6 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.461 ' HG3' ' HB2' ' A' ' 18' ' ' ASP . 1.8 mt-30 -114.5 6.27 15.82 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.988 HD12 ' O ' ' A' ' 41' ' ' ALA . 0.9 OUTLIER -118.67 142.34 47.76 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.157 -0.928 . . . . 0.0 111.567 -178.913 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.498 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 26.1 m95 -134.51 169.47 17.23 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.187 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.516 ' CE2' ' HB2' ' A' ' 55' ' ' ARG . 42.1 p90 -141.25 164.14 31.05 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.533 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.593 HG22 HG23 ' A' ' 54' ' ' ILE . 0.7 OUTLIER -108.58 135.18 50.26 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.784 0.326 . . . . 0.0 111.443 -178.876 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -78.19 170.93 15.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.144 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -66.33 -24.3 66.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.097 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.505 ' HG3' HG23 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -91.8 -4.09 55.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.253 179.846 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.38 9.78 49.8 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.875 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.505 HG23 ' HG3' ' A' ' 51' ' ' GLN . 40.1 t -97.48 119.73 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 CA-C-N 116.883 0.341 . . . . 0.0 110.512 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.593 HG23 HG22 ' A' ' 48' ' ' THR . 0.6 OUTLIER -78.77 150.86 5.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.495 0.664 . . . . 0.0 111.951 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.733 ' HD3' ' HB2' ' A' ' 62' ' ' ALA . 11.2 mmm-85 -147.36 132.94 18.76 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.628 178.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.498 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.591 0 CA-C-O 121.713 0.768 . . . . 0.0 111.981 -178.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.808 0.337 . . . . 0.0 110.838 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.733 ' HB2' ' HD3' ' A' ' 55' ' ' ARG . . . -98.29 150.71 21.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.938 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.863 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -80.82 150.89 4.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.273 179.476 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.58 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 8.6 p-10 -133.06 131.58 40.79 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.215 0.531 . . . . 0.0 111.603 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.631 ' HB2' ' CZ2' ' A' ' 84' ' ' TRP . . . -96.18 40.96 1.11 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.256 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 68.2 m -73.91 -43.41 58.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.342 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 65.0 m80 -97.59 172.56 7.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.11 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -48.04 -47.15 33.79 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.136 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -102.33 146.5 27.94 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.912 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.863 HG22 HG22 ' A' ' 63' ' ' ILE . 1.9 mm -78.1 144.15 11.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-O 121.614 0.721 . . . . 0.0 111.755 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -144.51 168.75 19.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.001 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.569 HG21 HD12 ' A' ' 19' ' ' ILE . 80.9 p -105.44 136.98 44.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.993 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.451 ' CB ' ' HD2' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -161.2 168.06 12.21 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.136 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.451 ' HD2' ' CB ' ' A' ' 73' ' ' GLN . 13.9 Cg_endo -57.37 134.49 64.08 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.404 2.07 . . . . 0.0 112.055 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.477 ' CE1' ' HB2' ' A' ' 83' ' ' ALA . 19.6 t80 -62.46 132.61 53.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.864 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -121.62 139.22 29.54 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.775 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.12 -34.05 17.63 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.515 2.143 . . . . 0.0 112.67 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -88.13 -0.72 57.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.653 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.442 ' HB3' ' HD2' ' A' ' 82' ' ' ARG . 1.7 m120 -109.31 100.02 39.23 Favored Pre-proline 0 C--O 1.232 0.175 0 CA-C-O 120.583 0.23 . . . . 0.0 111.029 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.849 ' O ' HD21 ' A' ' 94' ' ' LEU . 4.0 Cg_exo -76.44 25.48 0.43 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.923 2.415 . . . . 0.0 113.027 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.58 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 0.1 OUTLIER -118.71 -21.33 7.92 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 120.616 0.246 . . . . 0.0 111.19 -179.721 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.487 ' HG3' ' HB3' ' A' ' 64' ' ' ASP . 0.4 OUTLIER -88.56 18.94 4.18 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.064 -0.517 . . . . 0.0 112.365 -179.028 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 1.155 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -128.41 99.26 5.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.097 0.475 . . . . 0.0 110.775 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.631 ' CZ2' ' HB2' ' A' ' 65' ' ' ALA . 58.3 m95 -108.84 136.45 48.37 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.15 0.5 . . . . 0.0 111.907 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.9 pt -113.81 154.47 15.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.085 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.7 t -102.53 127.84 55.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.988 0.423 . . . . 0.0 111.111 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 30.5 t -120.88 95.14 4.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.35 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.2 -101.07 0.84 Allowed Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.477 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.498 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -121.02 30.15 7.0 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.496 0.189 . . . . 0.0 110.867 -179.802 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.421 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.34 147.49 30.38 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.597 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.709 ' HB ' HD12 ' A' ' 101' ' ' LEU . 19.1 mm -94.06 119.98 42.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.336 178.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.935 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -123.98 144.57 49.74 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.404 ' HB3' ' HB2' ' A' ' 96' ' ' ASP . 0.6 OUTLIER -63.86 149.53 46.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.661 179.568 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.155 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.6 pt? -62.33 -57.11 12.54 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.672 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.566 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 92.6 p -79.8 -2.64 44.19 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.404 ' HB2' ' HB3' ' A' ' 93' ' ' GLN . 49.0 m-20 -137.52 84.65 2.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.841 0.353 . . . . 0.0 111.004 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.6 mpp_? -66.34 -18.18 65.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.174 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.407 ' O ' ' HA ' ' A' ' 118' ' ' LYS . 0.4 OUTLIER -91.46 10.29 28.32 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.538 179.316 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.857 ' CG2' ' HB1' ' A' ' 116' ' ' ALA . 11.2 mm -124.36 129.39 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.466 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.935 HG12 ' HB2' ' A' ' 92' ' ' ALA . 30.8 m -146.68 136.01 16.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.709 HD12 ' HB ' ' A' ' 91' ' ' ILE . 12.7 mt -46.47 153.79 0.34 Allowed 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 121.753 0.787 . . . . 0.0 111.837 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.748 ' O ' HG22 ' A' ' 114' ' ' ILE . 9.9 t70 -158.36 168.02 28.11 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.587 -177.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.664 HD12 ' O ' ' A' ' 124' ' ' ASN . 4.4 mp -87.26 122.38 39.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.194 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.8 HG22 ' O ' ' A' ' 113' ' ' HIS . 3.1 tt -65.37 136.73 26.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.072 0.463 . . . . 0.0 111.482 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 70.63 1.22 3.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.997 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 51.4 p 43.68 31.39 0.45 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.761 0.315 . . . . 0.0 111.365 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -94.7 154.29 17.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.267 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.91 -14.14 58.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.156 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -49.03 118.51 2.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.265 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.592 ' HB2' ' HE2' ' A' ' 15' ' ' LYS . . . -62.1 157.93 17.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.054 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 73.25 15.67 78.79 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.214 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.94 132.86 39.28 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.834 0.349 . . . . 0.0 110.95 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.8 ' O ' HG22 ' A' ' 104' ' ' ILE . 17.1 m170 -65.58 172.02 3.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.925 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.748 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -136.42 161.63 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.517 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.597 ' HA ' HD11 ' A' ' 70' ' ' ILE . 95.7 m -153.77 168.96 24.56 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.857 ' HB1' ' CG2' ' A' ' 99' ' ' ILE . . . -95.7 126.62 41.1 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.467 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 76.1 t-105 -134.49 162.57 31.88 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.603 0.716 . . . . 0.0 112.129 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.467 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.1 OUTLIER -62.43 117.43 6.15 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.596 -1.183 . . . . 0.0 110.781 179.885 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -62.4 126.65 28.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.962 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -138.18 13.72 2.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.165 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 76.19 60.8 2.98 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.518 -0.848 . . . . 0.0 112.315 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -117.3 145.99 18.7 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.551 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.68 -32.39 75.36 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.403 2.069 . . . . 0.0 112.013 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.664 ' O ' HD12 ' A' ' 103' ' ' ILE . 30.3 p-10 -76.29 -2.69 32.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.586 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.421 ' O ' ' CG2' ' A' ' 90' ' ' THR . 0.9 OUTLIER -107.8 11.06 28.55 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.466 0.174 . . . . 0.0 111.172 180.0 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.433 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 1.7 mmmm -106.76 138.21 43.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.846 0.355 . . . . 0.0 111.529 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.413 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 7.0 m-85 -138.59 155.77 48.05 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.246 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.3 mt -113.36 138.64 42.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.149 0.5 . . . . 0.0 110.776 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.471 ' CD1' HG23 ' A' ' 8' ' ' ILE . 26.4 mm -113.86 139.71 38.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.524 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -139.5 94.68 2.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.655 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 18.6 p -51.34 110.73 0.47 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.327 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.614 ' HG3' HD21 ' A' ' 45' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.948 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.453 ' HA ' ' O ' ' A' ' 46' ' ' TRP . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.091 0 N-CA-C 110.476 -0.194 . . . . 0.0 110.476 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.758 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -158.84 173.95 15.74 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 120.469 -0.492 . . . . 0.0 111.496 179.883 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.836 ' OH ' ' HB1' ' A' ' 41' ' ' ALA . 0.4 OUTLIER -109.46 123.79 49.96 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.204 179.13 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.611 HG23 ' CD1' ' A' ' 129' ' ' ILE . 0.0 OUTLIER -109.02 104.56 17.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.939 -179.755 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.86 ' HE2' HD12 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -122.81 140.11 53.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.453 -179.751 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.41 ' O ' ' HD2' ' A' ' 9' ' ' LYS . 1.9 m -60.69 135.45 57.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.925 0.393 . . . . 0.0 110.744 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 4.2 tt0 -77.99 -11.84 59.94 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.961 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 41.1 tp -89.03 -58.64 2.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.793 0.33 . . . . 0.0 110.986 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.572 HD21 HG21 ' A' ' 103' ' ' ILE . 6.2 m-20 -84.94 -17.74 36.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.262 -0.426 . . . . 0.0 112.017 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.4 5.81 73.72 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.308 -0.949 . . . . 0.0 112.231 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.649 ' HE2' ' HB2' ' A' ' 110' ' ' ALA . 1.5 mmmt -86.29 165.64 16.28 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.765 HG12 ' HB3' ' A' ' 9' ' ' LYS . 9.5 m -106.5 137.15 38.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.822 0.344 . . . . 0.0 110.723 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.3 mt -69.13 137.58 53.52 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -143.7 151.19 39.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.018 0.437 . . . . 0.0 111.439 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.062 HD13 HG21 ' A' ' 72' ' ' THR . 23.1 mt . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.459 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 CA-C-O 120.293 -0.171 . . . . 0.0 113.239 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.7 t -77.2 132.54 38.8 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 117.093 0.446 . . . . 0.0 111.345 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.6 mmtt -81.46 160.53 23.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.645 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.572 HD13 HG21 ' A' ' 63' ' ' ILE . 47.3 pt -120.98 149.03 23.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.445 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.423 HG22 ' HA ' ' A' ' 113' ' ' HIS . 0.2 OUTLIER -155.73 -178.98 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.173 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.75 -179.812 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 p -101.36 149.19 24.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.419 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 19.5 t-105 -156.81 171.49 20.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.732 0.301 . . . . 0.0 110.989 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -71.33 138.54 49.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.705 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.529 ' HA ' HG21 ' A' ' 16' ' ' VAL . 4.6 tt0 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.284 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.844 ' O ' HD12 ' A' ' 45' ' ' LEU . . . . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.744 0.307 . . . . 0.0 110.951 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.5 t -50.33 -27.65 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.961 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -64.65 -10.56 27.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.619 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -118.56 7.79 11.87 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.135 0.493 . . . . 0.0 109.675 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.844 HD12 ' O ' ' A' ' 41' ' ' ALA . 1.3 mp -117.05 140.37 49.57 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.664 -179.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.661 ' CZ2' HD11 ' A' ' 19' ' ' ILE . 25.9 m95 -134.43 169.4 17.31 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.035 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.587 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 15.1 p90 -141.42 165.51 27.32 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.954 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.599 HG22 HG23 ' A' ' 54' ' ' ILE . 4.2 p -109.68 136.67 48.66 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.902 0.382 . . . . 0.0 111.475 -178.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.0 173.39 12.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.327 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -63.29 -21.24 66.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.12 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -101.36 -2.8 30.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.168 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.21 2.6 51.28 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.868 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.554 HG12 ' HD3' ' A' ' 55' ' ' ARG . 21.8 t -83.06 114.26 23.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.873 0.368 . . . . 0.0 110.82 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.599 HG23 HG22 ' A' ' 48' ' ' THR . 0.7 OUTLIER -76.78 146.72 8.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.253 0.549 . . . . 0.0 111.766 -179.795 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.659 ' HD2' ' HB2' ' A' ' 62' ' ' ALA . 2.7 mmm-85 -151.56 133.68 15.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.539 178.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 12.5 m . . . . . 0 C--N 1.326 -0.419 0 CA-C-O 121.271 0.558 . . . . 0.0 111.903 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.41 ' CE2' ' HD3' ' A' ' 74' ' ' PRO . 1.1 m-85 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.894 0.378 . . . . 0.0 110.759 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.659 ' HB2' ' HD2' ' A' ' 55' ' ' ARG . . . -105.73 150.03 25.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.081 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.824 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -78.64 153.76 4.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.92 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.564 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 5.1 p-10 -133.6 132.91 41.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.227 0.537 . . . . 0.0 111.569 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.668 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -96.73 41.78 1.1 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.197 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.4 m -74.53 -46.36 39.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.225 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -93.95 170.66 9.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.952 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -47.29 -48.06 25.04 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.944 0.402 . . . . 0.0 110.959 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -99.73 144.24 29.04 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.917 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.824 HG22 HG22 ' A' ' 63' ' ' ILE . 2.7 mm -71.05 136.13 26.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-O 121.527 0.679 . . . . 0.0 111.366 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -130.33 162.76 28.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.237 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 1.062 HG21 HD13 ' A' ' 19' ' ' ILE . 18.0 p -105.5 138.71 41.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.549 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.82 159.16 19.3 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.668 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.423 ' O ' ' HD3' ' A' ' 82' ' ' ARG . 53.7 Cg_exo -52.03 143.29 41.27 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.429 2.086 . . . . 0.0 111.737 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.532 ' CE1' HG11 ' A' ' 53' ' ' VAL . 66.7 t80 -59.07 126.03 26.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.915 0.388 . . . . 0.0 111.354 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.422 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 8.1 t70 -119.54 130.32 24.9 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.166 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.6 -33.82 21.07 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.602 2.202 . . . . 0.0 113.47 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -85.71 0.25 53.29 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.422 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 3.2 m120 -106.49 104.33 50.13 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.563 0.221 . . . . 0.0 111.343 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.842 ' O ' HD21 ' A' ' 94' ' ' LEU . 5.6 Cg_exo -77.34 20.07 0.69 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.868 2.379 . . . . 0.0 112.697 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.579 ' HD2' ' HB3' ' A' ' 65' ' ' ALA . 24.6 mmtp -120.15 -18.34 8.09 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.038 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.525 ' HG2' ' HB3' ' A' ' 64' ' ' ASP . 6.4 mtt180 -88.66 18.73 4.42 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.943 -0.572 . . . . 0.0 112.187 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 1.132 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -127.79 99.27 5.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.131 0.491 . . . . 0.0 110.647 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.668 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 61.8 m95 -108.55 136.42 48.18 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.114 0.483 . . . . 0.0 111.859 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 pt -115.21 154.24 16.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.272 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.5 t -101.2 124.41 54.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.012 0.434 . . . . 0.0 110.987 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 23.1 t -116.8 94.43 4.6 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.437 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.66 -100.95 0.79 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.505 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.51 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.79 30.17 7.03 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.587 0.232 . . . . 0.0 110.915 -179.63 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.92 148.0 30.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.394 0.616 . . . . 0.0 112.537 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.751 ' HB ' HD12 ' A' ' 101' ' ' LEU . 13.6 mm -93.94 120.15 42.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.411 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.989 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -124.89 146.67 49.2 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -178.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.437 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -67.17 148.83 51.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.811 179.808 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.132 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.7 pt? -61.07 -56.54 19.75 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.719 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.578 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 57.9 m -80.17 -3.44 48.98 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -136.56 85.44 2.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.838 0.351 . . . . 0.0 111.075 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -66.83 -17.97 65.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.155 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -92.08 9.83 31.75 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.521 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.823 ' CG2' ' HB1' ' A' ' 116' ' ' ALA . 12.2 mm -123.14 127.4 74.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.531 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.989 HG12 ' HB2' ' A' ' 92' ' ' ALA . 23.5 m -146.17 135.04 16.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.86 0.362 . . . . 0.0 111.862 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.751 HD12 ' HB ' ' A' ' 91' ' ' ILE . 11.0 mt -46.72 154.37 0.32 Allowed 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.7 0.762 . . . . 0.0 112.008 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.804 ' O ' HG22 ' A' ' 114' ' ' ILE . 9.8 t70 -155.63 167.78 29.29 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.319 -1.31 . . . . 0.0 110.694 -177.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.572 HG21 HD21 ' A' ' 13' ' ' ASN . 3.7 mp -92.94 124.52 45.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.509 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.8 HG22 ' O ' ' A' ' 113' ' ' HIS . 0.9 OUTLIER -68.24 139.6 20.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.961 0.41 . . . . 0.0 111.324 -179.83 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.422 ' N ' HG13 ' A' ' 104' ' ' ILE . 0.0 OUTLIER 78.4 -9.8 1.45 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.851 179.745 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.4 m 47.13 34.94 3.19 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.806 0.336 . . . . 0.0 111.188 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -106.94 166.92 10.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.195 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.4 -14.39 58.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.037 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -50.47 135.84 21.73 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.202 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.649 ' HB2' ' HE2' ' A' ' 15' ' ' LYS . . . -88.97 162.3 16.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.095 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.01 16.45 79.51 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.233 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.43 137.87 33.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.897 0.379 . . . . 0.0 110.967 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.8 ' O ' HG22 ' A' ' 104' ' ' ILE . 3.1 m170 -61.9 167.98 3.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.847 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.804 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -138.74 161.01 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.582 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.672 ' HA ' HD11 ' A' ' 70' ' ' ILE . 25.7 p -156.75 170.68 21.88 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.823 ' HB1' ' CG2' ' A' ' 99' ' ' ILE . . . -95.49 127.01 41.18 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 178.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.456 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 70.7 t-105 -132.37 162.88 29.98 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.529 0.68 . . . . 0.0 112.282 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.456 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.5 OUTLIER -63.55 120.78 12.39 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.659 179.843 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -58.91 124.45 19.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.177 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -132.68 8.1 4.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.631 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 82.38 6.74 88.42 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.164 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -66.0 142.62 43.55 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.401 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -56.86 -25.15 60.16 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.457 2.105 . . . . 0.0 112.508 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 34.5 p-10 -70.46 -9.09 55.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.706 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -107.02 17.99 22.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.698 0.285 . . . . 0.0 111.014 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.427 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 4.5 mmtp -103.59 123.78 47.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.793 0.33 . . . . 0.0 111.157 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.431 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 4.3 m-85 -127.96 153.0 47.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.632 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.86 HD12 ' HE2' ' A' ' 9' ' ' LYS . 1.6 mt -115.61 139.47 41.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.452 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.611 ' CD1' HG23 ' A' ' 8' ' ' ILE . 32.3 mm -113.94 144.05 22.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.677 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -136.07 94.18 3.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.609 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.47 109.3 0.43 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.312 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.913 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.4 ' HA ' ' O ' ' A' ' 46' ' ' TRP . 97.9 m-85 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.726 0.298 . . . . 0.0 110.757 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.636 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -151.92 170.71 19.19 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 120.97 0.414 . . . . 0.0 111.213 178.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.432 ' O ' ' HA ' ' A' ' 129' ' ' ILE . 0.1 OUTLIER -111.45 123.82 50.99 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.143 179.173 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.616 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -107.12 106.36 20.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.245 179.879 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.424 ' HG3' ' O ' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -106.77 137.06 45.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.384 -178.7 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.9 108.67 10.11 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.421 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 3.1 tt0 -62.69 -10.53 12.92 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.483 -178.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.638 HD22 ' HA ' ' A' ' 124' ' ' ASN . 30.3 tp -83.36 -62.47 1.58 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.865 0.364 . . . . 0.0 111.039 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.639 HD21 HG21 ' A' ' 103' ' ' ILE . 6.9 m-20 -86.83 -10.65 52.98 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.1 5.03 69.7 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.086 -1.054 . . . . 0.0 111.398 -178.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.424 ' O ' ' HG3' ' A' ' 9' ' ' LYS . 1.7 mmmm -91.78 178.22 5.97 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.625 HG21 ' HA ' ' A' ' 35' ' ' GLN . 5.9 m -119.93 142.59 34.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.689 0.281 . . . . 0.0 110.507 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.3 mt -68.11 135.93 52.94 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.453 ' CB ' ' HG3' ' A' ' 44' ' ' GLN . 19.9 t0 -145.33 142.44 29.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.719 0.295 . . . . 0.0 111.114 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.737 HD12 HG21 ' A' ' 72' ' ' THR . 14.0 mm . . . . . 0 C--N 1.327 -0.402 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.394 0 N-CA-C 112.806 -0.118 . . . . 0.0 112.806 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.91 134.56 41.57 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.96 0.409 . . . . 0.0 111.213 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.417 ' HD3' ' HB3' ' A' ' 71' ' ' GLU . 45.9 mmtt -81.72 157.03 24.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.213 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.595 HD13 HG21 ' A' ' 63' ' ' ILE . 47.5 pt -116.63 145.96 21.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.906 -0.317 . . . . 0.0 111.483 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.447 HG22 ' HA ' ' A' ' 113' ' ' HIS . 0.2 OUTLIER -155.49 -178.85 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.196 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.982 -179.667 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.5 p -101.98 148.88 24.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.551 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 32.4 t-105 -159.13 173.28 16.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.686 0.279 . . . . 0.0 110.845 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -70.14 134.58 48.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.813 0.339 . . . . 0.0 110.757 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.625 ' HA ' HG21 ' A' ' 16' ' ' VAL . 20.4 tt0 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.01 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.52 ' O ' HD12 ' A' ' 45' ' ' LEU . . . . . . . . 0 C--O 1.23 0.056 0 N-CA-C 111.525 0.194 . . . . 0.0 111.525 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.488 ' HA ' ' CD1' ' A' ' 45' ' ' LEU . 2.2 t -58.95 -18.21 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-O 120.706 0.289 . . . . 0.0 110.596 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -61.84 -11.86 14.72 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.928 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.453 ' HG3' ' CB ' ' A' ' 18' ' ' ASP . 7.7 mp0 -111.56 7.76 20.72 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.636 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 1.4 mp -121.06 146.44 46.72 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.232 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.461 ' CH2' ' CG1' ' A' ' 63' ' ' ILE . 25.4 m95 -133.27 170.11 15.93 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.65 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.549 ' CE2' ' HB2' ' A' ' 55' ' ' ARG . 1.5 p90 -136.09 159.46 41.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.92 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.529 HG22 HG23 ' A' ' 54' ' ' ILE . 17.8 p -107.17 134.18 50.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.786 0.327 . . . . 0.0 111.303 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 53' ' ' VAL . 14.7 t70 -77.87 166.53 22.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.147 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -59.37 -22.69 61.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.164 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -97.4 -2.83 41.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.281 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.91 5.45 55.0 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.873 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.412 HG12 ' HD3' ' A' ' 55' ' ' ARG . 21.2 t -87.84 116.67 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-O 120.8 0.333 . . . . 0.0 110.635 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.529 HG23 HG22 ' A' ' 48' ' ' THR . 0.8 OUTLIER -78.55 150.49 5.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.326 0.584 . . . . 0.0 111.942 -179.758 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.549 ' HB2' ' CE2' ' A' ' 47' ' ' TYR . 2.9 mmm-85 -147.44 133.18 18.93 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.207 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.424 ' HB2' ' CE2' ' A' ' 46' ' ' TRP . 47.2 t . . . . . 0 C--N 1.325 -0.474 0 CA-C-O 121.307 0.575 . . . . 0.0 112.138 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.436 ' CE2' ' HD3' ' A' ' 74' ' ' PRO . 3.8 m-85 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 121.018 0.437 . . . . 0.0 110.597 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.417 ' HB2' ' CD ' ' A' ' 55' ' ' ARG . . . -98.46 150.06 22.04 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.894 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.836 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -77.92 150.8 5.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.214 179.713 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.583 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 7.8 p-10 -131.59 133.02 44.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.156 0.503 . . . . 0.0 111.558 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.638 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -99.65 41.44 1.16 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.178 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.4 m -73.49 -42.62 61.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.061 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -98.2 172.83 7.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.936 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -49.47 -47.82 48.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.181 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -99.74 144.33 28.94 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.141 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.836 HG22 HG22 ' A' ' 63' ' ' ILE . 2.3 mm -76.31 142.86 13.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 CA-C-O 121.541 0.686 . . . . 0.0 111.764 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.417 ' HB3' ' HD3' ' A' ' 29' ' ' LYS . 0.5 OUTLIER -141.8 168.41 19.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.196 -179.835 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.737 HG21 HD12 ' A' ' 19' ' ' ILE . 49.4 p -108.24 139.88 42.29 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.085 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.49 165.17 14.51 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.304 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.436 ' HD3' ' CE2' ' A' ' 61' ' ' PHE . 10.6 Cg_endo -53.6 139.37 66.81 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.533 2.155 . . . . 0.0 111.92 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -61.5 131.74 51.13 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.881 0.372 . . . . 0.0 111.232 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.405 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 0.3 OUTLIER -120.92 133.84 24.21 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.555 179.729 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -69.05 -34.48 16.86 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.451 2.101 . . . . 0.0 112.664 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -88.04 0.31 56.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.77 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.405 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 3.1 t30 -105.71 102.21 37.04 Favored Pre-proline 0 C--O 1.233 0.2 0 CA-C-O 120.517 0.199 . . . . 0.0 111.051 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.852 ' O ' HD21 ' A' ' 94' ' ' LEU . 5.9 Cg_exo -77.62 22.05 0.61 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.921 2.414 . . . . 0.0 112.994 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.583 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 33.7 mmtt -119.93 -18.54 8.18 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 120.599 0.238 . . . . 0.0 111.139 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.527 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 3.1 mtm180 -89.63 18.84 5.06 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.357 -179.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 1.087 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -127.8 99.06 5.39 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.054 0.454 . . . . 0.0 110.802 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.638 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 58.0 m95 -108.77 135.53 49.84 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.192 0.52 . . . . 0.0 111.938 -178.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.3 pt -113.58 154.41 14.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.254 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.3 t -101.32 125.83 55.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.967 0.413 . . . . 0.0 111.045 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 47.0 t -118.44 93.68 4.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.456 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.9 -100.41 0.77 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.519 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.495 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.42 29.19 7.58 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.532 0.206 . . . . 0.0 111.017 -179.578 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.426 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.57 147.56 30.21 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.607 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.627 ' HB ' HD12 ' A' ' 101' ' ' LEU . 18.9 mm -93.76 120.47 43.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.127 178.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.967 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -123.87 145.31 49.19 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.423 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -66.22 148.45 51.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.648 179.786 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.087 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.6 pt? -60.77 -57.02 14.44 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.804 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.566 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 66.9 p -78.99 -3.7 46.33 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -137.09 86.59 2.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.877 0.37 . . . . 0.0 111.001 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.59 -18.68 65.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.082 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.402 ' O ' ' HA ' ' A' ' 118' ' ' LYS . 9.5 m-20 -91.96 9.87 31.28 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.459 179.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.817 ' CG2' ' HB1' ' A' ' 116' ' ' ALA . 13.3 mm -121.84 126.46 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.47 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.967 HG12 ' HB2' ' A' ' 92' ' ' ALA . 25.4 m -146.14 134.9 16.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.96 0.41 . . . . 0.0 111.973 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.627 HD12 ' HB ' ' A' ' 91' ' ' ILE . 13.6 mt -47.94 154.22 0.56 Allowed 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 121.782 0.801 . . . . 0.0 112.095 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.783 ' O ' HG22 ' A' ' 114' ' ' ILE . 9.9 t70 -156.2 167.02 31.74 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.271 -1.331 . . . . 0.0 110.78 -177.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.704 HD12 ' O ' ' A' ' 124' ' ' ASN . 4.4 mp -88.62 122.92 40.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.256 179.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.834 HG22 ' O ' ' A' ' 113' ' ' HIS . 2.8 tt -69.03 139.47 20.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.066 0.46 . . . . 0.0 111.675 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 75.61 -7.21 1.83 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.074 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.1 m 46.61 29.15 0.88 Allowed 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.766 0.317 . . . . 0.0 111.179 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -99.43 161.53 13.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.071 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.403 ' HG3' ' HA ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -78.64 -14.36 59.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.202 179.769 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -49.06 123.6 7.45 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.895 0.379 . . . . 0.0 111.252 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.59 162.17 29.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.103 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 70.63 18.96 76.13 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.0 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.37 136.41 35.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.903 0.382 . . . . 0.0 111.0 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.834 ' O ' HG22 ' A' ' 104' ' ' ILE . 1.2 m170 -63.61 171.39 2.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.751 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.783 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.7 OUTLIER -142.44 162.02 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.806 -179.681 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.652 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 5.0 p -155.51 172.02 18.95 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.817 ' HB1' ' CG2' ' A' ' 99' ' ' ILE . . . -96.02 126.99 41.64 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 178.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.458 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 69.8 t-105 -132.77 162.01 32.58 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.567 0.699 . . . . 0.0 112.158 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.458 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 2.4 tptt -61.21 121.14 11.79 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.637 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -62.0 125.28 23.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.896 0.379 . . . . 0.0 111.211 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -134.92 12.17 3.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.169 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 79.62 8.16 87.94 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.927 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -60.47 149.76 42.52 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.52 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.21 -25.2 57.8 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.639 2.226 . . . . 0.0 112.206 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.704 ' O ' HD12 ' A' ' 103' ' ' ILE . 13.3 p-10 -74.0 -5.16 39.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.426 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.426 ' O ' ' CG2' ' A' ' 90' ' ' THR . 83.8 mt-30 -108.14 18.69 20.85 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.615 0.245 . . . . 0.0 111.19 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.421 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 1.5 mmmt -104.74 127.69 52.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.798 0.332 . . . . 0.0 111.273 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.432 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 15.1 m-85 -134.04 154.38 51.19 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 120.939 0.4 . . . . 0.0 110.399 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.4 mt -113.56 138.98 41.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.456 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.513 ' CD1' HG23 ' A' ' 8' ' ' ILE . 36.2 mm -113.64 140.85 31.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.613 -179.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -138.45 112.15 8.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.512 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.82 109.07 3.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.047 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.905 179.958 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.458 ' HA ' ' O ' ' A' ' 46' ' ' TRP . 25.3 m-85 . . . . . 0 C--O 1.231 0.097 0 N-CA-C 110.516 -0.179 . . . . 0.0 110.516 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.722 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -159.46 176.34 12.21 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.793 179.764 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.839 ' CE2' HD21 ' A' ' 45' ' ' LEU . 21.5 m-85 -111.84 124.29 52.06 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.276 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.611 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -107.61 107.07 21.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.818 0.342 . . . . 0.0 110.275 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 15' ' ' LYS . 6.0 tttt -106.5 137.07 45.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.099 -0.501 . . . . 0.0 112.322 -178.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.0 m -75.94 109.83 9.89 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 178.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.411 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 3.8 tt0 -64.46 -11.38 32.95 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.492 -178.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.455 HD22 ' CB ' ' A' ' 124' ' ' ASN . 24.0 tp -84.34 -62.3 1.59 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.939 0.399 . . . . 0.0 111.034 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.648 HD21 HG21 ' A' ' 103' ' ' ILE . 8.0 m-20 -85.28 -12.6 52.05 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.79 3.07 72.43 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.095 -1.05 . . . . 0.0 111.485 -178.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.432 ' HG2' ' HB2' ' A' ' 13' ' ' ASN . 1.7 mmtt -90.43 -179.2 5.54 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.541 HG21 ' HA ' ' A' ' 35' ' ' GLN . 4.3 m -121.93 142.44 38.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.728 0.299 . . . . 0.0 110.586 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.3 mt -67.23 135.08 52.87 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.44 ' O ' HD13 ' A' ' 31' ' ' ILE . 12.7 t70 -145.41 146.64 31.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.683 0.278 . . . . 0.0 111.13 -178.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.405 HD11 ' CZ2' ' A' ' 46' ' ' TRP . 3.0 mm . . . . . 0 C--N 1.33 -0.266 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 CA-C-O 120.367 -0.129 . . . . 0.0 112.99 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.3 m -76.67 126.59 31.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.901 0.381 . . . . 0.0 111.259 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -76.14 159.94 30.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.282 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.605 HD13 HG21 ' A' ' 63' ' ' ILE . 50.9 pt -119.96 147.4 23.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.892 0.377 . . . . 0.0 111.824 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.44 HD13 ' O ' ' A' ' 18' ' ' ASP . 0.2 OUTLIER -155.9 -177.81 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.163 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.495 -179.901 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 p -103.36 150.38 23.86 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.648 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 27.2 t-105 -156.53 170.74 21.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.668 0.27 . . . . 0.0 110.849 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -69.6 132.9 46.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.758 0.313 . . . . 0.0 110.665 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.541 ' HA ' HG21 ' A' ' 16' ' ' VAL . 4.5 pt20 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.16 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.985 ' O ' HD12 ' A' ' 45' ' ' LEU . . . . . . . . 0 N--CA 1.457 -0.088 0 CA-C-O 120.831 0.348 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 73.4 t -50.06 -35.12 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.965 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.438 ' HB3' ' OD1' ' A' ' 18' ' ' ASP . 17.8 t30 -69.13 -7.82 39.68 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.995 -179.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -118.01 7.75 12.34 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.985 HD12 ' O ' ' A' ' 41' ' ' ALA . 0.9 OUTLIER -117.68 140.72 49.27 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.312 -179.096 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.524 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 25.4 m95 -134.67 169.29 17.55 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.813 -178.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.498 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 6.3 p90 -137.86 161.18 37.3 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.296 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.61 HG22 ' CG2' ' A' ' 54' ' ' ILE . 65.1 p -107.58 136.32 47.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.729 0.299 . . . . 0.0 111.003 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.424 ' HB2' ' O ' ' A' ' 53' ' ' VAL . 25.4 t70 -77.77 166.59 22.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.938 0.399 . . . . 0.0 111.168 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -57.81 -20.93 39.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.189 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -102.79 -2.45 28.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.386 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.24 0.47 47.54 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.043 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.48 HG13 ' HA ' ' A' ' 83' ' ' ALA . 23.2 t -81.24 113.32 20.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.921 0.36 . . . . 0.0 110.58 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.61 ' CG2' HG22 ' A' ' 48' ' ' THR . 0.6 OUTLIER -79.59 150.33 5.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.439 0.638 . . . . 0.0 112.089 -179.602 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.851 ' CD ' ' HB2' ' A' ' 62' ' ' ALA . 9.0 mmm-85 -151.02 132.59 14.79 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.834 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.524 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 66.2 p . . . . . 0 CA--C 1.509 -0.63 0 CA-C-O 121.648 0.737 . . . . 0.0 111.384 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.441 ' CE2' ' HD3' ' A' ' 74' ' ' PRO . 3.7 m-85 . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.808 0.337 . . . . 0.0 111.054 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.851 ' HB2' ' CD ' ' A' ' 55' ' ' ARG . . . -103.61 150.85 23.58 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.21 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.954 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -80.49 152.04 4.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.178 179.499 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.558 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 6.9 p-10 -133.36 135.72 44.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.17 0.51 . . . . 0.0 111.653 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.653 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -98.13 44.08 1.05 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.205 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 94.2 p -74.12 -43.64 56.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.462 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -100.89 176.06 5.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.084 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -49.03 -44.71 41.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.823 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.74 148.87 26.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.602 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.954 HG22 HG22 ' A' ' 63' ' ' ILE . 1.3 mm -77.93 140.84 16.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 CA-C-O 121.651 0.738 . . . . 0.0 111.612 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -133.31 159.84 39.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.766 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 39.2 p -102.29 137.53 40.43 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.34 179.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.496 ' CB ' ' HD2' ' A' ' 74' ' ' PRO . 0.3 OUTLIER -164.47 170.95 6.12 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.253 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.496 ' HD2' ' CB ' ' A' ' 73' ' ' GLN . 20.0 Cg_endo -60.45 133.35 48.48 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.19 1.927 . . . . 0.0 111.815 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.416 ' CE1' ' HB2' ' A' ' 83' ' ' ALA . 28.8 t80 -57.63 135.71 56.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.953 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.08 122.96 26.82 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.787 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -56.39 -34.58 94.72 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.467 2.111 . . . . 0.0 112.698 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -87.94 -0.67 57.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.761 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.402 ' HB3' ' HD2' ' A' ' 82' ' ' ARG . 3.0 m120 -108.74 100.31 38.46 Favored Pre-proline 0 C--O 1.232 0.183 0 CA-C-O 120.603 0.24 . . . . 0.0 110.922 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.85 ' O ' HD21 ' A' ' 94' ' ' LEU . 3.8 Cg_exo -76.47 25.37 0.44 Allowed 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.91 2.407 . . . . 0.0 113.236 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.561 ' HD2' ' HB3' ' A' ' 65' ' ' ALA . 21.0 mmtp -120.01 -19.91 7.66 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 120.581 0.229 . . . . 0.0 111.066 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.469 ' HG3' ' HB3' ' A' ' 64' ' ' ASP . 0.2 OUTLIER -88.89 18.75 4.55 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.162 -179.304 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 1.127 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -127.56 99.16 5.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.13 0.491 . . . . 0.0 110.738 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.695 ' HH2' ' HB2' ' A' ' 116' ' ' ALA . 58.8 m95 -108.48 135.39 49.84 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.138 0.494 . . . . 0.0 111.734 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 pt -113.55 155.27 14.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.257 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.7 t -103.38 129.06 55.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.965 0.412 . . . . 0.0 111.139 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 40.3 t -121.74 95.72 4.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.308 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.13 -101.14 0.85 Allowed Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.274 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.5 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.85 30.41 6.9 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.573 0.225 . . . . 0.0 110.811 -179.797 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.405 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.66 147.44 29.99 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.621 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.461 ' HB ' HD12 ' A' ' 101' ' ' LEU . 18.4 mm -94.38 120.24 43.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.385 178.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.901 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -123.66 145.34 49.03 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -178.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.438 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -65.65 148.38 51.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.513 179.646 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.127 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.6 pt? -62.19 -56.77 15.42 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.836 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.563 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 20.6 p -77.91 -4.13 45.22 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -178.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.568 ' O ' HG22 ' A' ' 99' ' ' ILE . 2.1 m-20 -138.05 87.0 2.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.777 0.322 . . . . 0.0 110.863 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.11 -16.16 63.07 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.204 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -90.35 11.83 20.2 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.182 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.568 HG22 ' O ' ' A' ' 96' ' ' ASP . 6.3 tt -130.94 137.92 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.901 HG12 ' HB2' ' A' ' 92' ' ' ALA . 23.9 m -148.86 137.12 14.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.763 0.316 . . . . 0.0 111.729 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.557 ' HA ' ' O ' ' A' ' 115' ' ' CYS . 24.8 mt -45.53 153.4 0.25 Allowed 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.705 0.764 . . . . 0.0 111.788 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.437 ' O ' HG22 ' A' ' 114' ' ' ILE . 10.0 t70 -158.46 168.4 27.06 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.381 -1.282 . . . . 0.0 110.763 -177.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.648 HG21 HD21 ' A' ' 13' ' ' ASN . 4.5 mp -90.48 123.55 42.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.452 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.85 HG22 ' O ' ' A' ' 113' ' ' HIS . 6.2 tp -67.9 140.73 18.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.938 0.399 . . . . 0.0 111.332 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 76.56 -5.83 2.11 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.945 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.7 t 46.36 29.69 0.91 Allowed 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.77 0.319 . . . . 0.0 111.194 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -100.79 161.75 13.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.105 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.9 -13.98 58.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.141 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -48.6 123.43 6.74 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.237 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.88 160.27 32.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.063 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 72.56 16.32 77.63 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.092 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -79.26 135.09 36.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.816 0.341 . . . . 0.0 110.886 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.85 ' O ' HG22 ' A' ' 104' ' ' ILE . 18.8 m170 -61.83 166.6 4.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.911 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.454 HG22 ' HA ' ' A' ' 103' ' ' ILE . 0.0 OUTLIER -136.35 160.44 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.476 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.735 ' HA ' HD11 ' A' ' 70' ' ' ILE . 26.2 p -157.8 172.29 18.74 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.695 ' HB2' ' HH2' ' A' ' 84' ' ' TRP . . . -95.51 127.67 41.74 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.625 -0.43 . . . . 0.0 109.922 178.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.461 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 75.7 t-105 -133.23 163.04 30.19 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.578 0.704 . . . . 0.0 111.97 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.461 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.0 OUTLIER -64.23 123.11 18.26 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.727 179.93 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.93 121.83 9.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.157 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.429 ' CE1' ' HA3' ' A' ' 122' ' ' GLY . 6.9 p80 -126.59 3.01 6.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.434 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 80.82 5.92 89.74 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.973 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.429 ' HA3' ' CE1' ' A' ' 120' ' ' HIS . . . -64.8 154.0 49.5 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.575 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.9 -23.58 54.58 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.616 2.211 . . . . 0.0 112.348 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.544 ' O ' HD12 ' A' ' 103' ' ' ILE . 27.1 p-10 -76.76 -2.17 31.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.56 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.405 ' O ' ' CG2' ' A' ' 90' ' ' THR . 0.0 OUTLIER -108.97 9.6 26.47 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.219 -179.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.411 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 19.9 mmmt -103.38 136.92 42.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.773 0.32 . . . . 0.0 111.249 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.42 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 6.6 m-85 -137.57 155.61 49.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.45 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.3 mt -113.47 138.89 41.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.098 0.475 . . . . 0.0 110.559 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.477 HD12 HG23 ' A' ' 8' ' ' ILE . 27.1 mm -114.17 141.34 30.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.661 -179.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -138.95 94.64 2.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.611 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.75 113.41 0.9 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.422 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.964 179.989 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.433 ' CD2' ' HB3' ' A' ' 132' ' ' GLU . 1.4 p90 . . . . . 0 C--O 1.231 0.115 0 N-CA-C 110.422 -0.214 . . . . 0.0 110.422 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.703 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -156.89 175.26 14.31 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 120.481 -0.487 . . . . 0.0 111.731 179.806 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.59 ' CZ ' HD11 ' A' ' 45' ' ' LEU . 9.9 m-85 -109.33 124.58 51.18 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.157 179.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.607 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -108.51 106.24 20.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.871 0.367 . . . . 0.0 110.296 179.735 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -105.76 134.6 48.63 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -178.566 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 57.9 p -75.78 106.55 7.42 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.404 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 3.6 tt0 -63.4 -10.54 17.43 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.591 -178.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.427 HD22 ' CB ' ' A' ' 124' ' ' ASN . 33.1 tp -83.5 -62.91 1.46 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.924 0.392 . . . . 0.0 110.794 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.525 HD21 HG21 ' A' ' 103' ' ' ILE . 4.9 m-20 -84.23 -10.27 57.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.313 -178.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.45 3.75 67.33 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.129 -1.034 . . . . 0.0 111.382 -178.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.1 mmmt -92.66 -176.59 4.31 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.659 HG21 ' HA ' ' A' ' 35' ' ' GLN . 7.5 m -121.78 142.44 38.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.708 0.29 . . . . 0.0 110.58 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.7 mt -70.05 134.63 48.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.014 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.405 ' HB2' ' HG3' ' A' ' 44' ' ' GLN . 9.5 t0 -146.71 150.36 35.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.707 0.289 . . . . 0.0 111.033 -179.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.518 HD12 HG21 ' A' ' 72' ' ' THR . 2.7 mm . . . . . 0 C--N 1.328 -0.351 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.412 0 CA-C-O 120.349 -0.14 . . . . 0.0 113.188 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.52 127.51 32.76 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 117.027 0.414 . . . . 0.0 111.037 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -78.75 159.83 27.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.189 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.654 HD11 ' HB ' ' A' ' 70' ' ' ILE . 42.6 pt -117.89 146.29 22.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.771 0.32 . . . . 0.0 111.783 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.453 ' HA ' ' CD1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -154.44 178.01 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.17 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.78 -179.806 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.2 p -101.13 148.69 24.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.623 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 34.9 t-105 -158.23 172.9 17.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.708 0.289 . . . . 0.0 110.918 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -69.01 132.93 47.44 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.758 0.313 . . . . 0.0 110.738 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.659 ' HA ' HG21 ' A' ' 16' ' ' VAL . 2.4 pt20 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.019 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.994 ' O ' HD12 ' A' ' 45' ' ' LEU . . . . . . . . 0 CA--C 1.529 0.164 0 N-CA-C 111.619 0.229 . . . . 0.0 111.619 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 59.4 t -50.92 -33.57 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.116 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.406 ' OD1' ' HB ' ' A' ' 19' ' ' ILE . 0.6 OUTLIER -69.73 -7.51 40.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.76 -179.649 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.405 ' HG3' ' HB2' ' A' ' 18' ' ' ASP . 2.6 mt-30 -115.79 6.26 14.32 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.994 HD12 ' O ' ' A' ' 41' ' ' ALA . 0.9 OUTLIER -117.8 142.22 47.54 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.216 -179.273 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.478 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 26.3 m95 -133.74 168.71 18.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.541 -179.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.526 ' CZ ' ' HB2' ' A' ' 55' ' ' ARG . 43.1 p90 -141.32 164.16 31.01 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.382 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.671 HG22 ' CG2' ' A' ' 54' ' ' ILE . 67.5 p -109.19 135.37 50.42 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.783 0.325 . . . . 0.0 111.539 -178.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -78.36 170.88 15.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.12 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.34 -25.15 65.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.999 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -89.3 -5.02 57.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.201 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.24 11.74 44.45 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.837 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.658 HG13 ' HA ' ' A' ' 83' ' ' ALA . 37.2 t -100.68 120.43 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-O 120.779 0.323 . . . . 0.0 110.489 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.671 ' CG2' HG22 ' A' ' 48' ' ' THR . 0.6 OUTLIER -78.78 149.75 5.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.541 0.686 . . . . 0.0 111.883 -179.806 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.657 ' HD3' ' HB2' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -147.0 132.53 18.71 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.647 178.612 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.478 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.492 0 CA-C-O 121.569 0.699 . . . . 0.0 111.857 -178.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.409 ' CE2' ' HG3' ' A' ' 74' ' ' PRO . 32.7 m-85 . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.96 0.41 . . . . 0.0 110.858 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.657 ' HB2' ' HD3' ' A' ' 55' ' ' ARG . . . -104.4 154.16 20.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.397 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.858 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -79.86 150.37 5.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.59 179.665 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.573 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 6.3 p-10 -132.6 134.75 45.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.138 0.494 . . . . 0.0 111.501 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.673 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -99.06 43.29 1.06 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.334 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.1 m -74.06 -43.07 59.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.142 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 57.2 m80 -98.78 173.1 7.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.931 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -49.32 -46.96 47.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.983 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -99.69 145.03 28.09 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.936 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.858 HG22 HG22 ' A' ' 63' ' ' ILE . 2.4 mm -76.8 142.38 14.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-O 121.591 0.71 . . . . 0.0 111.511 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -140.31 168.61 19.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.062 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.518 HG21 HD12 ' A' ' 19' ' ' ILE . 58.8 p -106.87 138.51 42.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.97 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.48 161.11 17.9 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.329 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.409 ' HG3' ' CE2' ' A' ' 61' ' ' PHE . 57.3 Cg_exo -51.44 139.19 46.58 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.449 2.099 . . . . 0.0 112.074 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.576 ' HE1' ' HB2' ' A' ' 83' ' ' ALA . 90.6 t80 -62.94 127.8 32.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.129 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.412 ' HB2' ' HD3' ' A' ' 82' ' ' ARG . 0.1 OUTLIER -117.56 136.32 23.54 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.597 179.68 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -68.96 -34.81 16.5 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.56 2.173 . . . . 0.0 112.93 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -87.34 0.15 55.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.8 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.409 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 1.6 t30 -108.53 101.03 41.26 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 120.588 0.232 . . . . 0.0 111.147 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.854 ' O ' HD21 ' A' ' 94' ' ' LEU . 4.8 Cg_exo -77.09 24.7 0.48 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.989 2.459 . . . . 0.0 113.043 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.573 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 21.0 mmtp -120.26 -19.72 7.57 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 120.568 0.223 . . . . 0.0 111.101 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.481 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 0.4 OUTLIER -88.72 17.07 5.85 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.09 -0.505 . . . . 0.0 112.285 -179.208 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 1.091 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -126.61 98.85 5.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.081 0.467 . . . . 0.0 110.823 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.673 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 56.2 m95 -107.94 136.05 48.29 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.157 0.503 . . . . 0.0 111.81 -178.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.5 pt -111.25 153.5 13.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.197 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.2 t -102.28 127.69 55.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.008 0.432 . . . . 0.0 111.042 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.4 t -120.59 94.75 4.46 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.448 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.99 -100.13 0.75 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.531 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.499 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.85 29.74 7.23 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.52 0.2 . . . . 0.0 110.868 -179.676 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.425 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -148.14 147.77 29.84 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.577 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.813 ' HB ' HD12 ' A' ' 101' ' ' LEU . 11.9 mm -94.13 120.34 43.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.047 -0.978 . . . . 0.0 109.351 178.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.875 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -122.26 144.01 49.25 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -178.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.415 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -64.61 148.91 49.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.527 179.834 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.091 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.6 pt? -64.34 -57.23 9.96 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.688 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.561 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 13.5 t -74.22 -4.1 33.9 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -178.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.555 ' O ' HG22 ' A' ' 99' ' ' ILE . 56.7 m-20 -143.46 92.22 2.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.919 0.39 . . . . 0.0 111.025 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -72.89 -14.32 61.46 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.287 179.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -90.25 11.19 21.91 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.297 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.555 HG22 ' O ' ' A' ' 96' ' ' ASP . 9.0 tt -130.64 138.27 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.875 HG12 ' HB2' ' A' ' 92' ' ' ALA . 26.7 m -148.99 138.15 15.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.837 0.351 . . . . 0.0 111.907 -179.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.813 HD12 ' HB ' ' A' ' 91' ' ' ILE . 11.1 mt -45.53 153.3 0.26 Allowed 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 121.754 0.788 . . . . 0.0 111.772 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.713 ' O ' HG22 ' A' ' 114' ' ' ILE . 9.8 t70 -158.63 168.24 27.42 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.833 -177.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.664 HD12 ' O ' ' A' ' 124' ' ' ASN . 4.4 mp -88.0 122.96 40.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.204 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.826 HG22 ' O ' ' A' ' 113' ' ' HIS . 7.8 tp -66.63 138.27 23.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.057 0.456 . . . . 0.0 111.476 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.4 1.06 3.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.983 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.4 t 44.17 30.88 0.48 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.781 0.324 . . . . 0.0 111.344 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.7 p30 -96.67 155.79 16.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.152 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -82.24 -17.17 46.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.106 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -45.28 116.12 1.06 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.279 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.4 156.74 9.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.247 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.63 14.47 81.2 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.312 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.88 131.81 39.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.902 0.382 . . . . 0.0 110.985 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.826 ' O ' HG22 ' A' ' 104' ' ' ILE . 12.5 m170 -64.87 171.25 3.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.014 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.713 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -136.38 161.75 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.445 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.605 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 26.5 p -153.51 168.45 26.11 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.663 ' HB2' ' HH2' ' A' ' 84' ' ' TRP . . . -95.06 126.71 40.59 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 178.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.468 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 76.5 t-105 -134.71 162.49 32.2 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.63 0.729 . . . . 0.0 112.196 -179.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.468 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.9 OUTLIER -62.53 120.87 11.96 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.646 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -58.55 125.5 23.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.089 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.432 ' CE1' ' HA3' ' A' ' 122' ' ' GLY . 19.9 p80 -132.97 8.51 4.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.357 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 81.82 7.17 88.34 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.086 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.432 ' HA3' ' CE1' ' A' ' 120' ' ' HIS . . . -63.73 152.15 48.44 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.58 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.59 -26.35 54.14 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.604 2.203 . . . . 0.0 112.33 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.664 ' O ' HD12 ' A' ' 103' ' ' ILE . 30.6 p-10 -75.05 -4.11 36.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.506 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.425 ' O ' ' CG2' ' A' ' 90' ' ' THR . 0.0 OUTLIER -107.5 14.38 25.89 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.183 -179.811 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.404 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 2.3 mmmm -107.08 136.92 46.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.793 0.33 . . . . 0.0 111.472 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.435 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 6.1 m-85 -138.2 155.23 48.88 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.21 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.3 mt -112.03 138.43 40.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.091 0.472 . . . . 0.0 110.392 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 27.9 mm -112.99 140.19 34.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.563 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.7 112.02 8.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.457 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 5.7 t -66.4 109.95 2.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.13 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.477 ' HG3' HD21 ' A' ' 45' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.188 -0.911 . . . . 0.0 110.898 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.436 ' HA ' ' O ' ' A' ' 46' ' ' TRP . 1.4 p90 . . . . . 0 N--CA 1.462 0.16 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.691 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -159.01 175.61 13.32 Favored 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.94 179.889 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.582 ' CZ ' HD11 ' A' ' 45' ' ' LEU . 4.7 m-85 -110.6 124.01 51.06 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.055 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.768 HG13 HD11 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -106.5 106.87 21.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.844 0.354 . . . . 0.0 110.436 179.824 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 15' ' ' LYS . 8.7 tttt -107.85 138.54 43.91 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.305 -178.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.91 109.2 10.53 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -64.01 -10.95 24.7 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.579 -178.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.618 HD22 ' HA ' ' A' ' 124' ' ' ASN . 56.8 tp -84.26 -62.48 1.55 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.88 0.371 . . . . 0.0 111.026 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.703 HD21 HG21 ' A' ' 103' ' ' ILE . 6.1 m-20 -85.43 -12.93 50.79 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 77.17 0.84 72.18 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.103 -1.046 . . . . 0.0 111.413 -177.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.421 ' HG2' ' HB2' ' A' ' 13' ' ' ASN . 0.5 OUTLIER -89.01 179.74 6.1 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.503 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.418 HG11 ' HG2' ' A' ' 35' ' ' GLN . 4.2 m -121.36 141.46 41.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.768 HD11 HG13 ' A' ' 8' ' ' ILE . 0.4 OUTLIER -73.49 137.61 44.57 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.123 179.475 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -142.6 153.09 43.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.873 0.368 . . . . 0.0 111.127 -179.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.051 HD13 HG21 ' A' ' 72' ' ' THR . 25.3 mt . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.662 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.387 0 CA-C-O 120.249 -0.195 . . . . 0.0 113.108 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.11 137.04 50.8 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 117.122 0.461 . . . . 0.0 110.918 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.3 mmtp -88.32 157.6 18.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.606 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.668 HD11 ' HB ' ' A' ' 70' ' ' ILE . 44.2 pt -117.96 146.77 22.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.348 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.444 HG22 ' HA ' ' A' ' 113' ' ' HIS . 0.2 OUTLIER -155.19 179.73 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.182 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.885 -179.737 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.1 p -101.6 149.0 24.56 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.48 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 35.4 t-105 -157.81 172.21 18.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.711 0.291 . . . . 0.0 110.965 -179.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -72.48 139.08 47.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.81 0.338 . . . . 0.0 110.805 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.418 ' HG2' HG11 ' A' ' 16' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.939 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.882 ' O ' HD12 ' A' ' 45' ' ' LEU . . . . . . . . 0 CA--C 1.528 0.121 0 CA-C-O 120.657 0.265 . . . . 0.0 111.037 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 48.5 t -50.29 -27.48 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.065 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -66.83 -9.45 37.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.582 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -118.46 5.89 11.76 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.882 HD12 ' O ' ' A' ' 41' ' ' ALA . 1.3 mp -116.98 141.44 48.23 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.531 -179.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.57 ' CZ2' HD11 ' A' ' 19' ' ' ILE . 26.1 m95 -134.18 169.01 17.81 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.249 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.55 ' CZ ' ' HB2' ' A' ' 55' ' ' ARG . 11.3 p90 -141.98 166.22 25.31 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.981 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.405 HG22 ' CG2' ' A' ' 54' ' ' ILE . 39.7 p -108.38 133.87 51.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.882 0.372 . . . . 0.0 111.559 -178.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 53' ' ' VAL . 42.9 t0 -77.96 167.78 20.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.026 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -60.9 -24.85 66.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.138 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.2 tp60 -92.74 -3.34 54.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.269 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.96 8.79 55.16 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.765 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.421 ' O ' ' HB2' ' A' ' 49' ' ' ASP . 31.1 t -93.83 119.68 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-O 120.744 0.307 . . . . 0.0 110.587 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.535 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -75.96 145.64 10.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.168 0.509 . . . . 0.0 111.779 -179.835 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.742 ' CD ' ' HB2' ' A' ' 62' ' ' ALA . 13.5 mmm-85 -149.47 133.73 17.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.719 179.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 74.5 m . . . . . 0 C--N 1.327 -0.396 0 CA-C-O 121.598 0.714 . . . . 0.0 111.984 -179.087 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.411 ' CZ ' ' HG3' ' A' ' 74' ' ' PRO . 2.7 m-85 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.814 0.34 . . . . 0.0 110.899 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.742 ' HB2' ' CD ' ' A' ' 55' ' ' ARG . . . -99.42 145.55 27.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.205 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.826 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -76.95 152.64 5.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.6 179.733 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.626 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 5.0 p-10 -132.37 129.87 39.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.249 0.547 . . . . 0.0 111.777 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.745 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -94.29 40.8 1.09 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.272 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.4 t -75.11 -45.5 40.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.543 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -94.7 170.33 9.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.962 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -49.16 -42.18 38.89 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.014 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.59 140.05 38.57 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.813 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.826 HG22 HG22 ' A' ' 63' ' ' ILE . 3.1 mm -69.94 137.12 24.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-O 121.464 0.649 . . . . 0.0 111.367 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.401 ' O ' HG22 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -134.54 165.68 24.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.118 -0.947 . . . . 0.0 111.17 -179.708 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 1.051 HG21 HD13 ' A' ' 19' ' ' ILE . 23.9 p -106.62 140.25 39.79 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.238 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.11 163.79 13.33 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.481 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.461 ' O ' ' HD3' ' A' ' 82' ' ' ARG . 40.4 Cg_exo -56.73 142.81 91.54 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.451 2.1 . . . . 0.0 111.673 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.421 ' CD2' HG11 ' A' ' 53' ' ' VAL . 58.2 t80 -57.13 128.77 38.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.859 0.362 . . . . 0.0 111.358 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -118.17 131.02 24.38 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.532 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -68.14 -36.77 16.02 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.453 2.102 . . . . 0.0 112.758 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -87.55 0.31 55.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.812 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -105.19 102.65 37.78 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-O 120.53 0.205 . . . . 0.0 111.086 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.566 ' O ' HD21 ' A' ' 94' ' ' LEU . 5.7 Cg_exo -77.32 21.63 0.61 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.887 2.391 . . . . 0.0 112.978 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.626 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 7.6 mptt -119.92 -21.03 7.3 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 120.753 0.311 . . . . 0.0 111.001 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.546 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 2.7 mtt180 -86.85 20.84 2.44 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 1.033 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -130.68 99.58 5.01 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.276 0.56 . . . . 0.0 110.937 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.745 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 61.0 m95 -109.39 136.07 49.41 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.923 -178.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 27.8 pt -113.17 153.45 14.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.196 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.0 t -100.2 123.0 52.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.901 0.382 . . . . 0.0 110.948 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 37.6 t -115.8 93.49 4.28 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.438 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.97 -100.56 0.78 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.533 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.502 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.73 29.67 7.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.496 0.189 . . . . 0.0 110.923 -179.594 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.406 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -148.05 148.23 30.45 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.36 0.6 . . . . 0.0 112.583 -178.63 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.508 ' HB ' HD12 ' A' ' 101' ' ' LEU . 23.9 mm -93.65 119.47 41.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.542 178.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.981 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -123.99 147.56 47.68 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.421 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.3 OUTLIER -65.17 149.88 49.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.849 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.033 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.7 pt? -64.29 -56.88 11.48 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.444 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.612 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 0.3 OUTLIER -77.25 -1.77 31.3 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.363 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.554 ' O ' HG22 ' A' ' 99' ' ' ILE . 49.7 t0 -145.09 91.14 2.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.165 0.507 . . . . 0.0 110.942 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 3.8 mmm180 -74.09 -13.69 60.87 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.526 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -87.35 9.81 19.32 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.518 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.831 HG12 ' HB1' ' A' ' 116' ' ' ALA . 6.8 tt -132.89 140.24 47.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 179.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.981 HG12 ' HB2' ' A' ' 92' ' ' ALA . 20.0 m -149.77 138.84 15.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.77 0.319 . . . . 0.0 111.826 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.508 HD12 ' HB ' ' A' ' 91' ' ' ILE . 21.8 mt -46.15 154.89 0.23 Allowed 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 121.733 0.778 . . . . 0.0 111.948 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.805 ' O ' HG22 ' A' ' 114' ' ' ILE . 11.0 t70 -156.97 167.67 29.77 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.792 -177.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.703 HG21 HD21 ' A' ' 13' ' ' ASN . 4.6 mp -89.38 123.96 41.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.427 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.788 HG22 ' O ' ' A' ' 113' ' ' HIS . 3.9 tt -68.04 144.48 14.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.947 0.403 . . . . 0.0 111.421 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 5.2 mttt 70.34 -0.8 2.71 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.015 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.1 m 42.09 31.61 0.25 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.734 0.302 . . . . 0.0 111.474 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -102.78 162.39 12.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.068 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.23 -14.5 57.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.255 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -48.21 133.11 15.8 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.21 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -81.91 159.37 23.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.147 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.49 16.37 80.05 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.287 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -82.0 135.79 35.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.841 0.353 . . . . 0.0 111.124 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.788 ' O ' HG22 ' A' ' 104' ' ' ILE . 6.7 m80 -61.86 172.85 1.19 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.962 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.805 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.7 OUTLIER -143.28 161.6 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.758 -179.777 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.645 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 4.6 t -155.43 169.95 23.07 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.831 ' HB1' HG12 ' A' ' 99' ' ' ILE . . . -93.6 126.53 38.81 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.458 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 75.9 t-105 -131.47 160.98 33.58 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.635 0.731 . . . . 0.0 112.361 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.458 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.3 OUTLIER -62.87 124.77 21.91 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.764 -179.885 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.88 121.28 8.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.127 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.438 ' CE1' ' HA3' ' A' ' 122' ' ' GLY . 6.6 p80 -127.34 2.4 6.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.493 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 79.4 5.23 89.26 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.881 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.438 ' HA3' ' CE1' ' A' ' 120' ' ' HIS . . . -63.34 156.28 42.32 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.536 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.75 -25.04 46.54 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.589 2.193 . . . . 0.0 112.365 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.618 ' HA ' HD22 ' A' ' 12' ' ' LEU . 36.3 p-10 -74.53 -3.8 33.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.644 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.406 ' O ' ' CG2' ' A' ' 90' ' ' THR . 0.0 OUTLIER -108.88 15.81 23.2 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.533 0.206 . . . . 0.0 111.116 -179.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -106.3 131.29 53.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.835 0.35 . . . . 0.0 111.465 -179.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.435 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 3.0 m-85 -134.9 154.6 51.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.285 179.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 mt -114.07 140.04 36.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.131 0.491 . . . . 0.0 110.677 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.472 HD12 HG23 ' A' ' 8' ' ' ILE . 20.8 mm -113.38 141.4 29.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.602 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.46 94.66 2.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.711 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 5.0 t -49.96 109.64 0.31 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.426 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.433 179.751 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.467 ' HA ' ' O ' ' A' ' 46' ' ' TRP . 1.1 p90 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.402 0.144 . . . . 0.0 110.629 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.743 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -159.87 176.57 11.75 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.861 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.822 ' OH ' ' HB1' ' A' ' 41' ' ' ALA . 0.7 OUTLIER -112.64 124.16 51.94 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.299 179.371 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.616 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -105.54 108.48 25.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.914 0.387 . . . . 0.0 110.339 179.873 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.456 ' HG2' ' HZ2' ' A' ' 9' ' ' LYS . 1.5 tptp -105.27 135.3 46.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.422 -178.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.7 t -75.65 108.04 8.21 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.448 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 2.7 tt0 -63.84 -10.76 22.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.633 -178.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.567 HD22 ' CB ' ' A' ' 124' ' ' ASN . 52.5 tp -83.25 -62.71 1.52 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.92 0.391 . . . . 0.0 110.924 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.621 HD21 HG21 ' A' ' 103' ' ' ILE . 6.7 m-20 -86.32 -9.85 55.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.429 -178.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.86 5.01 68.41 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.145 -1.026 . . . . 0.0 111.369 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.41 ' HG2' ' HB2' ' A' ' 13' ' ' ASN . 1.8 mmmt -91.57 -177.18 4.73 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.537 HG11 ' HG2' ' A' ' 35' ' ' GLN . 2.9 m -120.3 140.28 44.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.784 0.326 . . . . 0.0 110.513 179.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.3 mt -70.89 136.06 48.39 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -143.83 158.57 43.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.936 0.398 . . . . 0.0 111.345 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.014 HD13 HG21 ' A' ' 72' ' ' THR . 27.5 mt . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.406 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.409 0 CA-C-O 120.409 -0.106 . . . . 0.0 112.951 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.71 130.05 38.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.987 0.422 . . . . 0.0 111.198 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -80.73 161.83 24.39 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.422 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.626 HG22 HG12 ' A' ' 19' ' ' ILE . 48.4 pt -122.82 150.29 26.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.783 0.325 . . . . 0.0 111.705 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.455 HG22 ' HA ' ' A' ' 113' ' ' HIS . 0.3 OUTLIER -156.39 -178.62 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.785 -179.738 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.2 p -100.29 148.59 24.5 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.468 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 30.6 t-105 -157.16 171.9 19.62 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.77 0.319 . . . . 0.0 111.109 -179.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.7 140.6 47.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.799 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.537 ' HG2' HG11 ' A' ' 16' ' ' VAL . 36.4 mt-30 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.946 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.858 ' O ' HD12 ' A' ' 45' ' ' LEU . . . . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.691 0.281 . . . . 0.0 111.163 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.7 t -49.34 -26.2 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.19 179.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -65.74 -10.02 33.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.738 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -119.6 6.04 11.05 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.103 0.478 . . . . 0.0 109.772 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.858 HD12 ' O ' ' A' ' 41' ' ' ALA . 1.4 mp -116.59 139.8 50.1 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.617 -179.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.555 ' CZ2' HD11 ' A' ' 19' ' ' ILE . 25.5 m95 -133.73 168.09 19.34 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.228 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.567 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 6.4 p90 -139.61 163.51 32.37 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.009 178.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.547 HG22 ' CG2' ' A' ' 54' ' ' ILE . 81.1 p -109.13 136.41 48.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.786 0.327 . . . . 0.0 111.4 -178.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.83 173.2 12.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.288 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.85 -20.93 65.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.063 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -101.74 -2.14 30.87 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.221 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.75 1.91 52.61 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.929 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.695 HG12 ' HD3' ' A' ' 55' ' ' ARG . 21.7 t -81.8 114.41 22.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.915 0.358 . . . . 0.0 110.767 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.567 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -77.5 148.02 6.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.263 0.554 . . . . 0.0 111.783 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.695 ' HD3' HG12 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -154.4 133.85 12.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.608 179.139 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.47 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 1.9 m . . . . . 0 C--N 1.328 -0.341 0 CA-C-O 121.356 0.598 . . . . 0.0 111.913 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.89 0.376 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.582 ' HB2' ' HD2' ' A' ' 55' ' ' ARG . . . -105.04 150.79 24.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.348 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.843 HG22 HG22 ' A' ' 70' ' ' ILE . 0.3 OUTLIER -77.08 155.07 5.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.527 179.76 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.55 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 4.4 p-10 -134.48 133.48 40.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.173 0.511 . . . . 0.0 111.873 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.597 ' HB2' ' CZ2' ' A' ' 84' ' ' TRP . . . -100.25 40.09 1.29 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.367 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.0 p -74.27 -43.87 55.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.458 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -98.43 173.48 6.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.117 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -46.08 -48.77 17.01 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.816 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -104.59 149.84 25.17 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.843 HG22 HG22 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -78.39 144.65 10.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 CA-C-O 121.729 0.776 . . . . 0.0 111.805 -179.203 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -135.91 158.61 43.98 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.052 179.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 1.014 HG21 HD13 ' A' ' 19' ' ' ILE . 36.4 p -101.15 140.81 34.92 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.541 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.456 ' HG2' ' C ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -163.67 164.24 15.28 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.896 179.8 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.49 139.99 74.81 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.341 2.027 . . . . 0.0 111.754 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -56.16 122.84 12.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.911 0.386 . . . . 0.0 111.007 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.401 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 9.9 t70 -112.69 129.44 24.43 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.58 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.96 -34.81 22.32 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.449 2.099 . . . . 0.0 112.971 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -88.0 -0.64 57.27 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.401 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 4.3 t-20 -102.88 103.95 36.52 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 120.509 0.195 . . . . 0.0 110.957 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.581 ' O ' HD21 ' A' ' 94' ' ' LEU . 4.9 Cg_exo -77.1 19.95 0.67 Allowed 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.87 2.38 . . . . 0.0 113.246 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 11.5 mptt -120.45 -18.08 7.97 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 120.584 0.23 . . . . 0.0 111.27 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.487 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 4.4 mtt180 -90.3 21.59 3.76 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 1.111 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -129.32 99.5 5.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.231 0.539 . . . . 0.0 110.928 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.632 ' HH2' ' HB2' ' A' ' 116' ' ' ALA . 59.1 m95 -109.91 133.96 52.6 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.271 0.558 . . . . 0.0 112.151 -178.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.9 pt -113.23 154.57 14.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.066 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.8 t -103.24 131.07 52.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.965 0.412 . . . . 0.0 111.228 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 43.7 t -124.43 94.87 4.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.406 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.02 -100.71 0.87 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.449 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.496 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -121.13 28.98 7.55 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.603 0.24 . . . . 0.0 110.703 -179.933 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.433 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.2 146.97 30.02 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.321 0.582 . . . . 0.0 112.446 -178.642 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.849 ' HB ' HD12 ' A' ' 101' ' ' LEU . 10.6 mm -94.56 121.24 44.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.338 178.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.815 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -120.96 141.49 50.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.247 0.546 . . . . 0.0 112.462 -178.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.68 146.56 54.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.545 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.111 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.7 pt? -61.04 -56.6 19.16 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.826 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.601 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 97.2 p -73.81 -6.73 48.85 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -178.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.411 ' CB ' ' HB ' ' A' ' 99' ' ' ILE . 61.9 m-20 -139.63 91.06 2.45 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.869 -0.333 . . . . 0.0 111.203 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -66.6 -17.8 65.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.093 178.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.31 12.51 26.64 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.467 179.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.84 ' CG2' ' HB1' ' A' ' 116' ' ' ALA . 10.2 mm -124.5 128.49 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.412 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.815 HG12 ' HB2' ' A' ' 92' ' ' ALA . 19.3 m -146.31 135.54 16.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.832 0.348 . . . . 0.0 111.93 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.849 HD12 ' HB ' ' A' ' 91' ' ' ILE . 6.7 mt -45.55 152.2 0.34 Allowed 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.728 0.775 . . . . 0.0 111.781 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.821 ' O ' HG22 ' A' ' 114' ' ' ILE . 10.6 t70 -157.46 167.65 29.61 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.88 -177.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.621 HG21 HD21 ' A' ' 13' ' ' ASN . 4.6 mp -88.57 121.12 38.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.278 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.826 HG22 ' HG2' ' A' ' 105' ' ' LYS . 56.1 mt -70.48 138.33 22.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.748 0.309 . . . . 0.0 111.161 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.826 ' HG2' HG22 ' A' ' 104' ' ' ILE . 0.1 OUTLIER 81.34 -9.68 1.26 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.7 179.893 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 46.76 29.99 1.09 Allowed 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 120.757 0.313 . . . . 0.0 111.425 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.5 p30 -102.34 160.41 14.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.931 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.69 -14.28 58.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.484 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -51.95 118.95 3.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.83 0.348 . . . . 0.0 111.158 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.44 161.07 23.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.114 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.33 14.74 80.56 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.202 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.38 133.84 38.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.82 0.343 . . . . 0.0 111.063 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.572 ' HB2' HD12 ' A' ' 104' ' ' ILE . 35.9 m80 -61.38 163.25 6.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.06 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.821 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.6 OUTLIER -135.6 161.7 38.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.708 -179.836 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.608 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 26.2 p -162.3 176.94 10.05 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.84 ' HB1' ' CG2' ' A' ' 99' ' ' ILE . . . -96.91 132.24 42.89 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.826 -0.349 . . . . 0.0 110.261 178.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.467 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 75.9 t-105 -136.32 163.23 30.91 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.422 0.629 . . . . 0.0 111.756 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.467 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.1 OUTLIER -64.98 117.18 7.25 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.774 179.956 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -62.8 125.62 24.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.877 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -136.1 13.17 3.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.215 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 77.49 59.74 2.99 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.354 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -116.16 152.55 17.91 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.486 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.55 -30.67 79.76 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.51 2.14 . . . . 0.0 111.976 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.567 ' CB ' HD22 ' A' ' 12' ' ' LEU . 28.6 p-10 -77.21 -2.05 32.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.403 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.433 ' O ' ' CG2' ' A' ' 90' ' ' THR . 5.2 mm-40 -107.82 9.69 28.84 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.746 -0.206 . . . . 0.0 111.276 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.448 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 10.0 mmtt -106.5 140.99 38.52 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.872 0.368 . . . . 0.0 111.39 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -141.12 156.27 45.99 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.234 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.3 mt -112.14 138.45 41.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.072 0.463 . . . . 0.0 110.639 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.492 HD12 HG23 ' A' ' 8' ' ' ILE . 23.7 mm -113.73 140.29 34.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.599 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -139.58 94.84 2.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.668 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 53.0 m -53.0 111.14 0.62 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.35 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.739 ' OE2' HD21 ' A' ' 45' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.884 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 . . . . . 0 C--O 1.231 0.12 0 N-CA-C 110.488 -0.19 . . . . 0.0 110.488 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.613 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -152.66 170.53 20.02 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.405 179.302 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.426 ' O ' ' HA ' ' A' ' 129' ' ' ILE . 0.1 OUTLIER -112.06 123.6 50.62 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.815 178.863 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.672 ' HB ' HD21 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -106.56 108.67 25.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.892 0.377 . . . . 0.0 110.488 -179.866 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -107.81 137.14 46.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.252 -178.907 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.3 t -75.13 107.76 7.42 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.403 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 5.4 tt0 -62.4 -12.05 19.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.451 -178.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.8 tp -82.92 -62.15 1.68 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.871 0.367 . . . . 0.0 111.163 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.404 ' HB2' ' HG2' ' A' ' 15' ' ' LYS . 8.9 m-20 -86.79 -11.85 49.76 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -178.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.64 0.68 68.78 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.041 -1.076 . . . . 0.0 111.46 -178.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.407 ' O ' ' HG3' ' A' ' 9' ' ' LYS . 7.6 mmtm -89.06 177.69 6.58 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.556 HG21 ' HA ' ' A' ' 35' ' ' GLN . 4.5 m -119.72 141.26 40.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 179.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.672 HD21 ' HB ' ' A' ' 8' ' ' ILE . 0.1 OUTLIER -72.24 136.51 46.36 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.242 179.613 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.406 ' CB ' ' HG3' ' A' ' 44' ' ' GLN . 25.8 t0 -140.97 148.7 40.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.899 -179.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.078 HD13 HG21 ' A' ' 72' ' ' THR . 1.1 mt . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.128 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 CA-C-O 120.165 -0.242 . . . . 0.0 113.665 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.437 ' HB3' HG22 ' A' ' 19' ' ' ILE . 5.2 m -71.52 122.41 20.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.316 0.558 . . . . 0.0 111.141 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -76.6 160.56 29.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.586 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.585 HG22 HG23 ' A' ' 19' ' ' ILE . 44.5 pt -121.37 147.63 25.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.902 0.382 . . . . 0.0 111.992 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.427 HG22 ' HA ' ' A' ' 113' ' ' HIS . 0.3 OUTLIER -155.77 -178.29 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.219 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.386 179.805 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.5 p -102.31 149.48 24.29 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.603 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 20.8 t-105 -160.38 174.56 13.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.676 0.274 . . . . 0.0 110.843 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -71.12 136.29 48.11 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.814 0.34 . . . . 0.0 110.729 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.556 ' HA ' HG21 ' A' ' 16' ' ' VAL . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.947 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.55 ' O ' HD12 ' A' ' 45' ' ' LEU . . . . . . . . 0 CA--C 1.527 0.074 0 N-CA-C 111.525 0.195 . . . . 0.0 111.525 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.541 ' HA ' HD13 ' A' ' 45' ' ' LEU . 1.6 t -58.62 -18.48 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 120.686 0.279 . . . . 0.0 110.79 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -62.57 -9.93 10.42 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.12 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.406 ' HG3' ' CB ' ' A' ' 18' ' ' ASP . 1.1 mt-30 -114.55 7.46 16.13 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.622 HD22 ' OE1' ' A' ' 132' ' ' GLU . 1.7 mp -119.12 145.72 45.72 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.159 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.462 ' CH2' ' CG1' ' A' ' 63' ' ' ILE . 22.8 m95 -133.22 170.65 15.11 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.882 -178.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.54 ' CE2' ' HB2' ' A' ' 55' ' ' ARG . 1.1 p90 -135.85 159.8 40.55 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.856 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.43 HG22 HG23 ' A' ' 54' ' ' ILE . 11.8 p -106.15 132.98 51.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.732 0.301 . . . . 0.0 111.196 -179.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -77.57 164.64 25.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.949 0.404 . . . . 0.0 111.268 -179.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 22.2 mm100 -57.77 -23.3 51.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.13 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.61 -1.84 42.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.292 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.31 4.67 56.24 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.987 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.604 HG11 ' CE1' ' A' ' 75' ' ' PHE . 23.9 t -87.72 117.68 32.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.921 0.361 . . . . 0.0 110.544 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.526 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.9 OUTLIER -78.62 150.03 5.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.278 0.561 . . . . 0.0 111.939 -179.77 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.54 ' HB2' ' CE2' ' A' ' 47' ' ' TYR . 8.8 mmm-85 -146.9 133.2 19.5 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.308 178.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.422 ' OG ' ' CE2' ' A' ' 46' ' ' TRP . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.413 0 CA-C-O 121.333 0.587 . . . . 0.0 112.098 -178.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.422 ' CE2' ' HD3' ' A' ' 74' ' ' PRO . 3.7 m-85 . . . . . 0 C--O 1.233 0.235 0 CA-C-O 120.96 0.41 . . . . 0.0 110.627 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.406 ' HB2' ' CD ' ' A' ' 55' ' ' ARG . . . -102.15 151.27 22.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.042 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.838 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -78.61 151.19 5.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.484 179.692 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.591 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 7.7 p-10 -131.95 129.87 40.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.084 0.469 . . . . 0.0 111.646 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.623 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -95.32 41.42 1.1 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.363 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.9 m -74.51 -44.65 50.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.218 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 33.6 m170 -94.94 170.73 9.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.976 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -48.59 -44.62 37.07 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.939 0.399 . . . . 0.0 110.951 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.13 144.67 31.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.659 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.838 HG22 HG22 ' A' ' 63' ' ' ILE . 2.1 mm -76.35 143.9 12.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.521 0.677 . . . . 0.0 111.649 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -143.31 167.86 21.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.947 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 1.078 HG21 HD13 ' A' ' 19' ' ' ILE . 71.6 p -107.49 140.31 40.66 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.296 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.33 164.76 15.25 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.309 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.422 ' HD3' ' CE2' ' A' ' 61' ' ' PHE . 51.4 Cg_exo -52.82 138.34 60.34 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.399 2.066 . . . . 0.0 111.844 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.604 ' CE1' HG11 ' A' ' 53' ' ' VAL . 41.4 t80 -60.74 133.48 56.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.85 0.357 . . . . 0.0 111.113 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.408 ' CB ' ' HB2' ' A' ' 79' ' ' ASN . 0.5 OUTLIER -123.86 134.79 25.61 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.639 179.724 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.03 -34.78 16.22 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.46 2.106 . . . . 0.0 112.847 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 36.6 m-20 -86.87 -0.52 56.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.735 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.408 ' HB2' ' CB ' ' A' ' 76' ' ' ASP . 0.3 OUTLIER -105.8 101.38 32.68 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-O 120.639 0.257 . . . . 0.0 111.078 -179.859 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.856 ' O ' HD21 ' A' ' 94' ' ' LEU . 74.1 Cg_endo -77.2 21.45 0.61 Allowed 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.63 2.22 . . . . 0.0 113.091 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.591 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 6.6 mptt -117.97 -19.86 8.98 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.127 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.531 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 3.2 mtm180 -88.88 19.99 3.79 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -178.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 1.1 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -128.86 99.23 5.23 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.091 0.472 . . . . 0.0 110.81 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.623 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 59.5 m95 -109.54 135.5 50.44 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.148 0.499 . . . . 0.0 111.91 -178.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.2 pp -114.05 154.37 15.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.297 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.5 t -100.53 125.05 54.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.919 0.39 . . . . 0.0 111.085 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 12.9 t -117.62 93.55 4.2 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.433 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.12 -100.52 0.79 Allowed Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.538 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.492 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.64 29.42 7.43 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.534 0.207 . . . . 0.0 110.927 -179.658 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.488 HG22 ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.87 147.83 30.19 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.334 0.588 . . . . 0.0 112.473 -178.729 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.77 ' HB ' HD12 ' A' ' 101' ' ' LEU . 14.7 mm -93.49 119.88 42.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.144 178.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.982 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -122.25 145.17 48.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.236 0.541 . . . . 0.0 112.434 -178.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.434 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -66.84 148.3 52.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.627 179.719 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.1 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.7 pt? -60.6 -56.74 17.7 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.554 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.572 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 0.3 OUTLIER -77.74 -3.51 41.6 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 -178.428 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.407 ' HB2' ' HB3' ' A' ' 93' ' ' GLN . 4.9 m-20 -138.1 86.33 2.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.799 0.333 . . . . 0.0 110.961 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 14.7 mmt180 -67.74 -18.04 64.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.21 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -92.93 11.33 27.67 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.43 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.846 ' CG2' ' HB1' ' A' ' 116' ' ' ALA . 9.8 mm -124.93 130.25 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.569 179.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.982 HG12 ' HB2' ' A' ' 92' ' ' ALA . 27.7 m -147.34 136.91 16.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.84 0.352 . . . . 0.0 111.783 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.77 HD12 ' HB ' ' A' ' 91' ' ' ILE . 9.4 mt -46.71 154.7 0.3 Allowed 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.674 0.749 . . . . 0.0 111.909 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.771 ' O ' HG22 ' A' ' 114' ' ' ILE . 10.1 t70 -160.49 169.74 22.39 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.493 -1.231 . . . . 0.0 110.746 -177.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.803 HD12 ' O ' ' A' ' 124' ' ' ASN . 4.0 mp -86.48 124.13 40.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.238 179.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.799 HG22 ' O ' ' A' ' 113' ' ' HIS . 1.1 tt -63.57 138.38 23.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.066 0.46 . . . . 0.0 111.582 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 25.5 mttp 48.62 24.99 0.86 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.6 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 33.2 t 44.48 -121.32 0.82 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.98 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 61.11 150.26 0.02 OUTLIER 'General case' 0 C--N 1.334 -0.079 0 CA-C-O 120.923 0.392 . . . . 0.0 111.203 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.22 -13.5 55.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.182 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -45.74 136.5 6.07 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.369 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -89.84 162.2 15.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.21 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 73.36 18.03 79.15 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.192 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -85.03 136.67 33.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.805 0.336 . . . . 0.0 110.885 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.799 ' O ' HG22 ' A' ' 104' ' ' ILE . 2.6 m80 -61.07 170.84 1.45 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.888 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.771 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.7 OUTLIER -142.11 161.63 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.685 -179.859 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.666 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 20.8 p -156.84 173.75 16.53 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.846 ' HB1' ' CG2' ' A' ' 99' ' ' ILE . . . -95.47 128.79 42.61 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.464 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 73.9 t-105 -136.61 162.44 33.13 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.585 0.707 . . . . 0.0 112.128 -179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.464 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.1 OUTLIER -60.26 119.43 7.9 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.663 179.887 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -62.45 129.04 38.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.095 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -139.35 12.88 2.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.107 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 80.64 11.79 83.62 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.833 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.25 139.08 41.67 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.497 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.51 -28.37 54.54 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.472 2.115 . . . . 0.0 112.326 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.803 ' O ' HD12 ' A' ' 103' ' ' ILE . 14.5 p-10 -74.66 -2.15 24.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.622 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.488 ' O ' HG22 ' A' ' 90' ' ' THR . 91.5 mt-30 -104.45 -15.53 15.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.745 -0.207 . . . . 0.0 111.441 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.415 ' O ' ' CD1' ' A' ' 127' ' ' PHE . 0.2 OUTLIER -78.07 137.87 38.47 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.899 0.38 . . . . 0.0 111.361 -179.29 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.415 ' CD1' ' O ' ' A' ' 126' ' ' LYS . 8.4 m-85 -137.5 156.26 48.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.155 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 mt -114.32 137.03 48.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.151 0.501 . . . . 0.0 110.57 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.507 ' CD1' HG23 ' A' ' 8' ' ' ILE . 33.5 mm -113.59 139.49 38.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.574 -179.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -138.82 109.39 6.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.501 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.76 110.24 1.11 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.047 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.622 ' OE1' HD22 ' A' ' 45' ' ' LEU . 3.4 tt0 . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.894 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.138 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.762 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -155.89 172.39 18.44 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.804 179.638 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.458 ' CE1' ' HB3' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -112.95 123.85 51.27 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.13 179.135 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.621 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -105.18 108.96 26.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.906 0.384 . . . . 0.0 110.389 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.423 ' HG3' ' O ' ' A' ' 15' ' ' LYS . 7.7 tttt -105.82 136.14 45.99 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.235 -178.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.514 ' OG ' HD21 ' A' ' 17' ' ' LEU . 70.3 m -73.85 109.17 7.15 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.445 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 3.8 tt0 -63.14 -12.39 27.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.521 -178.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.494 HD22 ' CB ' ' A' ' 124' ' ' ASN . 43.5 tp -84.8 -62.12 1.62 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.894 0.378 . . . . 0.0 111.115 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.724 HD21 HG21 ' A' ' 103' ' ' ILE . 8.9 m-20 -84.33 -12.71 54.1 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -178.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.5 3.02 70.4 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.007 -1.092 . . . . 0.0 111.632 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.44 ' HG2' ' HB2' ' A' ' 13' ' ' ASN . 13.2 mmtp -91.58 -177.26 4.75 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.643 HG21 ' HA ' ' A' ' 35' ' ' GLN . 4.3 m -121.7 142.21 38.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.787 0.327 . . . . 0.0 110.614 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.514 HD21 ' OG ' ' A' ' 10' ' ' SER . 9.2 mt -70.56 134.94 48.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.276 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 19' ' ' ILE . 61.5 t0 -142.51 141.72 32.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.767 0.318 . . . . 0.0 111.043 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.028 HD13 HG21 ' A' ' 72' ' ' THR . 25.1 mt . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.564 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.462 0 CA-C-O 120.28 -0.178 . . . . 0.0 112.912 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.88 139.73 50.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 117.028 0.414 . . . . 0.0 110.784 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.88 158.38 16.33 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.485 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.718 HD11 ' HB ' ' A' ' 70' ' ' ILE . 37.3 pt -117.53 147.56 20.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.548 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.463 ' HA ' ' CD1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -155.44 -179.72 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.728 -179.84 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 p -103.77 150.55 23.98 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.667 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 31.4 t-105 -158.8 173.49 16.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.643 0.259 . . . . 0.0 110.922 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -68.89 131.68 45.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.82 0.343 . . . . 0.0 110.693 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.643 ' HA ' HG21 ' A' ' 16' ' ' VAL . 5.3 tt0 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.348 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.827 ' O ' HD12 ' A' ' 45' ' ' LEU . . . . . . . . 0 N--CA 1.456 -0.156 0 CA-C-O 120.767 0.317 . . . . 0.0 110.443 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.4 t -50.48 -28.84 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.817 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -57.65 -13.75 4.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.144 -179.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.458 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -121.31 12.24 10.91 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 120.926 0.393 . . . . 0.0 110.364 -179.909 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.827 HD12 ' O ' ' A' ' 41' ' ' ALA . 1.2 mp -118.32 140.13 50.29 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.062 -179.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.707 ' CZ2' HD11 ' A' ' 19' ' ' ILE . 23.8 m95 -133.3 169.19 17.27 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.098 -179.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.53 ' CZ ' ' HB2' ' A' ' 55' ' ' ARG . 31.1 p90 -142.39 165.71 26.67 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.317 179.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.442 HG22 ' CG2' ' A' ' 54' ' ' ILE . 74.6 p -106.84 131.79 53.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.81 0.338 . . . . 0.0 111.272 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -77.44 165.6 24.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.077 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -63.12 -26.9 69.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.951 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -85.97 -4.64 59.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.277 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.431 ' O ' HG22 ' A' ' 85' ' ' ILE . . . 96.48 15.08 41.97 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.82 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.507 HG12 ' HD3' ' A' ' 55' ' ' ARG . 40.2 t -106.09 123.74 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-O 120.662 0.267 . . . . 0.0 110.495 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.464 HD11 ' HB2' ' A' ' 84' ' ' TRP . 0.6 OUTLIER -77.5 148.74 6.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.289 0.566 . . . . 0.0 111.828 -179.963 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.552 ' CD ' ' HB2' ' A' ' 62' ' ' ALA . 0.2 OUTLIER -150.06 133.28 16.34 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.323 178.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.518 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 16.5 m . . . . . 0 C--N 1.326 -0.437 0 CA-C-O 121.512 0.673 . . . . 0.0 112.029 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.443 ' CE2' ' HD3' ' A' ' 74' ' ' PRO . 2.9 m-85 . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.818 0.342 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.552 ' HB2' ' CD ' ' A' ' 55' ' ' ARG . . . -109.51 153.24 24.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.405 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.817 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -79.15 151.82 4.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.595 179.647 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.633 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 10.5 p-10 -133.42 130.54 38.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.261 0.553 . . . . 0.0 111.787 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.691 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -93.58 41.26 1.08 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.398 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 77.7 p -74.73 -42.87 57.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.379 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -98.11 171.04 8.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.096 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -47.6 -46.34 28.26 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.095 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.05 143.98 31.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.029 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.817 HG22 HG22 ' A' ' 63' ' ' ILE . 3.0 mm -71.38 136.38 25.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 CA-C-O 121.605 0.717 . . . . 0.0 111.454 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.438 ' O ' HG22 ' A' ' 63' ' ' ILE . 18.3 mt-10 -133.07 165.59 24.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.351 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 1.028 HG21 HD13 ' A' ' 19' ' ' ILE . 27.5 p -105.21 134.45 48.29 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.212 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.462 ' HG2' ' C ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -161.75 167.82 12.22 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.181 -179.681 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.443 ' HD3' ' CE2' ' A' ' 61' ' ' PHE . 21.4 Cg_endo -61.11 139.44 84.12 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.308 2.005 . . . . 0.0 112.015 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.466 ' CE1' ' HB2' ' A' ' 83' ' ' ALA . 16.9 t80 -59.58 139.65 56.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.935 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.406 ' HB3' ' CB ' ' A' ' 79' ' ' ASN . 1.1 t0 -129.38 135.0 26.89 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.791 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -68.24 -35.63 18.52 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.505 2.137 . . . . 0.0 112.762 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -88.79 -1.25 57.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.699 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.427 ' HB3' ' HD2' ' A' ' 82' ' ' ARG . 2.9 t-20 -110.91 99.05 41.02 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-O 120.611 0.243 . . . . 0.0 110.846 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.532 ' O ' HD21 ' A' ' 94' ' ' LEU . 4.4 Cg_exo -74.94 27.98 0.36 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.878 2.385 . . . . 0.0 113.387 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.633 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -119.03 -23.63 6.8 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-O 120.673 0.273 . . . . 0.0 111.036 -179.833 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.47 ' HG3' ' HB3' ' A' ' 64' ' ' ASP . 0.6 OUTLIER -86.35 22.97 1.68 Allowed 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -179.076 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 1.04 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -133.7 99.96 4.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.206 0.527 . . . . 0.0 111.17 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.691 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 59.7 m95 -109.67 136.61 48.75 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.891 -178.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.44 HD11 ' HD3' ' A' ' 97' ' ' ARG . 20.4 pt -113.37 154.52 14.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.112 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.5 t -101.75 125.93 55.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.993 0.425 . . . . 0.0 111.057 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.9 t -118.74 93.87 4.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.338 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.41 -100.73 0.83 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.425 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.499 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -121.15 29.78 7.15 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.544 0.211 . . . . 0.0 110.842 -179.868 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.408 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.12 147.46 30.58 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -178.6 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.765 ' HB ' HD12 ' A' ' 101' ' ' LEU . 14.1 mm -93.86 119.17 41.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.492 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.964 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -123.27 146.68 47.67 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -178.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.422 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.1 OUTLIER -64.78 149.18 49.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.599 179.867 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.04 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.7 pt? -64.61 -56.88 11.08 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.551 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.612 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 47.3 t -76.2 -2.3 30.57 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -178.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.555 ' O ' HG22 ' A' ' 99' ' ' ILE . 11.1 m-20 -145.85 90.85 2.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.029 0.442 . . . . 0.0 110.939 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.44 ' HD3' HD11 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -73.43 -13.7 61.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.546 179.351 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -86.15 10.44 14.49 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.486 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.854 HG12 ' HB1' ' A' ' 116' ' ' ALA . 3.2 tt -135.12 142.38 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.964 HG12 ' HB2' ' A' ' 92' ' ' ALA . 32.1 m -150.51 139.51 15.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.851 0.357 . . . . 0.0 111.871 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.765 HD12 ' HB ' ' A' ' 91' ' ' ILE . 11.9 mt -45.58 154.13 0.22 Allowed 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.8 0.809 . . . . 0.0 111.997 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.718 ' O ' HG22 ' A' ' 114' ' ' ILE . 9.4 t70 -157.51 167.71 29.41 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 114.18 -1.373 . . . . 0.0 110.563 -177.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.724 HG21 HD21 ' A' ' 13' ' ' ASN . 4.5 mp -90.42 122.44 41.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.406 179.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.749 HG22 ' O ' ' A' ' 113' ' ' HIS . 8.9 tt -67.45 140.86 18.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.971 0.415 . . . . 0.0 111.379 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt 76.95 -7.32 1.87 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.935 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.6 m 46.56 28.85 0.82 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 120.76 0.314 . . . . 0.0 111.232 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -99.63 159.96 14.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.052 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.36 -14.43 58.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.182 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -47.48 126.18 9.39 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.163 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.87 158.31 36.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.225 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.57 14.77 80.89 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.327 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.1 131.91 38.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.816 0.341 . . . . 0.0 110.872 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.749 ' O ' HG22 ' A' ' 104' ' ' ILE . 8.1 m170 -65.1 173.52 2.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.024 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.718 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -136.35 161.5 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.367 179.928 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.579 ' HA ' HD11 ' A' ' 70' ' ' ILE . 7.4 t -152.47 166.57 31.55 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.854 ' HB1' HG12 ' A' ' 99' ' ' ILE . . . -93.92 125.02 38.3 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.46 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 68.2 t-105 -131.49 161.72 31.89 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.672 0.748 . . . . 0.0 112.455 -179.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.46 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.0 OUTLIER -63.85 121.13 13.3 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.792 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -60.43 124.11 19.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.977 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -136.18 8.4 3.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.503 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 79.53 57.16 3.18 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.479 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -116.51 143.31 18.01 Favored Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.488 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.82 -32.53 77.44 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.57 2.18 . . . . 0.0 112.326 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.576 ' O ' HD12 ' A' ' 103' ' ' ILE . 18.7 p-10 -73.71 -5.33 39.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.632 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.408 ' O ' ' CG2' ' A' ' 90' ' ' THR . 93.0 mt-30 -107.29 10.11 29.85 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.509 0.195 . . . . 0.0 111.362 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.445 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -106.21 140.86 38.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.864 0.364 . . . . 0.0 111.104 -179.627 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.428 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 7.9 m-85 -139.35 156.84 46.74 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.45 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.4 mt -113.79 139.17 40.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.095 0.474 . . . . 0.0 110.679 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.53 ' CD1' HG23 ' A' ' 8' ' ' ILE . 25.5 mm -114.6 139.96 37.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.62 -179.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -137.47 94.56 2.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.59 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 27.2 m -51.04 108.67 0.26 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.356 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.198 -0.906 . . . . 0.0 111.172 179.824 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.474 ' HA ' ' O ' ' A' ' 46' ' ' TRP . 17.0 m-85 . . . . . 0 C--O 1.231 0.087 0 N-CA-C 110.493 -0.188 . . . . 0.0 110.493 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.77 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -159.42 176.02 12.61 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.76 179.694 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.442 ' CE1' ' HB3' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -114.96 124.12 50.87 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.365 179.099 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.614 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -105.89 109.4 27.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.465 179.921 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 16' ' ' VAL . 1.3 tttm -105.82 136.61 45.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.064 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 79.3 p -76.51 107.76 9.02 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 178.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.419 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 2.2 tt0 -63.15 -10.33 14.57 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.467 -178.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 27.0 tp -83.16 -62.67 1.53 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.862 0.363 . . . . 0.0 110.911 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.65 HD21 HG21 ' A' ' 103' ' ' ILE . 8.0 m-20 -86.25 -10.83 53.86 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -178.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.39 3.74 72.07 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.172 -1.014 . . . . 0.0 111.421 -178.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.0 mmmm -91.67 -177.73 4.86 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 122.583 0.353 . . . . 0.0 110.054 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.574 HG21 ' HA ' ' A' ' 35' ' ' GLN . 4.5 m -121.27 140.83 44.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.69 0.281 . . . . 0.0 110.484 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.1 mt -70.67 136.26 48.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.233 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -140.51 153.98 46.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.85 0.357 . . . . 0.0 111.147 -179.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.912 HD13 HG21 ' A' ' 72' ' ' THR . 1.6 mt . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.59 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.404 0 N-CA-C 112.7 -0.16 . . . . 0.0 112.7 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.7 m -71.75 137.47 47.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.903 0.382 . . . . 0.0 111.134 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.99 156.64 19.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.299 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.701 HD11 ' HB ' ' A' ' 70' ' ' ILE . 44.2 pt -116.42 145.59 21.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.913 0.387 . . . . 0.0 111.598 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.442 HG22 ' HA ' ' A' ' 113' ' ' HIS . 0.2 OUTLIER -155.93 -178.91 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.164 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.529 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.4 p -101.2 148.92 24.53 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.561 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 18.1 t-105 -156.81 171.67 19.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.721 0.296 . . . . 0.0 110.98 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.45 134.51 47.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.719 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.574 ' HA ' HG21 ' A' ' 16' ' ' VAL . 3.5 tt0 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.112 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.987 ' O ' HD12 ' A' ' 45' ' ' LEU . . . . . . . . 0 N--CA 1.457 -0.115 0 CA-C-O 120.722 0.296 . . . . 0.0 111.109 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 81.6 t -49.44 -33.24 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.103 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -66.26 -9.26 30.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.046 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.442 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 6.4 mt-30 -118.95 8.22 11.61 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.987 HD12 ' O ' ' A' ' 41' ' ' ALA . 0.9 OUTLIER -117.65 140.11 50.09 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.71 -178.943 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.627 ' CZ2' HD11 ' A' ' 19' ' ' ILE . 23.1 m95 -134.0 168.62 18.46 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.545 -178.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.531 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 5.3 p90 -136.53 160.29 39.21 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.081 179.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.427 HG22 HG23 ' A' ' 54' ' ' ILE . 29.1 p -105.72 134.55 48.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.708 0.29 . . . . 0.0 110.9 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 53' ' ' VAL . 28.2 t70 -77.42 165.68 24.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.88 0.371 . . . . 0.0 111.092 -179.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.1 mm-40 -55.45 -21.76 17.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.28 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -103.94 -1.26 27.9 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.414 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.62 -0.15 49.4 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.69 -0.766 . . . . 0.0 113.068 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.405 ' O ' ' HB2' ' A' ' 49' ' ' ASP . 19.0 t -78.95 113.62 18.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.817 0.342 . . . . 0.0 110.695 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.531 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.8 OUTLIER -79.55 147.14 6.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.407 0.622 . . . . 0.0 112.212 -179.537 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.776 ' CD ' ' HB2' ' A' ' 62' ' ' ALA . 0.1 OUTLIER -150.82 132.58 14.98 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.904 178.5 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.501 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 99.9 p . . . . . 0 CA--C 1.508 -0.639 0 CA-C-O 121.758 0.789 . . . . 0.0 111.818 -179.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.745 0.307 . . . . 0.0 110.816 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.776 ' HB2' ' CD ' ' A' ' 55' ' ' ARG . . . -104.94 151.22 24.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.514 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.839 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -79.79 151.82 4.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.465 179.607 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.618 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 7.4 p-10 -133.38 130.69 39.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.244 0.545 . . . . 0.0 111.776 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.676 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -93.33 43.48 1.12 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.245 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.0 m -75.48 -45.63 37.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.448 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -95.85 171.89 8.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.018 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -49.17 -41.77 37.68 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.91 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.24 144.23 32.32 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.801 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.839 HG22 HG22 ' A' ' 63' ' ' ILE . 2.5 mm -74.3 139.71 18.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.537 0.684 . . . . 0.0 111.441 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.406 ' O ' HG22 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -138.61 166.83 23.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.718 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.912 HG21 HD13 ' A' ' 19' ' ' ILE . 47.3 p -105.09 138.91 40.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.139 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.07 169.54 8.03 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.2 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -61.16 137.35 70.67 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.491 2.128 . . . . 0.0 112.028 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -54.84 128.0 31.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.074 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.444 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 8.9 t70 -116.9 129.33 25.39 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.64 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -68.52 -35.35 17.69 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.546 2.164 . . . . 0.0 113.01 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 56.4 m-20 -86.78 -1.59 57.88 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.444 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 1.6 t-20 -116.36 99.52 52.79 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-O 120.659 0.266 . . . . 0.0 110.795 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.542 ' O ' HD21 ' A' ' 94' ' ' LEU . 8.1 Cg_exo -72.51 32.63 0.28 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.068 2.512 . . . . 0.0 113.498 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.618 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 0.7 OUTLIER -118.89 -23.96 6.76 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 120.656 0.265 . . . . 0.0 111.171 -179.718 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.489 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 8.3 mtt-85 -85.13 18.71 2.44 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.998 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -127.76 99.26 5.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.201 0.524 . . . . 0.0 111.317 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.676 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 59.7 m95 -109.93 135.56 50.61 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.803 -179.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.9 pt -114.79 155.6 15.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.19 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.3 t -103.22 130.25 53.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.962 0.41 . . . . 0.0 111.143 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 30.5 t -123.04 94.99 4.44 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.286 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.25 -100.51 0.8 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.423 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.501 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.93 29.68 7.25 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.532 0.206 . . . . 0.0 110.919 -179.756 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.403 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.39 147.24 30.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.394 0.616 . . . . 0.0 112.648 -178.536 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.74 ' HB ' HD12 ' A' ' 101' ' ' LEU . 17.3 mm -94.12 119.87 42.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.2 178.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.977 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -122.54 144.88 48.8 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.432 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -64.99 147.74 52.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.52 179.452 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.998 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.6 pt? -62.73 -56.52 16.86 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.436 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.617 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 45.6 p -75.15 -4.59 39.62 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -178.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.583 ' O ' HG22 ' A' ' 99' ' ' ILE . 8.6 m-20 -140.1 89.03 2.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.815 0.34 . . . . 0.0 110.864 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.8 mmm-85 -70.78 -15.87 62.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.235 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.22 11.88 21.99 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.154 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.583 HG22 ' O ' ' A' ' 96' ' ' ASP . 1.0 OUTLIER -130.38 136.84 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.086 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.977 HG12 ' HB2' ' A' ' 92' ' ' ALA . 26.8 m -148.47 138.41 16.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.777 0.322 . . . . 0.0 111.643 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.74 HD12 ' HB ' ' A' ' 91' ' ' ILE . 10.7 mt -45.98 153.84 0.28 Allowed 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.723 0.773 . . . . 0.0 111.768 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.782 ' O ' HG22 ' A' ' 114' ' ' ILE . 10.3 t70 -157.51 167.7 29.43 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.789 -177.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.691 HD12 ' O ' ' A' ' 124' ' ' ASN . 4.3 mp -89.18 120.57 38.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.553 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.453 HG12 ' HA ' ' A' ' 114' ' ' ILE . 45.7 mm -69.2 143.25 15.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.823 0.344 . . . . 0.0 111.13 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 80.13 -9.82 1.36 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.689 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 46.76 29.51 0.99 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.749 0.309 . . . . 0.0 111.238 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 54.0 p30 -105.46 163.54 12.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.033 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -80.56 -14.38 58.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.181 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -49.24 120.96 4.4 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.174 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.03 161.99 30.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.25 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 72.24 18.53 78.14 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.231 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -82.85 136.48 34.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.803 0.335 . . . . 0.0 111.112 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.442 ' HA ' HG22 ' A' ' 31' ' ' ILE . 5.5 m170 -62.61 168.08 3.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.939 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.782 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.7 OUTLIER -138.33 161.35 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.74 -179.772 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.65 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 5.2 t -155.15 169.67 23.62 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.667 ' HB2' ' HH2' ' A' ' 84' ' ' TRP . . . -94.08 125.91 38.99 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.046 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.459 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 76.3 t-105 -132.88 162.28 31.99 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.622 0.725 . . . . 0.0 112.311 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.459 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.1 OUTLIER -61.2 120.2 9.9 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.581 -1.191 . . . . 0.0 110.608 179.855 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -59.25 126.63 28.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.122 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -134.63 10.01 3.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.289 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 78.92 8.85 87.59 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.923 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.36 152.32 44.61 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.537 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.88 -27.09 59.06 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.606 2.204 . . . . 0.0 112.206 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.691 ' O ' HD12 ' A' ' 103' ' ' ILE . 25.4 p-10 -76.31 -1.93 29.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.479 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.403 ' O ' ' CG2' ' A' ' 90' ' ' THR . 0.0 OUTLIER -109.17 13.31 24.51 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 116.736 -0.211 . . . . 0.0 111.072 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.419 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 7.5 mmmt -104.61 132.53 50.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.789 0.328 . . . . 0.0 111.273 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.43 ' CD1' ' N ' ' A' ' 127' ' ' PHE . 1.7 m-85 -135.83 154.99 51.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.376 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 mt -114.33 139.82 38.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.163 0.506 . . . . 0.0 110.706 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.584 ' CD1' HG23 ' A' ' 8' ' ' ILE . 24.6 mm -114.54 140.73 33.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.707 -179.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -139.15 95.33 2.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.616 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.8 m -50.25 113.15 0.8 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.466 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.908 -179.986 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 46' ' ' TRP . 1.6 p90 . . . . . 0 C--O 1.231 0.087 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.766 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -159.9 176.16 12.21 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.746 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.457 ' CE1' ' HB3' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -113.71 123.91 51.01 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.26 179.195 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.696 ' HB ' HD21 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -105.09 109.42 27.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.912 0.386 . . . . 0.0 110.58 -179.983 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.41 ' HG3' ' O ' ' A' ' 15' ' ' LYS . 2.8 tttt -107.09 138.61 42.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.022 -0.535 . . . . 0.0 112.271 -178.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.1 p -77.54 109.29 11.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.658 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.429 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 4.1 tt0 -64.58 -10.14 24.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.598 -178.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.569 HD22 ' HA ' ' A' ' 124' ' ' ASN . 65.0 tp -84.0 -62.79 1.48 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.974 0.416 . . . . 0.0 110.906 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.586 HD21 HG21 ' A' ' 103' ' ' ILE . 6.1 m-20 -85.53 -12.36 51.89 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -178.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.83 1.9 74.5 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.038 -1.077 . . . . 0.0 111.245 -178.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.432 ' HG2' ' HB2' ' A' ' 13' ' ' ASN . 6.6 mmmt -90.41 179.81 5.78 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.485 HG21 ' HA ' ' A' ' 35' ' ' GLN . 4.0 m -121.13 141.66 40.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.696 HD21 ' HB ' ' A' ' 8' ' ' ILE . 0.1 OUTLIER -71.89 136.62 46.99 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.374 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -142.1 150.37 41.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.948 0.404 . . . . 0.0 111.335 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.891 HD13 HG21 ' A' ' 72' ' ' THR . 23.7 mt . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.507 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 CA-C-O 120.361 -0.133 . . . . 0.0 113.09 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.23 129.71 37.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.942 0.401 . . . . 0.0 111.118 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.408 ' HA ' ' HG3' ' A' ' 71' ' ' GLU . 9.8 mmtt -81.16 159.51 24.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.554 179.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.626 HD11 ' HB ' ' A' ' 70' ' ' ILE . 48.2 pt -119.89 147.91 23.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.976 0.417 . . . . 0.0 111.729 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.431 HG22 ' HA ' ' A' ' 113' ' ' HIS . 0.2 OUTLIER -155.74 -179.34 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.176 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.581 -179.881 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.693 HG21 HD12 ' A' ' 103' ' ' ILE . 2.8 p -100.97 148.45 25.0 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.639 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 51.6 t-105 -156.77 170.92 21.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.681 0.277 . . . . 0.0 110.819 -179.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.62 135.53 48.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.744 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.485 ' HA ' HG21 ' A' ' 16' ' ' VAL . 28.2 tt0 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.019 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.93 ' O ' HD12 ' A' ' 45' ' ' LEU . . . . . . . . 0 CA--C 1.528 0.105 0 CA-C-O 120.684 0.278 . . . . 0.0 111.307 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 57.3 t -48.88 -27.12 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.272 179.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -64.38 -11.74 35.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.912 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.471 ' NE2' HG23 ' A' ' 16' ' ' VAL . 5.6 mt-30 -120.28 7.16 10.7 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.096 0.474 . . . . 0.0 109.784 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.93 HD12 ' O ' ' A' ' 41' ' ' ALA . 1.3 mp -118.18 140.21 50.12 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.949 -179.064 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.568 ' CZ2' HD11 ' A' ' 19' ' ' ILE . 25.5 m95 -135.12 169.88 16.77 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.019 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.567 ' CZ ' ' HB2' ' A' ' 55' ' ' ARG . 5.2 p90 -141.13 165.5 27.36 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.158 178.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.53 131.7 52.6 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.827 0.346 . . . . 0.0 111.195 -179.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -77.61 165.48 24.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.093 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -59.94 -25.26 65.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.12 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -91.84 -3.57 55.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.391 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.84 ' O ' HG22 ' A' ' 85' ' ' ILE . . . 97.75 10.4 52.9 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.891 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.639 HG13 ' HA ' ' A' ' 83' ' ' ALA . 5.5 t -98.23 121.22 48.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.778 0.323 . . . . 0.0 110.495 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.552 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -75.63 147.5 8.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.198 0.523 . . . . 0.0 111.884 -179.733 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.596 ' HD2' ' HB2' ' A' ' 62' ' ' ALA . 0.2 OUTLIER -151.79 135.59 16.36 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.62 179.063 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 73.1 m . . . . . 0 C--N 1.328 -0.368 0 CA-C-O 121.255 0.55 . . . . 0.0 112.047 -179.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.42 ' CZ ' ' HG3' ' A' ' 74' ' ' PRO . 2.3 m-85 . . . . . 0 C--O 1.233 0.185 0 CA-C-O 120.81 0.338 . . . . 0.0 110.725 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.596 ' HB2' ' HD2' ' A' ' 55' ' ' ARG . . . -109.4 150.96 27.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.458 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.857 HG22 HG22 ' A' ' 70' ' ' ILE . 0.3 OUTLIER -78.45 153.77 5.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.583 179.614 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.606 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 4.7 p-10 -133.28 130.19 38.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.226 0.536 . . . . 0.0 111.832 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.67 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -93.95 39.92 1.08 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.433 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.31 -44.73 51.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.172 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 50.6 m170 -94.11 169.44 10.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.928 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -46.9 -47.66 21.44 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.999 0.428 . . . . 0.0 110.956 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.409 ' OE1' ' CE1' ' A' ' 113' ' ' HIS . 0.0 OUTLIER -100.98 145.17 29.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.623 179.212 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.857 HG22 HG22 ' A' ' 63' ' ' ILE . 2.3 mm -73.09 137.8 22.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-O 121.553 0.692 . . . . 0.0 111.489 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.408 ' HG3' ' HA ' ' A' ' 29' ' ' LYS . 3.7 tt0 -132.34 161.93 32.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.015 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.891 HG21 HD13 ' A' ' 19' ' ' ILE . 28.3 p -104.04 138.89 39.92 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.635 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.91 160.46 15.02 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.654 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.421 ' O ' ' HD3' ' A' ' 82' ' ' ARG . 51.1 Cg_exo -53.51 141.88 61.12 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.441 2.094 . . . . 0.0 111.785 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -55.13 134.6 49.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.875 0.369 . . . . 0.0 111.352 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -126.31 118.96 23.33 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.609 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -58.33 -36.66 97.41 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.633 2.222 . . . . 0.0 113.231 -179.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 29.1 m-20 -86.1 -0.68 56.2 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -106.5 103.54 46.65 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.6 0.238 . . . . 0.0 111.137 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.529 ' O ' HD21 ' A' ' 94' ' ' LEU . 79.1 Cg_endo -77.37 23.09 0.55 Allowed 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.649 2.233 . . . . 0.0 113.132 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.606 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 0.7 OUTLIER -119.87 -21.18 7.27 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.966 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.54 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 2.5 mtm180 -86.66 20.93 2.34 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.991 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -129.79 99.91 5.3 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.275 0.56 . . . . 0.0 111.066 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.67 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 63.4 m95 -110.47 136.8 49.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.846 -178.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.84 HG22 ' O ' ' A' ' 52' ' ' GLY . 1.2 pp -117.01 155.45 18.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.215 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.1 t -100.79 125.77 54.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.917 0.389 . . . . 0.0 111.054 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 12.7 t -118.5 93.62 4.18 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.487 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.22 -100.84 0.82 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.517 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.501 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.74 29.32 7.47 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.557 0.218 . . . . 0.0 110.939 -179.655 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.419 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.82 148.18 30.61 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.379 0.609 . . . . 0.0 112.552 -178.576 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.754 ' HB ' HD12 ' A' ' 101' ' ' LEU . 16.7 mm -93.41 119.98 42.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.303 178.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.953 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -123.55 145.29 48.99 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -178.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.434 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -66.67 147.05 53.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.723 179.713 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.991 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.6 pt? -60.81 -56.23 23.65 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.499 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.616 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 2.8 m -76.75 -3.95 40.83 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -178.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -139.04 87.88 2.24 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.88 0.371 . . . . 0.0 111.071 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -66.92 -18.25 65.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.173 179.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.27 10.42 32.03 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.509 179.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.839 ' CG2' ' HB1' ' A' ' 116' ' ' ALA . 12.1 mm -122.37 127.29 75.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.596 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.953 HG12 ' HB2' ' A' ' 92' ' ' ALA . 29.6 m -146.14 135.52 17.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.821 0.343 . . . . 0.0 111.796 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.754 HD12 ' HB ' ' A' ' 91' ' ' ILE . 10.8 mt -45.97 154.0 0.27 Allowed 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.66 0.743 . . . . 0.0 111.913 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.821 ' O ' HG22 ' A' ' 114' ' ' ILE . 10.8 t70 -157.92 168.59 26.74 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.88 -177.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.693 HD12 HG21 ' A' ' 32' ' ' THR . 34.6 mm -88.77 126.95 41.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.603 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.713 HG22 ' O ' ' A' ' 113' ' ' HIS . 0.5 OUTLIER -64.16 134.11 29.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.184 0.516 . . . . 0.0 111.449 -179.699 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 12.7 tttm 62.46 10.2 3.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.929 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.0 p 40.22 33.21 0.15 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.697 0.284 . . . . 0.0 111.587 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.93 154.73 18.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.931 0.396 . . . . 0.0 111.191 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.28 -16.17 56.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.322 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -49.36 126.52 13.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.791 0.329 . . . . 0.0 111.308 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -73.1 157.95 36.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.031 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.48 14.08 81.27 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.17 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.52 134.03 38.4 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.924 0.392 . . . . 0.0 111.035 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.713 ' O ' HG22 ' A' ' 104' ' ' ILE . 0.3 OUTLIER -60.91 167.08 3.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.878 -179.798 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.821 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.1 OUTLIER -139.48 161.41 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.728 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.673 ' HA ' HD11 ' A' ' 70' ' ' ILE . 5.7 p -157.6 173.3 17.07 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.839 ' HB1' ' CG2' ' A' ' 99' ' ' ILE . . . -95.27 129.47 42.38 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.456 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 75.7 t-105 -136.04 162.47 32.79 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.565 0.698 . . . . 0.0 112.096 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.456 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.0 OUTLIER -61.63 118.77 7.51 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.773 179.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -59.01 127.13 30.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.997 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -134.08 11.25 3.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.155 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 77.44 7.64 87.06 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.864 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.5 154.88 41.4 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.507 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.46 -28.4 53.99 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.625 2.216 . . . . 0.0 112.28 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.569 ' HA ' HD22 ' A' ' 12' ' ' LEU . 30.3 p-10 -74.52 -4.07 34.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.589 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.419 ' O ' ' CG2' ' A' ' 90' ' ' THR . 0.0 OUTLIER -108.34 15.81 23.69 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.571 0.224 . . . . 0.0 111.176 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.429 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 16.7 mmtt -107.06 134.01 50.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.765 0.317 . . . . 0.0 111.384 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.43 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 4.5 m-85 -137.05 155.29 49.85 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.303 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.4 mt -113.55 139.14 40.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.174 0.511 . . . . 0.0 110.587 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.575 HD12 HG23 ' A' ' 8' ' ' ILE . 24.0 mm -113.97 139.79 37.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.616 -179.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -136.77 94.68 3.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.628 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.3 p -52.48 110.81 0.54 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.253 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.448 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 5.2 tp10 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.996 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.471 ' CE2' ' HB3' ' A' ' 132' ' ' GLU . 2.3 p90 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.451 0.167 . . . . 0.0 110.7 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.723 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -161.08 177.8 9.94 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.628 179.73 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.75 ' OH ' ' HB1' ' A' ' 41' ' ' ALA . 1.0 OUTLIER -112.61 123.83 51.18 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.42 179.379 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.617 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -103.97 109.42 27.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.123 0.487 . . . . 0.0 109.802 179.552 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.506 ' HE2' HD12 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -102.89 130.84 50.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.579 -178.025 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.68 103.18 7.46 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 178.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.421 ' HB3' ' O ' ' A' ' 126' ' ' LYS . 3.3 tt0 -65.58 -8.22 18.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.768 -178.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.722 HD22 ' CB ' ' A' ' 124' ' ' ASN . 36.1 tp -83.16 -63.6 1.33 Allowed 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.44 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.44 HD21 HG21 ' A' ' 103' ' ' ILE . 3.3 m-80 -83.72 -7.78 59.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.862 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.78 4.85 72.54 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.11 -1.043 . . . . 0.0 111.234 -177.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm -94.43 -166.31 1.46 Allowed 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 122.809 0.444 . . . . 0.0 109.958 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.58 HG21 ' HA ' ' A' ' 35' ' ' GLN . 6.3 m -130.78 143.93 39.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.3 mt -70.19 135.11 48.76 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -145.15 155.97 43.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.915 0.388 . . . . 0.0 111.196 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.066 HD13 HG21 ' A' ' 72' ' ' THR . 17.4 mt . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.517 179.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 CA-C-O 120.285 -0.175 . . . . 0.0 113.3 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.55 125.24 26.97 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 117.102 0.451 . . . . 0.0 111.258 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -77.64 159.99 28.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.562 179.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.53 HD13 HG21 ' A' ' 63' ' ' ILE . 47.9 pt -121.1 148.27 24.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.885 0.374 . . . . 0.0 111.771 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.457 HG22 ' HA ' ' A' ' 113' ' ' HIS . 0.3 OUTLIER -156.01 -178.3 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.219 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.551 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.633 HG21 HD12 ' A' ' 103' ' ' ILE . 1.6 p -100.54 147.94 25.35 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.617 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 25.6 t-105 -159.15 173.79 15.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.66 0.267 . . . . 0.0 110.798 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -69.8 134.7 48.83 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.815 0.34 . . . . 0.0 110.762 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.58 ' HA ' HG21 ' A' ' 16' ' ' VAL . 6.6 tt0 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.125 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.775 ' O ' HD12 ' A' ' 45' ' ' LEU . . . . . . . . 0 N--CA 1.456 -0.151 0 CA-C-O 120.754 0.311 . . . . 0.0 110.447 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.413 ' HA ' ' CD1' ' A' ' 45' ' ' LEU . 28.3 t -50.32 -25.77 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.091 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -61.62 -11.33 11.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.712 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -120.13 8.43 10.95 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.015 0.436 . . . . 0.0 109.978 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.775 HD12 ' O ' ' A' ' 41' ' ' ALA . 1.5 mp -116.98 139.77 50.27 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.828 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.468 ' O ' ' HA ' ' A' ' 5' ' ' PHE . 23.9 m95 -134.38 168.04 19.65 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.027 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.526 ' CE1' ' HB2' ' A' ' 55' ' ' ARG . 26.5 p90 -140.11 164.2 30.69 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.101 178.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -106.45 133.74 50.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.859 0.361 . . . . 0.0 111.327 -179.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -77.69 166.03 23.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.063 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.28 -24.08 62.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.112 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -94.74 -3.23 49.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.42 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.555 ' O ' HG22 ' A' ' 85' ' ' ILE . . . 98.99 7.82 54.76 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.826 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.545 HG13 ' HA ' ' A' ' 83' ' ' ALA . 21.2 t -92.76 118.48 38.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.76 0.28 . . . . 0.0 110.549 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.523 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -76.11 146.98 8.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.294 0.568 . . . . 0.0 111.863 -179.786 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.792 ' CD ' ' HB2' ' A' ' 62' ' ' ALA . 7.7 mmm-85 -150.21 135.27 17.81 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.629 179.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 15.0 m . . . . . 0 C--N 1.327 -0.411 0 CA-C-O 121.369 0.604 . . . . 0.0 112.012 -179.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.874 0.368 . . . . 0.0 110.787 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.792 ' HB2' ' CD ' ' A' ' 55' ' ' ARG . . . -113.07 154.12 27.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.352 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.893 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -79.77 153.09 4.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.725 179.776 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.599 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 6.3 p-10 -132.33 132.8 43.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.126 0.489 . . . . 0.0 111.609 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.73 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -97.75 39.86 1.19 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.317 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.42 -43.52 60.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.252 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -96.29 172.08 8.18 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.018 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -47.73 -48.72 29.57 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.042 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.83 147.64 26.26 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.666 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.893 HG22 HG22 ' A' ' 63' ' ' ILE . 1.6 mm -78.62 144.01 11.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-O 121.649 0.738 . . . . 0.0 111.992 -179.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.73 166.07 25.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.799 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 1.066 HG21 HD13 ' A' ' 19' ' ' ILE . 73.9 p -102.33 138.95 38.57 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.051 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.48 159.94 20.38 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.392 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.402 ' O ' ' HD3' ' A' ' 82' ' ' ARG . 52.2 Cg_exo -52.54 136.59 57.32 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.441 2.094 . . . . 0.0 111.887 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.478 ' CD2' HG11 ' A' ' 53' ' ' VAL . 17.4 t80 -57.09 132.19 52.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.223 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -121.75 134.46 24.64 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.608 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.3 -34.93 15.02 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.424 2.083 . . . . 0.0 112.608 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -87.4 -0.77 57.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.55 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -108.96 100.18 38.74 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-O 120.622 0.248 . . . . 0.0 111.021 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.826 ' O ' HD21 ' A' ' 94' ' ' LEU . 4.0 Cg_exo -76.73 25.14 0.45 Allowed 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.988 2.459 . . . . 0.0 113.02 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.707 ' HD2' ' HB3' ' A' ' 65' ' ' ALA . 42.7 mmtt -119.72 -21.06 7.41 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 120.635 0.255 . . . . 0.0 110.893 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.521 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 3.6 mtm180 -87.01 17.91 3.88 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.24 -179.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 1.102 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -127.25 99.29 5.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.166 0.508 . . . . 0.0 110.764 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.73 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 62.1 m95 -109.27 136.27 49.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.105 0.479 . . . . 0.0 111.77 -178.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.555 HG22 ' O ' ' A' ' 52' ' ' GLY . 2.6 pp -115.73 154.6 17.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.139 179.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.8 t -102.03 130.0 52.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.932 0.396 . . . . 0.0 111.184 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 36.7 t -122.61 95.18 4.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.447 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.45 -100.71 0.83 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.545 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.499 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.97 29.67 7.25 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.509 0.195 . . . . 0.0 110.789 -179.731 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.424 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.72 147.63 30.13 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -178.49 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.501 ' HB ' HD12 ' A' ' 101' ' ' LEU . 27.5 mm -94.03 120.47 43.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.421 178.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.95 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -124.27 146.11 48.97 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -178.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.437 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.1 OUTLIER -65.42 150.06 48.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.673 179.894 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.102 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.7 pt? -62.81 -57.22 11.63 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.721 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.585 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 1.5 m -79.8 -2.06 41.64 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -178.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.526 ' O ' HG22 ' A' ' 99' ' ' ILE . 1.5 m-20 -137.48 85.54 2.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.842 0.353 . . . . 0.0 110.809 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 16.4 mmt85 -69.48 -16.68 63.51 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.158 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -90.35 11.29 21.87 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.138 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.526 HG22 ' O ' ' A' ' 96' ' ' ASP . 5.6 tt -130.21 136.42 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.95 HG12 ' HB2' ' A' ' 92' ' ' ALA . 19.8 m -148.57 137.36 15.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.455 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.509 ' HA ' ' O ' ' A' ' 115' ' ' CYS . 25.8 mt -45.31 153.99 0.19 Allowed 'General case' 0 CA--C 1.51 -0.596 0 CA-C-O 121.713 0.768 . . . . 0.0 111.622 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.825 ' O ' HG22 ' A' ' 114' ' ' ILE . 27.4 t70 -157.49 167.72 29.38 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.964 -177.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.633 HD12 HG21 ' A' ' 32' ' ' THR . 33.1 mm -86.46 123.34 39.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.232 179.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.82 HG22 ' O ' ' A' ' 113' ' ' HIS . 0.8 OUTLIER -68.26 139.3 20.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.1 0.476 . . . . 0.0 111.65 -179.549 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.12 18.36 3.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.815 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.405 ' HA ' HD21 ' A' ' 12' ' ' LEU . 13.4 m 45.1 -132.87 0.84 Allowed 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.918 -0.128 . . . . 0.0 111.041 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 65.45 162.9 0.15 Allowed 'General case' 0 CA--C 1.526 0.037 0 CA-C-O 120.772 0.32 . . . . 0.0 111.025 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -90.04 -12.4 38.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.448 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -44.81 132.54 6.56 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.391 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -89.22 164.74 14.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.245 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 71.61 19.01 77.61 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.048 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -86.18 138.34 31.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.841 0.353 . . . . 0.0 110.915 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.82 ' O ' HG22 ' A' ' 104' ' ' ILE . 34.7 m80 -62.12 170.52 2.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.749 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.825 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.6 OUTLIER -143.94 161.84 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.928 -179.497 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.673 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 6.0 p -156.65 173.49 16.86 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.673 ' HB2' ' HH2' ' A' ' 84' ' ' TRP . . . -95.99 128.71 43.13 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 178.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.451 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 75.0 t-105 -134.81 162.68 31.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.494 0.664 . . . . 0.0 112.059 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.451 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.3 OUTLIER -62.33 122.99 17.05 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.787 179.929 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -56.99 124.1 17.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.054 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -128.78 5.57 5.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.394 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 81.69 6.86 88.75 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.88 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -65.98 148.93 51.32 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.528 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.03 -27.01 57.91 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.564 2.176 . . . . 0.0 112.382 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.722 ' CB ' HD22 ' A' ' 12' ' ' LEU . 42.5 p-10 -66.95 -12.26 59.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.561 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.425 ' HG2' ' HB2' ' A' ' 102' ' ' ASP . 6.0 mt-30 -103.5 17.57 23.79 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.338 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.421 ' O ' ' HB3' ' A' ' 11' ' ' GLU . 12.3 mmtp -106.43 136.28 46.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.856 0.36 . . . . 0.0 111.568 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.432 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 3.0 m-85 -141.13 155.28 46.13 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.909 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.506 HD12 ' HE2' ' A' ' 9' ' ' LYS . 1.5 mt -110.65 139.68 33.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.146 0.498 . . . . 0.0 110.651 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.434 HD12 HG23 ' A' ' 8' ' ' ILE . 21.9 mm -112.98 139.69 36.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.648 -179.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -138.08 94.46 2.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.618 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.5 t -52.13 113.16 0.94 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.341 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.471 ' HB3' ' CE2' ' A' ' 5' ' ' PHE . 2.2 tm-20 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.272 -0.871 . . . . 0.0 110.932 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.593 0.235 . . . . 0.0 110.665 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.613 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -152.46 170.22 20.66 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 120.952 0.406 . . . . 0.0 111.14 179.303 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.458 ' O ' ' HA ' ' A' ' 129' ' ' ILE . 0.1 OUTLIER -108.62 123.74 49.42 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.932 178.942 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.629 ' HB ' HD21 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -107.72 106.12 20.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.341 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.434 ' HD3' HG13 ' A' ' 16' ' ' VAL . 1.3 tptp -104.92 134.63 47.71 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 54.2 m -75.82 107.13 7.79 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.45 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 4.3 tt0 -63.14 -10.49 15.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.61 -178.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 51.1 tp -81.84 -62.96 1.49 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.97 0.414 . . . . 0.0 110.869 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.463 HD21 HG21 ' A' ' 103' ' ' ILE . 6.5 m-20 -86.31 -7.46 58.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.244 -178.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.48 6.54 62.38 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.05 -1.071 . . . . 0.0 111.459 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.6 mmmm -94.94 -176.22 3.78 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.576 HG21 ' HA ' ' A' ' 35' ' ' GLN . 3.6 m -122.52 142.2 39.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.629 HD21 ' HB ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -72.56 138.23 46.74 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.174 179.52 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 19' ' ' ILE . 31.5 t0 -146.01 142.38 28.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.78 0.324 . . . . 0.0 111.033 -178.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.763 HD12 HG21 ' A' ' 72' ' ' THR . 7.9 mm . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.319 -0.4 . . . . 0.0 109.925 179.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 CA-C-O 120.236 -0.202 . . . . 0.0 113.066 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.5 m -72.55 138.61 47.01 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 117.085 0.443 . . . . 0.0 110.69 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.48 157.44 19.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.784 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.657 HD11 ' HB ' ' A' ' 70' ' ' ILE . 42.1 pt -115.74 145.9 20.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.377 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.435 ' HA ' ' CD1' ' A' ' 114' ' ' ILE . 0.3 OUTLIER -153.46 177.71 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.156 -179.741 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.8 p -102.03 148.89 24.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.759 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 41.0 t-105 -157.45 172.08 19.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.713 0.292 . . . . 0.0 110.826 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.65 134.21 48.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.732 0.301 . . . . 0.0 110.734 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.576 ' HA ' HG21 ' A' ' 16' ' ' VAL . 8.0 tt0 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.055 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.547 ' O ' HD12 ' A' ' 45' ' ' LEU . . . . . . . . 0 CA--C 1.524 -0.03 0 CA-C-O 120.545 0.212 . . . . 0.0 111.168 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.544 ' HA ' HD13 ' A' ' 45' ' ' LEU . 2.5 t -60.27 -17.29 14.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.761 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 29.7 p30 -60.36 -13.51 13.55 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.047 178.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -111.38 7.36 20.87 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.613 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 1.8 mp -120.09 147.63 44.61 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.469 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.634 ' CZ2' HD11 ' A' ' 19' ' ' ILE . 25.4 m95 -133.34 169.57 16.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.818 -179.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.505 ' CE2' ' HB2' ' A' ' 55' ' ' ARG . 1.5 p90 -136.14 159.19 42.47 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.007 178.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.509 HG22 ' CG2' ' A' ' 54' ' ' ILE . 40.0 p -106.22 132.88 51.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.763 0.316 . . . . 0.0 111.256 -179.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -77.67 165.36 24.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.108 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -60.94 -24.07 65.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.017 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -93.17 -3.35 54.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.44 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.95 8.75 53.69 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.883 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.555 HG11 ' CD2' ' A' ' 75' ' ' PHE . 33.8 t -95.5 119.74 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 116.946 0.373 . . . . 0.0 110.638 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.509 ' CG2' HG22 ' A' ' 48' ' ' THR . 0.8 OUTLIER -79.35 151.9 4.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.246 0.546 . . . . 0.0 111.863 -179.826 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.557 ' CD ' ' HB2' ' A' ' 62' ' ' ALA . 8.6 mmm-85 -148.11 133.3 18.36 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.289 179.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.48 0 CA-C-O 121.323 0.582 . . . . 0.0 111.968 -178.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.419 ' CE2' ' HA ' ' A' ' 73' ' ' GLN . 2.2 m-85 . . . . . 0 C--O 1.233 0.214 0 CA-C-O 121.121 0.486 . . . . 0.0 110.7 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.557 ' HB2' ' CD ' ' A' ' 55' ' ' ARG . . . -98.87 152.22 19.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.118 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.898 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -77.9 149.91 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.349 179.523 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.649 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 3.7 p-10 -131.51 133.16 44.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.133 0.492 . . . . 0.0 111.79 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.643 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -99.36 42.41 1.1 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.369 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 66.4 p -74.34 -44.53 52.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.15 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -96.72 172.53 7.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.963 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -48.86 -44.19 39.49 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.056 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.68 145.43 29.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.986 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.898 HG22 HG22 ' A' ' 63' ' ' ILE . 2.8 mm -75.77 141.8 15.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-O 121.555 0.693 . . . . 0.0 111.358 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -136.96 168.76 18.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.001 -0.999 . . . . 0.0 111.432 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.763 HG21 HD12 ' A' ' 19' ' ' ILE . 23.2 p -108.54 135.79 49.23 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.213 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.419 ' HA ' ' CE2' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -165.54 171.9 4.77 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.429 -179.725 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.415 ' HD3' ' CE2' ' A' ' 61' ' ' PHE . 75.6 Cg_exo -49.09 139.83 25.87 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.506 2.137 . . . . 0.0 111.957 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.555 ' CD2' HG11 ' A' ' 53' ' ' VAL . 48.4 t80 -47.74 -59.58 3.19 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -179.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.403 ' HB2' ' HD3' ' A' ' 82' ' ' ARG . 0.3 OUTLIER 63.56 118.83 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 -179.166 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.47 -28.65 21.6 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.527 2.151 . . . . 0.0 113.445 -179.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -87.25 0.58 55.15 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.45 ' CB ' ' HD2' ' A' ' 82' ' ' ARG . 1.9 m120 -104.42 101.97 30.68 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 120.63 0.253 . . . . 0.0 111.328 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.862 ' O ' HD21 ' A' ' 94' ' ' LEU . 94.8 Cg_endo -77.58 18.6 0.81 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.733 2.288 . . . . 0.0 113.319 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.649 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -118.97 -19.84 8.35 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 120.716 0.293 . . . . 0.0 110.905 179.818 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.509 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 36.5 mtt180 -91.01 25.62 2.38 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.227 -178.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 1.054 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -136.96 99.48 4.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.94 0.4 . . . . 0.0 110.898 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.672 ' HH2' ' HB2' ' A' ' 116' ' ' ALA . 38.6 m95 -109.58 139.13 44.97 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.246 0.546 . . . . 0.0 111.78 -178.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 pp -112.7 155.92 13.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.287 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.6 t -102.64 128.15 55.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.962 0.41 . . . . 0.0 111.246 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.9 t -120.92 94.6 4.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.209 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.41 -100.98 0.85 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.34 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.5 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.76 29.84 7.2 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.579 0.228 . . . . 0.0 110.843 -179.81 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.425 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.44 147.51 30.29 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.383 0.611 . . . . 0.0 112.64 -178.595 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.718 ' HB ' HD12 ' A' ' 101' ' ' LEU . 20.1 mm -94.02 120.29 43.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.292 178.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.9 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -122.2 144.11 49.16 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.441 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -64.82 148.14 51.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.435 179.566 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.054 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.5 pt? -62.79 -57.49 10.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.8 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.548 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 3.5 t -75.81 -3.91 37.69 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.477 ' O ' HG22 ' A' ' 99' ' ' ILE . 19.0 t0 -141.14 89.63 2.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.841 0.353 . . . . 0.0 110.891 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 8.8 mmt85 -70.79 -16.02 62.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.232 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -88.93 10.87 19.79 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.253 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.477 HG22 ' O ' ' A' ' 96' ' ' ASP . 5.3 tt -131.05 137.54 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.9 HG12 ' HB2' ' A' ' 92' ' ' ALA . 17.5 m -148.39 138.59 16.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.774 0.321 . . . . 0.0 111.536 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.718 HD12 ' HB ' ' A' ' 91' ' ' ILE . 10.9 mt -46.32 153.87 0.31 Allowed 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.634 0.731 . . . . 0.0 111.581 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.735 ' O ' HG22 ' A' ' 114' ' ' ILE . 9.8 t70 -158.85 168.08 27.75 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.46 -1.245 . . . . 0.0 110.669 -177.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.558 HD12 ' O ' ' A' ' 124' ' ' ASN . 4.6 mp -87.34 120.69 37.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.139 179.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.765 HD11 ' HB2' ' A' ' 115' ' ' CYS . 40.2 mm -70.03 136.39 26.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.883 0.373 . . . . 0.0 111.253 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 8.4 tttt 78.92 -6.1 1.94 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.764 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.1 m 46.45 29.7 0.94 Allowed 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 120.809 0.338 . . . . 0.0 111.27 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.39 155.01 17.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.039 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.1 -13.74 59.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.097 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -48.78 123.14 6.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.229 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.4 157.86 30.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.037 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.24 12.55 81.76 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.146 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.51 131.52 41.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.873 0.368 . . . . 0.0 111.052 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -64.87 172.44 2.84 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.111 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.735 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -136.71 161.67 36.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.349 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.765 ' HB2' HD11 ' A' ' 104' ' ' ILE . 6.3 t -153.38 167.47 29.29 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.672 ' HB2' ' HH2' ' A' ' 84' ' ' TRP . . . -94.75 125.24 39.28 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 177.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.459 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 76.1 t-105 -133.56 162.38 32.07 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.629 0.728 . . . . 0.0 112.291 -179.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.459 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.0 OUTLIER -61.79 119.82 9.49 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.621 179.836 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -59.74 126.05 26.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.1 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.405 ' CE1' ' HA3' ' A' ' 122' ' ' GLY . 20.0 p80 -134.11 10.7 3.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.21 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 81.15 7.88 87.96 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.981 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.405 ' HA3' ' CE1' ' A' ' 120' ' ' HIS . . . -62.48 150.09 47.74 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.603 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.37 -27.02 55.29 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.561 2.174 . . . . 0.0 112.182 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.558 ' O ' HD12 ' A' ' 103' ' ' ILE . 32.1 p-10 -75.45 -4.42 39.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.425 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.425 ' O ' ' CG2' ' A' ' 90' ' ' THR . 0.0 OUTLIER -105.82 12.95 30.22 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.29 -179.741 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.45 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 5.9 mmtt -106.02 140.3 39.23 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.863 0.364 . . . . 0.0 111.367 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.414 ' CD1' ' O ' ' A' ' 126' ' ' LYS . 8.9 m-85 -138.67 155.27 48.42 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.162 179.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 mt -111.45 137.24 44.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.049 0.452 . . . . 0.0 110.41 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.458 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 36.6 mm -113.47 140.9 31.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.64 -179.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -140.83 106.2 5.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.596 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.61 109.11 0.94 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.044 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 34.5 tp10 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.232 -0.89 . . . . 0.0 111.127 179.888 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.474 ' HA ' ' O ' ' A' ' 46' ' ' TRP . 2.1 p90 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.484 0.183 . . . . 0.0 110.618 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.742 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -159.92 175.97 12.43 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.596 179.744 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.439 ' CE1' ' HB3' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -114.22 123.88 50.66 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.288 179.206 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.624 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -104.12 109.77 28.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.37 -179.924 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 16' ' ' VAL . 0.1 OUTLIER -105.63 135.42 47.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.464 -178.756 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.8 t -75.27 105.66 6.4 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -62.66 -11.88 19.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.594 -178.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.488 ' HB2' ' HA ' ' A' ' 124' ' ' ASN . 12.3 tp -84.51 -62.49 1.54 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.964 0.412 . . . . 0.0 110.967 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.626 HD21 HG21 ' A' ' 103' ' ' ILE . 12.9 m-20 -83.08 -12.81 56.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.48 -178.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.53 2.9 76.7 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.143 -1.027 . . . . 0.0 111.491 -178.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -91.86 -175.14 4.04 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.74 HG11 ' HG3' ' A' ' 35' ' ' GLN . 5.4 m -121.62 140.22 46.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.656 0.265 . . . . 0.0 110.437 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.5 mt -69.4 134.76 49.41 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -143.61 153.99 43.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.888 0.375 . . . . 0.0 111.196 -178.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.06 HD13 HG21 ' A' ' 72' ' ' THR . 34.0 mt . . . . . 0 C--N 1.327 -0.409 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.572 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.395 0 CA-C-O 120.332 -0.149 . . . . 0.0 113.08 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.75 138.61 48.58 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.946 0.403 . . . . 0.0 111.056 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.3 mptt -89.4 157.71 18.04 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.216 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.721 HD11 ' HB ' ' A' ' 70' ' ' ILE . 38.0 pt -116.34 145.91 21.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.799 0.333 . . . . 0.0 111.743 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.461 ' HA ' ' CD1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -155.32 178.17 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.192 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.537 -179.827 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.6 p -100.68 148.77 24.49 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 121.001 -0.279 . . . . 0.0 110.65 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 24.3 t-105 -157.69 172.57 18.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.706 0.289 . . . . 0.0 110.883 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -69.77 133.93 48.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.852 0.358 . . . . 0.0 110.706 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.74 ' HG3' HG11 ' A' ' 16' ' ' VAL . 6.9 tt0 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.112 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.956 ' O ' HD12 ' A' ' 45' ' ' LEU . . . . . . . . 0 CA--C 1.527 0.088 0 CA-C-O 120.765 0.317 . . . . 0.0 111.124 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 45.3 t -49.69 -29.77 4.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.113 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -65.69 -10.91 40.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.927 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.439 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 3.5 mt-30 -118.2 7.59 12.14 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.956 HD12 ' O ' ' A' ' 41' ' ' ALA . 1.1 mp -118.82 140.38 50.05 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.981 -179.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.76 ' CZ2' HD11 ' A' ' 19' ' ' ILE . 24.8 m95 -134.12 168.82 18.13 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.92 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.52 ' CZ ' ' HB2' ' A' ' 55' ' ' ARG . 32.0 p90 -140.73 164.93 28.87 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.219 178.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.454 HG22 ' CG2' ' A' ' 54' ' ' ILE . 81.1 p -107.6 134.32 50.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.833 0.349 . . . . 0.0 111.378 -178.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -77.81 170.25 16.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.15 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.17 -23.62 67.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.077 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.3 mm100 -94.04 -3.45 51.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.242 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.95 8.78 53.65 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.917 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.429 HG11 ' CE2' ' A' ' 75' ' ' PHE . 42.2 t -95.14 119.63 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-O 120.83 0.348 . . . . 0.0 110.693 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -76.68 147.85 7.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.341 0.591 . . . . 0.0 111.9 -179.792 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.612 ' CD ' ' HB2' ' A' ' 62' ' ' ALA . 8.2 mmm-85 -149.48 133.69 17.31 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.39 179.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.46 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 70.0 m . . . . . 0 C--N 1.326 -0.422 0 CA-C-O 121.463 0.649 . . . . 0.0 111.848 -178.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.416 ' CE2' ' HD3' ' A' ' 74' ' ' PRO . 2.8 m-85 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.828 0.347 . . . . 0.0 110.77 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.612 ' HB2' ' CD ' ' A' ' 55' ' ' ARG . . . -109.26 154.9 21.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.547 -179.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.85 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -80.37 150.79 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.466 179.587 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.575 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 6.4 p-10 -131.61 132.09 43.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.064 0.459 . . . . 0.0 111.419 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.666 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -97.51 41.66 1.11 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.192 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.4 t -74.83 -45.54 42.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.158 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 59.6 m80 -94.44 170.76 9.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.982 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -47.83 -48.02 31.0 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.106 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -99.6 143.86 29.35 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.099 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.85 HG22 HG22 ' A' ' 63' ' ' ILE . 3.0 mm -74.2 139.95 18.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 CA-C-O 121.554 0.692 . . . . 0.0 111.478 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -139.88 168.94 18.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.262 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 1.06 HG21 HD13 ' A' ' 19' ' ' ILE . 63.4 p -108.59 139.2 43.7 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.281 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.6 163.02 16.72 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.485 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.416 ' HD3' ' CE2' ' A' ' 61' ' ' PHE . 50.7 Cg_exo -55.08 136.06 71.49 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.474 2.116 . . . . 0.0 111.729 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.429 ' CE2' HG11 ' A' ' 53' ' ' VAL . 32.7 t80 -52.77 134.72 36.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.97 0.414 . . . . 0.0 111.489 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.421 ' HB2' ' CZ ' ' A' ' 82' ' ' ARG . 21.6 t70 -124.21 116.8 27.03 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.477 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -56.98 -33.76 96.18 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.532 2.155 . . . . 0.0 113.045 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 33.5 m-20 -86.89 -0.07 55.86 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -179.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 -112.55 104.07 55.78 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 120.629 0.252 . . . . 0.0 111.114 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.828 ' O ' HD21 ' A' ' 94' ' ' LEU . 84.4 Cg_endo -76.84 27.11 0.43 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.733 2.289 . . . . 0.0 113.105 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.602 ' HD2' ' HB3' ' A' ' 65' ' ' ALA . 40.7 mmtt -120.29 -19.5 7.64 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 116.687 -0.233 . . . . 0.0 111.162 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.543 ' HG2' ' HB3' ' A' ' 64' ' ' ASP . 3.5 mtm180 -88.43 19.71 3.71 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.329 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 1.132 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -130.03 99.38 5.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.075 0.464 . . . . 0.0 110.784 179.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.666 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 58.8 m95 -109.05 135.77 49.66 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.146 0.498 . . . . 0.0 111.979 -178.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.796 HD11 ' HD3' ' A' ' 97' ' ' ARG . 1.1 pp -111.82 152.87 13.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.084 179.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.3 t -100.57 126.37 54.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.941 0.4 . . . . 0.0 111.133 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.3 t -119.39 94.85 4.56 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.577 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.81 -100.41 0.76 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.643 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.491 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.51 29.64 7.34 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.518 0.199 . . . . 0.0 110.977 -179.492 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -149.71 149.11 30.09 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.337 0.589 . . . . 0.0 112.493 -178.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.83 ' HB ' HD12 ' A' ' 101' ' ' LEU . 12.3 mm -94.01 120.71 43.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.449 178.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.882 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -121.38 144.54 48.61 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -178.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.419 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -66.33 149.02 51.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.929 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.132 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.6 pt? -64.26 -57.36 9.67 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.018 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.587 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 3.5 m -74.06 -4.12 33.54 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.586 ' O ' HG22 ' A' ' 99' ' ' ILE . 73.2 m-20 -146.73 93.01 2.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.099 0.476 . . . . 0.0 111.035 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.796 ' HD3' HD11 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -73.04 -13.12 61.15 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.587 179.37 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -87.89 12.02 14.23 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.481 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.824 HG12 ' HB1' ' A' ' 116' ' ' ALA . 2.6 tt -135.09 143.25 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.882 HG12 ' HB2' ' A' ' 92' ' ' ALA . 34.9 m -151.66 139.71 14.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.789 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.83 HD12 ' HB ' ' A' ' 91' ' ' ILE . 10.6 mt -46.2 154.31 0.27 Allowed 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 121.722 0.772 . . . . 0.0 111.706 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.733 ' O ' HG22 ' A' ' 114' ' ' ILE . 28.5 t70 -158.3 168.29 27.42 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.629 -177.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.626 HG21 HD21 ' A' ' 13' ' ' ASN . 26.8 mm -89.35 120.97 38.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.389 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.832 HG22 ' O ' ' A' ' 113' ' ' HIS . 7.9 tp -64.72 138.66 22.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.023 0.44 . . . . 0.0 111.457 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 73.54 -3.71 2.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.043 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 45.3 t 44.19 31.26 0.53 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.76 0.314 . . . . 0.0 111.428 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -97.36 158.12 15.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.194 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.99 -13.4 59.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.183 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -49.11 131.93 19.29 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.26 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -77.17 158.86 30.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.017 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 72.3 15.34 76.98 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.145 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.05 132.61 40.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.895 0.378 . . . . 0.0 110.929 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.832 ' O ' HG22 ' A' ' 104' ' ' ILE . 6.2 m80 -64.99 171.53 3.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.934 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.733 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -135.45 161.25 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.397 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.586 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 5.8 t -152.39 167.22 29.41 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.824 ' HB1' HG12 ' A' ' 99' ' ' ILE . . . -94.99 124.73 39.21 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.447 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 77.0 t-105 -133.49 161.4 34.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.619 0.723 . . . . 0.0 112.236 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.447 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.0 OUTLIER -61.03 123.0 16.38 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.57 -1.195 . . . . 0.0 110.806 -179.906 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -58.84 125.05 21.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.951 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 13.3 p80 -136.98 6.32 2.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.595 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 78.26 57.1 3.49 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.273 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -112.0 138.73 15.18 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.509 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.67 -31.42 60.32 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.447 2.098 . . . . 0.0 112.18 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.488 ' HA ' ' HB2' ' A' ' 12' ' ' LEU . 10.9 p-10 -72.0 -8.0 52.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.575 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -101.9 -14.31 17.28 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.57 0.211 . . . . 0.0 111.57 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.428 ' O ' ' CD1' ' A' ' 127' ' ' PHE . 2.3 mmtt -78.27 136.73 37.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.811 0.339 . . . . 0.0 111.373 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.428 ' CD1' ' O ' ' A' ' 126' ' ' LYS . 6.8 m-85 -139.15 156.22 47.28 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.136 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 mt -112.33 137.77 43.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.176 0.513 . . . . 0.0 110.592 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.569 HD12 HG23 ' A' ' 8' ' ' ILE . 19.5 mm -114.36 138.7 43.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.527 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -134.52 94.29 3.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.54 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.15 108.06 0.48 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.134 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.295 -0.86 . . . . 0.0 111.358 179.726 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mmm . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.878 0.371 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.9 mmmt -116.02 91.22 30.77 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.948 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.0 -170.35 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.489 2.126 . . . . 0.0 112.253 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.402 ' O ' ' CB ' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -114.67 141.3 47.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.92 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.488 ' HD2' HD22 ' A' ' 45' ' ' LEU . 0.1 OUTLIER -104.05 175.82 5.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.351 179.821 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.793 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -155.24 171.28 20.08 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.613 179.815 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.81 ' OH ' ' HB1' ' A' ' 41' ' ' ALA . 2.0 m-85 -109.2 123.41 49.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.23 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.616 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -108.23 103.72 15.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.842 0.353 . . . . 0.0 110.275 179.674 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.855 ' HB3' HG12 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -127.98 126.84 42.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.763 -179.036 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.467 ' O ' ' HD2' ' A' ' 9' ' ' LYS . 0.9 OUTLIER -46.15 138.44 5.29 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.019 0.437 . . . . 0.0 111.575 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.543 ' HA ' HD11 ' A' ' 128' ' ' ILE . 3.2 tt0 -81.13 -11.28 59.5 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.082 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 61.4 tp -92.9 -56.54 2.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.165 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -83.24 -21.09 33.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.83 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.18 4.08 77.7 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.284 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.59 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 1.1 mmmm -85.26 164.25 18.15 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.855 HG12 ' HB3' ' A' ' 9' ' ' LYS . 12.6 m -106.95 137.0 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-O 120.769 0.318 . . . . 0.0 110.722 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 21.0 mt -68.31 136.57 53.65 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -138.26 152.01 48.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.841 0.353 . . . . 0.0 111.111 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.929 HD13 HG21 ' A' ' 72' ' ' THR . 1.5 mt -101.12 118.92 48.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.872 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.444 ' HG3' HD12 ' A' ' 31' ' ' ILE . 1.6 mt-10 -63.42 95.87 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.891 0.377 . . . . 0.0 110.444 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 157.24 -44.16 0.51 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.373 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 48.7 51.24 16.03 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.812 0.339 . . . . 0.0 111.323 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -177.17 171.98 0.86 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.053 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.56 -17.15 40.05 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.748 2.299 . . . . 0.0 112.418 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -45.51 99.49 0.21 Allowed Pre-proline 0 CA--C 1.531 0.215 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.329 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.422 ' HB3' ' HD3' ' A' ' 74' ' ' PRO . 14.9 Cg_exo -69.17 150.65 72.06 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.69 2.26 . . . . 0.0 112.134 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.55 8.66 55.88 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.588 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.37 132.91 37.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.945 0.403 . . . . 0.0 111.114 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.87 155.65 30.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.311 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.698 HG22 HG23 ' A' ' 19' ' ' ILE . 47.8 pt -115.31 144.59 22.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.921 0.391 . . . . 0.0 111.676 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.444 HD12 ' HG3' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -156.09 -176.68 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.581 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.513 HG21 HD12 ' A' ' 103' ' ' ILE . 1.2 p -101.75 148.56 25.14 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.343 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 10.4 t-105 -159.1 173.84 15.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.709 0.29 . . . . 0.0 111.009 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -71.85 138.32 48.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.815 0.341 . . . . 0.0 110.86 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.619 ' HA ' HG21 ' A' ' 16' ' ' VAL . 28.4 tt0 -64.79 137.28 57.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.176 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.9 mmmt -109.17 165.04 11.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.683 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.3 mtmt -128.14 112.19 14.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.983 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 146.05 -163.35 28.36 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.638 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -72.2 -1.18 9.7 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.983 2.455 . . . . 0.0 112.884 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.5 t -111.91 36.45 3.3 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.098 0.475 . . . . 0.0 110.666 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.898 ' O ' HD12 ' A' ' 45' ' ' LEU . . . -107.89 -18.95 13.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.885 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.97 HG13 ' HB3' ' A' ' 57' ' ' LYS . 99.6 t -49.73 -28.07 3.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.191 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -67.07 -9.0 34.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.804 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -119.6 6.14 11.05 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.153 0.501 . . . . 0.0 109.821 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.898 HD12 ' O ' ' A' ' 41' ' ' ALA . 1.2 mp -116.07 138.86 50.86 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.583 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.576 ' CZ2' HD11 ' A' ' 19' ' ' ILE . 21.1 m95 -132.54 167.92 19.15 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.035 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.509 ' CE1' ' HB2' ' A' ' 55' ' ' ARG . 41.2 p90 -140.44 163.93 31.48 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.146 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -105.1 132.6 51.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.849 0.357 . . . . 0.0 111.345 -178.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -77.65 165.85 23.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.154 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -62.71 -24.16 67.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.14 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -90.3 -4.1 57.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.328 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.738 ' O ' HG22 ' A' ' 85' ' ' ILE . . . 97.11 13.37 46.08 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.858 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.553 HG13 ' HA ' ' A' ' 83' ' ' ALA . 21.6 t -103.97 123.02 57.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.712 0.291 . . . . 0.0 110.533 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -75.71 149.23 6.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.369 0.604 . . . . 0.0 111.941 -179.828 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.684 ' CD ' ' HB2' ' A' ' 62' ' ' ALA . 7.5 mmm-85 -149.36 133.5 17.26 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.235 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 8.2 m -57.57 140.49 50.77 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.468 0.651 . . . . 0.0 111.862 -178.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.97 ' HB3' HG13 ' A' ' 42' ' ' VAL . 4.0 tttt -51.51 -24.32 5.04 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.838 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.465 HD12 ' N ' ' A' ' 59' ' ' ASN . 3.9 pp -56.46 -41.24 76.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.287 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.465 ' N ' HD12 ' A' ' 58' ' ' LEU . 3.2 t-20 177.91 178.67 0.34 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.921 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.74 84.0 0.19 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.759 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -145.85 128.13 15.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.872 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.684 ' HB2' ' CD ' ' A' ' 55' ' ' ARG . . . -114.0 153.2 29.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.265 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.762 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -78.54 153.65 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.475 179.742 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.56 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 6.9 p-10 -133.63 132.94 41.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.203 0.525 . . . . 0.0 111.554 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.647 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -97.28 43.63 1.06 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.27 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.7 m -74.54 -45.56 44.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.084 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -94.66 171.9 8.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.834 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -50.87 -41.94 58.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.086 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.77 144.3 31.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.967 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.762 HG22 HG22 ' A' ' 63' ' ' ILE . 2.8 mm -72.47 135.95 26.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-O 121.642 0.734 . . . . 0.0 111.516 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.417 ' O ' HG22 ' A' ' 63' ' ' ILE . 6.8 tt0 -135.99 163.25 30.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.724 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.929 HG21 HD13 ' A' ' 19' ' ' ILE . 31.7 p -105.73 140.03 39.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.965 0.412 . . . . 0.0 111.195 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.467 ' CB ' ' HD2' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -162.41 169.09 9.7 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.29 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.467 ' HD2' ' CB ' ' A' ' 73' ' ' GLN . 19.4 Cg_endo -60.54 139.31 85.47 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.307 2.005 . . . . 0.0 111.913 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.43 ' HE1' ' HB2' ' A' ' 83' ' ' ALA . 8.7 t80 -57.0 138.21 54.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.088 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.4 ' HB3' ' CB ' ' A' ' 79' ' ' ASN . 24.4 t0 -129.98 119.15 18.77 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.685 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -56.53 -34.64 95.57 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.538 2.159 . . . . 0.0 112.907 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -86.54 -1.39 57.59 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.4 ' CB ' ' HB3' ' A' ' 76' ' ' ASP . 2.8 t-20 -108.92 102.42 48.38 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.656 0.265 . . . . 0.0 110.957 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.833 ' O ' HD21 ' A' ' 94' ' ' LEU . 88.0 Cg_endo -76.78 24.57 0.47 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.725 2.283 . . . . 0.0 113.276 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.584 ' HD2' ' HB3' ' A' ' 65' ' ' ALA . 37.7 mmtt -120.03 -18.43 8.14 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 120.519 0.2 . . . . 0.0 111.195 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 2.0 mtt180 -89.14 20.06 3.91 Favored 'General case' 0 C--N 1.341 0.219 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 1.103 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -129.3 99.62 5.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.093 0.473 . . . . 0.0 110.691 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.647 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 60.5 m95 -108.99 134.92 51.0 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.123 0.487 . . . . 0.0 112.057 -178.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.738 HG22 ' O ' ' A' ' 52' ' ' GLY . 3.4 pt -112.82 153.76 14.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.296 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.2 t -101.76 127.0 55.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.898 0.38 . . . . 0.0 111.087 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 25.2 t -119.49 95.21 4.69 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.632 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.47 -100.03 0.7 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.677 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.501 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.32 29.67 7.36 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.575 0.226 . . . . 0.0 110.962 -179.449 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.6 149.98 30.58 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.315 0.579 . . . . 0.0 112.474 -178.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.835 ' HB ' HD12 ' A' ' 101' ' ' LEU . 12.6 mm -94.28 122.09 45.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.458 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.929 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -122.29 142.32 50.6 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.419 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -64.74 148.09 51.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.469 179.648 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.103 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.7 pt? -62.43 -56.79 14.84 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.918 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.58 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 7.0 p -75.99 -4.0 38.78 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -178.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.409 ' HB3' ' HB ' ' A' ' 99' ' ' ILE . 5.3 m-20 -141.16 89.82 2.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.866 0.365 . . . . 0.0 111.241 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -67.6 -16.4 64.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.259 178.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -92.5 10.03 31.93 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.476 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.812 ' CG2' ' HB1' ' A' ' 116' ' ' ALA . 11.6 mm -123.51 128.24 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.477 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.929 HG12 ' HB2' ' A' ' 92' ' ' ALA . 30.5 m -146.48 135.84 16.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.771 0.32 . . . . 0.0 111.667 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.835 HD12 ' HB ' ' A' ' 91' ' ' ILE . 8.6 mt -47.09 154.4 0.36 Allowed 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.639 0.733 . . . . 0.0 111.475 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.81 ' O ' HG22 ' A' ' 114' ' ' ILE . 30.0 t70 -155.85 166.89 32.15 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.875 -177.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.531 ' HA ' HG22 ' A' ' 114' ' ' ILE . 35.0 mm -89.73 120.54 38.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.426 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.805 HG22 ' O ' ' A' ' 113' ' ' HIS . 0.6 OUTLIER -64.84 138.89 22.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.038 0.447 . . . . 0.0 111.512 -179.622 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.402 ' N ' HG13 ' A' ' 104' ' ' ILE . 10.1 mmtp 76.01 -4.02 2.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.031 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 17.1 m 45.68 30.04 0.75 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.823 0.344 . . . . 0.0 111.285 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -100.41 165.09 11.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.215 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.54 -15.55 51.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.058 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -47.28 128.81 12.34 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.203 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -80.95 161.46 24.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.115 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 72.05 17.93 77.48 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.178 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.85 138.23 33.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.888 0.375 . . . . 0.0 110.967 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.805 ' O ' HG22 ' A' ' 104' ' ' ILE . 28.9 m170 -62.87 171.07 2.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.787 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.81 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.7 OUTLIER -142.67 161.76 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.688 -179.657 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.648 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 28.4 p -155.71 171.4 20.06 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.812 ' HB1' ' CG2' ' A' ' 99' ' ' ILE . . . -95.83 126.84 41.36 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.459 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 76.1 t-105 -134.98 162.61 31.94 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.567 0.699 . . . . 0.0 112.123 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.459 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.0 OUTLIER -60.72 120.92 11.01 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.607 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -52.09 123.8 11.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.886 0.374 . . . . 0.0 111.277 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.416 ' CE1' ' HA3' ' A' ' 122' ' ' GLY . 6.6 p80 -128.84 3.3 5.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.361 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.62 8.48 81.31 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.836 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.416 ' HA3' ' CE1' ' A' ' 120' ' ' HIS . . . -63.67 142.0 46.21 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.55 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.81 -31.2 71.36 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.528 2.152 . . . . 0.0 112.295 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -69.42 -11.95 61.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.319 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -101.68 13.5 34.73 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.703 0.287 . . . . 0.0 111.138 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.6 mmmm -100.34 126.27 46.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.351 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.449 ' HE2' HD11 ' A' ' 103' ' ' ILE . 32.6 m-85 -129.13 154.98 46.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.333 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.543 HD11 ' HA ' ' A' ' 11' ' ' GLU . 2.0 mt -116.21 141.57 33.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.295 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.587 HD12 HG23 ' A' ' 8' ' ' ILE . 26.1 mm -113.33 141.16 30.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.288 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -141.59 95.3 2.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.753 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 47.5 m -54.77 108.12 0.36 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.289 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.383 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.3 mtt . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.837 0.351 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ttpp -94.78 123.14 58.78 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.839 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.73 179.06 5.59 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.468 2.112 . . . . 0.0 112.402 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.414 ' O ' ' HB2' ' A' ' 47' ' ' TYR . 0.9 OUTLIER -95.87 122.46 38.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.78 179.907 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.425 ' HA ' ' O ' ' A' ' 46' ' ' TRP . 71.7 m-85 -96.22 174.24 6.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.691 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.681 ' C ' HD23 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -153.75 171.6 18.62 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 120.978 0.418 . . . . 0.0 111.178 179.118 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.439 ' O ' ' HA ' ' A' ' 129' ' ' ILE . 0.1 OUTLIER -111.66 123.6 50.58 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.213 179.044 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.61 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -106.97 106.55 20.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.886 0.374 . . . . 0.0 110.095 179.802 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -106.78 137.73 44.27 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.648 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.38 109.42 10.08 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.469 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 6.0 tt0 -62.88 -10.91 15.08 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.521 -178.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.609 HD22 ' HA ' ' A' ' 124' ' ' ASN . 43.0 tp -84.24 -62.32 1.59 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.938 0.399 . . . . 0.0 111.037 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.718 HD21 HG21 ' A' ' 103' ' ' ILE . 8.6 m-20 -86.25 -12.32 49.93 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.23 3.98 71.9 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.071 -1.061 . . . . 0.0 111.545 -178.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.438 ' O ' ' HG3' ' A' ' 9' ' ' LYS . 5.1 mmtm -91.85 175.91 6.71 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.607 HG21 ' HA ' ' A' ' 35' ' ' GLN . 5.9 m -118.47 143.83 28.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.725 0.298 . . . . 0.0 110.603 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.3 mt -69.25 136.29 51.75 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.004 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.402 ' CB ' ' HG3' ' A' ' 44' ' ' GLN . 14.0 t0 -144.96 144.24 30.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.795 0.331 . . . . 0.0 111.146 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.831 HD12 HG21 ' A' ' 72' ' ' THR . 4.3 mm -75.65 131.26 35.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.93 115.72 3.04 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.771 0.32 . . . . 0.0 111.129 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 47.95 48.71 24.59 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.302 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 61.48 -168.69 0.18 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.633 0.254 . . . . 0.0 110.341 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.768 ' HB2' HG21 ' A' ' 19' ' ' ILE . 51.9 t30 -140.11 62.71 21.77 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.141 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.445 ' HD3' ' N ' ' A' ' 23' ' ' ASN . 21.0 Cg_exo -64.99 -28.94 57.54 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.502 2.134 . . . . 0.0 111.808 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.462 ' HB1' ' HD2' ' A' ' 26' ' ' PRO . . . -139.21 157.49 70.92 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.071 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.484 ' HB3' ' HD2' ' A' ' 74' ' ' PRO . 18.7 Cg_endo -60.38 146.71 96.12 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.763 2.309 . . . . 0.0 112.544 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.67 3.17 40.25 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.503 -0.856 . . . . 0.0 113.192 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.3 t -73.34 128.85 36.66 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 117.243 0.521 . . . . 0.0 110.994 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.1 mmtp -80.38 158.12 26.11 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.282 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.675 HD11 ' HB ' ' A' ' 70' ' ' ILE . 43.3 pt -117.0 145.97 22.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.613 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.466 ' HA ' ' CD1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -153.65 178.61 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.182 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.943 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.3 p -101.87 149.4 24.24 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.567 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 26.0 t-105 -159.27 173.89 15.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.635 0.255 . . . . 0.0 110.869 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -69.46 133.02 47.22 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.798 0.332 . . . . 0.0 110.776 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.607 ' HA ' HG21 ' A' ' 16' ' ' VAL . 27.9 pt20 -61.25 148.53 40.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.992 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -115.79 160.66 19.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.823 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.6 mmtm -119.66 107.32 13.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.949 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 150.34 176.41 23.33 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.525 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -71.06 -3.9 13.79 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.882 2.388 . . . . 0.0 112.735 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.6 p -106.07 29.53 6.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.769 0.319 . . . . 0.0 111.018 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.514 ' O ' HD12 ' A' ' 45' ' ' LEU . . . -121.92 4.97 9.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.566 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.692 HG12 ' HB3' ' A' ' 57' ' ' LYS . 1.6 t -59.26 -18.53 14.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.675 0.274 . . . . 0.0 110.821 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.415 ' HA ' ' HG2' ' A' ' 57' ' ' LYS . 2.2 t-20 -63.8 -10.65 21.26 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.755 0.312 . . . . 0.0 110.894 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.402 ' HG3' ' CB ' ' A' ' 18' ' ' ASP . 1.2 mt-30 -111.12 7.95 21.55 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.681 HD23 ' C ' ' A' ' 6' ' ' PHE . 1.1 mp -121.1 146.45 46.72 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 114.662 -1.153 . . . . 0.0 111.296 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.601 ' CZ2' HD11 ' A' ' 19' ' ' ILE . 26.0 m95 -133.46 170.46 15.46 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.678 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.54 ' CE2' ' HB2' ' A' ' 55' ' ' ARG . 1.5 p90 -136.62 160.39 38.94 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.039 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.556 HG22 HG23 ' A' ' 54' ' ' ILE . 33.2 p -107.77 134.41 50.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.71 0.29 . . . . 0.0 111.285 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -77.67 170.47 16.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.281 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -63.22 -22.79 67.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.038 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -97.35 -2.93 41.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.148 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.6 5.52 53.88 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.976 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.436 HG11 ' CE1' ' A' ' 75' ' ' PHE . 23.6 t -88.08 116.59 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 CA-C-O 120.864 0.364 . . . . 0.0 110.778 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.556 HG23 HG22 ' A' ' 48' ' ' THR . 0.7 OUTLIER -78.5 150.27 5.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.242 0.544 . . . . 0.0 111.821 -179.86 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.54 ' HB2' ' CE2' ' A' ' 47' ' ' TYR . 10.0 mmm-85 -147.16 133.14 19.17 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.454 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.517 ' HB2' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -66.88 -178.36 0.74 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.162 0.505 . . . . 0.0 111.877 -178.876 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.692 ' HB3' HG12 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -47.2 -23.09 0.47 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.448 179.806 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.641 ' H ' HD22 ' A' ' 58' ' ' LEU . 1.8 mm? -47.48 -23.66 0.67 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.508 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.444 ' CB ' ' O ' ' A' ' 58' ' ' LEU . 22.0 m-20 85.43 -9.15 0.81 Allowed 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -176.68 53.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.918 0.389 . . . . 0.0 111.466 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.491 ' HB2' ' HB2' ' A' ' 58' ' ' LEU . 23.2 m-85 -140.85 108.99 5.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.99 0.424 . . . . 0.0 110.642 179.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -97.17 150.19 21.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.807 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.895 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -78.07 150.23 5.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.283 179.903 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.583 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 15.7 p-10 -130.71 131.34 44.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.071 0.462 . . . . 0.0 111.583 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.674 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -96.83 42.77 1.08 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.175 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.8 -45.18 45.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.216 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -96.45 172.86 7.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.014 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -47.33 -49.41 24.28 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.923 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -98.96 146.96 25.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.929 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.895 HG22 HG22 ' A' ' 63' ' ' ILE . 2.6 mm -76.22 140.82 16.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-O 121.531 0.681 . . . . 0.0 111.441 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -133.05 166.54 22.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.618 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.831 HG21 HD12 ' A' ' 19' ' ' ILE . 24.8 p -112.13 137.06 50.73 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.717 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.487 ' HG2' ' C ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -163.57 165.63 13.74 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.062 179.655 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.484 ' HD2' ' HB3' ' A' ' 26' ' ' PRO . 54.1 Cg_exo -52.38 141.26 51.31 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.379 2.053 . . . . 0.0 111.935 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.436 ' CE1' HG11 ' A' ' 53' ' ' VAL . 36.0 t80 -60.5 132.55 54.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.388 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.405 ' HB2' ' NH1' ' A' ' 82' ' ' ARG . 20.2 t0 -123.49 132.13 24.29 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.411 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -68.79 -33.56 20.49 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.52 2.147 . . . . 0.0 113.283 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -87.14 1.04 54.28 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -105.57 103.69 44.53 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.56 0.219 . . . . 0.0 111.28 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.839 ' O ' HD21 ' A' ' 94' ' ' LEU . 6.1 Cg_exo -77.78 20.42 0.71 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.959 2.439 . . . . 0.0 112.828 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.583 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 11.3 mmtm -120.35 -17.89 8.09 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.993 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.509 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 39.2 mtt180 -89.08 19.59 4.13 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.305 -179.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 1.114 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -130.03 99.1 4.96 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.053 0.454 . . . . 0.0 110.937 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.674 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 54.3 m95 -108.58 134.9 50.7 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.14 0.495 . . . . 0.0 111.801 -178.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.4 pp -111.48 154.52 13.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.318 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.4 t -102.3 128.57 54.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.993 0.425 . . . . 0.0 111.139 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.6 t -121.33 94.23 4.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.398 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.16 -100.13 0.76 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.503 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.493 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.63 29.25 7.52 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.617 0.246 . . . . 0.0 110.974 -179.737 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.408 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.78 147.29 29.7 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.633 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.731 ' HB ' HD12 ' A' ' 101' ' ' LEU . 20.0 mm -94.29 120.52 43.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.384 178.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.903 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -121.91 145.07 48.45 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -178.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.441 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -65.4 149.09 50.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.493 179.568 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.114 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.6 pt? -62.91 -57.35 11.09 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.819 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.564 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -76.22 -3.89 38.86 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -178.559 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.561 ' O ' HG22 ' A' ' 99' ' ' ILE . 8.4 m-20 -139.84 88.6 2.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.783 0.325 . . . . 0.0 110.926 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.48 -16.34 62.9 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.181 179.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.86 11.76 19.31 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.216 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.561 HG22 ' O ' ' A' ' 96' ' ' ASP . 6.9 tt -131.53 137.78 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.903 HG12 ' HB2' ' A' ' 92' ' ' ALA . 18.6 m -148.66 138.5 16.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.819 0.343 . . . . 0.0 111.789 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.731 HD12 ' HB ' ' A' ' 91' ' ' ILE . 10.8 mt -45.96 153.24 0.31 Allowed 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 121.708 0.766 . . . . 0.0 111.791 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.731 ' O ' HG22 ' A' ' 114' ' ' ILE . 10.9 t70 -156.64 166.94 31.95 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.383 -1.28 . . . . 0.0 110.745 -177.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.718 HG21 HD21 ' A' ' 13' ' ' ASN . 4.3 mp -89.73 120.58 38.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.33 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.816 HG22 ' O ' ' A' ' 113' ' ' HIS . 3.7 tp -64.66 139.05 22.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.999 0.428 . . . . 0.0 111.494 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 71.46 -2.13 2.54 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.165 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.4 m 41.91 32.23 0.27 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.803 0.335 . . . . 0.0 111.52 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -96.39 156.83 16.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.18 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.27 -13.92 59.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.097 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -52.0 124.51 12.98 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.157 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.4 159.76 33.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.086 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.86 14.0 81.96 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.288 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.46 132.33 39.56 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.853 0.359 . . . . 0.0 110.993 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.816 ' O ' HG22 ' A' ' 104' ' ' ILE . 37.5 m80 -65.02 171.15 3.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.964 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.731 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -135.92 161.67 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.514 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.623 ' HA ' HD11 ' A' ' 70' ' ' ILE . 13.6 p -153.98 169.03 24.46 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.672 ' HB2' ' HH2' ' A' ' 84' ' ' TRP . . . -95.34 126.13 40.43 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.521 -0.471 . . . . 0.0 109.747 178.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.461 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 76.0 t-105 -133.92 162.47 31.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.566 0.698 . . . . 0.0 112.298 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.461 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 4.3 tmtm? -61.89 122.58 15.8 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.752 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.407 ' HA ' ' NE2' ' A' ' 125' ' ' GLN . 29.1 tt0 -60.54 125.52 24.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.346 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -134.68 9.0 3.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.631 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 80.82 7.45 88.56 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.486 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.54 152.93 44.34 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.505 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.71 -26.12 53.45 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.654 2.236 . . . . 0.0 112.324 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.621 ' O ' HD12 ' A' ' 103' ' ' ILE . 26.9 p-10 -75.39 -3.5 34.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.485 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.408 ' O ' ' CG2' ' A' ' 90' ' ' THR . 0.5 OUTLIER -108.95 14.41 24.13 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.194 -179.815 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.469 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 1.3 mmtp -105.53 133.22 50.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.768 0.318 . . . . 0.0 111.321 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.421 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 5.9 m-85 -136.41 155.77 49.56 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.544 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.4 mt -113.72 138.86 42.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.187 0.518 . . . . 0.0 110.409 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.524 ' CD1' HG23 ' A' ' 8' ' ' ILE . 36.4 mm -113.41 140.41 33.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.589 -179.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -139.16 111.48 7.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.509 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.35 110.63 2.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.118 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.957 -179.993 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.2 ttm . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.805 0.336 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.76 118.55 66.77 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.85 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.59 100.22 0.48 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.436 2.091 . . . . 0.0 112.302 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.72 74.29 1.4 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.005 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.462 ' CD1' ' HG3' ' A' ' 57' ' ' LYS . 1.3 p90 -97.64 175.79 6.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.31 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.754 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -158.84 175.57 13.42 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.795 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.447 ' CE1' ' HB3' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -114.74 123.81 50.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.24 179.196 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.616 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -104.56 109.88 28.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.926 0.393 . . . . 0.0 110.374 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -104.64 135.87 45.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.32 -178.824 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.702 ' OG ' HD11 ' A' ' 103' ' ' ILE . 0.6 OUTLIER -75.55 107.21 7.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.516 178.299 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.424 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 1.8 tt0 -63.82 -11.03 23.59 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.661 -178.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.689 HD22 ' CB ' ' A' ' 124' ' ' ASN . 37.7 tp -84.68 -62.77 1.47 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.898 0.38 . . . . 0.0 110.988 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -84.23 -11.48 56.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.333 -178.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.81 3.53 73.93 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.136 -1.03 . . . . 0.0 111.416 -178.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -91.28 -172.8 3.41 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.613 HG21 ' HA ' ' A' ' 35' ' ' GLN . 3.5 m -124.48 140.83 46.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.708 0.29 . . . . 0.0 110.469 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.4 mt -69.8 134.78 48.92 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.016 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -142.99 158.58 43.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.968 0.413 . . . . 0.0 111.239 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.949 HD13 HG21 ' A' ' 72' ' ' THR . 19.2 mt -100.91 133.72 43.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.419 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -40.51 96.77 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.769 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 49.03 64.27 3.4 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.61 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 59.47 -163.27 0.23 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.582 0.23 . . . . 0.0 110.421 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.459 ' N ' ' HD3' ' A' ' 24' ' ' PRO . 9.2 t-20 -138.96 62.2 25.44 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.71 0.29 . . . . 0.0 111.079 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.459 ' HD3' ' N ' ' A' ' 23' ' ' ASN . 16.7 Cg_exo -67.08 -37.59 18.43 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.524 2.15 . . . . 0.0 111.798 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.94 152.89 80.72 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.995 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.42 ' HB3' ' CD ' ' A' ' 74' ' ' PRO . 23.9 Cg_exo -63.66 139.96 72.25 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.645 2.23 . . . . 0.0 112.204 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.52 4.57 24.97 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.445 -0.883 . . . . 0.0 113.347 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.6 m -75.81 129.94 37.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.157 0.479 . . . . 0.0 111.258 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.2 mmtp -82.4 160.81 22.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.437 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.714 HD11 ' HB ' ' A' ' 70' ' ' ILE . 41.1 pt -119.4 147.09 23.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.78 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.46 ' HA ' ' CD1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -155.17 179.39 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.208 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.511 -179.777 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.49 HG21 HD12 ' A' ' 103' ' ' ILE . 1.6 p -101.77 149.07 24.55 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.622 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 24.3 t-105 -156.99 171.85 19.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.857 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -70.12 135.79 49.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.76 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.613 ' HA ' HG21 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -53.1 114.85 1.6 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.145 -179.835 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.63 161.99 22.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.813 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.9 mtpp -131.83 108.94 9.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.914 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 154.65 -163.6 31.3 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.517 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -76.86 4.27 5.84 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 123.09 2.526 . . . . 0.0 112.862 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.1 t -113.64 18.82 17.27 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.692 0.282 . . . . 0.0 111.207 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.862 ' O ' HD12 ' A' ' 45' ' ' LEU . . . -79.85 -19.44 48.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.189 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 1.009 HG13 ' HB3' ' A' ' 57' ' ' LYS . 47.7 t -49.38 -27.73 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.085 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -64.97 -9.59 22.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.791 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.447 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 6.0 mt-30 -120.45 7.42 10.64 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.099 0.476 . . . . 0.0 109.766 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.862 HD12 ' O ' ' A' ' 41' ' ' ALA . 1.3 mp -116.95 139.88 50.13 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.781 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.697 ' CZ2' HD11 ' A' ' 19' ' ' ILE . 24.7 m95 -133.95 168.82 18.09 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.127 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.524 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 30.1 p90 -140.71 165.0 28.69 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.112 178.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.559 HG22 HG23 ' A' ' 54' ' ' ILE . 15.0 p -107.76 134.0 51.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.813 0.34 . . . . 0.0 111.429 -178.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -77.8 169.89 17.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.192 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -63.49 -24.15 67.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.143 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -93.95 -2.82 52.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.136 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.49 8.49 54.66 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.84 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.469 HG12 ' HD3' ' A' ' 55' ' ' ARG . 40.4 t -93.98 119.43 41.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.89 0.345 . . . . 0.0 110.552 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.559 HG23 HG22 ' A' ' 48' ' ' THR . 0.7 OUTLIER -77.26 147.92 7.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.299 0.571 . . . . 0.0 111.763 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.7 ' CD ' ' HB2' ' A' ' 62' ' ' ALA . 9.0 mmm-85 -149.85 133.74 16.95 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.474 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.466 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 37.9 m -54.83 143.48 25.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.476 0.655 . . . . 0.0 111.863 -178.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 1.009 ' HB3' HG13 ' A' ' 42' ' ' VAL . 11.7 tttm -53.45 -23.82 11.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.719 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.537 HD12 ' N ' ' A' ' 59' ' ' ASN . 3.6 pp -56.15 -43.62 78.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.202 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.537 ' N ' HD12 ' A' ' 58' ' ' LEU . 1.4 t30 178.34 -171.15 0.11 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.862 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.81 83.16 1.65 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.835 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.413 ' CD1' ' OD1' ' A' ' 23' ' ' ASN . 31.9 m-85 -144.94 122.0 11.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.825 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.7 ' HB2' ' CD ' ' A' ' 55' ' ' ARG . . . -110.55 155.85 21.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.492 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.848 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -82.89 151.76 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.636 179.6 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.598 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 10.0 p-10 -132.44 130.31 40.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.106 0.479 . . . . 0.0 111.429 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.67 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -94.3 39.62 1.08 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.467 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.3 m -74.34 -45.89 44.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.141 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 15.3 m170 -91.13 167.91 12.01 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.943 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -46.74 -47.19 20.71 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.928 0.394 . . . . 0.0 110.833 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.34 146.18 27.92 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.701 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.848 HG22 HG22 ' A' ' 63' ' ' ILE . 2.7 mm -73.51 136.45 25.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 CA-C-O 121.738 0.78 . . . . 0.0 111.595 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -132.34 163.82 27.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.094 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.949 HG21 HD13 ' A' ' 19' ' ' ILE . 41.6 p -109.33 136.71 48.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.591 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.466 ' HG2' ' C ' ' A' ' 72' ' ' THR . 0.5 OUTLIER -163.1 167.32 11.9 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.452 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.432 ' O ' ' HD3' ' A' ' 82' ' ' ARG . 50.4 Cg_exo -53.46 137.0 65.04 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.432 2.088 . . . . 0.0 111.759 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -65.47 141.6 58.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.964 0.411 . . . . 0.0 111.412 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.12 139.62 35.51 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.59 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.02 -30.53 20.91 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.511 2.141 . . . . 0.0 112.864 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -89.57 0.05 57.18 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -106.19 102.57 40.81 Favored Pre-proline 0 CA--C 1.529 0.17 0 CA-C-O 120.568 0.223 . . . . 0.0 111.187 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.853 ' O ' HD21 ' A' ' 94' ' ' LEU . 5.8 Cg_exo -77.27 20.1 0.68 Allowed 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.94 2.427 . . . . 0.0 113.034 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.598 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 0.1 OUTLIER -117.85 -20.42 8.83 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 120.634 0.254 . . . . 0.0 110.96 -179.859 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.503 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 6.8 mtm-85 -88.41 19.76 3.66 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.414 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 1.131 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -128.58 99.2 5.28 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.089 0.471 . . . . 0.0 110.696 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.67 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 62.7 m95 -108.85 134.63 51.28 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.216 0.531 . . . . 0.0 112.016 -178.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.6 pt -112.12 153.23 13.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.201 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.4 t -101.75 127.02 55.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.943 0.402 . . . . 0.0 110.98 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.9 t -119.82 95.06 4.61 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.566 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.87 -100.27 0.75 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.557 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.499 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.79 29.82 7.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.603 0.239 . . . . 0.0 110.864 -179.668 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.413 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -148.76 148.43 29.97 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 121.358 0.599 . . . . 0.0 112.595 -178.548 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.809 ' HB ' HD12 ' A' ' 101' ' ' LEU . 14.6 mm -93.93 120.93 44.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.393 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.966 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -123.71 144.06 49.89 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.411 ' HB3' ' HB2' ' A' ' 96' ' ' ASP . 0.6 OUTLIER -62.83 152.34 36.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.476 179.605 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.131 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.7 pt? -65.73 -56.9 9.59 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.402 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.577 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 1.2 m -79.34 -1.93 39.16 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.411 ' HB2' ' HB3' ' A' ' 93' ' ' GLN . 9.6 m-20 -138.07 85.03 2.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.891 0.377 . . . . 0.0 110.998 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.45 -17.79 64.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.221 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' A' ' 118' ' ' LYS . 4.6 m-20 -92.7 10.28 31.35 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.466 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.848 ' CG2' ' HB1' ' A' ' 116' ' ' ALA . 11.9 mm -123.07 128.66 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.501 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.966 HG12 ' HB2' ' A' ' 92' ' ' ALA . 28.5 m -146.39 135.17 16.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.809 HD12 ' HB ' ' A' ' 91' ' ' ILE . 11.3 mt -45.62 154.21 0.22 Allowed 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.746 0.784 . . . . 0.0 111.861 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.607 ' O ' HG22 ' A' ' 114' ' ' ILE . 13.6 t70 -159.55 169.39 23.93 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.65 -177.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.702 HD11 ' OG ' ' A' ' 10' ' ' SER . 17.6 mm -88.07 121.11 38.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.168 179.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.437 HD12 ' CB ' ' A' ' 113' ' ' HIS . 52.7 mt -70.42 136.83 25.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.841 0.353 . . . . 0.0 111.215 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.403 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 0.2 OUTLIER 80.88 -9.03 1.38 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.802 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 38.2 m 47.39 30.49 1.58 Allowed 'General case' 0 N--CA 1.461 0.108 0 CA-C-O 120.785 0.326 . . . . 0.0 111.289 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -98.55 154.05 18.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.015 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.25 -11.56 60.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.316 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -52.36 129.12 27.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.206 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.95 161.51 29.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.008 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 70.64 15.62 73.47 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.867 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.92 133.41 39.25 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.824 0.345 . . . . 0.0 110.793 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.437 ' CB ' HD12 ' A' ' 104' ' ' ILE . 14.8 m80 -64.0 170.43 3.56 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.019 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.607 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -135.89 161.71 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.425 179.779 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.631 ' HA ' HD11 ' A' ' 70' ' ' ILE . 29.1 p -154.53 169.06 24.69 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.848 ' HB1' ' CG2' ' A' ' 99' ' ' ILE . . . -94.84 127.63 41.0 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.459 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 75.8 t-105 -135.9 162.75 31.95 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.608 0.718 . . . . 0.0 112.212 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.459 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 12.2 tptt -61.95 117.14 5.54 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.625 -1.171 . . . . 0.0 110.875 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.56 127.59 32.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.772 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -139.08 12.02 2.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.27 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 75.86 60.46 3.15 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.266 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -116.15 144.26 18.36 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.557 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.78 -33.89 72.57 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.5 2.134 . . . . 0.0 112.226 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.689 ' CB ' HD22 ' A' ' 12' ' ' LEU . 12.9 p-10 -76.68 -2.22 31.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.508 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.413 ' O ' ' CG2' ' A' ' 90' ' ' THR . 0.0 OUTLIER -107.97 9.82 28.51 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.745 -0.207 . . . . 0.0 111.184 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.424 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 9.8 mmtp -106.5 139.43 40.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.762 0.315 . . . . 0.0 111.439 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.43 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 7.5 m-85 -138.61 156.34 47.54 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.244 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.4 mt -113.17 138.64 41.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.158 0.504 . . . . 0.0 110.65 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.557 ' CD1' HG23 ' A' ' 8' ' ' ILE . 25.2 mm -114.17 140.36 35.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.62 -179.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.95 96.04 3.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.588 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.2 t -51.91 111.48 0.62 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.313 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.444 ' HB3' ' CD2' ' A' ' 5' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.898 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.825 0.345 . . . . 0.0 111.189 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.76 132.46 24.19 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.803 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.6 173.24 14.67 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.47 2.113 . . . . 0.0 112.397 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.44 148.01 49.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.684 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.5 ' HA ' ' O ' ' A' ' 46' ' ' TRP . 3.1 p90 -89.72 173.04 8.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.851 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.743 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -159.48 173.75 15.71 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.204 179.693 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.549 ' OH ' ' HB1' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -109.41 123.47 49.4 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.359 179.091 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.62 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -107.92 104.11 16.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.847 -179.709 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.837 ' HB3' HG12 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -127.22 125.44 41.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.471 -179.504 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.473 ' O ' ' HD2' ' A' ' 9' ' ' LYS . 28.7 t -46.24 139.7 4.52 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.04 0.447 . . . . 0.0 111.474 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.551 ' HA ' HD11 ' A' ' 128' ' ' ILE . 3.9 tt0 -82.64 -10.73 58.82 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.02 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 38.1 tp -90.25 -58.31 2.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.804 0.335 . . . . 0.0 111.034 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -84.1 -19.09 34.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.846 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.13 5.28 75.71 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.306 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.585 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 2.9 mmmm -85.74 165.49 16.88 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.837 HG12 ' HB3' ' A' ' 9' ' ' LYS . 15.4 m -107.2 136.43 42.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.823 0.344 . . . . 0.0 110.754 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.7 mt -69.99 137.91 51.8 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -140.05 149.95 43.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.836 0.35 . . . . 0.0 111.157 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.856 HD13 HG21 ' A' ' 72' ' ' THR . 1.1 mt -99.33 116.25 42.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.839 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -61.72 96.13 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.864 0.364 . . . . 0.0 110.611 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 158.21 -45.01 0.47 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.372 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 52.12 48.64 22.3 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.832 0.349 . . . . 0.0 111.176 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.403 ' CB ' ' CD ' ' A' ' 24' ' ' PRO . 1.0 OUTLIER -177.65 175.66 0.54 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.996 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.403 ' CD ' ' CB ' ' A' ' 23' ' ' ASN . 25.3 Cg_exo -62.89 -12.64 30.29 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.824 2.349 . . . . 0.0 112.605 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -43.35 102.43 0.28 Allowed Pre-proline 0 CA--C 1.53 0.176 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.497 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.457 ' HB3' ' HD3' ' A' ' 74' ' ' PRO . 70.1 Cg_endo -72.96 143.96 37.43 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.585 2.19 . . . . 0.0 112.272 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.68 6.68 52.34 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.515 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.8 m -77.22 137.48 38.87 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.039 0.447 . . . . 0.0 111.171 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.3 mmtm -83.86 157.62 21.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.219 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.824 HG22 HG23 ' A' ' 19' ' ' ILE . 44.1 pt -115.95 145.68 21.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.889 0.376 . . . . 0.0 111.633 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.453 ' HA ' ' CD1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -155.4 -179.5 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.126 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.779 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.8 p -103.18 150.73 23.39 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.579 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 28.0 t-105 -155.47 170.59 21.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.657 0.265 . . . . 0.0 110.979 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -71.83 137.27 47.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.831 0.348 . . . . 0.0 110.763 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -56.63 135.19 54.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.008 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.9 168.12 9.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.83 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.26 103.29 6.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.926 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 163.94 -164.8 36.69 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.593 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -80.92 7.39 4.94 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.801 2.334 . . . . 0.0 113.102 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.1 17.55 21.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.652 0.263 . . . . 0.0 111.184 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.972 ' O ' HD12 ' A' ' 45' ' ' LEU . . . -82.17 -18.52 42.45 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.308 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.945 HG13 ' HB3' ' A' ' 57' ' ' LYS . 65.8 t -51.26 -31.25 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.937 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -66.99 -10.62 51.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.696 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -116.09 7.41 14.23 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.972 HD12 ' O ' ' A' ' 41' ' ' ALA . 0.9 OUTLIER -117.66 141.29 48.56 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.713 -179.083 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.634 ' CZ2' HD11 ' A' ' 19' ' ' ILE . 24.4 m95 -133.27 167.69 19.91 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.041 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.518 ' CE1' ' HB2' ' A' ' 55' ' ' ARG . 37.6 p90 -140.56 165.03 28.55 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.106 178.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 46.0 p -105.6 132.63 51.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.828 0.346 . . . . 0.0 111.336 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -77.79 165.84 23.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.117 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.13 -25.49 67.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.234 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -90.86 -4.05 56.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.469 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.563 ' O ' HG22 ' A' ' 85' ' ' ILE . . . 97.96 11.87 48.28 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.845 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.451 HG13 ' HA ' ' A' ' 83' ' ' ALA . 30.9 t -100.7 121.44 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-O 120.744 0.307 . . . . 0.0 110.488 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.482 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -76.07 148.43 7.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.31 0.576 . . . . 0.0 111.889 -179.751 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.734 ' CD ' ' HB2' ' A' ' 62' ' ' ALA . 12.3 mmm-85 -149.23 133.74 17.61 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.408 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.506 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -56.51 142.12 40.22 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.54 0.686 . . . . 0.0 111.893 -178.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.945 ' HB3' HG13 ' A' ' 42' ' ' VAL . 21.0 tttt -54.09 -22.31 10.65 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.715 -1.13 . . . . 0.0 111.673 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.467 ' HA ' HG11 ' A' ' 42' ' ' VAL . 3.4 pp -58.93 -41.87 88.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.777 0.322 . . . . 0.0 111.12 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.434 ' N ' HD12 ' A' ' 58' ' ' LEU . 1.2 t-20 -179.36 -179.69 0.56 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.791 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -70.99 84.4 0.69 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.806 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.402 ' CZ ' ' O ' ' A' ' 24' ' ' PRO . 1.9 m-85 -145.92 123.5 11.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.899 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.734 ' HB2' ' CD ' ' A' ' 55' ' ' ARG . . . -108.83 152.59 24.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.081 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.786 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -78.66 152.99 4.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.68 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.537 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 6.7 p-10 -134.2 133.42 40.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.277 0.56 . . . . 0.0 111.69 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.674 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -97.42 43.49 1.07 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.217 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.0 t -74.71 -43.98 52.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.087 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 65.8 m170 -97.2 172.47 7.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.925 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -48.32 -48.81 35.92 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.14 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -99.0 145.62 26.88 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.126 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.786 HG22 HG22 ' A' ' 63' ' ' ILE . 3.1 mm -73.93 138.54 20.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.552 0.692 . . . . 0.0 111.455 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.43 ' O ' HG22 ' A' ' 63' ' ' ILE . 1.3 pt-20 -139.2 167.75 21.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.799 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.856 HG21 HD13 ' A' ' 19' ' ' ILE . 57.0 p -106.77 139.41 41.24 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.052 0.453 . . . . 0.0 111.528 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.403 ' CB ' ' CD ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -159.46 175.07 3.44 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.993 179.643 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.457 ' HD3' ' HB3' ' A' ' 26' ' ' PRO . 17.3 Cg_exo -66.65 138.86 50.91 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.513 2.142 . . . . 0.0 111.583 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -62.29 128.82 37.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.814 0.34 . . . . 0.0 111.031 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.409 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 0.4 OUTLIER -122.18 125.85 26.46 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.674 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -56.92 -35.4 98.55 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.457 2.105 . . . . 0.0 112.794 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 21.3 m-20 -86.35 -2.73 58.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.777 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.41 ' CB ' ' HD2' ' A' ' 82' ' ' ARG . 8.7 t-20 -101.19 100.6 13.77 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-O 120.611 0.243 . . . . 0.0 110.786 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.555 ' O ' HD21 ' A' ' 94' ' ' LEU . 82.9 Cg_endo -76.66 21.16 0.58 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.638 2.225 . . . . 0.0 113.48 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.659 ' HD2' ' HB3' ' A' ' 65' ' ' ALA . 40.3 mmtt -120.94 -18.37 7.58 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 120.689 0.28 . . . . 0.0 111.134 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.495 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 40.3 mtt180 -88.09 21.42 2.76 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -178.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 1.003 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -130.25 99.84 5.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.203 0.525 . . . . 0.0 111.051 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.674 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 60.4 m95 -110.21 135.06 51.57 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.227 0.537 . . . . 0.0 111.914 -178.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.563 HG22 ' O ' ' A' ' 52' ' ' GLY . 2.4 pt -113.86 154.24 15.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.125 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.9 t -102.14 127.99 55.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.912 0.387 . . . . 0.0 111.115 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 46.6 t -121.07 95.1 4.56 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.553 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.28 -100.66 0.81 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.554 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.504 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.94 29.86 7.16 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.587 0.232 . . . . 0.0 110.735 -179.76 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -149.16 148.36 29.54 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 121.358 0.599 . . . . 0.0 112.348 -178.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.768 ' HB ' HD12 ' A' ' 101' ' ' LEU . 14.3 mm -94.32 121.08 44.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.629 178.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.833 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -120.84 143.0 49.12 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -178.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.438 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -67.31 146.05 54.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.699 179.763 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.003 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.6 pt? -61.05 -56.13 24.55 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.664 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.628 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 7.9 m -73.72 -6.68 48.36 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -178.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.533 ' O ' HG22 ' A' ' 99' ' ' ILE . 0.6 OUTLIER -139.75 89.65 2.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.881 0.372 . . . . 0.0 111.071 -179.777 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.26 -16.23 63.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.182 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.73 12.86 21.95 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.096 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.533 HG22 ' O ' ' A' ' 96' ' ' ASP . 6.8 tt -131.08 137.16 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.833 HG12 ' HB2' ' A' ' 92' ' ' ALA . 15.9 m -148.9 138.46 15.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.855 0.359 . . . . 0.0 111.637 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.768 HD12 ' HB ' ' A' ' 91' ' ' ILE . 10.5 mt -46.39 155.19 0.23 Allowed 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.593 0.711 . . . . 0.0 111.71 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.71 ' O ' HG22 ' A' ' 114' ' ' ILE . 35.6 t70 -157.49 166.71 32.23 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.588 -177.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.528 ' HA ' HG22 ' A' ' 114' ' ' ILE . 3.0 mp -92.8 118.33 38.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.461 179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.773 HG22 ' O ' ' A' ' 113' ' ' HIS . 8.5 tt -62.45 141.98 17.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.791 0.329 . . . . 0.0 111.164 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.425 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 10.5 tptt 82.43 -20.81 0.33 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.71 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.6 m 53.9 39.41 30.41 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.917 0.389 . . . . 0.0 111.013 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -113.36 167.01 10.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.029 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.75 -13.83 58.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.984 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -48.29 142.41 5.54 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.098 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.476 ' HB2' ' NZ ' ' A' ' 15' ' ' LYS . . . -90.1 158.16 17.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.2 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 76.35 12.84 83.91 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.543 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.5 132.9 39.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.878 0.37 . . . . 0.0 111.01 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.773 ' O ' HG22 ' A' ' 104' ' ' ILE . 12.9 m80 -65.52 173.33 2.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.029 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.71 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -137.36 161.5 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.513 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.598 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 7.2 t -152.52 166.14 32.93 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.638 ' HB2' ' HH2' ' A' ' 84' ' ' TRP . . . -92.91 121.54 34.37 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.471 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 76.2 t-105 -128.73 162.19 27.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.67 0.747 . . . . 0.0 112.241 -179.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.471 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.8 OUTLIER -64.8 123.38 19.22 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.7 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -58.48 123.29 15.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.045 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -134.2 4.44 3.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.493 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 79.39 56.56 3.37 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.286 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -109.28 147.47 16.91 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.519 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.74 -29.3 59.63 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.57 2.18 . . . . 0.0 112.083 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -76.91 -4.35 43.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.234 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.421 ' NE2' ' CG2' ' A' ' 100' ' ' VAL . 3.2 mt-30 -102.73 -7.14 21.92 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.463 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.44 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 8.6 mmtm -83.73 132.66 34.83 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.772 0.32 . . . . 0.0 111.295 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -131.11 153.64 49.14 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.344 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.813 HD12 ' CE ' ' A' ' 9' ' ' LYS . 1.4 mt -113.68 137.48 46.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.163 0.506 . . . . 0.0 110.644 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.575 HD12 HG23 ' A' ' 8' ' ' ILE . 20.8 mm -114.26 142.05 28.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.593 -179.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -137.02 110.41 7.91 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.285 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 44.1 m -60.02 114.41 2.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.322 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.23 -0.89 . . . . 0.0 111.494 179.714 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.6 ttt . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.786 0.327 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 63.59 126.21 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.863 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.6 148.21 36.24 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.466 2.11 . . . . 0.0 112.343 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -118.92 139.94 50.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.826 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.493 ' CD1' ' HG3' ' A' ' 57' ' ' LYS . 1.5 p90 -95.1 175.04 6.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.501 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.746 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -160.38 176.45 11.66 Favored 'General case' 0 CA--C 1.512 -0.512 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.774 179.919 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.449 ' CE1' ' HB3' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -114.86 123.78 50.04 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.297 179.228 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.623 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -104.14 109.89 28.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.23 179.904 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.29 136.85 45.28 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.273 -178.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.54 ' OG ' HD21 ' A' ' 17' ' ' LEU . 48.7 m -75.95 107.82 8.41 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 5.2 tt0 -63.19 -11.15 18.72 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.47 -178.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.568 HD22 ' HA ' ' A' ' 124' ' ' ASN . 56.3 tp -84.66 -62.49 1.53 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.848 0.356 . . . . 0.0 110.973 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.65 HD21 HG21 ' A' ' 103' ' ' ILE . 6.7 m-20 -84.97 -12.94 52.19 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.69 2.57 76.45 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.214 -0.993 . . . . 0.0 111.513 -178.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.41 -178.64 5.65 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.601 HG21 ' HA ' ' A' ' 35' ' ' GLN . 7.9 m -120.37 140.34 44.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.673 0.273 . . . . 0.0 110.527 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.54 HD21 ' OG ' ' A' ' 10' ' ' SER . 10.6 mt -70.19 134.8 48.45 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -142.61 158.21 43.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.901 0.381 . . . . 0.0 111.204 -179.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.119 HD13 HG21 ' A' ' 72' ' ' THR . 31.3 mt -100.19 137.86 26.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.458 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -41.16 96.0 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.73 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' A' ' 23' ' ' ASN . . . 45.12 39.13 6.58 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.182 -0.532 . . . . 0.0 112.987 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.74 -74.31 0.06 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.85 0.357 . . . . 0.0 110.766 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 21' ' ' GLY . 1.7 t30 59.8 92.52 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.025 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -64.96 -9.39 21.3 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.705 2.27 . . . . 0.0 112.571 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -93.5 151.84 40.47 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-O 120.724 0.297 . . . . 0.0 111.078 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.449 ' HB3' ' HB3' ' A' ' 73' ' ' GLN . 16.2 Cg_exo -68.41 135.73 34.7 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.832 2.355 . . . . 0.0 112.468 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.21 1.29 16.36 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.604 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.85 136.25 43.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 117.316 0.558 . . . . 0.0 111.0 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.2 159.78 18.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.694 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.664 HG22 HG12 ' A' ' 19' ' ' ILE . 46.4 pt -120.33 148.03 23.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.821 0.343 . . . . 0.0 111.637 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.465 HG22 ' HA ' ' A' ' 113' ' ' HIS . 0.3 OUTLIER -156.26 -178.39 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.243 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.425 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.531 HG21 HD12 ' A' ' 103' ' ' ILE . 1.6 p -100.87 148.55 24.84 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.585 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 28.0 t-105 -158.42 172.63 17.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.689 0.28 . . . . 0.0 110.91 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -70.86 135.76 48.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.765 0.317 . . . . 0.0 110.708 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.601 ' HA ' HG21 ' A' ' 16' ' ' VAL . 5.7 tm0? -56.73 125.96 24.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.007 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.25 164.55 12.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.951 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.7 mmmt -131.68 111.22 11.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.961 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 154.23 -165.76 31.9 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.635 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.64 2.52 6.84 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.131 2.554 . . . . 0.0 112.859 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.12 16.95 19.08 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.653 0.263 . . . . 0.0 111.153 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.846 ' O ' HD12 ' A' ' 45' ' ' LEU . . . -80.35 -18.1 50.04 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.412 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.967 HG13 ' HB3' ' A' ' 57' ' ' LYS . 49.4 t -50.08 -27.39 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.055 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -64.57 -10.27 25.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.718 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.449 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 1.6 mt-30 -118.92 7.76 11.55 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.846 HD12 ' O ' ' A' ' 41' ' ' ALA . 1.3 mp -117.65 140.7 49.3 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.8 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.719 ' CZ2' HD11 ' A' ' 19' ' ' ILE . 26.9 m95 -134.12 168.77 18.23 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.938 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.555 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 15.7 p90 -141.69 165.93 26.13 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.1 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 72.8 p -106.79 132.4 52.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.768 0.318 . . . . 0.0 111.313 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -77.63 165.62 24.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.09 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -58.69 -25.49 62.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.027 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -93.55 -3.52 52.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.324 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.34 6.8 55.1 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.874 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.3 t -90.43 117.65 34.13 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-O 120.771 0.319 . . . . 0.0 110.687 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.563 ' O ' ' HG3' ' A' ' 55' ' ' ARG . 0.6 OUTLIER -75.99 144.08 12.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.076 0.465 . . . . 0.0 111.049 179.596 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.563 ' HG3' ' O ' ' A' ' 54' ' ' ILE . 0.4 OUTLIER -149.75 133.54 16.89 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.88 179.222 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 72.7 m -51.5 144.74 9.81 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.582 0.706 . . . . 0.0 112.127 -178.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.967 ' HB3' HG13 ' A' ' 42' ' ' VAL . 10.0 tttt -57.96 -20.26 36.67 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.877 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.548 ' HA ' HG11 ' A' ' 42' ' ' VAL . 0.5 OUTLIER -47.58 -45.81 27.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.794 -179.253 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -171.24 -72.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.66 0.266 . . . . 0.0 111.282 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -176.42 81.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.913 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.414 ' CE2' ' HD3' ' A' ' 74' ' ' PRO . 1.5 m-85 -140.84 122.99 15.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.874 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -101.68 148.3 25.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.201 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.874 HG22 HG22 ' A' ' 70' ' ' ILE . 0.3 OUTLIER -77.99 152.45 5.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.684 179.786 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.634 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 6.6 p-10 -133.18 130.72 39.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.191 0.52 . . . . 0.0 111.682 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.675 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -95.07 42.05 1.09 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.418 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 60.4 p -74.62 -43.18 56.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.369 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 23.4 m80 -97.89 171.81 8.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.102 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -48.82 -44.01 38.88 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.916 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.06 144.49 31.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.641 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.874 HG22 HG22 ' A' ' 63' ' ' ILE . 1.7 mm -76.37 141.95 15.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.666 0.746 . . . . 0.0 111.8 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -139.26 166.59 24.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.863 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 1.119 HG21 HD13 ' A' ' 19' ' ' ILE . 41.6 p -104.27 138.18 41.1 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.861 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.449 ' HB3' ' HB3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -163.53 167.54 11.14 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.26 179.755 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.415 ' CD ' ' HB3' ' A' ' 26' ' ' PRO . 32.2 Cg_exo -57.88 137.33 80.46 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.415 2.077 . . . . 0.0 111.861 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.536 ' CE1' ' HB2' ' A' ' 83' ' ' ALA . 16.8 t80 -67.18 127.2 31.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.855 0.359 . . . . 0.0 110.886 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -117.48 139.55 26.3 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.48 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.4 -32.26 41.01 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.527 2.151 . . . . 0.0 112.905 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 32.3 m-20 -88.79 -1.59 58.16 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -107.11 101.12 36.4 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.571 0.224 . . . . 0.0 111.007 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.85 ' O ' HD21 ' A' ' 94' ' ' LEU . 5.6 Cg_exo -77.16 21.28 0.61 Allowed 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.869 2.379 . . . . 0.0 112.98 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.634 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -116.47 -21.92 8.98 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.94 -179.827 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.477 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 41.7 mtt180 -87.62 20.28 3.02 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.47 -179.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 1.071 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -130.01 99.33 5.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.074 0.464 . . . . 0.0 110.854 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.675 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 58.9 m95 -109.45 137.26 47.56 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.223 0.535 . . . . 0.0 111.89 -178.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.3 pt -115.1 153.63 16.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.237 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.9 t -100.21 125.39 53.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.905 0.383 . . . . 0.0 110.948 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 21.5 t -117.85 93.89 4.32 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.526 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.89 -100.57 0.78 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.601 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.499 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.55 29.36 7.48 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.568 0.223 . . . . 0.0 110.921 -179.549 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -148.76 148.55 30.11 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.314 0.578 . . . . 0.0 112.522 -178.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.639 ' HB ' HD12 ' A' ' 101' ' ' LEU . 17.6 mm -93.38 121.28 43.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.44 178.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.99 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -124.67 145.3 49.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.32 0.581 . . . . 0.0 112.557 -178.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.421 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -65.26 149.53 49.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.508 179.729 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.071 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.7 pt? -62.2 -56.88 14.27 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.717 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.575 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 35.7 m -79.65 -1.61 38.99 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.405 ' HB2' ' HB3' ' A' ' 93' ' ' GLN . 72.9 m-20 -138.5 85.9 2.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.875 0.369 . . . . 0.0 111.009 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.63 -18.32 65.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.072 178.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -91.51 8.73 35.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.445 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.822 ' CG2' ' HB1' ' A' ' 116' ' ' ALA . 12.7 mm -121.15 126.29 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.494 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.99 HG12 ' HB2' ' A' ' 92' ' ' ALA . 22.3 m -145.98 134.49 16.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.836 0.351 . . . . 0.0 111.892 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.639 HD12 ' HB ' ' A' ' 91' ' ' ILE . 16.2 mt -46.26 154.09 0.29 Allowed 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 121.755 0.788 . . . . 0.0 111.964 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.826 ' O ' HG22 ' A' ' 114' ' ' ILE . 25.6 t70 -156.85 167.41 30.56 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.293 -1.321 . . . . 0.0 110.752 -177.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.65 HG21 HD21 ' A' ' 13' ' ' ASN . 34.0 mm -89.0 126.08 42.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.566 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.787 HG22 ' O ' ' A' ' 113' ' ' HIS . 1.2 tt -68.05 137.99 23.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.01 0.434 . . . . 0.0 111.558 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 29.7 mtpt 67.44 3.41 3.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.114 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 40.0 t 40.9 32.33 0.16 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.744 0.307 . . . . 0.0 111.454 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.1 p30 -96.08 157.41 15.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.181 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.93 -14.97 58.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.199 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -51.1 123.07 8.62 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.847 0.356 . . . . 0.0 111.107 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.18 161.15 31.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.172 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 73.29 16.64 78.7 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.181 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.85 135.58 35.95 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 120.875 0.369 . . . . 0.0 111.056 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.787 ' O ' HG22 ' A' ' 104' ' ' ILE . 1.4 m80 -61.86 170.29 2.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.783 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.826 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.5 OUTLIER -143.22 161.8 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.872 -179.698 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.655 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 12.8 p -157.15 174.16 15.9 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.822 ' HB1' ' CG2' ' A' ' 99' ' ' ILE . . . -95.81 129.67 42.98 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 178.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.458 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 75.8 t-105 -136.05 162.38 33.04 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.602 0.715 . . . . 0.0 112.051 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.458 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.2 OUTLIER -60.36 119.74 8.54 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.689 179.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.414 ' HA ' ' NE2' ' A' ' 125' ' ' GLN . 12.2 tt0 -60.1 127.3 31.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.081 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -137.52 11.0 2.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.207 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 78.4 10.28 86.34 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.882 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.78 139.78 46.82 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.521 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.5 -28.92 57.14 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.495 2.13 . . . . 0.0 112.24 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.568 ' HA ' HD22 ' A' ' 12' ' ' LEU . 30.6 p-10 -74.55 -5.42 42.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.423 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.414 ' NE2' ' HA ' ' A' ' 119' ' ' GLN . 0.1 OUTLIER -106.57 16.36 24.69 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.096 -179.829 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.443 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 2.7 mmmt -105.91 132.95 51.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.743 0.306 . . . . 0.0 111.398 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.436 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 5.2 m-85 -136.12 155.1 50.67 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.417 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 mt -114.27 140.32 35.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.179 0.514 . . . . 0.0 110.67 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.543 HD12 HG23 ' A' ' 8' ' ' ILE . 20.1 mm -114.04 139.78 38.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.617 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.21 96.14 3.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.614 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.4 m -50.76 111.71 0.59 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.405 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.435 ' HB3' ' CD2' ' A' ' 5' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.918 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.5 mtp . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 120.807 0.337 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -115.92 105.37 51.41 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.92 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.45 ' HG2' ' CD1' ' A' ' 47' ' ' TYR . 39.3 Cg_endo -67.04 161.07 44.32 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.37 2.047 . . . . 0.0 112.322 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -47.94 151.35 0.95 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.673 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.485 ' CD1' ' HG3' ' A' ' 57' ' ' LYS . 0.2 OUTLIER -105.85 176.46 5.16 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.139 179.666 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.761 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -156.41 172.76 17.95 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.735 179.878 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.487 ' OH ' ' HB1' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -112.22 123.86 51.2 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.103 179.04 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.619 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -105.1 109.29 27.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.004 0.431 . . . . 0.0 110.693 -179.73 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 16' ' ' VAL . 0.1 OUTLIER -102.15 132.49 48.02 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.008 -179.065 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.1 p -74.16 107.29 6.25 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.415 ' HB3' ' O ' ' A' ' 126' ' ' LYS . 3.6 tt0 -63.8 -9.86 16.96 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.537 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.502 HD13 ' HA ' ' A' ' 124' ' ' ASN . 28.7 tp -83.44 -62.99 1.44 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.815 0.34 . . . . 0.0 110.752 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.555 HD21 HG21 ' A' ' 103' ' ' ILE . 5.0 m-80 -85.59 -7.87 58.61 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.79 6.65 67.75 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.071 -1.062 . . . . 0.0 111.558 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -94.11 -171.97 2.69 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 4.8 m -121.84 140.65 45.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.755 0.312 . . . . 0.0 110.528 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.1 mt -69.79 133.47 47.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.329 -0.396 . . . . 0.0 109.95 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -144.04 147.79 34.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.827 0.346 . . . . 0.0 111.144 -179.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.1 HD13 HG21 ' A' ' 72' ' ' THR . 22.3 mt -89.52 133.77 30.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.42 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -41.85 101.57 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.196 -0.456 . . . . 0.0 112.025 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 23' ' ' ASN . . . 42.6 31.41 1.07 Allowed Glycine 0 C--N 1.332 0.32 0 CA-C-N 115.927 -0.579 . . . . 0.0 113.351 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.2 mp0 63.48 -76.06 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.746 0.308 . . . . 0.0 111.332 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.404 ' N ' ' O ' ' A' ' 21' ' ' GLY . 3.0 m120 63.32 100.44 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.819 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -62.43 -11.01 20.87 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.625 2.217 . . . . 0.0 112.631 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . . . -95.58 147.94 33.8 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-O 120.68 0.276 . . . . 0.0 111.048 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.452 ' HB3' ' HB3' ' A' ' 73' ' ' GLN . 19.6 Cg_exo -66.31 144.19 73.3 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.738 2.292 . . . . 0.0 112.476 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.07 2.19 22.06 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.454 -0.879 . . . . 0.0 113.439 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.2 t -73.17 139.29 46.23 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 117.22 0.51 . . . . 0.0 111.121 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.3 mptm? -90.65 158.49 16.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.487 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.704 HD11 ' HB ' ' A' ' 70' ' ' ILE . 36.8 pt -116.88 145.53 22.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.854 0.359 . . . . 0.0 111.708 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.46 ' HA ' ' CD1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -154.97 177.92 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.458 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.5 p -100.94 149.57 23.76 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.498 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 9.0 t-105 -155.47 170.66 21.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.745 0.307 . . . . 0.0 110.993 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.09 135.43 47.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.827 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -58.98 130.03 45.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.906 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.23 176.43 5.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.838 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.0 mttp -127.9 156.67 42.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.823 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 110.3 -164.04 12.32 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.501 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -80.89 7.84 4.66 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.746 2.297 . . . . 0.0 113.13 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 43.1 p -106.25 16.27 25.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.635 0.255 . . . . 0.0 111.244 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.981 ' O ' HD12 ' A' ' 45' ' ' LEU . . . -84.11 -19.85 33.54 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.311 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 1.012 HG13 ' HB3' ' A' ' 57' ' ' LYS . 53.2 t -50.6 -31.9 9.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.915 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -65.19 -11.25 38.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.889 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.454 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 3.7 mt-30 -117.6 8.78 12.95 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.981 HD12 ' O ' ' A' ' 41' ' ' ALA . 0.9 OUTLIER -118.43 141.15 48.83 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.861 -179.143 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.746 ' CZ2' HD11 ' A' ' 19' ' ' ILE . 26.1 m95 -134.23 169.49 17.1 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.052 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.523 ' CZ ' ' HB2' ' A' ' 55' ' ' ARG . 28.3 p90 -141.45 164.47 30.15 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.143 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.493 HG22 HG23 ' A' ' 54' ' ' ILE . 0.7 OUTLIER -109.11 136.41 48.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.829 0.347 . . . . 0.0 111.397 -178.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -77.75 170.7 16.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.2 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -62.31 -22.48 66.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.089 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -98.77 -2.46 37.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.167 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.8 3.77 54.82 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.884 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.669 HG11 ' CD2' ' A' ' 75' ' ' PHE . 21.8 t -85.99 116.24 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 CA-C-N 116.977 0.389 . . . . 0.0 110.693 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.515 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -78.21 147.8 6.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.383 0.611 . . . . 0.0 112.034 -179.59 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.802 ' CD ' ' HB2' ' A' ' 62' ' ' ALA . 8.8 mmm-85 -150.62 133.67 16.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.152 178.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.638 ' HB2' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -55.27 146.05 20.15 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.456 0.646 . . . . 0.0 112.055 -178.721 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 1.012 ' HB3' HG13 ' A' ' 42' ' ' VAL . 8.2 tttm -57.89 -20.7 38.82 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.81 -1.087 . . . . 0.0 111.886 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.704 HD23 ' H ' ' A' ' 59' ' ' ASN . 0.8 OUTLIER -59.49 -33.1 70.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.832 0.349 . . . . 0.0 111.087 -179.533 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.704 ' H ' HD23 ' A' ' 58' ' ' LEU . 1.1 t30 174.74 -169.82 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.712 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -82.34 82.78 7.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.721 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -144.23 124.97 14.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.979 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.802 ' HB2' ' CD ' ' A' ' 55' ' ' ARG . . . -107.46 153.19 23.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.524 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.797 HG22 HG22 ' A' ' 70' ' ' ILE . 0.3 OUTLIER -78.85 152.05 5.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.778 179.667 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.568 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 4.1 p-10 -132.78 137.83 46.95 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.964 0.411 . . . . 0.0 111.368 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.635 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -104.06 42.37 1.19 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.429 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.37 -44.82 50.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.833 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 7.2 m80 -93.84 169.22 10.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.934 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -48.4 -46.0 36.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.956 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -99.73 142.74 30.82 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.138 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.797 HG22 HG22 ' A' ' 63' ' ' ILE . 3.5 mm -73.44 139.53 19.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-O 121.55 0.691 . . . . 0.0 111.382 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -140.56 169.35 17.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.944 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 1.1 HG21 HD13 ' A' ' 19' ' ' ILE . 49.9 p -106.28 138.65 42.09 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.262 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.475 ' HG2' ' C ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -164.92 169.36 7.65 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.033 179.684 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.433 ' HD3' ' HB3' ' A' ' 26' ' ' PRO . 77.1 Cg_exo -49.56 141.82 25.38 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.416 2.077 . . . . 0.0 112.08 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.669 ' CD2' HG11 ' A' ' 53' ' ' VAL . 53.1 t80 -47.94 -56.62 7.19 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.3 t70 61.29 118.15 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.67 0.272 . . . . 0.0 110.346 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.08 -27.32 25.06 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.488 2.125 . . . . 0.0 113.546 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -88.43 0.85 55.81 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.46 ' CB ' ' HD2' ' A' ' 82' ' ' ARG . 1.7 m-80 -105.96 103.76 46.04 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.586 0.232 . . . . 0.0 111.331 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.88 ' O ' HD21 ' A' ' 94' ' ' LEU . 5.6 Cg_exo -77.33 18.79 0.76 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.996 2.464 . . . . 0.0 113.105 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.568 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 8.2 mmtt -119.95 -18.27 8.23 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 120.648 0.261 . . . . 0.0 110.91 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.487 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 32.2 mtt180 -90.97 23.13 3.31 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.15 -179.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 1.149 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -131.23 99.8 4.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.983 0.421 . . . . 0.0 110.765 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.635 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 51.3 m95 -110.35 136.94 48.75 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.246 0.546 . . . . 0.0 112.106 -178.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.409 ' C ' HD12 ' A' ' 85' ' ' ILE . 2.7 pp -114.13 154.71 15.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.198 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.2 t -101.47 127.21 55.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.95 0.405 . . . . 0.0 111.105 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.3 t -119.51 94.38 4.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.347 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.19 -100.43 0.79 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.497 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.502 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.89 29.77 7.21 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.56 0.219 . . . . 0.0 110.871 -179.692 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.411 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -148.03 148.05 30.28 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.502 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.775 ' HB ' HD12 ' A' ' 101' ' ' LEU . 15.2 mm -93.69 120.09 42.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.131 -0.941 . . . . 0.0 109.336 178.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.919 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -121.94 143.73 49.29 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.432 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -67.28 147.34 53.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.732 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.149 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.6 pt? -60.97 -56.86 16.13 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.798 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.569 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 2.2 m -75.17 -4.63 39.92 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -139.6 87.61 2.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.789 0.328 . . . . 0.0 110.967 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 16.3 mmt85 -67.6 -17.42 64.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.117 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.41 ' O ' ' HA ' ' A' ' 118' ' ' LYS . 0.8 OUTLIER -94.05 11.78 28.61 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.486 179.165 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.848 ' CG2' ' HB1' ' A' ' 116' ' ' ALA . 10.2 mm -124.4 130.83 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.919 HG12 ' HB2' ' A' ' 92' ' ' ALA . 34.7 m -147.64 136.75 15.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.836 0.351 . . . . 0.0 111.91 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.775 HD12 ' HB ' ' A' ' 91' ' ' ILE . 11.2 mt -46.06 154.29 0.26 Allowed 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.693 0.758 . . . . 0.0 111.867 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.731 ' O ' HG22 ' A' ' 114' ' ' ILE . 10.3 t70 -159.59 168.57 25.78 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 114.375 -1.284 . . . . 0.0 110.666 -177.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.695 HD12 ' O ' ' A' ' 124' ' ' ASN . 4.4 mp -87.41 119.46 35.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.031 179.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.595 HG22 ' HG2' ' A' ' 105' ' ' LYS . 52.9 mt -70.24 137.51 23.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.913 0.387 . . . . 0.0 111.525 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.595 ' HG2' HG22 ' A' ' 104' ' ' ILE . 0.0 OUTLIER 67.0 10.77 7.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.714 179.763 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.3 m 45.69 -139.18 0.47 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.938 -0.119 . . . . 0.0 110.94 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 68.84 162.88 0.22 Allowed 'General case' 0 N--CA 1.46 0.067 0 CA-C-O 120.803 0.335 . . . . 0.0 110.878 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 4.3 tttp -89.32 -11.57 43.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.533 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -41.94 135.74 2.28 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.812 0.339 . . . . 0.0 111.62 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -88.46 161.31 17.1 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.303 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 71.94 17.2 76.83 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.027 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.79 135.08 35.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.801 0.334 . . . . 0.0 110.896 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 15.5 m170 -65.14 173.96 2.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.012 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.731 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -137.77 161.94 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.476 -179.917 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.599 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 4.9 t -152.77 167.3 29.48 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.848 ' HB1' ' CG2' ' A' ' 99' ' ' ILE . . . -94.93 126.08 40.03 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.458 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 75.8 t-105 -136.92 162.65 32.68 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.589 0.709 . . . . 0.0 112.304 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.458 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.1 OUTLIER -59.6 119.73 8.11 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.884 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -66.68 130.35 42.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.013 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -142.54 16.07 2.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.88 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 81.95 13.11 80.12 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.83 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.62 136.84 41.83 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.433 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.46 -31.79 70.29 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.465 2.11 . . . . 0.0 112.115 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.695 ' O ' HD12 ' A' ' 103' ' ' ILE . 22.7 p-10 -75.45 -4.21 38.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.323 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.411 ' O ' ' CG2' ' A' ' 90' ' ' THR . 0.0 OUTLIER -105.53 13.63 29.76 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.244 -179.812 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.415 ' O ' ' HB3' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -107.96 142.69 37.69 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.871 0.367 . . . . 0.0 111.373 -179.432 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.443 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 6.6 m-85 -140.84 156.45 46.13 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.118 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 mt -112.4 139.62 36.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.109 0.481 . . . . 0.0 110.75 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.495 ' CD1' HG23 ' A' ' 8' ' ' ILE . 24.4 mm -114.63 141.74 29.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.67 -179.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -139.17 94.37 2.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.7 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.8 m -54.29 107.09 0.24 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.227 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.888 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mtp . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.867 0.365 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.411 ' CB ' ' CD ' ' A' ' 3' ' ' PRO . 17.7 mttt -76.47 -61.24 0.8 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.041 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.411 ' CD ' ' CB ' ' A' ' 2' ' ' LYS . 65.7 Cg_endo -73.86 143.3 33.0 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.503 2.135 . . . . 0.0 112.405 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -87.31 118.42 26.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.93 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.469 ' CG ' ' HD2' ' A' ' 57' ' ' LYS . 0.8 OUTLIER -99.61 176.19 5.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.495 179.875 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.739 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -157.5 174.49 15.3 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 120.49 -0.484 . . . . 0.0 111.648 179.634 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.495 ' OH ' ' HB1' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -113.13 123.76 51.01 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.132 179.17 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.621 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -105.53 109.78 28.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.891 0.377 . . . . 0.0 110.387 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.423 ' HA ' ' HA ' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -105.81 134.63 48.61 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.325 -178.709 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.6 p -75.74 106.29 7.23 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.433 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 4.3 tt0 -62.66 -10.68 13.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.539 -178.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.583 HD22 ' CB ' ' A' ' 124' ' ' ASN . 51.2 tp -82.79 -62.82 1.5 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.894 0.378 . . . . 0.0 110.856 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.549 HD21 HG21 ' A' ' 103' ' ' ILE . 6.4 m-20 -85.98 -9.78 56.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.319 -178.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.12 5.0 69.7 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.139 -1.029 . . . . 0.0 111.48 -178.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.592 ' HE2' ' HB2' ' A' ' 110' ' ' ALA . 8.4 mmtm -91.76 -177.98 4.91 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.585 HG11 ' HG3' ' A' ' 35' ' ' GLN . 10.8 m -120.85 141.39 41.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.703 0.287 . . . . 0.0 110.538 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.9 mt -69.33 134.26 48.87 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.038 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.461 ' HB2' ' HG3' ' A' ' 44' ' ' GLN . 9.7 t70 -146.62 153.74 40.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.864 0.364 . . . . 0.0 111.108 -179.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.569 HD12 HG21 ' A' ' 72' ' ' THR . 6.9 mm -74.9 143.39 13.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.431 ' HG2' ' N ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -69.85 128.81 37.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.967 0.413 . . . . 0.0 111.659 -179.116 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 60.89 15.4 42.17 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.823 -0.626 . . . . 0.0 113.193 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 45.84 29.81 0.77 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.907 0.354 . . . . 0.0 111.215 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.479 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 9.4 t-20 -76.62 111.14 14.12 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.093 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 23' ' ' ASN . 6.5 Cg_exo -73.66 0.41 8.21 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.696 2.264 . . . . 0.0 112.686 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.479 ' HB3' ' OD1' ' A' ' 23' ' ' ASN . . . -84.12 144.78 44.76 Favored Pre-proline 0 C--N 1.332 -0.165 0 CA-C-O 120.675 0.274 . . . . 0.0 111.216 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.445 ' HB3' ' CD ' ' A' ' 74' ' ' PRO . 50.1 Cg_exo -54.35 141.43 71.79 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.65 2.233 . . . . 0.0 112.445 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.25 3.45 55.55 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.762 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.3 m -73.64 124.96 26.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.974 0.416 . . . . 0.0 111.105 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.431 ' N ' ' HG2' ' A' ' 20' ' ' GLU . 0.3 OUTLIER -75.08 161.45 29.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.045 179.479 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.546 HD11 ' HB ' ' A' ' 70' ' ' ILE . 41.6 pt -118.88 146.56 23.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.853 0.359 . . . . 0.0 111.928 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.459 ' HA ' ' CD1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -153.56 178.01 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.139 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.686 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.4 p -103.73 151.14 23.37 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.695 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 27.0 t-105 -154.86 169.64 23.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.735 0.303 . . . . 0.0 110.884 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.56 132.68 46.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.767 0.318 . . . . 0.0 110.666 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.585 ' HG3' HG11 ' A' ' 16' ' ' VAL . 9.4 tt0 -55.08 114.84 1.92 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.217 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.19 170.29 10.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.678 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.6 mtmm -130.94 112.89 13.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.915 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 151.1 -162.82 29.59 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.594 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -74.95 1.01 8.18 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 123.013 2.475 . . . . 0.0 112.866 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.0 t -104.41 26.11 9.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.709 0.29 . . . . 0.0 111.123 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.988 ' O ' HD12 ' A' ' 45' ' ' LEU . . . -93.93 -20.58 19.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.975 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.665 HG13 ' HB3' ' A' ' 57' ' ' LYS . 50.0 t -51.21 -33.93 14.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.301 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -68.91 -7.86 38.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.6 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.461 ' HG3' ' HB2' ' A' ' 18' ' ' ASP . 1.8 mt-30 -114.5 6.27 15.82 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.988 HD12 ' O ' ' A' ' 41' ' ' ALA . 0.9 OUTLIER -118.67 142.34 47.76 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.157 -0.928 . . . . 0.0 111.567 -178.913 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.498 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 26.1 m95 -134.51 169.47 17.23 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.187 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.516 ' CE2' ' HB2' ' A' ' 55' ' ' ARG . 42.1 p90 -141.25 164.14 31.05 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.533 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.593 HG22 HG23 ' A' ' 54' ' ' ILE . 0.7 OUTLIER -108.58 135.18 50.26 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.784 0.326 . . . . 0.0 111.443 -178.876 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -78.19 170.93 15.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.144 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -66.33 -24.3 66.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.097 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.505 ' HG3' HG23 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -91.8 -4.09 55.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.253 179.846 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.38 9.78 49.8 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.875 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.505 HG23 ' HG3' ' A' ' 51' ' ' GLN . 40.1 t -97.48 119.73 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 CA-C-N 116.883 0.341 . . . . 0.0 110.512 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.593 HG23 HG22 ' A' ' 48' ' ' THR . 0.6 OUTLIER -78.77 150.86 5.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.495 0.664 . . . . 0.0 111.951 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.733 ' HD3' ' HB2' ' A' ' 62' ' ' ALA . 11.2 mmm-85 -147.36 132.94 18.76 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.628 178.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.791 ' HB2' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -60.83 141.97 56.57 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.713 0.768 . . . . 0.0 111.981 -178.481 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.665 ' HB3' HG13 ' A' ' 42' ' ' VAL . 21.9 tttm -56.64 -20.58 22.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.445 -1.252 . . . . 0.0 111.69 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.791 HD22 ' HB2' ' A' ' 56' ' ' SER . 1.0 OUTLIER -48.19 -31.7 6.11 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.736 -179.188 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.661 ' H ' HD23 ' A' ' 58' ' ' LEU . 0.3 OUTLIER -179.86 -81.46 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.735 0.303 . . . . 0.0 111.036 179.897 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 32.0 p-10 -176.44 77.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.897 0.38 . . . . 0.0 110.926 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -145.22 132.26 20.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.838 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.733 ' HB2' ' HD3' ' A' ' 55' ' ' ARG . . . -98.29 150.71 21.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.938 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.863 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -80.82 150.89 4.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.273 179.476 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.58 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 8.6 p-10 -133.06 131.58 40.79 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.215 0.531 . . . . 0.0 111.603 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.631 ' HB2' ' CZ2' ' A' ' 84' ' ' TRP . . . -96.18 40.96 1.11 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.256 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 68.2 m -73.91 -43.41 58.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.342 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 65.0 m80 -97.59 172.56 7.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.11 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -48.04 -47.15 33.79 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.136 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -102.33 146.5 27.94 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.912 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.863 HG22 HG22 ' A' ' 63' ' ' ILE . 1.9 mm -78.1 144.15 11.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-O 121.614 0.721 . . . . 0.0 111.755 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -144.51 168.75 19.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.001 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.569 HG21 HD12 ' A' ' 19' ' ' ILE . 80.9 p -105.44 136.98 44.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.993 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.451 ' CB ' ' HD2' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -161.2 168.06 12.21 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.136 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.451 ' HD2' ' CB ' ' A' ' 73' ' ' GLN . 13.9 Cg_endo -57.37 134.49 64.08 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.404 2.07 . . . . 0.0 112.055 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.477 ' CE1' ' HB2' ' A' ' 83' ' ' ALA . 19.6 t80 -62.46 132.61 53.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.864 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -121.62 139.22 29.54 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.775 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.12 -34.05 17.63 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.515 2.143 . . . . 0.0 112.67 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -88.13 -0.72 57.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.653 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.442 ' HB3' ' HD2' ' A' ' 82' ' ' ARG . 1.7 m120 -109.31 100.02 39.23 Favored Pre-proline 0 C--O 1.232 0.175 0 CA-C-O 120.583 0.23 . . . . 0.0 111.029 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.849 ' O ' HD21 ' A' ' 94' ' ' LEU . 4.0 Cg_exo -76.44 25.48 0.43 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.923 2.415 . . . . 0.0 113.027 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.58 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 0.1 OUTLIER -118.71 -21.33 7.92 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 120.616 0.246 . . . . 0.0 111.19 -179.721 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.487 ' HG3' ' HB3' ' A' ' 64' ' ' ASP . 0.4 OUTLIER -88.56 18.94 4.18 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.064 -0.517 . . . . 0.0 112.365 -179.028 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 1.155 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -128.41 99.26 5.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.097 0.475 . . . . 0.0 110.775 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.631 ' CZ2' ' HB2' ' A' ' 65' ' ' ALA . 58.3 m95 -108.84 136.45 48.37 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.15 0.5 . . . . 0.0 111.907 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.9 pt -113.81 154.47 15.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.085 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.7 t -102.53 127.84 55.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.988 0.423 . . . . 0.0 111.111 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 30.5 t -120.88 95.14 4.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.35 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.2 -101.07 0.84 Allowed Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.477 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.498 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -121.02 30.15 7.0 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.496 0.189 . . . . 0.0 110.867 -179.802 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.421 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.34 147.49 30.38 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.597 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.709 ' HB ' HD12 ' A' ' 101' ' ' LEU . 19.1 mm -94.06 119.98 42.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.336 178.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.935 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -123.98 144.57 49.74 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.404 ' HB3' ' HB2' ' A' ' 96' ' ' ASP . 0.6 OUTLIER -63.86 149.53 46.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.661 179.568 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.155 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.6 pt? -62.33 -57.11 12.54 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.672 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.566 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 92.6 p -79.8 -2.64 44.19 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.404 ' HB2' ' HB3' ' A' ' 93' ' ' GLN . 49.0 m-20 -137.52 84.65 2.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.841 0.353 . . . . 0.0 111.004 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.6 mpp_? -66.34 -18.18 65.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.174 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.407 ' O ' ' HA ' ' A' ' 118' ' ' LYS . 0.4 OUTLIER -91.46 10.29 28.32 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.538 179.316 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.857 ' CG2' ' HB1' ' A' ' 116' ' ' ALA . 11.2 mm -124.36 129.39 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.466 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.935 HG12 ' HB2' ' A' ' 92' ' ' ALA . 30.8 m -146.68 136.01 16.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.709 HD12 ' HB ' ' A' ' 91' ' ' ILE . 12.7 mt -46.47 153.79 0.34 Allowed 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 121.753 0.787 . . . . 0.0 111.837 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.748 ' O ' HG22 ' A' ' 114' ' ' ILE . 9.9 t70 -158.36 168.02 28.11 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.587 -177.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.664 HD12 ' O ' ' A' ' 124' ' ' ASN . 4.4 mp -87.26 122.38 39.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.194 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.8 HG22 ' O ' ' A' ' 113' ' ' HIS . 3.1 tt -65.37 136.73 26.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.072 0.463 . . . . 0.0 111.482 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 70.63 1.22 3.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.997 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 51.4 p 43.68 31.39 0.45 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.761 0.315 . . . . 0.0 111.365 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -94.7 154.29 17.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.267 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.91 -14.14 58.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.156 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -49.03 118.51 2.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.265 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.592 ' HB2' ' HE2' ' A' ' 15' ' ' LYS . . . -62.1 157.93 17.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.054 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 73.25 15.67 78.79 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.214 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.94 132.86 39.28 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.834 0.349 . . . . 0.0 110.95 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.8 ' O ' HG22 ' A' ' 104' ' ' ILE . 17.1 m170 -65.58 172.02 3.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.925 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.748 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -136.42 161.63 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.517 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.597 ' HA ' HD11 ' A' ' 70' ' ' ILE . 95.7 m -153.77 168.96 24.56 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.857 ' HB1' ' CG2' ' A' ' 99' ' ' ILE . . . -95.7 126.62 41.1 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.467 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 76.1 t-105 -134.49 162.57 31.88 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.603 0.716 . . . . 0.0 112.129 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.467 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.1 OUTLIER -62.43 117.43 6.15 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.596 -1.183 . . . . 0.0 110.781 179.885 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -62.4 126.65 28.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.962 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -138.18 13.72 2.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.165 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 76.19 60.8 2.98 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.518 -0.848 . . . . 0.0 112.315 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -117.3 145.99 18.7 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.551 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.68 -32.39 75.36 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.403 2.069 . . . . 0.0 112.013 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.664 ' O ' HD12 ' A' ' 103' ' ' ILE . 30.3 p-10 -76.29 -2.69 32.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.586 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.421 ' O ' ' CG2' ' A' ' 90' ' ' THR . 0.9 OUTLIER -107.8 11.06 28.55 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.466 0.174 . . . . 0.0 111.172 180.0 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.433 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 1.7 mmmm -106.76 138.21 43.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.846 0.355 . . . . 0.0 111.529 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.413 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 7.0 m-85 -138.59 155.77 48.05 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.246 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.3 mt -113.36 138.64 42.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.149 0.5 . . . . 0.0 110.776 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.471 ' CD1' HG23 ' A' ' 8' ' ' ILE . 26.4 mm -113.86 139.71 38.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.524 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -139.5 94.68 2.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.655 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 18.6 p -51.34 110.73 0.47 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.327 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.614 ' HG3' HD21 ' A' ' 45' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.948 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 mtt . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.796 0.331 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.4 mttt 60.33 82.12 0.23 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.837 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.62 106.78 1.88 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.547 2.164 . . . . 0.0 112.327 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 11.4 mttm -96.46 121.16 37.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.817 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.507 ' CD1' ' HG3' ' A' ' 57' ' ' LYS . 0.9 OUTLIER -100.64 175.93 5.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.476 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.758 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -158.84 173.95 15.74 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 120.469 -0.492 . . . . 0.0 111.496 179.883 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.836 ' OH ' ' HB1' ' A' ' 41' ' ' ALA . 0.4 OUTLIER -109.46 123.79 49.96 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.204 179.13 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.611 HG23 ' CD1' ' A' ' 129' ' ' ILE . 0.0 OUTLIER -109.02 104.56 17.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.939 -179.755 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.86 ' HE2' HD12 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -122.81 140.11 53.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.453 -179.751 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.41 ' O ' ' HD2' ' A' ' 9' ' ' LYS . 1.9 m -60.69 135.45 57.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.925 0.393 . . . . 0.0 110.744 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 4.2 tt0 -77.99 -11.84 59.94 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.961 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 41.1 tp -89.03 -58.64 2.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.793 0.33 . . . . 0.0 110.986 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.572 HD21 HG21 ' A' ' 103' ' ' ILE . 6.2 m-20 -84.94 -17.74 36.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.262 -0.426 . . . . 0.0 112.017 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.4 5.81 73.72 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.308 -0.949 . . . . 0.0 112.231 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.649 ' HE2' ' HB2' ' A' ' 110' ' ' ALA . 1.5 mmmt -86.29 165.64 16.28 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.765 HG12 ' HB3' ' A' ' 9' ' ' LYS . 9.5 m -106.5 137.15 38.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.822 0.344 . . . . 0.0 110.723 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.3 mt -69.13 137.58 53.52 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -143.7 151.19 39.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.018 0.437 . . . . 0.0 111.439 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.062 HD13 HG21 ' A' ' 72' ' ' THR . 23.1 mt -92.73 133.64 33.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.459 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -40.64 96.3 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.962 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 44.43 32.94 2.92 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.925 -0.58 . . . . 0.0 113.302 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 67.67 -66.06 0.22 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.784 0.326 . . . . 0.0 111.021 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 63.55 90.75 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.847 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.63 -21.09 13.7 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.579 2.186 . . . . 0.0 112.505 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -96.23 153.94 38.9 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.066 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.477 ' HB3' ' HB3' ' A' ' 73' ' ' GLN . 10.7 Cg_exo -70.81 146.48 53.79 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.772 2.315 . . . . 0.0 112.092 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.98 3.38 23.25 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.52 -0.847 . . . . 0.0 113.239 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.7 t -77.2 132.54 38.8 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 117.093 0.446 . . . . 0.0 111.345 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.6 mmtt -81.46 160.53 23.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.645 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.572 HD13 HG21 ' A' ' 63' ' ' ILE . 47.3 pt -120.98 149.03 23.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.445 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.423 HG22 ' HA ' ' A' ' 113' ' ' HIS . 0.2 OUTLIER -155.73 -178.98 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.173 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.75 -179.812 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 p -101.36 149.19 24.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.419 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 19.5 t-105 -156.81 171.49 20.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.732 0.301 . . . . 0.0 110.989 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -71.33 138.54 49.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.705 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.529 ' HA ' HG21 ' A' ' 16' ' ' VAL . 4.6 tt0 -52.1 112.14 0.74 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.284 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.0 168.01 13.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.902 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.98 151.6 51.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.877 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.96 -162.81 12.3 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.496 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -79.13 7.9 4.13 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.169 2.579 . . . . 0.0 112.849 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -114.07 18.0 17.44 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.655 0.264 . . . . 0.0 111.208 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.844 ' O ' HD12 ' A' ' 45' ' ' LEU . . . -82.42 -22.37 35.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.951 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.922 HG13 ' HB3' ' A' ' 57' ' ' LYS . 17.5 t -50.33 -27.65 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.961 179.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -64.65 -10.56 27.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.619 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -118.56 7.79 11.87 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.135 0.493 . . . . 0.0 109.675 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.844 HD12 ' O ' ' A' ' 41' ' ' ALA . 1.3 mp -117.05 140.37 49.57 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.664 -179.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.661 ' CZ2' HD11 ' A' ' 19' ' ' ILE . 25.9 m95 -134.43 169.4 17.31 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.035 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.587 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 15.1 p90 -141.42 165.51 27.32 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.954 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.599 HG22 HG23 ' A' ' 54' ' ' ILE . 4.2 p -109.68 136.67 48.66 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.902 0.382 . . . . 0.0 111.475 -178.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.0 173.39 12.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.327 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -63.29 -21.24 66.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.12 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -101.36 -2.8 30.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.168 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.21 2.6 51.28 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.868 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.554 HG12 ' HD3' ' A' ' 55' ' ' ARG . 21.8 t -83.06 114.26 23.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.873 0.368 . . . . 0.0 110.82 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.599 HG23 HG22 ' A' ' 48' ' ' THR . 0.7 OUTLIER -76.78 146.72 8.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.253 0.549 . . . . 0.0 111.766 -179.795 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.659 ' HD2' ' HB2' ' A' ' 62' ' ' ALA . 2.7 mmm-85 -151.56 133.68 15.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.539 178.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.532 ' CB ' HD22 ' A' ' 58' ' ' LEU . 12.5 m -52.78 150.2 5.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.271 0.558 . . . . 0.0 111.903 -179.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.922 ' HB3' HG13 ' A' ' 42' ' ' VAL . 1.1 ttpt -60.33 -26.56 66.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.763 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.728 HD23 ' H ' ' A' ' 59' ' ' ASN . 0.8 OUTLIER -56.29 -32.91 65.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.282 -179.316 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.728 ' H ' HD23 ' A' ' 58' ' ' LEU . 1.3 m-20 170.77 -171.87 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.775 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -76.4 84.78 3.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.705 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.41 ' CE2' ' HD3' ' A' ' 74' ' ' PRO . 1.1 m-85 -141.06 115.17 9.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.759 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.659 ' HB2' ' HD2' ' A' ' 55' ' ' ARG . . . -105.73 150.03 25.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.081 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.824 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -78.64 153.76 4.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.92 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.564 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 5.1 p-10 -133.6 132.91 41.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.227 0.537 . . . . 0.0 111.569 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.668 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -96.73 41.78 1.1 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.197 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.4 m -74.53 -46.36 39.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.225 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -93.95 170.66 9.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.952 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -47.29 -48.06 25.04 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.944 0.402 . . . . 0.0 110.959 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -99.73 144.24 29.04 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.917 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.824 HG22 HG22 ' A' ' 63' ' ' ILE . 2.7 mm -71.05 136.13 26.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-O 121.527 0.679 . . . . 0.0 111.366 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -130.33 162.76 28.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.237 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 1.062 HG21 HD13 ' A' ' 19' ' ' ILE . 18.0 p -105.5 138.71 41.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.549 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.477 ' HB3' ' HB3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -162.82 159.16 19.3 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.668 -179.769 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.423 ' O ' ' HD3' ' A' ' 82' ' ' ARG . 53.7 Cg_exo -52.03 143.29 41.27 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.429 2.086 . . . . 0.0 111.737 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.532 ' CE1' HG11 ' A' ' 53' ' ' VAL . 66.7 t80 -59.07 126.03 26.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.915 0.388 . . . . 0.0 111.354 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.422 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 8.1 t70 -119.54 130.32 24.9 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.166 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.6 -33.82 21.07 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.602 2.202 . . . . 0.0 113.47 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -85.71 0.25 53.29 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.422 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 3.2 m120 -106.49 104.33 50.13 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.563 0.221 . . . . 0.0 111.343 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.842 ' O ' HD21 ' A' ' 94' ' ' LEU . 5.6 Cg_exo -77.34 20.07 0.69 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.868 2.379 . . . . 0.0 112.697 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.579 ' HD2' ' HB3' ' A' ' 65' ' ' ALA . 24.6 mmtp -120.15 -18.34 8.09 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.038 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.525 ' HG2' ' HB3' ' A' ' 64' ' ' ASP . 6.4 mtt180 -88.66 18.73 4.42 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.943 -0.572 . . . . 0.0 112.187 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 1.132 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -127.79 99.27 5.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.131 0.491 . . . . 0.0 110.647 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.668 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 61.8 m95 -108.55 136.42 48.18 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.114 0.483 . . . . 0.0 111.859 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 pt -115.21 154.24 16.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.272 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.5 t -101.2 124.41 54.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.012 0.434 . . . . 0.0 110.987 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 23.1 t -116.8 94.43 4.6 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.437 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.66 -100.95 0.79 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.505 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.51 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.79 30.17 7.03 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.587 0.232 . . . . 0.0 110.915 -179.63 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.92 148.0 30.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.394 0.616 . . . . 0.0 112.537 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.751 ' HB ' HD12 ' A' ' 101' ' ' LEU . 13.6 mm -93.94 120.15 42.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.411 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.989 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -124.89 146.67 49.2 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -178.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.437 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -67.17 148.83 51.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.811 179.808 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.132 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.7 pt? -61.07 -56.54 19.75 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.719 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.578 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 57.9 m -80.17 -3.44 48.98 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -136.56 85.44 2.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.838 0.351 . . . . 0.0 111.075 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -66.83 -17.97 65.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.155 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -92.08 9.83 31.75 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.521 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.823 ' CG2' ' HB1' ' A' ' 116' ' ' ALA . 12.2 mm -123.14 127.4 74.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.531 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.989 HG12 ' HB2' ' A' ' 92' ' ' ALA . 23.5 m -146.17 135.04 16.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.86 0.362 . . . . 0.0 111.862 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.751 HD12 ' HB ' ' A' ' 91' ' ' ILE . 11.0 mt -46.72 154.37 0.32 Allowed 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.7 0.762 . . . . 0.0 112.008 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.804 ' O ' HG22 ' A' ' 114' ' ' ILE . 9.8 t70 -155.63 167.78 29.29 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.319 -1.31 . . . . 0.0 110.694 -177.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.572 HG21 HD21 ' A' ' 13' ' ' ASN . 3.7 mp -92.94 124.52 45.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.509 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.8 HG22 ' O ' ' A' ' 113' ' ' HIS . 0.9 OUTLIER -68.24 139.6 20.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.961 0.41 . . . . 0.0 111.324 -179.83 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.422 ' N ' HG13 ' A' ' 104' ' ' ILE . 0.0 OUTLIER 78.4 -9.8 1.45 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.851 179.745 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.4 m 47.13 34.94 3.19 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.806 0.336 . . . . 0.0 111.188 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -106.94 166.92 10.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.195 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.4 -14.39 58.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.037 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -50.47 135.84 21.73 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.202 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.649 ' HB2' ' HE2' ' A' ' 15' ' ' LYS . . . -88.97 162.3 16.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.095 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.01 16.45 79.51 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.233 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.43 137.87 33.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.897 0.379 . . . . 0.0 110.967 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.8 ' O ' HG22 ' A' ' 104' ' ' ILE . 3.1 m170 -61.9 167.98 3.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.847 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.804 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -138.74 161.01 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.582 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.672 ' HA ' HD11 ' A' ' 70' ' ' ILE . 25.7 p -156.75 170.68 21.88 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.823 ' HB1' ' CG2' ' A' ' 99' ' ' ILE . . . -95.49 127.01 41.18 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 178.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.456 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 70.7 t-105 -132.37 162.88 29.98 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.529 0.68 . . . . 0.0 112.282 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.456 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.5 OUTLIER -63.55 120.78 12.39 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.659 179.843 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -58.91 124.45 19.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.177 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -132.68 8.1 4.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.631 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 82.38 6.74 88.42 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.164 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -66.0 142.62 43.55 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.401 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -56.86 -25.15 60.16 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.457 2.105 . . . . 0.0 112.508 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 34.5 p-10 -70.46 -9.09 55.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.706 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -107.02 17.99 22.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.698 0.285 . . . . 0.0 111.014 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.427 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 4.5 mmtp -103.59 123.78 47.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.793 0.33 . . . . 0.0 111.157 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.431 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 4.3 m-85 -127.96 153.0 47.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.632 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.86 HD12 ' HE2' ' A' ' 9' ' ' LYS . 1.6 mt -115.61 139.47 41.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.452 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.611 ' CD1' HG23 ' A' ' 8' ' ' ILE . 32.3 mm -113.94 144.05 22.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.677 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -136.07 94.18 3.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.609 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.47 109.3 0.43 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.312 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.913 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.83 0.348 . . . . 0.0 111.166 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.457 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 0.1 OUTLIER -80.17 -47.78 1.33 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.2 -179.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.457 ' CD ' ' N ' ' A' ' 2' ' ' LYS . 85.0 Cg_endo -82.56 111.4 2.04 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.405 2.07 . . . . 0.0 112.539 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.426 ' O ' ' HB2' ' A' ' 47' ' ' TYR . 0.5 OUTLIER -102.76 76.84 1.54 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.773 179.876 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.4 ' HA ' ' O ' ' A' ' 46' ' ' TRP . 97.9 m-85 -99.21 175.04 6.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.757 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.636 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -151.92 170.71 19.19 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 120.97 0.414 . . . . 0.0 111.213 178.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.432 ' O ' ' HA ' ' A' ' 129' ' ' ILE . 0.1 OUTLIER -111.45 123.82 50.99 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.143 179.173 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.616 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -107.12 106.36 20.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.245 179.879 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.424 ' HG3' ' O ' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -106.77 137.06 45.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.384 -178.7 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.9 108.67 10.11 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.421 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 3.1 tt0 -62.69 -10.53 12.92 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.483 -178.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.638 HD22 ' HA ' ' A' ' 124' ' ' ASN . 30.3 tp -83.36 -62.47 1.58 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.865 0.364 . . . . 0.0 111.039 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.639 HD21 HG21 ' A' ' 103' ' ' ILE . 6.9 m-20 -86.83 -10.65 52.98 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.1 5.03 69.7 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.086 -1.054 . . . . 0.0 111.398 -178.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.424 ' O ' ' HG3' ' A' ' 9' ' ' LYS . 1.7 mmmm -91.78 178.22 5.97 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.625 HG21 ' HA ' ' A' ' 35' ' ' GLN . 5.9 m -119.93 142.59 34.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.689 0.281 . . . . 0.0 110.507 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.3 mt -68.11 135.93 52.94 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.453 ' CB ' ' HG3' ' A' ' 44' ' ' GLN . 19.9 t0 -145.33 142.44 29.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.719 0.295 . . . . 0.0 111.114 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.737 HD12 HG21 ' A' ' 72' ' ' THR . 14.0 mm -66.28 145.78 13.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -51.04 109.2 0.3 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.911 0.386 . . . . 0.0 111.511 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 49.76 26.38 7.97 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.97 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 50.75 68.94 0.7 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.848 0.356 . . . . 0.0 110.985 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.457 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 2.1 t-20 -102.37 106.25 47.76 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.927 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.27 -7.92 20.42 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.739 2.293 . . . . 0.0 112.68 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.514 ' HB1' ' HD2' ' A' ' 26' ' ' PRO . . . -82.08 160.46 63.02 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.787 0.327 . . . . 0.0 111.088 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.514 ' HD2' ' HB1' ' A' ' 25' ' ' ALA . 72.1 Cg_endo -75.49 141.07 24.83 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.742 2.294 . . . . 0.0 112.387 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.14 5.5 52.85 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.806 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.91 134.56 41.57 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.96 0.409 . . . . 0.0 111.213 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.417 ' HD3' ' HB3' ' A' ' 71' ' ' GLU . 45.9 mmtt -81.72 157.03 24.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.213 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.595 HD13 HG21 ' A' ' 63' ' ' ILE . 47.5 pt -116.63 145.96 21.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.906 -0.317 . . . . 0.0 111.483 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.447 HG22 ' HA ' ' A' ' 113' ' ' HIS . 0.2 OUTLIER -155.49 -178.85 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.196 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.982 -179.667 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.5 p -101.98 148.88 24.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.551 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 32.4 t-105 -159.13 173.28 16.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.686 0.279 . . . . 0.0 110.845 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -70.14 134.58 48.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.813 0.339 . . . . 0.0 110.757 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.625 ' HA ' HG21 ' A' ' 16' ' ' VAL . 20.4 tt0 -61.36 130.51 46.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.01 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.71 159.97 14.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.784 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -122.45 105.76 10.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.967 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 159.31 -178.12 35.58 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.51 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -77.19 4.57 5.73 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.04 2.493 . . . . 0.0 112.782 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.2 t -119.98 30.02 7.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.797 0.332 . . . . 0.0 110.917 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.52 ' O ' HD12 ' A' ' 45' ' ' LEU . . . -109.29 2.52 20.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.525 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.691 HG12 ' HB3' ' A' ' 57' ' ' LYS . 2.2 t -58.95 -18.21 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-O 120.706 0.289 . . . . 0.0 110.596 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.41 ' HA ' ' HG2' ' A' ' 57' ' ' LYS . 64.0 t30 -61.84 -11.86 14.72 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.928 178.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.453 ' HG3' ' CB ' ' A' ' 18' ' ' ASP . 7.7 mp0 -111.56 7.76 20.72 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.636 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 1.4 mp -121.06 146.44 46.72 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.232 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.461 ' CH2' ' CG1' ' A' ' 63' ' ' ILE . 25.4 m95 -133.27 170.11 15.93 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.65 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.549 ' CE2' ' HB2' ' A' ' 55' ' ' ARG . 1.5 p90 -136.09 159.46 41.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.92 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.529 HG22 HG23 ' A' ' 54' ' ' ILE . 17.8 p -107.17 134.18 50.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.786 0.327 . . . . 0.0 111.303 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 53' ' ' VAL . 14.7 t70 -77.87 166.53 22.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.147 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -59.37 -22.69 61.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.164 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -97.4 -2.83 41.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.281 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.91 5.45 55.0 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.873 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.412 HG12 ' HD3' ' A' ' 55' ' ' ARG . 21.2 t -87.84 116.67 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-O 120.8 0.333 . . . . 0.0 110.635 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.529 HG23 HG22 ' A' ' 48' ' ' THR . 0.8 OUTLIER -78.55 150.49 5.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.326 0.584 . . . . 0.0 111.942 -179.758 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.549 ' HB2' ' CE2' ' A' ' 47' ' ' TYR . 2.9 mmm-85 -147.44 133.18 18.93 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.207 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.426 ' HB3' ' CD2' ' A' ' 58' ' ' LEU . 47.2 t -68.8 -177.2 0.94 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.307 0.575 . . . . 0.0 112.138 -178.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.691 ' HB3' HG12 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -46.05 -23.56 0.33 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.838 -179.761 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.537 ' HB2' ' HB2' ' A' ' 61' ' ' PHE . 0.9 OUTLIER -50.45 -21.3 1.41 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.652 -179.315 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 58' ' ' LEU . 8.0 t30 84.44 -10.24 0.88 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 179.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -175.36 53.49 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.861 0.362 . . . . 0.0 111.546 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.537 ' HB2' ' HB2' ' A' ' 58' ' ' LEU . 3.8 m-85 -141.07 110.5 6.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.018 0.437 . . . . 0.0 110.597 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.417 ' HB2' ' CD ' ' A' ' 55' ' ' ARG . . . -98.46 150.06 22.04 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.894 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.836 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -77.92 150.8 5.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.214 179.713 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.583 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 7.8 p-10 -131.59 133.02 44.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.156 0.503 . . . . 0.0 111.558 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.638 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -99.65 41.44 1.16 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.178 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.4 m -73.49 -42.62 61.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.061 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -98.2 172.83 7.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.936 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -49.47 -47.82 48.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.181 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -99.74 144.33 28.94 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.141 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.836 HG22 HG22 ' A' ' 63' ' ' ILE . 2.3 mm -76.31 142.86 13.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 CA-C-O 121.541 0.686 . . . . 0.0 111.764 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.417 ' HB3' ' HD3' ' A' ' 29' ' ' LYS . 0.5 OUTLIER -141.8 168.41 19.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.196 -179.835 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.737 HG21 HD12 ' A' ' 19' ' ' ILE . 49.4 p -108.24 139.88 42.29 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.085 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.49 165.17 14.51 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.304 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.468 ' CD ' ' HB3' ' A' ' 26' ' ' PRO . 10.6 Cg_endo -53.6 139.37 66.81 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.533 2.155 . . . . 0.0 111.92 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -61.5 131.74 51.13 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.881 0.372 . . . . 0.0 111.232 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.405 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 0.3 OUTLIER -120.92 133.84 24.21 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.555 179.729 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -69.05 -34.48 16.86 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.451 2.101 . . . . 0.0 112.664 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -88.04 0.31 56.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.77 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.405 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 3.1 t30 -105.71 102.21 37.04 Favored Pre-proline 0 C--O 1.233 0.2 0 CA-C-O 120.517 0.199 . . . . 0.0 111.051 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.852 ' O ' HD21 ' A' ' 94' ' ' LEU . 5.9 Cg_exo -77.62 22.05 0.61 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.921 2.414 . . . . 0.0 112.994 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.583 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 33.7 mmtt -119.93 -18.54 8.18 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 120.599 0.238 . . . . 0.0 111.139 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.527 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 3.1 mtm180 -89.63 18.84 5.06 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.357 -179.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 1.087 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -127.8 99.06 5.39 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.054 0.454 . . . . 0.0 110.802 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.638 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 58.0 m95 -108.77 135.53 49.84 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.192 0.52 . . . . 0.0 111.938 -178.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.3 pt -113.58 154.41 14.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.254 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.3 t -101.32 125.83 55.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.967 0.413 . . . . 0.0 111.045 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 47.0 t -118.44 93.68 4.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.456 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.9 -100.41 0.77 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.519 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.495 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.42 29.19 7.58 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.532 0.206 . . . . 0.0 111.017 -179.578 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.426 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.57 147.56 30.21 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.607 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.627 ' HB ' HD12 ' A' ' 101' ' ' LEU . 18.9 mm -93.76 120.47 43.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.127 178.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.967 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -123.87 145.31 49.19 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.423 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -66.22 148.45 51.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.648 179.786 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.087 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.6 pt? -60.77 -57.02 14.44 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.804 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.566 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 66.9 p -78.99 -3.7 46.33 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -137.09 86.59 2.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.877 0.37 . . . . 0.0 111.001 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.59 -18.68 65.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.082 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.402 ' O ' ' HA ' ' A' ' 118' ' ' LYS . 9.5 m-20 -91.96 9.87 31.28 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.459 179.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.817 ' CG2' ' HB1' ' A' ' 116' ' ' ALA . 13.3 mm -121.84 126.46 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.47 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.967 HG12 ' HB2' ' A' ' 92' ' ' ALA . 25.4 m -146.14 134.9 16.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.96 0.41 . . . . 0.0 111.973 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.627 HD12 ' HB ' ' A' ' 91' ' ' ILE . 13.6 mt -47.94 154.22 0.56 Allowed 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 121.782 0.801 . . . . 0.0 112.095 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.783 ' O ' HG22 ' A' ' 114' ' ' ILE . 9.9 t70 -156.2 167.02 31.74 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.271 -1.331 . . . . 0.0 110.78 -177.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.704 HD12 ' O ' ' A' ' 124' ' ' ASN . 4.4 mp -88.62 122.92 40.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.256 179.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.834 HG22 ' O ' ' A' ' 113' ' ' HIS . 2.8 tt -69.03 139.47 20.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.066 0.46 . . . . 0.0 111.675 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 75.61 -7.21 1.83 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.074 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.1 m 46.61 29.15 0.88 Allowed 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.766 0.317 . . . . 0.0 111.179 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -99.43 161.53 13.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.071 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.403 ' HG3' ' HA ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -78.64 -14.36 59.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.202 179.769 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -49.06 123.6 7.45 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.895 0.379 . . . . 0.0 111.252 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.59 162.17 29.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.103 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 70.63 18.96 76.13 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.0 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.37 136.41 35.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.903 0.382 . . . . 0.0 111.0 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.834 ' O ' HG22 ' A' ' 104' ' ' ILE . 1.2 m170 -63.61 171.39 2.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.751 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.783 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.7 OUTLIER -142.44 162.02 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.806 -179.681 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.652 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 5.0 p -155.51 172.02 18.95 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.817 ' HB1' ' CG2' ' A' ' 99' ' ' ILE . . . -96.02 126.99 41.64 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 178.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.458 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 69.8 t-105 -132.77 162.01 32.58 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.567 0.699 . . . . 0.0 112.158 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.458 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 2.4 tptt -61.21 121.14 11.79 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.637 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -62.0 125.28 23.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.896 0.379 . . . . 0.0 111.211 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -134.92 12.17 3.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.169 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 79.62 8.16 87.94 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.927 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -60.47 149.76 42.52 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.52 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.21 -25.2 57.8 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.639 2.226 . . . . 0.0 112.206 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.704 ' O ' HD12 ' A' ' 103' ' ' ILE . 13.3 p-10 -74.0 -5.16 39.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.426 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.426 ' O ' ' CG2' ' A' ' 90' ' ' THR . 83.8 mt-30 -108.14 18.69 20.85 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.615 0.245 . . . . 0.0 111.19 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.421 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 1.5 mmmt -104.74 127.69 52.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.798 0.332 . . . . 0.0 111.273 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.432 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 15.1 m-85 -134.04 154.38 51.19 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 120.939 0.4 . . . . 0.0 110.399 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.4 mt -113.56 138.98 41.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.456 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.513 ' CD1' HG23 ' A' ' 8' ' ' ILE . 36.2 mm -113.64 140.85 31.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.613 -179.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -138.45 112.15 8.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.512 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.82 109.07 3.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.047 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.905 179.958 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.6 mmt . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.799 0.333 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.411 ' CB ' ' HD3' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -87.66 -52.98 0.39 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.943 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.411 ' HD3' ' CB ' ' A' ' 2' ' ' LYS . 50.2 Cg_exo -53.63 132.12 47.42 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.487 2.125 . . . . 0.0 112.246 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -78.69 109.61 13.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.911 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.51 ' CD1' ' HG3' ' A' ' 57' ' ' LYS . 25.3 m-85 -92.39 175.2 6.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.516 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.722 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -159.46 176.34 12.21 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.793 179.764 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.839 ' CE2' HD21 ' A' ' 45' ' ' LEU . 21.5 m-85 -111.84 124.29 52.06 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.276 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.611 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -107.61 107.07 21.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.818 0.342 . . . . 0.0 110.275 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 15' ' ' LYS . 6.0 tttt -106.5 137.07 45.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.099 -0.501 . . . . 0.0 112.322 -178.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.0 m -75.94 109.83 9.89 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 178.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.411 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 3.8 tt0 -64.46 -11.38 32.95 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.492 -178.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.455 HD22 ' CB ' ' A' ' 124' ' ' ASN . 24.0 tp -84.34 -62.3 1.59 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.939 0.399 . . . . 0.0 111.034 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.648 HD21 HG21 ' A' ' 103' ' ' ILE . 8.0 m-20 -85.28 -12.6 52.05 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.79 3.07 72.43 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.095 -1.05 . . . . 0.0 111.485 -178.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.432 ' HG2' ' HB2' ' A' ' 13' ' ' ASN . 1.7 mmtt -90.43 -179.2 5.54 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.541 HG21 ' HA ' ' A' ' 35' ' ' GLN . 4.3 m -121.93 142.44 38.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.728 0.299 . . . . 0.0 110.586 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.3 mt -67.23 135.08 52.87 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.44 ' O ' HD13 ' A' ' 31' ' ' ILE . 12.7 t70 -145.41 146.64 31.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.683 0.278 . . . . 0.0 111.13 -178.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.405 HD11 ' CZ2' ' A' ' 46' ' ' TRP . 3.0 mm -74.32 144.9 11.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.662 ' HG2' HD12 ' A' ' 31' ' ' ILE . 1.7 mt-10 -62.28 128.68 37.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.013 0.435 . . . . 0.0 111.909 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 47.35 24.94 2.67 Favored Glycine 0 C--N 1.331 0.298 0 CA-C-N 115.825 -0.625 . . . . 0.0 113.671 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 47.63 27.49 1.04 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.851 0.326 . . . . 0.0 111.333 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -66.03 108.02 1.96 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.064 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -76.0 -2.82 13.07 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.727 2.285 . . . . 0.0 112.489 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -85.32 147.97 48.61 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 120.725 0.298 . . . . 0.0 111.232 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -56.94 134.35 63.97 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.532 2.155 . . . . 0.0 112.372 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.32 5.44 32.33 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.99 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.3 m -76.67 126.59 31.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.901 0.381 . . . . 0.0 111.259 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -76.14 159.94 30.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.282 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.605 HD13 HG21 ' A' ' 63' ' ' ILE . 50.9 pt -119.96 147.4 23.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.892 0.377 . . . . 0.0 111.824 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.662 HD12 ' HG2' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -155.9 -177.81 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.163 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.495 -179.901 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 p -103.36 150.38 23.86 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.648 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 27.2 t-105 -156.53 170.74 21.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.668 0.27 . . . . 0.0 110.849 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -69.6 132.9 46.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.758 0.313 . . . . 0.0 110.665 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.541 ' HA ' HG21 ' A' ' 16' ' ' VAL . 4.5 pt20 -57.27 147.4 25.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.16 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.53 165.45 15.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.775 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.9 mttm -125.6 109.61 12.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 144.29 -160.8 27.9 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.623 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -72.73 -1.91 11.09 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 123.005 2.47 . . . . 0.0 112.861 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.7 p -102.14 30.49 4.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.94 0.4 . . . . 0.0 111.033 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.985 ' O ' HD12 ' A' ' 45' ' ' LEU . . . -106.62 -17.11 14.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.908 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.871 HG13 ' HB3' ' A' ' 57' ' ' LYS . 73.4 t -50.06 -35.12 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.965 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.438 ' HB3' ' OD1' ' A' ' 18' ' ' ASP . 17.8 t30 -69.13 -7.82 39.68 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.995 -179.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -118.01 7.75 12.34 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.985 HD12 ' O ' ' A' ' 41' ' ' ALA . 0.9 OUTLIER -117.68 140.72 49.27 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.312 -179.096 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.524 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 25.4 m95 -134.67 169.29 17.55 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.813 -178.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.498 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 6.3 p90 -137.86 161.18 37.3 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.296 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.61 HG22 ' CG2' ' A' ' 54' ' ' ILE . 65.1 p -107.58 136.32 47.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.729 0.299 . . . . 0.0 111.003 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.424 ' HB2' ' O ' ' A' ' 53' ' ' VAL . 25.4 t70 -77.77 166.59 22.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.938 0.399 . . . . 0.0 111.168 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -57.81 -20.93 39.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.189 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -102.79 -2.45 28.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.386 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.24 0.47 47.54 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.043 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.48 HG13 ' HA ' ' A' ' 83' ' ' ALA . 23.2 t -81.24 113.32 20.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.921 0.36 . . . . 0.0 110.58 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.61 ' CG2' HG22 ' A' ' 48' ' ' THR . 0.6 OUTLIER -79.59 150.33 5.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.439 0.638 . . . . 0.0 112.089 -179.602 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.851 ' CD ' ' HB2' ' A' ' 62' ' ' ALA . 9.0 mmm-85 -151.02 132.59 14.79 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.834 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.524 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 66.2 p -57.42 156.59 7.67 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.648 0.737 . . . . 0.0 111.384 -179.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.871 ' HB3' HG13 ' A' ' 42' ' ' VAL . 58.7 tttm -61.25 -9.32 4.81 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.686 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.506 HD13 ' HB2' ' A' ' 56' ' ' SER . 4.6 mp -42.13 -49.86 4.81 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.059 0.457 . . . . 0.0 111.035 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.7 p30 172.52 -53.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.534 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.5 t0 179.71 76.82 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.668 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.441 ' CE2' ' HD3' ' A' ' 74' ' ' PRO . 3.7 m-85 -143.49 126.88 16.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.054 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.851 ' HB2' ' CD ' ' A' ' 55' ' ' ARG . . . -103.61 150.85 23.58 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.21 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.954 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -80.49 152.04 4.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.178 179.499 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.558 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 6.9 p-10 -133.36 135.72 44.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.17 0.51 . . . . 0.0 111.653 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.653 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -98.13 44.08 1.05 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.205 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 94.2 p -74.12 -43.64 56.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.462 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -100.89 176.06 5.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.084 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -49.03 -44.71 41.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.823 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.74 148.87 26.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.602 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.954 HG22 HG22 ' A' ' 63' ' ' ILE . 1.3 mm -77.93 140.84 16.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 CA-C-O 121.651 0.738 . . . . 0.0 111.612 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -133.31 159.84 39.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.766 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 39.2 p -102.29 137.53 40.43 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.34 179.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.496 ' CB ' ' HD2' ' A' ' 74' ' ' PRO . 0.3 OUTLIER -164.47 170.95 6.12 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.253 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.496 ' HD2' ' CB ' ' A' ' 73' ' ' GLN . 20.0 Cg_endo -60.45 133.35 48.48 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.19 1.927 . . . . 0.0 111.815 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.416 ' CE1' ' HB2' ' A' ' 83' ' ' ALA . 28.8 t80 -57.63 135.71 56.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.953 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.08 122.96 26.82 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.787 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -56.39 -34.58 94.72 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.467 2.111 . . . . 0.0 112.698 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -87.94 -0.67 57.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.761 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.402 ' HB3' ' HD2' ' A' ' 82' ' ' ARG . 3.0 m120 -108.74 100.31 38.46 Favored Pre-proline 0 C--O 1.232 0.183 0 CA-C-O 120.603 0.24 . . . . 0.0 110.922 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.85 ' O ' HD21 ' A' ' 94' ' ' LEU . 3.8 Cg_exo -76.47 25.37 0.44 Allowed 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.91 2.407 . . . . 0.0 113.236 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.561 ' HD2' ' HB3' ' A' ' 65' ' ' ALA . 21.0 mmtp -120.01 -19.91 7.66 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 120.581 0.229 . . . . 0.0 111.066 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.469 ' HG3' ' HB3' ' A' ' 64' ' ' ASP . 0.2 OUTLIER -88.89 18.75 4.55 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.162 -179.304 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 1.127 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -127.56 99.16 5.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.13 0.491 . . . . 0.0 110.738 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.695 ' HH2' ' HB2' ' A' ' 116' ' ' ALA . 58.8 m95 -108.48 135.39 49.84 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.138 0.494 . . . . 0.0 111.734 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 pt -113.55 155.27 14.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.257 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.7 t -103.38 129.06 55.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.965 0.412 . . . . 0.0 111.139 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 40.3 t -121.74 95.72 4.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.308 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.13 -101.14 0.85 Allowed Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.274 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.5 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.85 30.41 6.9 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.573 0.225 . . . . 0.0 110.811 -179.797 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.405 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.66 147.44 29.99 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.621 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.461 ' HB ' HD12 ' A' ' 101' ' ' LEU . 18.4 mm -94.38 120.24 43.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.385 178.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.901 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -123.66 145.34 49.03 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -178.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.438 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -65.65 148.38 51.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.513 179.646 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.127 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.6 pt? -62.19 -56.77 15.42 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.836 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.563 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 20.6 p -77.91 -4.13 45.22 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -178.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.568 ' O ' HG22 ' A' ' 99' ' ' ILE . 2.1 m-20 -138.05 87.0 2.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.777 0.322 . . . . 0.0 110.863 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.11 -16.16 63.07 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.204 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -90.35 11.83 20.2 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.182 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.568 HG22 ' O ' ' A' ' 96' ' ' ASP . 6.3 tt -130.94 137.92 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.901 HG12 ' HB2' ' A' ' 92' ' ' ALA . 23.9 m -148.86 137.12 14.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.763 0.316 . . . . 0.0 111.729 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.557 ' HA ' ' O ' ' A' ' 115' ' ' CYS . 24.8 mt -45.53 153.4 0.25 Allowed 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.705 0.764 . . . . 0.0 111.788 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.437 ' O ' HG22 ' A' ' 114' ' ' ILE . 10.0 t70 -158.46 168.4 27.06 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.381 -1.282 . . . . 0.0 110.763 -177.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.648 HG21 HD21 ' A' ' 13' ' ' ASN . 4.5 mp -90.48 123.55 42.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.452 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.85 HG22 ' O ' ' A' ' 113' ' ' HIS . 6.2 tp -67.9 140.73 18.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.938 0.399 . . . . 0.0 111.332 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 76.56 -5.83 2.11 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.945 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.7 t 46.36 29.69 0.91 Allowed 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.77 0.319 . . . . 0.0 111.194 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -100.79 161.75 13.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.105 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.9 -13.98 58.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.141 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -48.6 123.43 6.74 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.237 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.88 160.27 32.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.063 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 72.56 16.32 77.63 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.092 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -79.26 135.09 36.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.816 0.341 . . . . 0.0 110.886 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.85 ' O ' HG22 ' A' ' 104' ' ' ILE . 18.8 m170 -61.83 166.6 4.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.911 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.454 HG22 ' HA ' ' A' ' 103' ' ' ILE . 0.0 OUTLIER -136.35 160.44 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.476 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.735 ' HA ' HD11 ' A' ' 70' ' ' ILE . 26.2 p -157.8 172.29 18.74 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.695 ' HB2' ' HH2' ' A' ' 84' ' ' TRP . . . -95.51 127.67 41.74 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.625 -0.43 . . . . 0.0 109.922 178.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.461 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 75.7 t-105 -133.23 163.04 30.19 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.578 0.704 . . . . 0.0 111.97 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.461 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.0 OUTLIER -64.23 123.11 18.26 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.727 179.93 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.93 121.83 9.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.157 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.429 ' CE1' ' HA3' ' A' ' 122' ' ' GLY . 6.9 p80 -126.59 3.01 6.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.434 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 80.82 5.92 89.74 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.973 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.429 ' HA3' ' CE1' ' A' ' 120' ' ' HIS . . . -64.8 154.0 49.5 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.575 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.9 -23.58 54.58 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.616 2.211 . . . . 0.0 112.348 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.544 ' O ' HD12 ' A' ' 103' ' ' ILE . 27.1 p-10 -76.76 -2.17 31.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.56 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.405 ' O ' ' CG2' ' A' ' 90' ' ' THR . 0.0 OUTLIER -108.97 9.6 26.47 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.219 -179.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.411 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 19.9 mmmt -103.38 136.92 42.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.773 0.32 . . . . 0.0 111.249 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.42 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 6.6 m-85 -137.57 155.61 49.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.45 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.3 mt -113.47 138.89 41.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.098 0.475 . . . . 0.0 110.559 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.477 HD12 HG23 ' A' ' 8' ' ' ILE . 27.1 mm -114.17 141.34 30.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.661 -179.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -138.95 94.64 2.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.611 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.75 113.41 0.9 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.422 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.964 179.989 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.863 0.363 . . . . 0.0 111.165 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 58.1 mttt 61.92 153.77 0.11 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.93 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.7 -178.01 0.12 Allowed 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.703 2.269 . . . . 0.0 112.274 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.4 mmmm -147.59 80.91 1.51 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.103 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.454 ' CG ' ' HD2' ' A' ' 57' ' ' LYS . 1.4 p90 -100.27 176.73 5.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.422 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.703 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -156.89 175.26 14.31 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 120.481 -0.487 . . . . 0.0 111.731 179.806 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.59 ' CZ ' HD11 ' A' ' 45' ' ' LEU . 9.9 m-85 -109.33 124.58 51.18 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.157 179.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.607 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -108.51 106.24 20.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.871 0.367 . . . . 0.0 110.296 179.735 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -105.76 134.6 48.63 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -178.566 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 57.9 p -75.78 106.55 7.42 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.404 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 3.6 tt0 -63.4 -10.54 17.43 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.591 -178.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.427 HD22 ' CB ' ' A' ' 124' ' ' ASN . 33.1 tp -83.5 -62.91 1.46 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.924 0.392 . . . . 0.0 110.794 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.525 HD21 HG21 ' A' ' 103' ' ' ILE . 4.9 m-20 -84.23 -10.27 57.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.313 -178.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.45 3.75 67.33 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.129 -1.034 . . . . 0.0 111.382 -178.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.1 mmmt -92.66 -176.59 4.31 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.659 HG21 ' HA ' ' A' ' 35' ' ' GLN . 7.5 m -121.78 142.44 38.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.708 0.29 . . . . 0.0 110.58 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.7 mt -70.05 134.63 48.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.014 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.405 ' HB2' ' HG3' ' A' ' 44' ' ' GLN . 9.5 t0 -146.71 150.36 35.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.707 0.289 . . . . 0.0 111.033 -179.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.518 HD12 HG21 ' A' ' 72' ' ' THR . 2.7 mm -73.32 147.37 9.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.44 ' HG2' HD12 ' A' ' 31' ' ' ILE . 0.4 OUTLIER -58.58 122.96 14.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.925 0.393 . . . . 0.0 111.485 -179.455 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 45.9 28.26 2.72 Favored Glycine 0 C--N 1.332 0.36 0 CA-C-N 115.986 -0.552 . . . . 0.0 113.104 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 43.2 60.53 2.51 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.934 0.397 . . . . 0.0 111.428 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.95 106.0 48.31 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.922 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -71.24 1.01 5.85 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.75 2.3 . . . . 0.0 112.853 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.402 ' HB1' ' HD2' ' A' ' 26' ' ' PRO . . . -82.96 155.8 67.49 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-O 120.796 0.331 . . . . 0.0 111.174 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.419 ' HB3' ' CD ' ' A' ' 74' ' ' PRO . 35.9 Cg_endo -65.21 131.31 28.04 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.735 2.29 . . . . 0.0 112.46 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.04 2.59 36.23 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.477 -0.868 . . . . 0.0 113.188 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.52 127.51 32.76 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 117.027 0.414 . . . . 0.0 111.037 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -78.75 159.83 27.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.189 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.654 HD11 ' HB ' ' A' ' 70' ' ' ILE . 42.6 pt -117.89 146.29 22.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.771 0.32 . . . . 0.0 111.783 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.453 ' HA ' ' CD1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -154.44 178.01 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.17 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.78 -179.806 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.2 p -101.13 148.69 24.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.623 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 34.9 t-105 -158.23 172.9 17.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.708 0.289 . . . . 0.0 110.918 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -69.01 132.93 47.44 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.758 0.313 . . . . 0.0 110.738 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.659 ' HA ' HG21 ' A' ' 16' ' ' VAL . 2.4 pt20 -58.55 138.95 56.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.019 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.1 mmmm -102.79 157.67 16.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.771 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.16 101.72 8.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.845 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 146.3 -164.61 28.33 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.631 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -72.08 -2.44 11.58 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.968 2.445 . . . . 0.0 112.853 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.4 p -94.6 0.96 55.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.535 0.207 . . . . 0.0 111.346 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.994 ' O ' HD12 ' A' ' 45' ' ' LEU . . . -82.09 -9.44 59.54 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.619 0.229 . . . . 0.0 111.619 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.74 HG13 ' HB3' ' A' ' 57' ' ' LYS . 59.4 t -50.92 -33.57 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.116 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.406 ' OD1' ' HB ' ' A' ' 19' ' ' ILE . 0.6 OUTLIER -69.73 -7.51 40.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.76 -179.649 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.405 ' HG3' ' HB2' ' A' ' 18' ' ' ASP . 2.6 mt-30 -115.79 6.26 14.32 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.994 HD12 ' O ' ' A' ' 41' ' ' ALA . 0.9 OUTLIER -117.8 142.22 47.54 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.216 -179.273 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.478 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 26.3 m95 -133.74 168.71 18.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.541 -179.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.526 ' CZ ' ' HB2' ' A' ' 55' ' ' ARG . 43.1 p90 -141.32 164.16 31.01 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.382 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.671 HG22 ' CG2' ' A' ' 54' ' ' ILE . 67.5 p -109.19 135.37 50.42 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.783 0.325 . . . . 0.0 111.539 -178.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -78.36 170.88 15.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.12 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.34 -25.15 65.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.999 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -89.3 -5.02 57.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.201 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.24 11.74 44.45 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.837 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.658 HG13 ' HA ' ' A' ' 83' ' ' ALA . 37.2 t -100.68 120.43 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-O 120.779 0.323 . . . . 0.0 110.489 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.671 ' CG2' HG22 ' A' ' 48' ' ' THR . 0.6 OUTLIER -78.78 149.75 5.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.541 0.686 . . . . 0.0 111.883 -179.806 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.657 ' HD3' ' HB2' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -147.0 132.53 18.71 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.647 178.612 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.478 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -57.64 143.06 42.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.569 0.699 . . . . 0.0 111.857 -178.679 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.74 ' HB3' HG13 ' A' ' 42' ' ' VAL . 5.4 tttp -53.96 -22.18 9.74 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 114.634 -1.166 . . . . 0.0 111.471 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.543 HD12 ' HB2' ' A' ' 59' ' ' ASN . 3.6 pp -56.74 -39.04 73.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.857 0.36 . . . . 0.0 111.089 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.543 ' HB2' HD12 ' A' ' 58' ' ' LEU . 1.3 t30 176.31 172.82 0.39 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.669 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.41 79.24 0.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.817 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.409 ' CE2' ' HG3' ' A' ' 74' ' ' PRO . 32.7 m-85 -145.08 123.97 12.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.858 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.657 ' HB2' ' HD3' ' A' ' 55' ' ' ARG . . . -104.4 154.16 20.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.397 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.858 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -79.86 150.37 5.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.59 179.665 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.573 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 6.3 p-10 -132.6 134.75 45.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.138 0.494 . . . . 0.0 111.501 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.673 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -99.06 43.29 1.06 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.334 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.1 m -74.06 -43.07 59.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.142 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 57.2 m80 -98.78 173.1 7.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.931 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -49.32 -46.96 47.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.983 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -99.69 145.03 28.09 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.936 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.858 HG22 HG22 ' A' ' 63' ' ' ILE . 2.4 mm -76.8 142.38 14.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-O 121.591 0.71 . . . . 0.0 111.511 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -140.31 168.61 19.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.062 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.518 HG21 HD12 ' A' ' 19' ' ' ILE . 58.8 p -106.87 138.51 42.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.97 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.48 161.11 17.9 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.329 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.419 ' CD ' ' HB3' ' A' ' 26' ' ' PRO . 57.3 Cg_exo -51.44 139.19 46.58 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.449 2.099 . . . . 0.0 112.074 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.576 ' HE1' ' HB2' ' A' ' 83' ' ' ALA . 90.6 t80 -62.94 127.8 32.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.129 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.412 ' HB2' ' HD3' ' A' ' 82' ' ' ARG . 0.1 OUTLIER -117.56 136.32 23.54 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.597 179.68 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -68.96 -34.81 16.5 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.56 2.173 . . . . 0.0 112.93 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -87.34 0.15 55.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.8 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.409 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 1.6 t30 -108.53 101.03 41.26 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 120.588 0.232 . . . . 0.0 111.147 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.854 ' O ' HD21 ' A' ' 94' ' ' LEU . 4.8 Cg_exo -77.09 24.7 0.48 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.989 2.459 . . . . 0.0 113.043 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.573 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 21.0 mmtp -120.26 -19.72 7.57 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 120.568 0.223 . . . . 0.0 111.101 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.481 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 0.4 OUTLIER -88.72 17.07 5.85 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.09 -0.505 . . . . 0.0 112.285 -179.208 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 1.091 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -126.61 98.85 5.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.081 0.467 . . . . 0.0 110.823 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.673 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 56.2 m95 -107.94 136.05 48.29 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.157 0.503 . . . . 0.0 111.81 -178.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.5 pt -111.25 153.5 13.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.197 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.2 t -102.28 127.69 55.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.008 0.432 . . . . 0.0 111.042 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.4 t -120.59 94.75 4.46 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.448 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.99 -100.13 0.75 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.531 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.499 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.85 29.74 7.23 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.52 0.2 . . . . 0.0 110.868 -179.676 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.425 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -148.14 147.77 29.84 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.577 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.813 ' HB ' HD12 ' A' ' 101' ' ' LEU . 11.9 mm -94.13 120.34 43.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.047 -0.978 . . . . 0.0 109.351 178.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.875 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -122.26 144.01 49.25 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -178.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.415 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -64.61 148.91 49.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.527 179.834 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.091 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.6 pt? -64.34 -57.23 9.96 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.688 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.561 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 13.5 t -74.22 -4.1 33.9 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -178.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.555 ' O ' HG22 ' A' ' 99' ' ' ILE . 56.7 m-20 -143.46 92.22 2.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.919 0.39 . . . . 0.0 111.025 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -72.89 -14.32 61.46 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.287 179.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -90.25 11.19 21.91 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.297 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.555 HG22 ' O ' ' A' ' 96' ' ' ASP . 9.0 tt -130.64 138.27 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.875 HG12 ' HB2' ' A' ' 92' ' ' ALA . 26.7 m -148.99 138.15 15.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.837 0.351 . . . . 0.0 111.907 -179.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.813 HD12 ' HB ' ' A' ' 91' ' ' ILE . 11.1 mt -45.53 153.3 0.26 Allowed 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 121.754 0.788 . . . . 0.0 111.772 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.713 ' O ' HG22 ' A' ' 114' ' ' ILE . 9.8 t70 -158.63 168.24 27.42 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.833 -177.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.664 HD12 ' O ' ' A' ' 124' ' ' ASN . 4.4 mp -88.0 122.96 40.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.204 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.826 HG22 ' O ' ' A' ' 113' ' ' HIS . 7.8 tp -66.63 138.27 23.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.057 0.456 . . . . 0.0 111.476 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.4 1.06 3.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.983 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.4 t 44.17 30.88 0.48 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.781 0.324 . . . . 0.0 111.344 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.7 p30 -96.67 155.79 16.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.152 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -82.24 -17.17 46.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.106 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -45.28 116.12 1.06 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.279 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.4 156.74 9.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.247 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.63 14.47 81.2 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.312 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.88 131.81 39.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.902 0.382 . . . . 0.0 110.985 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.826 ' O ' HG22 ' A' ' 104' ' ' ILE . 12.5 m170 -64.87 171.25 3.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.014 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.713 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -136.38 161.75 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.445 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.605 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 26.5 p -153.51 168.45 26.11 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.663 ' HB2' ' HH2' ' A' ' 84' ' ' TRP . . . -95.06 126.71 40.59 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 178.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.468 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 76.5 t-105 -134.71 162.49 32.2 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.63 0.729 . . . . 0.0 112.196 -179.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.468 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.9 OUTLIER -62.53 120.87 11.96 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.646 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -58.55 125.5 23.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.089 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.432 ' CE1' ' HA3' ' A' ' 122' ' ' GLY . 19.9 p80 -132.97 8.51 4.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.357 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 81.82 7.17 88.34 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.086 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.432 ' HA3' ' CE1' ' A' ' 120' ' ' HIS . . . -63.73 152.15 48.44 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.58 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.59 -26.35 54.14 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.604 2.203 . . . . 0.0 112.33 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.664 ' O ' HD12 ' A' ' 103' ' ' ILE . 30.6 p-10 -75.05 -4.11 36.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.506 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.425 ' O ' ' CG2' ' A' ' 90' ' ' THR . 0.0 OUTLIER -107.5 14.38 25.89 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.183 -179.811 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.404 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 2.3 mmmm -107.08 136.92 46.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.793 0.33 . . . . 0.0 111.472 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.435 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 6.1 m-85 -138.2 155.23 48.88 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.21 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.3 mt -112.03 138.43 40.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.091 0.472 . . . . 0.0 110.392 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 27.9 mm -112.99 140.19 34.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.563 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.7 112.02 8.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.457 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 5.7 t -66.4 109.95 2.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.13 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.477 ' HG3' HD21 ' A' ' 45' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.188 -0.911 . . . . 0.0 110.898 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.792 0.329 . . . . 0.0 111.147 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.75 68.9 82.21 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.889 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.12 105.55 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.623 2.215 . . . . 0.0 112.304 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.51 121.86 42.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.993 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.502 ' CD1' ' HG3' ' A' ' 57' ' ' LYS . 1.4 p90 -95.79 175.21 6.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.254 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.691 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -159.01 175.61 13.32 Favored 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.94 179.889 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.582 ' CZ ' HD11 ' A' ' 45' ' ' LEU . 4.7 m-85 -110.6 124.01 51.06 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.055 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.768 HG13 HD11 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -106.5 106.87 21.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.844 0.354 . . . . 0.0 110.436 179.824 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 15' ' ' LYS . 8.7 tttt -107.85 138.54 43.91 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.305 -178.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.91 109.2 10.53 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -64.01 -10.95 24.7 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.579 -178.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.618 HD22 ' HA ' ' A' ' 124' ' ' ASN . 56.8 tp -84.26 -62.48 1.55 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.88 0.371 . . . . 0.0 111.026 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.703 HD21 HG21 ' A' ' 103' ' ' ILE . 6.1 m-20 -85.43 -12.93 50.79 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 77.17 0.84 72.18 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.103 -1.046 . . . . 0.0 111.413 -177.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.421 ' HG2' ' HB2' ' A' ' 13' ' ' ASN . 0.5 OUTLIER -89.01 179.74 6.1 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.503 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.418 HG11 ' HG2' ' A' ' 35' ' ' GLN . 4.2 m -121.36 141.46 41.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.768 HD11 HG13 ' A' ' 8' ' ' ILE . 0.4 OUTLIER -73.49 137.61 44.57 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.123 179.475 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -142.6 153.09 43.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.873 0.368 . . . . 0.0 111.127 -179.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.051 HD13 HG21 ' A' ' 72' ' ' THR . 25.3 mt -93.03 134.66 30.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.662 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -43.6 96.25 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.917 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 43.23 32.93 1.8 Allowed Glycine 0 C--N 1.331 0.28 0 CA-C-N 115.981 -0.554 . . . . 0.0 113.363 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.42 ' HG2' ' ND2' ' A' ' 43' ' ' ASN . 3.2 mp0 68.41 -66.54 0.23 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.835 0.35 . . . . 0.0 110.931 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 64.82 90.73 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.79 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -51.94 -22.08 13.47 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.649 2.233 . . . . 0.0 112.482 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.3 149.36 35.62 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.115 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.445 ' HB3' ' CD ' ' A' ' 74' ' ' PRO . 33.7 Cg_endo -64.63 151.85 84.08 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.654 2.236 . . . . 0.0 112.371 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 109.12 0.59 31.54 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.475 -0.869 . . . . 0.0 113.108 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.11 137.04 50.8 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 117.122 0.461 . . . . 0.0 110.918 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.3 mmtp -88.32 157.6 18.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.606 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.668 HD11 ' HB ' ' A' ' 70' ' ' ILE . 44.2 pt -117.96 146.77 22.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.348 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.444 HG22 ' HA ' ' A' ' 113' ' ' HIS . 0.2 OUTLIER -155.19 179.73 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.182 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.885 -179.737 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.1 p -101.6 149.0 24.56 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.48 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 35.4 t-105 -157.81 172.21 18.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.711 0.291 . . . . 0.0 110.965 -179.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -72.48 139.08 47.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.81 0.338 . . . . 0.0 110.805 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.418 ' HG2' HG11 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -58.89 137.43 57.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.939 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.94 168.02 9.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.86 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.04 95.98 4.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.969 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 166.52 170.17 31.06 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.488 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -51.32 -24.93 16.81 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.595 2.197 . . . . 0.0 112.335 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 43.1 p -78.09 9.84 3.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.035 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.882 ' O ' HD12 ' A' ' 45' ' ' LEU . . . -77.41 -17.23 58.32 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.657 0.265 . . . . 0.0 111.037 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.974 HG13 ' HB3' ' A' ' 57' ' ' LYS . 48.5 t -50.29 -27.48 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.065 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.42 ' ND2' ' HG2' ' A' ' 22' ' ' GLN . 1.5 m120 -66.83 -9.45 37.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.582 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -118.46 5.89 11.76 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.882 HD12 ' O ' ' A' ' 41' ' ' ALA . 1.3 mp -116.98 141.44 48.23 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.531 -179.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.57 ' CZ2' HD11 ' A' ' 19' ' ' ILE . 26.1 m95 -134.18 169.01 17.81 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.249 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.55 ' CZ ' ' HB2' ' A' ' 55' ' ' ARG . 11.3 p90 -141.98 166.22 25.31 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.981 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.405 HG22 ' CG2' ' A' ' 54' ' ' ILE . 39.7 p -108.38 133.87 51.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.882 0.372 . . . . 0.0 111.559 -178.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 53' ' ' VAL . 42.9 t0 -77.96 167.78 20.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.026 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -60.9 -24.85 66.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.138 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.2 tp60 -92.74 -3.34 54.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.269 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.96 8.79 55.16 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.765 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.421 ' O ' ' HB2' ' A' ' 49' ' ' ASP . 31.1 t -93.83 119.68 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-O 120.744 0.307 . . . . 0.0 110.587 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.535 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -75.96 145.64 10.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.168 0.509 . . . . 0.0 111.779 -179.835 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.742 ' CD ' ' HB2' ' A' ' 62' ' ' ALA . 13.5 mmm-85 -149.47 133.73 17.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.719 179.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.405 ' HB2' HD21 ' A' ' 58' ' ' LEU . 74.5 m -50.5 147.1 4.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.598 0.714 . . . . 0.0 111.984 -179.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.974 ' HB3' HG13 ' A' ' 42' ' ' VAL . 17.6 tttm -60.26 -18.24 47.67 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 114.658 -1.156 . . . . 0.0 112.022 -179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.504 ' HA ' HG11 ' A' ' 42' ' ' VAL . 0.6 OUTLIER -51.08 -49.62 60.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.747 -179.325 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.416 ' N ' HD12 ' A' ' 58' ' ' LEU . 22.6 m-20 -166.06 -69.24 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.745 0.307 . . . . 0.0 111.062 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.2 p30 179.65 82.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.733 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.411 ' CZ ' ' HG3' ' A' ' 74' ' ' PRO . 2.7 m-85 -138.05 119.95 15.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.899 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.742 ' HB2' ' CD ' ' A' ' 55' ' ' ARG . . . -99.42 145.55 27.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.205 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.826 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -76.95 152.64 5.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.6 179.733 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.626 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 5.0 p-10 -132.37 129.87 39.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.249 0.547 . . . . 0.0 111.777 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.745 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -94.29 40.8 1.09 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.272 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.4 t -75.11 -45.5 40.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.543 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -94.7 170.33 9.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.962 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -49.16 -42.18 38.89 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.014 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.59 140.05 38.57 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.813 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.826 HG22 HG22 ' A' ' 63' ' ' ILE . 3.1 mm -69.94 137.12 24.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-O 121.464 0.649 . . . . 0.0 111.367 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.401 ' O ' HG22 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -134.54 165.68 24.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.118 -0.947 . . . . 0.0 111.17 -179.708 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 1.051 HG21 HD13 ' A' ' 19' ' ' ILE . 23.9 p -106.62 140.25 39.79 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.238 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.11 163.79 13.33 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.481 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.461 ' O ' ' HD3' ' A' ' 82' ' ' ARG . 40.4 Cg_exo -56.73 142.81 91.54 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.451 2.1 . . . . 0.0 111.673 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.421 ' CD2' HG11 ' A' ' 53' ' ' VAL . 58.2 t80 -57.13 128.77 38.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.859 0.362 . . . . 0.0 111.358 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -118.17 131.02 24.38 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.532 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -68.14 -36.77 16.02 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.453 2.102 . . . . 0.0 112.758 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -87.55 0.31 55.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.812 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -105.19 102.65 37.78 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-O 120.53 0.205 . . . . 0.0 111.086 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.566 ' O ' HD21 ' A' ' 94' ' ' LEU . 5.7 Cg_exo -77.32 21.63 0.61 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.887 2.391 . . . . 0.0 112.978 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.626 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 7.6 mptt -119.92 -21.03 7.3 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 120.753 0.311 . . . . 0.0 111.001 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.546 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 2.7 mtt180 -86.85 20.84 2.44 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 1.033 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -130.68 99.58 5.01 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.276 0.56 . . . . 0.0 110.937 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.745 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 61.0 m95 -109.39 136.07 49.41 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.923 -178.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 27.8 pt -113.17 153.45 14.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.196 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.0 t -100.2 123.0 52.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.901 0.382 . . . . 0.0 110.948 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 37.6 t -115.8 93.49 4.28 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.438 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.97 -100.56 0.78 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.533 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.502 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.73 29.67 7.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.496 0.189 . . . . 0.0 110.923 -179.594 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.406 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -148.05 148.23 30.45 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.36 0.6 . . . . 0.0 112.583 -178.63 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.508 ' HB ' HD12 ' A' ' 101' ' ' LEU . 23.9 mm -93.65 119.47 41.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.542 178.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.981 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -123.99 147.56 47.68 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.421 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.3 OUTLIER -65.17 149.88 49.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.849 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.033 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.7 pt? -64.29 -56.88 11.48 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.444 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.612 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 0.3 OUTLIER -77.25 -1.77 31.3 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.363 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.554 ' O ' HG22 ' A' ' 99' ' ' ILE . 49.7 t0 -145.09 91.14 2.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.165 0.507 . . . . 0.0 110.942 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 3.8 mmm180 -74.09 -13.69 60.87 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.526 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -87.35 9.81 19.32 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.518 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.831 HG12 ' HB1' ' A' ' 116' ' ' ALA . 6.8 tt -132.89 140.24 47.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 179.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.981 HG12 ' HB2' ' A' ' 92' ' ' ALA . 20.0 m -149.77 138.84 15.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.77 0.319 . . . . 0.0 111.826 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.508 HD12 ' HB ' ' A' ' 91' ' ' ILE . 21.8 mt -46.15 154.89 0.23 Allowed 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 121.733 0.778 . . . . 0.0 111.948 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.805 ' O ' HG22 ' A' ' 114' ' ' ILE . 11.0 t70 -156.97 167.67 29.77 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.792 -177.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.703 HG21 HD21 ' A' ' 13' ' ' ASN . 4.6 mp -89.38 123.96 41.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.427 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.788 HG22 ' O ' ' A' ' 113' ' ' HIS . 3.9 tt -68.04 144.48 14.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.947 0.403 . . . . 0.0 111.421 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 5.2 mttt 70.34 -0.8 2.71 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.015 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.1 m 42.09 31.61 0.25 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.734 0.302 . . . . 0.0 111.474 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -102.78 162.39 12.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.068 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.23 -14.5 57.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.255 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -48.21 133.11 15.8 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.21 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -81.91 159.37 23.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.147 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.49 16.37 80.05 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.287 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -82.0 135.79 35.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.841 0.353 . . . . 0.0 111.124 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.788 ' O ' HG22 ' A' ' 104' ' ' ILE . 6.7 m80 -61.86 172.85 1.19 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.962 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.805 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.7 OUTLIER -143.28 161.6 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.758 -179.777 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.645 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 4.6 t -155.43 169.95 23.07 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.831 ' HB1' HG12 ' A' ' 99' ' ' ILE . . . -93.6 126.53 38.81 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.458 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 75.9 t-105 -131.47 160.98 33.58 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.635 0.731 . . . . 0.0 112.361 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.458 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.3 OUTLIER -62.87 124.77 21.91 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.764 -179.885 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.88 121.28 8.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.127 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.438 ' CE1' ' HA3' ' A' ' 122' ' ' GLY . 6.6 p80 -127.34 2.4 6.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.493 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 79.4 5.23 89.26 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.881 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.438 ' HA3' ' CE1' ' A' ' 120' ' ' HIS . . . -63.34 156.28 42.32 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.536 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.75 -25.04 46.54 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.589 2.193 . . . . 0.0 112.365 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.618 ' HA ' HD22 ' A' ' 12' ' ' LEU . 36.3 p-10 -74.53 -3.8 33.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.644 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.406 ' O ' ' CG2' ' A' ' 90' ' ' THR . 0.0 OUTLIER -108.88 15.81 23.2 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.533 0.206 . . . . 0.0 111.116 -179.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -106.3 131.29 53.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.835 0.35 . . . . 0.0 111.465 -179.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.435 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 3.0 m-85 -134.9 154.6 51.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.285 179.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 mt -114.07 140.04 36.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.131 0.491 . . . . 0.0 110.677 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.472 HD12 HG23 ' A' ' 8' ' ' ILE . 20.8 mm -113.38 141.4 29.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.602 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.46 94.66 2.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.711 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 5.0 t -49.96 109.64 0.31 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.426 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.433 179.751 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.715 0.293 . . . . 0.0 111.183 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.486 ' HB2' ' HD3' ' A' ' 3' ' ' PRO . 75.1 mmtt -91.97 -46.91 0.34 Allowed Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.765 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.486 ' HD3' ' HB2' ' A' ' 2' ' ' LYS . 87.7 Cg_endo -83.64 112.82 1.89 Allowed 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.374 2.05 . . . . 0.0 112.667 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.8 tppt? -63.75 117.03 6.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.743 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.504 ' CD1' ' HG3' ' A' ' 57' ' ' LYS . 1.1 p90 -96.67 176.06 6.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.629 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.743 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -159.87 176.57 11.75 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.861 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.822 ' OH ' ' HB1' ' A' ' 41' ' ' ALA . 0.7 OUTLIER -112.64 124.16 51.94 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.299 179.371 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.616 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -105.54 108.48 25.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.914 0.387 . . . . 0.0 110.339 179.873 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.456 ' HG2' ' HZ2' ' A' ' 9' ' ' LYS . 1.5 tptp -105.27 135.3 46.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.422 -178.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.7 t -75.65 108.04 8.21 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.448 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 2.7 tt0 -63.84 -10.76 22.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.633 -178.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.567 HD22 ' CB ' ' A' ' 124' ' ' ASN . 52.5 tp -83.25 -62.71 1.52 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.92 0.391 . . . . 0.0 110.924 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.621 HD21 HG21 ' A' ' 103' ' ' ILE . 6.7 m-20 -86.32 -9.85 55.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.429 -178.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.86 5.01 68.41 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.145 -1.026 . . . . 0.0 111.369 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.41 ' HG2' ' HB2' ' A' ' 13' ' ' ASN . 1.8 mmmt -91.57 -177.18 4.73 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.537 HG11 ' HG2' ' A' ' 35' ' ' GLN . 2.9 m -120.3 140.28 44.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.784 0.326 . . . . 0.0 110.513 179.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.3 mt -70.89 136.06 48.39 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -143.83 158.57 43.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.936 0.398 . . . . 0.0 111.345 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.014 HD13 HG21 ' A' ' 72' ' ' THR . 27.5 mt -98.92 136.13 31.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.406 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -39.67 95.97 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.983 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 42.28 33.58 1.38 Allowed Glycine 0 C--N 1.333 0.389 0 CA-C-N 115.925 -0.58 . . . . 0.0 113.225 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.41 ' CG ' HD13 ' A' ' 58' ' ' LEU . 17.5 tt0 68.31 -66.33 0.23 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.787 0.327 . . . . 0.0 110.771 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 50.0 t30 61.83 92.53 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.992 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.18 -22.02 18.52 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.502 2.135 . . . . 0.0 112.406 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -93.47 145.01 29.18 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.094 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.516 ' HB3' ' HD2' ' A' ' 74' ' ' PRO . 24.4 Cg_exo -63.24 155.86 59.07 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.535 2.157 . . . . 0.0 112.13 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.22 3.87 47.68 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.951 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.71 130.05 38.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.987 0.422 . . . . 0.0 111.198 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -80.73 161.83 24.39 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.422 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.626 HG22 HG12 ' A' ' 19' ' ' ILE . 48.4 pt -122.82 150.29 26.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.783 0.325 . . . . 0.0 111.705 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.455 HG22 ' HA ' ' A' ' 113' ' ' HIS . 0.3 OUTLIER -156.39 -178.62 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.785 -179.738 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.2 p -100.29 148.59 24.5 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.468 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 30.6 t-105 -157.16 171.9 19.62 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.77 0.319 . . . . 0.0 111.109 -179.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.7 140.6 47.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.799 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.537 ' HG2' HG11 ' A' ' 16' ' ' VAL . 36.4 mt-30 -57.76 154.6 11.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.946 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -137.11 173.29 11.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.856 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.7 mmtp -135.84 116.42 13.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.98 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 157.24 -169.05 34.22 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.606 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -77.19 4.68 5.63 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.145 2.563 . . . . 0.0 112.83 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.6 t -114.49 16.44 17.69 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.654 0.264 . . . . 0.0 111.164 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.858 ' O ' HD12 ' A' ' 45' ' ' LEU . . . -79.23 -20.14 48.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.163 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.877 HG13 ' HB3' ' A' ' 57' ' ' LYS . 15.7 t -49.34 -26.2 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.19 179.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -65.74 -10.02 33.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.738 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -119.6 6.04 11.05 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.103 0.478 . . . . 0.0 109.772 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.858 HD12 ' O ' ' A' ' 41' ' ' ALA . 1.4 mp -116.59 139.8 50.1 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.617 -179.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.555 ' CZ2' HD11 ' A' ' 19' ' ' ILE . 25.5 m95 -133.73 168.09 19.34 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.228 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.567 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 6.4 p90 -139.61 163.51 32.37 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.009 178.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.547 HG22 ' CG2' ' A' ' 54' ' ' ILE . 81.1 p -109.13 136.41 48.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.786 0.327 . . . . 0.0 111.4 -178.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.83 173.2 12.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.288 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.85 -20.93 65.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.063 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -101.74 -2.14 30.87 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.221 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.75 1.91 52.61 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.929 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.695 HG12 ' HD3' ' A' ' 55' ' ' ARG . 21.7 t -81.8 114.41 22.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.915 0.358 . . . . 0.0 110.767 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.567 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -77.5 148.02 6.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.263 0.554 . . . . 0.0 111.783 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.695 ' HD3' HG12 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -154.4 133.85 12.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.608 179.139 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.552 ' CB ' HD22 ' A' ' 58' ' ' LEU . 1.9 m -51.1 153.35 1.94 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.356 0.598 . . . . 0.0 111.913 -179.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.877 ' HB3' HG13 ' A' ' 42' ' ' VAL . 0.4 OUTLIER -61.84 -24.08 66.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.841 -179.513 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.66 HD23 ' H ' ' A' ' 59' ' ' ASN . 1.3 pt? -57.64 -37.0 72.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.325 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.66 ' H ' HD23 ' A' ' 58' ' ' LEU . 0.7 OUTLIER 170.89 -173.96 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.751 179.943 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -69.38 84.58 0.4 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.733 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -142.31 114.0 7.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.908 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.582 ' HB2' ' HD2' ' A' ' 55' ' ' ARG . . . -105.04 150.79 24.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.348 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.843 HG22 HG22 ' A' ' 70' ' ' ILE . 0.3 OUTLIER -77.08 155.07 5.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.527 179.76 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.55 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 4.4 p-10 -134.48 133.48 40.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.173 0.511 . . . . 0.0 111.873 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.597 ' HB2' ' CZ2' ' A' ' 84' ' ' TRP . . . -100.25 40.09 1.29 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.367 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.0 p -74.27 -43.87 55.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.458 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -98.43 173.48 6.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.117 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -46.08 -48.77 17.01 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.816 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -104.59 149.84 25.17 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.843 HG22 HG22 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -78.39 144.65 10.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 CA-C-O 121.729 0.776 . . . . 0.0 111.805 -179.203 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -135.91 158.61 43.98 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.052 179.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 1.014 HG21 HD13 ' A' ' 19' ' ' ILE . 36.4 p -101.15 140.81 34.92 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.541 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.456 ' HG2' ' C ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -163.67 164.24 15.28 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.896 179.8 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.516 ' HD2' ' HB3' ' A' ' 26' ' ' PRO . 10.8 Cg_endo -54.49 139.99 74.81 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.341 2.027 . . . . 0.0 111.754 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -56.16 122.84 12.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.911 0.386 . . . . 0.0 111.007 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.401 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 9.9 t70 -112.69 129.44 24.43 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.58 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.96 -34.81 22.32 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.449 2.099 . . . . 0.0 112.971 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -88.0 -0.64 57.27 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.401 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 4.3 t-20 -102.88 103.95 36.52 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 120.509 0.195 . . . . 0.0 110.957 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.581 ' O ' HD21 ' A' ' 94' ' ' LEU . 4.9 Cg_exo -77.1 19.95 0.67 Allowed 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.87 2.38 . . . . 0.0 113.246 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 11.5 mptt -120.45 -18.08 7.97 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 120.584 0.23 . . . . 0.0 111.27 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.487 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 4.4 mtt180 -90.3 21.59 3.76 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 1.111 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -129.32 99.5 5.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.231 0.539 . . . . 0.0 110.928 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.632 ' HH2' ' HB2' ' A' ' 116' ' ' ALA . 59.1 m95 -109.91 133.96 52.6 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.271 0.558 . . . . 0.0 112.151 -178.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.9 pt -113.23 154.57 14.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.066 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.8 t -103.24 131.07 52.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.965 0.412 . . . . 0.0 111.228 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 43.7 t -124.43 94.87 4.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.406 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.02 -100.71 0.87 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.449 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.496 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -121.13 28.98 7.55 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.603 0.24 . . . . 0.0 110.703 -179.933 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.433 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.2 146.97 30.02 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.321 0.582 . . . . 0.0 112.446 -178.642 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.849 ' HB ' HD12 ' A' ' 101' ' ' LEU . 10.6 mm -94.56 121.24 44.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.338 178.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.815 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -120.96 141.49 50.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.247 0.546 . . . . 0.0 112.462 -178.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.68 146.56 54.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.545 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.111 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.7 pt? -61.04 -56.6 19.16 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.826 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.601 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 97.2 p -73.81 -6.73 48.85 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -178.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.411 ' CB ' ' HB ' ' A' ' 99' ' ' ILE . 61.9 m-20 -139.63 91.06 2.45 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.869 -0.333 . . . . 0.0 111.203 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -66.6 -17.8 65.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.093 178.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.31 12.51 26.64 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.467 179.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.84 ' CG2' ' HB1' ' A' ' 116' ' ' ALA . 10.2 mm -124.5 128.49 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.412 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.815 HG12 ' HB2' ' A' ' 92' ' ' ALA . 19.3 m -146.31 135.54 16.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.832 0.348 . . . . 0.0 111.93 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.849 HD12 ' HB ' ' A' ' 91' ' ' ILE . 6.7 mt -45.55 152.2 0.34 Allowed 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.728 0.775 . . . . 0.0 111.781 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.821 ' O ' HG22 ' A' ' 114' ' ' ILE . 10.6 t70 -157.46 167.65 29.61 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.88 -177.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.621 HG21 HD21 ' A' ' 13' ' ' ASN . 4.6 mp -88.57 121.12 38.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.278 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.826 HG22 ' HG2' ' A' ' 105' ' ' LYS . 56.1 mt -70.48 138.33 22.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.748 0.309 . . . . 0.0 111.161 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.826 ' HG2' HG22 ' A' ' 104' ' ' ILE . 0.1 OUTLIER 81.34 -9.68 1.26 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.7 179.893 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 46.76 29.99 1.09 Allowed 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 120.757 0.313 . . . . 0.0 111.425 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.5 p30 -102.34 160.41 14.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.931 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.69 -14.28 58.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.484 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -51.95 118.95 3.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.83 0.348 . . . . 0.0 111.158 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.44 161.07 23.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.114 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.33 14.74 80.56 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.202 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.38 133.84 38.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.82 0.343 . . . . 0.0 111.063 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.572 ' HB2' HD12 ' A' ' 104' ' ' ILE . 35.9 m80 -61.38 163.25 6.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.06 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.821 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.6 OUTLIER -135.6 161.7 38.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.708 -179.836 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.608 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 26.2 p -162.3 176.94 10.05 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.84 ' HB1' ' CG2' ' A' ' 99' ' ' ILE . . . -96.91 132.24 42.89 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.826 -0.349 . . . . 0.0 110.261 178.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.467 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 75.9 t-105 -136.32 163.23 30.91 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.422 0.629 . . . . 0.0 111.756 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.467 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.1 OUTLIER -64.98 117.18 7.25 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.774 179.956 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -62.8 125.62 24.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.877 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -136.1 13.17 3.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.215 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 77.49 59.74 2.99 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.354 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -116.16 152.55 17.91 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.486 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.55 -30.67 79.76 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.51 2.14 . . . . 0.0 111.976 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.567 ' CB ' HD22 ' A' ' 12' ' ' LEU . 28.6 p-10 -77.21 -2.05 32.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.403 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.433 ' O ' ' CG2' ' A' ' 90' ' ' THR . 5.2 mm-40 -107.82 9.69 28.84 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.746 -0.206 . . . . 0.0 111.276 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.448 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 10.0 mmtt -106.5 140.99 38.52 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.872 0.368 . . . . 0.0 111.39 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -141.12 156.27 45.99 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.234 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.3 mt -112.14 138.45 41.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.072 0.463 . . . . 0.0 110.639 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.492 HD12 HG23 ' A' ' 8' ' ' ILE . 23.7 mm -113.73 140.29 34.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.599 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -139.58 94.84 2.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.668 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 53.0 m -53.0 111.14 0.62 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.35 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.739 ' OE2' HD21 ' A' ' 45' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.884 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 ttt . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.769 0.319 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.72 94.13 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.923 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.09 178.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.538 2.158 . . . . 0.0 112.315 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.89 117.85 21.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.951 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.505 ' CE1' ' HA ' ' A' ' 57' ' ' LYS . 27.8 m-85 -97.63 173.13 7.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.488 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.613 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -152.66 170.53 20.02 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.405 179.302 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.426 ' O ' ' HA ' ' A' ' 129' ' ' ILE . 0.1 OUTLIER -112.06 123.6 50.62 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.815 178.863 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.672 ' HB ' HD21 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -106.56 108.67 25.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.892 0.377 . . . . 0.0 110.488 -179.866 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -107.81 137.14 46.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.252 -178.907 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.3 t -75.13 107.76 7.42 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.403 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 5.4 tt0 -62.4 -12.05 19.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.451 -178.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.8 tp -82.92 -62.15 1.68 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.871 0.367 . . . . 0.0 111.163 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.404 ' HB2' ' HG2' ' A' ' 15' ' ' LYS . 8.9 m-20 -86.79 -11.85 49.76 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -178.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.64 0.68 68.78 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.041 -1.076 . . . . 0.0 111.46 -178.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.407 ' O ' ' HG3' ' A' ' 9' ' ' LYS . 7.6 mmtm -89.06 177.69 6.58 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.556 HG21 ' HA ' ' A' ' 35' ' ' GLN . 4.5 m -119.72 141.26 40.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 179.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.672 HD21 ' HB ' ' A' ' 8' ' ' ILE . 0.1 OUTLIER -72.24 136.51 46.36 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.242 179.613 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.406 ' CB ' ' HG3' ' A' ' 44' ' ' GLN . 25.8 t0 -140.97 148.7 40.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.899 -179.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.078 HD13 HG21 ' A' ' 72' ' ' THR . 1.1 mt -89.03 122.02 39.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.128 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.65 117.86 9.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.923 0.392 . . . . 0.0 110.904 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 128.12 -32.39 3.44 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.537 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 53.01 24.74 3.6 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.828 0.346 . . . . 0.0 111.024 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.408 ' HA ' ' HD3' ' A' ' 24' ' ' PRO . 67.6 m-20 -125.16 153.7 71.66 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.567 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.414 ' O ' ' CZ ' ' A' ' 61' ' ' PHE . 3.9 Cg_endo -86.18 36.98 0.52 Allowed 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.019 2.48 . . . . 0.0 112.865 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -99.28 143.14 25.87 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-O 120.594 0.235 . . . . 0.0 110.986 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.407 ' HB3' ' CD ' ' A' ' 74' ' ' PRO . 16.7 Cg_exo -67.9 131.96 25.33 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.676 2.251 . . . . 0.0 112.698 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.4 0.71 27.95 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.623 -0.798 . . . . 0.0 113.665 179.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.437 ' HB3' HG22 ' A' ' 19' ' ' ILE . 5.2 m -71.52 122.41 20.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.316 0.558 . . . . 0.0 111.141 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -76.6 160.56 29.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.586 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.585 HG22 HG23 ' A' ' 19' ' ' ILE . 44.5 pt -121.37 147.63 25.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.902 0.382 . . . . 0.0 111.992 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.427 HG22 ' HA ' ' A' ' 113' ' ' HIS . 0.3 OUTLIER -155.77 -178.29 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.219 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.386 179.805 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.5 p -102.31 149.48 24.29 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.603 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 20.8 t-105 -160.38 174.56 13.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.676 0.274 . . . . 0.0 110.843 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -71.12 136.29 48.11 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.814 0.34 . . . . 0.0 110.729 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.556 ' HA ' HG21 ' A' ' 16' ' ' VAL . 0.7 OUTLIER -63.24 159.78 17.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.947 -179.964 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -128.9 163.62 24.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.848 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 47.7 mmtt -122.78 107.67 12.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.921 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 156.73 178.77 31.15 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.493 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -77.35 0.93 9.27 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.703 2.269 . . . . 0.0 112.904 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 41.5 p -111.67 29.66 7.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.744 0.306 . . . . 0.0 111.036 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.55 ' O ' HD12 ' A' ' 45' ' ' LEU . . . -116.44 4.19 13.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.525 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.691 HG12 ' HB3' ' A' ' 57' ' ' LYS . 1.6 t -58.62 -18.48 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 120.686 0.279 . . . . 0.0 110.79 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -62.57 -9.93 10.42 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.12 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.406 ' HG3' ' CB ' ' A' ' 18' ' ' ASP . 1.1 mt-30 -114.55 7.46 16.13 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.622 HD22 ' OE1' ' A' ' 132' ' ' GLU . 1.7 mp -119.12 145.72 45.72 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.159 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.462 ' CH2' ' CG1' ' A' ' 63' ' ' ILE . 22.8 m95 -133.22 170.65 15.11 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.882 -178.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.54 ' CE2' ' HB2' ' A' ' 55' ' ' ARG . 1.1 p90 -135.85 159.8 40.55 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.856 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.43 HG22 HG23 ' A' ' 54' ' ' ILE . 11.8 p -106.15 132.98 51.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.732 0.301 . . . . 0.0 111.196 -179.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -77.57 164.64 25.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.949 0.404 . . . . 0.0 111.268 -179.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 22.2 mm100 -57.77 -23.3 51.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.13 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.61 -1.84 42.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.292 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.31 4.67 56.24 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.987 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.604 HG11 ' CE1' ' A' ' 75' ' ' PHE . 23.9 t -87.72 117.68 32.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.921 0.361 . . . . 0.0 110.544 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.526 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.9 OUTLIER -78.62 150.03 5.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.278 0.561 . . . . 0.0 111.939 -179.77 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.54 ' HB2' ' CE2' ' A' ' 47' ' ' TYR . 8.8 mmm-85 -146.9 133.2 19.5 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.308 178.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.654 ' HB3' HD22 ' A' ' 58' ' ' LEU . 0.1 OUTLIER -69.51 -177.53 1.21 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.333 0.587 . . . . 0.0 112.098 -178.621 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.691 ' HB3' HG12 ' A' ' 42' ' ' VAL . 17.9 pttt -46.78 -22.56 0.32 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.742 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.654 HD22 ' HB3' ' A' ' 56' ' ' SER . 1.4 mm? -50.39 -21.62 1.51 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.555 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.503 ' CB ' ' O ' ' A' ' 58' ' ' LEU . 7.8 t30 91.91 -34.54 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 122.729 0.412 . . . . 0.0 111.686 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -156.51 60.33 0.55 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.854 0.359 . . . . 0.0 111.423 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.541 ' HB2' ' HB2' ' A' ' 58' ' ' LEU . 3.7 m-85 -142.53 114.07 7.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.627 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.406 ' HB2' ' CD ' ' A' ' 55' ' ' ARG . . . -102.15 151.27 22.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.042 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.838 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -78.61 151.19 5.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.484 179.692 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.591 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 7.7 p-10 -131.95 129.87 40.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.084 0.469 . . . . 0.0 111.646 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.623 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -95.32 41.42 1.1 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.363 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.9 m -74.51 -44.65 50.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.218 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 33.6 m170 -94.94 170.73 9.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.976 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -48.59 -44.62 37.07 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.939 0.399 . . . . 0.0 110.951 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.13 144.67 31.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.659 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.838 HG22 HG22 ' A' ' 63' ' ' ILE . 2.1 mm -76.35 143.9 12.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.521 0.677 . . . . 0.0 111.649 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -143.31 167.86 21.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.947 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 1.078 HG21 HD13 ' A' ' 19' ' ' ILE . 71.6 p -107.49 140.31 40.66 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.296 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.33 164.76 15.25 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.309 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.422 ' HD3' ' CE2' ' A' ' 61' ' ' PHE . 51.4 Cg_exo -52.82 138.34 60.34 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.399 2.066 . . . . 0.0 111.844 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.604 ' CE1' HG11 ' A' ' 53' ' ' VAL . 41.4 t80 -60.74 133.48 56.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.85 0.357 . . . . 0.0 111.113 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.408 ' CB ' ' HB2' ' A' ' 79' ' ' ASN . 0.5 OUTLIER -123.86 134.79 25.61 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.639 179.724 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.03 -34.78 16.22 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.46 2.106 . . . . 0.0 112.847 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 36.6 m-20 -86.87 -0.52 56.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.735 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.408 ' HB2' ' CB ' ' A' ' 76' ' ' ASP . 0.3 OUTLIER -105.8 101.38 32.68 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-O 120.639 0.257 . . . . 0.0 111.078 -179.859 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.856 ' O ' HD21 ' A' ' 94' ' ' LEU . 74.1 Cg_endo -77.2 21.45 0.61 Allowed 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.63 2.22 . . . . 0.0 113.091 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.591 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 6.6 mptt -117.97 -19.86 8.98 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.127 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.531 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 3.2 mtm180 -88.88 19.99 3.79 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -178.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 1.1 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -128.86 99.23 5.23 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.091 0.472 . . . . 0.0 110.81 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.623 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 59.5 m95 -109.54 135.5 50.44 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.148 0.499 . . . . 0.0 111.91 -178.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.2 pp -114.05 154.37 15.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.297 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.5 t -100.53 125.05 54.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.919 0.39 . . . . 0.0 111.085 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 12.9 t -117.62 93.55 4.2 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.433 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.12 -100.52 0.79 Allowed Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.538 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.492 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.64 29.42 7.43 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.534 0.207 . . . . 0.0 110.927 -179.658 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.488 HG22 ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.87 147.83 30.19 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.334 0.588 . . . . 0.0 112.473 -178.729 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.77 ' HB ' HD12 ' A' ' 101' ' ' LEU . 14.7 mm -93.49 119.88 42.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.144 178.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.982 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -122.25 145.17 48.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.236 0.541 . . . . 0.0 112.434 -178.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.434 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -66.84 148.3 52.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.627 179.719 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.1 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.7 pt? -60.6 -56.74 17.7 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.554 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.572 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 0.3 OUTLIER -77.74 -3.51 41.6 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 -178.428 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.407 ' HB2' ' HB3' ' A' ' 93' ' ' GLN . 4.9 m-20 -138.1 86.33 2.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.799 0.333 . . . . 0.0 110.961 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 14.7 mmt180 -67.74 -18.04 64.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.21 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -92.93 11.33 27.67 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.43 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.846 ' CG2' ' HB1' ' A' ' 116' ' ' ALA . 9.8 mm -124.93 130.25 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.569 179.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.982 HG12 ' HB2' ' A' ' 92' ' ' ALA . 27.7 m -147.34 136.91 16.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.84 0.352 . . . . 0.0 111.783 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.77 HD12 ' HB ' ' A' ' 91' ' ' ILE . 9.4 mt -46.71 154.7 0.3 Allowed 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.674 0.749 . . . . 0.0 111.909 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.771 ' O ' HG22 ' A' ' 114' ' ' ILE . 10.1 t70 -160.49 169.74 22.39 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.493 -1.231 . . . . 0.0 110.746 -177.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.803 HD12 ' O ' ' A' ' 124' ' ' ASN . 4.0 mp -86.48 124.13 40.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.238 179.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.799 HG22 ' O ' ' A' ' 113' ' ' HIS . 1.1 tt -63.57 138.38 23.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.066 0.46 . . . . 0.0 111.582 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 25.5 mttp 48.62 24.99 0.86 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.6 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 33.2 t 44.48 -121.32 0.82 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.98 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 61.11 150.26 0.02 OUTLIER 'General case' 0 C--N 1.334 -0.079 0 CA-C-O 120.923 0.392 . . . . 0.0 111.203 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.22 -13.5 55.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.182 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -45.74 136.5 6.07 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.369 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -89.84 162.2 15.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.21 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 73.36 18.03 79.15 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.192 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -85.03 136.67 33.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.805 0.336 . . . . 0.0 110.885 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.799 ' O ' HG22 ' A' ' 104' ' ' ILE . 2.6 m80 -61.07 170.84 1.45 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.888 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.771 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.7 OUTLIER -142.11 161.63 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.685 -179.859 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.666 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 20.8 p -156.84 173.75 16.53 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.846 ' HB1' ' CG2' ' A' ' 99' ' ' ILE . . . -95.47 128.79 42.61 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.464 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 73.9 t-105 -136.61 162.44 33.13 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.585 0.707 . . . . 0.0 112.128 -179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.464 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.1 OUTLIER -60.26 119.43 7.9 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.663 179.887 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -62.45 129.04 38.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.095 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -139.35 12.88 2.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.107 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 80.64 11.79 83.62 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.833 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.25 139.08 41.67 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.497 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.51 -28.37 54.54 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.472 2.115 . . . . 0.0 112.326 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.803 ' O ' HD12 ' A' ' 103' ' ' ILE . 14.5 p-10 -74.66 -2.15 24.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.622 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.488 ' O ' HG22 ' A' ' 90' ' ' THR . 91.5 mt-30 -104.45 -15.53 15.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.745 -0.207 . . . . 0.0 111.441 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.415 ' O ' ' CD1' ' A' ' 127' ' ' PHE . 0.2 OUTLIER -78.07 137.87 38.47 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.899 0.38 . . . . 0.0 111.361 -179.29 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.415 ' CD1' ' O ' ' A' ' 126' ' ' LYS . 8.4 m-85 -137.5 156.26 48.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.155 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 mt -114.32 137.03 48.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.151 0.501 . . . . 0.0 110.57 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.507 ' CD1' HG23 ' A' ' 8' ' ' ILE . 33.5 mm -113.59 139.49 38.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.574 -179.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -138.82 109.39 6.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.501 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.76 110.24 1.11 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.047 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.622 ' OE1' HD22 ' A' ' 45' ' ' LEU . 3.4 tt0 . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.894 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.824 0.345 . . . . 0.0 111.172 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.406 ' N ' ' HD3' ' A' ' 3' ' ' PRO . 4.3 mttp 59.77 64.81 2.7 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.921 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.406 ' HD3' ' N ' ' A' ' 2' ' ' LYS . 33.8 Cg_exo -61.14 79.71 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.616 2.211 . . . . 0.0 112.175 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.76 126.65 41.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.041 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.465 ' CD1' ' HG3' ' A' ' 57' ' ' LYS . 0.1 OUTLIER -105.17 175.22 5.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.07 179.683 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.762 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -155.89 172.39 18.44 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.804 179.638 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.458 ' CE1' ' HB3' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -112.95 123.85 51.27 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.13 179.135 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.621 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -105.18 108.96 26.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.906 0.384 . . . . 0.0 110.389 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.423 ' HG3' ' O ' ' A' ' 15' ' ' LYS . 7.7 tttt -105.82 136.14 45.99 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.235 -178.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.514 ' OG ' HD21 ' A' ' 17' ' ' LEU . 70.3 m -73.85 109.17 7.15 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.445 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 3.8 tt0 -63.14 -12.39 27.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.521 -178.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.494 HD22 ' CB ' ' A' ' 124' ' ' ASN . 43.5 tp -84.8 -62.12 1.62 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.894 0.378 . . . . 0.0 111.115 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.724 HD21 HG21 ' A' ' 103' ' ' ILE . 8.9 m-20 -84.33 -12.71 54.1 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -178.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.5 3.02 70.4 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.007 -1.092 . . . . 0.0 111.632 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.44 ' HG2' ' HB2' ' A' ' 13' ' ' ASN . 13.2 mmtp -91.58 -177.26 4.75 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.643 HG21 ' HA ' ' A' ' 35' ' ' GLN . 4.3 m -121.7 142.21 38.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.787 0.327 . . . . 0.0 110.614 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.514 HD21 ' OG ' ' A' ' 10' ' ' SER . 9.2 mt -70.56 134.94 48.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.276 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 19' ' ' ILE . 61.5 t0 -142.51 141.72 32.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.767 0.318 . . . . 0.0 111.043 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.028 HD13 HG21 ' A' ' 72' ' ' THR . 25.1 mt -84.03 134.8 26.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.564 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -39.39 104.79 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 41.04 34.19 0.8 Allowed Glycine 0 C--N 1.332 0.315 0 CA-C-N 115.74 -0.664 . . . . 0.0 113.841 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.645 ' HG3' HD22 ' A' ' 58' ' ' LEU . 10.3 tt0 48.71 35.1 5.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.911 0.355 . . . . 0.0 111.217 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -46.28 102.63 0.31 Allowed Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.262 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -62.65 -14.63 41.18 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.658 2.239 . . . . 0.0 112.526 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -91.98 147.71 35.42 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.203 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.434 ' HB3' ' HB3' ' A' ' 73' ' ' GLN . 25.5 Cg_exo -62.52 145.56 95.45 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.675 2.25 . . . . 0.0 112.169 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.51 1.6 40.54 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.411 -0.9 . . . . 0.0 112.912 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.88 139.73 50.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 117.028 0.414 . . . . 0.0 110.784 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.88 158.38 16.33 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.485 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.718 HD11 ' HB ' ' A' ' 70' ' ' ILE . 37.3 pt -117.53 147.56 20.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.548 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.463 ' HA ' ' CD1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -155.44 -179.72 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.728 -179.84 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 p -103.77 150.55 23.98 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.667 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 31.4 t-105 -158.8 173.49 16.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.643 0.259 . . . . 0.0 110.922 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -68.89 131.68 45.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.82 0.343 . . . . 0.0 110.693 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.643 ' HA ' HG21 ' A' ' 16' ' ' VAL . 5.3 tt0 -59.71 141.13 55.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.348 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.78 158.35 17.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.414 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.59 108.71 13.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.837 0.351 . . . . 0.0 111.234 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 41' ' ' ALA . . . 109.28 -139.2 15.19 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.526 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.441 ' O ' HG22 ' A' ' 40' ' ' THR . 74.6 Cg_exo -48.12 166.72 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.451 2.101 . . . . 0.0 112.414 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.441 HG22 ' O ' ' A' ' 39' ' ' PRO . 14.4 t 44.34 23.14 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.536 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.827 ' O ' HD12 ' A' ' 45' ' ' LEU . . . -86.33 -26.59 24.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.767 0.317 . . . . 0.0 110.443 178.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 1.015 HG13 ' HB3' ' A' ' 57' ' ' LYS . 60.4 t -50.48 -28.84 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.817 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -57.65 -13.75 4.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.144 -179.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.458 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -121.31 12.24 10.91 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 120.926 0.393 . . . . 0.0 110.364 -179.909 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.827 HD12 ' O ' ' A' ' 41' ' ' ALA . 1.2 mp -118.32 140.13 50.29 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.062 -179.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.707 ' CZ2' HD11 ' A' ' 19' ' ' ILE . 23.8 m95 -133.3 169.19 17.27 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.098 -179.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.53 ' CZ ' ' HB2' ' A' ' 55' ' ' ARG . 31.1 p90 -142.39 165.71 26.67 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.317 179.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.442 HG22 ' CG2' ' A' ' 54' ' ' ILE . 74.6 p -106.84 131.79 53.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.81 0.338 . . . . 0.0 111.272 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -77.44 165.6 24.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.077 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -63.12 -26.9 69.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.951 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -85.97 -4.64 59.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.277 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.431 ' O ' HG22 ' A' ' 85' ' ' ILE . . . 96.48 15.08 41.97 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.82 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.507 HG12 ' HD3' ' A' ' 55' ' ' ARG . 40.2 t -106.09 123.74 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-O 120.662 0.267 . . . . 0.0 110.495 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.464 HD11 ' HB2' ' A' ' 84' ' ' TRP . 0.6 OUTLIER -77.5 148.74 6.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.289 0.566 . . . . 0.0 111.828 -179.963 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.552 ' CD ' ' HB2' ' A' ' 62' ' ' ALA . 0.2 OUTLIER -150.06 133.28 16.34 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.323 178.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.518 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 16.5 m -54.76 141.75 31.41 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.512 0.673 . . . . 0.0 112.029 -178.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 1.015 ' HB3' HG13 ' A' ' 42' ' ' VAL . 25.5 tttt -54.02 -23.24 12.75 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.427 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.645 HD22 ' HG3' ' A' ' 22' ' ' GLN . 3.6 pp -57.74 -38.97 76.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.007 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 178.93 -178.0 0.3 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.746 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -74.83 82.45 2.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.813 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.443 ' CE2' ' HD3' ' A' ' 74' ' ' PRO . 2.9 m-85 -144.64 125.58 14.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.903 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.552 ' HB2' ' CD ' ' A' ' 55' ' ' ARG . . . -109.51 153.24 24.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.405 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.817 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -79.15 151.82 4.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.595 179.647 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.633 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 10.5 p-10 -133.42 130.54 38.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.261 0.553 . . . . 0.0 111.787 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.691 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -93.58 41.26 1.08 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.398 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 77.7 p -74.73 -42.87 57.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.379 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -98.11 171.04 8.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.096 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -47.6 -46.34 28.26 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.095 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.05 143.98 31.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.029 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.817 HG22 HG22 ' A' ' 63' ' ' ILE . 3.0 mm -71.38 136.38 25.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 CA-C-O 121.605 0.717 . . . . 0.0 111.454 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.438 ' O ' HG22 ' A' ' 63' ' ' ILE . 18.3 mt-10 -133.07 165.59 24.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.351 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 1.028 HG21 HD13 ' A' ' 19' ' ' ILE . 27.5 p -105.21 134.45 48.29 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.212 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.462 ' HG2' ' C ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -161.75 167.82 12.22 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.181 -179.681 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.443 ' HD3' ' CE2' ' A' ' 61' ' ' PHE . 21.4 Cg_endo -61.11 139.44 84.12 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.308 2.005 . . . . 0.0 112.015 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.466 ' CE1' ' HB2' ' A' ' 83' ' ' ALA . 16.9 t80 -59.58 139.65 56.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.935 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.406 ' HB3' ' CB ' ' A' ' 79' ' ' ASN . 1.1 t0 -129.38 135.0 26.89 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.791 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -68.24 -35.63 18.52 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.505 2.137 . . . . 0.0 112.762 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -88.79 -1.25 57.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.699 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.427 ' HB3' ' HD2' ' A' ' 82' ' ' ARG . 2.9 t-20 -110.91 99.05 41.02 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-O 120.611 0.243 . . . . 0.0 110.846 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.532 ' O ' HD21 ' A' ' 94' ' ' LEU . 4.4 Cg_exo -74.94 27.98 0.36 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.878 2.385 . . . . 0.0 113.387 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.633 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -119.03 -23.63 6.8 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-O 120.673 0.273 . . . . 0.0 111.036 -179.833 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.47 ' HG3' ' HB3' ' A' ' 64' ' ' ASP . 0.6 OUTLIER -86.35 22.97 1.68 Allowed 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -179.076 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 1.04 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -133.7 99.96 4.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.206 0.527 . . . . 0.0 111.17 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.691 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 59.7 m95 -109.67 136.61 48.75 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.891 -178.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.44 HD11 ' HD3' ' A' ' 97' ' ' ARG . 20.4 pt -113.37 154.52 14.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.112 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.5 t -101.75 125.93 55.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.993 0.425 . . . . 0.0 111.057 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.9 t -118.74 93.87 4.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.338 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.41 -100.73 0.83 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.425 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.499 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -121.15 29.78 7.15 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.544 0.211 . . . . 0.0 110.842 -179.868 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.408 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.12 147.46 30.58 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -178.6 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.765 ' HB ' HD12 ' A' ' 101' ' ' LEU . 14.1 mm -93.86 119.17 41.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.492 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.964 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -123.27 146.68 47.67 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -178.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.422 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.1 OUTLIER -64.78 149.18 49.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.599 179.867 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.04 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.7 pt? -64.61 -56.88 11.08 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.551 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.612 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 47.3 t -76.2 -2.3 30.57 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -178.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.555 ' O ' HG22 ' A' ' 99' ' ' ILE . 11.1 m-20 -145.85 90.85 2.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.029 0.442 . . . . 0.0 110.939 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.44 ' HD3' HD11 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -73.43 -13.7 61.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.546 179.351 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -86.15 10.44 14.49 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.486 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.854 HG12 ' HB1' ' A' ' 116' ' ' ALA . 3.2 tt -135.12 142.38 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.964 HG12 ' HB2' ' A' ' 92' ' ' ALA . 32.1 m -150.51 139.51 15.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.851 0.357 . . . . 0.0 111.871 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.765 HD12 ' HB ' ' A' ' 91' ' ' ILE . 11.9 mt -45.58 154.13 0.22 Allowed 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.8 0.809 . . . . 0.0 111.997 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.718 ' O ' HG22 ' A' ' 114' ' ' ILE . 9.4 t70 -157.51 167.71 29.41 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 114.18 -1.373 . . . . 0.0 110.563 -177.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.724 HG21 HD21 ' A' ' 13' ' ' ASN . 4.5 mp -90.42 122.44 41.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.406 179.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.749 HG22 ' O ' ' A' ' 113' ' ' HIS . 8.9 tt -67.45 140.86 18.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.971 0.415 . . . . 0.0 111.379 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt 76.95 -7.32 1.87 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.935 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.6 m 46.56 28.85 0.82 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 120.76 0.314 . . . . 0.0 111.232 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -99.63 159.96 14.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.052 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.36 -14.43 58.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.182 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -47.48 126.18 9.39 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.163 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.87 158.31 36.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.225 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.57 14.77 80.89 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.327 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.1 131.91 38.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.816 0.341 . . . . 0.0 110.872 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.749 ' O ' HG22 ' A' ' 104' ' ' ILE . 8.1 m170 -65.1 173.52 2.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.024 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.718 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -136.35 161.5 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.367 179.928 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.579 ' HA ' HD11 ' A' ' 70' ' ' ILE . 7.4 t -152.47 166.57 31.55 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.854 ' HB1' HG12 ' A' ' 99' ' ' ILE . . . -93.92 125.02 38.3 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.46 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 68.2 t-105 -131.49 161.72 31.89 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.672 0.748 . . . . 0.0 112.455 -179.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.46 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.0 OUTLIER -63.85 121.13 13.3 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.792 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -60.43 124.11 19.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.977 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -136.18 8.4 3.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.503 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 79.53 57.16 3.18 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.479 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -116.51 143.31 18.01 Favored Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.488 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.82 -32.53 77.44 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.57 2.18 . . . . 0.0 112.326 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.576 ' O ' HD12 ' A' ' 103' ' ' ILE . 18.7 p-10 -73.71 -5.33 39.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.632 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.408 ' O ' ' CG2' ' A' ' 90' ' ' THR . 93.0 mt-30 -107.29 10.11 29.85 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.509 0.195 . . . . 0.0 111.362 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.445 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -106.21 140.86 38.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.864 0.364 . . . . 0.0 111.104 -179.627 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.428 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 7.9 m-85 -139.35 156.84 46.74 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.45 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.4 mt -113.79 139.17 40.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.095 0.474 . . . . 0.0 110.679 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.53 ' CD1' HG23 ' A' ' 8' ' ' ILE . 25.5 mm -114.6 139.96 37.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.62 -179.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -137.47 94.56 2.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.59 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 27.2 m -51.04 108.67 0.26 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.356 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.198 -0.906 . . . . 0.0 111.172 179.824 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mtt . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.819 0.343 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.411 ' N ' ' HD2' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -60.13 -61.12 8.56 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.972 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.411 ' HD2' ' N ' ' A' ' 2' ' ' LYS . 48.2 Cg_endo -68.84 141.03 47.89 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.472 2.115 . . . . 0.0 112.356 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.8 pttp -118.44 138.55 52.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.933 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.475 ' CE1' ' HG3' ' A' ' 57' ' ' LYS . 17.0 m-85 -94.08 175.29 6.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.493 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.77 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -159.42 176.02 12.61 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.76 179.694 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.442 ' CE1' ' HB3' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -114.96 124.12 50.87 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.365 179.099 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.614 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -105.89 109.4 27.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.465 179.921 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 16' ' ' VAL . 1.3 tttm -105.82 136.61 45.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.064 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 79.3 p -76.51 107.76 9.02 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 178.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.419 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 2.2 tt0 -63.15 -10.33 14.57 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.467 -178.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 27.0 tp -83.16 -62.67 1.53 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.862 0.363 . . . . 0.0 110.911 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.65 HD21 HG21 ' A' ' 103' ' ' ILE . 8.0 m-20 -86.25 -10.83 53.86 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -178.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.39 3.74 72.07 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.172 -1.014 . . . . 0.0 111.421 -178.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.0 mmmm -91.67 -177.73 4.86 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 122.583 0.353 . . . . 0.0 110.054 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.574 HG21 ' HA ' ' A' ' 35' ' ' GLN . 4.5 m -121.27 140.83 44.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.69 0.281 . . . . 0.0 110.484 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.1 mt -70.67 136.26 48.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.233 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -140.51 153.98 46.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.85 0.357 . . . . 0.0 111.147 -179.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.912 HD13 HG21 ' A' ' 72' ' ' THR . 1.6 mt -100.43 118.35 46.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.59 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -65.26 96.13 0.21 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.876 0.369 . . . . 0.0 110.602 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 156.16 -41.29 0.57 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.379 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 53.37 49.23 20.17 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.796 0.331 . . . . 0.0 111.124 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -176.97 170.69 1.01 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.064 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.428 ' O ' ' CZ ' ' A' ' 61' ' ' PHE . 24.2 Cg_exo -63.78 -12.34 31.13 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.834 2.356 . . . . 0.0 112.627 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -40.39 97.8 0.15 Allowed Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.657 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.429 ' HB3' ' HD3' ' A' ' 74' ' ' PRO . 37.9 Cg_exo -61.11 142.33 96.6 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.652 2.235 . . . . 0.0 112.327 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.98 3.26 55.91 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.7 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.7 m -71.75 137.47 47.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.903 0.382 . . . . 0.0 111.134 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.99 156.64 19.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.299 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.701 HD11 ' HB ' ' A' ' 70' ' ' ILE . 44.2 pt -116.42 145.59 21.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.913 0.387 . . . . 0.0 111.598 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.442 HG22 ' HA ' ' A' ' 113' ' ' HIS . 0.2 OUTLIER -155.93 -178.91 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.164 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.529 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.4 p -101.2 148.92 24.53 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.561 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 18.1 t-105 -156.81 171.67 19.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.721 0.296 . . . . 0.0 110.98 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.45 134.51 47.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.719 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.574 ' HA ' HG21 ' A' ' 16' ' ' VAL . 3.5 tt0 -56.18 126.41 25.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.112 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.8 mmmt -92.43 160.99 14.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.926 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -126.03 102.52 7.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.869 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 151.02 -159.52 28.2 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.651 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -74.15 0.14 8.83 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.082 2.521 . . . . 0.0 112.904 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.2 t -103.99 22.22 15.0 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.806 0.336 . . . . 0.0 111.082 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.987 ' O ' HD12 ' A' ' 45' ' ' LEU . . . -89.96 -20.9 22.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.109 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.884 HG13 ' HB3' ' A' ' 57' ' ' LYS . 81.6 t -49.44 -33.24 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.103 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -66.26 -9.26 30.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.046 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.442 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 6.4 mt-30 -118.95 8.22 11.61 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.987 HD12 ' O ' ' A' ' 41' ' ' ALA . 0.9 OUTLIER -117.65 140.11 50.09 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.71 -178.943 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.627 ' CZ2' HD11 ' A' ' 19' ' ' ILE . 23.1 m95 -134.0 168.62 18.46 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.545 -178.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.531 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 5.3 p90 -136.53 160.29 39.21 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.081 179.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.427 HG22 HG23 ' A' ' 54' ' ' ILE . 29.1 p -105.72 134.55 48.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.708 0.29 . . . . 0.0 110.9 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 53' ' ' VAL . 28.2 t70 -77.42 165.68 24.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.88 0.371 . . . . 0.0 111.092 -179.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.1 mm-40 -55.45 -21.76 17.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.28 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -103.94 -1.26 27.9 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.414 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.62 -0.15 49.4 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.69 -0.766 . . . . 0.0 113.068 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.405 ' O ' ' HB2' ' A' ' 49' ' ' ASP . 19.0 t -78.95 113.62 18.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.817 0.342 . . . . 0.0 110.695 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.531 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.8 OUTLIER -79.55 147.14 6.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.407 0.622 . . . . 0.0 112.212 -179.537 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.776 ' CD ' ' HB2' ' A' ' 62' ' ' ALA . 0.1 OUTLIER -150.82 132.58 14.98 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.904 178.5 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.783 ' OG ' HD22 ' A' ' 58' ' ' LEU . 99.9 p -53.88 153.59 4.62 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 121.758 0.789 . . . . 0.0 111.818 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.884 ' HB3' HG13 ' A' ' 42' ' ' VAL . 79.5 tttt -59.69 -10.74 3.96 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 114.358 -1.292 . . . . 0.0 111.271 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.783 HD22 ' OG ' ' A' ' 56' ' ' SER . 0.7 OUTLIER -43.85 -50.53 7.89 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.956 0.408 . . . . 0.0 111.19 179.612 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 175.43 -55.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.548 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 179.55 77.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.947 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.428 ' CZ ' ' O ' ' A' ' 24' ' ' PRO . 1.8 m-85 -142.15 125.61 16.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.816 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.776 ' HB2' ' CD ' ' A' ' 55' ' ' ARG . . . -104.94 151.22 24.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.514 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.839 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -79.79 151.82 4.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.465 179.607 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.618 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 7.4 p-10 -133.38 130.69 39.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.244 0.545 . . . . 0.0 111.776 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.676 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -93.33 43.48 1.12 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.245 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.0 m -75.48 -45.63 37.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.448 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -95.85 171.89 8.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.018 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -49.17 -41.77 37.68 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.91 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.24 144.23 32.32 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.801 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.839 HG22 HG22 ' A' ' 63' ' ' ILE . 2.5 mm -74.3 139.71 18.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.537 0.684 . . . . 0.0 111.441 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.406 ' O ' HG22 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -138.61 166.83 23.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.718 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.912 HG21 HD13 ' A' ' 19' ' ' ILE . 47.3 p -105.09 138.91 40.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.139 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.07 169.54 8.03 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.2 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.429 ' HD3' ' HB3' ' A' ' 26' ' ' PRO . 32.6 Cg_exo -61.16 137.35 70.67 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.491 2.128 . . . . 0.0 112.028 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -54.84 128.0 31.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.074 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.444 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 8.9 t70 -116.9 129.33 25.39 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.64 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -68.52 -35.35 17.69 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.546 2.164 . . . . 0.0 113.01 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 56.4 m-20 -86.78 -1.59 57.88 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.444 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 1.6 t-20 -116.36 99.52 52.79 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-O 120.659 0.266 . . . . 0.0 110.795 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.542 ' O ' HD21 ' A' ' 94' ' ' LEU . 8.1 Cg_exo -72.51 32.63 0.28 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.068 2.512 . . . . 0.0 113.498 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.618 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 0.7 OUTLIER -118.89 -23.96 6.76 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 120.656 0.265 . . . . 0.0 111.171 -179.718 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.489 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 8.3 mtt-85 -85.13 18.71 2.44 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.998 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -127.76 99.26 5.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.201 0.524 . . . . 0.0 111.317 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.676 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 59.7 m95 -109.93 135.56 50.61 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.803 -179.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.9 pt -114.79 155.6 15.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.19 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.3 t -103.22 130.25 53.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.962 0.41 . . . . 0.0 111.143 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 30.5 t -123.04 94.99 4.44 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.286 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.25 -100.51 0.8 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.423 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.501 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.93 29.68 7.25 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.532 0.206 . . . . 0.0 110.919 -179.756 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.403 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.39 147.24 30.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.394 0.616 . . . . 0.0 112.648 -178.536 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.74 ' HB ' HD12 ' A' ' 101' ' ' LEU . 17.3 mm -94.12 119.87 42.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.2 178.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.977 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -122.54 144.88 48.8 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.432 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -64.99 147.74 52.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.52 179.452 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.998 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.6 pt? -62.73 -56.52 16.86 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.436 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.617 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 45.6 p -75.15 -4.59 39.62 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -178.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.583 ' O ' HG22 ' A' ' 99' ' ' ILE . 8.6 m-20 -140.1 89.03 2.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.815 0.34 . . . . 0.0 110.864 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.8 mmm-85 -70.78 -15.87 62.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.235 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.22 11.88 21.99 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.154 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.583 HG22 ' O ' ' A' ' 96' ' ' ASP . 1.0 OUTLIER -130.38 136.84 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.086 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.977 HG12 ' HB2' ' A' ' 92' ' ' ALA . 26.8 m -148.47 138.41 16.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.777 0.322 . . . . 0.0 111.643 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.74 HD12 ' HB ' ' A' ' 91' ' ' ILE . 10.7 mt -45.98 153.84 0.28 Allowed 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.723 0.773 . . . . 0.0 111.768 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.782 ' O ' HG22 ' A' ' 114' ' ' ILE . 10.3 t70 -157.51 167.7 29.43 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.789 -177.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.691 HD12 ' O ' ' A' ' 124' ' ' ASN . 4.3 mp -89.18 120.57 38.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.553 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.453 HG12 ' HA ' ' A' ' 114' ' ' ILE . 45.7 mm -69.2 143.25 15.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.823 0.344 . . . . 0.0 111.13 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 80.13 -9.82 1.36 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.689 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 46.76 29.51 0.99 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.749 0.309 . . . . 0.0 111.238 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 54.0 p30 -105.46 163.54 12.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.033 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -80.56 -14.38 58.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.181 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -49.24 120.96 4.4 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.174 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.03 161.99 30.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.25 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 72.24 18.53 78.14 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.231 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -82.85 136.48 34.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.803 0.335 . . . . 0.0 111.112 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.442 ' HA ' HG22 ' A' ' 31' ' ' ILE . 5.5 m170 -62.61 168.08 3.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.939 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.782 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.7 OUTLIER -138.33 161.35 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.74 -179.772 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.65 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 5.2 t -155.15 169.67 23.62 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.667 ' HB2' ' HH2' ' A' ' 84' ' ' TRP . . . -94.08 125.91 38.99 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.046 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.459 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 76.3 t-105 -132.88 162.28 31.99 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.622 0.725 . . . . 0.0 112.311 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.459 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.1 OUTLIER -61.2 120.2 9.9 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.581 -1.191 . . . . 0.0 110.608 179.855 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -59.25 126.63 28.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.122 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -134.63 10.01 3.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.289 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 78.92 8.85 87.59 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.923 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.36 152.32 44.61 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.537 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.88 -27.09 59.06 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.606 2.204 . . . . 0.0 112.206 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.691 ' O ' HD12 ' A' ' 103' ' ' ILE . 25.4 p-10 -76.31 -1.93 29.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.479 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.403 ' O ' ' CG2' ' A' ' 90' ' ' THR . 0.0 OUTLIER -109.17 13.31 24.51 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 116.736 -0.211 . . . . 0.0 111.072 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.419 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 7.5 mmmt -104.61 132.53 50.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.789 0.328 . . . . 0.0 111.273 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.43 ' CD1' ' N ' ' A' ' 127' ' ' PHE . 1.7 m-85 -135.83 154.99 51.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.376 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 mt -114.33 139.82 38.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.163 0.506 . . . . 0.0 110.706 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.584 ' CD1' HG23 ' A' ' 8' ' ' ILE . 24.6 mm -114.54 140.73 33.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.707 -179.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -139.15 95.33 2.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.616 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.8 m -50.25 113.15 0.8 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.466 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.908 -179.986 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 ttm . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.764 0.316 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.18 127.55 71.1 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.898 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.16 175.2 5.04 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.438 2.092 . . . . 0.0 112.248 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -140.38 76.4 1.55 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.015 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 46' ' ' TRP . 1.6 p90 -98.13 176.36 5.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.438 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.766 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -159.9 176.16 12.21 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.746 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.457 ' CE1' ' HB3' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -113.71 123.91 51.01 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.26 179.195 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.696 ' HB ' HD21 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -105.09 109.42 27.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.912 0.386 . . . . 0.0 110.58 -179.983 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.41 ' HG3' ' O ' ' A' ' 15' ' ' LYS . 2.8 tttt -107.09 138.61 42.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.022 -0.535 . . . . 0.0 112.271 -178.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.1 p -77.54 109.29 11.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.658 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.429 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 4.1 tt0 -64.58 -10.14 24.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.598 -178.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.569 HD22 ' HA ' ' A' ' 124' ' ' ASN . 65.0 tp -84.0 -62.79 1.48 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.974 0.416 . . . . 0.0 110.906 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.586 HD21 HG21 ' A' ' 103' ' ' ILE . 6.1 m-20 -85.53 -12.36 51.89 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -178.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.83 1.9 74.5 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.038 -1.077 . . . . 0.0 111.245 -178.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.432 ' HG2' ' HB2' ' A' ' 13' ' ' ASN . 6.6 mmmt -90.41 179.81 5.78 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.485 HG21 ' HA ' ' A' ' 35' ' ' GLN . 4.0 m -121.13 141.66 40.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.696 HD21 ' HB ' ' A' ' 8' ' ' ILE . 0.1 OUTLIER -71.89 136.62 46.99 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.374 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -142.1 150.37 41.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.948 0.404 . . . . 0.0 111.335 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.891 HD13 HG21 ' A' ' 72' ' ' THR . 23.7 mt -89.98 135.58 25.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.507 179.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -41.26 96.08 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.857 -179.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 44.24 35.07 3.56 Favored Glycine 0 C--N 1.331 0.304 0 CA-C-N 115.924 -0.58 . . . . 0.0 113.303 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 37.52 48.09 0.85 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.808 0.337 . . . . 0.0 111.726 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -48.34 105.85 0.54 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.069 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -49.95 -24.28 10.32 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.538 2.159 . . . . 0.0 112.486 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -91.99 147.98 35.96 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.983 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -63.11 144.92 93.42 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.55 2.167 . . . . 0.0 112.058 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.59 4.42 24.92 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.496 -0.859 . . . . 0.0 113.09 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.23 129.71 37.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.942 0.401 . . . . 0.0 111.118 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.408 ' HA ' ' HG3' ' A' ' 71' ' ' GLU . 9.8 mmtt -81.16 159.51 24.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.554 179.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.626 HD11 ' HB ' ' A' ' 70' ' ' ILE . 48.2 pt -119.89 147.91 23.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.976 0.417 . . . . 0.0 111.729 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.431 HG22 ' HA ' ' A' ' 113' ' ' HIS . 0.2 OUTLIER -155.74 -179.34 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.176 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.581 -179.881 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.693 HG21 HD12 ' A' ' 103' ' ' ILE . 2.8 p -100.97 148.45 25.0 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.639 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 51.6 t-105 -156.77 170.92 21.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.681 0.277 . . . . 0.0 110.819 -179.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.62 135.53 48.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.744 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.485 ' HA ' HG21 ' A' ' 16' ' ' VAL . 28.2 tt0 -56.79 133.96 54.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.019 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.34 168.15 9.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.851 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.5 mttp -128.19 104.77 7.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.878 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 167.75 165.02 24.45 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.56 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.24 -27.5 30.54 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.609 2.206 . . . . 0.0 112.347 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.9 t -81.44 13.13 3.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.928 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.93 ' O ' HD12 ' A' ' 45' ' ' LEU . . . -72.8 -10.4 59.75 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.684 0.278 . . . . 0.0 111.307 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.806 HG13 ' CG ' ' A' ' 57' ' ' LYS . 57.3 t -48.88 -27.12 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.272 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -64.38 -11.74 35.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.912 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.471 ' NE2' HG23 ' A' ' 16' ' ' VAL . 5.6 mt-30 -120.28 7.16 10.7 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.096 0.474 . . . . 0.0 109.784 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.93 HD12 ' O ' ' A' ' 41' ' ' ALA . 1.3 mp -118.18 140.21 50.12 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.949 -179.064 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.568 ' CZ2' HD11 ' A' ' 19' ' ' ILE . 25.5 m95 -135.12 169.88 16.77 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.019 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.567 ' CZ ' ' HB2' ' A' ' 55' ' ' ARG . 5.2 p90 -141.13 165.5 27.36 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.158 178.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.53 131.7 52.6 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.827 0.346 . . . . 0.0 111.195 -179.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -77.61 165.48 24.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.093 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -59.94 -25.26 65.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.12 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -91.84 -3.57 55.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.391 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.84 ' O ' HG22 ' A' ' 85' ' ' ILE . . . 97.75 10.4 52.9 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.891 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.639 HG13 ' HA ' ' A' ' 83' ' ' ALA . 5.5 t -98.23 121.22 48.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.778 0.323 . . . . 0.0 110.495 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.552 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -75.63 147.5 8.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.198 0.523 . . . . 0.0 111.884 -179.733 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.596 ' HD2' ' HB2' ' A' ' 62' ' ' ALA . 0.2 OUTLIER -151.79 135.59 16.36 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.62 179.063 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 73.1 m -49.9 149.32 2.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.255 0.55 . . . . 0.0 112.047 -179.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.806 ' CG ' HG13 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -59.49 -20.07 52.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.996 179.914 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.641 HD12 ' OD1' ' A' ' 59' ' ' ASN . 0.5 OUTLIER -61.35 -49.59 76.33 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.241 -179.665 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.641 ' OD1' HD12 ' A' ' 58' ' ' LEU . 32.2 p30 -176.56 -173.82 0.54 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.959 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -68.02 82.55 0.22 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.174 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.42 ' CZ ' ' HG3' ' A' ' 74' ' ' PRO . 2.3 m-85 -141.39 116.15 9.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.725 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.596 ' HB2' ' HD2' ' A' ' 55' ' ' ARG . . . -109.4 150.96 27.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.458 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.857 HG22 HG22 ' A' ' 70' ' ' ILE . 0.3 OUTLIER -78.45 153.77 5.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.583 179.614 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.606 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 4.7 p-10 -133.28 130.19 38.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.226 0.536 . . . . 0.0 111.832 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.67 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -93.95 39.92 1.08 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.433 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.31 -44.73 51.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.172 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 50.6 m170 -94.11 169.44 10.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.928 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -46.9 -47.66 21.44 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.999 0.428 . . . . 0.0 110.956 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.409 ' OE1' ' CE1' ' A' ' 113' ' ' HIS . 0.0 OUTLIER -100.98 145.17 29.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.623 179.212 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.857 HG22 HG22 ' A' ' 63' ' ' ILE . 2.3 mm -73.09 137.8 22.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-O 121.553 0.692 . . . . 0.0 111.489 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.408 ' HG3' ' HA ' ' A' ' 29' ' ' LYS . 3.7 tt0 -132.34 161.93 32.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.015 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.891 HG21 HD13 ' A' ' 19' ' ' ILE . 28.3 p -104.04 138.89 39.92 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.635 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.91 160.46 15.02 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.654 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.421 ' O ' ' HD3' ' A' ' 82' ' ' ARG . 51.1 Cg_exo -53.51 141.88 61.12 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.441 2.094 . . . . 0.0 111.785 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -55.13 134.6 49.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.875 0.369 . . . . 0.0 111.352 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -126.31 118.96 23.33 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.609 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -58.33 -36.66 97.41 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.633 2.222 . . . . 0.0 113.231 -179.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 29.1 m-20 -86.1 -0.68 56.2 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -106.5 103.54 46.65 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.6 0.238 . . . . 0.0 111.137 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.529 ' O ' HD21 ' A' ' 94' ' ' LEU . 79.1 Cg_endo -77.37 23.09 0.55 Allowed 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.649 2.233 . . . . 0.0 113.132 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.606 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 0.7 OUTLIER -119.87 -21.18 7.27 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.966 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.54 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 2.5 mtm180 -86.66 20.93 2.34 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.991 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -129.79 99.91 5.3 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.275 0.56 . . . . 0.0 111.066 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.67 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 63.4 m95 -110.47 136.8 49.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.846 -178.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.84 HG22 ' O ' ' A' ' 52' ' ' GLY . 1.2 pp -117.01 155.45 18.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.215 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.1 t -100.79 125.77 54.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.917 0.389 . . . . 0.0 111.054 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 12.7 t -118.5 93.62 4.18 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.487 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.22 -100.84 0.82 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.517 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.501 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.74 29.32 7.47 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.557 0.218 . . . . 0.0 110.939 -179.655 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.419 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.82 148.18 30.61 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.379 0.609 . . . . 0.0 112.552 -178.576 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.754 ' HB ' HD12 ' A' ' 101' ' ' LEU . 16.7 mm -93.41 119.98 42.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.303 178.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.953 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -123.55 145.29 48.99 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -178.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.434 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -66.67 147.05 53.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.723 179.713 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.991 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.6 pt? -60.81 -56.23 23.65 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.499 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.616 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 2.8 m -76.75 -3.95 40.83 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -178.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -139.04 87.88 2.24 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.88 0.371 . . . . 0.0 111.071 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -66.92 -18.25 65.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.173 179.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.27 10.42 32.03 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.509 179.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.839 ' CG2' ' HB1' ' A' ' 116' ' ' ALA . 12.1 mm -122.37 127.29 75.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.596 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.953 HG12 ' HB2' ' A' ' 92' ' ' ALA . 29.6 m -146.14 135.52 17.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.821 0.343 . . . . 0.0 111.796 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.754 HD12 ' HB ' ' A' ' 91' ' ' ILE . 10.8 mt -45.97 154.0 0.27 Allowed 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.66 0.743 . . . . 0.0 111.913 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.821 ' O ' HG22 ' A' ' 114' ' ' ILE . 10.8 t70 -157.92 168.59 26.74 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.88 -177.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.693 HD12 HG21 ' A' ' 32' ' ' THR . 34.6 mm -88.77 126.95 41.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.603 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.713 HG22 ' O ' ' A' ' 113' ' ' HIS . 0.5 OUTLIER -64.16 134.11 29.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.184 0.516 . . . . 0.0 111.449 -179.699 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 12.7 tttm 62.46 10.2 3.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.929 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.0 p 40.22 33.21 0.15 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.697 0.284 . . . . 0.0 111.587 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.93 154.73 18.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.931 0.396 . . . . 0.0 111.191 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.28 -16.17 56.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.322 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -49.36 126.52 13.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.791 0.329 . . . . 0.0 111.308 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -73.1 157.95 36.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.031 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.48 14.08 81.27 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.17 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.52 134.03 38.4 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.924 0.392 . . . . 0.0 111.035 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.713 ' O ' HG22 ' A' ' 104' ' ' ILE . 0.3 OUTLIER -60.91 167.08 3.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.878 -179.798 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.821 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.1 OUTLIER -139.48 161.41 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.728 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.673 ' HA ' HD11 ' A' ' 70' ' ' ILE . 5.7 p -157.6 173.3 17.07 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.839 ' HB1' ' CG2' ' A' ' 99' ' ' ILE . . . -95.27 129.47 42.38 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.456 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 75.7 t-105 -136.04 162.47 32.79 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.565 0.698 . . . . 0.0 112.096 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.456 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.0 OUTLIER -61.63 118.77 7.51 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.773 179.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -59.01 127.13 30.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.997 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -134.08 11.25 3.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.155 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 77.44 7.64 87.06 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.864 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.5 154.88 41.4 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.507 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.46 -28.4 53.99 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.625 2.216 . . . . 0.0 112.28 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.569 ' HA ' HD22 ' A' ' 12' ' ' LEU . 30.3 p-10 -74.52 -4.07 34.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.589 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.419 ' O ' ' CG2' ' A' ' 90' ' ' THR . 0.0 OUTLIER -108.34 15.81 23.69 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.571 0.224 . . . . 0.0 111.176 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.429 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 16.7 mmtt -107.06 134.01 50.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.765 0.317 . . . . 0.0 111.384 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.43 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 4.5 m-85 -137.05 155.29 49.85 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.303 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.4 mt -113.55 139.14 40.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.174 0.511 . . . . 0.0 110.587 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.575 HD12 HG23 ' A' ' 8' ' ' ILE . 24.0 mm -113.97 139.79 37.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.616 -179.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -136.77 94.68 3.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.628 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.3 p -52.48 110.81 0.54 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.253 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.448 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 5.2 tp10 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.996 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 ptp . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 120.894 0.378 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.48 143.9 27.5 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.85 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.05 133.9 17.07 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.516 2.144 . . . . 0.0 112.473 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.0 tttt -96.96 116.88 29.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.654 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.492 ' CD1' ' HG3' ' A' ' 57' ' ' LYS . 2.3 p90 -91.44 174.94 7.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.7 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.723 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -161.08 177.8 9.94 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.628 179.73 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.75 ' OH ' ' HB1' ' A' ' 41' ' ' ALA . 1.0 OUTLIER -112.61 123.83 51.18 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.42 179.379 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.617 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -103.97 109.42 27.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.123 0.487 . . . . 0.0 109.802 179.552 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.506 ' HE2' HD12 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -102.89 130.84 50.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.579 -178.025 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.68 103.18 7.46 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 178.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.421 ' HB3' ' O ' ' A' ' 126' ' ' LYS . 3.3 tt0 -65.58 -8.22 18.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.768 -178.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.722 HD22 ' CB ' ' A' ' 124' ' ' ASN . 36.1 tp -83.16 -63.6 1.33 Allowed 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.44 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.44 HD21 HG21 ' A' ' 103' ' ' ILE . 3.3 m-80 -83.72 -7.78 59.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.862 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.78 4.85 72.54 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.11 -1.043 . . . . 0.0 111.234 -177.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm -94.43 -166.31 1.46 Allowed 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 122.809 0.444 . . . . 0.0 109.958 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.58 HG21 ' HA ' ' A' ' 35' ' ' GLN . 6.3 m -130.78 143.93 39.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.3 mt -70.19 135.11 48.76 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -145.15 155.97 43.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.915 0.388 . . . . 0.0 111.196 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.066 HD13 HG21 ' A' ' 72' ' ' THR . 17.4 mt -97.53 130.77 45.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.517 179.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.45 104.27 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.042 -178.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 23' ' ' ASN . . . 44.83 29.41 2.01 Favored Glycine 0 C--N 1.332 0.334 0 CA-C-N 115.824 -0.625 . . . . 0.0 113.406 179.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.817 ' HG2' HD22 ' A' ' 58' ' ' LEU . 0.2 OUTLIER 65.82 -71.17 0.09 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.789 0.328 . . . . 0.0 111.063 179.877 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 21' ' ' GLY . 49.4 t30 68.25 91.71 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.866 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.38 -20.42 20.18 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.6 2.2 . . . . 0.0 112.487 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -94.63 153.86 40.14 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.083 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.421 ' HB3' ' CD ' ' A' ' 74' ' ' PRO . 17.1 Cg_exo -66.96 151.42 82.16 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.672 2.248 . . . . 0.0 112.11 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.53 2.33 35.09 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.463 -0.875 . . . . 0.0 113.3 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.55 125.24 26.97 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 117.102 0.451 . . . . 0.0 111.258 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -77.64 159.99 28.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.562 179.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.53 HD13 HG21 ' A' ' 63' ' ' ILE . 47.9 pt -121.1 148.27 24.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.885 0.374 . . . . 0.0 111.771 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.457 HG22 ' HA ' ' A' ' 113' ' ' HIS . 0.3 OUTLIER -156.01 -178.3 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.219 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.551 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.633 HG21 HD12 ' A' ' 103' ' ' ILE . 1.6 p -100.54 147.94 25.35 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.617 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 25.6 t-105 -159.15 173.79 15.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.66 0.267 . . . . 0.0 110.798 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -69.8 134.7 48.83 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.815 0.34 . . . . 0.0 110.762 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.58 ' HA ' HG21 ' A' ' 16' ' ' VAL . 6.6 tt0 -62.86 137.45 58.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.125 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.7 mmmt -99.66 157.12 16.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.824 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.63 106.27 11.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.302 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 113.82 -123.87 6.28 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.507 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -66.52 169.4 14.3 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.354 2.036 . . . . 0.0 112.153 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.1 p 43.85 23.99 0.06 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.775 ' O ' HD12 ' A' ' 45' ' ' LEU . . . -87.26 -26.36 23.5 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.916 -0.314 . . . . 0.0 110.447 178.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.94 HG13 ' HB3' ' A' ' 57' ' ' LYS . 28.3 t -50.32 -25.77 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.091 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -61.62 -11.33 11.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.712 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -120.13 8.43 10.95 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.015 0.436 . . . . 0.0 109.978 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.775 HD12 ' O ' ' A' ' 41' ' ' ALA . 1.5 mp -116.98 139.77 50.27 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.828 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.468 ' O ' ' HA ' ' A' ' 5' ' ' PHE . 23.9 m95 -134.38 168.04 19.65 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.027 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.526 ' CE1' ' HB2' ' A' ' 55' ' ' ARG . 26.5 p90 -140.11 164.2 30.69 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.101 178.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -106.45 133.74 50.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.859 0.361 . . . . 0.0 111.327 -179.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -77.69 166.03 23.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.063 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.28 -24.08 62.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.112 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -94.74 -3.23 49.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.42 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.555 ' O ' HG22 ' A' ' 85' ' ' ILE . . . 98.99 7.82 54.76 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.826 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.545 HG13 ' HA ' ' A' ' 83' ' ' ALA . 21.2 t -92.76 118.48 38.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.76 0.28 . . . . 0.0 110.549 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.523 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -76.11 146.98 8.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.294 0.568 . . . . 0.0 111.863 -179.786 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.792 ' CD ' ' HB2' ' A' ' 62' ' ' ALA . 7.7 mmm-85 -150.21 135.27 17.81 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.629 179.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 15.0 m -55.6 143.75 28.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.369 0.604 . . . . 0.0 112.012 -179.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.94 ' HB3' HG13 ' A' ' 42' ' ' VAL . 4.6 tttt -54.15 -25.45 22.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.052 -179.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.817 HD22 ' HG2' ' A' ' 22' ' ' GLN . 1.9 pp -56.58 -48.52 77.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.763 0.316 . . . . 0.0 111.351 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.538 ' N ' HD12 ' A' ' 58' ' ' LEU . 0.8 OUTLIER -172.12 -179.74 2.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.9 -179.941 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.83 84.77 0.48 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.944 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -145.91 125.17 12.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.787 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.792 ' HB2' ' CD ' ' A' ' 55' ' ' ARG . . . -113.07 154.12 27.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.352 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.893 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -79.77 153.09 4.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.725 179.776 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.599 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 6.3 p-10 -132.33 132.8 43.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.126 0.489 . . . . 0.0 111.609 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.73 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -97.75 39.86 1.19 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.317 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.42 -43.52 60.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.252 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -96.29 172.08 8.18 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.018 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -47.73 -48.72 29.57 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.042 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.83 147.64 26.26 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.666 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.893 HG22 HG22 ' A' ' 63' ' ' ILE . 1.6 mm -78.62 144.01 11.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-O 121.649 0.738 . . . . 0.0 111.992 -179.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.73 166.07 25.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.799 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 1.066 HG21 HD13 ' A' ' 19' ' ' ILE . 73.9 p -102.33 138.95 38.57 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.051 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.48 159.94 20.38 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.392 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.421 ' CD ' ' HB3' ' A' ' 26' ' ' PRO . 52.2 Cg_exo -52.54 136.59 57.32 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.441 2.094 . . . . 0.0 111.887 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.478 ' CD2' HG11 ' A' ' 53' ' ' VAL . 17.4 t80 -57.09 132.19 52.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.223 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -121.75 134.46 24.64 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.608 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.3 -34.93 15.02 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.424 2.083 . . . . 0.0 112.608 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -87.4 -0.77 57.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.55 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -108.96 100.18 38.74 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-O 120.622 0.248 . . . . 0.0 111.021 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.826 ' O ' HD21 ' A' ' 94' ' ' LEU . 4.0 Cg_exo -76.73 25.14 0.45 Allowed 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.988 2.459 . . . . 0.0 113.02 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.707 ' HD2' ' HB3' ' A' ' 65' ' ' ALA . 42.7 mmtt -119.72 -21.06 7.41 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 120.635 0.255 . . . . 0.0 110.893 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.521 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 3.6 mtm180 -87.01 17.91 3.88 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.24 -179.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 1.102 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -127.25 99.29 5.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.166 0.508 . . . . 0.0 110.764 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.73 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 62.1 m95 -109.27 136.27 49.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.105 0.479 . . . . 0.0 111.77 -178.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.555 HG22 ' O ' ' A' ' 52' ' ' GLY . 2.6 pp -115.73 154.6 17.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.139 179.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.8 t -102.03 130.0 52.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.932 0.396 . . . . 0.0 111.184 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 36.7 t -122.61 95.18 4.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.447 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.45 -100.71 0.83 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.545 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.499 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.97 29.67 7.25 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.509 0.195 . . . . 0.0 110.789 -179.731 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.424 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.72 147.63 30.13 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -178.49 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.501 ' HB ' HD12 ' A' ' 101' ' ' LEU . 27.5 mm -94.03 120.47 43.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.421 178.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.95 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -124.27 146.11 48.97 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -178.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.437 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.1 OUTLIER -65.42 150.06 48.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.673 179.894 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.102 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.7 pt? -62.81 -57.22 11.63 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.721 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.585 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 1.5 m -79.8 -2.06 41.64 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -178.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.526 ' O ' HG22 ' A' ' 99' ' ' ILE . 1.5 m-20 -137.48 85.54 2.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.842 0.353 . . . . 0.0 110.809 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 16.4 mmt85 -69.48 -16.68 63.51 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.158 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -90.35 11.29 21.87 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.138 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.526 HG22 ' O ' ' A' ' 96' ' ' ASP . 5.6 tt -130.21 136.42 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.95 HG12 ' HB2' ' A' ' 92' ' ' ALA . 19.8 m -148.57 137.36 15.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.455 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.509 ' HA ' ' O ' ' A' ' 115' ' ' CYS . 25.8 mt -45.31 153.99 0.19 Allowed 'General case' 0 CA--C 1.51 -0.596 0 CA-C-O 121.713 0.768 . . . . 0.0 111.622 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.825 ' O ' HG22 ' A' ' 114' ' ' ILE . 27.4 t70 -157.49 167.72 29.38 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.964 -177.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.633 HD12 HG21 ' A' ' 32' ' ' THR . 33.1 mm -86.46 123.34 39.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.232 179.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.82 HG22 ' O ' ' A' ' 113' ' ' HIS . 0.8 OUTLIER -68.26 139.3 20.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.1 0.476 . . . . 0.0 111.65 -179.549 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.12 18.36 3.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.815 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.405 ' HA ' HD21 ' A' ' 12' ' ' LEU . 13.4 m 45.1 -132.87 0.84 Allowed 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.918 -0.128 . . . . 0.0 111.041 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 65.45 162.9 0.15 Allowed 'General case' 0 CA--C 1.526 0.037 0 CA-C-O 120.772 0.32 . . . . 0.0 111.025 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -90.04 -12.4 38.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.448 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -44.81 132.54 6.56 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.391 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -89.22 164.74 14.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.245 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 71.61 19.01 77.61 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.048 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -86.18 138.34 31.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.841 0.353 . . . . 0.0 110.915 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.82 ' O ' HG22 ' A' ' 104' ' ' ILE . 34.7 m80 -62.12 170.52 2.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.749 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.825 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.6 OUTLIER -143.94 161.84 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.928 -179.497 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.673 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 6.0 p -156.65 173.49 16.86 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.673 ' HB2' ' HH2' ' A' ' 84' ' ' TRP . . . -95.99 128.71 43.13 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 178.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.451 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 75.0 t-105 -134.81 162.68 31.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.494 0.664 . . . . 0.0 112.059 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.451 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.3 OUTLIER -62.33 122.99 17.05 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.787 179.929 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -56.99 124.1 17.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.054 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -128.78 5.57 5.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.394 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 81.69 6.86 88.75 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.88 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -65.98 148.93 51.32 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.528 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.03 -27.01 57.91 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.564 2.176 . . . . 0.0 112.382 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.722 ' CB ' HD22 ' A' ' 12' ' ' LEU . 42.5 p-10 -66.95 -12.26 59.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.561 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.425 ' HG2' ' HB2' ' A' ' 102' ' ' ASP . 6.0 mt-30 -103.5 17.57 23.79 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.338 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.421 ' O ' ' HB3' ' A' ' 11' ' ' GLU . 12.3 mmtp -106.43 136.28 46.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.856 0.36 . . . . 0.0 111.568 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.432 ' O ' ' HB2' ' A' ' 89' ' ' ASN . 3.0 m-85 -141.13 155.28 46.13 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.909 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.506 HD12 ' HE2' ' A' ' 9' ' ' LYS . 1.5 mt -110.65 139.68 33.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.146 0.498 . . . . 0.0 110.651 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.434 HD12 HG23 ' A' ' 8' ' ' ILE . 21.9 mm -112.98 139.69 36.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.648 -179.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -138.08 94.46 2.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.618 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.5 t -52.13 113.16 0.94 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.341 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.471 ' HB3' ' CE2' ' A' ' 5' ' ' PHE . 2.2 tm-20 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.272 -0.871 . . . . 0.0 110.932 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.827 0.346 . . . . 0.0 111.203 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.7 mttp -128.67 89.44 49.24 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.849 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.02 60.35 3.75 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.595 2.197 . . . . 0.0 112.381 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -92.9 122.94 35.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.886 179.982 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -98.76 175.05 6.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.665 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.613 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -152.46 170.22 20.66 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 120.952 0.406 . . . . 0.0 111.14 179.303 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.458 ' O ' ' HA ' ' A' ' 129' ' ' ILE . 0.1 OUTLIER -108.62 123.74 49.42 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.932 178.942 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.629 ' HB ' HD21 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -107.72 106.12 20.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.341 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.434 ' HD3' HG13 ' A' ' 16' ' ' VAL . 1.3 tptp -104.92 134.63 47.71 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 54.2 m -75.82 107.13 7.79 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.45 ' HB3' ' HB2' ' A' ' 126' ' ' LYS . 4.3 tt0 -63.14 -10.49 15.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.61 -178.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 51.1 tp -81.84 -62.96 1.49 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.97 0.414 . . . . 0.0 110.869 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.463 HD21 HG21 ' A' ' 103' ' ' ILE . 6.5 m-20 -86.31 -7.46 58.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.244 -178.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.48 6.54 62.38 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.05 -1.071 . . . . 0.0 111.459 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.6 mmmm -94.94 -176.22 3.78 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.576 HG21 ' HA ' ' A' ' 35' ' ' GLN . 3.6 m -122.52 142.2 39.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.629 HD21 ' HB ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -72.56 138.23 46.74 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.174 179.52 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 19' ' ' ILE . 31.5 t0 -146.01 142.38 28.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.78 0.324 . . . . 0.0 111.033 -178.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.763 HD12 HG21 ' A' ' 72' ' ' THR . 7.9 mm -69.06 141.94 16.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.319 -0.4 . . . . 0.0 109.925 179.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -52.67 105.9 0.14 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.951 0.405 . . . . 0.0 111.468 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 53.46 31.77 44.27 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.993 -0.623 . . . . 0.0 113.01 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 43.91 30.5 0.41 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.728 0.299 . . . . 0.0 111.591 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -58.77 108.46 1.33 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.676 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -78.52 36.61 0.6 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.858 2.372 . . . . 0.0 112.928 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -124.72 150.04 64.24 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.655 0.264 . . . . 0.0 110.877 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.4 ' HG3' ' HD3' ' A' ' 74' ' ' PRO . 23.1 Cg_exo -63.22 130.91 30.22 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.513 2.142 . . . . 0.0 112.026 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.72 1.49 32.39 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.442 -0.885 . . . . 0.0 113.066 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.5 m -72.55 138.61 47.01 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 117.085 0.443 . . . . 0.0 110.69 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.48 157.44 19.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.784 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.657 HD11 ' HB ' ' A' ' 70' ' ' ILE . 42.1 pt -115.74 145.9 20.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.377 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.435 ' HA ' ' CD1' ' A' ' 114' ' ' ILE . 0.3 OUTLIER -153.46 177.71 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.156 -179.741 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.8 p -102.03 148.89 24.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.759 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 41.0 t-105 -157.45 172.08 19.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.713 0.292 . . . . 0.0 110.826 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.65 134.21 48.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.732 0.301 . . . . 0.0 110.734 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.576 ' HA ' HG21 ' A' ' 16' ' ' VAL . 8.0 tt0 -56.88 127.7 33.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.055 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.87 162.47 13.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.868 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.18 101.87 7.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.878 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 166.84 158.78 11.6 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.461 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.49 -28.54 36.43 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.644 2.229 . . . . 0.0 112.348 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.8 t -90.12 28.86 1.31 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.476 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.547 ' O ' HD12 ' A' ' 45' ' ' LEU . . . -101.94 2.73 38.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.168 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.697 HG12 ' HB3' ' A' ' 57' ' ' LYS . 2.5 t -60.27 -17.29 14.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.761 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 29.7 p30 -60.36 -13.51 13.55 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.047 178.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -111.38 7.36 20.87 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.613 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 1.8 mp -120.09 147.63 44.61 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.469 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.634 ' CZ2' HD11 ' A' ' 19' ' ' ILE . 25.4 m95 -133.34 169.57 16.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.818 -179.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.505 ' CE2' ' HB2' ' A' ' 55' ' ' ARG . 1.5 p90 -136.14 159.19 42.47 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.007 178.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.509 HG22 ' CG2' ' A' ' 54' ' ' ILE . 40.0 p -106.22 132.88 51.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.763 0.316 . . . . 0.0 111.256 -179.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -77.67 165.36 24.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.108 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -60.94 -24.07 65.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.017 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -93.17 -3.35 54.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.44 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.95 8.75 53.69 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.883 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.555 HG11 ' CD2' ' A' ' 75' ' ' PHE . 33.8 t -95.5 119.74 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 116.946 0.373 . . . . 0.0 110.638 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.509 ' CG2' HG22 ' A' ' 48' ' ' THR . 0.8 OUTLIER -79.35 151.9 4.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.246 0.546 . . . . 0.0 111.863 -179.826 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.557 ' CD ' ' HB2' ' A' ' 62' ' ' ALA . 8.6 mmm-85 -148.11 133.3 18.36 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.289 179.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.598 ' HB3' HD22 ' A' ' 58' ' ' LEU . 0.1 OUTLIER -69.58 -176.77 1.07 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.323 0.582 . . . . 0.0 111.968 -178.708 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.697 ' HB3' HG12 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -46.09 -23.54 0.33 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.714 -179.876 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.599 ' H ' HD22 ' A' ' 58' ' ' LEU . 1.5 mm? -49.08 -21.65 0.76 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.728 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.493 ' CB ' ' O ' ' A' ' 58' ' ' LEU . 10.9 t30 89.53 -25.64 0.07 Allowed 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 179.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -164.93 58.2 0.13 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.934 0.397 . . . . 0.0 111.419 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.475 ' HB2' ' HB2' ' A' ' 58' ' ' LEU . 2.2 m-85 -143.39 113.36 7.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.121 0.486 . . . . 0.0 110.7 179.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.557 ' HB2' ' CD ' ' A' ' 55' ' ' ARG . . . -98.87 152.22 19.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.118 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.898 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -77.9 149.91 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.349 179.523 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.649 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 3.7 p-10 -131.51 133.16 44.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.133 0.492 . . . . 0.0 111.79 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.643 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -99.36 42.41 1.1 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.369 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 66.4 p -74.34 -44.53 52.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.15 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -96.72 172.53 7.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.963 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -48.86 -44.19 39.49 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.056 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.68 145.43 29.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.986 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.898 HG22 HG22 ' A' ' 63' ' ' ILE . 2.8 mm -75.77 141.8 15.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-O 121.555 0.693 . . . . 0.0 111.358 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -136.96 168.76 18.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.001 -0.999 . . . . 0.0 111.432 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.763 HG21 HD12 ' A' ' 19' ' ' ILE . 23.2 p -108.54 135.79 49.23 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.213 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.419 ' HA ' ' CE2' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -165.54 171.9 4.77 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.429 -179.725 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.415 ' HD3' ' CE2' ' A' ' 61' ' ' PHE . 75.6 Cg_exo -49.09 139.83 25.87 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.506 2.137 . . . . 0.0 111.957 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.555 ' CD2' HG11 ' A' ' 53' ' ' VAL . 48.4 t80 -47.74 -59.58 3.19 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -179.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.403 ' HB2' ' HD3' ' A' ' 82' ' ' ARG . 0.3 OUTLIER 63.56 118.83 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 -179.166 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.47 -28.65 21.6 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.527 2.151 . . . . 0.0 113.445 -179.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -87.25 0.58 55.15 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.45 ' CB ' ' HD2' ' A' ' 82' ' ' ARG . 1.9 m120 -104.42 101.97 30.68 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 120.63 0.253 . . . . 0.0 111.328 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.862 ' O ' HD21 ' A' ' 94' ' ' LEU . 94.8 Cg_endo -77.58 18.6 0.81 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.733 2.288 . . . . 0.0 113.319 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.649 ' O ' ' HA ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -118.97 -19.84 8.35 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 120.716 0.293 . . . . 0.0 110.905 179.818 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.509 ' CG ' ' HB3' ' A' ' 64' ' ' ASP . 36.5 mtt180 -91.01 25.62 2.38 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.227 -178.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 1.054 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -136.96 99.48 4.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.94 0.4 . . . . 0.0 110.898 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.672 ' HH2' ' HB2' ' A' ' 116' ' ' ALA . 38.6 m95 -109.58 139.13 44.97 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.246 0.546 . . . . 0.0 111.78 -178.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 pp -112.7 155.92 13.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.287 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.6 t -102.64 128.15 55.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.962 0.41 . . . . 0.0 111.246 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.9 t -120.92 94.6 4.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.209 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.41 -100.98 0.85 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.34 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.5 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.76 29.84 7.2 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.579 0.228 . . . . 0.0 110.843 -179.81 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.425 ' CG2' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -147.44 147.51 30.29 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.383 0.611 . . . . 0.0 112.64 -178.595 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.718 ' HB ' HD12 ' A' ' 101' ' ' LEU . 20.1 mm -94.02 120.29 43.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.292 178.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.9 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -122.2 144.11 49.16 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.441 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -64.82 148.14 51.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.435 179.566 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.054 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.5 pt? -62.79 -57.49 10.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.8 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.548 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 3.5 t -75.81 -3.91 37.69 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.477 ' O ' HG22 ' A' ' 99' ' ' ILE . 19.0 t0 -141.14 89.63 2.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.841 0.353 . . . . 0.0 110.891 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 8.8 mmt85 -70.79 -16.02 62.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.232 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -88.93 10.87 19.79 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.253 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.477 HG22 ' O ' ' A' ' 96' ' ' ASP . 5.3 tt -131.05 137.54 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.9 HG12 ' HB2' ' A' ' 92' ' ' ALA . 17.5 m -148.39 138.59 16.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.774 0.321 . . . . 0.0 111.536 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.718 HD12 ' HB ' ' A' ' 91' ' ' ILE . 10.9 mt -46.32 153.87 0.31 Allowed 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.634 0.731 . . . . 0.0 111.581 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.735 ' O ' HG22 ' A' ' 114' ' ' ILE . 9.8 t70 -158.85 168.08 27.75 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.46 -1.245 . . . . 0.0 110.669 -177.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.558 HD12 ' O ' ' A' ' 124' ' ' ASN . 4.6 mp -87.34 120.69 37.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.139 179.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.765 HD11 ' HB2' ' A' ' 115' ' ' CYS . 40.2 mm -70.03 136.39 26.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.883 0.373 . . . . 0.0 111.253 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 8.4 tttt 78.92 -6.1 1.94 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.764 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.1 m 46.45 29.7 0.94 Allowed 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 120.809 0.338 . . . . 0.0 111.27 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.39 155.01 17.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.039 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.1 -13.74 59.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.097 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -48.78 123.14 6.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.229 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.4 157.86 30.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.037 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.24 12.55 81.76 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.146 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.51 131.52 41.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.873 0.368 . . . . 0.0 111.052 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -64.87 172.44 2.84 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.111 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.735 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -136.71 161.67 36.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.349 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.765 ' HB2' HD11 ' A' ' 104' ' ' ILE . 6.3 t -153.38 167.47 29.29 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.672 ' HB2' ' HH2' ' A' ' 84' ' ' TRP . . . -94.75 125.24 39.28 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 177.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.459 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 76.1 t-105 -133.56 162.38 32.07 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.629 0.728 . . . . 0.0 112.291 -179.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.459 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.0 OUTLIER -61.79 119.82 9.49 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.621 179.836 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -59.74 126.05 26.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.1 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.405 ' CE1' ' HA3' ' A' ' 122' ' ' GLY . 20.0 p80 -134.11 10.7 3.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.21 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 81.15 7.88 87.96 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.981 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.405 ' HA3' ' CE1' ' A' ' 120' ' ' HIS . . . -62.48 150.09 47.74 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.603 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.37 -27.02 55.29 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.561 2.174 . . . . 0.0 112.182 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.558 ' O ' HD12 ' A' ' 103' ' ' ILE . 32.1 p-10 -75.45 -4.42 39.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.425 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.425 ' O ' ' CG2' ' A' ' 90' ' ' THR . 0.0 OUTLIER -105.82 12.95 30.22 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.29 -179.741 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.45 ' HB2' ' HB3' ' A' ' 11' ' ' GLU . 5.9 mmtt -106.02 140.3 39.23 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.863 0.364 . . . . 0.0 111.367 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.414 ' CD1' ' O ' ' A' ' 126' ' ' LYS . 8.9 m-85 -138.67 155.27 48.42 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.162 179.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 mt -111.45 137.24 44.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.049 0.452 . . . . 0.0 110.41 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.458 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 36.6 mm -113.47 140.9 31.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.64 -179.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -140.83 106.2 5.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.596 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.61 109.11 0.94 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.044 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 34.5 tp10 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.232 -0.89 . . . . 0.0 111.127 179.888 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 mmt . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 120.795 0.331 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -145.04 117.39 5.33 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.802 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.39 -173.92 0.91 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.389 2.059 . . . . 0.0 112.391 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.58 112.36 23.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.831 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.474 ' HA ' ' O ' ' A' ' 46' ' ' TRP . 2.1 p90 -92.8 174.97 6.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.618 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.742 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -159.92 175.97 12.43 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.596 179.744 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.439 ' CE1' ' HB3' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -114.22 123.88 50.66 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.288 179.206 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.624 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -104.12 109.77 28.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.37 -179.924 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 16' ' ' VAL . 0.1 OUTLIER -105.63 135.42 47.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.464 -178.756 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.8 t -75.27 105.66 6.4 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -62.66 -11.88 19.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.594 -178.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.488 ' HB2' ' HA ' ' A' ' 124' ' ' ASN . 12.3 tp -84.51 -62.49 1.54 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.964 0.412 . . . . 0.0 110.967 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.626 HD21 HG21 ' A' ' 103' ' ' ILE . 12.9 m-20 -83.08 -12.81 56.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.48 -178.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.53 2.9 76.7 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.143 -1.027 . . . . 0.0 111.491 -178.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -91.86 -175.14 4.04 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.74 HG11 ' HG3' ' A' ' 35' ' ' GLN . 5.4 m -121.62 140.22 46.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.656 0.265 . . . . 0.0 110.437 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.5 mt -69.4 134.76 49.41 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -143.61 153.99 43.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.888 0.375 . . . . 0.0 111.196 -178.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.06 HD13 HG21 ' A' ' 72' ' ' THR . 34.0 mt -95.98 137.24 24.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.572 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -34.14 97.85 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -179.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 44.1 39.52 5.29 Favored Glycine 0 C--N 1.332 0.309 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.498 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 46.77 30.72 1.24 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.707 0.289 . . . . 0.0 111.348 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -47.11 102.87 0.33 Allowed Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.147 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.11 -12.21 31.31 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.644 2.229 . . . . 0.0 112.635 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . . . -88.46 145.0 34.61 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.642 0.258 . . . . 0.0 111.121 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.418 ' HB3' ' CD ' ' A' ' 74' ' ' PRO . 29.3 Cg_exo -61.55 142.67 95.6 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.599 2.2 . . . . 0.0 112.143 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.82 3.44 39.72 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.477 -0.868 . . . . 0.0 113.08 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.75 138.61 48.58 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.946 0.403 . . . . 0.0 111.056 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.3 mptt -89.4 157.71 18.04 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.216 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.721 HD11 ' HB ' ' A' ' 70' ' ' ILE . 38.0 pt -116.34 145.91 21.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.799 0.333 . . . . 0.0 111.743 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.461 ' HA ' ' CD1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -155.32 178.17 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.192 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.537 -179.827 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.6 p -100.68 148.77 24.49 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 121.001 -0.279 . . . . 0.0 110.65 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 24.3 t-105 -157.69 172.57 18.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.706 0.289 . . . . 0.0 110.883 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -69.77 133.93 48.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.852 0.358 . . . . 0.0 110.706 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.74 ' HG3' HG11 ' A' ' 16' ' ' VAL . 6.9 tt0 -56.68 119.51 6.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.112 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.34 164.83 13.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.795 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.0 mtpm? -131.68 116.85 17.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.94 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 149.2 -162.56 29.01 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.585 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -74.84 1.16 7.95 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.026 2.484 . . . . 0.0 112.827 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.09 19.13 18.72 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.661 0.267 . . . . 0.0 111.202 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.956 ' O ' HD12 ' A' ' 45' ' ' LEU . . . -81.89 -20.51 38.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.124 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.996 HG13 ' HB3' ' A' ' 57' ' ' LYS . 45.3 t -49.69 -29.77 4.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.113 179.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -65.69 -10.91 40.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.927 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.439 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 3.5 mt-30 -118.2 7.59 12.14 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.956 HD12 ' O ' ' A' ' 41' ' ' ALA . 1.1 mp -118.82 140.38 50.05 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.981 -179.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.76 ' CZ2' HD11 ' A' ' 19' ' ' ILE . 24.8 m95 -134.12 168.82 18.13 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.92 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.52 ' CZ ' ' HB2' ' A' ' 55' ' ' ARG . 32.0 p90 -140.73 164.93 28.87 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.219 178.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.454 HG22 ' CG2' ' A' ' 54' ' ' ILE . 81.1 p -107.6 134.32 50.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.833 0.349 . . . . 0.0 111.378 -178.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -77.81 170.25 16.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.15 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.17 -23.62 67.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.077 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.3 mm100 -94.04 -3.45 51.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.242 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.95 8.78 53.65 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.917 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.429 HG11 ' CE2' ' A' ' 75' ' ' PHE . 42.2 t -95.14 119.63 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-O 120.83 0.348 . . . . 0.0 110.693 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -76.68 147.85 7.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.341 0.591 . . . . 0.0 111.9 -179.792 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.612 ' CD ' ' HB2' ' A' ' 62' ' ' ALA . 8.2 mmm-85 -149.48 133.69 17.31 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.39 179.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.46 ' HA ' ' HA ' ' A' ' 46' ' ' TRP . 70.0 m -55.07 143.8 25.76 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.463 0.649 . . . . 0.0 111.848 -178.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.996 ' HB3' HG13 ' A' ' 42' ' ' VAL . 12.9 tttt -52.69 -24.07 7.87 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.7 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.742 HD12 ' N ' ' A' ' 59' ' ' ASN . 3.5 pp -56.59 -49.21 75.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.183 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.742 ' N ' HD12 ' A' ' 58' ' ' LEU . 1.8 t-20 -178.12 -176.47 0.54 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.871 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.75 83.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.855 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.416 ' CE2' ' HD3' ' A' ' 74' ' ' PRO . 2.8 m-85 -144.18 119.38 10.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.77 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.612 ' HB2' ' CD ' ' A' ' 55' ' ' ARG . . . -109.26 154.9 21.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.547 -179.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.85 HG22 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -80.37 150.79 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.466 179.587 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.575 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 6.4 p-10 -131.61 132.09 43.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.064 0.459 . . . . 0.0 111.419 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.666 ' HB2' ' HZ2' ' A' ' 84' ' ' TRP . . . -97.51 41.66 1.11 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.192 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.4 t -74.83 -45.54 42.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.158 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 59.6 m80 -94.44 170.76 9.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.982 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -47.83 -48.02 31.0 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.106 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -99.6 143.86 29.35 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.099 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.85 HG22 HG22 ' A' ' 63' ' ' ILE . 3.0 mm -74.2 139.95 18.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 CA-C-O 121.554 0.692 . . . . 0.0 111.478 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -139.88 168.94 18.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.262 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 1.06 HG21 HD13 ' A' ' 19' ' ' ILE . 63.4 p -108.59 139.2 43.7 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.281 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.6 163.02 16.72 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.485 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.418 ' CD ' ' HB3' ' A' ' 26' ' ' PRO . 50.7 Cg_exo -55.08 136.06 71.49 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.474 2.116 . . . . 0.0 111.729 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.429 ' CE2' HG11 ' A' ' 53' ' ' VAL . 32.7 t80 -52.77 134.72 36.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.97 0.414 . . . . 0.0 111.489 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.421 ' HB2' ' CZ ' ' A' ' 82' ' ' ARG . 21.6 t70 -124.21 116.8 27.03 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.477 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -56.98 -33.76 96.18 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.532 2.155 . . . . 0.0 113.045 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 33.5 m-20 -86.89 -0.07 55.86 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -179.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 -112.55 104.07 55.78 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 120.629 0.252 . . . . 0.0 111.114 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.828 ' O ' HD21 ' A' ' 94' ' ' LEU . 84.4 Cg_endo -76.84 27.11 0.43 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.733 2.289 . . . . 0.0 113.105 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.602 ' HD2' ' HB3' ' A' ' 65' ' ' ALA . 40.7 mmtt -120.29 -19.5 7.64 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 116.687 -0.233 . . . . 0.0 111.162 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.543 ' HG2' ' HB3' ' A' ' 64' ' ' ASP . 3.5 mtm180 -88.43 19.71 3.71 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.329 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 1.132 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -130.03 99.38 5.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.075 0.464 . . . . 0.0 110.784 179.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.666 ' HZ2' ' HB2' ' A' ' 65' ' ' ALA . 58.8 m95 -109.05 135.77 49.66 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.146 0.498 . . . . 0.0 111.979 -178.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.796 HD11 ' HD3' ' A' ' 97' ' ' ARG . 1.1 pp -111.82 152.87 13.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.084 179.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.3 t -100.57 126.37 54.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.941 0.4 . . . . 0.0 111.133 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.3 t -119.39 94.85 4.56 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.577 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.81 -100.41 0.76 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.643 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.491 ' O ' ' ND2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -120.51 29.64 7.34 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.518 0.199 . . . . 0.0 110.977 -179.492 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -149.71 149.11 30.09 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.337 0.589 . . . . 0.0 112.493 -178.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.83 ' HB ' HD12 ' A' ' 101' ' ' LEU . 12.3 mm -94.01 120.71 43.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.449 178.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.882 ' HB2' HG12 ' A' ' 100' ' ' VAL . . . -121.38 144.54 48.61 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -178.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.419 ' OE1' ' CZ2' ' A' ' 84' ' ' TRP . 0.0 OUTLIER -66.33 149.02 51.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.929 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.132 HD13 ' HB3' ' A' ' 83' ' ' ALA . 2.6 pt? -64.26 -57.36 9.67 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.018 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.587 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 3.5 m -74.06 -4.12 33.54 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.586 ' O ' HG22 ' A' ' 99' ' ' ILE . 73.2 m-20 -146.73 93.01 2.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.099 0.476 . . . . 0.0 111.035 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.796 ' HD3' HD11 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -73.04 -13.12 61.15 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.587 179.37 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -87.89 12.02 14.23 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.481 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.824 HG12 ' HB1' ' A' ' 116' ' ' ALA . 2.6 tt -135.09 143.25 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.882 HG12 ' HB2' ' A' ' 92' ' ' ALA . 34.9 m -151.66 139.71 14.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.789 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.83 HD12 ' HB ' ' A' ' 91' ' ' ILE . 10.6 mt -46.2 154.31 0.27 Allowed 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 121.722 0.772 . . . . 0.0 111.706 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.733 ' O ' HG22 ' A' ' 114' ' ' ILE . 28.5 t70 -158.3 168.29 27.42 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.629 -177.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.626 HG21 HD21 ' A' ' 13' ' ' ASN . 26.8 mm -89.35 120.97 38.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.389 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.832 HG22 ' O ' ' A' ' 113' ' ' HIS . 7.9 tp -64.72 138.66 22.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.023 0.44 . . . . 0.0 111.457 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 73.54 -3.71 2.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.043 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 45.3 t 44.19 31.26 0.53 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.76 0.314 . . . . 0.0 111.428 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -97.36 158.12 15.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.194 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.99 -13.4 59.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.183 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -49.11 131.93 19.29 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.26 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -77.17 158.86 30.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.017 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 72.3 15.34 76.98 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.145 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.05 132.61 40.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.895 0.378 . . . . 0.0 110.929 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.832 ' O ' HG22 ' A' ' 104' ' ' ILE . 6.2 m80 -64.99 171.53 3.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.934 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.733 HG22 ' O ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -135.45 161.25 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.397 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.586 ' HA ' ' CG1' ' A' ' 70' ' ' ILE . 5.8 t -152.39 167.22 29.41 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.824 ' HB1' HG12 ' A' ' 99' ' ' ILE . . . -94.99 124.73 39.21 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.447 ' CG ' ' N ' ' A' ' 118' ' ' LYS . 77.0 t-105 -133.49 161.4 34.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.619 0.723 . . . . 0.0 112.236 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.447 ' N ' ' CG ' ' A' ' 117' ' ' TRP . 0.0 OUTLIER -61.03 123.0 16.38 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.57 -1.195 . . . . 0.0 110.806 -179.906 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -58.84 125.05 21.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.951 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 13.3 p80 -136.98 6.32 2.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.595 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 78.26 57.1 3.49 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.273 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -112.0 138.73 15.18 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.509 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.67 -31.42 60.32 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.447 2.098 . . . . 0.0 112.18 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.488 ' HA ' ' HB2' ' A' ' 12' ' ' LEU . 10.9 p-10 -72.0 -8.0 52.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.575 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -101.9 -14.31 17.28 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.57 0.211 . . . . 0.0 111.57 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.428 ' O ' ' CD1' ' A' ' 127' ' ' PHE . 2.3 mmtt -78.27 136.73 37.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.811 0.339 . . . . 0.0 111.373 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.428 ' CD1' ' O ' ' A' ' 126' ' ' LYS . 6.8 m-85 -139.15 156.22 47.28 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.136 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 mt -112.33 137.77 43.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.176 0.513 . . . . 0.0 110.592 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.569 HD12 HG23 ' A' ' 8' ' ' ILE . 19.5 mm -114.36 138.7 43.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.527 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -134.52 94.29 3.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.54 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.15 108.06 0.48 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.134 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.295 -0.86 . . . . 0.0 111.358 179.726 . . . . . . . . 0 0 . 1 stop_ save_